Citrus Sinensis ID: 027015
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 229 | 2.2.26 [Sep-21-2011] | |||||||
| P85193 | 242 | Putative serine/threonine | N/A | no | 0.759 | 0.719 | 0.640 | 1e-65 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.899 | 0.216 | 0.509 | 2e-57 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.868 | 0.195 | 0.522 | 4e-57 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.886 | 0.196 | 0.512 | 3e-56 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.890 | 0.197 | 0.514 | 3e-56 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.860 | 0.190 | 0.527 | 5e-56 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.860 | 0.189 | 0.527 | 8e-56 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.812 | 0.183 | 0.534 | 8e-55 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.882 | 0.427 | 0.5 | 2e-53 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.812 | 0.182 | 0.537 | 7e-53 |
| >sp|P85193|PK01_HELAN Putative serine/threonine-protein kinase (Fragment) OS=Helianthus annuus PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 249 bits (636), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 114/178 (64%), Positives = 144/178 (80%), Gaps = 4/178 (2%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
RL DGT+VA+KVLSVE S +GE+EF+SE+A++++ HENLV LHG C++ R LVY
Sbjct: 67 RLTDGTMVAIKVLSVELESMRGEREFISEIAALSDAQ--HENLVNLHGCCVEEATRCLVY 124
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
DYM NNSL+ LG E+ R F W R+ +++G+ + LAY+HEEI PH+VHRDIK SN+L
Sbjct: 125 DYMENNSLAYQFLGREQNRNSFDWTKRKNVLLGVAKALAYLHEEINPHIVHRDIKASNVL 184
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
LD NFNPK++DFGL++LF E T+HISTRVAGTLGYL+PEYA+S RLTRKSDVYSFGVL
Sbjct: 185 LDHNFNPKVADFGLARLFQEGTSHISTRVAGTLGYLSPEYAVSERLTRKSDVYSFGVL 242
|
Helianthus annuus (taxid: 4232) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 106/208 (50%), Positives = 153/208 (73%), Gaps = 2/208 (0%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+L DGTI+AVK LS SKQG +EF++E+ ++ ++ H NLVKL+G C++G +LVY++
Sbjct: 642 KLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALH--HPNLVKLYGCCVEGGQLLLVYEF 699
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+ NNSL++ L G ++ + + W RR+I +G+ RGLAY+HEE + +VHRDIK +N+LLD
Sbjct: 700 VENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLD 759
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+ NPKISDFGL+KL E++THISTR+AGT GY+APEYA+ G LT K+DVYSFG++ LEI
Sbjct: 760 KQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEI 819
Query: 199 VSGRTAVDFDVQLGEYHLVDKVRSINMK 226
V GR+ + ++L+D V + K
Sbjct: 820 VHGRSNKIERSKNNTFYLIDWVEVLREK 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 4e-57, Method: Compositional matrix adjust.
Identities = 105/201 (52%), Positives = 148/201 (73%), Gaps = 2/201 (0%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
+ DGT++AVK LS +SKQG +EF++E+A ++ + H +LVKL+G C++G +LVY+Y+
Sbjct: 691 MTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQ--HPHLVKLYGCCVEGDQLLLVYEYL 748
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
NNSL++ L G ++ + W R++I +GI RGLAY+HEE + +VHRDIK +N+LLD+
Sbjct: 749 ENNSLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 808
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
NPKISDFGL+KL E THISTRVAGT GY+APEYA+ G LT K+DVYSFGV+ LEIV
Sbjct: 809 ELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIV 868
Query: 200 SGRTAVDFDVQLGEYHLVDKV 220
G++ + ++L+D V
Sbjct: 869 HGKSNTSSRSKADTFYLLDWV 889
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 3e-56, Method: Compositional matrix adjust.
Identities = 106/207 (51%), Positives = 150/207 (72%), Gaps = 4/207 (1%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DG +VAVK+LSV S+QG+ +F++E+ ++++V H NLVKL+G C +G R+LVY+Y+
Sbjct: 713 LNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSV--LHRNLVKLYGCCFEGEHRMLVYEYL 770
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
PN SL Q L G+ + W R EI +G+ RGL Y+HEE +VHRD+K SNILLD
Sbjct: 771 PNGSLDQALFGD--KTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDS 828
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
P+ISDFGL+KL+ + THISTRVAGT+GYLAPEYA+ G LT K+DVY+FGV+ LE+V
Sbjct: 829 RLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELV 888
Query: 200 SGRTAVDFDVQLGEYHLVDKVRSINMK 226
SGR D +++ + +L++ +++ K
Sbjct: 889 SGRPNSDENLEEEKKYLLEWAWNLHEK 915
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 3e-56, Method: Compositional matrix adjust.
Identities = 107/208 (51%), Positives = 150/208 (72%), Gaps = 4/208 (1%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+L DG VAVK+LSV S+QG+ +F++E+ +++ V H NLVKL+G C +G R+LVY+Y
Sbjct: 711 KLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQ--HRNLVKLYGCCYEGEHRLLVYEY 768
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+PN SL Q L GE + W R EI +G+ RGL Y+HEE + +VHRD+K SNILLD
Sbjct: 769 LPNGSLDQALFGE--KTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLD 826
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
PK+SDFGL+KL+ + THISTRVAGT+GYLAPEYA+ G LT K+DVY+FGV+ LE+
Sbjct: 827 SKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALEL 886
Query: 199 VSGRTAVDFDVQLGEYHLVDKVRSINMK 226
VSGR D +++ + +L++ +++ K
Sbjct: 887 VSGRPNSDENLEDEKRYLLEWAWNLHEK 914
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 5e-56, Method: Compositional matrix adjust.
Identities = 105/199 (52%), Positives = 146/199 (73%), Gaps = 2/199 (1%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DG +AVK LS +SKQG +EF++E+ ++ + H NLVKL+G CI+G +LVY+Y+
Sbjct: 686 LADGMTIAVKQLSSKSKQGNREFVTEIGMISALQ--HPNLVKLYGCCIEGKELLLVYEYL 743
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
NNSL++ L G EK+R W R ++ +GI +GLAY+HEE + +VHRDIK +N+LLD
Sbjct: 744 ENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDL 803
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
+ N KISDFGL+KL E THISTR+AGT+GY+APEYA+ G LT K+DVYSFGV+ LEIV
Sbjct: 804 SLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIV 863
Query: 200 SGRTAVDFDVQLGEYHLVD 218
SG++ ++ + +L+D
Sbjct: 864 SGKSNTNYRPKEEFIYLLD 882
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (551), Expect = 8e-56, Method: Compositional matrix adjust.
Identities = 105/199 (52%), Positives = 146/199 (73%), Gaps = 2/199 (1%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DG +AVK LS +SKQG +EF++E+ ++ + H NLVKL+G CI+G +LVY+Y+
Sbjct: 688 LADGMTIAVKQLSSKSKQGNREFVTEIGMISALQ--HPNLVKLYGCCIEGKELLLVYEYL 745
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
NNSL++ L G EK+R W R +I +GI +GLAY+HEE + +VHRDIK +N+LLD
Sbjct: 746 ENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDL 805
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
+ N KISDFGL+KL + THISTR+AGT+GY+APEYA+ G LT K+DVYSFGV+ LEIV
Sbjct: 806 SLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIV 865
Query: 200 SGRTAVDFDVQLGEYHLVD 218
SG++ ++ + +L+D
Sbjct: 866 SGKSNTNYRPKEEFVYLLD 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 8e-55, Method: Compositional matrix adjust.
Identities = 101/189 (53%), Positives = 142/189 (75%), Gaps = 3/189 (1%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L +G ++AVK LS +S+QG +EF++E+ ++ + H NLVKL+G C++G ILVY+Y+
Sbjct: 697 LSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQ--HPNLVKLYGCCVEGNQLILVYEYL 754
Query: 80 PNNSLSQTLLG-EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
NN LS+ L G +E R K W R++I +GI +GL ++HEE + +VHRDIK SN+LLD
Sbjct: 755 ENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLD 814
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
++ N KISDFGL+KL + THISTR+AGT+GY+APEYA+ G LT K+DVYSFGV+ LEI
Sbjct: 815 KDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVALEI 874
Query: 199 VSGRTAVDF 207
VSG++ +F
Sbjct: 875 VSGKSNTNF 883
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 208 bits (530), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 102/204 (50%), Positives = 143/204 (70%), Gaps = 2/204 (0%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DGT VAVK L Q EKEF EV + V H+NLV+L G C++G R+LVYD++
Sbjct: 173 LTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAYRMLVYDFV 230
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N +L Q + G+ + W R II+G+ +GLAY+HE ++P VVHRDIK+SNILLD+
Sbjct: 231 DNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDR 290
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
+N K+SDFGL+KL +++++TRV GT GY+APEYA +G L KSD+YSFG+L++EI+
Sbjct: 291 QWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEII 350
Query: 200 SGRTAVDFDVQLGEYHLVDKVRSI 223
+GR VD+ GE +LVD ++S+
Sbjct: 351 TGRNPVDYSRPQGETNLVDWLKSM 374
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (526), Expect = 7e-53, Method: Compositional matrix adjust.
Identities = 101/188 (53%), Positives = 136/188 (72%), Gaps = 2/188 (1%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DG +VAVK LS +S+QG +EF++E+ +++ + H NLVKLHG C++ +L Y+YM
Sbjct: 700 LADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQ--HPNLVKLHGFCVERAQLLLAYEYM 757
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
NNSLS L + ++ W R +I GI +GLA++HEE VHRDIK +NILLD+
Sbjct: 758 ENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIKATNILLDK 817
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
+ PKISDFGL++L E THIST+VAGT+GY+APEYA+ G LT K+DVYSFGVL+LEIV
Sbjct: 818 DLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVLEIV 877
Query: 200 SGRTAVDF 207
+G T +F
Sbjct: 878 AGITNSNF 885
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 229 | ||||||
| 224113013 | 345 | predicted protein [Populus trichocarpa] | 0.868 | 0.576 | 0.771 | 4e-88 | |
| 296086032 | 288 | unnamed protein product [Vitis vinifera] | 0.873 | 0.694 | 0.787 | 1e-87 | |
| 225449074 | 449 | PREDICTED: probable LRR receptor-like se | 0.868 | 0.443 | 0.786 | 2e-87 | |
| 224097961 | 340 | predicted protein [Populus trichocarpa] | 0.868 | 0.585 | 0.751 | 2e-85 | |
| 255577375 | 392 | ATP binding protein, putative [Ricinus c | 0.864 | 0.505 | 0.745 | 5e-84 | |
| 255557018 | 378 | ATP binding protein, putative [Ricinus c | 0.868 | 0.526 | 0.684 | 6e-79 | |
| 297741595 | 433 | unnamed protein product [Vitis vinifera] | 0.873 | 0.461 | 0.671 | 9e-77 | |
| 225439972 | 399 | PREDICTED: putative serine/threonine-pro | 0.873 | 0.501 | 0.671 | 1e-76 | |
| 449450984 | 364 | PREDICTED: putative serine/threonine-pro | 0.868 | 0.546 | 0.640 | 4e-71 | |
| 414877990 | 494 | TPA: putative protein kinase superfamily | 0.886 | 0.410 | 0.604 | 3e-68 |
| >gi|224113013|ref|XP_002316361.1| predicted protein [Populus trichocarpa] gi|222865401|gb|EEF02532.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 330 bits (845), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 155/201 (77%), Positives = 179/201 (89%), Gaps = 2/201 (0%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
LQDG IVA+K+LS ESKQG +EFMSE+AS++N+N HENLV LHGGCIDGPC+ILVYDYM
Sbjct: 46 LQDGRIVAIKMLSAESKQGHREFMSEIASVSNIN--HENLVNLHGGCIDGPCKILVYDYM 103
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N SL+QTLLG E+ RA+FGW+ RR I +GI +GLAYIHEEI+PH+VHRDIK SNILLD+
Sbjct: 104 ENGSLAQTLLGGEENRARFGWETRRGISLGIAQGLAYIHEEIKPHIVHRDIKASNILLDK 163
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
N PK+SDFGLSKLFPEN TH+STRVAGTLGYLAPEYAISGRLTRK+DVYSFGVLLLEIV
Sbjct: 164 NLCPKVSDFGLSKLFPENFTHVSTRVAGTLGYLAPEYAISGRLTRKTDVYSFGVLLLEIV 223
Query: 200 SGRTAVDFDVQLGEYHLVDKV 220
SGR A DFD +LGE++LV+K
Sbjct: 224 SGRKATDFDPELGEHYLVEKA 244
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296086032|emb|CBI31473.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 328 bits (840), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 159/202 (78%), Positives = 178/202 (88%), Gaps = 2/202 (0%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
RLQDGT+VAVKVLS ESKQG++EFMSE+AS++N+N HENLVKLHGGC+ G R+LVYDY
Sbjct: 70 RLQDGTVVAVKVLSAESKQGDREFMSEMASISNIN--HENLVKLHGGCVHGARRMLVYDY 127
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M NNSLS TLL EKRRAKF WK RREI +GI RGLAYIHE+I PHVVHRDIK SNILLD
Sbjct: 128 MQNNSLSHTLLRGEKRRAKFSWKTRREICLGIARGLAYIHEDITPHVVHRDIKASNILLD 187
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+F PKISDFGLSKLF N THI+TRVAGTLGYLAPEYA+SG LTRKSDVYSFGVL+LEI
Sbjct: 188 GDFTPKISDFGLSKLFYTNITHITTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLILEI 247
Query: 199 VSGRTAVDFDVQLGEYHLVDKV 220
VSGRTA+DFD+ LGE++LV KV
Sbjct: 248 VSGRTAIDFDLDLGEHYLVQKV 269
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225449074|ref|XP_002274408.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 327 bits (838), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 158/201 (78%), Positives = 177/201 (88%), Gaps = 2/201 (0%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
RLQDGT+VAVKVLS ESKQG++EFMSE+AS++N+N HENLVKLHGGC+ G R+LVYDY
Sbjct: 149 RLQDGTVVAVKVLSAESKQGDREFMSEMASISNIN--HENLVKLHGGCVHGARRMLVYDY 206
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M NNSLS TLL EKRRAKF WK RREI +GI RGLAYIHE+I PHVVHRDIK SNILLD
Sbjct: 207 MQNNSLSHTLLRGEKRRAKFSWKTRREICLGIARGLAYIHEDITPHVVHRDIKASNILLD 266
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+F PKISDFGLSKLF N THI+TRVAGTLGYLAPEYA+SG LTRKSDVYSFGVL+LEI
Sbjct: 267 GDFTPKISDFGLSKLFYTNITHITTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLILEI 326
Query: 199 VSGRTAVDFDVQLGEYHLVDK 219
VSGRTA+DFD+ LGE++LV K
Sbjct: 327 VSGRTAIDFDLDLGEHYLVQK 347
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097961|ref|XP_002311099.1| predicted protein [Populus trichocarpa] gi|222850919|gb|EEE88466.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 321 bits (822), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 151/201 (75%), Positives = 179/201 (89%), Gaps = 2/201 (0%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
LQDG +VAVK+LS SKQG++EF+SE+AS++N+N HENLVKLHGGCIDGP +ILVYDYM
Sbjct: 41 LQDGRMVAVKMLSAGSKQGDREFISEIASVSNIN--HENLVKLHGGCIDGPYKILVYDYM 98
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N SL+QTLLG E++RAKF W+ RREI +GI +GLAYIHEEI+P +VHRDIK SNILLDQ
Sbjct: 99 ENGSLAQTLLGSEEKRAKFRWETRREISLGIAQGLAYIHEEIKPRIVHRDIKASNILLDQ 158
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
N PK+SDFGLSKLFPE+ TH+STRVAGTLGYLAPEYAISGRLTRK+DVYSFGVLLL+I+
Sbjct: 159 NLCPKVSDFGLSKLFPEDFTHVSTRVAGTLGYLAPEYAISGRLTRKTDVYSFGVLLLQII 218
Query: 200 SGRTAVDFDVQLGEYHLVDKV 220
GR AVDFD +LGE++LV+K
Sbjct: 219 CGRKAVDFDPELGEHYLVEKA 239
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577375|ref|XP_002529567.1| ATP binding protein, putative [Ricinus communis] gi|223530943|gb|EEF32801.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 316 bits (809), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 149/200 (74%), Positives = 176/200 (88%), Gaps = 2/200 (1%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L++G VAVKVLS ES+QG+KEF+SE+AS+++++ HENLV LHG CIDGPCRILVYDYM
Sbjct: 92 LENGKFVAVKVLSAESRQGDKEFLSEIASLSSIS--HENLVILHGACIDGPCRILVYDYM 149
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N +L+Q LLG +K + KF W+ RREI +GI GLA+IHEEI+PH+VHRDIK SNILLDQ
Sbjct: 150 ENGNLAQILLGGDKIKRKFCWRVRREISLGIAEGLAHIHEEIKPHIVHRDIKASNILLDQ 209
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
NF PK+SDFGLSKLF +N THISTRVAGTLGYLAPEYAISG LTRKSD+YSFGVLLLEIV
Sbjct: 210 NFAPKVSDFGLSKLFADNITHISTRVAGTLGYLAPEYAISGHLTRKSDIYSFGVLLLEIV 269
Query: 200 SGRTAVDFDVQLGEYHLVDK 219
SGRTAVDFD++LGE+ LV+K
Sbjct: 270 SGRTAVDFDLELGEHFLVEK 289
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557018|ref|XP_002519542.1| ATP binding protein, putative [Ricinus communis] gi|223541405|gb|EEF42956.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 299 bits (765), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 139/203 (68%), Positives = 178/203 (87%), Gaps = 4/203 (1%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+L++G+IVAVKVLSVE S +GE+EF+SE+A++++++ HENLVKL G C+DG R LVY
Sbjct: 66 QLKNGSIVAVKVLSVELESMRGEREFISELAALSDIS--HENLVKLQGCCVDGANRYLVY 123
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
DYM NNSL+QTLLG+E+ R KF W+ARR I G+ RGLAYIHEE++PH++HRDIK SNIL
Sbjct: 124 DYMENNSLTQTLLGKEQNRMKFSWEARRNISFGVARGLAYIHEEVKPHILHRDIKASNIL 183
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
LD++F PK++DFGLS++ +NT+H+STRVAGTLGYLAPEYA+SG LTRKSDVYSFGVLLL
Sbjct: 184 LDKDFTPKVADFGLSRILRDNTSHVSTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLLL 243
Query: 197 EIVSGRTAVDFDVQLGEYHLVDK 219
EI+SGR+AVDFD++LGE+ LV K
Sbjct: 244 EIISGRSAVDFDLELGEHFLVQK 266
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741595|emb|CBI32727.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 292 bits (747), Expect = 9e-77, Method: Compositional matrix adjust.
Identities = 137/204 (67%), Positives = 175/204 (85%), Gaps = 4/204 (1%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+L+DGT VAVKVLSVE S +GE+EF+SE++++ ++ HENLV L G C++G R LVY
Sbjct: 104 QLRDGTTVAVKVLSVEIESMRGEREFVSELSALTDIK--HENLVTLQGCCVEGASRFLVY 161
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
DYM NNSL+QTLLG ++ R +FGW+ARR I +G+GRGLAY+HEE+QPH++HRDIK +NIL
Sbjct: 162 DYMENNSLAQTLLGAKQNRMEFGWEARRGISLGVGRGLAYLHEEVQPHIIHRDIKAANIL 221
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
LDQN PKISDFGLSKLF ++ +HISTRVAGTLGYLAPEYA+SGRLTRKSDVYSFGVLLL
Sbjct: 222 LDQNLAPKISDFGLSKLFVDSRSHISTRVAGTLGYLAPEYALSGRLTRKSDVYSFGVLLL 281
Query: 197 EIVSGRTAVDFDVQLGEYHLVDKV 220
EI+SG + V++D++ GE++LV+K
Sbjct: 282 EIISGHSVVEYDLEHGEHYLVEKA 305
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439972|ref|XP_002281059.1| PREDICTED: putative serine/threonine-protein kinase [Vitis vinifera] gi|147770086|emb|CAN69887.1| hypothetical protein VITISV_005073 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 291 bits (745), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 137/204 (67%), Positives = 175/204 (85%), Gaps = 4/204 (1%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+L+DGT VAVKVLSVE S +GE+EF+SE++++ ++ HENLV L G C++G R LVY
Sbjct: 70 QLRDGTTVAVKVLSVEIESMRGEREFVSELSALTDIK--HENLVTLQGCCVEGASRFLVY 127
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
DYM NNSL+QTLLG ++ R +FGW+ARR I +G+GRGLAY+HEE+QPH++HRDIK +NIL
Sbjct: 128 DYMENNSLAQTLLGAKQNRMEFGWEARRGISLGVGRGLAYLHEEVQPHIIHRDIKAANIL 187
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
LDQN PKISDFGLSKLF ++ +HISTRVAGTLGYLAPEYA+SGRLTRKSDVYSFGVLLL
Sbjct: 188 LDQNLAPKISDFGLSKLFVDSRSHISTRVAGTLGYLAPEYALSGRLTRKSDVYSFGVLLL 247
Query: 197 EIVSGRTAVDFDVQLGEYHLVDKV 220
EI+SG + V++D++ GE++LV+K
Sbjct: 248 EIISGHSVVEYDLEHGEHYLVEKA 271
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450984|ref|XP_004143242.1| PREDICTED: putative serine/threonine-protein kinase-like [Cucumis sativus] gi|449482501|ref|XP_004156301.1| PREDICTED: putative serine/threonine-protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 273 bits (698), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 130/203 (64%), Positives = 165/203 (81%), Gaps = 4/203 (1%)
Query: 20 LQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
L+D +AVKVLS VES +GE+EF++E+ S++N+ HENLV+L G +DG R LVYD
Sbjct: 66 LRDDRKIAVKVLSIEVESMRGEREFIAELTSLSNIR--HENLVELKGFYVDGSNRYLVYD 123
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
YM NNSL+ L G + R + W AR+EI++G+ RGLAY+HEE++PH+VHRDIK SNILL
Sbjct: 124 YMENNSLAYVLQGVRENRMRLRWIARKEILIGVARGLAYLHEEVEPHIVHRDIKASNILL 183
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
D NF PK++DFGL+KL EN++H+STRVAGT+GYLAPEYA+SG LTRKSDVYSFGVLLLE
Sbjct: 184 DHNFKPKVADFGLAKLLRENSSHVSTRVAGTIGYLAPEYAVSGHLTRKSDVYSFGVLLLE 243
Query: 198 IVSGRTAVDFDVQLGEYHLVDKV 220
IVSGR VDFD++ GE+HLV +V
Sbjct: 244 IVSGRATVDFDLEHGEHHLVQRV 266
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|414877990|tpg|DAA55121.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 263 bits (673), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 124/205 (60%), Positives = 162/205 (79%), Gaps = 2/205 (0%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+L G VA+KVLS ES+QG KEF++E++ ++N+ H NLVKLHG C+DG ++LVY+Y
Sbjct: 179 KLNKGEKVAIKVLSSESRQGTKEFLNELSVISNIT--HHNLVKLHGCCVDGGQKMLVYNY 236
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+ NNSL+QTLLG + +FGW+ R +I +G+ GL Y+HE+++P +VHRDIK SNILLD
Sbjct: 237 VENNSLAQTLLGNSRSGIRFGWRTRVDICIGVADGLTYLHEQVRPRIVHRDIKASNILLD 296
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+N PKI+DFGL+K FP N THISTRVAGTLGYLAPEYAI G+LTRK+DVYSFGVLLLEI
Sbjct: 297 RNLRPKIADFGLAKFFPGNMTHISTRVAGTLGYLAPEYAIRGQLTRKADVYSFGVLLLEI 356
Query: 199 VSGRTAVDFDVQLGEYHLVDKVRSI 223
VSGR D ++L E L++KV ++
Sbjct: 357 VSGRCHTDPRLRLDEQFLLEKVWTL 381
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 229 | ||||||
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.799 | 0.465 | 0.616 | 8.1e-60 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.794 | 0.466 | 0.591 | 1.2e-58 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.899 | 0.216 | 0.509 | 4.1e-53 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.886 | 0.196 | 0.512 | 2.6e-52 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.886 | 0.193 | 0.507 | 2.7e-52 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.860 | 0.190 | 0.527 | 1.9e-51 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.882 | 0.427 | 0.5 | 7.4e-50 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.868 | 0.281 | 0.495 | 1.5e-49 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.860 | 0.422 | 0.517 | 4.1e-49 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.860 | 0.400 | 0.517 | 5.2e-49 |
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
Identities = 114/185 (61%), Positives = 147/185 (79%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L+DGT VAVK LS ESKQG +EF++E+ ++N++ H NLVKL G CI+G RILVY+Y+
Sbjct: 65 LRDGTQVAVKSLSAESKQGTREFLTEINLISNIH--HPNLVKLIGCCIEGNNRILVYEYL 122
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
NNSL+ LLG R W R I +G GLA++HEE++PHVVHRDIK SNILLD
Sbjct: 123 ENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNILLDS 182
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
NF+PKI DFGL+KLFP+N TH+STRVAGT+GYLAPEYA+ G+LT+K+DVYSFG+L+LE++
Sbjct: 183 NFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILVLEVI 242
Query: 200 SGRTA 204
SG ++
Sbjct: 243 SGNSS 247
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 1.2e-58, P = 1.2e-58
Identities = 110/186 (59%), Positives = 151/186 (81%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L+DG + A+KVLS ES+QG KEF++E+ ++ + HENLVKL+G C++G RILVY+++
Sbjct: 60 LKDGKLAAIKVLSAESRQGVKEFLTEINVISEIQ--HENLVKLYGCCVEGNHRILVYNFL 117
Query: 80 PNNSLSQTLL--GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
NNSL +TLL G + +F W +R I +G+ +GLA++HEE++PH++HRDIK SNILL
Sbjct: 118 ENNSLDKTLLAGGYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILL 177
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
D+ +PKISDFGL++L P N TH+STRVAGT+GYLAPEYA+ G+LTRK+D+YSFGVLL+E
Sbjct: 178 DKYLSPKISDFGLARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLME 237
Query: 198 IVSGRT 203
IVSGR+
Sbjct: 238 IVSGRS 243
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 557 (201.1 bits), Expect = 4.1e-53, P = 4.1e-53
Identities = 106/208 (50%), Positives = 153/208 (73%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+L DGTI+AVK LS SKQG +EF++E+ ++ ++ H NLVKL+G C++G +LVY++
Sbjct: 642 KLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALH--HPNLVKLYGCCVEGGQLLLVYEF 699
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+ NNSL++ L G ++ + + W RR+I +G+ RGLAY+HEE + +VHRDIK +N+LLD
Sbjct: 700 VENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLD 759
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+ NPKISDFGL+KL E++THISTR+AGT GY+APEYA+ G LT K+DVYSFG++ LEI
Sbjct: 760 KQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEI 819
Query: 199 VSGRTAVDFDVQLGEYHLVDKVRSINMK 226
V GR+ + ++L+D V + K
Sbjct: 820 VHGRSNKIERSKNNTFYLIDWVEVLREK 847
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 551 (199.0 bits), Expect = 2.6e-52, P = 2.6e-52
Identities = 106/207 (51%), Positives = 150/207 (72%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DG +VAVK+LSV S+QG+ +F++E+ ++++V H NLVKL+G C +G R+LVY+Y+
Sbjct: 713 LNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSV--LHRNLVKLYGCCFEGEHRMLVYEYL 770
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
PN SL Q L G+ + W R EI +G+ RGL Y+HEE +VHRD+K SNILLD
Sbjct: 771 PNGSLDQALFGD--KTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDS 828
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
P+ISDFGL+KL+ + THISTRVAGT+GYLAPEYA+ G LT K+DVY+FGV+ LE+V
Sbjct: 829 RLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELV 888
Query: 200 SGRTAVDFDVQLGEYHLVDKVRSINMK 226
SGR D +++ + +L++ +++ K
Sbjct: 889 SGRPNSDENLEEEKKYLLEWAWNLHEK 915
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 551 (199.0 bits), Expect = 2.7e-52, P = 2.7e-52
Identities = 105/207 (50%), Positives = 149/207 (71%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DG VAVK LS+ S+QG+ +F++E+ ++++V H NLVKL+G C +G R+LVY+Y+
Sbjct: 729 LNDGREVAVKQLSIGSRQGKGQFVAEIIAISSV--LHRNLVKLYGCCFEGDHRLLVYEYL 786
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
PN SL Q L G++ W R EI +G+ RGL Y+HEE ++HRD+K SNILLD
Sbjct: 787 PNGSLDQALFGDKSLH--LDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDS 844
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
PK+SDFGL+KL+ + THISTRVAGT+GYLAPEYA+ G LT K+DVY+FGV+ LE+V
Sbjct: 845 ELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELV 904
Query: 200 SGRTAVDFDVQLGEYHLVDKVRSINMK 226
SGR D +++ G+ +L++ +++ K
Sbjct: 905 SGRKNSDENLEEGKKYLLEWAWNLHEK 931
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 1.9e-51, P = 1.9e-51
Identities = 105/199 (52%), Positives = 146/199 (73%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DG +AVK LS +SKQG +EF++E+ ++ + H NLVKL+G CI+G +LVY+Y+
Sbjct: 686 LADGMTIAVKQLSSKSKQGNREFVTEIGMISALQ--HPNLVKLYGCCIEGKELLLVYEYL 743
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
NNSL++ L G EK+R W R ++ +GI +GLAY+HEE + +VHRDIK +N+LLD
Sbjct: 744 ENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDL 803
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
+ N KISDFGL+KL E THISTR+AGT+GY+APEYA+ G LT K+DVYSFGV+ LEIV
Sbjct: 804 SLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIV 863
Query: 200 SGRTAVDFDVQLGEYHLVD 218
SG++ ++ + +L+D
Sbjct: 864 SGKSNTNYRPKEEFIYLLD 882
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 7.4e-50, P = 7.4e-50
Identities = 102/204 (50%), Positives = 143/204 (70%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DGT VAVK L Q EKEF EV + V H+NLV+L G C++G R+LVYD++
Sbjct: 173 LTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAYRMLVYDFV 230
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N +L Q + G+ + W R II+G+ +GLAY+HE ++P VVHRDIK+SNILLD+
Sbjct: 231 DNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDR 290
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
+N K+SDFGL+KL +++++TRV GT GY+APEYA +G L KSD+YSFG+L++EI+
Sbjct: 291 QWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEII 350
Query: 200 SGRTAVDFDVQLGEYHLVDKVRSI 223
+GR VD+ GE +LVD ++S+
Sbjct: 351 TGRNPVDYSRPQGETNLVDWLKSM 374
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 1.5e-49, P = 1.5e-49
Identities = 101/204 (49%), Positives = 142/204 (69%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L DG +VAVK L + QG++EF +EV +++ ++ H +LV + G CI G R+L+YDY+
Sbjct: 396 LPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIH--HRHLVSIVGHCISGDRRLLIYDYV 453
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
NN L L GE ++ W R +I G RGLAY+HE+ P ++HRDIK+SNILL+
Sbjct: 454 SNNDLYFHLHGE---KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLED 510
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
NF+ ++SDFGL++L + THI+TRV GT GY+APEYA SG+LT KSDV+SFGV+LLE++
Sbjct: 511 NFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELI 570
Query: 200 SGRTAVDFDVQLGEYHLVDKVRSI 223
+GR VD LG+ LV+ R +
Sbjct: 571 TGRKPVDTSQPLGDESLVEWARPL 594
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 4.1e-49, P = 4.1e-49
Identities = 103/199 (51%), Positives = 138/199 (69%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L +G++VAVK + Q EKEF EV ++ +V H+NLV+L G CI+G RILVY+YM
Sbjct: 176 LVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVR--HKNLVRLLGYCIEGTNRILVYEYM 233
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N +L + L G K W+AR +++ G + LAY+HE I+P VVHRDIK+SNIL+D
Sbjct: 234 NNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDIKSSNILIDD 293
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
FN KISDFGL+KL + +H++TRV GT GY+APEYA +G L KSDVYSFGVL+LE +
Sbjct: 294 RFNAKISDFGLAKLLGDGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLVLEAI 353
Query: 200 SGRTAVDFDVQLGEYHLVD 218
+GR VD+ E +LV+
Sbjct: 354 TGRDPVDYARPANEVNLVE 372
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 5.2e-49, P = 5.2e-49
Identities = 103/199 (51%), Positives = 139/199 (69%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L +GT VAVK + + Q EKEF EV ++ +V H+NLV+L G CI+G RILVY+Y+
Sbjct: 198 LMNGTPVAVKKILNQLGQAEKEFRVEVDAIGHVR--HKNLVRLLGYCIEGTHRILVYEYV 255
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N +L Q L G ++ W+AR ++++G + LAY+HE I+P VVHRDIK+SNIL++
Sbjct: 256 NNGNLEQWLHGAMRQHGYLTWEARMKVLIGTSKALAYLHEAIEPKVVHRDIKSSNILIND 315
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
FN K+SDFGL+KL +H++TRV GT GY+APEYA SG L KSDVYSFGV+LLE +
Sbjct: 316 EFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAI 375
Query: 200 SGRTAVDFDVQLGEYHLVD 218
+GR VD+ E +LVD
Sbjct: 376 TGRDPVDYGRPAHEVNLVD 394
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.X.2631.1 | hypothetical protein (320 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 229 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-45
Identities = 66/191 (34%), Positives = 97/191 (50%), Gaps = 14/191 (7%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDG 69
V LA + G VA+K++ E E + E+ + +N H N+VKL+G D
Sbjct: 8 TVYLA--RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN--HPNIVKLYGVFEDE 63
Query: 70 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
LV +Y SL L ++ K I++ I GL Y+H ++HRD
Sbjct: 64 NHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 130 IKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSD 187
+K NILLD N K++DFGLSKL + + + T V GT Y+APE + G + KSD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSD 176
Query: 188 VYSFGVLLLEI 198
++S GV+L E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-43
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 22 DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
G IVAVK+L S + ++ E+ + ++ H N+V+L D LV +Y
Sbjct: 23 TGKIVAVKILKKRSEKSKKDQTARREIRILRRLS--HPNIVRLIDAFEDKDHLYLVMEYC 80
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
L L R ++I + I RGL Y+H ++HRD+K NILLD+
Sbjct: 81 EGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDE 133
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEI 198
N KI+DFGL+K ++++ ++T V GT Y+APE + G K DV+S GV+L E+
Sbjct: 134 NGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192
Query: 199 VSGRTAVDFDVQLGEYHLVDKVRS 222
++G+ + L + L+ ++
Sbjct: 193 LTGKPPFSGENILDQLQLIRRILG 216
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 6e-41
Identities = 61/176 (34%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 26 VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VAVK L + S+Q +EF+ E M ++ H N+VKL G C + +V +YM L
Sbjct: 31 VAVKTLKEDASEQQIEEFLREARIMRKLD--HPNVVKLLGVCTEEEPLYIVMEYMEGGDL 88
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
L K R K + I RG+ Y+ + + +HRD+ N L+ +N K
Sbjct: 89 LSYL---RKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 142
Query: 145 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
ISDFGLS+ ++ + + ++APE G+ T KSDV+SFGVLL EI +
Sbjct: 143 ISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-41
Identities = 54/187 (28%), Positives = 97/187 (51%), Gaps = 12/187 (6%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+ G +VA+KV+ + + ++E + E+ + + H N+V+L+ D LV
Sbjct: 19 RDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK--HPNIVRLYDVFEDEDKLYLVM 76
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+Y L L K+R + R + I L Y+H + +VHRD+K NIL
Sbjct: 77 EYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK---GIVHRDLKPENIL 129
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
LD++ + K++DFGL++ + ++T V GT Y+APE + + D++S GV+L
Sbjct: 130 LDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILY 187
Query: 197 EIVSGRT 203
E+++G+
Sbjct: 188 ELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 9e-40
Identities = 60/176 (34%), Positives = 92/176 (52%), Gaps = 8/176 (4%)
Query: 26 VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VAVK L + S+Q +EF+ E M ++ H N+VKL G C + ++V +YMP L
Sbjct: 31 VAVKTLKEDASEQQIEEFLREARIMRKLD--HPNIVKLLGVCTEEEPLMIVMEYMPGGDL 88
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
L + R + + I RG+ Y+ + + +HRD+ N L+ +N K
Sbjct: 89 LDYL--RKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 143
Query: 145 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
ISDFGLS+ ++ + + ++APE G+ T KSDV+SFGVLL EI +
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-38
Identities = 64/187 (34%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 21 QDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
T VAVK L + + E+ EF+ E + M ++ H N+V+L G C G +V +YM
Sbjct: 26 GTETKVAVKTLKEGASEEEREEFLEEASIMKKLS--HPNIVRLLGVCTQGEPLYIVTEYM 83
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
P L L K K K ++ + I +G+ Y+ + + VHRD+ N L+ +
Sbjct: 84 PGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTE 137
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVL 194
N KISDFGLS+ G L APE G+ T KSDV+SFGVL
Sbjct: 138 NLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVL 193
Query: 195 LLEIVSG 201
L EI +
Sbjct: 194 LWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 7e-36
Identities = 59/185 (31%), Positives = 88/185 (47%), Gaps = 14/185 (7%)
Query: 24 TIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T VAVK L S++ K+F+ E M + H N+V+L G C + LV +YM
Sbjct: 24 TEVAVKTLKEDASEEERKDFLKEARVMKKLG--HPNVVRLLGVCTEEEPLYLVLEYMEGG 81
Query: 83 SL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
L + ++ K + I +G+ Y+ + VHRD+ N L+
Sbjct: 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLV 138
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVLL 195
++ KISDFGLS+ + + + G L ++APE G T KSDV+SFGVLL
Sbjct: 139 GEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLL 197
Query: 196 LEIVS 200
EI +
Sbjct: 198 WEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-32
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCID 68
V LA + G ++AVK + + E + E+ ++++ H N+V+ +G D
Sbjct: 15 SVYLA--LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ--HPNIVRYYGSERD 70
Query: 69 GPCR-ILVY-DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYIHEEI 121
+ ++ +Y+ SLS L K+ K E ++ I GLAY+H
Sbjct: 71 EEKNTLNIFLEYVSGGSLSSLL----KKFGKL-----PEPVIRKYTRQILEGLAYLHSN- 120
Query: 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAPEYAISG 180
+VHRDIK +NIL+D + K++DFG +K + T T V GT ++APE
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 181 RLTRKSDVYSFGVLLLEIVSGR 202
R +D++S G ++E+ +G+
Sbjct: 179 EYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-28
Identities = 64/188 (34%), Positives = 96/188 (51%), Gaps = 23/188 (12%)
Query: 24 TIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
T VAVK L K G + F+ E M + H+ LV+L+ C + +V +YM
Sbjct: 31 TKVAVKTL----KPGTMSPEAFLQEAQIMKKLR--HDKLVQLYAVCSEEEPIYIVTEYMS 84
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
SL L E ++ + + + M I G+AY+ + +HRD+ NIL+
Sbjct: 85 KGSLLDFLKSGEGKKLRL----PQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVG 137
Query: 139 QNFNPKISDFGLSKLFPEN--TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
+N KI+DFGL++L ++ T + + + APE A GR T KSDV+SFG+LL
Sbjct: 138 ENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSDVWSFGILLT 195
Query: 197 EIVS-GRT 203
EIV+ GR
Sbjct: 196 EIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 19 RLQDGTIVAVKVLSV-ESKQGEKEF-MSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
R DG + +K + + + E+E ++EV + +N H N++K + + +V
Sbjct: 21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--HPNIIKYYESFEEKGKLCIVM 78
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG----IGRGLAYIHEEIQPHVVHRDIKT 132
+Y LSQ + K++ K G E I+ + L Y+H ++HRDIK
Sbjct: 79 EYADGGDLSQKI----KKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKP 131
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
NI L N K+ DFG+SK+ +T ++ V GT YL+PE + KSD++S G
Sbjct: 132 QNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLG 190
Query: 193 VLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222
+L E+ + + + + L L K+
Sbjct: 191 CVLYELCTLKHPFEGENLLE---LALKILK 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-27
Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 14/187 (7%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ G VA+KV+ +ESK+ +++ ++E+ + H N+VK +G + +V +
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK--HPNIVKYYGSYLKKDELWIVME 77
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+ SL LL + A +E++ G L Y+H ++HRDIK +NI
Sbjct: 78 FCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKG----LEYLHSN---GIIHRDIKAANI 129
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
LL + K+ DFGLS + T + GT ++APE K+D++S G+
Sbjct: 130 LLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187
Query: 196 LEIVSGR 202
+E+ G+
Sbjct: 188 IELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-27
Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 25/196 (12%)
Query: 21 QDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
D +VAVK L S K+F E + N HEN+VK +G C +G I+V++YM
Sbjct: 33 NDKELVAVKTLKETASNDARKDFEREAELLTNFQ--HENIVKFYGVCTEGDPPIMVFEYM 90
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARRE-----------IIMGIGRGLAYIHEEIQPHVVHR 128
+ L++ L A F I + I G+ Y+ + H VHR
Sbjct: 91 EHGDLNK-FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHR 146
Query: 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGRLTR 184
D+ T N L+ + KI DFG+S+ + RV G + ++ PE + + T
Sbjct: 147 DLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRKFTT 203
Query: 185 KSDVYSFGVLLLEIVS 200
+SDV+SFGV+L EI +
Sbjct: 204 ESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-27
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 21 QDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+D +VA+KVL+ + + + F+ E+ +A++N N+VKL+ D LV +
Sbjct: 20 RDRKLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVME 78
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
Y+ SL LL + R+ I+ I L Y+H + ++HRDIK NILL
Sbjct: 79 YVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILL 134
Query: 138 DQN-FNPKISDFGLSKLFPENTTHISTR-----VAGTLGYLAPEYAISGRL---TRKSDV 188
D++ K+ DFGL+KL P+ + S GT GY+APE + L + SD+
Sbjct: 135 DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI 194
Query: 189 YSFGVLLLEIVSGRTAVDFD 208
+S G+ L E+++G + +
Sbjct: 195 WSLGITLYELLTGLPPFEGE 214
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-26
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 23/200 (11%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV L + G + A+KVL + ++ + ++E ++ +N H +VKLH
Sbjct: 8 KVLLV--RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--HPFIVKLHYAFQ 63
Query: 68 DGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQP 123
LV +Y P L + L +E R RA+F + A EI++ + Y+H
Sbjct: 64 TEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARF-YAA--EIVLALE----YLHSL--- 112
Query: 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 183
+++RD+K NILLD + + K++DFGL+K + +T GT YLAPE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171
Query: 184 RKSDVYSFGVLLLEIVSGRT 203
+ D +S GVLL E+++G+
Sbjct: 172 KAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 11 KVDLAPFIRLQDGT--IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV+L + L D T VAVK L+ +Q +F E+ + ++ HEN+VK G C
Sbjct: 19 KVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD--HENIVKYKGVCE 76
Query: 68 DGPCRI--LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 125
R L+ +Y+P+ SL L ++ R + K I +G+ Y+ +
Sbjct: 77 KPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLGSQ---RY 130
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAISGRLT 183
+HRD+ NIL++ KISDFGL+K+ PE+ + + G + APE + + +
Sbjct: 131 IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFS 190
Query: 184 RKSDVYSFGVLLLEIVS 200
SDV+SFGV L E+ +
Sbjct: 191 SASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 5e-25
Identities = 56/186 (30%), Positives = 97/186 (52%), Gaps = 14/186 (7%)
Query: 20 LQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
L+ G VA+K +S+E + E K M E+ + N+ H N+VK G ++ +
Sbjct: 22 LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--HPNIVKYIGSIETSDSLYIILE 79
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
Y N SL Q + K+ F + + +GLAY+HE+ V+HRDIK +NIL
Sbjct: 80 YAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILT 132
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLL 196
++ K++DFG++ + + ++ V GT ++APE I + SD++S G ++
Sbjct: 133 TKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPE-VIEMSGASTASDIWSLGCTVI 190
Query: 197 EIVSGR 202
E+++G
Sbjct: 191 ELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 5e-24
Identities = 62/178 (34%), Positives = 91/178 (51%), Gaps = 13/178 (7%)
Query: 26 VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VAVK L E G+KEF+ E + MA ++ H +V+L G C G +LV + P L
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLD--HPCIVRLIGVCK-GEPLMLVMELAPLGPL 82
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ L K+R + +E+ + G+AY+ + H VHRD+ N+LL K
Sbjct: 83 LKYL----KKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAK 135
Query: 145 ISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
ISDFG+S+ + + AG L + APE G+ + KSDV+S+GV L E S
Sbjct: 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-23
Identities = 56/180 (31%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 24 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
T VAVK L + K+F++E M + H L++L+ C +V + M S
Sbjct: 31 TPVAVKTLKPGTMD-PKDFLAEAQIMKKLR--HPKLIQLYAVCTLEEPIYIVTELMKYGS 87
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L + L G R K ++ + G+AY+ + + +HRD+ N+L+ +N
Sbjct: 88 LLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNIC 142
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GR 202
K++DFGL+++ E+ + + APE A+ R + KSDV+SFG+LL EIV+ GR
Sbjct: 143 KVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-23
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 24/183 (13%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 85
VA+K+L + +++F EV ++ + H++L+ L C G ++ + M SL
Sbjct: 33 VAIKILKSDDLLKQQDFQKEVQALKRLR--HKHLISLFAVCSVGEPVYIITELMEKGSLL 90
Query: 86 QTLLGEEKRRAK------FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
L E + + + G+AY+ E+ + +HRD+ NIL+ +
Sbjct: 91 AFLRSPEGQVLPVASLIDMACQ--------VAEGMAYLEEQ---NSIHRDLAARNILVGE 139
Query: 140 NFNPKISDFGLSKLFPEN--TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
+ K++DFGL++L E+ + ++ + APE A G + KSDV+SFG+LL E
Sbjct: 140 DLVCKVADFGLARLIKEDVYLSS-DKKIP--YKWTAPEAASHGTFSTKSDVWSFGILLYE 196
Query: 198 IVS 200
+ +
Sbjct: 197 MFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-23
Identities = 55/187 (29%), Positives = 98/187 (52%), Gaps = 10/187 (5%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
+ VA+K + E E++F+ E M + + H LV+L+G C + LV+++M
Sbjct: 26 LEKRKVAIKTIR-EGAMSEEDFIEEAQVM--MKLSHPKLVQLYGVCTERSPICLVFEFME 82
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
+ LS L +R KF + + + + G+AY+ +V+HRD+ N L+ +N
Sbjct: 83 HGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGEN 136
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
K+SDFG+++ ++ ST + + +PE + + KSDV+SFGVL+ E+ S
Sbjct: 137 QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
Query: 201 -GRTAVD 206
G+T +
Sbjct: 197 EGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 6e-23
Identities = 55/188 (29%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 22 DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-LVYDYM 79
G I A+K + V+ + K+ + E+ ++ + +VK +G I +V +YM
Sbjct: 25 TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SPYVVKCYGAFYK-EGEISIVLEYM 81
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYIHEEIQPHVVHRDIKTSN 134
SL+ L K+ K E ++ I +GL Y+H + H++HRDIK SN
Sbjct: 82 DGGSLADLL----KKVGKIP-----EPVLAYIARQILKGLDYLHTKR--HIIHRDIKPSN 130
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+L++ KI+DFG+SK+ +T V GT+ Y++PE + +D++S G+
Sbjct: 131 LLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 195 LLEIVSGR 202
LLE G+
Sbjct: 190 LLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-22
Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVYDYMPNNSL 84
VA+K++ E E +F+ E M ++ H NLV+L+G C P I V +YM N L
Sbjct: 31 VAIKMIR-EGAMSEDDFIEEAKVMMKLS--HPNLVQLYGVCTKQRPIFI-VTEYMANGCL 86
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
L +R+ K G + ++ + + Y+ +HRD+ N L+ ++ K
Sbjct: 87 LNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVK 140
Query: 145 ISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
+SDFGL++ L + T+ T+ + + PE R + KSDV+SFGVL+ E+ S
Sbjct: 141 VSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-22
Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 13/178 (7%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 85
VAVK L +S + F++E + M + H NLV+L G + G +V +YM SL
Sbjct: 32 VAVKCLKDDSTAAQA-FLAEASVMTTLR--HPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88
Query: 86 QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145
L + RA + + + G+ Y+ E+ + VHRD+ N+L+ ++ K+
Sbjct: 89 DYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKV 143
Query: 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GR 202
SDFGL+K + S ++ + + APE + + KSDV+SFG+LL EI S GR
Sbjct: 144 SDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-22
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 25/200 (12%)
Query: 21 QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
+ T+VAVK+L E S + +F E A MA + H N+VKL G C G L+++YM
Sbjct: 33 EPFTMVAVKMLKEEASADMQADFQREAALMAEFD--HPNIVKLLGVCAVGKPMCLLFEYM 90
Query: 80 PNNSLSQTLLGEEKRR----AKFGWKARRE--------------IIMGIGRGLAYIHEEI 121
L++ L R + AR+ I + G+AY+ E
Sbjct: 91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER- 149
Query: 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISG 180
VHRD+ T N L+ +N KI+DFGLS ++ + S A + ++ PE
Sbjct: 150 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN 207
Query: 181 RLTRKSDVYSFGVLLLEIVS 200
R T +SDV+++GV+L EI S
Sbjct: 208 RYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-22
Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 15/190 (7%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
QD +VAVK L S K+F E + N+ HE++VK +G C++G I+V++YM
Sbjct: 33 QDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCVEGDPLIMVFEYMK 90
Query: 81 NNSLSQ---------TLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+ L++ L+ E R A+ I I G+ Y+ + H VHRD+
Sbjct: 91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLA 147
Query: 132 TSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYS 190
T N L+ +N KI DFG+S+ ++ + + + ++ PE + + T +SDV+S
Sbjct: 148 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 207
Query: 191 FGVLLLEIVS 200
GV+L EI +
Sbjct: 208 LGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-22
Identities = 60/187 (32%), Positives = 97/187 (51%), Gaps = 10/187 (5%)
Query: 19 RLQDGTIVAVKVLSVES-KQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
RL D A+K + + S Q E+E ++E+ +A+VN H N++ +DG +V
Sbjct: 21 RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN--HPNIISYKEAFLDGNKLCIVM 78
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+Y P LS+ + +K+R + I + + RGL +HE+ ++HRD+K++NIL
Sbjct: 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANIL 135
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
L N KI D G+SK+ +N GT Y+APE + KSD++S G LL
Sbjct: 136 LVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGRPYSYKSDIWSLGCLLY 192
Query: 197 EIVSGRT 203
E+ +
Sbjct: 193 EMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-22
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 12 VDLAPFIRLQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 69
V+L + LQD G +VAVK L + + ++F E+ + ++ H+N+VK G C
Sbjct: 20 VELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ--HDNIVKYKGVCY-S 76
Query: 70 PCRI---LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 126
R LV +Y+P SL L +K R + + I +G+ Y+ + V
Sbjct: 77 AGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSK---RYV 130
Query: 127 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAISGRLTR 184
HRD+ T NIL++ KI DFGL+K+ P++ + R G + + APE + +
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV 190
Query: 185 KSDVYSFGVLLLEIVS 200
SDV+SFGV+L E+ +
Sbjct: 191 ASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-22
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 10 EKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 69
E +L+P +D +VAVK L + K+F E + N+ HE++VK +G C DG
Sbjct: 25 ECYNLSP---TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDG 79
Query: 70 PCRILVYDYMPNNSLSQ----------TLLGEEKRRAK--FGWKARREIIMGIGRGLAYI 117
I+V++YM + L++ L+ + R+AK G I I G+ Y+
Sbjct: 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 139
Query: 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEY 176
+ H VHRD+ T N L+ N KI DFG+S+ ++ + + + ++ PE
Sbjct: 140 ASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES 196
Query: 177 AISGRLTRKSDVYSFGVLLLEIVS 200
+ + T +SDV+SFGV+L EI +
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 4e-21
Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 22 DGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
A+K+L + ++ K E + +N H ++KL+ D V +Y
Sbjct: 25 TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG-HPGIIKLYYTFQDEENLYFVLEY 83
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
PN L Q + ++ K R I L Y+H ++HRD+K NILLD
Sbjct: 84 APNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLD 136
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVA-------------------GTLGYLAPEYAIS 179
++ + KI+DFG +K+ N++ S + GT Y++PE
Sbjct: 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196
Query: 180 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSIN 224
+ SD+++ G ++ ++++G+ F EY K+ +
Sbjct: 197 KPAGKSSDLWALGCIIYQMLTGKPP--FR-GSNEYLTFQKILKLE 238
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-21
Identities = 62/180 (34%), Positives = 95/180 (52%), Gaps = 10/180 (5%)
Query: 24 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
T VA+K L + E F+ E M + HE LV+L+ + P I V +YM S
Sbjct: 31 TRVAIKTLKPGTMSPEA-FLQEAQVMKKLR--HEKLVQLYAVVSEEPIYI-VTEYMSKGS 86
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L GE + + ++ I G+AY+ + + VHRD++ +NIL+ +N
Sbjct: 87 LLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVC 141
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GR 202
K++DFGL++L +N + + APE A+ GR T KSDV+SFG+LL E+ + GR
Sbjct: 142 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-21
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 17/194 (8%)
Query: 18 IRLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
+ L G ++AVK + ++ + KE E+ + + H NLVK +G + +
Sbjct: 20 VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK--HPNLVKYYGVEVHREKVYIF 77
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+Y +L + L E R R + + GLAY+H +VHRDIK +NI
Sbjct: 78 MEYCSGGTLEELL--EHGRILDE--HVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANI 130
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG---YLAPEYAISGRLT---RKSDVY 189
LD N K+ DFG + NTT + V G Y+APE G+ R +D++
Sbjct: 131 FLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIW 190
Query: 190 SFGVLLLEIVSGRT 203
S G ++LE+ +G+
Sbjct: 191 SLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-20
Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 22/190 (11%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G VA+K + + + E E+ M + H N+V + + G +V +
Sbjct: 39 TDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCK--HPNIVDYYDSYLVGDELWVVME 95
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
YM SL+ ++ + R A RE++ +GL Y+H +V+HRDIK+ NI
Sbjct: 96 YMDGGSLTD-IITQNFVRMNEPQIAYVCREVL----QGLEYLH---SQNVIHRDIKSDNI 147
Query: 136 LLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
LL ++ + K++DFG L+K + + V GT ++APE K D++S
Sbjct: 148 LLSKDGSVKLADFGFAAQLTKEKSKRNS-----VVGTPYWMAPEVIKRKDYGPKVDIWSL 202
Query: 192 GVLLLEIVSG 201
G++ +E+ G
Sbjct: 203 GIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-20
Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 13/186 (6%)
Query: 21 QDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVC-HENLVKLHGGCID-GPCRI-LVY 76
G I A+K ++ + +K+ + E+ C +VK +G +D I +
Sbjct: 24 NTGMIFALKTITTDPNPDLQKQILRELEIN---KSCKSPYIVKYYGAFLDESSSSIGIAM 80
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+Y SL +KR + G K +I + +GL+Y+H ++HRDIK SNIL
Sbjct: 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNIL 137
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
L + K+ DFG+S E ++ GT Y+APE + SDV+S G+ LL
Sbjct: 138 LTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194
Query: 197 EIVSGR 202
E+ R
Sbjct: 195 EVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-20
Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 15/180 (8%)
Query: 26 VAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VAVK L + +F+ E A M +++ HENL++L+G + P +V + P SL
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLD--HENLIRLYGVVLTHPLM-MVTELAPLGSL 82
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
L + F + + I G+ Y+ +HRD+ NILL + K
Sbjct: 83 LDRL--RKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVK 137
Query: 145 ISDFGLSKLFPENTTHIST----RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
I DFGL + P+N H +V + APE + + SDV+ FGV L E+ +
Sbjct: 138 IGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-20
Identities = 63/185 (34%), Positives = 92/185 (49%), Gaps = 20/185 (10%)
Query: 24 TIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
T VA+K L KQG F++E M + H LV+L+ P I + +YM
Sbjct: 31 TKVAIKSL----KQGSMSPEAFLAEANLMKQLQ--HPRLVRLYAVVTQEPIYI-ITEYME 83
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
N SL L E + + I M I G+A+I + + +HRD++ +NIL+
Sbjct: 84 NGSLVDFLKTPEGIKLTI----NKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVS 136
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+ KI+DFGL++L +N + + APE G T KSDV+SFG+LL EI
Sbjct: 137 ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196
Query: 199 VS-GR 202
V+ GR
Sbjct: 197 VTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-20
Identities = 59/184 (32%), Positives = 94/184 (51%), Gaps = 24/184 (13%)
Query: 26 VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K L S ++ +F++E + M + H N+++L G +++ +YM N SL
Sbjct: 35 VAIKTLKAGSSDKQRLDFLTEASIMGQFD--HPNIIRLEGVVTKSRPVMIITEYMENGSL 92
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ L + KF ++ GI G+ Y+ E + VHRD+ NIL++ N K
Sbjct: 93 DKFL---RENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCK 146
Query: 145 ISDFGLSKLF----PENTTH---ISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLL 196
+SDFGLS+ TT I R + APE AI+ R T SDV+SFG+++
Sbjct: 147 VSDFGLSRRLEDSEATYTTKGGKIPIR------WTAPE-AIAYRKFTSASDVWSFGIVMW 199
Query: 197 EIVS 200
E++S
Sbjct: 200 EVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-20
Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 11/182 (6%)
Query: 22 DGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G I+AVK + +E + K+ + E+ + N +V +G + + +YM
Sbjct: 25 TGKIMAVKTIRLEINEAIQKQILRELDILHKCN--SPYIVGFYGAFYNNGDISICMEYMD 82
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
SL + L + R + +I + + +GL Y+HE + ++HRD+K SNIL++
Sbjct: 83 GGSLDKILKEVQGR---IPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSR 137
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
K+ DFG+S + ++ GT Y+APE + KSD++S G+ L+E+ +
Sbjct: 138 GQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT 194
Query: 201 GR 202
GR
Sbjct: 195 GR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-20
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VAVK L E +EF+ E A M + H NLV+L G C P ++ ++M
Sbjct: 31 SLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYIITEFMTYG 87
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
+L L E R + + I + Y+ ++ + +HRD+ N L+ +N
Sbjct: 88 NLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHL 142
Query: 143 PKISDFGLSKLFPENTTHISTRVAGT---LGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
K++DFGLS+L +T T AG + + APE + + KSDV++FGVLL EI
Sbjct: 143 VKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 199
Query: 200 SGRTAVDFDVQLGE-YHLVDK 219
+ + + L + Y L++K
Sbjct: 200 TYGMSPYPGIDLSQVYELLEK 220
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-20
Identities = 54/192 (28%), Positives = 95/192 (49%), Gaps = 17/192 (8%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
QD +VAVK L S+ ++F E + + H+++V+ +G C +G ++V++YM
Sbjct: 33 QDKMLVAVKALKEASESARQDFQREAELLTVLQ--HQHIVRFYGVCTEGRPLLMVFEYMR 90
Query: 81 NNSLSQTLL-----------GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
+ L++ L GE+ + I I G+ Y+ H VHRD
Sbjct: 91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRD 147
Query: 130 IKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDV 188
+ T N L+ Q KI DFG+S+ ++ + + R + ++ PE + + T +SD+
Sbjct: 148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDI 207
Query: 189 YSFGVLLLEIVS 200
+SFGV+L EI +
Sbjct: 208 WSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-20
Identities = 63/180 (35%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 24 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
T VAVK L + E F+ E M + H+ LV+L+ + P I V +YM S
Sbjct: 31 TKVAVKTLKPGTMSPES-FLEEAQIMKKLR--HDKLVQLYAVVSEEPIYI-VTEYMSKGS 86
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L E R K ++ + G+AYI + + +HRD++++NIL+
Sbjct: 87 LLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVC 141
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GR 202
KI+DFGL++L +N + + APE A+ GR T KSDV+SFG+LL E+V+ GR
Sbjct: 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-20
Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 26 VAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+KVL E+ + KE + E MA+V+ H ++V+L G C+ L+ MP L
Sbjct: 39 VAIKVLREETSPKANKEILDEAYVMASVD--HPHVVRLLGICL-SSQVQLITQLMPLGCL 95
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ + G + + I +G++Y+ E+ +VHRD+ N+L+ + K
Sbjct: 96 LDYV---RNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVK 149
Query: 145 ISDFGLSKLFPENTTHISTRVAG---TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
I+DFGL+KL + G + ++A E + T KSDV+S+GV + E+++
Sbjct: 150 ITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-19
Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 21/187 (11%)
Query: 26 VAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K + +E Q + + EV +M+ N H N+VK + + G LV Y+ SL
Sbjct: 29 VAIKRIDLEKCQTSVDELRKEVQAMSQCN--HPNVVKYYTSFVVGDELWLVMPYLSGGSL 86
Query: 85 SQTLLGEEKRRAKFGWKARREIIM-----GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
+ ++ + E I+ + +GL Y+H Q +HRDIK NILL +
Sbjct: 87 LDIM------KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGE 137
Query: 140 NFNPKISDFGLSKLFPENTTHISTR---VAGTLGYLAPEYAISGR-LTRKSDVYSFGVLL 195
+ + KI+DFG+S + GT ++APE K+D++SFG+
Sbjct: 138 DGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197
Query: 196 LEIVSGR 202
+E+ +G
Sbjct: 198 IELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-19
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 17/196 (8%)
Query: 18 IRLQDGTIVAVKVLSVES-KQGEKEFM-SEVASMANVNVCHENLVKLHGGCIDGPCRIL- 74
R DG I+ K + + + EK+ + SEV + + H N+V+ + ID + L
Sbjct: 20 RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK--HPNIVRYYDRIIDRSNQTLY 77
Query: 75 -VYDYMPNNSLSQTL--LGEEKRRA--KFGWKARREIIMGIGRGLAYIHEEIQPH--VVH 127
V +Y L+Q + +E++ +F W+ I+ + L H P V+H
Sbjct: 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLLLALYECHNRSDPGNTVLH 133
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 187
RD+K +NI LD N N K+ DFGL+K+ +++ T V GT Y++PE KSD
Sbjct: 134 RDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSD 192
Query: 188 VYSFGVLLLEIVSGRT 203
++S G L+ E+ +
Sbjct: 193 IWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-19
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 11 KVDLAPFIRLQDGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV L + DGT +VAVK L E +Q + E+ + + HEN+VK G C
Sbjct: 19 KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY--HENIVKYKGCCS 76
Query: 68 DGPCRI--LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 125
+ + L+ +Y+P SL L + A+ A++ I G+AY+H + H
Sbjct: 77 EQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ-----ICEGMAYLHSQ---HY 128
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAISGRLT 183
+HRD+ N+LLD + KI DFGL+K PE + R G + + A E + +
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS 188
Query: 184 RKSDVYSFGVLLLEIVS 200
SDV+SFGV L E+++
Sbjct: 189 YASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 5e-19
Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLVKLHG---GCIDGP 70
+ G +VA+K + +E+ EKE + ++ + + H N+V+L G
Sbjct: 19 RNKKTGELVALKKIRMEN---EKEGFP-ITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74
Query: 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
+V++YM ++ L+ L + KF + + + GL Y+H ++HRDI
Sbjct: 75 I-YMVFEYMDHD-LTGLL---DSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDI 126
Query: 131 KTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDV 188
K SNIL++ + K++DFGL++ + N+ + RV TL Y PE + + R + D+
Sbjct: 127 KGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDM 185
Query: 189 YSFGVLLLEIVSGR 202
+S G +L E+ G+
Sbjct: 186 WSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-19
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVKL 62
G + A +VAVKVL S ++F+ EV ++ ++ N+ +L
Sbjct: 27 DGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS--DPNIARL 84
Query: 63 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG-LAYIHEEI 121
G C P ++ +YM N L+Q L ++ + L Y+ +I
Sbjct: 85 LGVCTVDPPLCMIMEYMENGDLNQFL-----QKHVAETSGLACNSKSLSFSTLLYMATQI 139
Query: 122 --------QPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYL 172
+ VHRD+ T N L+ +N+ KI+DFG+S+ L+ + + R + ++
Sbjct: 140 ASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWM 199
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVS 200
A E + G+ T KSDV++FGV L EI++
Sbjct: 200 AWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-19
Identities = 58/190 (30%), Positives = 87/190 (45%), Gaps = 20/190 (10%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
L+ T VAVK K F+ E + + H N+VKL G C+ +V +
Sbjct: 15 VLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD--HPNIVKLIGVCVQKQPIYIVME 72
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI--GRGLAYIHEEIQPHVVHRDIKTSNI 135
+P SL L R+ K ++ + M + G+ Y+ + +HRD+ N
Sbjct: 73 LVPGGSLLTFL-----RKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNC 124
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGRLTRKSDVYSF 191
L+ +N KISDFG+S+ E I T G + + APE GR T +SDV+S+
Sbjct: 125 LVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSY 181
Query: 192 GVLLLEIVSG 201
G+LL E S
Sbjct: 182 GILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-19
Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 17/164 (10%)
Query: 44 SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 103
SE+A M + H N+VKL G C L+++Y+ +LS+ L W+ R
Sbjct: 732 SEIADMGKLQ--HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERR 782
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHIS 162
R+I +GI + L ++H P VV ++ I++D P + L L + IS
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841
Query: 163 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206
+ Y+APE + +T KSD+Y FG++L+E+++G++ D
Sbjct: 842 S------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-18
Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 18 IRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
+R D + A+K + + +++ +E + E +A ++ +++ + +D +V
Sbjct: 20 VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD--SSYIIRYYESFLDKGKLNIV 77
Query: 76 YDYMPNNSLSQTLLGEEKRR--AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+Y N L + L + R W+ +I++G LA++H + ++HRDIK+
Sbjct: 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHSK---KILHRDIKSL 130
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
N+ LD N KI D G++KL +NT +T V GT YL+PE KSDV++ GV
Sbjct: 131 NLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 194 LLLEIVSGRTAVDFDVQ 210
+L E +G+ D + Q
Sbjct: 190 VLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-18
Identities = 54/182 (29%), Positives = 100/182 (54%), Gaps = 12/182 (6%)
Query: 23 GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRILVYDYMP 80
G +VA+K++++++ + + EVA ++ + N+ K +G + GP ++ +Y
Sbjct: 26 GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
S+ +TL+ K+ RE+++ L YIH+ V+HRDIK +NIL+
Sbjct: 86 GGSV-RTLMKAGPIAEKYISVIIREVLVA----LKYIHKV---GVIHRDIKAANILVTNT 137
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIV 199
N K+ DFG++ L +N++ ST V GT ++APE G+ K+D++S G+ + E+
Sbjct: 138 GNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196
Query: 200 SG 201
+G
Sbjct: 197 TG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-18
Identities = 52/187 (27%), Positives = 95/187 (50%), Gaps = 17/187 (9%)
Query: 25 IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
+VAVK+L + +K +F+ E+ M+ + + N+++L G C+ ++ +YM N
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLK--NPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRG-LAYIHEEIQP--------HVVHRDIKTSN 134
L+Q L + + + F I + L Y+ +I + VHRD+ T N
Sbjct: 104 LNQ-FLSQREIESTF---THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159
Query: 135 ILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
L+ ++ KI+DFG+S+ L+ + I R + ++A E + G+ T SDV++FGV
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 194 LLLEIVS 200
L E+ +
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-18
Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 11/178 (6%)
Query: 26 VAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K L +++ ++F+SE + M + H N++ L G ++V +YM N SL
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVTKSKPVMIVTEYMENGSL 92
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
L K +F ++ GI G+ Y+ + VHRD+ NIL++ N K
Sbjct: 93 DAFL---RKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCK 146
Query: 145 ISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+SDFGLS++ ++ T G + + APE + T SDV+S+G+++ E++S
Sbjct: 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-18
Identities = 61/180 (33%), Positives = 93/180 (51%), Gaps = 10/180 (5%)
Query: 24 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
T VA+K L + E F+ E M + H+ LV L+ + P I V ++M S
Sbjct: 31 TKVAIKTLKPGTMMPEA-FLQEAQIMKKLR--HDKLVPLYAVVSEEPIYI-VTEFMGKGS 86
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L + + K ++ I G+AYI + + +HRD++ +NIL+ N
Sbjct: 87 LLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVC 141
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GR 202
KI+DFGL++L +N + + APE A+ GR T KSDV+SFG+LL E+V+ GR
Sbjct: 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-18
Identities = 57/177 (32%), Positives = 91/177 (51%), Gaps = 13/177 (7%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 85
VA+K++ E E EF+ E M ++ HE LV+L+G C +V +YM N L
Sbjct: 31 VAIKMIK-EGSMSEDEFIEEAKVMMKLS--HEKLVQLYGVCTKQRPIYIVTEYMSNGCL- 86
Query: 86 QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145
L E +R F E+ + G+AY+ + +HRD+ N L+D K+
Sbjct: 87 LNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKV 141
Query: 146 SDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
SDFGLS+ L E T+ + ++ + + PE + + + KSDV++FGVL+ E+ S
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-18
Identities = 60/181 (33%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 24 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
T VAVK + S E F++E M + H+ LVKLH P I+ ++M S
Sbjct: 31 TKVAVKTMKPGSMSVEA-FLAEANVMKTLQ--HDKLVKLHAVVTKEPIYIIT-EFMAKGS 86
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L +E + + I G+A+I Q + +HRD++ +NIL+ +
Sbjct: 87 LLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVC 141
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GR 202
KI+DFGL+++ +N + + APE G T KSDV+SFG+LL+EIV+ GR
Sbjct: 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
Query: 203 T 203
Sbjct: 202 I 202
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-18
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 23/194 (11%)
Query: 18 IRLQDGTIVAVKVLSV-----ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 72
+ L DG AVK +S+ ++ K+ E+A ++ + H N+V+ G +
Sbjct: 20 LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL--QHPNIVQYLGTEREEDNL 77
Query: 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRD 129
+ + +P SL++ L K+G I + I GL Y+H+ + VHRD
Sbjct: 78 YIFLELVPGGSLAKLL-------KKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRD 127
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDV 188
IK +NIL+D N K++DFG++K E + S G+ ++APE G +D+
Sbjct: 128 IKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 189 YSFGVLLLEIVSGR 202
+S G +LE+ +G+
Sbjct: 186 WSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-18
Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 15/184 (8%)
Query: 26 VAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VAVK L S+Q E +F+ E M+ N H+N+V+L G + R ++ + M L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFN--HQNIVRLIGVSFERLPRFILLELMAGGDL 96
Query: 85 SQTLLGEEKRRAKFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
L R + ++++ + +G Y+ E H +HRDI N LL
Sbjct: 97 KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK- 152
Query: 142 NP----KISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
P KI+DFG+++ ++ + R + ++ PE + G T K+DV+SFGVLL
Sbjct: 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLW 212
Query: 197 EIVS 200
EI S
Sbjct: 213 EIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-18
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 19/194 (9%)
Query: 21 QDGTIVAVK--VLSVESKQGEKEFMSEVASMAN-----VNVCHENLVKLHGGCIDGPCRI 73
G ++AVK L S + S + ++A + HEN+V+ G +D
Sbjct: 23 SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+ +Y+P S+ LL F R + I +GL Y+H ++HRDIK +
Sbjct: 83 IFLEYVPGGSV-AALL---NNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGA 135
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVA-----GTLGYLAPEYAISGRLTRKSDV 188
NIL+D KISDFG+SK N+ T A G++ ++APE TRK+D+
Sbjct: 136 NILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADI 195
Query: 189 YSFGVLLLEIVSGR 202
+S G L++E+++G+
Sbjct: 196 WSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-18
Identities = 61/190 (32%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 26 VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VAVK L + EK EF+ E M+N N H N+VKL G C+ + ++ + M L
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFN--HPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 85 SQTLLGEEKRRAKFG-----WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-- 137
L R +FG K +I + + +G Y+ Q H +HRD+ N L+
Sbjct: 87 LSYLRD--ARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSE 141
Query: 138 ---DQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGRLTRKSDVYS 190
D + KI DFGL++ ++ + R G + ++APE + G+ T +SDV+S
Sbjct: 142 KGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGLLPVRWMAPESLLDGKFTTQSDVWS 198
Query: 191 FGVLLLEIVS 200
FGVL+ EI++
Sbjct: 199 FGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-17
Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 19 RLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRILVY 76
+ GT++A KV+ + +K K+ + E+ M C +V +G ++ +
Sbjct: 26 HIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE---CRSPYIVSFYGAFLNENNICMCM 82
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
++M SL + K+ + +I + + GL Y++ ++HRDIK SNIL
Sbjct: 83 EFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNIL 136
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
++ K+ DFG+S E I+ GT Y++PE G+ T KSDV+S G+ ++
Sbjct: 137 VNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISII 193
Query: 197 EIVSGR 202
E+ G+
Sbjct: 194 ELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-17
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 27/199 (13%)
Query: 24 TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T VAVK+L + E ++ +SE + VN H +++KL+G C +L+ +Y
Sbjct: 31 TTVAVKMLKENASSSELRDLLSEFNLLKQVN--HPHVIKLYGACSQDGPLLLIVEYAKYG 88
Query: 83 SLSQTL----------LGEEKRRAKFGWKA--RREIIMG--------IGRGLAYIHEEIQ 122
SL L LG + R R + MG I RG+ Y+ E
Sbjct: 89 SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-- 146
Query: 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTLGYLAPEYAISGR 181
+VHRD+ N+L+ + KISDFGLS+ E +++ ++ + ++A E
Sbjct: 147 -KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI 205
Query: 182 LTRKSDVYSFGVLLLEIVS 200
T +SDV+SFGVLL EIV+
Sbjct: 206 YTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-17
Identities = 54/179 (30%), Positives = 95/179 (53%), Gaps = 13/179 (7%)
Query: 26 VAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K L +++ ++F+SE + M H N+++L G +++ +YM N +L
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQF--SHHNIIRLEGVVTKFKPAMIITEYMENGAL 93
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ L +F ++ GI G+ Y+ + + VHRD+ NIL++ N K
Sbjct: 94 DKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECK 147
Query: 145 ISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAISGR-LTRKSDVYSFGVLLLEIVS 200
+SDFGLS++ ++ T G + + APE AI+ R T SDV+SFG+++ E++S
Sbjct: 148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-17
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 17/176 (9%)
Query: 28 VKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQT 87
V+ SV + E+ + E+ H LV L D LV D + L
Sbjct: 39 VEKGSVRNVLNERRILQELN--------HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYH 90
Query: 88 LLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 147
L ++ KF + + I I L Y+H + ++HRDIK NILLD+ + I+D
Sbjct: 91 LS----QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITD 143
Query: 148 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
F ++ +T ++T +GT GY+APE + D +S GV E + G+
Sbjct: 144 FNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-17
Identities = 57/166 (34%), Positives = 90/166 (54%), Gaps = 25/166 (15%)
Query: 45 EVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 102
E+ + +VN H N+VK H D G ++L+ ++M SL T + +E+ A
Sbjct: 122 EIEILRDVN--HPNVVKCHD-MFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVA--- 174
Query: 103 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 162
R+I+ GI AY+H H+VHRDIK SN+L++ N KI+DFG+S++ + +
Sbjct: 175 -RQILSGI----AYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226
Query: 163 TRVAGTLGYLAPEYAISGRLTR------KSDVYSFGVLLLEIVSGR 202
+ V GT+ Y++PE I+ L D++S GV +LE GR
Sbjct: 227 SSV-GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-17
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 16 PF-IRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73
PF +R +VAVK+L + +K +F+ EV ++ + N+++L G C+D
Sbjct: 38 PFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK--DPNIIRLLGVCVDEDPLC 95
Query: 74 LVYDYMPNNSLSQTL---------------LGEEKRRAKFGWKARREIIMGIGRGLAYIH 118
++ +YM N L+Q L + + + + + I G+ Y+
Sbjct: 96 MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155
Query: 119 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYA 177
+ VHRD+ T N L+ +N KI+DFG+S+ L+ + I R + ++A E
Sbjct: 156 ---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 178 ISGRLTRKSDVYSFGVLLLEIVS 200
+ G+ T SDV++FGV L EI+
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-17
Identities = 54/183 (29%), Positives = 97/183 (53%), Gaps = 19/183 (10%)
Query: 26 VAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K L +++ ++F+SE + M + H N++ L G +++ ++M N +L
Sbjct: 35 VAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVTKSRPVMIITEFMENGAL 92
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
L + +F ++ GI G+ Y+ E + VHRD+ NIL++ N K
Sbjct: 93 DSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK 146
Query: 145 ISDFGLSKLFPENTTHISTRVAGTLG------YLAPEYAISGR-LTRKSDVYSFGVLLLE 197
+SDFGLS+ ++T+ + +LG + APE AI+ R T SDV+S+G+++ E
Sbjct: 147 VSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWE 203
Query: 198 IVS 200
++S
Sbjct: 204 VMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 6e-17
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 36/192 (18%)
Query: 23 GTIVAVKVLS----VESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73
G A+K+LS V+ KQ EK + + H LV L+G D
Sbjct: 26 GKYYALKILSKAKIVKLKQVEHVLNEKRILQSI--------RHPFLVNLYGSFQDDSNLY 77
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGRGLAYIHEEIQPHVVHRD 129
LV +Y+P L L ++ +F R ++++ + Y+H +V+RD
Sbjct: 78 LVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLALE----YLHSL---DIVYRD 126
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 189
+K N+LLD + KI+DFG +K T + GT YLAPE +S + D +
Sbjct: 127 LKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSKGYGKAVDWW 182
Query: 190 SFGVLLLEIVSG 201
+ G+L+ E+++G
Sbjct: 183 ALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-17
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 25/194 (12%)
Query: 24 TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T VA+K L + ++EF E M+++ H N+V L G C ++++Y+ +
Sbjct: 36 TSVAIKTLKENAEPKVQQEFRQEAELMSDLQ--HPNIVCLLGVCTKEQPTCMLFEYLAHG 93
Query: 83 SLSQTLL----------GEEKRRAKFGWKARR--EIIMGIGRGLAYIHEEIQPHVVHRDI 130
L + L+ K I + I G+ Y+ H VHRD+
Sbjct: 94 DLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDL 150
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGRLTRKS 186
N L+ + KISDFGLS+ + + RV + ++ PE + G+ T +S
Sbjct: 151 AARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES 207
Query: 187 DVYSFGVLLLEIVS 200
D++SFGV+L EI S
Sbjct: 208 DIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 7e-17
Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 20 LQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ G VA+K +++ +G + + E+ ++ H +VKL G +LV +
Sbjct: 22 RETGETVALKKVALRRLEGGIPNQALREIKALQACQ--HPYVVKLLDVFPHGSGFVLVME 79
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
YMP+ LS+ L + + + +G+AY+H ++HRD+K +N+L+
Sbjct: 80 YMPS-DLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLI 132
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 175
+ KI+DFGL++LF E + + T Y APE
Sbjct: 133 SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-17
Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNV-----CHENLVKLHGGCIDGPC 71
R+ DG AVKV+ +E S+ + +EV + N + CHE+ K +
Sbjct: 53 RVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112
Query: 72 RI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG--RGLAYIHEEIQPHVVHR 128
I LV DY L Q E K RAK + RE G+ + L +H H++HR
Sbjct: 113 MIALVLDYANAGDLRQ----EIKSRAKTN-RTFREHEAGLLFIQVLLAVHHVHSKHMIHR 167
Query: 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSD 187
DIK++NILL N K+ DFG SK++ + + GT Y+APE ++K+D
Sbjct: 168 DIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227
Query: 188 VYSFGVLLLEIVSGRTAVD 206
++S GVLL E+++ + D
Sbjct: 228 MFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 8e-17
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 43/212 (20%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLVK 61
+V LA + G I A+KV+ V+ E++ +S+ S +VK
Sbjct: 8 RVFLA--KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS--------PYVVK 57
Query: 62 LHGGCIDGPCRILVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAY 116
L+ LV +Y+P L+ L L E+ R EI++ L Y
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LEY 108
Query: 117 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-------LFPENTTHISTRVAGTL 169
+H ++HRD+K NIL+D N + K++DFGLSK + + R+ GT
Sbjct: 109 LH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 170 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
Y+APE + ++ D +S G +L E + G
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 8e-17
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 31/197 (15%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENLVKLHGGCIDGPCR 72
+ G IVA+K + +++ E+E + E++ + + H N+VKL
Sbjct: 19 RDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELK--HPNIVKLLDVIHTERKL 73
Query: 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
LV++Y + L + L +KR + I+ + RGLAY H ++HRD+K
Sbjct: 74 YLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKP 126
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE-------YAISGRLTRK 185
NIL++++ K++DFGL++ F + V TL Y APE Y+ +
Sbjct: 127 QNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTA------ 179
Query: 186 SDVYSFGVLLLEIVSGR 202
D++S G + E+++G+
Sbjct: 180 VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 26 VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K ++ + E+ EF++E + M N CH ++V+L G G ++V + M L
Sbjct: 39 VAIKTVNENASMRERIEFLNEASVMKEFN-CH-HVVRLLGVVSTGQPTLVVMELMAKGDL 96
Query: 85 SQTLLG---EEKRRAKFGWKARREII-MG--IGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
L E + G ++ I M I G+AY+ + VHRD+ N ++
Sbjct: 97 KSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVA 153
Query: 139 QNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
++ KI DFG+++ ++ + + + ++APE G T KSDV+SFGV+L E
Sbjct: 154 EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE 213
Query: 198 IVS 200
+ +
Sbjct: 214 MAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-16
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
+ T VAVK L + + F+ E M + H+ LV+L+ ++ +YM
Sbjct: 29 NSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQ--HDKLVRLYAVVTKEEPIYIITEYMAK 85
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
SL L +E + + I G+AYI + + +HRD++ +N+L+ ++
Sbjct: 86 GSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESL 140
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS- 200
KI+DFGL+++ +N + + APE G T KSDV+SFG+LL EIV+
Sbjct: 141 MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200
Query: 201 ------GRTAVDFDVQLGEYHLVDKVRSINMKLY 228
G + D L + + ++ + +LY
Sbjct: 201 GKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY 234
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-16
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 10/176 (5%)
Query: 26 VAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VAVK + +E F+ E M + H ++VKL G + P I V + P L
Sbjct: 37 VAVKTCKNCTSPSVREKFLQEAYIMRQFD--HPHIVKLIGVITENPVWI-VMELAPLGEL 93
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
L + + + + LAY+ + VHRDI N+L+ K
Sbjct: 94 RSYL---QVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK 147
Query: 145 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ DFGLS+ + + + +++ + ++APE R T SDV+ FGV + EI+
Sbjct: 148 LGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-16
Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 14/185 (7%)
Query: 25 IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
+VAVK+L ++ K +F+ E+ M+ + N+++L CI ++ +YM N
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLK--DPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 84 LSQTLLGEEKRRAKFGWKAR-------REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
L+Q L E + A + I G+ Y+ + VHRD+ T N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCL 162
Query: 137 LDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
+ +N+ KI+DFG+S+ L+ + I R + +++ E + G+ T SDV++FGV L
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 196 LEIVS 200
EI++
Sbjct: 223 WEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-16
Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 23 GTIVAVKVLS-VESKQGEKE-----FMSEVASMANVNVCHENLVKLHGG-CIDGPCRILV 75
GT++AVK ++ V + E+E E+ MA +N H +++++ G C D + V
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN--HPHIIRMLGATCEDSHFNLFV 82
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
++M S+S L + F + RGL+Y+HE ++HRD+K +N+
Sbjct: 83 -EWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANL 134
Query: 136 LLDQNFNP-KISDFGLSKLFPENTT---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
L+D +I+DFG + T ++ GT+ ++APE + R DV+S
Sbjct: 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194
Query: 192 GVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSIN 224
G +++E+ + + + + L+ K+ S
Sbjct: 195 GCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-16
Identities = 53/183 (28%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 23 GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDYM 79
G VAVK L ES + E+ + N+ HEN+VK G C + L+ +++
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
P+ SL + L + + K K + + + I +G+ Y+ VHRD+ N+L++
Sbjct: 91 PSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVES 144
Query: 140 NFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
KI DFGL+K + + + + + + + APE I + SDV+SFGV L E
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 198 IVS 200
+++
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-16
Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 32/193 (16%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMAN-----VNVCHENLVKLHGGCIDGPCRILVY- 76
G +AVK V E EV ++ N+ HE +V+ +G C+ + ++
Sbjct: 27 GRELAVK--QVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFM 83
Query: 77 DYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+YMP S+ L L E R K R+I+ G+ Y+H +VHRDIK
Sbjct: 84 EYMPGGSVKDQLKAYGALTETVTR-----KYTRQIL----EGVEYLHSN---MIVHRDIK 131
Query: 132 TSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGYLAPEYAISGR-LTRKSD 187
+NIL D N K+ DFG SK + T + + V GT +++PE ISG RK+D
Sbjct: 132 GANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPE-VISGEGYGRKAD 189
Query: 188 VYSFGVLLLEIVS 200
V+S G ++E+++
Sbjct: 190 VWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-15
Identities = 53/179 (29%), Positives = 93/179 (51%), Gaps = 12/179 (6%)
Query: 26 VAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VAVK+L + E+E MSE+ M+++ HEN+V L G C G +++ +Y L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGN-HENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
L KR + + + +G+A++ + + +HRD+ N+LL K
Sbjct: 127 LNFL--RRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181
Query: 145 ISDFGLSKLFPENTTHI---STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
I DFGL++ ++ ++ + R+ + ++APE + T +SDV+S+G+LL EI S
Sbjct: 182 ICDFGLARDIMNDSNYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-15
Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 22 DGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
G IVA+K + + ES+ K + E+ + +N H N++KL LV+++M
Sbjct: 23 TGEIVAIKKIKLRFESEGIPKTALREIKLLKELN--HPNIIKLLDVFRHKGDLYLVFEFM 80
Query: 80 PNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
+ Q L E ++ + + +GLA+ H ++HRD+K N
Sbjct: 81 DTDLYKLIKDRQRGLPESLIKS---------YLYQLLQGLAFCH---SHGILHRDLKPEN 128
Query: 135 ILLDQNFNPKISDFGLSKLF-PEN---TTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVY 189
+L++ K++DFGL++ F T ++ TR Y APE + + D++
Sbjct: 129 LLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGYSTPVDIW 183
Query: 190 SFGVLLLEIVSGR 202
S G + E++S R
Sbjct: 184 SVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 19/191 (9%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMS--EVASMANVNVCHENLVKLHGGCIDGPCRILV 75
+ G +VA+K + + E E M+ EV S+ +N H N+VKL + V
Sbjct: 19 RNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNE-HPNIVKLKEVFRENDELYFV 76
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
++YM N L Q + + + F R II I +GLA+IH+ HRD+K N+
Sbjct: 77 FEYMEGN-LYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENL 130
Query: 136 LLDQNFNPKISDFGLSKLF---PENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSF 191
L+ KI+DFGL++ P T ++STR Y APE + S + D+++
Sbjct: 131 LVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEILLRSTSYSSPVDIWAL 185
Query: 192 GVLLLEIVSGR 202
G ++ E+ + R
Sbjct: 186 GCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-15
Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 15/181 (8%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G VAVK + + + F+ E A M ++ H+NLV+L G + I V + M
Sbjct: 29 GQKVAVKNIKCDVTA--QAFLEETAVMTKLH--HKNLVRLLGVILHNGLYI-VMELMSKG 83
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
+L L + RA + + + G+ Y+ + +VHRD+ NIL+ ++
Sbjct: 84 NLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGV 138
Query: 143 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-G 201
K+SDFGL+++ + V T APE + + KSDV+S+GVLL E+ S G
Sbjct: 139 AKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDVWSYGVLLWEVFSYG 194
Query: 202 R 202
R
Sbjct: 195 R 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-15
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 85
+A+K + + + E+A + + H N+V+ G + + + +P SLS
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIA--LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93
Query: 86 QTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
L R+K+G E + I GL Y+H+ +VHRDIK N+L++
Sbjct: 94 ALL------RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTY 144
Query: 141 FNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLE 197
KISDFG SK T GTL Y+APE G +D++S G ++E
Sbjct: 145 SGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203
Query: 198 IVSGRTAVDFDVQLGEYH 215
+ +G+ ++LGE
Sbjct: 204 MATGKPPF---IELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-15
Identities = 48/191 (25%), Positives = 96/191 (50%), Gaps = 12/191 (6%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
R D +V +K + VE +K +E + ++ H N+++ + ++ ++V
Sbjct: 21 RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS--HPNIIEYYENFLEDKALMIVM 78
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+Y P +L++ + +++ + + I L ++H ++HRD+KT NIL
Sbjct: 79 EYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNIL 133
Query: 137 LDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
LD++ KI DFG+SK+ ++ + V GT Y++PE +KSD+++ G +L
Sbjct: 134 LDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVL 191
Query: 196 LEIVSGRTAVD 206
E+ S + A +
Sbjct: 192 YELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-15
Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K ++ + G + F M + ++ H +V+L G C G LV P SL
Sbjct: 39 VAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSL 95
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ + R + + I +G+ Y+ E +VHR++ NILL + +
Sbjct: 96 LDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQ 149
Query: 145 ISDFGLSKL-FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
I+DFG++ L +P++ + + + ++A E + GR T +SDV+S+GV + E++S
Sbjct: 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-15
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
GL ++H+ +V+RD+K N+LLD + N +ISD GL+ AGT GY+
Sbjct: 107 GLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYM 161
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
APE D ++ G L E+++GR+
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-14
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 23/189 (12%)
Query: 24 TIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T+V VK L + + + EF E+ ++ H+N+V+L G C + ++ +Y
Sbjct: 36 TLVLVKALQKTKDENLQSEFRRELDMFRKLS--HKNVVRLLGLCREAEPHYMILEYTDLG 93
Query: 83 SLSQTLLGEEKRRAKFGW-----KARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
L Q L + + K K + + I G+ ++ VHRD+ N L+
Sbjct: 94 DLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLV 150
Query: 138 DQNFNPKISDFGLSK------LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
K+S LSK + I R +LAPE + KSDV+SF
Sbjct: 151 SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------WLAPEAVQEDDFSTKSDVWSF 204
Query: 192 GVLLLEIVS 200
GVL+ E+ +
Sbjct: 205 GVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-14
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 53 NVCHENLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 110
N+ HE +V+ +G D R L ++MP S+ L K R+I+
Sbjct: 60 NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL--- 116
Query: 111 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS----TRVA 166
G++Y+H + +VHRDIK +NIL D N K+ DFG SK T +S V
Sbjct: 117 -EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVT 170
Query: 167 GTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 202
GT +++PE ISG RK+D++S G ++E+++ +
Sbjct: 171 GTPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-14
Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 25/192 (13%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
I + G +VA+KV+ VE +E + E++ + + +VK +G +V +
Sbjct: 23 IHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCD--SPYIVKYYGSYFKNTDLWIVME 78
Query: 78 YMPNNSLS------QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
Y S+S L EE+ A I+ +GL Y+H +HRDIK
Sbjct: 79 YCGAGSVSDIMKITNKTLTEEEIAA---------ILYQTLKGLEYLH---SNKKIHRDIK 126
Query: 132 TSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYS 190
NILL++ K++DFG+S +L +T V GT ++APE K+D++S
Sbjct: 127 AGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184
Query: 191 FGVLLLEIVSGR 202
G+ +E+ G+
Sbjct: 185 LGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 37/103 (35%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 164
+I + I + L Y+H ++ V+HRD+K SN+L+++N K+ DFG+S ++ T
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTI 162
Query: 165 VAGTLGYLAPEYAISGRLTR-----KSDVYSFGVLLLEIVSGR 202
AG Y+APE I+ L + KSDV+S G+ ++E+ +GR
Sbjct: 163 DAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-14
Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 9/175 (5%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 85
VA+K ++ E E++F+ E M + + H LV+L+G C +V ++M N L
Sbjct: 31 VAIKAIN-EGAMSEEDFIEEAKVM--MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87
Query: 86 QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145
L +R+ K + + G+ Y+ + +HRD+ N L+ K+
Sbjct: 88 NYL---RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKV 141
Query: 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
SDFG+++ ++ S+ + + PE + + KSDV+SFGVL+ E+ +
Sbjct: 142 SDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 59/193 (30%), Positives = 83/193 (43%), Gaps = 33/193 (17%)
Query: 23 GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73
G + A+K L VES EK S H LV L C +
Sbjct: 24 GELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-----HPFLVNLFA-CFQTEDHV 77
Query: 74 -LVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
V +Y L + + + RA F + A +++G L Y+HE +V+RD+
Sbjct: 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVF-YAA--CVVLG----LQYLHEN---KIVYRDL 127
Query: 131 KTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDV 188
K N+LLD KI+DFGL K + + T ST GT +LAPE TR D
Sbjct: 128 KLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAPEVLTETSYTRAVDW 184
Query: 189 YSFGVLLLEIVSG 201
+ GVL+ E++ G
Sbjct: 185 WGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-14
Identities = 54/182 (29%), Positives = 94/182 (51%), Gaps = 15/182 (8%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPN 81
G VAVK +++ + F++E + M + H NLV+L G ++ + +V +YM
Sbjct: 29 GNKVAVKC--IKNDATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYIVTEYMAK 84
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
SL L + R+ G + + + + Y+ + VHRD+ N+L+ ++
Sbjct: 85 GSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDN 139
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS- 200
K+SDFGL+K ++T + ++ + + APE + + KSDV+SFG+LL EI S
Sbjct: 140 VAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195
Query: 201 GR 202
GR
Sbjct: 196 GR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-14
Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 12/178 (6%)
Query: 26 VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+KVL E+++ + E M E M ++ + +V++ G C + +LV + L
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLD--NPYIVRMIGVC-EAEALMLVMEMASGGPL 81
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
++ L G ++ + E++ + G+ Y+ + + VHRD+ N+LL K
Sbjct: 82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAK 135
Query: 145 ISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
ISDFGLSK + ++ R AG L + APE + + +SDV+S+G+ + E S
Sbjct: 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-14
Identities = 47/165 (28%), Positives = 90/165 (54%), Gaps = 18/165 (10%)
Query: 44 SEVASMANVNVCHENLVKLHGGCIDGPCRILVY-DYMPNNSLSQTLLGEEKRRAKFGWKA 102
SE+ ++ +++ H N+V+ + G + ++ +Y+P S+ L + +F +
Sbjct: 57 SEIETLKDLD--HLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQL 109
Query: 103 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTT 159
R + GLAY+H + ++HRD+K N+L+D + KISDFG+SK + N
Sbjct: 110 VRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166
Query: 160 HISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGR 202
++S + G++ ++APE S + K D++S G ++LE+ +GR
Sbjct: 167 NMSMQ--GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 16/185 (8%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLVKLHGGCIDGPCRILVYDY 78
G IVA+K + K+ E + + ++ V V HEN+V L LV++Y
Sbjct: 26 GEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+ L E A R I + + +AY H +++HRDIK NIL+
Sbjct: 82 VERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVS 134
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLE 197
++ K+ DFG ++ T T Y APE + K DV++ G ++ E
Sbjct: 135 ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAE 194
Query: 198 IVSGR 202
++ G
Sbjct: 195 LLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-14
Identities = 55/182 (30%), Positives = 88/182 (48%), Gaps = 9/182 (4%)
Query: 20 LQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
L+D T VAVK + Q K +F+SE + + H N+VKL G C +V +
Sbjct: 16 LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD--HPNIVKLIGVCTQRQPIYIVMEL 73
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+P L K++ + K + + G+AY+ + + +HRD+ N L+
Sbjct: 74 VPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVG 127
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+N KISDFG+S+ + S + + APE GR + +SDV+S+G+LL E
Sbjct: 128 ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWET 187
Query: 199 VS 200
S
Sbjct: 188 FS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-14
Identities = 39/91 (42%), Positives = 58/91 (63%), Gaps = 5/91 (5%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
GL +H+E +V+RD+K NILLD + + +ISD GL+ PE T I RV GT+GY+
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
APE + R T D ++ G LL E+++G++
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-14
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 39/201 (19%)
Query: 21 QDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRI----- 73
GTI+AVK + + E K + ++ + + C +VK +G +G C I
Sbjct: 27 PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC-PYIVKFYGALFREGDCWICMELM 85
Query: 74 ---------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 124
VY+ + + + + +LG+ I + + L Y+ EE+
Sbjct: 86 DISLDKFYKYVYEVL-KSVIPEEILGK--------------IAVATVKALNYLKEEL--K 128
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 184
++HRD+K SNILLD+N N K+ DFG+S ++ TR AG Y+APE
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDG 186
Query: 185 ---KSDVYSFGVLLLEIVSGR 202
+SDV+S G+ L E+ +G+
Sbjct: 187 YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-14
Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 32/225 (14%)
Query: 19 RLQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
R +D ++V K L+ S++ ++ ++E+ ++ + H N++ + +D ++
Sbjct: 21 RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ--HPNIIAYYNHFMDDNTLLIEM 78
Query: 77 DYMPNNSLSQ-------TLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
+Y +L L EE W + I ++YIH+ ++HRD
Sbjct: 79 EYANGGTLYDKIVRQKGQLFEEEM----VLW-----YLFQIVSAVSYIHKA---GILHRD 126
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 189
IKT NI L + K+ DFG+SK+ + T V GT Y++PE + KSD++
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 190 SFGVLLLEIVSGRTAVDFDVQL--------GEYHLVDKVRSINMK 226
+ G +L E+++ + D L G Y V V S +
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-14
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 26/188 (13%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
+ G +VA+KV+ +E + E++ + H N+V G + +V +Y
Sbjct: 25 IATGELVAIKVIKLEPGDDFEIIQQEISMLKECR--HPNIVAYFGSYLRRDKLWIVMEYC 82
Query: 80 PNNSLS---QTLLG--EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
SL Q G E + A RE + +GLAY+HE +HRDIK +N
Sbjct: 83 GGGSLQDIYQVTRGPLSELQIAYVC----RETL----KGLAYLHET---GKIHRDIKGAN 131
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYA---ISGRLTRKSDVY 189
ILL ++ + K++DFG+S T I+ R + GT ++APE A G K D++
Sbjct: 132 ILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIW 188
Query: 190 SFGVLLLE 197
+ G+ +E
Sbjct: 189 ALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-14
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 18 IRLQDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---- 69
+ DG+ VAVK + ++ + +EF+SE A M + + H N++KL G C +
Sbjct: 20 LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD--HPNVMKLIGVCFEASSLQ 77
Query: 70 --PCRILVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 125
P +++ +M + L LL K + + ++ I G+ Y+ +
Sbjct: 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NF 134
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGRLTR 184
+HRD+ N +L ++ ++DFGLSK + R+A + ++A E T
Sbjct: 135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS 194
Query: 185 KSDVYSFGVLLLEIVS 200
KSDV++FGV + EI +
Sbjct: 195 KSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-14
Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 20/191 (10%)
Query: 23 GTIVAVKVLSVESKQ---GEKEF---MSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
G ++AVK + +++ EKE+ EV + ++ H N+V+ G C+D +
Sbjct: 24 GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK--HVNIVQYLGTCLDDNTISIFM 81
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+++P S+S L R + I G+AY+H VVHRDIK +N++
Sbjct: 82 EFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVM 134
Query: 137 LDQNFNPKISDFGLSK---LFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
L N K+ DFG ++ + TH + + GT ++APE RKSD++S
Sbjct: 135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI 194
Query: 192 GVLLLEIVSGR 202
G + E+ +G+
Sbjct: 195 GCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 6e-14
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 23 GTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCH-ENLVKLHGGCIDGPCRILVYDYMP 80
+VA+KV+ +E + E E + E+ ++ C + K +G + G ++ +Y
Sbjct: 26 NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ---CRSPYITKYYGSFLKGSKLWIIMEYCG 82
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
S L + K I+ + GL Y+HEE +HRDIK +NILL +
Sbjct: 83 GGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEE 134
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ K++DFG+S + +T V GT ++APE K+D++S G+ +E+
Sbjct: 135 GDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193
Query: 201 G 201
G
Sbjct: 194 G 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-14
Identities = 46/142 (32%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 68 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR--EIIMG-----IGRGLAYIHEE 120
DG I + ++M SL Q L KA R E I+G + RGL Y+ E+
Sbjct: 71 DGEISICM-EHMDGGSLDQVLK-----------KAGRIPENILGKISIAVLRGLTYLREK 118
Query: 121 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 180
+ ++HRD+K SNIL++ K+ DFG+S ++ ++ GT Y++PE
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT 173
Query: 181 RLTRKSDVYSFGVLLLEIVSGR 202
T +SD++S G+ L+E+ GR
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-14
Identities = 38/96 (39%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAG 167
I RGL YIH +V+HRD+K SN+LL+ N + KI DFGL+++ H T
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 168 TLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 202
T Y APE ++ + K+ D++S G +L E++S R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 8e-14
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 33/205 (16%)
Query: 8 RLEKVDLAPFIRLQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLH 63
R+E V + A+K + VE+ Q ++ SE + N H +VKL+
Sbjct: 8 RVELVKVKS-----KNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECN--HPFIVKLY 59
Query: 64 GGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIH 118
D Y YM L + LG E + R F R I + Y+H
Sbjct: 60 RTFKDKK-----YIYM----LMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 119 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYA 177
+++RD+K N+LLD N K+ DFG +K L T T GT Y+APE
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEII 164
Query: 178 ISGRLTRKSDVYSFGVLLLEIVSGR 202
++ D +S G+LL E+++GR
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-14
Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 29/233 (12%)
Query: 19 RLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVY 76
+ ++ VAVK+L ++ + + + +SE+ M + H+N++ L G C DGP ++V
Sbjct: 43 KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNIINLLGACTQDGPLYVIV- 100
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARR------------EIIMGIGRGLAYIHEEIQPH 124
+Y +L + L ++ + R + RG+ Y+ +
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---K 157
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRL 182
+HRD+ N+L+ +N KI+DFGL++ N + G L ++APE
Sbjct: 158 CIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTNGRLPVKWMAPEALFDRVY 216
Query: 183 TRKSDVYSFGVLLLEIVS-------GRTAVDFDVQLGEYHLVDKVRSINMKLY 228
T +SDV+SFGVL+ EI + G + L E H +DK + +LY
Sbjct: 217 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY 269
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 29/202 (14%)
Query: 21 QDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------P 70
QD +I VAVK + + ++ ++F+SE M + H N+++L G C+ P
Sbjct: 22 QDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD--HPNVMRLIGVCLQTVESEGYP 79
Query: 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFG-------WKARREIIMGIGRGLAYIHEEIQP 123
+++ +M + L LL ++ G + + + I G+ Y+ +
Sbjct: 80 SPVVILPFMKHGDLHSFLL-----YSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK--- 131
Query: 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGRL 182
+HRD+ N +L++N N ++DFGLSK + R+A + ++A E
Sbjct: 132 SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY 191
Query: 183 TRKSDVYSFGVLLLEIVS-GRT 203
T KSDV+SFGV + EI + G+T
Sbjct: 192 TTKSDVWSFGVTMWEIATRGQT 213
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-13
Identities = 57/191 (29%), Positives = 101/191 (52%), Gaps = 28/191 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
G IVA+K + +++++G + E++ M + HEN+V+LH +LV++YM +
Sbjct: 25 GEIVALKEIHLDAEEGTPSTAIREISLMKELK--HENIVRLHDVIHTENKLMLVFEYM-D 81
Query: 82 NSLSQTLLGEEKRRA-------KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
L + + R A F ++ + +G+A+ HE V+HRD+K N
Sbjct: 82 KDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLKGIAFCHEN---RVLHRDLKPQN 130
Query: 135 ILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISGRLTRKS-DVYSF 191
+L+++ K++DFGL++ F P NT S V TL Y AP+ + R S D++S
Sbjct: 131 LLINKRGELKLADFGLARAFGIPVNT--FSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSV 187
Query: 192 GVLLLEIVSGR 202
G ++ E+++GR
Sbjct: 188 GCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 45/184 (24%), Positives = 87/184 (47%), Gaps = 9/184 (4%)
Query: 18 IRLQDGTIVAVKVLSV---ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
I L DG +VA+K + + + ++ + E+ + ++ H N++K I+ +
Sbjct: 22 ICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD--HPNVIKYLASFIENNELNI 79
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V + LS+ + +K++ + + + + L ++H + ++HRDIK +N
Sbjct: 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPAN 136
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ + K+ D GL + F TT + V GT Y++PE KSD++S G L
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCL 195
Query: 195 LLEI 198
L E+
Sbjct: 196 LYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 65/199 (32%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV LA DG AVKVL ++ K+ +K M+E + NV H LV LH
Sbjct: 10 KVLLAK--HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLK-NVKHPFLVGLHYSFQ 66
Query: 68 DGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 124
V DY+ L L E + RA+F + A EI +G Y+H +
Sbjct: 67 TADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAA--EIASALG----YLHSL---N 116
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRL 182
+++RD+K NILLD + ++DFGL K + TT + GT YLAPE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPEVLRKQPY 173
Query: 183 TRKSDVYSFGVLLLEIVSG 201
R D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 21 QDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRIL-VY 76
G VA+K+L ++ + E + F E A A + H N+V L P + V+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY--HPNIVALLDSGEAPPGLLFAVF 58
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+Y+P +L + L + A G R +++ + LA H + +VHRD+K NI+
Sbjct: 59 EYVPGRTLREVLAADGALPA--GETGR--LMLQVLDALACAHNQ---GIVHRDLKPQNIM 111
Query: 137 L---DQNFNPKISDFGLSKLFP------ENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 187
+ + K+ DFG+ L P T +T V GT Y APE +T SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 188 VYSFGVLLLEIVSGRTAV 205
+Y++G++ LE ++G+ V
Sbjct: 172 LYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-13
Identities = 52/189 (27%), Positives = 97/189 (51%), Gaps = 31/189 (16%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G VAVK + + +Q + +EV M + H N+V+++ + G +V +++
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HPNIVEMYSSYLVGDELWVVMEFLEGG 101
Query: 83 SL----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+L + T + EE+ + + + + L+++H + V+HRDIK+ +ILL
Sbjct: 102 ALTDIVTHTRMNEEQIAT---------VCLAVLKALSFLHAQ---GVIHRDIKSDSILLT 149
Query: 139 QNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS--DVYSFG 192
+ K+SDFG +SK P + + GT ++APE IS RL + D++S G
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPE-VIS-RLPYGTEVDIWSLG 202
Query: 193 VLLLEIVSG 201
++++E+V G
Sbjct: 203 IMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-13
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 15/156 (9%)
Query: 53 NVCHENLVKLHGGCIDGPCRILV--YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 110
N+ HE +V+ +G D + L +YMP S+ L K R+I+
Sbjct: 60 NLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL--- 116
Query: 111 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAG 167
G++Y+H + +VHRDIK +NIL D N K+ DFG SK + T I + V G
Sbjct: 117 -EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTG 171
Query: 168 TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 202
T +++PE ISG RK+DV+S G ++E+++ +
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-13
Identities = 56/186 (30%), Positives = 81/186 (43%), Gaps = 14/186 (7%)
Query: 22 DGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G + A+KVL V+ + + +E + V C LV LH L+ D
Sbjct: 27 AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC-PFLVTLHYAFQTDTKLHLILD 85
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
Y+ L L +R F R I I L ++H Q +++RDIK NILL
Sbjct: 86 YVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILL 138
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS--DVYSFGVLL 195
D + ++DFGLSK F + GT+ Y+APE G D +S GVL
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 196 LEIVSG 201
E+++G
Sbjct: 199 FELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-13
Identities = 37/95 (38%), Positives = 59/95 (62%), Gaps = 10/95 (10%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGT 168
I RGL Y+H VVHRD+K SNIL+++N + KI DFGL+++ P+ T ++STR
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--- 170
Query: 169 LGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR 202
Y APE ++ + + D++S G + E++ G+
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-13
Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 23/112 (20%)
Query: 105 EIIMG-----IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159
E I+G I + L Y+ E+ V+HRD+K SNILLD + N K+ DFG+S ++
Sbjct: 113 EDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170
Query: 160 HISTRVAGTLGYLAPEYAISGRLTRK---------SDVYSFGVLLLEIVSGR 202
TR AG Y+APE R+ +DV+S G+ L+E+ +G+
Sbjct: 171 K--TRSAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 38/199 (19%)
Query: 26 VAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILV-------- 75
VAVK+L ++ + + + +SE+ M + H+N++ L G C +GP ++V
Sbjct: 45 VAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNIINLLGVCTQEGPLYVVVEYAAHGNL 103
Query: 76 YDY-------MPNNSLSQTLLGEEKRRAK----FGWKARREIIMGIGRGLAYIHEEIQPH 124
D+ S EE K F ++ + RG+ ++
Sbjct: 104 RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ--------VARGMEFLA---SKK 152
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEYAISGRL 182
+HRD+ N+L+ ++ KI+DFGL++ + T G L +APE A+ R+
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-TNGRLPVKWMAPE-ALFDRV 210
Query: 183 -TRKSDVYSFGVLLLEIVS 200
T +SDV+SFGVLL EI +
Sbjct: 211 YTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-13
Identities = 50/177 (28%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 26 VAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K+L+ + EFM E MA+++ H +LV+L G C+ P LV MP+ L
Sbjct: 39 VAIKILNETTGPKANVEFMDEALIMASMD--HPHLVRLLGVCLS-PTIQLVTQLMPHGCL 95
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ + + G + + I +G+ Y+ E +VHRD+ N+L+ + K
Sbjct: 96 LDYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVK 149
Query: 145 ISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
I+DFGL++L + + + ++A E + T +SDV+S+GV + E+++
Sbjct: 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-13
Identities = 38/91 (41%), Positives = 54/91 (59%), Gaps = 5/91 (5%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
GL +H E +V+RD+K NILLD + +ISD GL+ PE T I RV GT+GY+
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYM 168
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
APE + R T D + G L+ E++ G++
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-13
Identities = 51/187 (27%), Positives = 95/187 (50%), Gaps = 27/187 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G VAVK++ + +Q + +EV M + H+N+V+++ + G ++ +++
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HQNVVEMYKSYLVGEELWVLMEFLQGG 103
Query: 83 SL----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+L SQT L EE+ + + + L Y+H + V+HRDIK+ +ILL
Sbjct: 104 ALTDIVSQTRLNEEQIAT---------VCESVLQALCYLHSQ---GVIHRDIKSDSILLT 151
Query: 139 QNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ K+SDFG +SK P+ + + GT ++APE + D++S G++
Sbjct: 152 LDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 195 LLEIVSG 201
++E+V G
Sbjct: 207 VIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 22/185 (11%)
Query: 23 GTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
G A+KVL + +K +E A M + KL+ LV +Y+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI-QGESPYVAKLYYSFQSKDYLYLVMEYL 79
Query: 80 PNN---SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
SL +TL G + AK + E+++G+ +H Q ++HRDIK N+L
Sbjct: 80 NGGDCASLIKTLGGLPEDWAK---QYIAEVVLGVE----DLH---QRGIIHRDIKPENLL 129
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
+DQ + K++DFGLS+ + + GT YLAPE + + SD +S G ++
Sbjct: 130 IDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIF 184
Query: 197 EIVSG 201
E + G
Sbjct: 185 EFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 24 TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMPN 81
VAVK+L ++ + + +SE+ M + H+N++ L G C DGP +LV +Y
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK-HKNIINLLGACTQDGPLYVLV-EYASK 102
Query: 82 NSLSQTLLGEEKRRAKFGWKARR------------EIIMGIGRGLAYIHEEIQPHVVHRD 129
+L + L + + + + RG+ Y+ + +HRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRD 159
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSD 187
+ N+L+ ++ KI+DFGL++ N + G L ++APE T +SD
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218
Query: 188 VYSFGVLLLEIVS-------GRTAVDFDVQLGEYHLVDKVRSINMKLY 228
V+SFGVLL EI + G + L E H +DK + +LY
Sbjct: 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELY 266
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-12
Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 38/194 (19%)
Query: 21 QDGTIVAVKVLSVESKQGEKE-----------FMSEVASMANVNVCHENLVKL-----HG 64
+ G IVA+K + + ++ K+ + E+ H N++ L H
Sbjct: 23 ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK--------HPNIIGLLDVFGHK 74
Query: 65 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 124
I+ LV+++M + L + + + K+ ++ RGL Y+H
Sbjct: 75 SNIN-----LVFEFMETD-LEKVIKDKSIVLTPADIKS---YMLMTLRGLEYLHSN---W 122
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-T 183
++HRD+K +N+L+ + K++DFGL++ F ++ +V T Y APE R
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHYG 181
Query: 184 RKSDVYSFGVLLLE 197
D++S G + E
Sbjct: 182 VGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 35/231 (15%)
Query: 24 TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMPN 81
T VAVK+L ++ + + + +SE+ M + H+N++ L G C DGP ++V +Y
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HKNIINLLGACTQDGPLYVIV-EYASK 108
Query: 82 NSLSQTLLGEEKRRAKFGWK---------ARREII---MGIGRGLAYIHEEIQPHVVHRD 129
+L + L ++ + + ++++ + RG+ Y+ + +HRD
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRD 165
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG-----YLAPEYAISGRLTR 184
+ N+L+ ++ KI+DFGL++ + HI T G ++APE T
Sbjct: 166 LAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221
Query: 185 KSDVYSFGVLLLEIVS-------GRTAVDFDVQLGEYHLVDKVRSINMKLY 228
+SDV+SFGVLL EI + G + L E H +DK + +LY
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY 272
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 66/199 (33%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 11 KVDLAPFIRLQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV LA R DG+ AVKVL ++ K+ + M+E + N+ H LV LH
Sbjct: 10 KVLLAK--RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLK-NLKHPFLVGLHYSFQ 66
Query: 68 DGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 124
V DY+ L L E + RA+F + A E+ IG Y+H +
Sbjct: 67 TAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAA--EVASAIG----YLHSL---N 116
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRL 182
+++RD+K NILLD + ++DFGL K + PE TT + GT YLAPE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRKEPY 173
Query: 183 TRKSDVYSFGVLLLEIVSG 201
R D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-12
Identities = 43/187 (22%), Positives = 92/187 (49%), Gaps = 13/187 (6%)
Query: 23 GTIVAVKVLSV---ESKQGEKEFMSEVASMAN-VNVC-----HENLVKLHGGCIDGPCRI 73
++A+K ++V + ++E + + + V + H N+V+ + ++
Sbjct: 26 QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY 85
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+V D + L + ++++ +F + I + + L Y+H+E + +VHRD+ +
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPN 143
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
NI+L ++ I+DFGL+K + T V GT+ Y PE + K+DV++FG
Sbjct: 144 NIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSCPEIVKNEPYGEKADVWAFGC 201
Query: 194 LLLEIVS 200
+L ++ +
Sbjct: 202 ILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-12
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 10/204 (4%)
Query: 20 LQDGTIVAVK---VLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
L DG VA+K + + + + + E+ + +N H N++K + I+ +V
Sbjct: 24 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIKYYASFIEDNELNIVL 81
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+ LS+ + +K++ K + + + L ++H V+HRDIK +N+
Sbjct: 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVF 138
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
+ K+ D GL + F TT + V GT Y++PE KSD++S G LL
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLY 197
Query: 197 EIVSGRTAVDFDVQLGEYHLVDKV 220
E+ + ++ D ++ Y L K+
Sbjct: 198 EMAALQSPFYGD-KMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-12
Identities = 54/186 (29%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T VA+K ++ + E+ EF++E + M N CH ++V+L G G +++ + M
Sbjct: 37 TRVAIKTVNEAASMRERIEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRG 94
Query: 83 SLS---QTLLGEEKRRAKFGWKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNIL 136
L ++L E + + +++I G G+AY++ VHRD+ N +
Sbjct: 95 DLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 151
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVL 194
+ ++F KI DFG+++ E T + G L +++PE G T SDV+SFGV+
Sbjct: 152 VAEDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210
Query: 195 LLEIVS 200
L EI +
Sbjct: 211 LWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-12
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 11 KVDLAPFIRLQDGTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCHENLVK 61
KV LA + + AVKVL VE EK ++ H L +
Sbjct: 10 KVLLAELKGTDE--LYAVKVLKKDVILQDDDVECTMTEKRVLALAGK-------HPFLTQ 60
Query: 62 LHGGCIDGPCRI-LVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 117
LH C R+ V +Y+ L Q ++ RA+F + A EI++G L ++
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAA--EIVLG----LQFL 112
Query: 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPE 175
HE +++RD+K N+LLD + KI+DFG+ K + TT + GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPE 166
Query: 176 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208
D ++ GVLL E+++G++ + D
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-12
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 23 GTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENLVKLHGGCIDGPCRI---- 73
G +VA+K + +++ EKE + E+ + +N H N+V L D +
Sbjct: 32 GELVALKKVRLDN---EKEGFPITAIREIKILRQLN--HRNIVNLKEIVTDKQDALDFKK 86
Query: 74 ------LVYDYMPNNSLSQTLLG-EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 126
LV++YM ++ L+G E F + + + GL Y H++ + +
Sbjct: 87 DKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFL 138
Query: 127 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRK 185
HRDIK SNILL+ K++DFGL++L+ + T TL Y PE + R
Sbjct: 139 HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPA 198
Query: 186 SDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 220
DV+S G +L E+ + + + +L + L+ ++
Sbjct: 199 IDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-12
Identities = 34/100 (34%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 106 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTR 164
++ I RGL YIH ++HRD+K SNI ++++ KI DFGL++ E T +++TR
Sbjct: 123 LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
Query: 165 VAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 203
Y APE ++ + D++S G ++ E+++G+T
Sbjct: 180 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 55/186 (29%), Positives = 96/186 (51%), Gaps = 22/186 (11%)
Query: 23 GTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMP 80
G I+A K++ +E K + + E+ + N + +V +G DG I + ++M
Sbjct: 30 GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY--IVGFYGAFYSDGEISICM-EHMD 86
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREII----MGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
SL Q L +E +R EI+ + + RGLAY+ E+ Q ++HRD+K SNIL
Sbjct: 87 GGSLDQVL--KEAKRIP------EEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNIL 136
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
++ K+ DFG+S ++ ++ GT Y++PE + +SD++S G+ L+
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 197 EIVSGR 202
E+ GR
Sbjct: 194 ELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-12
Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 5/91 (5%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
GL +H E + V+RD+K NILLD + +ISD GL+ PE + I RV GT+GY+
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYM 168
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
APE + R T D + G L+ E++ G++
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-12
Identities = 46/179 (25%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 24 TIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
+VA+K++ +E + E E E+ ++ + + + K +G + G ++ +Y+
Sbjct: 30 QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VTKYYGSYLKGTKLWIIMEYLGGG 87
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
S L R F ++ I +GL Y+H E + +HRDIK +N+LL + +
Sbjct: 88 SALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGD 139
Query: 143 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
K++DFG++ + +T V GT ++APE K+D++S G+ +E+ G
Sbjct: 140 VKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-12
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 26 VAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
VAVK+L ++ + E + E M ++ + +V++ G C + +LV +
Sbjct: 25 VAVKILKNDNNDPALKDELLREANVMQQLD--NPYIVRMIGIC-EAESWMLVMELAELGP 81
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L++ L ++ + K E++ + G+ Y+ E + VHRD+ N+LL
Sbjct: 82 LNKFL--QKNKHVTE--KNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYA 134
Query: 144 KISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
KISDFGLSK + + + G + + APE + + KSDV+SFGVL+ E S
Sbjct: 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-12
Identities = 50/187 (26%), Positives = 95/187 (50%), Gaps = 27/187 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G +VAVK + + +Q + +EV M + HEN+V+++ + G +V +++
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVMEFLEGG 102
Query: 83 SLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+L+ T + EE+ A + + + + L+ +H + V+HRDIK+ +ILL
Sbjct: 103 ALTDIVTHTRMNEEQIAA---------VCLAVLKALSVLHAQ---GVIHRDIKSDSILLT 150
Query: 139 QNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ K+SDFG +SK P + + GT ++APE + D++S G++
Sbjct: 151 HDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPELISRLPYGPEVDIWSLGIM 205
Query: 195 LLEIVSG 201
++E+V G
Sbjct: 206 VIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-12
Identities = 52/189 (27%), Positives = 98/189 (51%), Gaps = 23/189 (12%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANV----NVCHENLVKLH----GGCIDGPCRIL 74
G IVA+K + +++ E++ + ++S+ + N+ H N+V+L G +D L
Sbjct: 32 GEIVALKKVRMDN---ERDGIP-ISSLREITLLLNLRHPNIVELKEVVVGKHLDSI--FL 85
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V +Y + L+ L + F + +++ + RGL Y+HE ++HRD+K SN
Sbjct: 86 VMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSN 138
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGV 193
+LL KI+DFGL++ + ++ +V TL Y APE + T D+++ G
Sbjct: 139 LLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGC 197
Query: 194 LLLEIVSGR 202
+L E+++ +
Sbjct: 198 ILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-12
Identities = 50/187 (26%), Positives = 95/187 (50%), Gaps = 27/187 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G VAVK + + +Q + +EV M + + HEN+V ++ + G +V +++
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYH--HENVVDMYNSYLVGDELWVVMEFLEGG 104
Query: 83 SLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+L+ T + EE+ + + + R L+Y+H + V+HRDIK+ +ILL
Sbjct: 105 ALTDIVTHTRMNEEQIAT---------VCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 152
Query: 139 QNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ K+SDFG +SK P+ + + GT ++APE + D++S G++
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKS-----LVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
Query: 195 LLEIVSG 201
++E++ G
Sbjct: 208 VIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-12
Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 23/185 (12%)
Query: 26 VAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CRILVYDYMPNNS 83
AVK L+ + + ++F+ E M + + H N++ L G C+ ++V YM +
Sbjct: 26 CAVKSLNRITDLEEVEQFLKEGIIMKDFS--HPNVLSLLGICLPSEGSPLVVLPYMKHGD 83
Query: 84 LSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
L + E K FG + + +G+ Y+ + VHRD+ N +LD
Sbjct: 84 LRNFIRSETHNPTVKDLIGFG--------LQVAKGMEYLASK---KFVHRDLAARNCMLD 132
Query: 139 QNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
++F K++DFGL++ + + H T + ++A E + + T KSDV+SFGVLL
Sbjct: 133 ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192
Query: 196 LEIVS 200
E+++
Sbjct: 193 WELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-12
Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 19/153 (12%)
Query: 56 HENLVKLHGGCIDGPCR---ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 112
H+ +V+ +G C+ P + +YMP S+ L + R+I+ G+
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV-- 119
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS----TRVAGT 168
+Y+H + +VHRDIK +NIL D N K+ DFG SK T +S V GT
Sbjct: 120 --SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTGT 172
Query: 169 LGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVS 200
+++PE ISG RK+DV+S ++E+++
Sbjct: 173 PYWMSPE-VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 8e-12
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 39/202 (19%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-----HENLVKLHGGCIDGPCRI--- 73
G +VA+K++ + + E+E E N+ H N+ +G I
Sbjct: 30 TGQLVAIKIMDIIEDE-EEEIKEEY------NILRKYSNHPNIATFYGAFIKKNPPGNDD 82
Query: 74 ---LVYDYMPNNS---LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127
LV + S L + L ++ +R K W A I+ RGLAY+HE V+H
Sbjct: 83 QLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAY--ILRETLRGLAYLHEN---KVIH 136
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTR- 184
RDIK NILL +N K+ DFG+S + + + R GT ++APE I+
Sbjct: 137 RDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTPYWMAPE-VIACDEQPD 192
Query: 185 -----KSDVYSFGVLLLEIVSG 201
+SDV+S G+ +E+ G
Sbjct: 193 ASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 63/188 (33%), Positives = 84/188 (44%), Gaps = 22/188 (11%)
Query: 22 DGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ AVKVL ++ K+ EK MSE + NV H LV LH V DY
Sbjct: 19 EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLK-NVKHPFLVGLHFSFQTADKLYFVLDY 77
Query: 79 MPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+ L L E + RA+F + A I L Y+H ++V+RD+K NI
Sbjct: 78 INGGELFYHLQRERCFLEPRARF-YAAE------IASALGYLH---SLNIVYRDLKPENI 127
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHIST--RVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
LLD + ++DFGL K EN H T GT YLAPE R D + G
Sbjct: 128 LLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 184
Query: 194 LLLEIVSG 201
+L E++ G
Sbjct: 185 VLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 48/133 (36%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 74 LVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
LV DYM L L E + RAKF + A E+++ L ++H+ +V+RD+
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKF-YIA--ELVLA----LEHLHKY---DIVYRDL 122
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV-AGTLGYLAPEYAISGR-LTRKSDV 188
K NILLD + + DFGLSK T + +T GT YLAPE + + T+ D
Sbjct: 123 KPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 189 YSFGVLLLEIVSG 201
+S GVL+ E+ G
Sbjct: 181 WSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-11
Identities = 31/86 (36%), Positives = 49/86 (56%), Gaps = 7/86 (8%)
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 175
Y+H + +++RD+K N+LLD + K++DFG +K P+ T + GT YLAPE
Sbjct: 133 YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL----CGTPEYLAPE 185
Query: 176 YAISGRLTRKSDVYSFGVLLLEIVSG 201
S + D ++ GVLL E ++G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 1e-11
Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 8/96 (8%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVAGT 168
RGL Y+H +V+HRD+K SNIL++ N + KI DFGL++ + ++ V T
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169
Query: 169 LGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 203
Y APE +S R T+ D++S G + E+++ +
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 22/197 (11%)
Query: 20 LQDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ +VA+K L + + Q EF E + MA ++ H N+V L G ++++Y
Sbjct: 31 MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH--HPNIVCLLGVVTQEQPVCMLFEY 88
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARRE--------------IIMGIGRGLAYIHEEIQPH 124
+ L + L+ + G + + I + I G+ Y+
Sbjct: 89 LNQGDLHEFLIMRSPH-SDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--- 144
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLT 183
VH+D+ NIL+ + + KISD GLS+ ++ + + + + ++ PE + G+ +
Sbjct: 145 FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS 204
Query: 184 RKSDVYSFGVLLLEIVS 200
SD++SFGV+L EI S
Sbjct: 205 SDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 9/101 (8%)
Query: 107 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP----ENTTHIS 162
I I GL YIH +V+HRD+K N+L++ + KI DFGL++ F EN ++
Sbjct: 111 IYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 163 TRVAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 202
VA T Y APE +S + K+ DV+S G +L E++ +
Sbjct: 168 EYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 23 GTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G IVA+K S + K +K M E+ + + HENLV L LV++++
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR--HENLVNLIEVFRRKKRLYLVFEFVD 83
Query: 81 NNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
+ T+L + EK R+ + I RG+ + H +++HRDIK NIL+ Q
Sbjct: 84 H-----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQ 135
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEI 198
+ K+ DFG ++ + T T Y APE + + R D+++ G L+ E+
Sbjct: 136 SGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194
Query: 199 VSG 201
++G
Sbjct: 195 LTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 17 FIRLQDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--- 69
++ +DG+ VAVK+L + S +EF+ E A M + H N++KL G +
Sbjct: 19 QLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD--HPNVIKLIGVSLRSRAK 76
Query: 70 ---PCRILVYDYMPNNSLSQTLL----GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 122
P +++ +M + L LL GEE R ++ I G+ Y+ +
Sbjct: 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR--FMIDIASGMEYLSSK-- 132
Query: 123 PHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGR 181
+ +HRD+ N +L++N ++DFGLS K++ + + +LA E
Sbjct: 133 -NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV 191
Query: 182 LTRKSDVYSFGVLLLEIVS-GRT 203
T SDV++FGV + EI++ G+T
Sbjct: 192 YTTHSDVWAFGVTMWEIMTRGQT 214
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVAS---MANVNVCHENLVKLHGGCIDGPCRILVY 76
L+ TIV K + E + E++ + + + ++ + KLH L+
Sbjct: 36 LKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH----------LIL 84
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
DY+ L L +R +F +E+ + G + + + +++RDIK NIL
Sbjct: 85 DYINGGELFTHL----SQRERF---KEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL--TRKSDVYSFGVL 194
LD N + ++DFGLSK F E+ + GT+ Y+AP+ G + D +S GVL
Sbjct: 138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197
Query: 195 LLEIVSGRTAVDFD 208
+ E+++G + D
Sbjct: 198 MYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL---FPENTTHISTRVAGT 168
RGL YIH +V+HRD+K SN+L++++ +I DFG+++ P + T T
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 169 LGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR 202
Y APE +S T D++S G + E++ GR
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 44/187 (23%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
+ G A K++ +ES++ ++FM E+ ++ H N+V L+ ++ ++
Sbjct: 28 ETGLFAAAKIIQIESEEELEDFMVEIDILSECK--HPNIVGLYEAYFYENKLWILIEFCD 85
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
+L +L E+ R + + L ++H V+HRD+K NILL +
Sbjct: 86 GGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLD 139
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLL 195
+ K++DFG+S T + GT ++APE K+D++S G+ L
Sbjct: 140 GDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDYKADIWSLGITL 198
Query: 196 LEIVSGR 202
+E+
Sbjct: 199 IELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 26 VAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K L S + KE + E MA+V+ + ++ +L G C+ + L+ MP L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTSTVQ-LITQLMPFGCL 95
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ + + G + + I +G+ Y+ E +VHRD+ N+L+ + K
Sbjct: 96 LDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVK 149
Query: 145 ISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
I+DFGL+KL + + + + ++A E + T +SDV+S+GV + E+++
Sbjct: 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 60/224 (26%)
Query: 21 QDGTIVAVKVLS----VESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 71
G + A+KVL ++ Q E++ +++ S +VKL+ D
Sbjct: 24 DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW--------IVKLYYSFQDEEH 75
Query: 72 RILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127
LV +YMP L LL + A+F + A E+++ + +H + +H
Sbjct: 76 LYLVMEYMPGGDL-MNLLIRKDVFPEETARF-YIA--ELVLAL----DSVH---KLGFIH 124
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPE----------------------------NTT 159
RDIK NIL+D + + K++DFGL K +
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
+ GT Y+APE + D +S GV+L E++ G
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAG 167
I GL ++H + +++RD+K N++LD + KI+DFG+ K +F TT G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCG 163
Query: 168 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206
T Y+APE + D ++FGVLL E+++G+ D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGT 168
I RGL Y+H ++HRDIK N+L++ N KI DFGL+++ P+ + H++ V T
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 169 LGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 202
Y APE + S T D++S G + E++ R
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-11
Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 23/190 (12%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFM-SEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
I + G VA+K +++ +Q +KE + +E+ M H N+V + G +V
Sbjct: 39 IDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENK--HPNIVNYLDSYLVGDELWVVM 95
Query: 77 DYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
+Y+ SL+ +T + E + A RE + + L ++H V+HRDIK+
Sbjct: 96 EYLAGGSLTDVVTETCMDEGQIAA-----VCRECL----QALEFLHSN---QVIHRDIKS 143
Query: 133 SNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
NILL + + K++DFG +++ PE + + + GT ++APE K D++S
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 192 GVLLLEIVSG 201
G++ +E+V G
Sbjct: 202 GIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 48/186 (25%), Positives = 95/186 (51%), Gaps = 20/186 (10%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYM 79
+ G + A KV+ +S++ +++M E+ +A N H +VKL G DG I++ ++
Sbjct: 35 ETGALAAAKVIETKSEEELEDYMVEIEILATCN--HPYIVKLLGAFYWDGKLWIMI-EFC 91
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
P ++ +L ++ + + I + L Y+H ++HRD+K N+LL
Sbjct: 92 PGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTL 145
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGRLTR-----KSDVYSFG 192
+ + K++DFG+S +N + R + GT ++APE + + K+D++S G
Sbjct: 146 DGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG 202
Query: 193 VLLLEI 198
+ L+E+
Sbjct: 203 ITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 3e-11
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 23/195 (11%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRI----- 73
++ G + A+KV+ V + E+E E+ +M H N+ +G I P +
Sbjct: 28 VKTGQLAAIKVMDVTGDE-EEEIKQEI-NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYIHEEIQPHVVHRDIK 131
LV ++ S++ + + K W A REI+ RGL+++H Q V+HRDIK
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL----RGLSHLH---QHKVIHRDIK 138
Query: 132 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKS 186
N+LL +N K+ DFG+S +T + GT ++APE KS
Sbjct: 139 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKS 197
Query: 187 DVYSFGVLLLEIVSG 201
D++S G+ +E+ G
Sbjct: 198 DLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-11
Identities = 38/110 (34%), Positives = 62/110 (56%), Gaps = 18/110 (16%)
Query: 103 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN----- 157
+R I+ + + L YIH +V+HRD+K SNILL+ + K++DFGL++ E
Sbjct: 109 KRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 158 ----TTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 202
T +++TR Y APE + S R T+ D++S G +L E++ G+
Sbjct: 166 NPVLTDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-11
Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 22/187 (11%)
Query: 22 DGTIVAVK----VLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
D T VAVK L + K +F+ E + + H N+V+L G C +V +
Sbjct: 19 DNTPVAVKSCRETLPPDLKA---KFLQEARILKQYS--HPNIVRLIGVCTQKQPIYIVME 73
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+ T L E R K K +++ G+ Y+ + H +HRD+ N L+
Sbjct: 74 LVQGGDF-LTFLRTEGPRLKV--KELIQMVENAAAGMEYLESK---HCIHRDLAARNCLV 127
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGRLTRKSDVYSFGV 193
+ KISDFG+S+ E + G + + APE GR + +SDV+SFG+
Sbjct: 128 TEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGI 184
Query: 194 LLLEIVS 200
LL E S
Sbjct: 185 LLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-11
Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
GL + E +V+RD+K NILLD + +ISD GL+ PE T + RV GT+GY+
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYM 168
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
APE + + T D + G L+ E++ G++
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-11
Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 19/180 (10%)
Query: 53 NVCHENLVKLHGGCIDGPCRILVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIG 111
NV H +++++ + G +V +P+ +S T L + R I I
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPI--DQALIIEKQIL 167
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 171
GL Y+H ++HRD+KT NI ++ I D G ++ FP +AGT+
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAF-LGLAGTVET 222
Query: 172 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD--------VQLGEYHLVDKVRSI 223
APE + K+D++S G++L E+++ + + D V+ HL+ + ++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282
|
Length = 357 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-11
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 11/100 (11%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 164
EII+G L ++H VV+RD+K +NILLD++ + +ISD GL+ F + H S
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 156
Query: 165 VAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGRT 203
GT GY+APE G S D +S G +L +++ G +
Sbjct: 157 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-11
Identities = 51/177 (28%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 26 VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+KVL S + KE + E MA V + + +L G C+ + LV MP L
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPY--VCRLLGICLTSTVQ-LVTQLMPYGCL 95
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ + + + G + + I +G++Y+ EE++ +VHRD+ N+L+ + K
Sbjct: 96 LDYV---RENKDRIGSQDLLNWCVQIAKGMSYL-EEVR--LVHRDLAARNVLVKSPNHVK 149
Query: 145 ISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
I+DFGL++L + T + ++A E + R T +SDV+S+GV + E+++
Sbjct: 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-11
Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 26 VAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
VA+ L KQ + F++E ++ + H N+V+L G G ++V +YM N +
Sbjct: 36 VAIHTLRAGCSDKQ-RRGFLAEALTLGQFD--HSNIVRLEGVITRGNTMMIVTEYMSNGA 92
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L K + ++ G+ G+ Y+ E VH+ + +L++ +
Sbjct: 93 LDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVC 146
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYL--APEYAISGRLTRKSDVYSFGVLLLEIVS 200
KIS F +L + + I T ++G L APE + SDV+SFG+++ E++S
Sbjct: 147 KISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-11
Identities = 57/186 (30%), Positives = 90/186 (48%), Gaps = 15/186 (8%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T VAVK ++ + E+ EF++E + M CH ++V+L G G ++V + M +
Sbjct: 37 TRVAVKTVNESASLRERIEFLNEASVMKGFT-CH-HVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 83 SLSQTLLG----EEKRRAKFGWKARREIIMG--IGRGLAYIHEEIQPHVVHRDIKTSNIL 136
L L E + + I M I G+AY++ + VHRD+ N +
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCM 151
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVL 194
+ +F KI DFG+++ E T + G L ++APE G T SD++SFGV+
Sbjct: 152 VAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210
Query: 195 LLEIVS 200
L EI S
Sbjct: 211 LWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-11
Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDG 69
KV L R V VK L + E+ F+ EV +N H N+++ G CI+
Sbjct: 10 KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN--HPNVLQCLGQCIES 67
Query: 70 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK-ARREIIMGIGRGLAYIHEEIQPHVVHR 128
+LV ++ P L L A+ K + + + GL ++H Q +H
Sbjct: 68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHS 124
Query: 129 DIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYA-------ISG 180
D+ N L + + KI D+GL+ + +PE+ A L +LAPE +
Sbjct: 125 DLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPK 184
Query: 181 RLTRKSDVYSFGVLLLEI 198
T+KS+++S GV + E+
Sbjct: 185 DQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-11
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 23/195 (11%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPC-----RI 73
++ G + A+KV+ V + E+E E+ +M H N+ +G I P
Sbjct: 38 VKTGQLAAIKVMDVTEDE-EEEIKLEI-NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYIHEEIQPHVVHRDIK 131
LV ++ S++ + + K W A REI+ RGLA++H V+HRDIK
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL----RGLAHLHAH---KVIHRDIK 148
Query: 132 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKS 186
N+LL +N K+ DFG+S +T + GT ++APE +S
Sbjct: 149 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRS 207
Query: 187 DVYSFGVLLLEIVSG 201
D++S G+ +E+ G
Sbjct: 208 DIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-11
Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 14/182 (7%)
Query: 23 GTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMP 80
G I+A K++ +E K + + E+ + N + +V +G DG I + ++M
Sbjct: 30 GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY--IVGFYGAFYSDGEISICM-EHMD 86
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
SL Q L K+ + + ++ + + +GL Y+ E+ + ++HRD+K SNIL++
Sbjct: 87 GGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR 140
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
K+ DFG+S ++ ++ GT Y++PE + +SD++S G+ L+E+
Sbjct: 141 GEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197
Query: 201 GR 202
GR
Sbjct: 198 GR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-11
Identities = 46/178 (25%), Positives = 90/178 (50%), Gaps = 12/178 (6%)
Query: 25 IVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
+VA+K++ +E + E E E+ ++ + + + + +G + G ++ +Y+ S
Sbjct: 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--ITRYYGSYLKGTKLWIIMEYLGGGS 88
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
+ LL + REI+ +GL Y+H E + +HRDIK +N+LL + +
Sbjct: 89 -ALDLLKPGPLEETYIATILREIL----KGLDYLHSERK---IHRDIKAANVLLSEQGDV 140
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
K++DFG++ + +T V GT ++APE K+D++S G+ +E+ G
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-11
Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
G+ +IHE+ V+HRDIK+ NI L QN K+ DFG ++L + T V GT Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVS 200
PE + KSD++S G +L E+ +
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-11
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 46/203 (22%)
Query: 20 LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
G IVA+K + +E+ E E + E++ + +N H N+V+L L
Sbjct: 21 KLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELN--HPNIVRLLDVVHSENKLYL 75
Query: 75 VYDYM-----------PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 123
V++++ P L L+ + + + +G+AY H
Sbjct: 76 VFEFLDLDLKKYMDSSPLTGLDPPLI--------------KSYLYQLLQGIAYCH---SH 118
Query: 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPEYAISG 180
V+HRD+K N+L+D+ K++DFGL++ F P T TH V TL Y APE +
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLGS 174
Query: 181 RLTRKS-DVYSFGVLLLEIVSGR 202
R D++S G + E+V+ R
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-11
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 23 GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
+VA+K + +E ++G + EV+ + N+ H N+V LH C LV++Y+ +
Sbjct: 30 ENLVALKEIRLEHEEGAPCTAIREVSLLKNLK--HANIVTLHDIIHTERCLTLVFEYL-D 86
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
+ L Q L + K + + RGL+Y H+ ++HRD+K N+L+++
Sbjct: 87 SDLKQYLDNCGNLMSMHNVKI---FMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKG 140
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVS 200
K++DFGL++ T S V TL Y P+ + S + D++ G +L E+ +
Sbjct: 141 ELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
Query: 201 GRTAVDFDVQLGEYHLV 217
GR E HL+
Sbjct: 200 GRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-11
Identities = 44/180 (24%), Positives = 90/180 (50%), Gaps = 13/180 (7%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G VA+K ++++ + ++ ++E+ M + + N+V + G +V +Y+
Sbjct: 44 GQEVAIKQINLQKQPKKELIINEILVMKELK--NPNIVNFLDSFLVGDELFVVMEYLAGG 101
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
SL+ + A+ R + + L ++H V+HRDIK+ N+LL + +
Sbjct: 102 SLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVIHRDIKSDNVLLGMDGS 153
Query: 143 PKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
K++DFG +++ PE + + + GT ++APE K D++S G++ +E+V G
Sbjct: 154 VKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-11
Identities = 40/112 (35%), Positives = 65/112 (58%), Gaps = 11/112 (9%)
Query: 92 EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151
++ RA+F + A EII G L ++H++ +++RD+K N+LLD++ + KI+DFG+
Sbjct: 94 DEARARF-YAA--EIICG----LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMC 143
Query: 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
K ST GT Y+APE + D +SFGVLL E++ G++
Sbjct: 144 KENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 54/188 (28%), Positives = 93/188 (49%), Gaps = 18/188 (9%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
+G +VA+KV+S+++++G AS+ + H N+V LH V++YM
Sbjct: 29 NGQLVALKVISMKTEEGVPFTAIREASLLK-GLKHANIVLLHDIIHTKETLTFVFEYM-- 85
Query: 82 NSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
T L + + G R + + RGLAYIH + H++HRD+K N+L+
Sbjct: 86 ----HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISY 138
Query: 140 NFNPKISDFGL--SKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLL 196
K++DFGL +K P T S+ V TL Y P+ + + + D++ G + +
Sbjct: 139 LGELKLADFGLARAKSIPSQT--YSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFI 195
Query: 197 EIVSGRTA 204
E++ G+ A
Sbjct: 196 EMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 164
EII G L ++H + +V+RD+K NILLD + + KI+DFG+ K T
Sbjct: 104 EIICG----LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT- 155
Query: 165 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
GT Y+APE + + D +SFGVLL E++ G++
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 11/165 (6%)
Query: 42 FMSEVASMANVNVCHENLVKLHGGCIDGPCRILV-YDYMPNNSLSQTL----LGEEKRRA 96
+ E + ++ H+N++ + CI+ V Y YM +L L LGE
Sbjct: 55 LLQESCLLYGLS--HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112
Query: 97 KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFP 155
+ + + I G++Y+H+ V+H+DI N ++D+ KI+D LS+ LFP
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ + + ++A E ++ + SDV+SFGVLL E+++
Sbjct: 170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 33/93 (35%), Positives = 58/93 (62%), Gaps = 8/93 (8%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 170
GL ++H + +++RD+K N++LD++ + KI+DFG+ K +F +N ++ GT
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPD 161
Query: 171 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
Y+APE + T D +SFGVLL E++ G++
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 169
I G+ ++H +V+RD+K N+LLD N ++SD GL+ + T T+ AGT
Sbjct: 104 ITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTN 158
Query: 170 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
GY+APE + D ++ G + E+V+GRT
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 56 HENLVKLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMG 109
H LV LH C R+ V +++ L Q L EE R EI +
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-----EISLA 108
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAG 167
L ++HE +++RD+K N+LLD + K++D+G+ K + P +TT + G
Sbjct: 109 ----LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCG 158
Query: 168 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206
T Y+APE D ++ GVL+ E+++GR+ D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHE 57
A V +RL+K + R+ +V ++++ ++ Q EK + ++ H
Sbjct: 9 AKVLLVRLKKTE-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------HP 56
Query: 58 NLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 116
LV LH C R+ V +Y+ L + +R+ K + R I L Y
Sbjct: 57 FLVGLHS-CFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 117 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAP 174
+HE +++RD+K N+LLD + K++D+G+ K L P +TT + GT Y+AP
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAP 165
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206
E D ++ GVL+ E+++GR+ D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-10
Identities = 47/186 (25%), Positives = 91/186 (48%), Gaps = 10/186 (5%)
Query: 21 QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+DG +K +++ S + +E EVA ++N+ H N+V+ + +V DY
Sbjct: 23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK--HPNIVQYQESFEENGNLYIVMDY 80
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
L + + +R F + + I L ++H+ ++HRDIK+ NI L
Sbjct: 81 CEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLT 135
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
++ K+ DFG++++ +T ++ GT YL+PE + KSD+++ G +L E+
Sbjct: 136 KDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194
Query: 199 VSGRTA 204
+ + A
Sbjct: 195 CTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 65/206 (31%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLV 60
+G KV LA R DG AVKVL V +++ +K M+E + NV H LV
Sbjct: 3 IGKGSFGKVLLAK--RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK-NVKHPFLV 59
Query: 61 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYI 117
LH V D++ L L E + RA+F I L Y+
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYL 112
Query: 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPE 175
H ++V+RD+K NILLD + ++DFGL K + +TT T GT YLAPE
Sbjct: 113 H---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPE 166
Query: 176 YAISGRLTRKSDVYSFGVLLLEIVSG 201
D + G +L E++ G
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 11/100 (11%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 164
EII+G L ++H VV+RD+K +NILLD++ + +ISD GL+ F + H S
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 156
Query: 165 VAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGRT 203
GT GY+APE G S D +S G +L +++ G +
Sbjct: 157 --GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 59 LVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 117
LV LH C R+ LV +Y+ L + +R+ K + R I L ++
Sbjct: 58 LVGLHS-CFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIALNFL 112
Query: 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPE 175
HE +++RD+K N+LLD + + K++D+G+ K L P +TT + GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPE 166
Query: 176 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206
D ++ GVL+ E+++GR+ D
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 31/100 (31%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 164
E + I L Y+HE+ H++HRD+KT N+ L + K+ D G++++ EN +++
Sbjct: 106 EWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMAST 161
Query: 165 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 204
+ GT Y++PE + KSDV++ G + E+ + + A
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 32/79 (40%), Positives = 51/79 (64%), Gaps = 5/79 (6%)
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGRL 182
+++RD+K NILLD+ + K++DFGLSK E+ H + GT+ Y+APE
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 183 TRKSDVYSFGVLLLEIVSG 201
T+ +D +SFGVL+ E+++G
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 31/77 (40%), Positives = 46/77 (59%), Gaps = 1/77 (1%)
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 184
V++RD+K NILLD + + DFGL KL ++ +T GT YLAPE + T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTK 172
Query: 185 KSDVYSFGVLLLEIVSG 201
D ++ GVLL E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 34/186 (18%)
Query: 35 SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR 94
SK ++F E+ + + H N++ L G C L +Y P+ +L L K
Sbjct: 47 SKDDHRDFAGELEVLCKLGH-HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKS 102
Query: 95 RA-----KFGWKARREIIMG----------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
R F + + RG+ Y+ Q +HRD+ NIL+ +
Sbjct: 103 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE 159
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLG-----YLAPEYAISGRLTRKSDVYSFGVL 194
N+ KI+DFGLS+ V T+G ++A E T SDV+S+GVL
Sbjct: 160 NYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 212
Query: 195 LLEIVS 200
L EIVS
Sbjct: 213 LWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 4e-10
Identities = 53/191 (27%), Positives = 101/191 (52%), Gaps = 27/191 (14%)
Query: 23 GTIVAVKVLSVESKQGEKE-FMSEVASMANVNVC----HENLVKLH----GGCIDGPCRI 73
G IVA+K L +E EKE F + S+ +N+ H N+V + G +D +I
Sbjct: 30 GEIVALKKLKMEK---EKEGF--PITSLREINILLKLQHPNIVTVKEVVVGSNLD---KI 81
Query: 74 -LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
+V +Y+ ++ ++L+ K+ F + +++ + G+A++H+ ++HRD+KT
Sbjct: 82 YMVMEYVEHDL--KSLMETMKQP--FLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKT 134
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSF 191
SN+LL+ KI DFGL++ + T++ TL Y APE + + + D++S
Sbjct: 135 SNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193
Query: 192 GVLLLEIVSGR 202
G + E+++ +
Sbjct: 194 GCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-10
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 53/204 (25%)
Query: 18 IRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASM------------------ANVNVCHEN 58
L I+AVKV+ ++ + + +K+ MSE+ + +++C E
Sbjct: 21 YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE- 79
Query: 59 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 118
+ GG +D VY +P + L + I + + +GL Y+
Sbjct: 80 --FMDGGSLD------VYRKIPEHVLGR-------------------IAVAVVKGLTYLW 112
Query: 119 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 178
++HRD+K SN+L++ K+ DFG+S + I+ GT Y+APE
Sbjct: 113 ---SLKILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERIS 166
Query: 179 SGRLTRKSDVYSFGVLLLEIVSGR 202
+ SDV+S G+ +E+ GR
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-10
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 27 AVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL- 84
A+K + SK ++F E+ + + H N++ L G C L +Y P+ +L
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLL 84
Query: 85 -----SQTLLGEEKRRAKFGWKA---RREIIM---GIGRGLAYIHEEIQPHVVHRDIKTS 133
S+ L + + ++++ + RG+ Y+ ++ +HRD+
Sbjct: 85 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR 141
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
NIL+ +N+ KI+DFGLS+ + T + ++A E T SDV+S+GV
Sbjct: 142 NILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 199
Query: 194 LLLEIVS-------GRTAVDFDVQLGEYHLVDKVRSINMKLY 228
LL EIVS G T + +L + + ++K + + ++Y
Sbjct: 200 LLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY 241
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 60/235 (25%), Positives = 92/235 (39%), Gaps = 60/235 (25%)
Query: 24 TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCI--DGPCRILVYDYMP 80
VAVK+L + E K M+E+ + ++ H N+V L G C GP ++V +Y
Sbjct: 38 RTVAVKMLKEGATASEYKALMTELKILIHIGH-HLNVVNLLGACTKPGGPLMVIV-EYCK 95
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA-----------------------YI 117
+LS L + + + + K+ R+ M G
Sbjct: 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155
Query: 118 HEEIQP-------------------------------HVVHRDIKTSNILLDQNFNPKIS 146
EE + +HRD+ NILL +N KI
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKIC 215
Query: 147 DFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
DFGL++ ++ ++ A L ++APE T +SDV+SFGVLL EI S
Sbjct: 216 DFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVA 166
+ RG+ ++ +HRD+ NILL +N KI DFGL++ P+ S R+
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 167 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
L ++APE T +SDV+SFGVLL EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 42 FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK 101
F E MA+ N E +V+LH D +V +YMP L L+ K+
Sbjct: 90 FWEERDIMAHAN--SEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEKWARF 146
Query: 102 ARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTH 160
E+++ L IH +HRD+K N+LLD++ + K++DFG K+
Sbjct: 147 YTAEVVLA----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199
Query: 161 ISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 214
T V GT Y++PE S G R+ D +S GV L E++ G T D +G Y
Sbjct: 200 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 30/195 (15%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVC--HENLVKLHGGCI-DGPCRILVYDYMPNN 82
VAVK+L + +K+ ++ M + + H+N++ L G C +GP ++V +Y
Sbjct: 47 VAVKML--KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKG 103
Query: 83 SLSQTLL------------GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
+L + L + + +K + RG+ Y+ +HRD+
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDL 160
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG-----YLAPEYAISGRLTRK 185
N+L+ ++ KI+DFGL++ I + G ++APE T +
Sbjct: 161 AARNVLVTEDNVMKIADFGLAR----GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216
Query: 186 SDVYSFGVLLLEIVS 200
SDV+SFG+L+ EI +
Sbjct: 217 SDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 171
RGL YIH +V+HRD+K SN+LL+ N + KI DFGL++ E ++ V T Y
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 172 LAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 203
APE ++ T DV+S G + E++ +
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-10
Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 14/101 (13%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN----------TTHIS 162
G+ Y+HE H++HRDIK +NIL+D KI+DFGL++ + T
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 163 TRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 202
T + T Y PE + R T D++ G + E+ + R
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-10
Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGT 168
I GL +IH+ ++HRDIK+ NI L +N K+ DFG+++ ++ ++ GT
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGT 165
Query: 169 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
YL+PE + K+D++S G +L E+ +
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-10
Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 7 IRLEKVDLAPFIRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 59
I+LEK+ + + G +VA+K + +E ++G + EV+ + ++ H N+
Sbjct: 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANI 66
Query: 60 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 119
V LH LV++Y+ + L Q + + + + I RGLAY H
Sbjct: 67 VTLHDIVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 120 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI- 178
V+HRD+K N+L+++ K++DFGL++ T S V TL Y P+ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 179 SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 217
S + + D++ G + E+ SGR E HL+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-10
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 27 AVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL- 84
A+K+L S+ ++F E+ + + H N++ L G C + + +Y P +L
Sbjct: 33 AIKMLKEFASENDHRDFAGELEVLCKLGH-HPNIINLLGACENRGYLYIAIEYAPYGNLL 91
Query: 85 -----SQTLLGEEKRRAKFGWKA---RREII---MGIGRGLAYIHEEIQPHVVHRDIKTS 133
S+ L + + G + ++++ + G+ Y+ E+ +HRD+
Sbjct: 92 DFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAAR 148
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG-----YLAPEYAISGRLTRKSDV 188
N+L+ +N KI+DFGLS+ V T+G ++A E T KSDV
Sbjct: 149 NVLVGENLASKIADFGLSR-------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDV 201
Query: 189 YSFGVLLLEIVS-------GRTAVDFDVQLGEYHLVDKVRSINMKLY 228
+SFGVLL EIVS G T + +L + + ++K R+ + ++Y
Sbjct: 202 WSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVY 248
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-10
Identities = 48/184 (26%), Positives = 91/184 (49%), Gaps = 10/184 (5%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
+G +VA+KV+ ++ ++G AS+ + H N+V LH LV++Y+ +
Sbjct: 29 NGKLVALKVIRLQEEEGTPFTAIREASLLK-GLKHANIVLLHDIIHTKETLTLVFEYV-H 86
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
L Q + +K + + + + RGL+YIH Q +++HRD+K N+L+
Sbjct: 87 TDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTG 140
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVS 200
K++DFGL++ +H + TL Y P+ + S + D++ G + +E++
Sbjct: 141 ELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199
Query: 201 GRTA 204
G A
Sbjct: 200 GVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 12/100 (12%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST- 163
EI+ +G Y+H VV+RD+K N++LD++ + KI+DFGL K E + +T
Sbjct: 103 EIVSALG----YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATM 152
Query: 164 -RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
GT YLAPE R D + GV++ E++ GR
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 46/181 (25%), Positives = 89/181 (49%), Gaps = 15/181 (8%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASM-ANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
G VA+K ++++ + ++ ++E+ M N N N+V + G +V +Y+
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKN---PNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
SL+ + + R + + L ++H V+HRDIK+ NILL +
Sbjct: 101 GSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVIHRDIKSDNILLGMDG 152
Query: 142 NPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ K++DFG +++ PE + + + GT ++APE K D++S G++ +E+V
Sbjct: 153 SVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210
Query: 201 G 201
G
Sbjct: 211 G 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 8 RLEKVDLAPFIRLQDG------TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLV 60
+LEK+ F + G +VA+K++ +E + E ++ E+ ++ + + +
Sbjct: 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VT 65
Query: 61 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 120
K +G + ++ +Y+ S L + REI+ +GL Y+H E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-TILREIL----KGLDYLHSE 120
Query: 121 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 180
+ +HRDIK +N+LL ++ K++DFG++ + +T V GT ++APE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 181 RLTRKSDVYSFGVLLLEIVSG 201
K+D++S G+ +E+ G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAG 167
I L Y+H VV+RDIK N++LD++ + KI+DFGL K E + +T G
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 168 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
T YLAPE R D + GV++ E++ GR
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 169
I L Y+H E +VV+RD+K N++LD++ + KI+DFGL K ++ + T GT
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 160
Query: 170 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
YLAPE R D + GV++ E++ GR
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 34/100 (34%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 106 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTR 164
+I I RGL YIH ++HRD+K SN+ ++++ KI DFGL++ + T +++TR
Sbjct: 125 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 165 VAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 203
Y APE ++ + D++S G ++ E+++GRT
Sbjct: 182 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-- 179
Q H VHRDIK NIL+D N + +++DFG E+ T S+ GT Y++PE +
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 180 ---GRLTRKSDVYSFGVLLLEIVSGRT 203
G+ + D +S GV + E++ G T
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 38/198 (19%)
Query: 20 LQDGTIVAVKVLSVE-SKQGEKEFM-SEVASMANVNVC-HENLVKL----HGGCIDGPCR 72
L G VA+K + V S++G E+A + + H N+V+L HG D +
Sbjct: 21 LNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80
Query: 73 I-LVYDYMPNNSLSQTLLGEEKRRAKFG---WKARREIIMGIGRGLAYIHEEIQPH-VVH 127
+ LV++++ + L+ L + K G + ++ + RG+ ++H H +VH
Sbjct: 81 LTLVFEHV-DQDLATYL----SKCPKPGLPPETIKD-LMRQLLRGVDFLHS----HRIVH 130
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTLGYLAPE------YAISG 180
RD+K NIL+ + KI+DFGL++++ + ++ T V TL Y APE YA
Sbjct: 131 RDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLWYRAPEVLLQSSYATP- 186
Query: 181 RLTRKSDVYSFGVLLLEI 198
D++S G + E+
Sbjct: 187 -----VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 25 IVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
+VAVK +S KQ ++ + EV + + H N ++ G + LV +Y
Sbjct: 48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK--HPNTIEYKGCYLKEHTAWLVMEYCLG 105
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
S S L +K + A I G +GLAY+H +++HRDIK NILL +
Sbjct: 106 -SASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPG 158
Query: 142 NPKISDFG-LSKLFPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLE 197
K++DFG SK P N+ GT ++APE ++ G+ K DV+S G+ +E
Sbjct: 159 QVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 212
Query: 198 IVSGRTAV-DFDVQLGEYHL 216
+ + + + + YH+
Sbjct: 213 LAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 13/190 (6%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMA-NVNVCHENLVKLHGGCIDGPCRI--LVYD 77
+DG A+K + +Q S +A + HEN+V L ++ + L++D
Sbjct: 25 KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
Y ++ + +R + ++ I G+ Y+H V+HRD+K +NIL+
Sbjct: 85 YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILV 141
Query: 138 DQNFNP----KISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYS 190
KI D GL++LF P V T+ Y APE + R T+ D+++
Sbjct: 142 MGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201
Query: 191 FGVLLLEIVS 200
G + E+++
Sbjct: 202 IGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 28/77 (36%), Positives = 50/77 (64%), Gaps = 1/77 (1%)
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLT 183
++HRD+K++NI L K+ DFG SK + ++ + +++ GT YLAPE R +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 184 RKSDVYSFGVLLLEIVS 200
+K+D++S GV+L E+++
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 19/167 (11%)
Query: 56 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRG 113
H N+V+L LV++Y L L F R + + I RG
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF--PENT-THISTRVAGTL 169
+AY H V+HRD+K N+L+D+ N K++DFGL++ F P T TH TL
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TL 167
Query: 170 GYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 215
Y APE + R + D++S G + E+V+ + D ++ E
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-09
Identities = 44/181 (24%), Positives = 89/181 (49%), Gaps = 15/181 (8%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASM-ANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
G VA++ ++++ + ++ ++E+ M N N N+V + G +V +Y+
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKN---PNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
SL+ + + R + + L ++H V+HRDIK+ NILL +
Sbjct: 102 GSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVIHRDIKSDNILLGMDG 153
Query: 142 NPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ K++DFG +++ PE + + + GT ++APE K D++S G++ +E++
Sbjct: 154 SVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 201 G 201
G
Sbjct: 212 G 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-09
Identities = 39/143 (27%), Positives = 65/143 (45%), Gaps = 5/143 (3%)
Query: 56 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 115
H +VK H ++ ++ +Y L L + E + + G+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 175
Y+H+ ++HRD+K NI L N KI DFG+S+L + ++T GT Y++PE
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE 175
Query: 176 YAISGRLTRKSDVYSFGVLLLEI 198
KSD++S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 169
I + IH Q H VHRDIK N+LLD N + +++DFG ++ T S+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 170 GYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRT 203
Y++PE + G+ + D +S GV + E++ G T
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-09
Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 8/99 (8%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRV-AG 167
I GL ++H +++RD+K N++LD + KI+DFG+ K E+ ++TR G
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 168 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206
T Y+APE + D +++GVLL E+++G+ D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-09
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 171
+GLA+ H +V+HRD+K N+L+++N K++DFGL++ F S V TL Y
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWY 165
Query: 172 LAPEYAISGRLTRKS-DVYSFGVLLLEIVSG 201
P+ +L S D++S G + E+ +
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 31/79 (39%), Positives = 47/79 (59%), Gaps = 3/79 (3%)
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-- 182
+V+RDIK NILLD + ++DFGLSK F + GT+ Y+APE I G+
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIRGKGGH 184
Query: 183 TRKSDVYSFGVLLLEIVSG 201
+ D +S G+L+ E+++G
Sbjct: 185 GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 23 GTIVAVKVLSV---------ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73
A+KV+++ + EK + EV+ H +++L D
Sbjct: 26 EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--------HPFIIRLFWTEHDQRFLY 77
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
++ +Y+P L L + +F I L Y+H + +V+RD+K
Sbjct: 78 MLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPE 130
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
NILLD+ + K++DFG +K + T + GT YLAPE S + D ++ G+
Sbjct: 131 NILLDKEGHIKLTDFGFAKKLRDRTWTL----CGTPEYLAPEVIQSKGHNKAVDWWALGI 186
Query: 194 LLLEIVSG 201
L+ E++ G
Sbjct: 187 LIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 33/216 (15%)
Query: 23 GTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
T+VAVK ++++S E K E+ + + H N++ I +V M
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQL--QHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 81 NNSLSQTLLGEEKRRAKFGWK--ARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
S L K G A I+ + L YIH + +HR +K S+ILL
Sbjct: 83 YGSCEDLL----KTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLS 135
Query: 139 QNFNPKISDF---------GLSKLFPENTTHISTRVAGTLGYLAPEY---AISGRLTRKS 186
+ +S G + + S + L +L+PE + G KS
Sbjct: 136 GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWLSPEVLQQNLQG-YNEKS 191
Query: 187 DVYSFGVLLLEIVSGRTAVDF-DVQLGEYHLVDKVR 221
D+YS G+ E+ +G V F D+ L++KVR
Sbjct: 192 DIYSVGITACELANG--HVPFKDMPA-TQMLLEKVR 224
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 74 LVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+V +YMP L + + ++ AKF E+++ L IH ++HRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKF---YTAEVVLA----LDAIHSM---GLIHRDVK 169
Query: 132 TSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAIS----GRLTRKS 186
N+LLD++ + K++DFG K+ T V GT Y++PE S G R+
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228
Query: 187 DVYSFGVLLLEIVSGRTAVDFDVQLGEY-HLVDKVRSIN 224
D +S GV L E++ G T D +G Y ++D S+N
Sbjct: 229 DWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-09
Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 25/192 (13%)
Query: 26 VAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K L +++ +EF E +M + H N+V L G +++ Y ++ L
Sbjct: 38 VAIKTLKDKAEGPLREEFKHE--AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 85 SQTLL----------GEEKRRAKFGWKARR--EIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
+ L+ ++ + K + I+ I G+ ++ HVVH+D+ T
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLAT 152
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGRLTRKSDV 188
N+L+ N KISD G LF E ++ G + +++PE + G+ + SD+
Sbjct: 153 RNVLVFDKLNVKISDLG---LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI 209
Query: 189 YSFGVLLLEIVS 200
+S+GV+L E+ S
Sbjct: 210 WSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-09
Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 35/199 (17%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI------------ 73
VAVK + + Q K + E+ + ++ H+N+VK++ +
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90
Query: 74 --LVYDYMPN---NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128
+V +YM N L Q L EE R F ++ + RGL YIH +V+HR
Sbjct: 91 VYIVQEYMETDLANVLEQGPLSEEHARL-FMYQ--------LLRGLKYIH---SANVLHR 138
Query: 129 DIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAISGR-LTR 184
D+K +N+ ++ + KI DFGL+++ + +H G + Y +P +S T+
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198
Query: 185 KSDVYSFGVLLLEIVSGRT 203
D+++ G + E+++G+
Sbjct: 199 AIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-09
Identities = 41/173 (23%), Positives = 80/173 (46%), Gaps = 6/173 (3%)
Query: 28 VKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQT 87
V++ + + ++ + E+ + +N H N++K I+ +V + LSQ
Sbjct: 35 VQIFEMMDAKARQDCVKEIDLLKQLN--HPNVIKYLDSFIEDNELNIVLELADAGDLSQM 92
Query: 88 LLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 147
+ +K++ + + + + + ++H V+HRDIK +N+ + K+ D
Sbjct: 93 IKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGD 149
Query: 148 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
GL + F TT + V GT Y++PE KSD++S G LL E+ +
Sbjct: 150 LGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-09
Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
GL ++H Q +++RD+K N+LLD + N +ISD GL+ + + + AGT G++
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFM 164
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
APE D ++ GV L E+++ R
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-09
Identities = 48/185 (25%), Positives = 91/185 (49%), Gaps = 18/185 (9%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
+ G + A KV+ +S++ +++M E+ +A+ + H N+VKL ++ ++
Sbjct: 28 ETGVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIEFCA 85
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
++ +L E+ + R + L Y+HE ++HRD+K NIL +
Sbjct: 86 GGAVDAVMLELERPLTE---PQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLD 139
Query: 141 FNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGR-----LTRKSDVYSFGV 193
+ K++DFG+S +NT I R + GT ++APE + K+DV+S G+
Sbjct: 140 GDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 196
Query: 194 LLLEI 198
L+E+
Sbjct: 197 TLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL-FPENTTHIS-TRVAGTL 169
R L YIH +V HRD+K NIL + + KI DFGL+++ F + T I T T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 170 GYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGR 202
Y APE S + T D++S G + E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-09
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 44/179 (24%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENLVKLHGGCIDGP----- 70
+ IVA+K + +E+ EKE E+ + + HEN+V L C
Sbjct: 35 KTKQIVALKKVLMEN---EKEGFPITALREIKILQLLK--HENVVNLIEICRTKATPYNR 89
Query: 71 CR---ILVYDY-------MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 120
+ LV+++ + +N + L E K+ ++ + GL YIH
Sbjct: 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK-----------VMKMLLNGLYYIHRN 138
Query: 121 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT--THISTRVAGTLGYLAPE 175
++HRD+K +NIL+ ++ K++DFGL++ F +N+ + RV TL Y PE
Sbjct: 139 ---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-09
Identities = 32/76 (42%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTR 184
+HRD+ NILL +N KI DFGL++ ++ ++ A L ++APE T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 185 KSDVYSFGVLLLEIVS 200
+SDV+SFGVLL EI S
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-09
Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 22/181 (12%)
Query: 25 IVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
+VA+K +S KQ ++ + EV + + H N ++ G + LV +Y
Sbjct: 52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK--HPNSIEYKGCYLREHTAWLVMEYCLG 109
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
S S L +K + A I G +GLAY+H +++HRDIK NILL +
Sbjct: 110 -SASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPG 162
Query: 142 NPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLE 197
K++DFG + + P N+ GT ++APE ++ G+ K DV+S G+ +E
Sbjct: 163 QVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216
Query: 198 I 198
+
Sbjct: 217 L 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-09
Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 14/105 (13%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHIST 163
E+++ I +H Q VHRDIK N+LLD+N + +++DFG +L + T +
Sbjct: 110 EMVLAIDS----VH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV 162
Query: 164 RVAGTLGYLAPEY--AI---SGRLTRKSDVYSFGVLLLEIVSGRT 203
V GT Y++PE A+ GR + D +S GV + E++ G T
Sbjct: 163 AV-GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 8e-09
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 37/196 (18%)
Query: 20 LQDGTIVAVKVL-----SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CR 72
+ G A+K + S+E + + E+ ++ ++ H N+++L D
Sbjct: 21 RKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSP-HPNILRLIEVLFDRKTGRL 75
Query: 73 ILVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
LV++ M N L E + R+ K + + + + L ++H + + HRDI
Sbjct: 76 ALVFELMDMN------LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDI 126
Query: 131 KTSNILLDQNFNPKISDFG-----LSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTR 184
K NIL+ + K++DFG SK P T +ISTR Y APE + G
Sbjct: 127 KPENILIKDD-ILKLADFGSCRGIYSK--PPYTEYISTR-----WYRAPECLLTDGYYGP 178
Query: 185 KSDVYSFGVLLLEIVS 200
K D+++ G + EI+S
Sbjct: 179 KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-09
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 8/99 (8%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRV-AG 167
I GL ++H + +++RD+K N++LD + KI+DFG+ K EN ++T+ G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163
Query: 168 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206
T Y+APE + D ++FGVLL E+++G+ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 22/186 (11%)
Query: 20 LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+++ +VA+K +S KQ ++ + EV + + H N ++ G + LV
Sbjct: 37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWLVM 94
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+Y S S L +K + A + G +GLAY+H +++HRD+K NIL
Sbjct: 95 EYCLG-SASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSH---NMIHRDVKAGNIL 147
Query: 137 LDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFG 192
L + K+ DFG + + P N GT ++APE ++ G+ K DV+S G
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
Query: 193 VLLLEI 198
+ +E+
Sbjct: 202 ITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 32/188 (17%)
Query: 23 GTIVAVKVLSVESKQG-EK--EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
+VA+K +S KQ EK + + EV + + H N ++ G + LV +Y
Sbjct: 40 NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR--HPNTIEYKGCYLREHTAWLVMEY- 96
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARRE-----IIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
LG + K +E I G +GLAY+H +HRDIK N
Sbjct: 97 --------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGN 145
Query: 135 ILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYS 190
ILL + K++DFG + L P N+ GT ++APE ++ G+ K DV+S
Sbjct: 146 ILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWS 199
Query: 191 FGVLLLEI 198
G+ +E+
Sbjct: 200 LGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 34/119 (28%), Positives = 64/119 (53%), Gaps = 10/119 (8%)
Query: 87 TLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 146
T LG+ + K + ++ + +GL YIH ++HRD+K N+ ++++ KI
Sbjct: 104 TDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKIL 160
Query: 147 DFGLSKLF-PENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 203
DFGL++ E T ++ TR Y APE ++ T+ D++S G ++ E+++G+
Sbjct: 161 DFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAG 167
I L Y+H +V+RD+K N++LD++ + KI+DFGL K E T +T G
Sbjct: 104 IVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCG 157
Query: 168 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
T YLAPE R D + GV++ E++ GR
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHIS 162
EI + + ++H Q +++RD+K NILLD + K++DFGL K + TH
Sbjct: 108 EISLALE----HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT- 159
Query: 163 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
GT+ Y+APE + + D +S G L+ ++++G
Sbjct: 160 --FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 36/116 (31%), Positives = 60/116 (51%), Gaps = 14/116 (12%)
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 163
++++ + RGL ++H VVHRD+K NIL+ + K++DFGL++++ + T
Sbjct: 113 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALT 167
Query: 164 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE------IVSGRTAVDFDVQLGE 213
V TL Y APE + D++S G + E + G + VD QLG+
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGY 171
L ++H + V++RD+K NILLD + K++DFG+ K + TT T GT Y
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDY 162
Query: 172 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208
+APE D ++ GVL+ E+++G+ + D
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-08
Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 163
R I + +GL ++ EE ++HRD+K +N+L++ N K+ DFG+S ++
Sbjct: 105 RRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAK 159
Query: 164 RVAGTLGYLAPEYAISGRL------TRKSDVYSFGVLLLEIVSGR 202
G Y+APE SG T +SDV+S G+ +LE+ GR
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 38/221 (17%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSE---VASMANVNVCHENLVKLHG------GCIDGPC 71
+DG++ AVK+L S E E +E + S+ N H N+VK +G + G
Sbjct: 45 KDGSLAAVKILDPISDVDE-EIEAEYNILQSLPN----HPNVVKFYGMFYKADKLVGGQL 99
Query: 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
LV + S+++ + G + I+ G GL ++H ++HRD+K
Sbjct: 100 -WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVK 155
Query: 132 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE---------YAISGRL 182
+NILL K+ DFG+S +T V GT ++APE Y+ R
Sbjct: 156 GNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDAR- 213
Query: 183 TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSI 223
DV+S G+ +E+ G D L + H V + I
Sbjct: 214 ---CDVWSLGITAIELGDG------DPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST-RVAGT 168
+ RG+ ++ + + VHRD+ N+LL Q KI DFGL++ ++ ++S
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 169 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ ++APE T SDV+S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 22/141 (15%)
Query: 74 LVYDYMPNNSLSQTLLGE-----EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128
LV +Y P L +LL ++ A+F + A E+++ I H Q VHR
Sbjct: 78 LVMEYQPGGDL-LSLLNRYEDQFDEDMAQF-YLA--ELVLAI-------HSVHQMGYVHR 126
Query: 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS-- 186
DIK N+L+D+ + K++DFG + N S GT Y+APE + K
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 187 ----DVYSFGVLLLEIVSGRT 203
D +S GV+ E++ GR+
Sbjct: 187 GVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 46/146 (31%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+V +YMP L L+ K+ E+++ L IH +HRD+K
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLA----LDAIHSM---GFIHRDVKPD 171
Query: 134 NILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDV 188
N+LLD++ + K++DFG K+ E T V GT Y++PE S G R+ D
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 189 YSFGVLLLEIVSGRTAVDFDVQLGEY 214
+S GV L E++ G T D +G Y
Sbjct: 231 WSVGVFLYEMLVGDTPFYADSLVGTY 256
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 24/164 (14%)
Query: 45 EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 104
E AS+ + V H +L +HG C+ G I+V +++ + L L +EK R WK
Sbjct: 65 ETASLMS-QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-VCLRKEKGRVPVAWKI-- 120
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL-----LDQNFNP--KISDFGLSKLFPEN 157
+ + L+Y+ ++ ++VH ++ NIL L + +P K+SD G+S
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS------ 171
Query: 158 TTHIS--TRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEI 198
T +S RV + ++APE G L+ +D +SFG LLEI
Sbjct: 172 FTALSREERVE-RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 48/180 (26%), Positives = 87/180 (48%), Gaps = 12/180 (6%)
Query: 25 IVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
+VA+K + +E ++G + EV+ + ++ H N+V LH LV++Y+ +
Sbjct: 33 LVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIIHTEKSLTLVFEYL-DKD 89
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L Q L + + + + RGL Y H V+HRD+K N+L+++
Sbjct: 90 LKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGEL 143
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 202
K++DFGL++ T S V TL Y P+ + S + + D++ G + E+ +GR
Sbjct: 144 KLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-08
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 11/94 (11%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTL 169
GLA+ H V+HRD+K N+L++ K++DFGL++ F P T TH TL
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TL 164
Query: 170 GYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 202
Y APE + + + D++S G + E+V+ R
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL--SKLFPENTTHISTRVAGTL 169
RGLAY H Q V+HRD+K N+L+ + K++DFGL +K P T S V TL
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVV-TL 167
Query: 170 GYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 202
Y P+ + S + D++ G + E+ +GR
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-08
Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS- 162
++++ RGL ++H +VHRD+K NIL+ K++DFGL++++ + ++
Sbjct: 111 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMAL 164
Query: 163 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
T V TL Y APE + D++S G + E+
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-08
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 11/159 (6%)
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
LV++Y+ N L L EE K R I I + + + H+ +VHRDIK
Sbjct: 77 LVFEYVEKNMLE---LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKN---DIVHRDIKPE 129
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
N+L+ N K+ DFG ++ E + T T Y +PE + + D++S G
Sbjct: 130 NLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGC 189
Query: 194 LLLEIVSGRTAVDFDVQLGEYHLVDKV----RSINMKLY 228
+L E+ G+ + ++ + + KV + MKL+
Sbjct: 190 ILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-08
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV---- 165
I +G+ + H V+HRD+K N+L+D K++DFGL++ F I RV
Sbjct: 110 ILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYTHE 161
Query: 166 AGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 202
TL Y APE + S R + D++S G + E+ + +
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 32/194 (16%)
Query: 21 QDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 71
+ G + AVKVL VE EK +S + H L +L+ C P
Sbjct: 18 ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------HPFLTQLYC-CFQTPD 69
Query: 72 RIL-VYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127
R+ V +++ L Q ++ RA+F + A EI L ++H++ +++
Sbjct: 70 RLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAA--EIT----SALMFLHDK---GIIY 119
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 187
RD+K N+LLD + K++DFG+ K N ST GT Y+APE D
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYGPSVD 178
Query: 188 VYSFGVLLLEIVSG 201
++ GVLL E++ G
Sbjct: 179 WWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLG 170
GL YIH ++HRD+K N+ ++++ KI DFGL++ E T ++ TR
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 171 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 203
Y APE ++ + D++S G ++ E+++G+T
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-07
Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGR 181
+HRD+ NILL KI DFGL++ ++ ++ V G + ++APE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNARLPVKWMAPESIFNCV 292
Query: 182 LTRKSDVYSFGVLLLEIVS 200
T +SDV+S+G+LL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 4/76 (5%)
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 185
+HRD+K N L+D + + K++DFGLSK + V G+ Y+APE
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 186 SDVYSFGVLLLEIVSG 201
D +S G +L E + G
Sbjct: 179 VDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 30/79 (37%), Positives = 46/79 (58%), Gaps = 7/79 (8%)
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGR 181
VHRD+ N+L+ + KI DFGL++ ++ +IS G+ L ++APE +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GSTFLPLKWMAPESIFNNL 317
Query: 182 LTRKSDVYSFGVLLLEIVS 200
T SDV+SFG+LL EI +
Sbjct: 318 YTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-07
Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 26/189 (13%)
Query: 24 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
T V +KVL + + F E ASM + + H++LV +G C+ G I+V +Y+ S
Sbjct: 28 TEVLLKVLDKSHRNYSESFF-EAASMMS-QLSHKHLVLNYGVCVCGDESIMVQEYVKFGS 85
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY-IHEEIQPHVVHRDIKTSNILL----- 137
L T L + K WK + + + LA+ +H + H ++ N+LL
Sbjct: 86 LD-TYLKKNKNLINISWK------LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREED 138
Query: 138 DQNFNP---KISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFG 192
+ NP K+SD G+S + P+ + R+ ++ PE + + L+ +D +SFG
Sbjct: 139 RKTGNPPFIKLSDPGISITVLPKEI--LLERIP----WVPPECIENPQNLSLAADKWSFG 192
Query: 193 VLLLEIVSG 201
L EI SG
Sbjct: 193 TTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT------HIS--TR- 164
L Y+H +VHRD+K N+L+ + K++DFGLSK+ + T HI TR
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 165 -----VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
V GT Y+APE + + D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-07
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 12/90 (13%)
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRV----AGT 168
LAY+H ++HRD+KT NI LD+ N + DFG + KL H T +GT
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL----DAHPDTPQCYGWSGT 250
Query: 169 LGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
L +PE K+D++S G++L E+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-07
Identities = 32/92 (34%), Positives = 56/92 (60%), Gaps = 11/92 (11%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTL 169
+GLAY+H + + +HRDIK +NILL N + K++DFG++ + T I+ R + GT
Sbjct: 117 QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTP 170
Query: 170 GYLAPEYAI---SGRLTRKSDVYSFGVLLLEI 198
++APE A +G + D+++ G+ +E+
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 45/198 (22%)
Query: 23 GTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLV----------KLHGGCIDGP 70
G IVA+K V S + +K + E+ + + H NLV KLH
Sbjct: 26 GQIVAIKKFVESEDDPVIKKIALREIRMLKQLK--HPNLVNLIEVFRRKRKLH------- 76
Query: 71 CRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
LV++Y T+L E EK ++II + + + H + + +HRD
Sbjct: 77 ---LVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRD 125
Query: 130 IKTSNILLDQNFNPKISDFGLSKLF----PENTTHISTRVAGTLGYLAPEYAISGRLTRK 185
+K NIL+ + K+ DFG +++ + T +++TR Y APE + G
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LVGDTQYG 179
Query: 186 S--DVYSFGVLLLEIVSG 201
DV++ G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-07
Identities = 29/93 (31%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLG 170
RGL YIH ++HRD+K SN+ ++++ +I DFGL++ + T +++TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 171 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGR 202
Y APE ++ + D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-07
Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT- 168
+ +G+ ++ + + +HRD+ N+LL KI DFGL++ ++ ++ V G
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274
Query: 169 ---LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ ++APE T +SDV+S+G+LL EI S
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-07
Identities = 28/89 (31%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 114 LAYIHEEIQP-HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
+ I E +Q ++V+RD+K N+LLD++ K++DFG +K+ T + GT Y+
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL----CGTPEYI 195
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSG 201
APE ++ + +D ++ G+ + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 29/114 (25%), Positives = 50/114 (43%), Gaps = 24/114 (21%)
Query: 106 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK------------- 152
I I + Y+H + V+HRD+K NILL I D+G +
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 153 ------LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ T I ++ GT Y+APE + + +D+Y+ GV+L ++++
Sbjct: 175 VDERNICYSSMT--IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-07
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 7 IRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMS--EVASMANVNVCHENLVKLHG 64
+ + DL Q+ V +KVL ++ ++ E AS+ + + H++LVKL+G
Sbjct: 15 VLRVQSDLDIVGPGQE-VSVVLKVL----GSDHRDSLAFFETASLMSQ-LSHKHLVKLYG 68
Query: 65 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 124
C+ I+V +Y+ L L EK WK ++ + L Y+ ++
Sbjct: 69 VCVRDE-NIMVEEYVKFGPLD-VFLHREKNNVSLHWKL--DVAKQLASALHYLEDK---K 121
Query: 125 VVHRDIKTSNILL---DQNFNP----KISDFGLSKLFPENTTHISTRVAGTLGYLAPEY- 176
+VH ++ NIL+ N K+SD G+ P RV + ++APE
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVE-RIPWIAPECI 176
Query: 177 -AISGRLTRKSDVYSFGVLLLEIVSG 201
LT +D +SFG LLEI S
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 11/92 (11%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTL 169
G+ ++H ++HRD+K SNI++ + KI DFGL++ N T ++ TR
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY---- 187
Query: 170 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
Y APE + D++S G ++ E+V G
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G + A+KV+ +E + E+ M + H N+V G + + ++
Sbjct: 34 GELAAIKVIKLEPGEDFAVVQQEIIMMKDCK--HSNIVAYFGSYLRRDKLWICMEFCGGG 91
Query: 83 SLSQTL-LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
SL + ++ + +R + +GL Y+H + + +HRDIK +NILL N
Sbjct: 92 SLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK---MHRDIKGANILLTDNG 143
Query: 142 NPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAI---SGRLTRKSDVYSFGVLLL 196
+ K++DFG+S + T I+ R + GT ++APE A G + D+++ G+ +
Sbjct: 144 HVKLADFGVSA---QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAI 200
Query: 197 EI 198
E+
Sbjct: 201 EL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-06
Identities = 35/151 (23%), Positives = 66/151 (43%), Gaps = 11/151 (7%)
Query: 56 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 115
H N+++ G C++ +LV++Y L L E+ R + + I G+
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAP 174
++H+ + +H D+ N L + K+ D+G+ + E+ L +LAP
Sbjct: 114 HMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 175 EYA-------ISGRLTRKSDVYSFGVLLLEI 198
E I+ T+ S+V++ GV L E+
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 46/191 (24%), Positives = 77/191 (40%), Gaps = 55/191 (28%)
Query: 57 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRG 113
E +VKL+ D V DY+P + L+ E+ A+F I +
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARF-------YIAELTCA 113
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL---------SKLFPENTTH---- 160
+ +H + +HRDIK NIL+D++ + K++DFGL SK + + H
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 161 -----------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
++ + GT Y+APE + T+ D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 192 GVLLLEIVSGR 202
GV+L E++ G+
Sbjct: 231 GVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 31/191 (16%)
Query: 26 VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
V VK L V S Q + +F+ E ++ H NL++ G C + +LV ++ P
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQ--HSNLLQCLGQCTEVTPYLLVMEFCP---- 78
Query: 85 SQTLLGEEKRRAKFGWKAR---------REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
LG+ K + KA + + I GL ++H+ + +H D+ N
Sbjct: 79 ----LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNC 131
Query: 136 LLDQNFNPKISDFGLSKL-FPENTTHISTRVAGTLGYLAPEYA--ISGRL-----TRKSD 187
LL + KI D+GLS + E+ ++ L ++APE + G L T++S+
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 188 VYSFGVLLLEI 198
V+S GV + E+
Sbjct: 192 VWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 54/231 (23%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCHENLVKLHGGC 66
+V L RL+ G + A+KVL + + ++E +A ++ H L L+
Sbjct: 16 RVFLV---RLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--HPFLPTLYASF 70
Query: 67 IDGPCRILVYDYMPNNSLSQTLLGEEKRR-----AKFGWKARREIIMGIGRGLAYIHEEI 121
LV DY P L + L + + A+F + A E+++ L Y+H
Sbjct: 71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-YAA--EVLLA----LEYLHLL- 122
Query: 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSK----------------------------L 153
+V+RD+K NILL ++ + +SDF LSK
Sbjct: 123 --GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 154 FPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRT 203
F E + S GT Y+APE ISG D ++ G+LL E++ G T
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTT 230
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFP---ENTTHISTRVAG 167
+G+A+ H+ V+HRD+K N+L+D+ KI+D GL + F ++ TH
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV---- 173
Query: 168 TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSG 201
TL Y APE + + D++S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-06
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 21 QDGTIVAVKVLSV-----ESKQGEKEFMSEVASMANVNVCHENLVKLHG-----GCIDGP 70
++G+ AVK+L E + E + ++ H N+VK +G +G
Sbjct: 41 KNGSKAAVKILDPIHDIDEEIEAEYNILKALSD-------HPNVVKFYGMYYKKDVKNGD 93
Query: 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
LV + S++ + G KR + I+ GL ++H +HRD+
Sbjct: 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDV 150
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY-----AISGRLTRK 185
K +NILL K+ DFG+S +T GT ++APE + +
Sbjct: 151 KGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDAR 209
Query: 186 SDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 215
DV+S G+ +E+ G D L + H
Sbjct: 210 CDVWSLGITAIELGDG------DPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 55/222 (24%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLHGGCIDGPCRILVYDYMP 80
G I A+K L +S+ EKE ++ V + ++ +N +VKL+ D L+ +Y+P
Sbjct: 26 GHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84
Query: 81 NNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+ TLL ++ F + R E I+ I IH + +HRDIK N+L
Sbjct: 85 GGDM-MTLL---MKKDTFTEEETRFYIAETILAI----DSIH---KLGYIHRDIKPDNLL 133
Query: 137 LDQNFNPKISDFGLSK--------LFPENTTHI--------------STRVA-------- 166
LD + K+SDFGL F +H S R A
Sbjct: 134 LDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRR 193
Query: 167 -------GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
GT Y+APE + ++ D +S GV++ E++ G
Sbjct: 194 ALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 9/109 (8%)
Query: 98 FGWKAR------REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151
F WK R R I+ + + YIH++ ++HRDIK NI L+ + + DFG +
Sbjct: 258 FDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
F + GT+ +PE +D++S G++LL+++S
Sbjct: 315 MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 19/106 (17%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAG 167
R LAYIH + + HRD+K N+L+D N + K+ DFG +K + ++I +R
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-- 235
Query: 168 TLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV------SGRTAVD 206
Y APE + + T D++S G ++ E++ SG+++VD
Sbjct: 236 ---YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
G+ ++H ++HRD+K SNI++ + KI DFGL++ T+ + T T Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
APE + D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 1e-05
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 55 CHENLVKLHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 113
+ N +KL+ + +L+ DY+ + L L K+ K ++II +
Sbjct: 67 DNPNFIKLYY-SVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEA 121
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
L +H+ +++H DIK N+L D+ + D+GL K T S GTL Y
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTP--SCY-DGTLDYF 173
Query: 173 APEYAISGRLTRKS-DVYSFGVLLLEIVSG 201
+PE I G S D ++ GVL E+++G
Sbjct: 174 SPE-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV---AGT 168
R + Y+HE ++HRDIK NI ++ + + DFG + FP + + + AGT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN--ANKYYGWAGT 246
Query: 169 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 205
+ APE D++S G++L E+ + ++
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 39/162 (24%), Positives = 79/162 (48%), Gaps = 24/162 (14%)
Query: 56 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 115
HEN++ L ++G LV D M ++ L + + R+ + + I++ I GL
Sbjct: 79 HENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQILNGLN 133
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--------------PENTTHI 161
+H+ + +HRD+ +NI ++ KI+DFGL++ + + +
Sbjct: 134 VLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 162 STRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 202
+++V TL Y APE + + + D++S G + E+++G+
Sbjct: 191 TSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 22/131 (16%)
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNP-------------KISDF 148
+II G L Y H E+ H++H D+K NIL+ D +P +I D
Sbjct: 235 QIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 149 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208
G + H T + T Y +PE + +D++S G ++ E+ +G+ D
Sbjct: 293 GGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348
Query: 209 VQLGEYHLVDK 219
L HL++K
Sbjct: 349 DNLEHLHLMEK 359
|
Length = 467 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 113 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
G+ ++H ++HRD+K SNI++ + KI DFGL++ T+ + T T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVS------GRTAVD 206
APE + D++S G ++ E+V GR +D
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 44/215 (20%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLHGGCIDGPCRILVYDYMP 80
G I A+K+L ++ EKE ++ + + ++ V + +VK+ D L+ +++P
Sbjct: 26 GHIYAMKILR-KADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
+ L+ ++ + E ++ I IH Q +HRDIK N+LLD
Sbjct: 85 GGDMMTLLMKKDTLSEEATQFYIAETVLAIDA----IH---QLGFIHRDIKPDNLLLDAK 137
Query: 141 FNPKISDFGL--------SKLFPENTTH--------------------------ISTRVA 166
+ K+SDFGL F N TH ++
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV 197
Query: 167 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
GT Y+APE + + D +S GV++ E++ G
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 44/215 (20%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL--VKLHGGCIDGPCRILVYDYMP 80
G + A+K+L ++ EKE + + + ++ V ++L VK+ D L+ +++P
Sbjct: 26 GHVYAMKILR-KADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
+ L+ ++ + E ++ I IH Q +HRDIK N+LLD
Sbjct: 85 GGDMMTLLMKKDTLTEEETQFYIAETVLAIDS----IH---QLGFIHRDIKPDNLLLDSK 137
Query: 141 FNPKISDFGL----------------------------------SKLFPENTTHISTRVA 166
+ K+SDFGL ++ + N ++
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV 197
Query: 167 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
GT Y+APE + + D +S GV++ E++ G
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 184
++HRD+K SNI++ + KI DFGL++ T+ + T T Y APE +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 196
Query: 185 KSDVYSFGVLLLEIVSGR 202
D++S G ++ E++ G
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 46/152 (30%)
Query: 69 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128
G L+ Y P +S+ L+G I+ G RGL Y+H Q +HR
Sbjct: 84 GSANSLLKTYFPE-GMSEALIGN--------------ILFGALRGLNYLH---QNGYIHR 125
Query: 129 DIKTSNILLDQNFNPKISDFGLSKL---------------FPENTTHISTRVAGTLGYLA 173
+IK S+IL+ + +S GLS L FP+ +T + L +L+
Sbjct: 126 NIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV-------LPWLS 176
Query: 174 PEYA---ISGRLTRKSDVYSFGVLLLEIVSGR 202
PE + G KSD+YS G+ E+ +GR
Sbjct: 177 PELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 55/194 (28%)
Query: 56 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 115
+E +VKL+ D V DY+P + L+ R F R I + +
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIE 115
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL---------SKLFPENTTHI----- 161
+H + +HRDIK NIL+D + + K++DFGL SK + + +HI
Sbjct: 116 SVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY-QKGSHIRQDSM 171
Query: 162 ---------------------------------STRVAGTLGYLAPEYAISGRLTRKSDV 188
+ + GT Y+APE + T+ D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 189 YSFGVLLLEIVSGR 202
+S GV+L E++ G+
Sbjct: 232 WSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-05
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVAGTLGYLA 173
YIH E ++HRDIKT N+L++ + + DFG + F +T +AGT+ A
Sbjct: 275 YIHGE---GIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHYGIAGTVDTNA 330
Query: 174 PEYAISGRLTRKSDVYSFGVLLLE 197
PE T D++S G+++ E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-05
Identities = 17/29 (58%), Positives = 22/29 (75%)
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLF 154
+HRDIK NIL+D+ + K+SDFGLS F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 46/193 (23%), Positives = 75/193 (38%), Gaps = 53/193 (27%)
Query: 56 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 115
+E +V+L+ D V DY+P + L+ R F R I + +
Sbjct: 60 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVE 115
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--------------------- 154
+H + +HRDIK NIL+D++ + K++DFGL F
Sbjct: 116 SVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 155 -------PENT---------------TH---ISTRVAGTLGYLAPEYAISGRLTRKSDVY 189
P N H ++ + GT Y+APE + T+ D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 190 SFGVLLLEIVSGR 202
S GV+L E++ G+
Sbjct: 233 SVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF--PEN 157
+ ++ I G+ Y+H V+HRD+K +NIL+ + KI+D G ++LF P
Sbjct: 111 KSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 158 TTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVS 200
V T Y APE + R T+ D+++ G + E+++
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF--PEN 157
+ ++ I G+ Y+H V+HRD+K +NIL+ + KI+D G ++LF P
Sbjct: 111 KSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 158 TTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVS 200
V T Y APE + R T+ D+++ G + E+++
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 29/90 (32%), Positives = 42/90 (46%), Gaps = 9/90 (10%)
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA------G 167
L YIHE + H DIK NI++D N I D+G++ F + HI G
Sbjct: 139 LEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195
Query: 168 TLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
TL Y + +TR+ D+ S G +L+
Sbjct: 196 TLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 35/152 (23%), Positives = 74/152 (48%), Gaps = 18/152 (11%)
Query: 58 NLVKLHG---GCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 113
N++K++G +D R+ L+ +Y L + L E+ +K + ++ + +G
Sbjct: 79 NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKG 134
Query: 114 LAYIHEEI-QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
L +++ +P+ +++ + + L+ +N+ KI GL K+ ++ V + Y
Sbjct: 135 LYNLYKYTNKPY---KNLTSVSFLVTENYKLKIICHGLEKIL---SSPPFKNV-NFMVYF 187
Query: 173 APEYA--ISGRLTRKSDVYSFGVLLLEIVSGR 202
+ + I T K D+YS GV+L EI +G+
Sbjct: 188 SYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 4e-04
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 23/99 (23%)
Query: 125 VVHRDIKTSNILLD-------------QNFN----PKISDFGLSK-LFPENTTHISTRVA 166
V+HRD+K NI L N N KI DFGLSK + E+ H
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCV 202
Query: 167 GTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRT 203
GT Y +PE + + KSD+++ G ++ E+ SG+T
Sbjct: 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
|
Length = 1021 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153
L Y+H + ++HRD+K N+L+ + K++DFGLSK+
Sbjct: 117 LDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.003
Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 9/93 (9%)
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG-LSKLFPENTTHISTRVAGTLGYL 172
L +H E +V RD+ +NILLD + +++ F S++ + Y
Sbjct: 98 LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 205
APE T D +S G +L E+++G+T V
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 229 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.4 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.25 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.96 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.92 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.89 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.86 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.72 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.59 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.51 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.21 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.19 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.7 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.66 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.6 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.49 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.33 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.31 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.23 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.2 | |
| PLN02236 | 344 | choline kinase | 97.19 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.15 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.1 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.07 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.93 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.93 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.85 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.79 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.41 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.16 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.13 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.0 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=317.52 Aligned_cols=203 Identities=26% Similarity=0.451 Sum_probs=182.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||.|+||+||++ ++..++..||||.+... .++..+.+..|+.+|+.++ ||||+.+++++.+++..|+|||||
T Consensus 16 ~~iG~GsfavVykg--~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~--H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 16 REIGSGSFAVVYKG--RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK--HPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred hhccCcceEEEEEe--EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC--CcceeeEEEEEecCCeEEEEEEeC
Confidence 46999999999999 77788899999999766 5667788999999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC------CceEEeccccccc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN------FNPKISDFGLSKL 153 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~------~~~~l~dfg~~~~ 153 (229)
+||+|.+++ ...+.+++.+++.++.|++.|+++||++ +||||||||+||+++.+ -.+||+|||+++.
T Consensus 92 ~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 92 NGGDLSDYI----RRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999 6778999999999999999999999999 99999999999999754 4589999999998
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccch
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 217 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 217 (229)
... .......+|++-|||||++....|+.|+|+||+|+++|++++|+.||+..+..+-...+
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~ 226 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI 226 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 753 33456789999999999999999999999999999999999999999966555444433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-51 Score=301.64 Aligned_cols=218 Identities=26% Similarity=0.369 Sum_probs=194.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccce-EEEcCCc-eEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHG-GCIDGPC-RILVY 76 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~-~~~~~~~-~~lv~ 76 (229)
+++||.|+||.||++ ..+.+|..+|.|.++.. ..+..+.+..|+.+|++|+ ||||+++++ .|..+.. .+|||
T Consensus 24 l~~IG~GsFg~vykv--~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~--HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 24 LKKIGRGSFGEVYKV--QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN--HPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHcCCcchheEEe--eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC--CchHHHHHHHhhhccchhhHHHH
Confidence 368999999999999 88999999999999865 4555688999999999999 999999999 5555555 78999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP-HVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|+|++|+|.+.+....+....+++..+|.++.|++.||..+|+.+.. -++||||||.|||++.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999988878889999999999999999999999995322 28999999999999999999999999999886
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcccccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 226 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (229)
.... ......|||.||+||.+.+.+|+.++|||||||++|||+.-++||.++ .-+++.+++.++++|
T Consensus 180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDYP 246 (375)
T ss_pred chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCCC
Confidence 5543 445678999999999999999999999999999999999999999987 578888899888875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=302.03 Aligned_cols=209 Identities=27% Similarity=0.381 Sum_probs=186.5
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||+|+||+|+++ +...+++.+|+|+++.. ..+......+|..++..++ ||+|++++-.|++....|+|+|
T Consensus 30 lkviGkG~fGkV~~V--rk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~--hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQV--RKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK--HPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred eeeeeccCCceEEEE--EEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC--CCcEeeeEEecccCCeEEEEEe
Confidence 478999999999999 67789999999999755 3445678899999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+.||.|...+ ++.+.+++..+.-++..|+.||.|||+. ||+|||+||+|||++.+|+++|+|||+++.....
T Consensus 106 ~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 106 YLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred ccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999 7889999999999999999999999999 9999999999999999999999999999864333
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVR 221 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~ 221 (229)
. .....++||+.|||||++.+..++.++|.||||+++|+|++|.+||...+....++-+...+
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 2 23355899999999999999999999999999999999999999999887555554444433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=315.39 Aligned_cols=205 Identities=26% Similarity=0.411 Sum_probs=186.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+|+++|.+ +++.+|+.||+|++... .....+.+.+|+++.+.++ ||||++++++|++....|+|.|.
T Consensus 24 ~~LGkGgFA~cYe~--~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~--HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 24 RFLGKGGFARCYEA--RDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK--HPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeccCcceEEEEE--EEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC--CCcEEeeeeEeecCCceEEEEEe
Confidence 46999999999999 77789999999999743 4555688999999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
|..++|..++ ..++++++.+++.++.||+.|+.|||+. +|+|||||..|+|++++.++||+|||+|.....+.
T Consensus 100 C~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 100 CHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred cCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999 6889999999999999999999999999 99999999999999999999999999999876543
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchh
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 218 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 218 (229)
. ...+.+|||.|.|||++.....+..+||||+||++|.|+.|++||+...-.+.|..++
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik 231 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK 231 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH
Confidence 2 3456889999999999999999999999999999999999999999876555555443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=297.20 Aligned_cols=208 Identities=27% Similarity=0.410 Sum_probs=185.7
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc-eEEEEEc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-RILVYDY 78 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~-~~lv~e~ 78 (229)
++.||+|.-|+|+++ ++..+++.+|+|++..+. ....+++.+|+++++..+ ||+|+++++.|.+++. .+|+|||
T Consensus 84 ~~~lG~G~gG~V~kv--~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~--spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKV--RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ--SPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhcccCCCcEEEEE--EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC--CCCeeeEeEEEEeCCceEEeehhh
Confidence 467999999999999 888999999999997653 444588999999999998 9999999999999985 9999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|++|||.+++ ...+.+++..+..++.++++||.|||. . +|+||||||.|++++..|.+||||||.+..+..+
T Consensus 160 MDgGSLd~~~----k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDIL----KRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999 455889999999999999999999996 6 9999999999999999999999999999876544
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc--cccccccchhhhcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD--VQLGEYHLVDKVRS 222 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~--~~~~~~~~~~~~~~ 222 (229)
....+.||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ...+.+.+...+..
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 456788999999999999999999999999999999999999999874 34556666665554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=284.65 Aligned_cols=210 Identities=29% Similarity=0.410 Sum_probs=189.0
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+++||.|+||+|.++ +...+|..+|+|+++.+. -+..+...+|..+++.+. ||+++++++.|.+.+..++|||
T Consensus 49 ~~tlGtGSFGrV~LV--r~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~--~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLV--REKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS--HPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred eeeeccCccceEEEE--EEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc--CceeEEEEEeeccCCeEEEEEe
Confidence 478999999999999 777889999999997652 334567889999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|++||.|++++ .+.+++++..++-++.+++.||.|||+. ++++||+||+||++|++|.+||.|||+++.....
T Consensus 125 yv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 125 YVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred ccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999 7888999999999999999999999999 9999999999999999999999999999876443
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcccccccC
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMKLY 228 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (229)
.-+.+|||.|+|||++..+++..++|.||||+++|||+.|.+||....+ ..+.+++.+.+.+..
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~fP 261 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKFP 261 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccCC
Confidence 3557899999999999999999999999999999999999999998776 556666666655443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=298.42 Aligned_cols=210 Identities=23% Similarity=0.372 Sum_probs=179.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-------chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||.|-+| ....+|+.||||+++... ......+.+|+++|++++ ||+|+++.++|+.....|+
T Consensus 178 ~~LGsGafg~Vkla--~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~--HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 178 KTLGSGAFGLVKLA--YEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS--HPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eeecCCceeEEEEE--EEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC--CCCEEEEeeeeecCCceEE
Confidence 57999999999999 888999999999997541 112345679999999999 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC---CceEEeccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFGLS 151 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~---~~~~l~dfg~~ 151 (229)
||||++||.|.+.+ -.++.+.+..-..+++|++.|+.|||++ ||+||||||+||++..+ -.+||.|||++
T Consensus 254 VlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 254 VLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999 5677788888899999999999999999 99999999999999765 56899999999
Q ss_pred cccCCCCccccccccCCccccCccccccCCC---CCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcccccc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRL---TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 226 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (229)
+..++ .....+.+|||.|.|||++..+.. ..+.|+|||||++|-+++|.+||.... ....+.+++.+..+.
T Consensus 327 K~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~--~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 327 KVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY--TDPSLKEQILKGRYA 400 (475)
T ss_pred hcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc--CCccHHHHHhcCccc
Confidence 98653 445678999999999999986543 357899999999999999999998654 334455555554443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=284.99 Aligned_cols=202 Identities=22% Similarity=0.314 Sum_probs=178.7
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
++.+|+|++|.|+++ ++..+|+.||||.+.... ....+..++|++++++++ |+|++.++++|-...+.++|+||
T Consensus 7 LgkvGEGSYGvV~KC--rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk--H~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKC--RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK--HENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred hhccccCcceEEEEe--ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc--cchHHHHHHHHHhcceeEEEeee
Confidence 578999999999999 778899999999996332 223366889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
|+..-|.++- .....++...+..+++|++.|+.|+|++ +++||||||+||+++.+|.+||||||+|+.+..+.
T Consensus 83 ~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred cchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9887777665 6778899999999999999999999999 99999999999999999999999999999876532
Q ss_pred ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccccccc
Q 027015 159 THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 214 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~ 214 (229)
..-+....|.+|.|||++.| .+|....||||+||++.||++|++.|++.+..+..
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL 211 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL 211 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH
Confidence 23355677999999999997 78999999999999999999999999988765543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=290.13 Aligned_cols=197 Identities=27% Similarity=0.424 Sum_probs=175.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc----cc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE----SK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|.||+|+.+ .+..+|..||+|+++.+ .. ...+.+.+|+.+++.++ .||||+++++++.....+++||
T Consensus 23 ~~lG~GsfgkV~~a--~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~-~HpnI~~l~ev~~t~~~~~ivm 99 (370)
T KOG0583|consen 23 RTLGSGSFGKVKLA--KHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR-SHPNIIRLLEVFATPTKIYIVM 99 (370)
T ss_pred eeecCCCCeeEEEe--eeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc-cCCCEeEEEEEEecCCeEEEEE
Confidence 57999999999999 77888999999977653 12 23567778999999998 5999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-CceEEeccccccccC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFP 155 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-~~~~l~dfg~~~~~~ 155 (229)
||+.||.|.+++ ...+++.+.++..+++|+++|++|||+. ||+||||||+|++++.+ +++||+|||++....
T Consensus 100 Ey~~gGdL~~~i----~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 100 EYCSGGDLFDYI----VNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EecCCccHHHHH----HHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999 5588999999999999999999999999 99999999999999998 999999999998763
Q ss_pred CCCccccccccCCccccCccccccCC-CC-CcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGR-LT-RKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.........+|++.|+|||++.+.. |+ .++|+||+|+++|.|++|+.||+...
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 1223346688999999999999887 86 89999999999999999999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=293.07 Aligned_cols=212 Identities=26% Similarity=0.417 Sum_probs=184.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+|++|++| +...+++.||||++... ......-+..|-+.|.+|. .||.|++++-.|.|+..+|+|+||
T Consensus 79 ~~lGeGSYStV~~A--~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 79 KILGEGSYSTVVLA--REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-GHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred heeccccceeEEEe--eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-CCCCeEEEEEEeecccceEEEEEe
Confidence 46899999999999 77779999999998654 2333456778999999995 499999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++|.|.+++ .+.+.+++.-.+.++.+|+.||.|||+. |||||||||+|||+++|++++|.|||.+..+....
T Consensus 156 A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 156 APNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred cCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999 6779999999999999999999999999 99999999999999999999999999998875432
Q ss_pred cc------------ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcccccc
Q 027015 159 TH------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 226 (229)
Q Consensus 159 ~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (229)
.. ....+.||..|.+||++.....+..+|+|+||||+|+|+.|++||.+.+ +|.+-++|..+.++
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQKIQALDYE 305 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHHHHHHhccc
Confidence 11 1144789999999999999999999999999999999999999999765 56666666555543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=287.09 Aligned_cols=202 Identities=28% Similarity=0.401 Sum_probs=177.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (229)
..||+|.||.||+| ++..+|+.||+|.+..+. .....-..+|+.+|+++. ||||+++.+...+. +.+|+|+|
T Consensus 123 ~kIGeGTyg~VYkA--r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~--HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKA--RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD--HPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHhcCcchhheeEe--eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC--CCcccceeeEEEecCCceEEEEEe
Confidence 47999999999999 888999999999998764 445577889999999999 99999999988765 68899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
||+ .+|..++ ....-.+++.++..++.|++.||.|+|+. |++|||||..|||++++|.+||+|||+|..+...
T Consensus 199 YMd-hDL~GLl---~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 199 YMD-HDLSGLL---SSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred ccc-chhhhhh---cCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 995 4687777 24566899999999999999999999999 9999999999999999999999999999987665
Q ss_pred CccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccccccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 214 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~ 214 (229)
.....+...-|..|.|||++.|. .|+.+.|+||.|||+.||+.|++.|.+.+..++.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 55445556679999999998864 6999999999999999999999999987654443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=294.96 Aligned_cols=211 Identities=27% Similarity=0.392 Sum_probs=187.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
++||.|+.|.|-+| ++..+|+.+|||++... .......+.+|+.+++-+. |||++.+|++++++.++|+|.||
T Consensus 18 kTLG~Gstg~vrla--kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~--HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 18 KTLGKGSTGCVRLA--KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE--HPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred ccccCCCCceehhh--hcccccceeEEEeeccccccccccccchhhhhHHHHHhc--CCCeeeeeeeeccCceEEEEEEe
Confidence 57999999999999 88899999999999755 2333467899999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++|.|++++ -.++++++.++...+.||+.|+.|+|.. +|+|||+||+|++++..+++||+|||.|......
T Consensus 94 v~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 94 VPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred cCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999999 7889999999999999999999999999 9999999999999998888999999999764332
Q ss_pred ccccccccCCccccCccccccCCCC-CcccchhHHHHHHHHHhCCCcccCccccccccchhhhcccccccC
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMKLY 228 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (229)
..-++.||+|+|+|||++.|.+|. .++||||+|+|+|.|++|+.||++++ ...+..++++..+.+.
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQRGVFEMP 232 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCcccCC
Confidence 234667899999999999999986 89999999999999999999999664 5566677777655544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=292.13 Aligned_cols=204 Identities=26% Similarity=0.388 Sum_probs=183.3
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
-||+|+||.||++ ++..+.+.||+|.+... .+++.+.+.+|+++++.++ ||||+.++++|+...+.++|.||+.
T Consensus 9 ~iG~Gsfg~VYKg--rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk--Hpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 9 MIGEGSFGRVYKG--RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK--HPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred HhcCCccceeeec--ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC--CcchhhHHHhhcccceEEEEehhhh
Confidence 4899999999999 88889999999999644 4556688999999999999 9999999999999999999999996
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
| +|..++ .....++++.+..+..++++||.|||+. +|+|+|+||.||++..+|.+|+||||+++.+..+. .
T Consensus 85 g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~ 155 (808)
T KOG0597|consen 85 G-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S 155 (808)
T ss_pred h-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence 6 999999 7889999999999999999999999999 99999999999999999999999999999886643 3
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 222 (229)
......|||-|||||+..+.+|+..+|+|||||++||+++|++||-... .+.+++.|..
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I~~ 214 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSILK 214 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHHhc
Confidence 4456779999999999999999999999999999999999999998653 4555554443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=287.75 Aligned_cols=206 Identities=26% Similarity=0.374 Sum_probs=181.7
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||+|+||.||+| +...+|..+|+|+++.. .......+..|-.+|.... +|.|++++-.|++...+|||||
T Consensus 146 Lk~IgkGAfGeVrLa--rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d--s~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLA--RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD--SPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred heeeccccceeEEEE--EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC--CCcEEEEEEEecCCCeeEEEEE
Confidence 578999999999999 88889999999999754 4556678889999999987 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC-
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE- 156 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~- 156 (229)
|++||++-.++ .+...|++..+..++.+++-|+..+|+. |+|||||||+|+++|..|++||+|||++.-+..
T Consensus 222 ylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 222 YLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred ecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999 7888999999999999999999999999 999999999999999999999999999853211
Q ss_pred --------------C-----Ccc-c-------------------------cccccCCccccCccccccCCCCCcccchhH
Q 027015 157 --------------N-----TTH-I-------------------------STRVAGTLGYLAPEYAISGRLTRKSDVYSF 191 (229)
Q Consensus 157 --------------~-----~~~-~-------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 191 (229)
. ... . .....|||.|+|||++.++.|+...|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 000 0 012349999999999999999999999999
Q ss_pred HHHHHHHHhCCCcccCccccccccch
Q 027015 192 GVLLLEIVSGRTAVDFDVQLGEYHLV 217 (229)
Q Consensus 192 G~i~~~l~~g~~pf~~~~~~~~~~~~ 217 (229)
|||+||++.|.+||..+++.+.+.-+
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI 400 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKI 400 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999999887776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=283.25 Aligned_cols=196 Identities=37% Similarity=0.562 Sum_probs=171.8
Q ss_pred ccCCcccccccccceEeccCCcE-EEEEEeecccchh--hHHHHHHHHHHhhhccCCCcccccceEEEcCC-ceEEEEEc
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTI-VAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CRILVYDY 78 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-~~~lv~e~ 78 (229)
.||+|+||+||++.| .|+. ||+|.+....... .+.+.+|+.++.+++ ||||+++++.+.+.. ..++||||
T Consensus 48 ~iG~G~~g~V~~~~~----~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~--HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKW----RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLR--HPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hcccCCceeEEEEEe----CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCC--CCCeeeEEEEEcCCCCceEEEEEe
Confidence 489999999999855 4566 9999998653222 468999999999999 999999999999887 78999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEEcCCCCCCEEEcCCC-ceEEeccccccccCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-VVHRDIKTSNILLDQNF-NPKISDFGLSKLFPE 156 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~~~ 156 (229)
+++|+|.+++... ....++...+..++.+|+.|+.|||+. + ||||||||+|++++.++ ++||+|||++.....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999433 478999999999999999999999999 8 99999999999999997 999999999977543
Q ss_pred CCccccccccCCccccCccccc--cCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ...+...||..|||||++. ...++.++||||+|+++|||+||+.||.....
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 32 2233367999999999999 56999999999999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=260.60 Aligned_cols=201 Identities=21% Similarity=0.331 Sum_probs=176.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch--hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|.||.||+| ++..+|+.||||.++..... -.....+|++.++.++ |+||+.++|+|.+.....+|+||+
T Consensus 8 ~~lGEG~~gvVyka--~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~--h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 8 EKLGEGTYGVVYKA--RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK--HPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhcCcceEEEEEE--EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc--CcchhhhhhhccCCCceEEEEEec
Confidence 57999999999999 78889999999999876333 3467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
..+|...+ ..+...++...+.+++.++++|++|||+. .|+|||+||.|++++.+|.+||+|||+++.+.....
T Consensus 84 -~tdLe~vI---kd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 84 -PTDLEVVI---KDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred -cccHHHHh---cccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 66898888 36677899999999999999999999999 999999999999999999999999999998865443
Q ss_pred cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccccccc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 214 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~ 214 (229)
.... -.-|..|.|||++.| ..|+...|+||.|||+.||+.|.+-|++++..++.
T Consensus 157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 3222 256889999999986 56999999999999999999999999987654443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=281.35 Aligned_cols=211 Identities=54% Similarity=0.878 Sum_probs=178.5
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-ceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-~~~lv~e~~~~ 81 (229)
.||+|+||.||++ .+.+|+.||||.+..........+.+|++++.+++ |||++++++||.+.+ ..++|+||++.
T Consensus 82 ~ig~Ggfg~VYkG---~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~--H~Nlv~LlGyC~e~~~~~~LVYEym~n 156 (361)
T KOG1187|consen 82 LIGEGGFGTVYKG---VLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR--HPNLVKLLGYCLEGGEHRLLVYEYMPN 156 (361)
T ss_pred ceecCCCeEEEEE---EECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC--CcCcccEEEEEecCCceEEEEEEccCC
Confidence 6999999999998 66777999999887554321455999999999999 999999999999988 49999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|.++++..... +++|..+..|+.++++||+|||..+.+.|+||||||.|||+|++.+.||+|||++..........
T Consensus 157 GsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~ 234 (361)
T KOG1187|consen 157 GSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV 234 (361)
T ss_pred CCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce
Confidence 9999999643222 89999999999999999999999877789999999999999999999999999996544311111
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhh
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 220 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 220 (229)
.....||..|+|||.......+.++||||+|+++.|+++|+.|.+...+.++..+.+|.
T Consensus 235 ~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 235 STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 11117899999999999889999999999999999999999999876555555566654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=290.46 Aligned_cols=207 Identities=27% Similarity=0.331 Sum_probs=183.1
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||+|+||+|+++ ....+++.+|||+++.. ...+.+..+.|.++++... +||.++.++.+|+...+.|+|||
T Consensus 373 l~vLGkGsFGkV~la--e~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLA--ELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred EEEeccCcCceEEEE--EEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccccccCCeEEEEEE
Confidence 468999999999999 55668899999999866 4556678889999988887 69999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+.||++..+ .....+++..+.-++..++.||+|||++ ||||||||.+||++|.+|.+||+|||+++.--.
T Consensus 450 y~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 450 YVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred ecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC-
Confidence 9999994332 4668899999999999999999999999 999999999999999999999999999986422
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhh
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 219 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 219 (229)
......+++|||.|+|||++.+..|+.+.|.||||+++|+|+.|+.||.+++..+.++.+-.
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 22345779999999999999999999999999999999999999999999988777765543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=277.24 Aligned_cols=195 Identities=29% Similarity=0.441 Sum_probs=179.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhh---HHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
.+||.|.+|+|-+| .....|+.||||.++.+.-++. -.+.+|++++..|+ ||||+.++++|++.+...|||||
T Consensus 59 etLGkGTYGKVk~A--~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN--HPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLA--YEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN--HPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHhcCCcccceeeh--hhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC--CCceeehhhhhcCCceEEEEEEe
Confidence 57999999999999 6677999999999986644444 45678999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
..+|.|.+|+ +.++.+++.++..+++||++|+.|+|.+ +++|||+|.+||++|+++++||+|||++..+....
T Consensus 135 aS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 135 ASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred cCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999 8889999999999999999999999999 99999999999999999999999999998775543
Q ss_pred ccccccccCCccccCccccccCCCC-CcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..++++|++-|.+||+..|.+|. +..|-||||+++|.|+.|.+||++.+
T Consensus 208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 35779999999999999999986 89999999999999999999999865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=282.53 Aligned_cols=196 Identities=24% Similarity=0.414 Sum_probs=180.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..||+|+.|.||.| ....+++.||||.+........+-+++|+.+++..+ |+||+.+++.|.-....++||||++|
T Consensus 279 ~kigqgaSG~vy~A--~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~--H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 279 KKIGQGATGGVYVA--RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH--HPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hhhccccccceeee--eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc--chHHHHHHHHhcccceeEEEEeecCC
Confidence 57999999999999 788899999999999887777788999999999999 99999999999888999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|.+.+ ....+++.++..+++.+++||+|||.+ ||+|+|||.+||+++.+|.+||+|||+|..+..... .
T Consensus 355 gsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 355 GSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred Cchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999998 445599999999999999999999999 999999999999999999999999999988755443 3
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....||+.|||||+...+.|..+.||||||++++||+.|++||=+..+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P 474 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP 474 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence 4567899999999999999999999999999999999999999986544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=272.39 Aligned_cols=196 Identities=31% Similarity=0.458 Sum_probs=169.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC--ceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 79 (229)
+.||+|+||.||++ .+..+|...|||..........+.+.+|+.++.+++ ||||+++++...... .+++.|||+
T Consensus 23 ~~lG~Gs~G~V~l~--~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~--~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 23 KLLGRGSFGSVYLA--TNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN--HPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred ccccCccceEEEEE--EecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC--CCCEEeeCCccccccCeeeEeeeecc
Confidence 57999999999999 667779999999998764444678999999999999 999999999754443 588999999
Q ss_pred CCCCHHHHHhhhhcccc-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-CCceEEeccccccccCC-
Q 027015 80 PNNSLSQTLLGEEKRRA-KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPE- 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~~~~~- 156 (229)
++|||.+++ ...+ .+++..+..+..|+++||.|||++ |++||||||+||+++. ++.+||+|||.+.....
T Consensus 99 ~~GsL~~~~----~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 99 PGGSLSDLI----KRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred CCCcHHHHH----HHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999 3333 799999999999999999999999 9999999999999999 79999999999887653
Q ss_pred -CCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 -NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 -~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..........||+.|||||++.. .....++|||||||++.||+||+.||...
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 22233455789999999999985 33446999999999999999999999863
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=276.12 Aligned_cols=196 Identities=28% Similarity=0.322 Sum_probs=171.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||+|+++... ......+.+|+++++.++ ||||+++++.+...+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILV--REKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR--HPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCCCEEEEEEcCCEEEEEEeC
Confidence 46999999999999 667789999999997542 233456778999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 77 ANGGELFFHL----SRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence 9999999988 4567889999999999999999999999 99999999999999999999999999986532211
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 12234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=279.75 Aligned_cols=200 Identities=23% Similarity=0.337 Sum_probs=172.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+++.||+|+++... ......+.+|+.++..++ ||+|+++++.+.+....++||||
T Consensus 7 ~~LG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~--~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 7 KVIGRGAFGEVRLV--QKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD--SLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred EEEEeCCCEEEEEE--EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC--CCCcceEEEEEecCCeEEEEEcC
Confidence 57999999999999 667789999999997432 223356788999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 83 LPGGDMMTLL----MKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999998 4567899999999999999999999999 99999999999999999999999999986542210
Q ss_pred c----------------------------------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCc
Q 027015 159 T----------------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 204 (229)
Q Consensus 159 ~----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p 204 (229)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234689999999999999999999999999999999999999
Q ss_pred ccCccccc
Q 027015 205 VDFDVQLG 212 (229)
Q Consensus 205 f~~~~~~~ 212 (229)
|......+
T Consensus 236 f~~~~~~~ 243 (363)
T cd05628 236 FCSETPQE 243 (363)
T ss_pred CCCCCHHH
Confidence 98765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=272.75 Aligned_cols=196 Identities=29% Similarity=0.325 Sum_probs=170.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+|+.||+|.++... ......+.+|+++++.++ ||||+++++.+......++||||
T Consensus 1 ~~lG~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILV--REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEE--EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCcceeeEEecCCEEEEEEeC
Confidence 46999999999999 667789999999997542 233456778999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|..++ .....+++..+..++.|++.||+|||+. |++|+||||+||++++++.++|+|||++.......
T Consensus 77 ~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 77 ANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence 9999999888 4556789999999999999999999999 99999999999999999999999999886532221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 12233568999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=270.76 Aligned_cols=194 Identities=26% Similarity=0.382 Sum_probs=171.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+|+.||+|.+.... ....+.+.+|+++++.++ ||||+++++++.+....++||||
T Consensus 7 ~~lg~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 7 KTVGTGTFGRVHLV--RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--HPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred eeeecCCCeEEEEE--EEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC--CCcHhhhHhhhccCCeEEEEEeC
Confidence 57999999999999 667789999999997542 233466888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 83 VPGGELFSYL----RNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999998 4556789999999999999999999999 99999999999999999999999999987653321
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
....|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 234688999999999998899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=262.45 Aligned_cols=200 Identities=24% Similarity=0.370 Sum_probs=173.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCc-ccccceEEEcCC------ce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGP------CR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~-i~~~~~~~~~~~------~~ 72 (229)
..||+|+||+||+| +...+|+.||+|+++.+.. .......+|+.+++.++ |+| |+.+.+++...+ ..
T Consensus 17 eklGeGtyg~Vyka--r~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~--~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKA--RSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS--HANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHhCCCCceEEEEE--EEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC--CCcceEEEEeeeeecccccccceE
Confidence 35899999999999 7888999999999987744 35577899999999999 999 999999998776 78
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
++|+||+ ...|..++.........++...+..++.|++.|++|||++ +|+||||||+|++++++|.+||+|||++.
T Consensus 93 ~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHH
Confidence 8999999 7789999843322224688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.+.-+... -+.-..|..|.|||++.+. .|+...|+||+|||+.||++++..|+++..
T Consensus 169 a~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 169 AFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 76533222 2445678899999999876 689999999999999999999999998765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=271.88 Aligned_cols=197 Identities=27% Similarity=0.337 Sum_probs=171.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+|+.||+|++... .......+.+|+..++.++ ||||+++.+.+......++||||
T Consensus 1 ~~lG~G~~g~Vy~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILV--REKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR--HPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceEEEEEcCCEEEEEEeC
Confidence 46999999999999 66778999999999754 2334467788999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~~~g~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 77 VNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence 9999999888 4556799999999999999999999999 99999999999999999999999999986532221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 122345689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=275.34 Aligned_cols=214 Identities=30% Similarity=0.446 Sum_probs=185.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|-||.|+.+.+ .....||+|.++.. .-..+.+.+|++++++|+ |++|+++++++..+..++|||||++.
T Consensus 212 ~~LG~G~FG~V~~g~~---~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~--H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 212 RELGSGQFGEVWLGKW---NGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLR--HEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHhcCCccceEEEEEE---cCCCcccceEEecc-ccChhHHHHHHHHHHhCc--ccCeEEEEEEEecCCceEEEEEeccc
Confidence 5699999999999955 23348999999854 334578889999999999 99999999999998899999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|||.+++.. .....++...+..++.||++|++||+++ ++|||||-..||||++++.+||+|||+++...++....
T Consensus 286 GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred CcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 999999943 3567899999999999999999999999 99999999999999999999999999999655544333
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchhhhcccccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSINMK 226 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (229)
.....-+..|.|||.+....++.++||||+|+++||++| |+.||+..+..+....++...++..|
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P 426 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP 426 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC
Confidence 333334678999999999999999999999999999998 99999998877777777777666543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=278.44 Aligned_cols=198 Identities=27% Similarity=0.368 Sum_probs=170.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ++..+++.||+|++.... ......+.+|+++++.++ ||||+++++++.+....++||||
T Consensus 7 ~~LG~G~~g~Vy~~--~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 7 KTLGIGAFGEVCLA--CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred EEEeecCCEEEEEE--EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC--CCCeeeeEEEEecCCEEEEEEec
Confidence 67999999999999 677889999999997542 233467888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.+||+. |++||||||+||+++.++.++|+|||++..+....
T Consensus 83 ~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 83 IPGGDMMSLL----IRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998 4556789999999999999999999999 99999999999999999999999999875331100
Q ss_pred c----------------------------------------------cccccccCCccccCccccccCCCCCcccchhHH
Q 027015 159 T----------------------------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192 (229)
Q Consensus 159 ~----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 192 (229)
. .......||+.|+|||.+.+..++.++|+||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234689999999999988899999999999
Q ss_pred HHHHHHHhCCCcccCccc
Q 027015 193 VLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 193 ~i~~~l~~g~~pf~~~~~ 210 (229)
|++|+|++|+.||.....
T Consensus 236 ~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP 253 (381)
T ss_pred hHHHHHHhCCCCCcCCCH
Confidence 999999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=273.21 Aligned_cols=194 Identities=24% Similarity=0.380 Sum_probs=171.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+|+.||+|+++... ....+.+.+|+.+++.++ ||||+++++++.+++..++||||
T Consensus 24 ~~lg~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 24 ETLGTGSFGRVRIA--KHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS--HPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred EEEEecCCeEEEEE--EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEcCCEEEEEEcC
Confidence 46999999999999 667789999999997542 233466889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 100 VVGGELFTHL----RKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred CCCChHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999998 4556788999999999999999999999 99999999999999999999999999987653322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 235689999999999999999999999999999999999999986543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=269.21 Aligned_cols=194 Identities=27% Similarity=0.345 Sum_probs=170.0
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
||+|+||+||++ .+..+++.||+|.++.. .......+.+|+.+++.++ ||||+++++++.+....++||||++
T Consensus 1 lg~G~~g~Vy~~--~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQV--RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCcEeceeeEEecCCeEEEEEcCCC
Confidence 799999999999 66778999999999743 2334466788999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++....... .
T Consensus 77 ~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 148 (312)
T cd05585 77 GGELFHHL----QREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-D 148 (312)
T ss_pred CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-C
Confidence 99999998 4556789999999999999999999999 99999999999999999999999999987532221 1
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 2234568999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=278.17 Aligned_cols=199 Identities=26% Similarity=0.374 Sum_probs=170.6
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||+|+||+||++ +...+++.||+|.+.... ......+.+|+++++.+. ||+|+++++.+.+....++|||
T Consensus 6 ~~~LG~G~~g~Vy~a--~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~--h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 6 IKTLGIGAFGEVCLA--RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--NEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred EEEEEeCCCEEEEEE--EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC--CCcCCeEEEEEEeCCEEEEEEe
Confidence 367999999999999 677889999999997432 233467888999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..+..++.|++.||++||+. |++||||||+||+++.++.++|+|||++..+...
T Consensus 82 ~~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLL----IRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999998 3446788999999999999999999999 9999999999999999999999999987532100
Q ss_pred C----------------------------------------------ccccccccCCccccCccccccCCCCCcccchhH
Q 027015 158 T----------------------------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191 (229)
Q Consensus 158 ~----------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 191 (229)
. ........||+.|+|||++.+..++.++|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112468999999999999999999999999
Q ss_pred HHHHHHHHhCCCcccCccc
Q 027015 192 GVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 192 G~i~~~l~~g~~pf~~~~~ 210 (229)
||++|+|++|+.||....+
T Consensus 235 Gvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH
Confidence 9999999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=269.56 Aligned_cols=198 Identities=26% Similarity=0.335 Sum_probs=167.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.||+|.++... ....+....|...+.... .||||+++++++......++||||
T Consensus 1 ~~lG~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLA--ELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999 666788999999997542 223344556666665442 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~~gg~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 150 (316)
T cd05592 78 LNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150 (316)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence 9999999988 4556799999999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 223445689999999999998999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=277.82 Aligned_cols=198 Identities=26% Similarity=0.369 Sum_probs=171.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||+|++.... ......+.+|+++++.++ ||||+++++++.++...++||||
T Consensus 7 ~~lG~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 7 KVIGRGAFGEVRLV--QKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD--NPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred EEEEecCCEEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceEEEEEcCCeEEEEECC
Confidence 57999999999999 667789999999997532 233456788999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++..+....
T Consensus 83 ~~~g~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 83 LPGGDMMTLL----MKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCcHHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999998 4556799999999999999999999999 99999999999999999999999999986542211
Q ss_pred cc-------------------------------------ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhC
Q 027015 159 TH-------------------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201 (229)
Q Consensus 159 ~~-------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g 201 (229)
.. ......||+.|+|||++....++.++|+|||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124589999999999988999999999999999999999
Q ss_pred CCcccCccc
Q 027015 202 RTAVDFDVQ 210 (229)
Q Consensus 202 ~~pf~~~~~ 210 (229)
..||.....
T Consensus 236 ~~Pf~~~~~ 244 (364)
T cd05599 236 YPPFCSDNP 244 (364)
T ss_pred CCCCCCCCH
Confidence 999987653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=279.21 Aligned_cols=199 Identities=27% Similarity=0.386 Sum_probs=170.6
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||+|+||.||++ .+..+++.||+|++.... ......+.+|+++++.++ ||||+++++.+.+++..++|||
T Consensus 6 ~~~lG~G~~g~V~~a--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 6 IKTIGIGAFGEVCLV--RKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--NEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred EEEEEeCCCeEEEEE--EECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCEEEEEEe
Confidence 367999999999999 667789999999986432 223466788999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..+..++.|++.||++||+. |++||||||+||+++.++.++|+|||++..+...
T Consensus 82 ~~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLL----IRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999998 4556788999999999999999999999 9999999999999999999999999987532100
Q ss_pred ------------------------------------------CccccccccCCccccCccccccCCCCCcccchhHHHHH
Q 027015 158 ------------------------------------------TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195 (229)
Q Consensus 158 ------------------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~ 195 (229)
.........|++.|+|||++.+..++.++|+|||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00001124689999999999999999999999999999
Q ss_pred HHHHhCCCcccCccc
Q 027015 196 LEIVSGRTAVDFDVQ 210 (229)
Q Consensus 196 ~~l~~g~~pf~~~~~ 210 (229)
|+|++|+.||.....
T Consensus 235 yell~G~~Pf~~~~~ 249 (376)
T cd05598 235 YEMLVGQPPFLADTP 249 (376)
T ss_pred eehhhCCCCCCCCCH
Confidence 999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=278.28 Aligned_cols=198 Identities=25% Similarity=0.356 Sum_probs=170.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+|+.||+|++.... ......+.+|+++++.++ ||||+++++++.+....++||||
T Consensus 7 ~~lG~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 7 KVIGKGAFGEVRLV--QKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--SPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred EEEeecCCEEEEEE--EECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCeeEEEEeC
Confidence 57999999999999 677789999999986432 223456788999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..+....
T Consensus 83 ~~gg~L~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 83 LPGGDLMTML----IKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999998 4556789999999999999999999999 99999999999999999999999999985321100
Q ss_pred ------------cc----------------------------------ccccccCCccccCccccccCCCCCcccchhHH
Q 027015 159 ------------TH----------------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192 (229)
Q Consensus 159 ------------~~----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 192 (229)
.. ......||+.|+|||++.+..++.++|+||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124589999999999999999999999999
Q ss_pred HHHHHHHhCCCcccCccc
Q 027015 193 VLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 193 ~i~~~l~~g~~pf~~~~~ 210 (229)
|++|+|++|+.||.....
T Consensus 236 vil~elltG~~Pf~~~~~ 253 (377)
T cd05629 236 AIMFECLIGWPPFCSENS 253 (377)
T ss_pred hhhhhhhcCCCCCCCCCH
Confidence 999999999999986554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=273.54 Aligned_cols=195 Identities=26% Similarity=0.328 Sum_probs=172.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ +...+++.||+|+++... ......+.+|++++..++ ||||+++++++.+....++||||
T Consensus 7 ~~ig~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 7 TQVGQGGYGQVFLA--KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred EEEeecCCeEEEEE--EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC--CCCCccEEEEEEcCCEEEEEEeC
Confidence 57999999999999 667788999999997542 233466888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~g~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999998 4556789999999999999999999999 999999999999999999999999999876433
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 204 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH
Confidence 223456899999999999889999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=276.67 Aligned_cols=197 Identities=27% Similarity=0.332 Sum_probs=169.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.+|+|++... .......+.+|+.+++.++ ||||+++++++.++...++||||
T Consensus 49 ~~lG~G~fg~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~--hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 49 KVIGRGAFGEVQLV--RHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred EEEEecCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCEEEEEEcC
Confidence 56999999999999 66778999999998642 2223456778999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. ...+++..+..++.|++.||++||+. |++||||||+||++++++.++|+|||++.......
T Consensus 125 ~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 125 MPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred CCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999882 23578899999999999999999999 99999999999999999999999999988764332
Q ss_pred ccccccccCCccccCccccccCC----CCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.....
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 22234567899999999987543 78899999999999999999999987653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=271.01 Aligned_cols=197 Identities=28% Similarity=0.330 Sum_probs=170.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||+|+++... ......+..|++.++.++ ||||+++.+.+.+....++||||
T Consensus 1 ~~lG~G~~g~V~~~--~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~--hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILV--KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCCceEEEEEcCCEEEEEEeC
Confidence 46999999999999 667789999999997542 233456778999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
+++++|..++ .....+++..+..++.|++.||+|||+ . |++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 77 ANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence 9999999888 455679999999999999999999997 7 9999999999999999999999999998653222
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 150 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred Cc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 11 12335689999999999998999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=271.65 Aligned_cols=197 Identities=23% Similarity=0.389 Sum_probs=181.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
..||+|.||.||++ ....+++.||+|++..+. .....++.+|+.++.+++ ++||.++|+.+..+...+++||||.
T Consensus 19 ~~IgrGsfG~Vyk~--~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~--~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKA--IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD--SPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred hhccccccceeeee--eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC--cchHHhhhhheeecccHHHHHHHhc
Confidence 46999999999999 778899999999999874 445688999999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
||++.+.+ .....+++..+..++.+++.|+.|||.. +.+|+|||+.||++..+|.++|+|||.+.........
T Consensus 95 gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 95 GGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred Ccchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999 6666678999999999999999999999 9999999999999999999999999999877555444
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. .++.||+.|||||++.+..|+.++||||||++.+||.+|.+||....+
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 4 778999999999999999999999999999999999999999998776
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=268.64 Aligned_cols=198 Identities=27% Similarity=0.332 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|+++... ....+....|.+++..+. .||+|+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLA--ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEE--EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCeEEEEEeC
Confidence 46999999999999 667788999999997542 233455677888887653 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|...+ .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 150 (321)
T cd05591 78 VNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG 150 (321)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence 9999999888 4556789999999999999999999999 99999999999999999999999999987532221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 151 -VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred -ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 122345689999999999988999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=274.27 Aligned_cols=198 Identities=27% Similarity=0.321 Sum_probs=169.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+++.+|+|++... .......+.+|+.+++.++ ||||+++++.+.++...++||||
T Consensus 49 ~~lG~G~fg~Vy~~--~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~--hp~iv~~~~~~~~~~~~~lv~Ey 124 (371)
T cd05622 49 KVIGRGAFGEVQLV--RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFYAFQDDRYLYMVMEY 124 (371)
T ss_pred EEEeecCCeEEEEE--EECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEcCCEEEEEEcC
Confidence 57999999999999 67778999999998642 2223455778999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. ...+++..+..++.|++.||++||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 125 ~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 125 MPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred CCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999999882 23578899999999999999999999 99999999999999999999999999987664333
Q ss_pred ccccccccCCccccCccccccCC----CCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+..
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 253 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH
Confidence 22334567899999999987543 788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=258.33 Aligned_cols=201 Identities=23% Similarity=0.351 Sum_probs=173.7
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccch--hhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVY 76 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~ 76 (229)
+..|++|.||.||+| ++..+++.||+|.++.+..+ -....++|+.++.+++ ||||+.+-.+.... +..|+||
T Consensus 81 lnrI~EGtyGiVYRa--kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~--H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRA--KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR--HPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HhhcccCcceeEEEe--ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC--CCCeeeeEEEEeccccceeeeeH
Confidence 357999999999999 67778999999999866432 2367889999999999 99999999988744 4789999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||| ..+|...+ .....++...++..+..|+++|+.|||.+ .|+|||+||+|+++...|.+|++|||+|+.++.
T Consensus 157 e~~-EhDLksl~---d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 157 EYV-EHDLKSLM---ETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHH-HhhHHHHH---HhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999 45788887 34456899999999999999999999999 999999999999999999999999999998876
Q ss_pred CCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcccccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~ 213 (229)
.. ...+...-|..|.|||++.+ ..|+.+.|+||+|||+.|++++++.|.+.+..++
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ 286 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ 286 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH
Confidence 53 34455667999999999886 5699999999999999999999999998764443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=262.24 Aligned_cols=198 Identities=26% Similarity=0.336 Sum_probs=170.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+|+.||+|.+.... ......+.+|+.+++.++ |++|+++++++.+++..++++||
T Consensus 6 ~~lg~G~~g~V~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 6 RVLGKGGFGEVCAC--QVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN--SRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred EEEecCCCEEEEEE--EEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC--CCcEEEEEEEEccCCeEEEEEEe
Confidence 57999999999999 667789999999987442 223346778999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.. .....+++..+..++.|++.||++||+. |++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999887732 2334689999999999999999999999 99999999999999999999999999987653322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 1 2334689999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=267.85 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=170.5
Q ss_pred CCccCCcccccccccceEe-ccCCcEEEEEEeeccc----chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 1 MASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
++.||+|+||.||++.... ..+++.||+|.++... ......+.+|+++++.++ ||||+++++.+..++..++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~~~~~~~~~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK--HPFIVDLIYAFQTGGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC--CCchhceeeEEecCCeEEEE
Confidence 4789999999999985422 3578999999997432 223356778999999999 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||+++++|.+++ .....+.+..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 79 LEYLSGGELFMHL----EREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred EeCCCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 9999999999988 4566788999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 152 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 152 HEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred cCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 2211 2233568999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=267.74 Aligned_cols=198 Identities=25% Similarity=0.333 Sum_probs=169.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|+++... .........|...+..+. .||||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLA--RLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEE--EEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-CCCchhceeeEEEcCCEEEEEEcC
Confidence 46999999999999 667789999999997542 233456677888877663 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 78 ~~~g~L~~~i----~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~ 150 (320)
T cd05590 78 VNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150 (320)
T ss_pred CCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence 9999999988 4556799999999999999999999999 99999999999999999999999999986532221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 151 -KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred -CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 122345689999999999988999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=270.40 Aligned_cols=195 Identities=24% Similarity=0.345 Sum_probs=169.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++.+. ..++..||+|.+... .....+.+.+|+.+++.++ ||||+++++++.+.+..++||||
T Consensus 36 ~~ig~G~~g~Vy~a~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~~~~lv~Ey 112 (340)
T PTZ00426 36 RTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN--HPFCVNLYGSFKDESYLYLVLEF 112 (340)
T ss_pred EEEeecCCeEEEEEEEE-CCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCCcceEEEEEeCCEEEEEEeC
Confidence 57999999999999432 223468999998643 2233466888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 113 ~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 113 VIGGEFFTFL----RRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999998 4556799999999999999999999999 9999999999999999999999999998765332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....|++.|+|||++.+..++.++|+|||||++|+|++|+.||....+
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 2335689999999999988899999999999999999999999987643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=249.62 Aligned_cols=207 Identities=30% Similarity=0.429 Sum_probs=183.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
++||.|.||.||+| +...++-.||+|++... .....+++.+|+++-..|+ ||||+++|++|.++.+.|+++||
T Consensus 28 r~LgkgkFG~vYla--rekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~--hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 28 RPLGKGKFGNVYLA--REKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR--HPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccCCccccEeEe--eeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC--CccHHhhhhheeccceeEEEEEe
Confidence 57999999999999 66778899999998643 3445688999999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
...|+|...+. +.....+++.....++.|++.|+.|+|.. +++||||||+|++++..+.++++|||-+....
T Consensus 104 a~~gel~k~L~--~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 104 APRGELYKDLQ--EGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred cCCchHHHHHH--hcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 99999999882 23667899999999999999999999999 99999999999999999999999999987643
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhh
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 220 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 220 (229)
.....+.+||..|.|||...+...+...|+|++|++.|+++.|.+||......+.|.-+.++
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~ 237 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV 237 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence 33346688999999999999999999999999999999999999999988766666555444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=271.38 Aligned_cols=197 Identities=30% Similarity=0.381 Sum_probs=174.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-ceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 79 (229)
+.||.|.||.||+| ....+|..||||.++.. ..+++-.-++|+..|++++ .||||+++.+++.+.. ..++||||+
T Consensus 16 ~klGDGTfGsV~la--~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln-~hpniikL~Evi~d~~~~L~fVfE~M 92 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLA--KSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-PHPNIIKLKEVIRDNDRILYFVFEFM 92 (538)
T ss_pred HHhcCCcceeEEEe--eecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC-CCCcchhhHHHhhccCceEeeeHHhh
Confidence 57999999999999 88999999999999865 3444455678999999998 5999999999998887 889999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
..+|.+++. .++..+++..++.|++||++||+++|.+ |+.|||+||+||++..+..+||+|||+|+.+....
T Consensus 93 -d~NLYqLmK---~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp- 164 (538)
T KOG0661|consen 93 -DCNLYQLMK---DRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP- 164 (538)
T ss_pred -hhhHHHHHh---hcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC-
Confidence 678999994 4578999999999999999999999999 99999999999999988899999999998875433
Q ss_pred cccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
+-+....|..|.|||++. ...|+.+.|+||+|||++|+.+-++.|++.+.
T Consensus 165 -PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 165 -PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred -CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 235567899999999876 56789999999999999999999999998764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=273.15 Aligned_cols=197 Identities=28% Similarity=0.350 Sum_probs=168.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|.+... .......+.+|+.+++.++ ||||+++++++.+....++||||
T Consensus 49 ~~lg~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~--h~~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05596 49 KVIGRGAFGEVQLV--RHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN--SEWIVQLHYAFQDDKYLYMVMEY 124 (370)
T ss_pred EEEeeCCCEEEEEE--EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCcceEEEEEecCCEEEEEEcC
Confidence 46999999999999 66778999999999643 2233355778999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. ...+++..+..++.|++.||+|||+. |++||||||+||++++++.++|+|||.+.......
T Consensus 125 ~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 125 MPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred CCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999882 34578889999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccCCccccCccccccC----CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........|++.|+|||++.+. .++.++|+|||||++|+|++|+.||.....
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 2223345689999999988653 378999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=266.58 Aligned_cols=195 Identities=25% Similarity=0.346 Sum_probs=168.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.||+|+++... ......+.+|..+++.+. .||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLV--ELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCCCCceEEEEEcCCEEEEEEeC
Confidence 46999999999999 667789999999997542 223455778888888883 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~~~g~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 149 (329)
T cd05588 78 VSGGDLMFHM----QRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP- 149 (329)
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-
Confidence 9999999888 4557899999999999999999999999 9999999999999999999999999998643221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
........|++.|+|||++.+..++.++|+||||+++|+|++|+.||+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 1122345689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=274.19 Aligned_cols=200 Identities=24% Similarity=0.350 Sum_probs=172.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|+++.. .......+.+|+.++..++ ||+|+++++.+.+....++||||
T Consensus 7 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 7 KVIGRGAFGEVRLV--QKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD--GAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred EEEeeCCCEEEEEE--EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCEEEEEEeC
Confidence 57999999999999 66778999999999743 2333466788999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.+|++||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 83 LPGGDMMTLL----MKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999998 4566799999999999999999999999 99999999999999999999999999986542110
Q ss_pred c----------------------------------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCc
Q 027015 159 T----------------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 204 (229)
Q Consensus 159 ~----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p 204 (229)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001134689999999999999999999999999999999999999
Q ss_pred ccCccccc
Q 027015 205 VDFDVQLG 212 (229)
Q Consensus 205 f~~~~~~~ 212 (229)
|.......
T Consensus 236 f~~~~~~~ 243 (360)
T cd05627 236 FCSETPQE 243 (360)
T ss_pred CCCCCHHH
Confidence 98765433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=265.96 Aligned_cols=196 Identities=26% Similarity=0.342 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.||+|+++... ....+.+.+|+.++..+. .||+|+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLV--RLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-SNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-CCCCEeeEEEEEEeCCEEEEEEeC
Confidence 46999999999999 667788999999998542 233456778888888874 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|..++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~~~~~L~~~~----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 150 (327)
T cd05617 78 VNGGDLMFHM----QRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG 150 (327)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence 9999999888 4556799999999999999999999999 99999999999999999999999999886532211
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 151 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred -CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 1223456899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=266.98 Aligned_cols=196 Identities=32% Similarity=0.398 Sum_probs=166.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHH-HHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++ ++..+|+.||+|.+.... ......+..|.. .++.++ ||||+++++.+.+....++|||
T Consensus 1 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~--hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLA--KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK--HPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEE--EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC--CCCCCCeeEEEEeCCEEEEEEc
Confidence 46999999999999 677889999999997542 222344555544 456777 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 77 YVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred CCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence 99999999988 4566789999999999999999999999 9999999999999999999999999988653222
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 122334568999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=272.46 Aligned_cols=198 Identities=28% Similarity=0.358 Sum_probs=173.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ +...+|+.||+|+++... ......+.+|++++..++ ||||+++++.+.++...++||||
T Consensus 7 ~~lg~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 7 KVIGRGAFGEVWLV--RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD--SPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred EEEEeCCcEEEEEE--EECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC--CCCccchhhheecCCeEEEEEcC
Confidence 57999999999999 667789999999997542 234567888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLL----IRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999998 3447899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----------------------------ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 ----------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345689999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=265.13 Aligned_cols=198 Identities=26% Similarity=0.316 Sum_probs=168.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+|+.||+|.++... .........|...+.... .||+|+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLA--ELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-ENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEE--EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-CCCCccCeeEEEEeCCEEEEEECC
Confidence 46999999999999 667789999999997542 223455666777776542 299999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 149 (316)
T cd05620 78 LNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG- 149 (316)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-
Confidence 9999999988 4556789999999999999999999999 9999999999999999999999999988643211
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 1123445689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=264.71 Aligned_cols=197 Identities=26% Similarity=0.326 Sum_probs=167.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++ ....+++.||+|.++... .........|...+... + ||||+++++++.+....++|||
T Consensus 1 ~~lG~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--hp~iv~~~~~~~~~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLA--ELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFLTHLYCTFQTKENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEE--EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccC--CCcCcceEEEEEeCCEEEEEEe
Confidence 46999999999999 667788999999997542 23345566677777654 5 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 77 y~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 77 YLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG 149 (316)
T ss_pred CCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence 99999999988 4456789999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. .......|++.|+|||++.+..++.++|+||+||++|+|++|+.||.....
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (316)
T cd05619 150 D-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201 (316)
T ss_pred C-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence 1 122345689999999999998999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=260.73 Aligned_cols=198 Identities=24% Similarity=0.366 Sum_probs=174.5
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
.||.|..+.||+| +.++.++.||||.++.+. ..+...+.+|+..++.++ ||||++++..|..++..|+||+++.+
T Consensus 33 ~IG~G~sa~V~~A--~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~--HPNIv~~~~sFvv~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 33 VIGVGASAVVYLA--RCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID--HPNIVTYHCSFVVDSELWVVMPFMAG 108 (516)
T ss_pred EEeccceeEeeee--eecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC--CCCcceEEEEEEecceeEEeehhhcC
Confidence 4899999999999 778888999999999874 334588999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH- 160 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 160 (229)
||+.+.+... ....+++..+..+++++++||.|||++ |.||||||+.||+++.+|.++|+|||....+..+...
T Consensus 109 GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 109 GSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred CcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 9999999433 344699999999999999999999999 9999999999999999999999999987766443211
Q ss_pred -cc-ccccCCccccCccccc--cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 -IS-TRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 -~~-~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.. ..+.|+++|||||++. ...|+.|+||||+|++..||.+|+.||....
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 11 5578999999999954 4569999999999999999999999998644
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=262.50 Aligned_cols=198 Identities=23% Similarity=0.316 Sum_probs=170.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ +...+++.+|+|.++... ......+.+|+++++.++ ||||+++++++..++..++||||+
T Consensus 7 ~~lg~g~~~~v~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 7 GVVGEGAYGVVLKC--RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK--QENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred EEecccCCEEEEEE--EECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC--CccccchhhhEecCCEEEEEEecC
Confidence 57999999999999 667788999999987542 233466788999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++++..+. .....+++..+..++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 887776554 3456789999999999999999999999 999999999999999999999999999887643322
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 223345688999999999988899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=266.04 Aligned_cols=196 Identities=30% Similarity=0.384 Sum_probs=166.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHH-HHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++ ++..+|+.||+|++.... ......+.+|.. +++.++ ||||+++++.+.+.+..++|||
T Consensus 1 ~~lg~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLA--KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK--HPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEE--EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC--CCCccceeeEEEcCCEEEEEEc
Confidence 46999999999999 677789999999997432 222344555544 567777 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|...+ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 77 YVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred CCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence 99999999888 4556788999999999999999999999 9999999999999999999999999988653222
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 150 E-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred C-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 1 12234568999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=265.07 Aligned_cols=195 Identities=26% Similarity=0.358 Sum_probs=167.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.+|+|.++.. .......+.+|+..+..+. .||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLV--RLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEE--EECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-CCCcCCceeeEEEeCCEEEEEEeC
Confidence 46999999999999 66778999999999754 2233455777888877663 299999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|..++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~~~~~L~~~~----~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 78 VNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 150 (329)
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence 9999999888 4556799999999999999999999999 99999999999999999999999999986532211
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 122345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=266.93 Aligned_cols=197 Identities=31% Similarity=0.374 Sum_probs=167.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHH-HHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++ .+..+|+.+|+|++.... ......+..|.. +++.++ ||||+++++.+...+..++|||
T Consensus 1 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLA--KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK--HPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC--CCCCccEEEEEecCCEEEEEEc
Confidence 46999999999999 677889999999997542 223344555554 466677 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|..++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 77 FVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred CCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence 99999999888 4567899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence 1122345689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=265.19 Aligned_cols=198 Identities=26% Similarity=0.329 Sum_probs=168.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|++... .....+.+..|.+.+..+. .|++|+++++++.+.+..++||||
T Consensus 6 ~~lg~G~~g~Vy~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 6 MVLGKGSFGKVMLA--ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred EEEeeccCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCEEEEEEcC
Confidence 57999999999999 66778899999999754 2334466778888888887 245688899999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 83 VNGGDLMYHI----QQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999988 4556789999999999999999999999 99999999999999999999999999886432111
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......|++.|+|||++.+..++.++|+||+|+++|+|++|+.||.....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 122345689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=266.02 Aligned_cols=197 Identities=32% Similarity=0.375 Sum_probs=166.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHH-HHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++ ++..+++.||+|++.... ......+..|.. .++.++ ||||+++++++...+..++|||
T Consensus 1 ~~lg~G~fg~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLA--RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--HPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEE--EECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC--CCCCCceeEEEEcCCeEEEEEe
Confidence 47999999999999 667788999999997432 122234444443 456777 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..+..++.|++.||++||+. |++||||||+||+++.++.++|+|||++......
T Consensus 77 ~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 77 YINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred CCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence 99999999988 4556788899999999999999999999 9999999999999999999999999998653222
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 150 N-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred C-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 1 122345689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=261.63 Aligned_cols=209 Identities=24% Similarity=0.310 Sum_probs=170.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-----ceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----CRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-----~~~lv~ 76 (229)
+.+|+|+||+||++ +-..+++.||||..-.+.. --.+|+++++.+. ||||+++.-+|.... ...+||
T Consensus 30 ~liG~GsFg~Vyq~--~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~--HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQA--KLRETEEEVAIKKVLQDKR----YKNRELQIMRKLD--HPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeecccceEEEE--EEcCCCceeEEEEecCCCC----cCcHHHHHHHhcC--CcCeeeEEEEEEecCCCchhHHHHHH
Confidence 56899999999999 5566789999999854432 3357899999998 999999999886432 224899
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-CceEEeccccccccC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFP 155 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-~~~~l~dfg~~~~~~ 155 (229)
||+ ..+|.+.+......+..++.-.+.-+.+|+++||+|||+. ||+||||||.|+++|.+ |.+||||||.|+.+.
T Consensus 102 eym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred Hhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 999 6689998865555678899999999999999999999998 99999999999999854 899999999999875
Q ss_pred CCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcccccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 226 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (229)
..... .....+..|.|||++.| ..|+.+.|+||.||++.||+-|++.|.+++ +..++.++++-+++|
T Consensus 178 ~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s--~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 178 KGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS--SVDQLVEIIKVLGTP 245 (364)
T ss_pred cCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC--HHHHHHHHHHHhCCC
Confidence 54433 33456888999999986 569999999999999999999999999865 444455554444433
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=267.82 Aligned_cols=199 Identities=24% Similarity=0.380 Sum_probs=178.7
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc-eEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-RILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~-~~lv~e 77 (229)
+..+|+|+||.++++ ++..+++.+++|.+.... ....+...+|+.+++++. ||||+.+.+.|+.++. .+|||+
T Consensus 9 ~~~iG~GafG~a~lv--rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~--hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLV--RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL--HPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhcCccccchhhhh--hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc--CCCeeeeccchhcCCceEEEEEe
Confidence 357999999999999 777788999999998663 333457788999999999 9999999999999988 899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
||+||++.+.+.+. +..-++++.+..|+.|++.|+.|||+. +|+|||+|+.|||++.++.++|+|||+++.+...
T Consensus 85 Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999433 357899999999999999999999999 9999999999999999999999999999988665
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .......||+.|++||++.+.+|..++|+|||||++||+++=+++|...+
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 4 24466789999999999999999999999999999999999999999764
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=258.46 Aligned_cols=198 Identities=24% Similarity=0.308 Sum_probs=170.7
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
||+|+||+||++ ....+|+.+|+|.+..... ...+.+..|+.+++.++ ||+|+++.+.+......++||||++
T Consensus 1 lg~G~~g~Vy~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSAC--QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH--SRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEE--EEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC--CCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 799999999999 6677899999999875422 22355678999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+.+.........+++..+..++.|++.||+|||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~- 152 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS- 152 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence 9999988754434556799999999999999999999999 999999999999999999999999999876543322
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......|++.|+|||.+.+..++.++|+||+|+++|++++|+.||....
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233568899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=265.38 Aligned_cols=196 Identities=28% Similarity=0.343 Sum_probs=166.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHh---hhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMA---NVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~---~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||++ ....+|+.||+|.++... ....+.+.+|++.+. .++ ||||+++++++.+.+..++|
T Consensus 5 ~~lg~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~--hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 5 AVLGRGHFGKVLLA--EYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER--HPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred EEEeecCCEEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC--CCChhceeeEEEcCCEEEEE
Confidence 57999999999999 667789999999997542 223355666666554 455 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||+++++|...+ ....+++..+..++.|++.||+|||+. |++|+||||+||++++++.++|+|||++....
T Consensus 81 ~E~~~~~~L~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999998877 235689999999999999999999999 99999999999999999999999999886532
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 221 122345689999999999998999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=258.77 Aligned_cols=205 Identities=28% Similarity=0.393 Sum_probs=179.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEee--cccchhhHHHHHHHHHHhhhccCCCcccccceEEEc-----CCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-----GPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-----~~~~~l 74 (229)
+.||+|++|.|+.| .+..+|+.||+|.+. .+.....++..+|+..++.++ |+||+.+.+.+.. -+..|+
T Consensus 28 ~~iG~GAyGvVcsA--~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~--HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSA--KDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR--HENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ccccCcceeeEEEE--EEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc--CCCcceEEeecccccccccceeEE
Confidence 67999999999999 778899999999997 456667789999999999999 9999999999865 346799
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
|+|++ +.+|...+ .....+++..+..+++|++.||.|+|+. +++|||+||.|++++.+-.+|+||||+|+..
T Consensus 104 V~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 104 VFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence 99999 77899998 6666799999999999999999999999 9999999999999999999999999999887
Q ss_pred CCC-CccccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchh
Q 027015 155 PEN-TTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 218 (229)
Q Consensus 155 ~~~-~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 218 (229)
... .....+....|..|.|||+.. ...|+.+.||||+|||+.||++|++.|.+.+...+..++-
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~ 241 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL 241 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 432 222345667899999999776 6789999999999999999999999999987665555443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=264.81 Aligned_cols=198 Identities=25% Similarity=0.325 Sum_probs=168.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|+++... .........|...+..+. .|++|+++++++.+.+..++||||
T Consensus 6 ~~lg~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 6 MVLGKGSFGKVMLA--ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCeEeeEEEEEecCCEEEEEEcC
Confidence 57999999999999 667788999999997542 223345666777776664 389999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 83 VNGGDLMYQI----QQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999988 4556789999999999999999999999 99999999999999999999999999986532221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 122345689999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=265.41 Aligned_cols=198 Identities=26% Similarity=0.330 Sum_probs=169.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|+++.. .....+.+.+|+.++..++ |++|+++++++.+++..++||||
T Consensus 7 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 7 KVIGRGAFGEVAVV--KMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD--RRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred EEEEecCCeEEEEE--EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCCCceEEEEecCCeEEEEEec
Confidence 57999999999999 66778999999999742 2223456788999999988 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~g~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLS---KFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99999999983 2345789999999999999999999999 99999999999999999999999999987654333
Q ss_pred ccccccccCCccccCcccccc-----CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 222233468999999999863 347889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=265.29 Aligned_cols=200 Identities=27% Similarity=0.340 Sum_probs=168.9
Q ss_pred CccCCcccccccccceE-eccCCcEEEEEEeecc----cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI-RLQDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~-~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||+++.. ...+++.||+|++... .....+.+..|+.+++.++ .||+|+++++++...+..++||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc-CCCCcccEEEEEecCCEEEEEE
Confidence 57999999999998442 2357899999999743 1223456778999999885 3899999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 85 DYVSGGEMFTHL----YQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred eCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999998 4556789999999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..........|++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 322223345689999999998865 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=263.87 Aligned_cols=198 Identities=25% Similarity=0.339 Sum_probs=168.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+|+.||+|+++... ....+....|...+..+. +|++|+++.+++.+.+..++||||
T Consensus 6 ~~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 6 MVLGKGSFGKVMLA--ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred EEEEecCCeEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCchhheeeEEecCCEEEEEEcC
Confidence 57999999999999 667789999999997542 233455677888887776 367888999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 83 VNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999988 4556799999999999999999999999 99999999999999999999999999987542221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. ......|++.|+|||++.+..++.++|+||+|+++|+|++|+.||.....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 1 12335689999999999998999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=267.14 Aligned_cols=200 Identities=28% Similarity=0.370 Sum_probs=171.8
Q ss_pred CCccCCcccccccccceE-eccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFI-RLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~-~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||+|+||+||++... ...+|+.+|+|++..... ........|++++++++ ||||+++++.+.+.+..++|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN--HPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC--CCCcccEEEEEEcCCEEEEEEc
Confidence 468999999999998542 235789999999975422 23355778999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..+..++.|+++||+|||+. |++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 79 FLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 99999999988 4556789999999999999999999999 9999999999999999999999999998764332
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 152 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 203 (318)
T cd05582 152 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203 (318)
T ss_pred CC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH
Confidence 11 22345689999999999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=272.41 Aligned_cols=208 Identities=22% Similarity=0.266 Sum_probs=177.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC----CCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~----~~~i~~~~~~~~~~~~~~lv~e 77 (229)
..||+|.||.|-+| .+..+++.||||+++.. +.-..+...|+.+|+.++.. .-|+++++++|...++.|||+|
T Consensus 192 e~LGkGtFGQVvk~--~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 192 EVLGKGSFGQVVKA--YDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEecccccceeEEE--EecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 46999999999999 88899999999999733 33446677899999999832 2389999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC--CceEEeccccccccC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN--FNPKISDFGLSKLFP 155 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~--~~~~l~dfg~~~~~~ 155 (229)
.+ ..+|.+++.. ....+++...++.++.||+.+|.+||+. +|||+||||+|||+.+. ..+|++|||.+....
T Consensus 269 LL-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 269 LL-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred hh-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 88 8899999943 3556799999999999999999999999 99999999999999643 369999999998754
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 222 (229)
... ...+.+..|.|||++.|.+|+.+.||||||||++||++|.+.|.+++..++...+..+.-
T Consensus 343 q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 343 QRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred Ccc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence 432 244567789999999999999999999999999999999999999887776666655543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=262.47 Aligned_cols=197 Identities=28% Similarity=0.349 Sum_probs=168.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.||+|.++... ......+..|.++++.+. .||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLA--ELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEE--EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999 667788999999997542 233455677888887774 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 78 ~~~~~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 150 (318)
T cd05570 78 VNGGDLMFHI----QRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150 (318)
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence 9999999888 4556799999999999999999999999 99999999999999999999999999886432211
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 151 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 151 V-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred C-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 1 1233468899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=274.29 Aligned_cols=201 Identities=24% Similarity=0.326 Sum_probs=174.8
Q ss_pred CccCCcccccccccceEeccC-CcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|++|.||+| .+..+ ++.|++|.+..........+.+|+.+++.++ ||||+++++++...+..++||||++
T Consensus 73 ~~lg~G~~g~vy~a--~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 73 TLVGRNPTTAAFVA--TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD--HFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEeCCCcEEEEE--EEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEEECCEEEEEEECCC
Confidence 46899999999999 55555 7889999876555555567788999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc-
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT- 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 159 (229)
+++|.+++........++++..+..++.|++.+|.+||+. +++||||||+||+++.++.++|+|||++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998855445566799999999999999999999999 999999999999999999999999999987643322
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12344568999999999999999999999999999999999999998654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=259.18 Aligned_cols=197 Identities=24% Similarity=0.383 Sum_probs=166.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ .+..+++.||+|.++... ......+.+|+++++.++ ||||+++++++.+....++||||++
T Consensus 11 ~~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 11 DKLGEGTYATVFKG--RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK--HANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred eEEecCCCEEEEEE--EECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC--CCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 57999999999999 667789999999997543 233456788999999999 9999999999999888999999997
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+ +|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+........
T Consensus 87 ~-~l~~~l~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 87 S-DLKQYLD---NCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred c-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 5 8888873 2344678999999999999999999999 999999999999999999999999999875432211
Q ss_pred ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 161 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1233457889999998875 5689999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=265.08 Aligned_cols=198 Identities=27% Similarity=0.334 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|.+... .......+.+|..++..+. |++|+++++++.+.+..++||||
T Consensus 7 ~~lG~G~fg~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 7 KVIGRGAFGEVAVV--KMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD--CQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCEEEEEEeC
Confidence 57999999999999 66778899999998642 2223355778889998888 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..+..++.|++.+|++||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~gg~L~~~l~---~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLS---KFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999993 2245789999999999999999999999 99999999999999999999999999987664433
Q ss_pred ccccccccCCccccCcccccc-----CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........|++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 322334568999999998875 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=267.26 Aligned_cols=199 Identities=25% Similarity=0.331 Sum_probs=171.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+|+.||+|.++... ....+.+.+|+.+++.+. ||+|+++++++.+....++||||
T Consensus 7 ~~lg~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~--~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 7 SLVGRGHFGEVQVV--REKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--SPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred EEEEeccCEEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceeeEEecCCeEEEEECC
Confidence 57999999999999 667789999999997542 223456788999999988 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..+..++.|++.||++||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~---~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLN---RYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 99999999983 2236799999999999999999999999 99999999999999999999999999997764433
Q ss_pred ccccccccCCccccCccccc------cCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAI------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........+++.|+|||++. ...++.++|+||||+++|+|++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 32333456899999999986 45678999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=263.07 Aligned_cols=203 Identities=26% Similarity=0.364 Sum_probs=179.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|.|+.|-+| ++..+|..||||++.... ......+++|++.++.++ ||||+++|++...+-..|+|+|.-
T Consensus 24 kTlG~GHFAVVKLA--rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ--HpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLA--RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ--HPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred hhhcCCceehhhhh--hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc--CcCeeeeeehhcccceEEEEEEec
Confidence 57999999999999 778899999999997542 334467999999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE-cCCCceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-DQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~-~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++|.|++|+ ......+++....+++.||+.|+.|+|+. +++|||+||+|+.+ .+-|-+||.|||++..+....
T Consensus 100 D~GDl~DyI---mKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 100 DGGDLFDYI---MKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred CCchHHHHH---HhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999 46667899999999999999999999999 99999999999876 467889999999987765432
Q ss_pred ccccccccCCccccCccccccCCCC-CcccchhHHHHHHHHHhCCCcccCccccccccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 216 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~ 216 (229)
...+.+|+..|.|||++.|..|+ ++.||||||+|+|.|++|++||+.-+..+...+
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm 230 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM 230 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh
Confidence 34667899999999999999998 789999999999999999999987655554443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=246.80 Aligned_cols=201 Identities=25% Similarity=0.379 Sum_probs=175.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
.||+|.|+.|+++ .+..+|+.+++|+++.. +..+.+.+.+|+.+.+.++ ||||+++.+.+...+..|+|+|.++
T Consensus 18 ~igkG~FSvVrRc--~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq--HP~IvrL~~ti~~~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 18 ELGKGAFSVVRRC--VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFHYLVFDLVT 93 (355)
T ss_pred HHccCchHHHHHH--HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC--CCcEeehhhhhcccceeEEEEeccc
Confidence 4899999999999 88999999999999755 3446689999999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc---CCCceEEeccccccccCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~---~~~~~~l~dfg~~~~~~~~ 157 (229)
|+.|..-+ -.+.-+++..+...++||+.+|+|+|.+ +|+|||+||+|+++- ...-+||+|||++...+.
T Consensus 94 G~dl~~eI----V~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~- 165 (355)
T KOG0033|consen 94 GGELFEDI----VAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND- 165 (355)
T ss_pred chHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC-
Confidence 99987665 2446788999999999999999999999 999999999999994 344599999999988762
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 216 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~ 216 (229)
.....-..|+|.|+|||+....+++..+|||+.|+++|-|+.|.+||.+.++...|+.
T Consensus 166 -g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~ 223 (355)
T KOG0033|consen 166 -GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ 223 (355)
T ss_pred -ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH
Confidence 2233446799999999999999999999999999999999999999998665544443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=259.81 Aligned_cols=194 Identities=26% Similarity=0.393 Sum_probs=170.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ .+..+|..+|+|.+..+.. .....+.+|++.++.++ ||||+++++++.+++..++||||++
T Consensus 11 ~~lg~G~~g~V~~~--~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 11 SELGAGNGGVVTKV--QHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred EeecCCCCEEEEEE--EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECCEEEEEeecCC
Confidence 57999999999999 6777899999999986533 33467889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++ .....+++..+..++.|++.+|.|||+. .+++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 87 GGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 99999998 4456789999999999999999999985 169999999999999999999999999987653322
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.....+++.|+|||++.+..++.++|+||||+++|++++|+.||...
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23356889999999999989999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=262.98 Aligned_cols=199 Identities=26% Similarity=0.328 Sum_probs=168.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.+|+|.+... .......+.+|+..+..++ |++|+++++.+.+....++||||
T Consensus 7 ~~lG~G~fg~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 7 KVIGRGAFGEVAVV--KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--NQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred EEEEeCCCeEEEEE--EECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC--CCCEeeEEEEEecCCEEEEEEec
Confidence 57999999999999 66677899999998642 1222345778888888888 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..+..++.|++.+|++||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~g~L~~~l~---~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLS---KFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999993 2245789999999999999999999999 99999999999999999999999999987653332
Q ss_pred ccccccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........|++.|+|||++. ...++.++|+||||+++|+|++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 22223456899999999886 34578899999999999999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=261.15 Aligned_cols=198 Identities=29% Similarity=0.421 Sum_probs=165.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--------------hhhHHHHHHHHHHhhhccCCCcccccceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--------------QGEKEFMSEVASMANVNVCHENLVKLHGGCI 67 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~ 67 (229)
+.||+|.||+|-+| ++..+++.||+|++..... ...++..+|+.+++++. ||||++++++..
T Consensus 103 ~eiG~G~yGkVkLa--r~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~--H~nVV~LiEvLD 178 (576)
T KOG0585|consen 103 KEIGSGQYGKVKLA--RDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH--HPNVVKLIEVLD 178 (576)
T ss_pred hhhcCCccceEEEE--eecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC--CcCeeEEEEeec
Confidence 57999999999999 7888999999999853211 12368899999999999 999999999987
Q ss_pred cC--CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 68 DG--PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 68 ~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
+. ...|||+|||..|.+...- .....+++.+++.++.+++.||.|||.+ ||+||||||.|++++.+|++||
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred CcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEe
Confidence 65 4789999999988776543 2333399999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCC----ccccccccCCccccCccccccC---C-CCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 146 SDFGLSKLFPENT----THISTRVAGTLGYLAPEYAISG---R-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 146 ~dfg~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~---~-~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
+|||.+..+.... ........|||.|+|||...+. . .+.+.||||+|+++|.|+.|+.||-++..
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999988663221 1112346799999999988762 2 35789999999999999999999988753
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=252.53 Aligned_cols=206 Identities=25% Similarity=0.301 Sum_probs=176.5
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||.|..|+||++ ....++..+|+|++..+ ..+...+...|.++|+.+. ||.+..+|..|+.+...|++||
T Consensus 82 lk~LG~GdiG~VyL~--~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD--HPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLV--ELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD--HPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHcCCCCceeEEEE--EecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC--CCccchhhheeeccceeEEEEe
Confidence 367999999999999 44556799999999755 3445577888999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC-
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE- 156 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~- 156 (229)
||+||+|....+ .+..+.+++..++-++..++-||.|||.. |||+|||||+||++.++|++-|.||+++.....
T Consensus 158 yCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999884 34667899999999999999999999999 999999999999999999999999998643200
Q ss_pred --------------------------------C-Cc---------------------cccccccCCccccCccccccCCC
Q 027015 157 --------------------------------N-TT---------------------HISTRVAGTLGYLAPEYAISGRL 182 (229)
Q Consensus 157 --------------------------------~-~~---------------------~~~~~~~~~~~~~aPE~~~~~~~ 182 (229)
. .. .....+.||-.|.|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 00 00112458889999999999999
Q ss_pred CCcccchhHHHHHHHHHhCCCcccCcccccccc
Q 027015 183 TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 215 (229)
Q Consensus 183 ~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~ 215 (229)
+.+.|.|+||+++|||+.|..||.+.++.+.+.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~ 345 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR 345 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH
Confidence 999999999999999999999999987766543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=276.30 Aligned_cols=205 Identities=22% Similarity=0.284 Sum_probs=171.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceE-EEc---C---CceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG-CID---G---PCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~-~~~---~---~~~~l 74 (229)
+.|.+|+|+.||+| .....|..||+|.+-.......+.+.+|+++++.|+ +|+|||.++|. ... + -.+.|
T Consensus 43 ~vLAEGGFa~VYla--~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 43 KVLAEGGFAQVYLA--QDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS-GHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEccCCcEEEEEE--EecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc-CCCceeeEeccccccccCCCceeEEEe
Confidence 46899999999999 556666999999998777778899999999999999 69999999993 321 1 25679
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
+||||.|++|.+++..+.+. .|++.++++|++++++|+++||.. ++.+||||||-+|||+..+|..||||||.+...
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred ehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 99999999999999554333 399999999999999999999998 667999999999999999999999999998754
Q ss_pred CCCCccc--------cccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 155 PENTTHI--------STRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 155 ~~~~~~~--------~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
....... .-...-|+.|.|||.+. +.++++|+|||+|||++|.|+....||+..++..
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 2222111 11233688999999876 7789999999999999999999999999875433
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=257.41 Aligned_cols=195 Identities=24% Similarity=0.370 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||++ ....+++.||+|.++... ........+|+.+++.++ ||||+++++++.++...++||||++
T Consensus 11 ~~lg~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 11 EKLGEGSYATVYKG--KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK--HANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred eeEEecCCEEEEEE--EECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC--CCCcCeEEEEEecCCeEEEEEECCC
Confidence 57999999999999 667789999999987543 223356778999999999 9999999999999999999999995
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
++|.+++. .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+....... .
T Consensus 87 -~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 87 -TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred -cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 67777762 3446788999999999999999999999 99999999999999999999999999986543221 1
Q ss_pred ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 161 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2233457889999998865 45788999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=267.46 Aligned_cols=193 Identities=28% Similarity=0.517 Sum_probs=167.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
..||+|+||+||++.|+. .||||+++.+ .....+.|..|+..+++.+ |.||+-+.+++..++. .||+.||
T Consensus 398 ~rIGsGsFGtV~Rg~whG-----dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR--H~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 398 ERIGSGSFGTVYRGRWHG-----DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR--HENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred ceeccccccceeeccccc-----ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc--hhhheeeehhhcCCce-eeeehhc
Confidence 369999999999998743 8999999866 4445688999999999999 9999999999988876 9999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC-C
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN-T 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~-~ 158 (229)
+|.+|..+++ ..+..++....++|++|+++|+.|||.+ +|||+|+|..|||+.++++|+|+|||++..-..- .
T Consensus 470 eGsSLY~hlH---v~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 470 EGSSLYTHLH---VQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred cCchhhhhcc---chhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 9999999995 4457899999999999999999999999 9999999999999999999999999998653211 1
Q ss_pred ccccccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.......-|...|+|||++.. .+++..+||||+|+++|||++|..||...
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence 112233557889999999873 57999999999999999999999999944
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=260.76 Aligned_cols=203 Identities=28% Similarity=0.384 Sum_probs=165.1
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcC-CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDG-PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~-~~~~lv 75 (229)
+.||+|+||.||++.... ..++..||+|.++... ......+.+|+.++..+ + ||||+++++.+... +..+++
T Consensus 13 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN--HLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhcc--CcceeeEEeEecCCCCceEEE
Confidence 579999999999995422 3446789999987443 33346788999999999 6 99999999988754 457899
Q ss_pred EEccCCCCHHHHHhhhhc----------------------------------------------------------cccC
Q 027015 76 YDYMPNNSLSQTLLGEEK----------------------------------------------------------RRAK 97 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~----------------------------------------------------------~~~~ 97 (229)
|||+++++|.+++..... ...+
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 999999999999854211 0235
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-ccccccCCccccCccc
Q 027015 98 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEY 176 (229)
Q Consensus 98 l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~ 176 (229)
+++..+..++.|+++||+|||+. |++|+||||+||+++.++.++|+|||++......... ......+++.|+|||+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 78889999999999999999999 9999999999999999999999999998765332211 1122345678999999
Q ss_pred cccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 177 AISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 177 ~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
+.+..++.++|+||||+++|++++ |+.||....
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999999997 999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=240.19 Aligned_cols=203 Identities=25% Similarity=0.323 Sum_probs=173.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~lv~ 76 (229)
+.||+|+|+.|+++ .+..++..||+|.+...+.++.+..++|++..+.++ |||+++++++...+ ...|+++
T Consensus 27 ~~LgeGGfsfv~LV--~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~--s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 27 RLLGEGGFSFVDLV--KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN--SPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred eeecCCCceeeeee--cccCcccchhhheeeccchHHHHHHHHHHHHHHhhC--CcchHHHHHHHHHhhccCceeEEEEe
Confidence 46899999999999 678899999999998888888899999999999999 99999999987543 3479999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
+|...|||.+.+.........+++..+.+++.++++||.+||+. -+.+.|+||||.||++.+++.++|.|||.+....-
T Consensus 103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 99999999999977666677899999999999999999999998 22399999999999999999999999999876532
Q ss_pred CCccc--------cccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 157 NTTHI--------STRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 157 ~~~~~--------~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ...-..|..|.|||++.. ...++++|||||||++|+++.|..||+..-
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 21111 111236889999999874 457899999999999999999999998643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=260.11 Aligned_cols=196 Identities=25% Similarity=0.358 Sum_probs=165.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-----ceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----CRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-----~~~l 74 (229)
+.||+|+||.||++ ++..+|+.||+|.++.. .......+.+|+++++.++ ||||+++++++.... ..++
T Consensus 6 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 6 EVIGKGSYGVVCSA--IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred EEEeecCCeEEEEE--EECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC--CCCEeeecceEeccCCCCCceEEE
Confidence 57999999999999 77788999999998743 2334456889999999999 999999999886432 4799
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
||||+ +++|.+++ .....+++..+..++.|+++||+|||+. |++|+||||+||+++.++.++|+|||.+...
T Consensus 82 v~e~~-~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELM-ESDLHQVI----KANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecC-CCCHHHHH----HhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 99999 46898888 4556799999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCc--cccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 155 PENTT--HISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 155 ~~~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 22111 11233568899999998875 678999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=263.74 Aligned_cols=187 Identities=20% Similarity=0.260 Sum_probs=163.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ++..+++.||+|... ...+.+|+++++.++ ||||+++++++......++++|++ .
T Consensus 98 ~~lg~G~~g~V~~~--~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv~e~~-~ 166 (391)
T PHA03212 98 ETFTPGAEGFAFAC--IDNKTCEHVVIKAGQ------RGGTATEAHILRAIN--HPSIIQLKGTFTYNKFTCLILPRY-K 166 (391)
T ss_pred EEEcCCCCeEEEEE--EECCCCCEEEEechh------hhhhHHHHHHHHhCC--CCCCCCEeEEEEECCeeEEEEecC-C
Confidence 57999999999999 777889999999753 235678999999999 999999999999999999999999 4
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|..++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..........
T Consensus 167 ~~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 167 TDLYCYL----AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 6888887 4456789999999999999999999999 99999999999999999999999999986533222222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||-
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 334578999999999999899999999999999999999998764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=249.53 Aligned_cols=194 Identities=27% Similarity=0.326 Sum_probs=166.5
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
||+|+||.||++ ....+|+.+|+|.+.... .........|+++++.++ ||||+++.+.+.++...++||||++
T Consensus 1 lg~G~~g~Vy~~--~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAV--QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN--SPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEE--EEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC--CCcEEEEEEEEecCCeEEEEEecCC
Confidence 799999999999 666789999999986432 222345567999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++.. .....+++..+..++.|++.|+++||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 77 g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~- 150 (277)
T cd05607 77 GGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT- 150 (277)
T ss_pred CCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-
Confidence 9999988732 2334688999999999999999999999 999999999999999999999999999876543321
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.....++..|+|||.+.+..++.++|+||||+++|++++|+.||...
T Consensus 151 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 151 -ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred -eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 22345788999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=261.95 Aligned_cols=196 Identities=27% Similarity=0.324 Sum_probs=162.7
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhc-cCCCcccccceEEEcCCceEEEEEcc
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~-~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
||+|+||+||++ ++..+|+.||+|++..... ........|..++.... ..||+|+++++.+.+....++||||+
T Consensus 1 lG~G~~g~Vy~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQV--RKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEE--EECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 799999999999 6777899999999964321 12233445555555442 12999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++ .....+++..+..++.|+++||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~g~L~~~l----~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 79 SGGELFWHL----QKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred CCChHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 999999988 4567799999999999999999999999 99999999999999999999999999986532221
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......|++.|+|||++.+. .++.++|+||||+++|+|++|+.||....
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 122345689999999988754 47899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=258.53 Aligned_cols=201 Identities=26% Similarity=0.361 Sum_probs=177.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch---hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|.||.||++ +...+|+.+|+|.+...... +...+.+|+++++++. .||||+.+.+.|++....++|||+
T Consensus 41 ~~lG~G~Fg~v~~~--~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~-~hpniv~l~~~~e~~~~~~lvmEL 117 (382)
T KOG0032|consen 41 RELGRGQFGVVYLC--REKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS-GHPNIVQLKDAFEDPDSVYLVMEL 117 (382)
T ss_pred hhhCCCCceEEEEE--EecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc-CCCCEEEEEEEEEcCCeEEEEEEe
Confidence 46999999999999 77888999999999755332 3468999999999998 499999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC----CCceEEecccccccc
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ----NFNPKISDFGLSKLF 154 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~----~~~~~l~dfg~~~~~ 154 (229)
++||.|.+.+... .+++..+..++.|++.+++|||+. |++|+|+||+|+++.. ++.++++|||++...
T Consensus 118 ~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 118 CEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred cCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999999433 399999999999999999999999 9999999999999953 347999999999887
Q ss_pred CCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccccccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 215 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~ 215 (229)
.. .......+||+.|+|||++...+++...|+||+|+++|.|++|.+||..........
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 65 334466789999999999999999999999999999999999999999877544443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=262.54 Aligned_cols=198 Identities=23% Similarity=0.312 Sum_probs=168.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-----ceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----CRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-----~~~l 74 (229)
+.||+|+||.||++ .+..+|+.||+|.+... .....+.+.+|+++++.++ ||||+++++++.... ..++
T Consensus 6 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 6 RPIGYGAFGVVWSV--TDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK--HDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred ceeeeCCCEEEEEE--EECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC--CCCcCCHhheecCCCccccceEEE
Confidence 67999999999999 66778999999998643 2234467889999999999 999999999998766 7899
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
|+||+. ++|.+.+ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 82 VTELMQ-SDLHKII----VSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred Eeeccc-cCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 999995 5787777 4556799999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
............+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 33322223334578899999998874 4789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=256.64 Aligned_cols=195 Identities=25% Similarity=0.377 Sum_probs=170.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ....++..+|+|.+..... .....+.+|++.++.++ ||||+++++++.+++..++||||++
T Consensus 11 ~~lg~g~~g~V~~~--~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 11 SELGAGNGGVVFKV--SHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred ccccCCCCEEEEEE--EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC--CCcccceeEEEEECCEEEEEEecCC
Confidence 67999999999999 6677899999999876533 33467889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++ .....+++..+..++.+++.++.|||+. .+++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~L~~~l----~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 87 GGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 99999998 4456788999999999999999999974 179999999999999999999999999987543221
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||++.+..++.++|+|||||++|++++|+.||....
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 233467889999999998889999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=251.64 Aligned_cols=197 Identities=27% Similarity=0.343 Sum_probs=169.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.||+|.+..... .....+.+|+.+++.++ ||||+++++.+..+...++||||
T Consensus 6 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 6 RVLGKGGFGEVCAC--QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred EEEecCCCeEEEEE--EEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC--CCCEeeeeeeecCCCeEEEEEec
Confidence 57999999999999 5667889999999975422 22345678999999999 99999999999998899999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.. .....+++..+..++.|++.|+.+||+. |++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999988732 2335689999999999999999999999 99999999999999999999999999987653322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....+++.|+|||++.+..++.++|+||+|+++|++++|+.||....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1 123457889999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=258.01 Aligned_cols=191 Identities=28% Similarity=0.416 Sum_probs=161.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||++ ....+|+.||+|++..... .....+.+|+++++.++ |+||+++++++.+.+..++||||++
T Consensus 80 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 80 NRIGSGAGGTVYKV--IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN--HPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred hhccCCCCeEEEEE--EECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC--CCCcceeeeEeccCCeEEEEEecCC
Confidence 57999999999999 6677899999999965432 33467889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+. ...++..+..++.|++.||+|||+. |++|+||||+||++++++.++|+|||++..+.....
T Consensus 156 ~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9998653 2345778889999999999999999 999999999999999999999999999876543221
Q ss_pred ccccccCCccccCcccccc-----CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 161 ISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
......|+..|+|||.+.. ...+.++|||||||++|+|++|+.||...
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1233568999999998743 23456899999999999999999999843
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=244.72 Aligned_cols=196 Identities=24% Similarity=0.369 Sum_probs=172.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.||+|+++.|-.+ +++.+|..||||++.........++.+|++++.+.+ .|+||+.++++|+++.+.|+|||-+.||
T Consensus 85 ~LGeGAyasVqtc--v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq-gh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 85 LLGEGAYASVQTC--VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ-GHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HhcCccceeeeee--eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc-CCccHHHHHHHhcccceEEEEEecccCc
Confidence 4899999999998 889999999999998887778889999999999998 6999999999999999999999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc---eEEeccccccccCCC--
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPEN-- 157 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~---~~l~dfg~~~~~~~~-- 157 (229)
+|...+ ..+.-+++.++..+..+|++||.|||.. ||.|||+||+||+....+. +|||||++..-+.-.
T Consensus 162 plLshI----~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 162 PLLSHI----QKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred hHHHHH----HHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999 7888999999999999999999999999 9999999999999976554 799999987654211
Q ss_pred C----ccccccccCCccccCcccccc-----CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 158 T----THISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 158 ~----~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
- .....+++|+..|||||+..- ..|+.+.|+||||+|+|-|+.|.+||.+.
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 1 112234678889999998652 34789999999999999999999999874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=266.87 Aligned_cols=196 Identities=27% Similarity=0.371 Sum_probs=170.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceEEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRILV 75 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~lv 75 (229)
.||+|+||.||++ ++..+|+.||||.++.. .....+.-.+|++++++++ ||||++++++=++.. ...++
T Consensus 20 ~LG~Ga~g~V~rg--rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn--h~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 20 RLGKGAFGNVYRG--RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN--HPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred hhcCCccceeeee--cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC--chhhhhhcccCCccccCcccccceEE
Confidence 5899999999999 77889999999999865 3455677889999999999 999999999765443 45799
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc--CCCc--eEEeccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFN--PKISDFGLS 151 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~--~~~~--~~l~dfg~~ 151 (229)
||||.||||...+... .+..++++.+++.++..+..|+++||++ ||+||||||.||++. ++|+ .||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999543 4557899999999999999999999999 999999999999984 3344 699999999
Q ss_pred cccCCCCccccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
+...++. ......||..|.+||+.. .+.++...|+||+||++|++.||..||...
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9876654 345678999999999998 488999999999999999999999999754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=266.92 Aligned_cols=201 Identities=29% Similarity=0.412 Sum_probs=170.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC--------c
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--------C 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--------~ 71 (229)
+.||+|+||+||++ ....+|+.||+|.+.... ......+.+|+..+..++ |++|+++.+.+.... .
T Consensus 38 ~~LG~G~fG~Vy~a--~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~--h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 38 RVLGSGATGTVLCA--KRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD--FFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEecCCCEEEEEE--EEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC--CCcEEEeecceecccccCcccceE
Confidence 46999999999999 667789999999997542 334466788999999998 999999988765322 3
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
.++||||+++++|.+++.........+++..+..++.|++.+|+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 5799999999999999865444556799999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 152 KLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 152 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 7654322 122344678999999999999999999999999999999999999998654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=247.70 Aligned_cols=201 Identities=21% Similarity=0.321 Sum_probs=166.7
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
..||+|+||.||++.+.. ...+..||+|.++... ......+.+|+..++.++ ||||+++++++..+...++||||+
T Consensus 11 ~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD--HSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred eeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEecCCCcEEEEEeC
Confidence 469999999999985422 2346789999997653 333467889999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++++|||.+........
T Consensus 89 ~~~~L~~~l~---~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 89 SNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred CCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 9999999983 2245789999999999999999999999 999999999999999999999999998655322211
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.......++..|+|||.+.+..++.++|+||+|+++|++++ |+.||.....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 11122334568999999999999999999999999999875 9999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=263.38 Aligned_cols=185 Identities=28% Similarity=0.463 Sum_probs=167.3
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
=||+|+.|-||+++. .++.||||.++ +.-..+++.|++|+ ||||+.+.++|.....+|||||||..|
T Consensus 131 WlGSGaQGAVF~Grl----~netVAVKKV~-------elkETdIKHLRkLk--H~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL----HNETVAVKKVR-------ELKETDIKHLRKLK--HPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhccCcccceeeeec----cCceehhHHHh-------hhhhhhHHHHHhcc--CcceeeEeeeecCCceeEEeeeccccc
Confidence 489999999999844 45899999986 23345788999999 999999999999999999999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcccc
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 162 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (229)
-|.+.+ .....++...+.+|..+|+.++.|||.. .|||||||.-||+++.+..+||+|||.++...+. ...
T Consensus 198 qL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 198 QLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred cHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 999999 7788899999999999999999999999 9999999999999999999999999998876543 234
Q ss_pred ccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 163 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
-.++||..|||||++...+.++|.||||+|+++|||+||+.||.+-+
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 45889999999999999999999999999999999999999998754
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=248.46 Aligned_cols=195 Identities=32% Similarity=0.474 Sum_probs=172.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhh--HHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+..+++.+|+|.+........ ....+|+..+++++ ||||+++++++.+....+++||++
T Consensus 5 ~~lg~G~~g~v~~~--~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 5 KKLGSGGFGTVYKA--KNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR--HPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEESSEEEEEE--EETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT--BTTBCHEEEEEEESSEEEEEEEEE
T ss_pred EEEEeCCCEEEEEE--EECCCCeEEEEEEeccccccccccchhhhhhhcccccc--cccccccccccccccccccccccc
Confidence 57999999999999 7788899999999986644333 23456999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++ .....+++..+..++.|++.+|.+||+. +++|+||+|+||++++++.++|+|||.+...... .
T Consensus 81 ~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~ 152 (260)
T PF00069_consen 81 PGGSLQDYL----QKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N 152 (260)
T ss_dssp TTEBHHHHH----HHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred ccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 999999999 4677889999999999999999999999 9999999999999999999999999998754222 2
Q ss_pred cccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 HISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.......++..|+|||... +..++.++|+||||+++++|++|..||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2334456788999999988 888999999999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=249.71 Aligned_cols=194 Identities=19% Similarity=0.303 Sum_probs=164.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchh---hHHHHHHHHHHhhhccCCCcccccceEEEc----CCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQG---EKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----~~~~~l 74 (229)
..||+|+++.||++.+ +|+.||+|.++...... .+.+.+|+..+++++ ||||+++++++.+ ....++
T Consensus 26 ~~i~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID--SNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC--CCCEEEEeeeEEecccCCCceEE
Confidence 3589999999999843 78999999997543222 466789999999999 9999999999876 346789
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
+|||+++++|.+++ .....+++.....++.+++.++++||+.. +++|+||+|+||++++++.++|+|||++...
T Consensus 100 v~Ey~~~g~L~~~l----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 100 ILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred EEEeCCCCcHHHHH----hhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 99999999999999 44567889999999999999999999731 7889999999999999999999999998764
Q ss_pred CCCCccccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.... ....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||......
T Consensus 174 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~ 228 (283)
T PHA02988 174 SSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228 (283)
T ss_pred cccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence 3321 23457889999999876 67899999999999999999999999876433
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=259.55 Aligned_cols=195 Identities=31% Similarity=0.465 Sum_probs=176.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
++||+|.|++|.++ ++..++..||+|.+... .....+.+.+|+++++.++ ||||++++.+.+.....|+||||+
T Consensus 62 ~tig~g~f~~V~La--~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~--HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 62 KTIGKGNFAKVKLA--RHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN--HPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeccceeEEEEee--EecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC--CcceeeeeeeeeecceeEEEEEec
Confidence 68999999999999 77889999999999754 3333466899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
.++.+++++ ...+.+.+.++...+.|++++++|||++ .++|||||.+|++++++.+++|+|||++..+.. .
T Consensus 138 ~~ge~~~yl----~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~ 208 (596)
T KOG0586|consen 138 SGGELFDYL----VKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY--G 208 (596)
T ss_pred cCchhHHHH----HhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--c
Confidence 999999999 6777788899999999999999999999 999999999999999999999999999988753 3
Q ss_pred cccccccCCccccCccccccCCCC-CcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++|++.|.|||++.+..+. ++.|+||||+++|.|+.|..||++..
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 345678999999999999998875 89999999999999999999999754
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=243.30 Aligned_cols=196 Identities=28% Similarity=0.404 Sum_probs=169.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-----chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|++|.||++ ....+++++++|.+.... ....+.+.+|++.++.++ ||||+++++++.++...++++
T Consensus 8 ~~lg~g~~~~vy~~--~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 8 KLLGQGAFGRVYLC--YDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ--HERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ceecCCCceEEEEE--EEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC--CCCeeeeEEEEccCCeEEEEE
Confidence 57999999999999 667789999999986442 122356888999999999 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+.+ .....+++..+..++.|++.++++||+. |++|+||+|+||++++++.++|+|||.+.....
T Consensus 84 e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999988 4456788999999999999999999999 999999999999999999999999999876533
Q ss_pred CCcccc--ccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 NTTHIS--TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
...... ....++..|+|||.+.+..++.++|+||||+++|++++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 221111 2345778899999999988999999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=243.40 Aligned_cols=197 Identities=25% Similarity=0.425 Sum_probs=166.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++.+ .++..+++|.+... ......+.+|++.++.++ ||||+++++++......+++|||+++
T Consensus 10 ~~lg~G~~~~vy~~~~---~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 10 KELGSGQFGVVHLGKW---RAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLS--HPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred eEecCCcCceEEEEEe---ccCceEEEEecccC-CccHHHHHHHHHHHHHCC--CCCceeEEEEEccCCCEEEEEEcCCC
Confidence 5799999999999833 45678999988633 333467888999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 84 ~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLR---QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999883 2234688999999999999999999999 99999999999999999999999999887653322222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....++..|+|||...+..++.++|+||+|+++|++++ |+.||.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 222334567999999988889999999999999999999 9999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=250.97 Aligned_cols=197 Identities=24% Similarity=0.369 Sum_probs=165.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ +...+++.||+|.++... ......+.+|++.++.++ ||||+++++++..++..++||||++
T Consensus 12 ~~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 12 EKLGEGTYATVFKG--RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred EEecccCCEEEEEE--EecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC--CCCcceEEEEEeeCCeEEEEEeCCC
Confidence 57999999999999 666788999999997553 233356778999999999 9999999999999999999999996
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+ +|.+++. .....++...+..++.|++.||++||+. |++||||+|+||+++.++.++|+|||.+........
T Consensus 88 ~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 88 K-DLKQYMD---DCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred C-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 5 7877772 3345688999999999999999999999 999999999999999999999999999875433221
Q ss_pred ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 161 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1223456889999998865 4688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=247.36 Aligned_cols=204 Identities=27% Similarity=0.340 Sum_probs=180.5
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
|+.||+|.||+|.++ +...+|+.+|+|+++.+. +.....-+.|-++++..+ ||.+..+.-.|+.+.+.|+|||
T Consensus 173 LKvLGkGTFGKVIL~--rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~--HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILC--REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR--HPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred HHHhcCCccceEEEE--eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc--CcHHHHhhhhhccCceEEEEEE
Confidence 478999999999999 677899999999998662 334456677899999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|..||.|.-++ +....+++...+.+-..|++||.|||++ +|++||+|.+|++++++|++||.|||+|+.--..
T Consensus 249 yanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 249 YANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 99999999888 6778899999999999999999999999 9999999999999999999999999999753222
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 216 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~ 216 (229)
......++|||.|+|||++....|.++.|.|.+|+++|+|++|+.||.+.+...-+.+
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL 379 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL 379 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence 2345679999999999999999999999999999999999999999998765554443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=249.73 Aligned_cols=203 Identities=27% Similarity=0.459 Sum_probs=165.2
Q ss_pred CccCCcccccccccceEe--------------ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEE
Q 027015 2 ASVGPIRLEKVDLAPFIR--------------LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC 66 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~--------------~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~ 66 (229)
+.||+|+||.||++.+.. ..++..||+|.+.... ......+.+|+++++.++ ||||+++++++
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~ 88 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK--DPNIIRLLGVC 88 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC--CCCeeEEEEEE
Confidence 579999999999985321 1234579999987653 333467889999999998 99999999999
Q ss_pred EcCCceEEEEEccCCCCHHHHHhhhh---------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCC
Q 027015 67 IDGPCRILVYDYMPNNSLSQTLLGEE---------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131 (229)
Q Consensus 67 ~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~ 131 (229)
.+.+..+++|||+++++|.+++.... .....+++..+..++.|++.||++||+. |++|+|||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlk 165 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcc
Confidence 99999999999999999999884321 1123577889999999999999999999 99999999
Q ss_pred CCCEEEcCCCceEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh--CCCcccCc
Q 027015 132 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFD 208 (229)
Q Consensus 132 p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~--g~~pf~~~ 208 (229)
|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ +..||...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 9999999999999999999876533211 11223345678999999988889999999999999999986 56788754
Q ss_pred c
Q 027015 209 V 209 (229)
Q Consensus 209 ~ 209 (229)
.
T Consensus 246 ~ 246 (304)
T cd05096 246 T 246 (304)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=245.62 Aligned_cols=204 Identities=30% Similarity=0.476 Sum_probs=171.4
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++..... .+++.||+|.++..... ..+.+.+|+++++.+. ||||+++++++......+++||
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ--HENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC--CCCchheeeEEecCCCeEEEEe
Confidence 5799999999999965433 45688999999765443 4578899999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh----------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 027015 78 YMPNNSLSQTLLGEE----------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 147 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~d 147 (229)
|+++++|.+++.... .....+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECC
Confidence 999999999985431 2235688999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 148 FGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 148 fg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
||.+....... ........+++.|+|||.+.+..++.++|+||||+++|++++ |+.||.....
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99987543221 112233345678999999999999999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=242.44 Aligned_cols=199 Identities=27% Similarity=0.398 Sum_probs=167.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++.+....++..+|+|.++.... ...+.+.+|+.+++.+. ||||+++++++.. ...+++|||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~-~~~~lv~e~~ 77 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD--NPYIVRMIGICEA-ESWMLVMELA 77 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC--CCCcceEEEEEcC-CCcEEEEecC
Confidence 46999999999999766677889999999874432 23467888999999998 9999999998754 4678999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++ .....+++..+..++.|++.++++||+. |++|+||+|.||++++++.++|+|||.+........
T Consensus 78 ~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 78 ELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred CCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 999999998 4456789999999999999999999999 999999999999999999999999999876643322
Q ss_pred cc--cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.. .....++..|+|||.+....++.++|+||||+++|++++ |+.||.....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 11 122233568999999888888999999999999999998 9999986544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=247.69 Aligned_cols=202 Identities=36% Similarity=0.538 Sum_probs=167.1
Q ss_pred CccCCcccccccccceE--eccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||.|.||.||+|.+. ....+..|+||.++.... .....+.+|++.+++++ ||||+++++++...+..++|+||
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR--HPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS--BTTBE-EEEEEESSSSEEEEEE-
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc--ccccccccccccccccccccccc
Confidence 46999999999999776 344578899999975433 34688999999999998 99999999999988889999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC-
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN- 157 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~- 157 (229)
+++++|.+++... ....+++..+..++.|+++||+|||+. +++|++|+++||+++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999322 247789999999999999999999999 9999999999999999999999999998776222
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.............|+|||.+....++.++||||||+++||+++ |+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1222233446678999999998889999999999999999999 7899976543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=242.71 Aligned_cols=199 Identities=28% Similarity=0.390 Sum_probs=168.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++ ....+++.+++|.+..+ ......+.+|++.++.++ ||+|+++++++..+...+++|||+++
T Consensus 12 ~~ig~g~~~~v~~~--~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 12 HKLGGGQYGEVYEG--VWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eecCCcccceEEEE--EEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCC--CCChhheEEEEcCCCCcEEEEEeCCC
Confidence 56999999999999 55667899999998643 334567889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++.. .....+++..+..++.|++++|++||+. |++|+||+|+||++++++.++|+|||.+..........
T Consensus 87 ~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 87 GNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999998832 1234688999999999999999999999 99999999999999999999999999987654332221
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
......++.|+|||...+..++.++|+||||+++|+|++ |..||.....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 211 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 122233567999999988899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=247.29 Aligned_cols=199 Identities=27% Similarity=0.384 Sum_probs=161.0
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeecccc--hhhHHHHHHHHHHhhhcc-CCCcccccceEEE-----cCCce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNV-CHENLVKLHGGCI-----DGPCR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~-~~~~i~~~~~~~~-----~~~~~ 72 (229)
+.||+|+||+||++ .+.. +|+.||+|.++.... .......+|+..++.+.. .||||+++++++. .....
T Consensus 7 ~~lg~G~~g~Vy~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 7 AEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eEeccCCCeEEEEE--EEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 57999999999999 4433 468899999875432 223456667777766531 2999999999885 23567
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
++||||++ ++|.+++.. .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+.
T Consensus 85 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 89999995 688888832 1234689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|++||.....
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 65432 122345678999999999888999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=245.72 Aligned_cols=197 Identities=27% Similarity=0.336 Sum_probs=169.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.+|+|.+.... ......+.+|+++++.++ |++|+++.+.+..++..++++||
T Consensus 6 ~~lg~G~~g~vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 6 RVLGKGGFGEVCAC--QVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN--SQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred EEEecCCCeEEEEE--EECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CcCceeEEEEEecCCEEEEEEEe
Confidence 57999999999999 667789999999987542 223345778999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.. .....+++..+..++.|++.+|.+||+. |++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988732 2234699999999999999999999999 99999999999999999999999999886543221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....++..|+|||.+.+..++.++|+||+|+++|++++|+.||....
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 123468899999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=255.30 Aligned_cols=203 Identities=25% Similarity=0.392 Sum_probs=166.6
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++.+.. ..++..||+|.++... ......+.+|+++++.+ + ||||+++++++...+..++||
T Consensus 44 ~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~--h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQ--HKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred heecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhcc--CCceeeEeeEecCCCCeEEeH
Confidence 579999999999985432 2345689999997543 33346688999999999 6 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhc---------------------------------------------------------------
Q 027015 77 DYMPNNSLSQTLLGEEK--------------------------------------------------------------- 93 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~--------------------------------------------------------------- 93 (229)
||+++++|.+++.....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999998853211
Q ss_pred ---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-ccccccCCc
Q 027015 94 ---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTL 169 (229)
Q Consensus 94 ---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~ 169 (229)
...++++..+..++.|++.||+|||+. |++||||||+||++++++.++|+|||++......... ......++.
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 113578889999999999999999999 9999999999999999999999999998765332211 112233456
Q ss_pred cccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 170 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 170 ~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.|+|||++.+..++.++|+||||+++|+|++ |+.||....
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 7999999988899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=255.08 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=166.8
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++.+. ...++..||+|.++... ....+.+.+|+.++..+ + ||||+++++++.+.+..++||
T Consensus 41 ~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~--HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred heecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcC--CcceeeeeeeeccCCcceeee
Confidence 57999999999998543 23456789999997542 33446788999999999 6 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhc---------------------------------------------------------------
Q 027015 77 DYMPNNSLSQTLLGEEK--------------------------------------------------------------- 93 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~--------------------------------------------------------------- 93 (229)
||+++|+|.+++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 99999999998853211
Q ss_pred --------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-cccc
Q 027015 94 --------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTR 164 (229)
Q Consensus 94 --------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 164 (229)
....+++..+..++.|+++||+|||+. |++|+||||+||+++.++.++|+|||++......... ....
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 112578889999999999999999999 9999999999999999999999999998765432211 1122
Q ss_pred ccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCc
Q 027015 165 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 208 (229)
Q Consensus 165 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~ 208 (229)
..++..|+|||.+.+..++.++|+||||+++|++++ |..||...
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 334567999999999999999999999999999998 89999764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=241.75 Aligned_cols=200 Identities=25% Similarity=0.377 Sum_probs=166.0
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
.||+|+||.||++.+....++..||+|.+..... ...+.+.+|+.+++.++ ||||+++++.+.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD--NPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC--CCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 5899999999999665555677899999875533 33466889999999998 9999999998754 467899999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 ~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 79 GPLNKFLS---GKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99999883 3456789999999999999999999999 99999999999999999999999999987653332211
Q ss_pred c--ccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 162 S--TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 162 ~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
. ....++..|+|||...+..++.++|+||||+++|++++ |+.||......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 1 11223567999999988889999999999999999996 99999865543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=242.90 Aligned_cols=196 Identities=23% Similarity=0.325 Sum_probs=170.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....+++.|++|.++.........+.+|+..++.++ ||||+++++.+......++++||+++
T Consensus 15 ~~lg~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~--h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 15 QRIGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK--HSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHhCCCCCeEEEEE--EEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 46999999999999 667789999999998665555567788999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++ .....+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 91 ~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06645 91 GSLQDIY----HVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-K 162 (267)
T ss_pred CcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-c
Confidence 9999988 4556799999999999999999999999 999999999999999999999999999876543221 2
Q ss_pred cccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||.+. ...++.++|+||||+++|++++|+.||....
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 23356888999999874 4557889999999999999999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=242.38 Aligned_cols=196 Identities=24% Similarity=0.327 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....+++.||+|++..........+.+|+..++.++ ||||+++++++..+...++|+||+++
T Consensus 15 ~~lg~g~~g~vy~~--~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~--h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 15 QRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK--HCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred heeecCCCeEEEEE--EECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcC--CCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 57999999999999 667789999999997665555567888999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++ .....+++..+..++.|++.++++||+. |++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 91 ~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 91 GSLQDIY----HVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999988 4456789999999999999999999999 999999999999999999999999999876533221 1
Q ss_pred cccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||.+. ...++.++|+||+|+++|++++|+.||....
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 22345788899999875 3457889999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=240.49 Aligned_cols=199 Identities=25% Similarity=0.335 Sum_probs=166.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
..||+|+||.||++ ....+++.+|+|.+.... ......+.+|++.++.++ ||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~vy~~--~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSG--RLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEE--EEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEcCCCCeEEEEeecc
Confidence 36999999999999 666789999999886443 334467889999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++. .....+++..+..++.|++++|.|||+. |++|+||+|+||+++.++.++|+|||.+.........
T Consensus 77 ~~~L~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 77 GGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred CCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 999999983 2344688999999999999999999999 9999999999999999999999999998754322111
Q ss_pred c-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 161 I-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 161 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
. ......+..|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 1 111123456999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=270.93 Aligned_cols=201 Identities=24% Similarity=0.299 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ++..+|+.||+|.++.+. ....+++.+|+++++.++ ||||+++++++.+++..+++|||
T Consensus 8 ~~LGkGgfG~VYlA--~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~--HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 8 RLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI--HPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred EEEecCCCEEEEEE--EECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC--CcCcCeEEEEEeeCCEEEEEEEc
Confidence 57999999999999 667789999999987442 223467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhc-------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 79 MPNNSLSQTLLGEEK-------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
++|++|.+++..... ....++...+..++.|+++||++||+. |++||||||+||+++.++.++|+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999998853211 123456778889999999999999999 9999999999999999999999999998
Q ss_pred cccCCCC-----------------ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 152 KLFPENT-----------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 152 ~~~~~~~-----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....... ........||+.|+|||...+..++.++|+||+||++|+|++|+.||....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 7652110 011123468999999999999999999999999999999999999997643
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=244.73 Aligned_cols=198 Identities=25% Similarity=0.416 Sum_probs=178.7
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+++||+|++|.||+| ++.++|+.+|+|.+..+ .+.+.+..|+.+++++. .|+++++|+.+......++|||||.
T Consensus 38 ~~KLGEGSYGSV~KA--IH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~--S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKA--IHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCK--SKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHhcCCcchHHHHH--HHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcC--CchhhhhhhhhccCCceEeehhhcC
Confidence 367999999999999 88999999999998644 45678899999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
.||+.+.+ ..+++++++.++..++...+++|+|||.. .-+|||||..||+++.+|..||+|||.+-.+-+....
T Consensus 112 AGSiSDI~---R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 112 AGSISDIM---RARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCcHHHHH---HHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999 37889999999999999999999999999 8899999999999999999999999998765443332
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
..+..|||.|||||++..-.|..++|+||||++..+|..|++||.+-.+.
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM 235 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM 235 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc
Confidence 24577999999999999999999999999999999999999999875543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=258.13 Aligned_cols=193 Identities=22% Similarity=0.241 Sum_probs=166.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++.......+..|++|.+... ....+|+++++.++ ||||+++++.+......+++||++.
T Consensus 98 ~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTIS--HRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred EeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcC--CCCccceeeeEeeCCEEEEEehhcC-
Confidence 579999999999985545556788999988632 24567999999999 9999999999999999999999984
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH- 160 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 160 (229)
++|.+++ .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.........
T Consensus 170 ~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 170 CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 6788887 4567899999999999999999999999 9999999999999999999999999998765443221
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 2234568999999999999999999999999999999999999997654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=268.60 Aligned_cols=215 Identities=30% Similarity=0.444 Sum_probs=182.2
Q ss_pred CccCCcccccccccceEecc---CCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ---DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
..||+|+||+||+++..... +-+.||||.++..... ..++|.+|++.+..++ ||||+++++.+..++..++|+|
T Consensus 492 ~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~--H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 492 EELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ--HPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred hhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc--CCCeEEEEEEEccCCeeEEEEE
Confidence 46999999999999865543 4567999999977655 6689999999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhc----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 027015 78 YMPNNSLSQTLLGEEK----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 147 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~d 147 (229)
|+..|+|.+++..... ...+++..+...++.||+.|+.||-++ .++||||-..|++|.++-.+||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecc
Confidence 9999999999855311 134489999999999999999999999 999999999999999999999999
Q ss_pred ccccccc-CCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchhhhc
Q 027015 148 FGLSKLF-PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVR 221 (229)
Q Consensus 148 fg~~~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~ 221 (229)
||+++.+ ..+.-+......-+.+|||||.+....+|.++||||+|+++||+++ |+.||.+....+....+...+
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9998764 2222222223334678999999999999999999999999999997 999999887766665555443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=248.52 Aligned_cols=200 Identities=23% Similarity=0.320 Sum_probs=161.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (229)
+.||+|+||.||++......+++.+|+|.+.... ......+|+++++.++ ||||+++++.+.. +...++++||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELK--HPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcC--CCCCcceeeeEecCCCcEEEEEEecc
Confidence 4799999999999955455678899999986432 2345778999999999 9999999998864 34678999998
Q ss_pred CCCCHHHHHhhhh-----ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----cCCCceEEecccc
Q 027015 80 PNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGL 150 (229)
Q Consensus 80 ~~~sL~~~~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~----~~~~~~~l~dfg~ 150 (229)
+ ++|.+++.... .....+++..+..++.|++.||+|||+. |++|+||||+||++ +.++.++|+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 4 57887763221 1223688999999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCc--cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 151 SKLFPENTT--HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
+........ .......+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 976543221 12234567899999999876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=243.85 Aligned_cols=197 Identities=28% Similarity=0.358 Sum_probs=168.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|.+.... ......+..|+.+++.++ |++|+++++.+.+....++||||
T Consensus 6 ~~ig~G~~g~v~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 6 RVLGKGGFGEVCAC--QVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN--SRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred EEeecCCCeEEEEE--EEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC--CCCeeeeeEEEecCCEEEEEEEe
Confidence 56999999999999 667789999999986542 222345678999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998832 2334688999999999999999999999 99999999999999999999999999987643322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....|+..|+|||.+.+..++.++|+||+|+++|++++|+.||....
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1 122468899999999998889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=252.92 Aligned_cols=192 Identities=26% Similarity=0.308 Sum_probs=162.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~ 73 (229)
+.||+|+||.||++ .+..+|+.||+|.+... .......+.+|+..++.++ ||||+++++++.... ..+
T Consensus 27 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 27 KPIGSGAQGIVCAA--FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN--HKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred EEeecCCCEEEEEE--EEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC--CCCEeeeeeeeccCCCccccceeE
Confidence 57999999999999 66778999999998643 2334567788999999999 999999999986543 468
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++..
T Consensus 103 lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 103 LVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred EEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 99999965 5655541 3478889999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 173 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 173 ACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred cccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 43321 1233467889999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=245.92 Aligned_cols=196 Identities=21% Similarity=0.368 Sum_probs=171.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++ +...+++.+++|.+..........+.+|+..++.+. |||++++++.+..+...++||||+++
T Consensus 26 ~~lg~g~~~~v~~~--~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~--h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 26 EKIGQGASGTVYTA--MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred EEecCCCCeEEEEE--EECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC--CCCEeeEEEEEEeCCEEEEeecccCC
Confidence 46999999999999 667789999999998765556678889999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. ...+++..+..++.|++.+|.+||+. |++|+||+|+||++++++.++|+|||.+........ .
T Consensus 102 ~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 102 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 99999882 34578999999999999999999999 999999999999999999999999998876433221 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....+++.|+|||.+.+..++.++|+||+|+++|++++|+.||....+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234578899999999888899999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=244.21 Aligned_cols=193 Identities=28% Similarity=0.417 Sum_probs=170.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|++|.||++ ....+++.+|+|.+.... ......+.+|++.++.+. ||||+++++++.+....+++|||
T Consensus 7 ~~ig~g~~~~vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 7 KTLGTGSFGRVMLV--RHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--HPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred EEeecCCCeEEEEE--EEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCccceeeEEEcCCeEEEEEec
Confidence 56999999999999 566688999999987432 233467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.+|.+||+. |++|+||+|.||+++.++.++|+|||++......
T Consensus 83 ~~~~~L~~~~----~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHL----RKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999998 4557899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 233457889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=245.60 Aligned_cols=196 Identities=23% Similarity=0.373 Sum_probs=171.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++ +...+|+.||+|.+........+.+.+|+..++.++ ||||+++++++..+...++||||+++
T Consensus 25 ~~lg~g~~g~v~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (297)
T cd06656 25 EKIGQGASGTVYTA--IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVMEYLAG 100 (297)
T ss_pred eeeccCCCeEEEEE--EECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCEEEEeecccCC
Confidence 57999999999999 667789999999998665555677888999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. ...+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 101 GSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred CCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 99999882 34578899999999999999999999 999999999999999999999999999876533322 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....+++.|+|||...+..++.++|+||+|+++|++++|+.||.....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2234578889999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=243.66 Aligned_cols=206 Identities=27% Similarity=0.435 Sum_probs=169.1
Q ss_pred CCccCCcccccccccceEec---cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
++.||+|+||.||++..... .+...+++|.++... ......+.+|+..++.++ ||||+++++++.+....++++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ--HPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC--CcccceEEEEEcCCCceEEEE
Confidence 36799999999999954322 233689999987543 233456889999999999 999999999999988999999
Q ss_pred EccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceE
Q 027015 77 DYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~ 144 (229)
||+++++|.+++..... ....+++..+..++.|++.||.+||+. |++|+||+|+||++++++.++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence 99999999999854211 115688899999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 145 ISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 145 l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
|+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999876532211 12233456788999999988889999999999999999998 99999865443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=245.93 Aligned_cols=194 Identities=26% Similarity=0.400 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ .+..+|..+++|.++.+.. .....+.+|+++++.++ ||||+++++.+.+++..++++||++
T Consensus 7 ~~lg~G~~g~v~~~--~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 7 GELGAGNGGVVTKV--LHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN--SPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred eeccCCCCeEEEEE--EEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCCEEEEEeeccC
Confidence 57999999999999 6677889999999875533 23456889999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++ .....+++..+..++.|++++|.|||+ . +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 83 GGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999998 445678999999999999999999997 5 89999999999999999999999999886543221
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||.+.+..++.++|+||||+++|++++|+.||....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 233467889999999888889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=259.24 Aligned_cols=195 Identities=24% Similarity=0.320 Sum_probs=160.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC--------CceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--------PCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--------~~~~ 73 (229)
+.||+|+||.||++ +...+++.||+|.+.... ....+|+.+++.++ ||||+++++++... ...+
T Consensus 72 ~~LG~G~fg~Vy~~--~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~--h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 72 NIIGNGSFGVVYEA--ICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLN--HINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEEeCCCEEEEEE--EECCCCCEEEEEEEecCc----chHHHHHHHHHhcC--CCCCcceeeeEeecccccCCCceEEE
Confidence 46999999999999 667789999999885322 23457999999999 99999999887432 2356
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEecccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSK 152 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~ 152 (229)
+||||++ ++|.+++.........+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++.
T Consensus 144 lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 8999996 577777754445667899999999999999999999999 999999999999998654 69999999998
Q ss_pred ccCCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.+..... .....+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+...
T Consensus 220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 6543221 2234678899999988764 689999999999999999999999987643
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=241.78 Aligned_cols=188 Identities=26% Similarity=0.366 Sum_probs=165.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ++..+++.||+|.+.... ....+.+.+|+++++.++ ||||+++++.+...+..++++||++
T Consensus 7 ~~lg~g~~~~v~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 7 EILGHGNGGTVYKA--YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD--SPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred eeeccCCCeEEEEE--EEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEECCEEEEEEecCC
Confidence 57999999999999 677789999999987552 334467889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|..+. .+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 99986542 467888999999999999999999 99999999999999999999999999987653321
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.....++..|+|||.+.+..++.++|+||||+++|++++|+.||..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2335688899999999988999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=240.29 Aligned_cols=198 Identities=28% Similarity=0.422 Sum_probs=167.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++. ..+++.|++|.+.... ...+.+.+|+.+++.++ |+||+++++.+.+.+..++++||+++
T Consensus 12 ~~lg~g~~g~v~~~~---~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 12 KKLGAGQFGEVWMGY---YNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQ--HDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred eecCCcCCceEEEEE---ecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCC--CCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 579999999999993 3466789999986433 34568889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++++|++||+. +++|+||+|+||+++.++.++|+|||.+..........
T Consensus 86 ~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 86 GSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 9999988422 345688889999999999999999999 99999999999999999999999999998764432222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....++..|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 222335667999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=237.62 Aligned_cols=197 Identities=28% Similarity=0.383 Sum_probs=166.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
..||+|+||.||++ . ..+++.+|+|.++.... .....+.+|++.++.++ ||||+++++++...+..++||||++
T Consensus 1 ~~ig~g~~g~vy~~--~-~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKG--T-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD--HPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEE--E-ecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC--CCCcCeEEEEEecCCccEEEEECCC
Confidence 36999999999999 3 35788999999875532 23456888999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++. .....+++..+..++.+++.+|.++|+. |++|+|++|+||+++.++.++|+|||++.........
T Consensus 76 ~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 76 GGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 999999883 2345688999999999999999999999 9999999999999999999999999998654333222
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
......++..|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 2222334567999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=237.65 Aligned_cols=198 Identities=27% Similarity=0.427 Sum_probs=172.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+|+.|++|.+... .......+.+|++.++.++ ||||+++++++.+.+..++++||+
T Consensus 6 ~~l~~g~~~~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 6 NKIGKGSFGVVFKV--VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD--SSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred EEecCCCCeEEEEE--EEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC--CCCeehheeeeccCCEEEEEEEeC
Confidence 46999999999999 66778999999998754 3445577889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++... ....+++..++.++.+++.+|.+||+. |++|+|++|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999998422 246789999999999999999999999 999999999999999999999999999876644322
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||+..+..++.++|+||||++++++++|+.||....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 2233457888999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=245.91 Aligned_cols=195 Identities=24% Similarity=0.408 Sum_probs=170.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..||+|+||.||++ ....+++.|++|.+..........+.+|+..++.+. |||++++++.+..++..++++||+++
T Consensus 27 ~~ig~g~~g~v~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 27 IKIGEGSTGIVCIA--REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred hhcCCCCceeEEEE--EEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCC--CCchhhhhhheeeCCeEEEEEecCCC
Confidence 36899999999999 666788999999997655555567889999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++ ....+++..+..++.|++.+|++||+. |++|+||+|.||+++.++.++|+|||++........ .
T Consensus 103 ~~L~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 173 (297)
T cd06659 103 GALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 173 (297)
T ss_pred CCHHHHH-----hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence 9999876 335688999999999999999999999 999999999999999999999999999865533221 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||.+.+..++.++|+||+|+++++|++|+.||....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223457889999999998889999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=245.18 Aligned_cols=196 Identities=24% Similarity=0.410 Sum_probs=171.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..||+|+||.||++ ....++..||+|.+..........+.+|+..++.++ ||||+++++.+...+..++++||+++
T Consensus 28 ~~lg~g~~g~v~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 28 IKIGEGSTGIVCIA--TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH--HENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred hcccCCCCeEEEEE--EECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC--CCcHHHHHHheecCCeEEEEEeCCCC
Confidence 46999999999999 666788999999987655555677889999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++ ....+++..+..++.|++.++.+||+. +++|+||+|.||++++++.++|+|||++........ .
T Consensus 104 ~~L~~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 104 GALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CcHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 9999987 234688999999999999999999999 999999999999999999999999999875533222 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....++..|+|||...+..++.++|+||+|+++|++++|+.||.....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 223 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234578899999999888899999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=238.76 Aligned_cols=203 Identities=31% Similarity=0.431 Sum_probs=172.2
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++..... ..+..+++|.++..... ..+.+.+|++.++.++ |++|+++++++.+....+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG--HPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC--CCChheeeeeecCCCceEEEEEec
Confidence 4799999999999944332 23889999999865433 3678899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 80 PNNSLSQTLLGEEKR-----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
++++|.+++...... ...+++..++.++.|+++|+.+||+. |++|+||+|+||++++++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 999999998433111 47899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 155 PENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 155 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
..... .......+++.|+|||.+....++.++|+||||+++|++++ |..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 44321 11233456788999999988889999999999999999999 699998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.63 Aligned_cols=196 Identities=22% Similarity=0.276 Sum_probs=158.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC----CCcccccceEEEcC-CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLVKLHGGCIDG-PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~----~~~i~~~~~~~~~~-~~~~lv~ 76 (229)
+.||+|+||+||++ .+..+++.||||+++... ........|+++++.++.. |++++++++++... ..+++||
T Consensus 135 ~~lG~G~fg~V~~a--~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~ 211 (467)
T PTZ00284 135 SLLGEGTFGKVVEA--WDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM 211 (467)
T ss_pred EEEEeccCEEEEEE--EEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence 46999999999999 667788999999996432 2233455677777766511 44688888888765 4678999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCC--------------
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNF-------------- 141 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~-------------- 141 (229)
+++ +++|.+++ .....+++..+..++.|++.||+|||+ . ||+||||||+||+++.++
T Consensus 212 ~~~-g~~l~~~l----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 212 PKY-GPCLLDWI----MKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred ecc-CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 988 77888888 445679999999999999999999997 6 999999999999998665
Q ss_pred --ceEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 142 --NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 142 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 284 ~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 284 PCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998754321 2234578999999999999999999999999999999999999998765433
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=240.94 Aligned_cols=203 Identities=24% Similarity=0.313 Sum_probs=163.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++..........+++|.+.... ......+.+|++.++.++ ||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN--HPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC--CCCcceEEEEECCCCceEEEEEeCC
Confidence 4699999999999965454556789999876443 333456788999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 027015 81 NNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT- 158 (229)
Q Consensus 81 ~~sL~~~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 158 (229)
+++|.+++..... .....++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999854322 223456788899999999999999999 99999999999999999999999999886532221
Q ss_pred ccccccccCCccccCcccccc-------CCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
........+++.|+|||+... ..++.++|+||||+++|+|++ |..||....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 111223345677999998642 456889999999999999998 788997654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=239.66 Aligned_cols=203 Identities=25% Similarity=0.324 Sum_probs=165.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++......++..+++|.++.... .....+.+|+..++.++ ||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ--HSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46999999999999654445667899999875532 33457888999999999 9999999999998888999999999
Q ss_pred CCCHHHHHhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++..... .....++..+..++.|++.++++||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999854322 234567778889999999999999999 999999999999999999999999999865432211
Q ss_pred -cccccccCCccccCccccccC-------CCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 160 -HISTRVAGTLGYLAPEYAISG-------RLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 160 -~~~~~~~~~~~~~aPE~~~~~-------~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.......++..|+|||++.+. .++.++|+||+|+++|++++ |+.||....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 112234567789999988642 35789999999999999996 999997644
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=243.29 Aligned_cols=196 Identities=22% Similarity=0.383 Sum_probs=171.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||.|++|.||++ +...+|+.|++|.+..........+.+|++.++.++ ||||+++++++......++|+||+++
T Consensus 25 ~~lg~g~~g~vy~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 25 EKIGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKELIINEILVMKELK--NPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEecCCCeEEEEE--EEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC--CCceeeeeeeEecCceEEEEEEecCC
Confidence 46999999999999 677889999999997665555677889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. ...+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 101 GSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 99999882 34689999999999999999999999 999999999999999999999999998876533222 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....++..|+|||.+.+..++.++|+||||+++|++++|+.||....+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234578889999999888899999999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=238.46 Aligned_cols=197 Identities=25% Similarity=0.349 Sum_probs=172.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....+++.+++|.+........+.+.+|++.++.++ ||||+++++.+.+....+++|||+++
T Consensus 9 ~~l~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 9 QRIGSGTYGDVYKA--RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR--HPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred EEecCCCceEEEEe--EecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC--CCChhceEEEEEeCCEEEEEEeCCCC
Confidence 56899999999999 666688999999998765556688999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.++++||+. +++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 85 ~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 85 GSLQDIYQ---VTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CcHHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 99999883 2336789999999999999999999999 999999999999999999999999999876543221 1
Q ss_pred cccccCCccccCccccccC---CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||...+. .++.++|+||+|+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2334578889999998776 78899999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=241.31 Aligned_cols=198 Identities=24% Similarity=0.358 Sum_probs=170.1
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
++.||.|+||.||++ ....+++.+++|.+........+.+.+|+..++.++ ||||+++++.+..++..++||||++
T Consensus 17 ~~~lg~g~~g~vy~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 17 IGELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCN--HPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hheecCCCCeEEEEE--EECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCcEeeeEEEEEeCCeEEEEEecCC
Confidence 357999999999999 667788999999998666666778889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|..++. +....+++..+..++.|++.++++||+. +++|+|++|+||+++.++.++|+|||.+....... .
T Consensus 93 ~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 93 GGAVDAIML---ELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 999988773 3345789999999999999999999999 99999999999999999999999999876543221 1
Q ss_pred ccccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||++. ...++.++|+||||+++|+|++|+.||....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 123345788899999885 3456889999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=238.85 Aligned_cols=197 Identities=27% Similarity=0.442 Sum_probs=164.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++.+ .++..+++|.+.... .....+.+|+++++.++ ||||+++++++...+..++++||+++
T Consensus 10 ~~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 10 KELGSGQFGVVHLGKW---RGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLS--HPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred hhhccCCCceEEEeEe---cCCccEEEEEeccCC-CCHHHHHHHHHHHHhCC--CCCEEEEEEEEcCCCceEEEEecCCC
Confidence 5799999999999833 356789999986332 23456788999999998 99999999999998999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.++++||+. |++|+|++|+||++++++.++|+|||.+..........
T Consensus 84 ~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999983 2234789999999999999999999999 99999999999999999999999999887653322111
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....++..|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 112223457999999998889999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=248.62 Aligned_cols=191 Identities=26% Similarity=0.342 Sum_probs=162.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~ 73 (229)
+.||+|+||+||++ .+..+++.||+|.+.... ....+.+.+|++.++.++ ||||+++++++... ...+
T Consensus 21 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 21 TPVGSGAYGSVCSA--YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK--HENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred eecccCCCeEEEEE--EECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC--CCchhhhhhhhcccccccccCcEE
Confidence 67999999999999 667788999999987442 223456778999999999 99999999988643 3468
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
++++++ +++|.+++ ....+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++..
T Consensus 97 ~~~~~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 97 LVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EEeecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcccee
Confidence 999987 88898877 345699999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 168 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 168 ADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred cCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 5332 233467889999999876 568899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=238.26 Aligned_cols=198 Identities=28% Similarity=0.412 Sum_probs=166.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++. . .+++.||+|.++... ...+.+.+|++.++.++ ||||+++++++...+..++++||+++
T Consensus 12 ~~lg~g~~~~v~~~~--~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 12 RKLGAGQFGEVWEGL--W-NNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLR--HPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred EEecccCCccEEEEE--e-cCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCC--CCCccceeEEEecCCCeeeeeecccC
Confidence 579999999999983 2 456789999987443 33567889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 86 ~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 86 GSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred CcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999998322 134689999999999999999999999 99999999999999999999999999988764332211
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
......+..|+|||...+..++.++|+||||++++++++ |+.||.....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 111223457999999988889999999999999999999 9999986543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=240.57 Aligned_cols=197 Identities=24% Similarity=0.356 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....++..+++|.+........+.+.+|++.++.++ |||++++++.+..++..++++||+++
T Consensus 11 ~~lg~g~~g~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 11 GELGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred hhcccCCCeEEEEE--EECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC--CCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 57999999999999 666778999999987655555677889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|..++. ....++++..+..++.|++++|.+||+. |++|+||+|+||+++.++.++|+|||++........ .
T Consensus 87 ~~l~~~~~---~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 99988873 2346789999999999999999999999 999999999999999999999999999865433221 2
Q ss_pred cccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||.+. +..++.++|+||+|+++|+|++|+.||....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 23345788999999874 4457889999999999999999999997644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=239.05 Aligned_cols=200 Identities=26% Similarity=0.403 Sum_probs=170.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .... +..+++|.+..........+.+|+..++.++ ||||+++++++.+....+++|||+++
T Consensus 12 ~~ig~g~~~~vy~~--~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 12 RKLGSGYFGEVWEG--LWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR--HKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred hhhccCCCccEEEe--EecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC--CcchhheeeeEecCCCeEEEEeeccc
Confidence 57999999999999 3333 7899999998665555678889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.|+++||+. |++|+||+|+||++++++.++|+|||.+..........
T Consensus 87 ~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 87 GSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 9999998422 335688999999999999999999999 99999999999999999999999999987654332211
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
....++..|+|||...+..++.++|+||||+++|++++ |+.||......+
T Consensus 162 -~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 162 -SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred -cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 22335667999999988889999999999999999998 899998765433
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=246.08 Aligned_cols=197 Identities=26% Similarity=0.418 Sum_probs=163.3
Q ss_pred CccCCcccccccccceEeccCCc----EEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT----IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++.+ ..++. .||+|.++... ....+.+.+|+..++.++ ||||+++++++... ..++++
T Consensus 13 ~~lg~G~~g~Vy~~~~--~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 13 KVLGSGAFGTVYKGLW--IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred eeeecCCCceEEEEEE--ecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEcCC-Cceeee
Confidence 5799999999999944 33334 48999987443 344567889999999999 99999999998765 467999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
+|+++++|.+++. .....+++..+..++.|++.||+|||+. |++|+||||+||++++++.++|+|||++.....
T Consensus 88 e~~~~g~l~~~l~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 88 QLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred ecCCCCCHHHHHH---hccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999983 2345688899999999999999999999 999999999999999999999999999987643
Q ss_pred CCccc-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 157 NTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 157 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
..... ......+..|+|||.+.+..++.++|+||||+++|++++ |+.||....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 32211 112234567999999999999999999999999999997 999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=251.76 Aligned_cols=193 Identities=24% Similarity=0.284 Sum_probs=163.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~ 73 (229)
+.||+|+||.||++ .+..+++.||+|.+... .......+.+|+..++.++ ||||+++++++... ...+
T Consensus 30 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 30 KPIGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred EEeecCCCeEEEEE--EECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC--CCCccccceeecccccccccCeEE
Confidence 57999999999999 66778899999998743 2334567888999999999 99999999987543 3568
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||+++ +|.+.+. ..+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||++..
T Consensus 106 lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 106 IVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred EEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 99999964 6776662 2478889999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 176 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred cCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 53322 12334678999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=238.91 Aligned_cols=199 Identities=24% Similarity=0.352 Sum_probs=171.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ +...+++.||+|.++.. .......+.+|++.++.++ ||||+++++++.+.+..++++||
T Consensus 8 ~~l~~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 8 KKIGRGQFSEVYRA--TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN--HPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeccCCCeeEEEE--EEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--CcceeeeeeeEEECCeEEEEEEe
Confidence 57999999999999 66778999999988642 2333456888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999998854434456688999999999999999999999 99999999999999999999999999887654322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
. ......+++.|+|||.+.+..++.++|+||+|+++|++++|+.||...
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 1 122345788899999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=233.14 Aligned_cols=195 Identities=28% Similarity=0.442 Sum_probs=171.5
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccc----hh----hHHHHHHHHHHhhhccCCCcccccceEEEcCCceEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK----QG----EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~l 74 (229)
-||.|..+.|-++ .+..+|+.+|+|++..... .. .+.-.+|+.+++++. +||+|+++.|+++.+...++
T Consensus 24 ilgrgvss~vrRc--i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 24 ILGRGVSSVVRRC--IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-GHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred Hhcccchhhhhhh--hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeeccCcchhhh
Confidence 4799999999888 7888999999999864311 11 244567999999998 69999999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
|+|.++-|.|++++ .....+++.....++.|+..++.|||.. +|+|||+||+||+++++.+++|+|||++..+
T Consensus 101 VFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 101 VFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999 7888999999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCccccccccCCccccCcccccc------CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAIS------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ....+|||+|+|||.+.+ ..|+...|+|++|+|+|.|+.|.+||.-..
T Consensus 174 ~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk 232 (411)
T KOG0599|consen 174 EPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK 232 (411)
T ss_pred CCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence 55433 345789999999999874 358889999999999999999999997543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=238.14 Aligned_cols=196 Identities=29% Similarity=0.443 Sum_probs=164.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++.+ .++..+|+|.+.... .....+.+|+..++.++ ||||+++++++......+++|||+++
T Consensus 10 ~~lg~G~~~~vy~~~~---~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 10 KELGTGQFGVVKYGKW---RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLS--HEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred eEecCcccceEEEEEe---cCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCC--CCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 5799999999999833 345579999987432 33467889999999999 99999999999988889999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.+|++||+. |++|+||+|.||+++.++.++|+|||.+..........
T Consensus 84 ~~l~~~i~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999883 2234689999999999999999999999 99999999999999999999999999887653332211
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.....++..|+|||...+..++.++|+||||+++|++++ |+.||....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 122234567999999988889999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=255.87 Aligned_cols=199 Identities=30% Similarity=0.359 Sum_probs=169.2
Q ss_pred CccCCcccccccccceEeccC--CcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD--GTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||+++...... ...||+|..+.. .......++.|++++++++ ||||+++||+......+++||
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~--H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN--HPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEcCCCccEEEE
Confidence 579999999999997755432 123899999853 3566788999999999999 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhcccc-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 77 DYMPNNSLSQTLLGEEKRRA-KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|+|.||+|.+++ ...+ .++..+...++.+.+.||+|||+. +++||||-..|++++.++.+||+|||++..-.
T Consensus 241 El~~gGsL~~~L----~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYL----KKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EecCCCcHHHHH----HhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999999 3333 699999999999999999999999 99999999999999998889999999976532
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.-.. ......-+..|+|||.+....++.++||||+|+++||+++ |..||.+...
T Consensus 314 ~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 314 QYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred ceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 1111 1111124678999999998899999999999999999998 8999997653
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=240.79 Aligned_cols=203 Identities=32% Similarity=0.484 Sum_probs=169.3
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++.... ..++..+++|.+..........+.+|++.++.++ ||+|+++++++...+..++++||
T Consensus 11 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred cccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEecCCccEEEEEc
Confidence 569999999999985322 2345679999987555555677899999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhh---------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 027015 79 MPNNSLSQTLLGEE---------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 149 (229)
Q Consensus 79 ~~~~sL~~~~~~~~---------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg 149 (229)
+++++|.+++.... .....+++..+..++.|++.+|++||+. |++|+||+|+||++++++.++|+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCC
Confidence 99999999985321 1224589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 150 LSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 150 ~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.+....... ........+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 987653221 112223345678999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=240.50 Aligned_cols=200 Identities=24% Similarity=0.376 Sum_probs=167.9
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
++.||+|+||.||++ ....+|+.+|+|.++.. .......+.+|++.++.++ ||||+++++.+...+..++|+||+
T Consensus 6 ~~~ig~g~~g~v~~~--~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 6 LDELGKGNYGSVYKV--LHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV--SPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhcccCCeEEEEE--EEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC--CCcHHhhhhheecCCeEEEEEeec
Confidence 367999999999999 66668999999998754 2333467889999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++++|.+++... .....+++..+..++.++++++.+||+ . +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 82 DAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999998887321 123478999999999999999999996 5 89999999999999999999999999987653322
Q ss_pred ccccccccCCccccCccccccCC------CCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
. ....+++.|+|||.+.+.. ++.++|+||||+++|++++|+.||......
T Consensus 158 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 213 (286)
T cd06622 158 A---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213 (286)
T ss_pred c---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence 1 2345677899999886543 478999999999999999999999765433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=242.82 Aligned_cols=196 Identities=23% Similarity=0.364 Sum_probs=165.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ....+++.||+|.++... ......+.+|+..++.++ ||||+++++++.+.+..++|+||++
T Consensus 12 ~~lg~g~~g~vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 12 DKLGEGTYATVYKG--RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEeccCcCEEEEEE--EEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC--CCCcceEEEEEecCCeEEEEEeccc
Confidence 57999999999999 666788999999987543 333456778999999999 9999999999999999999999996
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
++|.+++. .....+++..+..++.|++.||.+||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 88 -~~l~~~l~---~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 88 -KDLKQYLD---DCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred -cCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 58888773 3345688999999999999999999999 999999999999999999999999999875432221
Q ss_pred ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122346788999998775 457889999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=238.10 Aligned_cols=198 Identities=24% Similarity=0.436 Sum_probs=169.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc------hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|++|.||++ ....+++.+++|.+..... ...+.+.+|+..++.++ |+||+++++++.+.+..++|
T Consensus 6 ~~lg~g~~~~v~~~--~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 6 QQLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN--HPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ceecCcCceEEEEE--EEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC--CCceehhhceeccCCeEEEE
Confidence 46899999999999 6677899999999874421 12467889999999999 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEecccccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLF 154 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~ 154 (229)
+||+++++|.+++ ....++++..+..++.|++.||.+||+. |++|+||+|.||+++.++ .++|+|||.+...
T Consensus 82 ~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 82 VEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EeccCCCcHHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998 4456789999999999999999999999 999999999999998765 5999999998766
Q ss_pred CCCCc---cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTT---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... .......++..|+|||.+.+..++.++|+||||++++++++|+.||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 43211 112234578899999999888899999999999999999999999975543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=236.80 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=171.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|++|.||++ ....+|+.|++|.++.. .......+.+|+++++.++ |++++++++.+.+++..+++|||
T Consensus 8 ~~lg~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 8 KKIGKGQFSVVYKA--ICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD--HPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeccCCceEEEEE--EEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCeeeeeeeeecCCeEEEEEec
Confidence 57999999999999 66678999999998642 2333567889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.........+++..+..++.++++++.+||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999854434456789999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.. .....+++.|.|||...+..++.++|+||+|+++|++++|+.||...
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 21 22345788899999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=250.26 Aligned_cols=192 Identities=24% Similarity=0.280 Sum_probs=162.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~ 73 (229)
+.||+|+||.||++ .+..+++.||+|.+... .......+.+|+..++.++ ||||+++++++.... ..+
T Consensus 23 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 23 KPIGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred EEeeecCCEEEEEE--EecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC--CCchhceeeeeeccccccccceeE
Confidence 57999999999999 66778899999998754 2334467788999999999 999999999886442 468
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
++|||+++ +|.+.+. ..+++..+..++.|++.||++||+. |++||||||+||+++.++.++|+|||++..
T Consensus 99 lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 99 LVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred EEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 99999965 5666552 2478899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred CCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 53322 1233567899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=238.15 Aligned_cols=197 Identities=30% Similarity=0.492 Sum_probs=168.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch---------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ---------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~ 72 (229)
+.||+|++|.||++ ....+++.+++|.+...... ..+.+.+|+.+++.++ ||||+++++++.+....
T Consensus 6 ~~ig~g~~~~v~~a--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 6 ALIGSGSFGSVYLG--MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ--HENIVQYLGSSLDADHL 81 (267)
T ss_pred ceeecCCCeEEEEE--EecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCcc
Confidence 57999999999999 56677899999988644221 1256788999999999 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
++++||+++++|.+++ .....+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHH----HhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999 4556788999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCc-----cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 153 LFPENTT-----HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 153 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....... .......++..|+|||.+.+..++.++|+||||+++|++++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 6642211 11122457788999999988889999999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=240.46 Aligned_cols=197 Identities=23% Similarity=0.346 Sum_probs=170.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||.|++|.||++ ....++..+++|.+........+.+.+|+++++.++ ||||+++++.+..+...++||||+++
T Consensus 11 ~~l~~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 11 GELGDGAFGKVYKA--QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK--HPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHhcCCCCceEEEE--EEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC--CCceeEEEEEEecCCeEEEEeeccCC
Confidence 57999999999999 555688999999998766666678889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.++.+||+. +++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 87 ~~L~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 87 GALDSIML---ELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred CcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 99999883 2345799999999999999999999999 999999999999999999999999998765432221 1
Q ss_pred cccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....+++.|+|||.+. ...++.++|+||||+++|++++|+.||....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 23345788899999875 3457789999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=268.10 Aligned_cols=201 Identities=25% Similarity=0.365 Sum_probs=166.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (229)
+.||+|+||+||++ .+..++..+|+|.+... .......+..|+.+++.++ ||||++++++|.+. ..+++|||
T Consensus 19 ~kLG~GgFGtVYLA--kdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~--HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 19 KKIGNGRFGEVFLV--KHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK--HKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEecCCCeEEEEE--EECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC--CCCcCeEEEEEEecCCCEEEEEEe
Confidence 57999999999999 66778899999998754 2334567889999999999 99999999988643 46789999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC----CCCeEEcCCCCCCEEEcC--------------
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI----QPHVVHRDIKTSNILLDQ-------------- 139 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~----~~~i~h~di~p~ni~~~~-------------- 139 (229)
|+++++|.+++.........+++..++.++.||+.||+|||+.. ..+|+|+||||+|||++.
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 99999999998654444568999999999999999999999851 015999999999999964
Q ss_pred ---CCceEEeccccccccCCCCccccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 140 ---NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 140 ---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.+.++|+|||++..+.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999987653322 1234568999999998864 45889999999999999999999999754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=241.16 Aligned_cols=198 Identities=25% Similarity=0.361 Sum_probs=161.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch--hhHHHHHHHHHHhhhcc-CCCcccccceEEEcC-----CceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNV-CHENLVKLHGGCIDG-----PCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~~~~l~~-~~~~i~~~~~~~~~~-----~~~~ 73 (229)
+.||+|+||.||++ .+..+|+.||+|.++..... ......+|++.++.+.. .||||+++++++... ...+
T Consensus 6 ~~lg~g~~g~v~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 6 AEIGVGAYGTVYKA--RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred eEEeecCCeEEEEE--EECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 57999999999999 66778999999998754222 22455667777766531 299999999988642 3568
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+++||++ ++|.+++... ....+++..+..++.|++.||.|||+. |++|+||+|+||++++++.++|+|||.+..
T Consensus 84 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 9999996 4888877321 234589999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ......++..|+|||++.+..++.++|+||+||++|+|++|++||....
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 53322 1233457889999999998889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=237.87 Aligned_cols=200 Identities=28% Similarity=0.424 Sum_probs=167.5
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
..||+|+||+||++.+... .+...+++|.++... ......+.+|+..++.++ ||||+++++.+...+..+++|||+
T Consensus 10 ~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD--HPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC--CCCcceEeEEEecCCceEEEEEcC
Confidence 4689999999999955332 235689999987543 334467888999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|++.++++||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 88 ~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 88 ENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred CCCCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999983 2334789999999999999999999999 999999999999999999999999999987642211
Q ss_pred c-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 160 H-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 160 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
. ......++..|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 1 1122234567999999998899999999999999999997 999997544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=238.76 Aligned_cols=195 Identities=27% Similarity=0.342 Sum_probs=160.1
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhcc-CCCcccccceEEEcCCceEEEEEc
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNV-CHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~-~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
.||+|+||.||++ ....+|+.+|+|.+.... ........+|...++.+.. .||+|+.+++++...+..++||||
T Consensus 1 ~lg~G~~g~Vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEE--EECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999 666789999999986432 1222334444444443321 289999999999988899999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||++||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 79 ~~~~~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 79 MNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 9999999988 4556799999999999999999999999 99999999999999999999999999986543222
Q ss_pred ccccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....+++.|+|||... +..++.++|+||+|+++|++++|+.||....
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 12345889999999886 4568899999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=237.60 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=171.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|++|.||++ ....+|+.+++|.+... .......+.+|+.+++.+. ||||+++++++...+..++++||
T Consensus 8 ~~ig~g~~g~v~~~--~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 8 KKIGRGQFSEVYRA--TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhcccCCeEEEEE--eecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc--CCchhhhhheeEeCCeEEEEEEe
Confidence 46999999999999 66778999999988643 2233467888999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.........+++..++.++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999998854444556789999999999999999999999 99999999999999999999999999887654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.. .....++..|+|||.+.+..++.++|+||+|+++|++++|+.||...
T Consensus 161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 21 12345788899999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=236.44 Aligned_cols=193 Identities=26% Similarity=0.372 Sum_probs=169.4
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
||.|++|.||++ +...+++.+++|.+.... ....+.+.+|+++++.++ ||||+++++.+.++...++++||++
T Consensus 1 lg~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELV--KVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN--HPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEE--EECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC--CCCEeeeeeeEEcCCccEEEEecCC
Confidence 799999999999 556678999999997542 234467889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++ .....+++..+..++.|++++|++||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~~~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-- 147 (262)
T cd05572 77 GGELWTIL----RDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-- 147 (262)
T ss_pred CCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence 99999998 4455689999999999999999999999 99999999999999999999999999987664432
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+..++.++|+||+|+++|++++|+.||....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1233457888999999888889999999999999999999999998655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=237.68 Aligned_cols=196 Identities=27% Similarity=0.385 Sum_probs=172.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||.|+||.||++ ....+++.+++|.+.... ....+.+.+|++.+++++ ||||+++++.+.+....++|+||
T Consensus 6 ~~i~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 6 RVIGKGAFGKVCIV--QKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN--HPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred EEeccCCCceEEEE--EEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC--CCChHHHHHhhcCCCeEEEEEeC
Confidence 57999999999999 666789999999997542 234578889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ ....++++..+..++.|++++|.+||++ +++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999998 3446899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......++..|+|||...+..++.++|+||||+++|++++|+.||.....
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 12334578889999999888899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=239.97 Aligned_cols=203 Identities=25% Similarity=0.406 Sum_probs=167.5
Q ss_pred CccCCcccccccccceE--eccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++... ...++..+++|.+.... ......+.+|++.++.++ ||||+++++++......+++|||
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH--HPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC--CCCeeeEEEEEecCCceEEEEEc
Confidence 57999999999999542 23467899999997443 333467888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhh-------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 79 MPNNSLSQTLLGEE-------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 79 ~~~~sL~~~~~~~~-------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
+++++|.+++.... .....+++..+..++.|++.+|+|||+. |++|+||+|+||++++++.++|
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEe
Confidence 99999999984221 1123578889999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 146 SDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 146 ~dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
+|||++....... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999987653321 111222335667999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=271.82 Aligned_cols=204 Identities=29% Similarity=0.360 Sum_probs=179.0
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||+|+||.|.++ +...+++.||+|.++.. ......-|..|-.++..-+ .+=|+.+.-.|.|+.+.|+|||
T Consensus 80 lKvIGrGaFGEV~lV--r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n--s~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALV--RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN--SEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred HHHhcccccceeEEE--EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC--cHHHHHHHHHhcCccceEEEEe
Confidence 367999999999999 77789999999999752 2333455777888888877 8899999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|++||+|-.++ ++...+++..++.++..++-||+.+|+. |+|||||||+|++++..|+++|+|||.|-.+...
T Consensus 156 Y~pGGDlltLl----Sk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 156 YMPGGDLLTLL----SKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred cccCchHHHHH----hhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999 5555899999999999999999999999 9999999999999999999999999999988766
Q ss_pred CccccccccCCccccCccccc----c-CCCCCcccchhHHHHHHHHHhCCCcccCcccccccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAI----S-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 215 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~----~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~ 215 (229)
..-......|||.|.+||++. + ..|++..|.||||+++|||+.|..||..++-.+.|.
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~ 291 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG 291 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH
Confidence 555566778999999999987 3 458999999999999999999999998876555553
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=238.73 Aligned_cols=195 Identities=25% Similarity=0.384 Sum_probs=171.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||.|++|.||++ +...+++.+++|.+.... ......+.+|+++++.++ |+||+++.+++.++...++|+||++
T Consensus 7 ~~lg~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 7 ECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--SPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhcCCCCeEEEEE--EECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC--CCCeeeeeEEEEECCeEEEEEEeeC
Confidence 57999999999999 666789999999997553 334467888999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++. . ..+++..+..++.|++.++.+||+. +++|+|++|+||++++++.++|+|||.+........
T Consensus 83 ~~~L~~~~~----~-~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 83 GGSCLDLLK----P-GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCcHHHHHh----h-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 999999983 2 2889999999999999999999999 999999999999999999999999999877654321
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+..++.++|+||||+++|++++|+.||....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 2233567888999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=235.28 Aligned_cols=199 Identities=23% Similarity=0.403 Sum_probs=172.7
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
++.||.|+||.|+.+ ....+++.+++|.+... .......+.+|++++++++ |+||+++++++.+....+++|||
T Consensus 5 ~~~ig~g~~g~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 5 IRVLGKGAFGEATLY--RRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ--HPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred eeEecccCCceEEEE--EEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC--CCCeeEEEeEEecCCeEEEEEEe
Confidence 367999999999999 66778999999998754 2444567889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++... ....+++..+..++.|++.++.+||+. |++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999988322 245689999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|.|||...+..++.++|+||+|++++++++|+.||....
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 2 2234567889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=259.13 Aligned_cols=195 Identities=27% Similarity=0.397 Sum_probs=174.4
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.||.|.+|+||.+ ++..++..+|||.+........+.+.+|+..-++++ |.||+++++.+..++..-|.||-++||
T Consensus 582 VLGKGTYG~VYA~--RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr--HkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAA--RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR--HKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEee--ccccceeEEEeeecccccchhhccHHHHHHHHHHHh--hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 4899999999999 556677999999998666667789999999999999 999999999999999888999999999
Q ss_pred CHHHHHhhhhccccCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-CCCceEEeccccccccCCCCc
Q 027015 83 SLSQTLLGEEKRRAKF--GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~ 159 (229)
||.+++ .+..+++ ++.++..+..||++||.|||.+ .|+|||||-+|++++ -.|.+||+|||.++.+..-+.
T Consensus 658 SLSsLL---rskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 658 SLSSLL---RSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred cHHHHH---HhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence 999999 4777888 8999999999999999999999 999999999999996 578899999999988754332
Q ss_pred cccccccCCccccCccccccC--CCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 HISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..+++-||..|||||++... .|..++|||||||++.||.||++||...
T Consensus 732 -~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 732 -CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred -cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 34668899999999999854 4889999999999999999999999754
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=235.83 Aligned_cols=199 Identities=32% Similarity=0.460 Sum_probs=165.3
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++.+.... .+..+++|.+..... ...+.+.+|+..++.+. ||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD--HPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcC--CCCeeeEEEEEcC-CceEEEEEeC
Confidence 46999999999999654433 347899999875533 34567889999999998 9999999998764 4679999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++ .....+++..+..++.|++.++++||.. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 78 PLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCcHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999999 3445789999999999999999999999 999999999999999999999999999876543322
Q ss_pred ccc--ccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HIS--TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
... ....++..|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 111 11123457999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=244.19 Aligned_cols=199 Identities=23% Similarity=0.324 Sum_probs=160.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (229)
..||+|+||+||++......++..||+|.+.... ....+.+|+++++.++ ||||+++++++.. +...++++||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELK--HPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCC--CCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3699999999999955455567899999986432 2346788999999999 9999999998854 45678999998
Q ss_pred CCCCHHHHHhhhh-----ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----cCCCceEEecccc
Q 027015 80 PNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGL 150 (229)
Q Consensus 80 ~~~sL~~~~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~----~~~~~~~l~dfg~ 150 (229)
+ ++|.+++.... .....+++..+..++.|++.||++||+. |++|+||||+||++ +.++.++|+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 5 57777663211 1234688999999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCcc--ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 151 SKLFPENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
+......... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9766433211 1233467889999998876 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=238.43 Aligned_cols=196 Identities=25% Similarity=0.301 Sum_probs=167.3
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
||+|+||+||++ ....+|+.|++|.+.... ......+..|+++++.++ ||+|+++++.+...+..++|+||++
T Consensus 1 lg~g~~g~vy~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCAC--QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS--SRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEE--EEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC--CCCEeeeeeEEecCCeEEEEEecCC
Confidence 799999999999 667789999999986432 223455678999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++... ....+++..+..++.|++.++.+||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 77 ~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 150 (277)
T cd05577 77 GGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK- 150 (277)
T ss_pred CCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc-
Confidence 99999988422 224789999999999999999999999 999999999999999999999999998876543211
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....++..|+|||...+..++.++|+||+|++++++++|+.||.....
T Consensus 151 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 151 -IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred -cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 1223567789999998888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=238.34 Aligned_cols=196 Identities=22% Similarity=0.388 Sum_probs=170.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||.|+||.||++ ....++..||+|.+.... ......+.+|+..++.+. ||||+++++++.++...++||||++
T Consensus 10 ~~lg~g~~~~vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 10 ERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhcccCCCeEEEEE--EEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCEEEEEEecCC
Confidence 57999999999999 666678999999987543 344577889999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++. ...+++..+..++.|++.++++||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 86 ~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 86 GGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999882 34688999999999999999999999 999999999999999999999999999876543221
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......++..|+|||.+.+..++.++|+||||+++|++++|+.||....+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence 12234577889999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=236.41 Aligned_cols=203 Identities=21% Similarity=0.322 Sum_probs=163.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||+++.........+++|.++... ......+.+|+..++.++ ||||+++++.+.+....+++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ--HPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC--CcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999865444445567788776443 344578899999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC-Cc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN-TT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~-~~ 159 (229)
+++|.+++..........+...+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999854433345577788889999999999999999 9999999999999999999999999987543211 11
Q ss_pred cccccccCCccccCcccccc-------CCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.......++..|+|||+... ..++.++|+||||+++|+|++ |..||....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 12233457788999998753 245789999999999999997 577886543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=239.51 Aligned_cols=204 Identities=31% Similarity=0.482 Sum_probs=170.9
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++.... ..++..+++|.+........+.+.+|++.++.++ ||||+++++++......++||||
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC--CCCcceEEEEEccCCceEEEEec
Confidence 469999999999985432 2456679999987666555678899999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 027015 79 MPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 146 (229)
Q Consensus 79 ~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~ 146 (229)
+++++|.+++.... .....+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEEC
Confidence 99999999985321 1234588999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 147 DFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 147 dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
|||++....... ........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999987653321 112233446778999999998899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=256.44 Aligned_cols=190 Identities=27% Similarity=0.417 Sum_probs=169.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+-||.|+||-||-| ++..+.+.||||.++.. +....+++..|+.++++++ |||++.+-++|......++||||
T Consensus 32 rEIGHGSFGAVYfA--rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~--HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 32 REIGHGSFGAVYFA--RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR--HPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHhcCCccceeEEe--eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc--CCCcccccceeeccchHHHHHHH
Confidence 45999999999999 66778899999999754 3444588999999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
| -||-.|++ .--++++.+.++..|+.+.+.||+|||+. +.||||||..||++++.|.+||+|||.+....
T Consensus 108 C-lGSAsDll---eVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 108 C-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred H-hccHHHHH---HHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 9 67788887 35678899999999999999999999999 99999999999999999999999999987643
Q ss_pred ccccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 159 THISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
+...+.|||.|||||++. ...|+-++||||||++..+|...++|+=+
T Consensus 178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 345678999999999987 46799999999999999999999987643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=236.55 Aligned_cols=195 Identities=26% Similarity=0.322 Sum_probs=160.0
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhcc-CCCcccccceEEEcCCceEEEEEc
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNV-CHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~-~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
.||+|+||.||++ ....+++.||+|.+..... ........|...++.++. .||+|+++.+.+......++|+||
T Consensus 1 ~ig~g~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEE--EEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999 6667889999999865421 112223344443333321 299999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|+++++.+||+. +++|+||+|+||+++.++.++|+|||.+..+....
T Consensus 79 ~~g~~L~~~l----~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 79 MNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 9999999988 4556799999999999999999999999 99999999999999999999999999987553322
Q ss_pred ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....|+..|+|||.+.+ ..++.++|+||+|+++|++++|+.||....
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 152 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred ---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 123468889999999874 468899999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=239.12 Aligned_cols=204 Identities=28% Similarity=0.444 Sum_probs=169.5
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++... ...++..+++|.+..........+.+|++.++.++ |+||+++++++.+....++++||
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ--HQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC--CCCCceEEEEEecCCceEEEEec
Confidence 57999999999998542 23456789999987655556678999999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhc-----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 027015 79 MPNNSLSQTLLGEEK-----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 147 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~d 147 (229)
+++++|.+++..... ....+++..+..++.|++.|++|||+. |++|+||+|+||++++++.++|+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECC
Confidence 999999999843211 113588999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 148 FGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
||++........ .......+++.|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 999875532211 11222334678999999998999999999999999999998 9999976443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=248.95 Aligned_cols=203 Identities=27% Similarity=0.346 Sum_probs=166.1
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.+... ..+..||+|.++... ....+.+.+|+++++.+. .||||+++++++...+..++|||
T Consensus 43 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-PHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred heecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCceEEEEE
Confidence 5799999999999854322 234579999997543 333467889999999994 39999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhc----------------------------------------------------------------
Q 027015 78 YMPNNSLSQTLLGEEK---------------------------------------------------------------- 93 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~---------------------------------------------------------------- 93 (229)
|+++++|.+++.....
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 9999999998854211
Q ss_pred ----------------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 94 ----------------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 94 ----------------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
....+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEE
Confidence 012477888899999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCc
Q 027015 146 SDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 208 (229)
Q Consensus 146 ~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~ 208 (229)
+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999998765332211 1122345678999999998889999999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=235.78 Aligned_cols=198 Identities=25% Similarity=0.341 Sum_probs=171.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ .+..+++.+++|.++.. .....+.+.+|+..++.++ ||||+++.+.+.++...++++||++
T Consensus 6 ~~lg~g~~g~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 6 RVVGEGSFGRALLV--QHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK--HPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred EEeeccCCeEEEEE--EEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC--CCCcceEEEEEEECCEEEEEEeeCC
Confidence 57999999999999 66778999999998754 3344567888999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++.. .....+++..+..++.|++.++.+||+. |++|+||+|+||++++++.++++|||.+........
T Consensus 82 ~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 82 GGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 9999998732 2345678999999999999999999999 999999999999999999999999999876533221
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||++.+..++.++|+||+|+++|++++|+.||....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 2233557888999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=239.43 Aligned_cols=196 Identities=23% Similarity=0.380 Sum_probs=170.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++ +...+++.+++|.+........+.+.+|+..++.++ |||++++++.+......++|+||+++
T Consensus 25 ~~lg~g~~g~v~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 25 EKIGQGASGTVYTA--IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK--HPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred eEecCCCCeEEEEE--EEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC--CCCeeehhheeeeCCcEEEEEecCCC
Confidence 57999999999999 667788999999987655555677889999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. ...+++..+..++.|++.++++||+. |++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 101 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 99999882 34578899999999999999999999 999999999999999999999999998765533222 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....+++.|+|||.+.+..++.++|+||+|+++|++++|+.||.....
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2234578889999999888899999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=242.25 Aligned_cols=200 Identities=27% Similarity=0.305 Sum_probs=170.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|++|.||++ ....+++.+|+|.+..... ...+.+.+|++.++.++ ||+|+++++.+.+....+++|||
T Consensus 7 ~~ig~g~~g~vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 7 KLLGKGDVGRVFLV--RLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--HPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eeecCCccEEEEEE--EEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC--CCCchhheeeeecCCEEEEEEEe
Confidence 57999999999999 6666899999999975532 24467888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+.+++|.+++.. .....+++..+..++.|++++|++||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 83 CPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred cCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999998832 2345789999999999999999999999 99999999999999999999999999876542211
Q ss_pred c----------------------------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 T----------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. .......|+..|+|||...+..++.++|+||||+++|++++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 011224578889999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=238.90 Aligned_cols=204 Identities=24% Similarity=0.341 Sum_probs=168.8
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++..... .++..|++|.+.... ......+.+|+..++.++ ||||+++++++......+++||
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC--CCceeEEEEEEcCCCCcEEEEe
Confidence 5699999999999965432 245789999986443 334467888999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhc------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
|+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccc
Confidence 9999999999854221 223578889999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 152 KLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
........ .......++..|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 76533221 12233445778999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=235.73 Aligned_cols=196 Identities=27% Similarity=0.358 Sum_probs=165.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-----chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~l 74 (229)
..||+|+||.||++ ....+|..|++|.+.... ....+.+.+|+..++.+. ||||+++++++.+. ...++
T Consensus 8 ~~l~~g~~g~v~~~--~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 8 KLLGQGAFGRVYLC--YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL--HERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred eEEecCCceEEEEE--EEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC--CCCeeeEEeEeccCCCceEEE
Confidence 46899999999999 667789999999986432 223457888999999999 99999999988764 45779
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
++||+++++|.+++ .....+++..+..++.|++.+|.+||+. +++|+||+|.||+++.++.++|+|||.+...
T Consensus 84 v~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 99999999999988 3445688899999999999999999999 9999999999999999999999999988765
Q ss_pred CCCCc--cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 155 PENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 155 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..... .......++..|+|||.+.+..++.++|+||||+++|++++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 32111 1122345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=237.11 Aligned_cols=199 Identities=26% Similarity=0.386 Sum_probs=162.0
Q ss_pred CccCCcccccccccceEeccCCc----EEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT----IVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++ ....+|. .+++|.+..... .....+..|+..+..+. ||||+++++++.. ...++++
T Consensus 13 ~~lg~G~~~~vy~~--~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~--h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 13 KLLGSGVFGTVHKG--IWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD--HAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred cccCccCCcceEEE--EEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC--CCCcceEEEEECC-CccEEEE
Confidence 57999999999999 4444555 477787753322 23356777888888888 9999999998754 4578999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++. .....+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 88 e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 88 QLSPLGSLLDHVR---QHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EeCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999983 3345789999999999999999999999 999999999999999999999999999876533
Q ss_pred CCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 157 NTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 157 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
... .......++..|+|||...+..++.++|+||||+++|++++ |+.||......
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 221 11223446678999999988889999999999999999998 99999876443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=234.30 Aligned_cols=195 Identities=28% Similarity=0.422 Sum_probs=169.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-----chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|++|+||++ +...+++.|++|.+.... ....+.+.+|++.++.++ |+||+++++++.++...++++
T Consensus 6 ~~ig~g~~~~vy~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 6 ELLGSGSFGSVYEG--LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ--HPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ceeeecCCceEEEE--EEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC--CCCchheeeeEecCCeEEEEE
Confidence 56999999999999 666689999999986543 234567889999999998 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++ .....+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998 4456788999999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccccCCccccCccccccCC-CCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.. ......++..|+|||.+.... ++.++|+||+|+++|++++|+.||....
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 32 123345788899999987766 8999999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=239.03 Aligned_cols=195 Identities=22% Similarity=0.381 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ....+++.||+|.+.... ....+.+.+|++.++.++ ||||+++++.+..+...++|+||++
T Consensus 10 ~~l~~g~~~~vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 10 ERIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHhcCCCCeeEEEE--EEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC--CCccHhhhcccccCCceEEEEEccC
Confidence 46899999999999 666788999999987543 344567889999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++. ...+++..+..++.|++.++.+||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 86 ~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 999999872 35688999999999999999999999 999999999999999999999999999876543221
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......++..|+|||.+.+..++.++|+||+|++++++++|+.||....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1223457888999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=237.08 Aligned_cols=197 Identities=30% Similarity=0.454 Sum_probs=163.7
Q ss_pred CccCCcccccccccce--EeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPF--IRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~--~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~ 76 (229)
+.||+|+||+||++.+ ....+++.||+|.++.... .....+.+|++.++.++ ||||+++++++... ...+++|
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY--HENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCCceEEEEe
Confidence 5799999999987643 2345788999999975532 34567788999999999 99999999987653 3578999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++. ...+++..+..++.|++.+|++||+. |++|+||+|+||++++++.++|+|||.+.....
T Consensus 88 e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 88 EYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred cCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999983 24589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcc--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 NTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.... ......++..|+|||...+..++.++|+||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 2211 112233456799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=242.70 Aligned_cols=198 Identities=23% Similarity=0.262 Sum_probs=164.1
Q ss_pred CccCCc--ccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPI--RLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G--~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
..||+| +|++||++ ....+|+.||+|.++.+. ......+.+|+++++.++ ||||+++++++..++..++|+|
T Consensus 4 ~~ig~G~~~~~~v~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 4 TVIGRGFEDLMTVNLA--RYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhccccccceEEEEEE--eecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEECCEEEEEEe
Confidence 568999 67899998 778899999999997553 233456778999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+++.||+........
T Consensus 80 ~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 80 FMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred ccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 99999999998322 234588999999999999999999999 9999999999999999999999999865433211
Q ss_pred Cc------cccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 158 TT------HISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 158 ~~------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.. .......++..|+|||.+.+ ..++.++|+||+||++|++++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 10 01122345677999999875 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=235.19 Aligned_cols=200 Identities=27% Similarity=0.402 Sum_probs=168.3
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++.+... .....+|+|.+..... ...+.+.+|+..+++++ ||||+++++.+.+ ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD--HENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC--CCCccceeEEEcC-CeEEEEEEec
Confidence 4689999999999966442 1223699999986655 56678999999999999 9999999999988 8889999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++..... ..+++..++.++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999999843211 5789999999999999999999999 999999999999999999999999999877643211
Q ss_pred c--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 160 H--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 160 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
. ......++..|+|||...+..++.++|+||||+++|+|++ |+.||....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1 1122446778999999988899999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=234.01 Aligned_cols=196 Identities=26% Similarity=0.402 Sum_probs=171.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..||+|++|.||++ +...+++.+++|.++.... .+.+.+|++.++.++ ||||+++++++.+....++++||+++
T Consensus 9 ~~i~~g~~~~v~~~--~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 9 EKLGEGSYGSVYKA--IHKETGQVVAIKVVPVEED--LQEIIKEISILKQCD--SPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred hhhcCCCCeEEEEE--EEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCC--CCcEeeeeeeeecCCcEEEEEecCCC
Confidence 57999999999999 5566789999999875432 678999999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.++.+||+. +++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 83 ~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 83 GSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 99999983 3456789999999999999999999999 999999999999999999999999999887643321 2
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 2334478889999999988999999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=234.91 Aligned_cols=197 Identities=30% Similarity=0.427 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++. ..+++.+|+|.+.... .....+.+|+..++.++ ||||+++++++. ....++++||+++
T Consensus 12 ~~ig~G~~g~v~~~~---~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 12 KKLGAGQFGEVWMGY---YNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQ--HPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred eeeccCccceEEeee---cCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcC--CcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 579999999999993 4567899999987443 34567889999999999 999999998874 4568999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++.. .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 85 ~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 85 GSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999998832 2345788999999999999999999999 99999999999999999999999999987654322222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....++..|+|||.+....++.++|+||||+++|++++ |+.||.....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 222335678999999988889999999999999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=237.96 Aligned_cols=197 Identities=22% Similarity=0.297 Sum_probs=167.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+|+.||+|.+.... ....+.+.+|+++++.++ |||++++++++......++++||+
T Consensus 7 ~~l~~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 7 SKIGEGSYGVVFKC--RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK--HPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeecccCCeEEEEE--EECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC--CCCEeeeeeEEeeCCEEEEEEecc
Confidence 57999999999999 666789999999986442 223356788999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|..+. .....+++..+..++.|++.+|.+||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 998888776 4455789999999999999999999999 999999999999999999999999999876643321
Q ss_pred cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||.....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 1123446788999998876 5578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=238.46 Aligned_cols=197 Identities=24% Similarity=0.373 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+|+.|++|.+.... ......+.+|+..++.++ ||||+++++++.++...++|+||+
T Consensus 6 ~~l~~g~~~~v~~~--~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 6 GRIGEGAHGIVFKA--KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ--HPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred eecccCCCcEEEEE--EECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC--CCCCcceeeEEecCCeeEEEeccc
Confidence 57999999999999 666789999999997553 334567889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++. .....+++..+..++.|++++|.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 -~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLR---DEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999999883 2336799999999999999999999999 999999999999999999999999999876644322
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......++..|+|||.+.+. .++.++|+||+|++++++++|++||....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 222334678899999988754 46899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=233.38 Aligned_cols=198 Identities=23% Similarity=0.368 Sum_probs=168.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEc-CCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-~~~~~lv~e~ 78 (229)
+.||.|++|.||++ .+..+++.+++|.+.... ....+.+.+|++.++.++ |+|++++.+.+.. +...++++||
T Consensus 6 ~~lg~g~~~~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 6 RVVGKGSYGEVSLV--RHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK--HPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred EEecCCCCeEEEEE--EEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC--CCCeeeeeeeecCCCCEEEEEecc
Confidence 57999999999999 666788999999997542 334467888999999999 9999999998764 4457899999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.. .....+++.++..++.+++.++++||+. |++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999998842 2345689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|+|||++.+..++.++|+||+|++++++++|+.||....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 2 2234567889999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=237.42 Aligned_cols=205 Identities=28% Similarity=0.389 Sum_probs=166.4
Q ss_pred CccCCcccccccccceEecc---CCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ---DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|++|.||++.+.... .+..|++|.+.... ......+.+|+..++.++ |+||+++++++.+....+++||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN--HQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCCcEEEEe
Confidence 57999999999999553321 56889999886443 333456888999999999 9999999999998888999999
Q ss_pred ccCCCCHHHHHhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC---ceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~---~~~l~dfg~~ 151 (229)
|+++++|.+++.... .....+++..+..++.|++.+|++||+. +++|+||+|+||+++.++ .++|+|||.+
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccc
Confidence 999999999984331 1123588999999999999999999999 999999999999998654 5899999998
Q ss_pred cccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 152 KLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
......... .......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~ 228 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 765322111 1122233567999999998889999999999999999996 99999875443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=237.66 Aligned_cols=198 Identities=24% Similarity=0.369 Sum_probs=165.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+++.|++|.++... ......+.+|+..++.++ ||||+++++++.++...++||||+
T Consensus 6 ~~l~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 6 EKIGEGTYGVVYKG--RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ--HPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred eEecccCceEEEEE--EECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC--CCCEeeeEEEEeeCCeEEEEEecC
Confidence 57999999999999 667789999999987542 223466788999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+ ++|.+++... .....+++..++.++.|+++||.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 82 S-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred C-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 6 5888877322 2235789999999999999999999999 999999999999999999999999999875533221
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+. .++.++|+||||++++++++|+.||....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 11223467889999987654 47889999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=239.37 Aligned_cols=204 Identities=24% Similarity=0.362 Sum_probs=167.3
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++..... .+++.||+|.++..... ....+.+|+.++..++ ||||+++++.+......++++|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ--HPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEcCCCceEEEEE
Confidence 5799999999999954332 34678999999755332 2356788999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 78 YMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
|+++++|.+++.... .....+++..+..++.|++.||++||+. |++|+||||+||++++++.++|
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEe
Confidence 999999999984211 1234588889999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 146 SDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 146 ~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999876533221 11223345678999999988889999999999999999998 8889976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=234.39 Aligned_cols=197 Identities=27% Similarity=0.386 Sum_probs=166.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-----chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~l 74 (229)
+.||+|+||.||++ ....++..+++|.+.... ......+.+|+.+++.++ ||||+++++++.+. ...++
T Consensus 8 ~~lg~g~~g~vy~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 8 KLLGQGAFGRVYLC--YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ--HERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ceecCCCCEEEEEE--EEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC--CCCeeeEEEEEEcCCCCEEEE
Confidence 57999999999999 667789999999986432 223456888999999999 99999999988753 56789
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
++||+++++|.+++ .....+++.....++.|++.++++||+. +++|+|++|+||+++.++.++|+|||++...
T Consensus 84 ~~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 84 FMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999998 4445688999999999999999999999 9999999999999999999999999998755
Q ss_pred CCCCc--cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 155 PENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 155 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 32111 11122447788999999999889999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=237.92 Aligned_cols=195 Identities=26% Similarity=0.427 Sum_probs=170.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|++|+||++ ....+|+.+|+|.+.... ......+.+|+++++.++ ||||+++++++......++|+||++
T Consensus 11 ~~ig~g~~g~v~~~--~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 11 SDLGAGNGGSVSKV--KHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR--SPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHcCCCCCeEEEEE--EEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC--CCCcceEeeeEecCCEEEEEEecCC
Confidence 57999999999999 667789999999987553 334567889999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++ ...+.+++..+..++.+++.++.|||+ . +++|+||+|+||++++++.++|+|||++.......
T Consensus 87 ~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 87 CGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999988 445678999999999999999999997 5 89999999999999999999999999876542221
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....++..|+|||.+.+..++.++|+||+|+++|++++|+.||.....
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 1234678899999999888899999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=235.93 Aligned_cols=200 Identities=24% Similarity=0.328 Sum_probs=165.5
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++.+... .+...+++|...... ....+.+.+|+..++.+. ||||+++++++.+. ..+++|||+
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~-~~~lv~e~~ 88 (270)
T cd05056 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD--HPHIVKLIGVITEN-PVWIVMELA 88 (270)
T ss_pred eeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC--CCchhceeEEEcCC-CcEEEEEcC
Confidence 4689999999999955443 224579999987554 344567889999999999 99999999988764 568999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.+++.+|.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 89 PLGELRSYLQ---VNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred CCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999983 2234689999999999999999999999 999999999999999999999999999876544322
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.......++..|+|||.+....++.++|+||||++++++++ |..||.....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 22223334567999999888889999999999999999986 9999976654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=237.41 Aligned_cols=204 Identities=25% Similarity=0.335 Sum_probs=166.0
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.+.. ..++..||+|.++... ......+.+|+..++.++ ||||+++++++......++|||
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEcCCCCeEEEEe
Confidence 569999999999985432 2346789999986432 233456889999999998 9999999999998889999999
Q ss_pred ccCCCCHHHHHhhhhc------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
|+++++|.+++..... ....+++..+..++.|++.+|.+||+. |++|+||+|+||++++++.++|+|||.+
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCc
Confidence 9999999999843211 123467888999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 152 KLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
......... ......+++.|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 755332211 1122345678999999998889999999999999999998 7899976543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=233.59 Aligned_cols=196 Identities=31% Similarity=0.476 Sum_probs=171.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+++.|++|.++.... ...+.+.+|++.++.++ |+||+++++.+.+.+..++++||+
T Consensus 6 ~~lg~G~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 6 NKIGGGTFGKVYTA--VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK--HPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred eEeecCCCcEEEEE--EECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC--CCChhheeeeEecCCEEEEEEecC
Confidence 57999999999999 6677889999999986544 35678999999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++ .....+++..+..++.++++++++||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHH----hhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998 4455688999999999999999999999 999999999999999999999999999877644322
Q ss_pred cccc---cccCCccccCccccccCC---CCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 HIST---RVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~~~~---~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.... ...+++.|+|||.+.+.. ++.++|+||+|++++++++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 2111 345778999999988766 889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=234.20 Aligned_cols=194 Identities=25% Similarity=0.335 Sum_probs=162.6
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHh-hhccCCCcccccceEEEcCCceEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMA-NVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~-~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
++.||+|++|.||+| ....+|+.||+|.+..... ........|...+. ... |+|++++++++......++++
T Consensus 1 ~~~l~~g~~~~v~~a--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 1 LKPISKGAFGSVYLA--KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred CccCCcCCCeeEEEE--EecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCC--CCCeeeeeeeEEcCCeEEEEE
Confidence 478999999999999 6677889999999864321 12223344444433 334 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++ .....+++..+..++.|++.||.+||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 77 EYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred eccCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 999999999998 4456789999999999999999999999 999999999999999999999999998865432
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....+++.|+|||...+..++.++|+||+|+++|++++|..||.....
T Consensus 150 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 150 -----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred -----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 2334577889999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=233.05 Aligned_cols=199 Identities=30% Similarity=0.444 Sum_probs=167.5
Q ss_pred CccCCcccccccccceEeccCC----cEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDG----TIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
..||.|+||.||++. ...++ ..||+|.++..... ..+.+..|++.++.++ |+||+++++++.+.+..+++|
T Consensus 5 ~~lg~g~~g~v~~~~--~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 5 KKLGEGAFGEVYKGT--LKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD--HPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred ceeccCCCcceEEEE--ecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC--CCchheEEEEEcCCCeeEEEE
Confidence 579999999999994 44444 88999999755433 5678889999999998 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++... ....+++..+..++.|++.+|++||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999998321 111289999999999999999999999 999999999999999999999999999876644
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
..........+++.|+|||...+..++.++|+||||++++++++ |+.||....
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 32222212336778999999988889999999999999999998 889997643
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=240.57 Aligned_cols=199 Identities=28% Similarity=0.400 Sum_probs=162.3
Q ss_pred CccCCcccccccccceEeccCCc--EEEEEEeecc-cchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT--IVAVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||+|. ...++. .+++|.++.. .......+.+|++.+.++ + ||||+++++++...+..++++|
T Consensus 13 ~~lg~G~~g~V~~a~--~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~--h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 13 DVIGEGNFGQVLKAR--IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred eeecCCCCceEEEEE--EccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcC--CCCcceEEEEECCCCCceEEEE
Confidence 469999999999994 444555 4577776543 233446788899999999 6 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 78 YMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
|+++++|.+++.... .....+++..+..++.|++.|+++||+. |++|+||+|+||+++.++.++|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEe
Confidence 999999999985432 1224688999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
+|||++....... .......+..|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 166 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred CccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9999886422111 1111223567999999988889999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=241.67 Aligned_cols=202 Identities=28% Similarity=0.385 Sum_probs=165.1
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcC-CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDG-PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~-~~~~lv 75 (229)
+.||+|+||.||++.... ..+++.||+|.++... ....+.+.+|++.++++ + |+||+++++++... ...+++
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~--h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH--HLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred cccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhcc--CcchhheeeeEecCCCCEEEE
Confidence 679999999999995432 2356899999987543 33346678899999999 5 99999999987644 567899
Q ss_pred EEccCCCCHHHHHhhhhc---------------------------------------------------------cccCC
Q 027015 76 YDYMPNNSLSQTLLGEEK---------------------------------------------------------RRAKF 98 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~---------------------------------------------------------~~~~l 98 (229)
+||+++++|.+++..... ...++
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 999999999998843211 12368
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-ccccccCCccccCcccc
Q 027015 99 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYA 177 (229)
Q Consensus 99 ~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~ 177 (229)
++..+..++.|++.+|.|||+. |++|+||||.||++++++.++|+|||++..+...... ......++..|+|||++
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 8999999999999999999999 9999999999999999999999999998765332221 12233456789999999
Q ss_pred ccCCCCCcccchhHHHHHHHHHh-CCCcccCc
Q 027015 178 ISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 208 (229)
Q Consensus 178 ~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~ 208 (229)
.+..++.++|+|||||++|++++ |+.||...
T Consensus 248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred cCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=236.07 Aligned_cols=198 Identities=28% Similarity=0.432 Sum_probs=163.3
Q ss_pred CccCCcccccccccceEeccCCc----EEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT----IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
..||+|+||.||++. ...+|. .||+|.++... ......+.+|+..++.+. ||||+++++++... ..++++
T Consensus 13 ~~lg~G~~g~vy~~~--~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~-~~~l~~ 87 (279)
T cd05109 13 KVLGSGAFGTVYKGI--WIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG--SPYVCRLLGICLTS-TVQLVT 87 (279)
T ss_pred eecCCCCCceEEEEE--EecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC--CCCCceEEEEEcCC-CcEEEE
Confidence 579999999999994 444555 48999987543 334567888999999998 99999999988754 467999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
+|+++++|.+++. .....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 88 ~~~~~g~l~~~l~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 88 QLMPYGCLLDYVR---ENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EcCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 9999999999983 2345689999999999999999999999 999999999999999999999999999876643
Q ss_pred CCccc-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 157 NTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
..... .....++..|+|||...+..++.++|+||||+++|++++ |..||.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 22211 112234567999999988889999999999999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=236.45 Aligned_cols=195 Identities=23% Similarity=0.396 Sum_probs=170.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++ ....+++.+++|.+........+.+.+|+..++.+. |||++++++++...+..++++||+++
T Consensus 25 ~~lg~g~~g~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~--h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 25 VKIGEGSTGIVCIA--TDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred eEeccCCCeEEEEE--EECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC--CCChheEEEEEEcCCeEEEEEeccCC
Confidence 47999999999999 666788999999987655555667889999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. . ..+++..+..++.|++.++++||+. |++|+||+|.||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~----~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVT----H-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHH----h-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 99999882 2 5689999999999999999999999 999999999999999999999999998765533222 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....+++.|+|||...+..++.++|+||+|+++|++++|+.||....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 223457889999999988889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=239.26 Aligned_cols=197 Identities=21% Similarity=0.280 Sum_probs=167.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+++.|++|.+.... ......+.+|++.++.++ ||||+++++.+..++..+++|||
T Consensus 7 ~~l~~g~~~~v~~~--~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 7 KLISNGAYGAVYLV--RHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE--NPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred eEeecCCCeeEEEE--EECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC--CCCeeeeEEEEecCCEEEEEEec
Confidence 57999999999999 677788999999987543 223456778999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC-
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN- 157 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~- 157 (229)
+++++|.+++ .....+++..+..++.|++.++++||+. +++|+||+|.||+++.++.++|+|||.+......
T Consensus 83 ~~g~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 83 VEGGDCATLL----KNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999998 4456789999999999999999999999 9999999999999999999999999987531100
Q ss_pred -------------CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 -------------TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 -------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.........++..|+|||.+.+..++.++|+||||+++|++++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0001112346778999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=234.38 Aligned_cols=201 Identities=27% Similarity=0.417 Sum_probs=166.2
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++..... .++..+++|.++... ......+.+|+..++.++ ||||+++++++.+++..+++|||+
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEecCCccEEEEEcC
Confidence 5799999999999954322 234479999987543 334467889999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|++.++++||+. +++|+||+|+||+++.++.++|+|||.+..+.....
T Consensus 88 ~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 88 ENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred CCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 9999999983 2335689999999999999999999999 999999999999999999999999999876643322
Q ss_pred ccc--ccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HIS--TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
... ....++..|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 111 11223457999999998889999999999999999886 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=265.18 Aligned_cols=209 Identities=28% Similarity=0.421 Sum_probs=176.8
Q ss_pred CccCCcccccccccceEeccC---CcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD---GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
..||+|.||.||.+.+..... -..||+|.++.. +......+++|..+++.++ ||||+++++++.+....+|++|
T Consensus 698 ~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~--HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 698 RVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD--HPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC--CcceeeEEEeecCCCCcEEEeh
Confidence 469999999999998766443 235899998755 4556688999999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 78 YMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
||++|+|..++.... -....++..+++.++.++++|..||+++ ++|||||...|+|+++...+||+|||+|+.+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 999999999995421 1256799999999999999999999999 9999999999999999999999999999854
Q ss_pred CCC-CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccccc
Q 027015 155 PEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 215 (229)
Q Consensus 155 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~ 215 (229)
-+. ......+..-+..|||||.+....++.++||||+|+++||+++ |..||...++.+...
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 332 2222222233568999999999999999999999999999998 999999887666555
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=249.21 Aligned_cols=195 Identities=26% Similarity=0.373 Sum_probs=172.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
..||+|.||+||-+ ++..+|+.||||++... .++.+.++.+|+.+++.+. ||.|+.+---|+...+.++|||-+
T Consensus 570 evLGSGQFG~VYgg--~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~--HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGG--KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH--HPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred hhccCCcceeeecc--eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC--CCCeeEEEEeecCCceEEEEehhh
Confidence 36999999999999 88899999999999654 3555678899999999999 999999998999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc---CCCceEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~---~~~~~~l~dfg~~~~~~~ 156 (229)
.|..|...+ .+..+.+++.....++.||+.||+|||-+ +|+|+|+||+|+++. ...++||||||+++.+++
T Consensus 646 ~GDMLEMIL---SsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 646 HGDMLEMIL---SSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred cchHHHHHH---HhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 666666666 46778999999999999999999999999 999999999999995 345699999999998876
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
... .....|||.|+|||++..+.|.++.|+||+|+|+|--++|.-||..+
T Consensus 720 ksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 720 KSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 532 34467999999999999999999999999999999999999999854
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=233.50 Aligned_cols=197 Identities=30% Similarity=0.443 Sum_probs=164.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++ . ..++..+++|.+..... ..+.+.+|+.+++.++ |++++++++++.. ...+++|||+++
T Consensus 12 ~~ig~g~~~~v~~~--~-~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~--~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 12 KKLGNGQFGEVWMG--T-WNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLR--HDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred heeccccCceEEEE--E-ecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcC--CCceEEEEeEECC-CCcEEEEEecCC
Confidence 57999999999998 3 34667899999875433 3467889999999999 9999999998754 567899999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++.. .....+++..+..++.+++.+|++||+. +++|+||+|+||++++++.++|+|||.+..........
T Consensus 85 ~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999842 1234688999999999999999999999 99999999999999999999999999987654332222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....++..|+|||...+..++.++|+||||+++|++++ |..||.....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 122234567999999988889999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=237.91 Aligned_cols=205 Identities=30% Similarity=0.396 Sum_probs=167.7
Q ss_pred CccCCcccccccccceEecc---CCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ---DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++...... ....+++|.+.... ......+.+|+..++.++ ||||+++++.+..++..++++|
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN--HPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC--CCCEeeEEEEEecCCCcEEEEE
Confidence 57999999999999554322 34679999887543 233467889999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh--------------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 027015 78 YMPNNSLSQTLLGEE--------------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~--------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~ 137 (229)
|+.+++|.+++.... .....+++..+..++.|++.+|.+||+. +++|+||+|.||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 999999999875321 1124588999999999999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 138 DQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
++++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++++|++ |..||....+.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999998754322211 1122335668999999888889999999999999999998 99999865443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=233.57 Aligned_cols=196 Identities=28% Similarity=0.400 Sum_probs=173.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|++|+||++ ....+++.+++|.+..... .....+.+|++.+..++ |+|++++++.+......++++||++
T Consensus 7 ~~i~~g~~~~v~~~--~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 7 KVLGQGSSGVVYKV--RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred eeeeecCCeEEEEE--EEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC--CCCeeeEEEEEccCCeEEEEEEecC
Confidence 57999999999999 6666899999999876543 45578899999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++ .....+++..+..++.|+++++++||+ . +++|+|++|+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~l----~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999 344789999999999999999999999 8 999999999999999999999999999876643322
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....++..|+|||......++.++|+||||+++|++++|+.||....
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 2 123457788999999988889999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=233.99 Aligned_cols=197 Identities=31% Similarity=0.452 Sum_probs=163.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ... +...|++|.++.... ....+.+|++.++.++ ||||+++++.+.. ...+++|||+++
T Consensus 12 ~~lg~g~~~~v~~~--~~~-~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~--~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 12 VKLGQGCFGEVWMG--TWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLR--HEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred eecCCCCCCcEEEE--Eec-CCceEEEEecccCcc-CHHHHHHHHHHHHhCC--CCCcceEEEEECC-CCcEEEEEcCCC
Confidence 57999999999999 333 345799999874332 3457889999999998 9999999988754 457899999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.+|++||+. +++|+||+|+||++++++.++|+|||.+..........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 85 GSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 9999998421 234578899999999999999999999 99999999999999999999999999987654332222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....++..|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 223345677999999988889999999999999999999 8899986543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=236.13 Aligned_cols=197 Identities=27% Similarity=0.394 Sum_probs=169.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (229)
+.||.|++|.||++ ....+++.+|+|.+.... ......+.+|++.++.++ ||||+++++++.+. +..++||||
T Consensus 7 ~~lg~g~~~~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 7 SRLGEGAGGSVTKC--RLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK--SPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred EEeccCCceEEEEE--EECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEccCCCeEEEEEEe
Confidence 57999999999999 556688999999987543 334567899999999998 99999999988643 467999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.........+++..+..++.|++.+|+|||+. |++|+|++|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999998754444566789999999999999999999999 99999999999999999999999999986543221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.....++..|+|||...+..++.++|+||||+++|+|++|+.||...
T Consensus 160 ---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 12345678899999998889999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=234.34 Aligned_cols=197 Identities=26% Similarity=0.414 Sum_probs=167.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc------chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||++ . ..+|+.+|+|.+.... ......+.+|++.++.++ |+||+++.+++.+....+++
T Consensus 6 ~~ig~g~~~~v~~~--~-~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 6 EVLGKGAYGTVYCG--L-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK--HVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ceEeccCCeEEEEE--E-EcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC--CCCEeeEeeEeecCCeEEEE
Confidence 57999999999998 3 3578899999986442 122356888999999999 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
+||+++++|.+++ .....+++..+..++.|++.++++||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999998 4446788999999999999999999999 99999999999999999999999999887542
Q ss_pred CC-----CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 156 EN-----TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 156 ~~-----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. .........++..|+|||...+..++.++|+||||++++++++|+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 213 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh
Confidence 21 11112234578899999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=238.10 Aligned_cols=203 Identities=26% Similarity=0.392 Sum_probs=167.8
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeecc-cchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
..||+|++|.||++..... .+...+++|.+... .......+.+|++.++.+ + ||||+++++++..++..+++|
T Consensus 18 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred eEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcC--CCCeeeEEEEEcCCCCeEEEE
Confidence 4689999999999955432 34578999998754 233446688899999998 6 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceE
Q 027015 77 DYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~ 144 (229)
||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEE
Confidence 9999999999985321 2345788999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 145 ISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 145 l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 9999998765432211 1122234567999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=234.01 Aligned_cols=197 Identities=31% Similarity=0.463 Sum_probs=166.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++ . ..+++.+++|.+.... .....+.+|+..++.++ ||||+++++++......++++||+++
T Consensus 12 ~~ig~g~~~~v~~~--~-~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 12 RKLGAGQFGEVWMG--T-WNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLR--HDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred eeeccCcceEEEEE--E-EcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCC--CCCEeeeeeeeecCCceEEEEeccCC
Confidence 56999999999998 3 3456889999987433 34467889999999999 99999999999988899999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.+++.++++||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 86 ~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 86 GSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999998422 234689999999999999999999999 99999999999999999999999999987664322211
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
......+..|+|||.+.+..++.++|+||+|++++++++ |+.||....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 222234567999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=233.17 Aligned_cols=204 Identities=25% Similarity=0.370 Sum_probs=165.3
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc------e
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC------R 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~------~ 72 (229)
+.||+|+||.||++..... ..+..||+|.++.+. ......+.+|++.++.++ ||||+++++.+..... .
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD--HPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC--CCCeeeEEeeeccCCccccCccc
Confidence 5799999999999944221 234789999987542 233467889999999999 9999999998765443 6
Q ss_pred EEEEEccCCCCHHHHHhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
++++||+++++|..++.... .....+++..+..++.|++.||.+||+. +++|+||+|+||++++++.++|+|||.
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999884432 2334789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccc-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 151 SKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
+.......... ......+..|+|||...+..++.++|+||||+++|++++ |..||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 87654332211 112234567999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=234.44 Aligned_cols=197 Identities=27% Similarity=0.388 Sum_probs=169.1
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
||.|+||.||++ ....+|+.+++|.+..... .....+.+|++.++.++ ||||+++++.+......++++||++
T Consensus 1 lg~g~~~~vy~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLA--KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ--SPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEE--EECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC--CcchhHHHHheecCcEEEEEEecCC
Confidence 799999999999 5666799999999875433 34567888999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc-
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT- 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 159 (229)
+++|.+++ .....+++..+..++.|++.+|++||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 77 ~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 77 GGDLASLL----ENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 99999998 3445789999999999999999999999 999999999999999999999999998775432211
Q ss_pred ------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 160 ------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 160 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.......++..|+|||.......+.++|+||||++++++++|+.||......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0122345678899999998888899999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=232.62 Aligned_cols=196 Identities=27% Similarity=0.368 Sum_probs=166.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc-----cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~l 74 (229)
+.||+|+||.||++ .+..+++.+++|.+... .......+.+|++.++.++ ||||+++++++.+. ...++
T Consensus 8 ~~lg~g~~g~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 8 KLLGRGAFGEVYLC--YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR--HDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeEccCCCeEEEEE--EEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC--CCCcceEEEEEEcCCCCEEEE
Confidence 57999999999999 66778999999987533 1223457888999999999 99999999998764 45789
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
++||+++++|.+++ .....+++..+..++.|+++++.+||+. |++|+|++|+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 99999999999998 4445688999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCc--cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 155 PENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 155 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..... .......++..|+|||.+.+..++.++|+||||++++++++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 32111 1112345788899999999888999999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=234.30 Aligned_cols=200 Identities=28% Similarity=0.392 Sum_probs=162.6
Q ss_pred CccCCcccccccccceEeccCCc--EEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
..||+|+||.||++ ....++. .+++|.++.. .....+.+.+|++.+..+. .||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~v~~~--~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKA--RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEE--EEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-cCCCeeeEEEEEecCCCceEEEEe
Confidence 36999999999999 4444554 5688888643 2344567889999999993 299999999999999999999999
Q ss_pred cCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 027015 79 MPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 146 (229)
Q Consensus 79 ~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~ 146 (229)
+++++|.+++.... .....+++..+..++.|++.|+++||+. |++|+||+|+||++++++.++|+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEEC
Confidence 99999999985421 1123578999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 147 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
|||++....... .......+..|+|||......++.++|+||||+++|++++ |+.||....
T Consensus 155 dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 155 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred CCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 999875321111 1111223567999999988889999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=234.33 Aligned_cols=201 Identities=26% Similarity=0.443 Sum_probs=164.8
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++...... ++..|++|.+... .......+..|+..++.+. ||||+++.+++.++...++++||+
T Consensus 10 ~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred eEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CcCcceEEEEECCCCceEEEEecC
Confidence 46999999999999443221 2346999998754 3334567899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 88 ~~~~L~~~l~---~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 88 ENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred CCCcHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999883 2345689999999999999999999999 999999999999999999999999998876533221
Q ss_pred cc--ccccc--CCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HI--STRVA--GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~--~~~~~--~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.. ..... .+..|+|||...+..++.++|+||+|+++|++++ |..||.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 11 11111 1346999999988899999999999999999886 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=233.89 Aligned_cols=196 Identities=28% Similarity=0.433 Sum_probs=166.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch----------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ----------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~ 71 (229)
+.||+|++|+||++ ....+|+.+|+|.++..... ..+.+.+|+..++.++ |||++++++++.....
T Consensus 7 ~~lg~g~~~~vy~~--~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 7 ELIGKGTYGRVYLA--LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD--HLNIVQYLGFETTEEY 82 (272)
T ss_pred ceecccCceEEEEE--eecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC--CCCcceEEEEeccCCc
Confidence 57999999999999 66778999999988643111 1245778999999998 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
.++|+||+++++|.+++ .....+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 83 ~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 83 LSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred eEEEEecCCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999998 3446789999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCcc-ccccccCCccccCccccccCC--CCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 152 KLFPENTTH-ISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
......... ......++..|+|||.+.... ++.++|+||||++++++++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 764332111 122345788899999887654 789999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=239.09 Aligned_cols=204 Identities=26% Similarity=0.407 Sum_probs=165.7
Q ss_pred CccCCcccccccccceEecc-----CCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||++.+.... ++..+|+|.++.+. ......+.+|++.++.+. .||||+++++++...+..++|
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEE
Confidence 57999999999999553322 34579999997542 334567888999999983 299999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 76 YDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
+||+++++|.+++..... ....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcE
Confidence 999999999999954211 123588899999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCccc-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 144 KISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
+|+|||.+.......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred EECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999987653321111 111223467999999988889999999999999999998 889997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=236.80 Aligned_cols=196 Identities=26% Similarity=0.353 Sum_probs=169.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+++.|++|.++... ......+.+|+++++.++ |+||+++++++.+++..++++||+
T Consensus 7 ~~i~~g~~~~v~~~--~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 7 GVVGEGAYGVVLKC--RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR--HENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred EEecccCCeeEEEE--EeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC--CCCeeehhheEEECCEEEEEEecC
Confidence 46899999999999 667788999999987542 333467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++.+..+. .....+++..+..++.|++.++++||+. +++|+|++|+||++++++.++|+|||.+........
T Consensus 83 ~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 887776655 4456689999999999999999999999 999999999999999999999999999877654432
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.......++..|+|||.+.+. .++.++|+||+|+++|++++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223345577889999999887 7899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=252.85 Aligned_cols=206 Identities=23% Similarity=0.357 Sum_probs=183.3
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+++||-|+||.|-++.. ..+...+|+|+++.. ....++.+..|-.++...+ +|.|+++|..|.++...|++||
T Consensus 425 iaTLGvGgFGRVELV~~--~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~--s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKV--NSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR--SDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhcccCccceEEEEEe--cccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC--chHHHHHHHHhccchhhhhhHH
Confidence 36899999999998733 222234899988754 4556677889999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
-|-||.|+..+ ..++.++..+...++..+++|+.|||+. |||+||+||+|.+++.+|-+||.|||+++.++..
T Consensus 501 aClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 501 ACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999 7889999999999999999999999999 9999999999999999999999999999987654
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhh
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 219 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 219 (229)
. ..-+++|||.|.|||++..+..+.++|.||||+++|||++|.+||.+.++...|.++-+
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 3 23458999999999999999999999999999999999999999999998888876543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=232.68 Aligned_cols=195 Identities=26% Similarity=0.352 Sum_probs=166.0
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.||+|+||.||++ +...++..|++|.+........+.+.+|+.+++.++ |+||+++++++..++..++++||++++
T Consensus 15 ~lg~g~~g~v~~~--~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 15 VLGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK--HRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred EEecCCceEEEEe--EecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC--CCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 5899999999999 556788999999987666666678999999999999 999999999999999999999999999
Q ss_pred CHHHHHhhhhccccCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-CCceEEeccccccccCCCCc
Q 027015 83 SLSQTLLGEEKRRAKF--GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~ 159 (229)
+|.+++.. ....+ ++..+..++.|++.++++||+. |++|+|++|.||+++. ++.++|+|||.+........
T Consensus 91 ~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 91 SLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 99999842 22344 7888899999999999999999 9999999999999976 67899999999876533221
Q ss_pred cccccccCCccccCccccccC--CCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 HISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
......+++.|+|||.+... .++.++|+||+|+++|++++|+.||...
T Consensus 165 -~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 165 -CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred -ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 12234578899999988654 3788999999999999999999999754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=232.20 Aligned_cols=200 Identities=27% Similarity=0.393 Sum_probs=171.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~e 77 (229)
+.||.|+||.||++ .+..+|+.+++|.++.. .....+.+..|++.++.++ ||||+++++++.. ....++++|
T Consensus 6 ~~lg~g~~~~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 6 ETIGKGSFGTVRKV--RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK--HPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred eeeccCCCeEEEEe--eecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC--CCccceeeeeeecCCCCEEEEEeh
Confidence 57999999999999 66778999999998754 2334467888999999999 9999999998764 345789999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH-----EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-----~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|+++++|.+++.........+++..++.++.|++.+|.+|| +. +++|+||+|+||++++++.++|+|||.+.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999998554444678999999999999999999999 77 99999999999999999999999999988
Q ss_pred ccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....... ......+++.|+|||.+.+..++.++|+||||++++++++|+.||....
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 159 ILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 7644322 1233467889999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=234.83 Aligned_cols=196 Identities=23% Similarity=0.335 Sum_probs=160.0
Q ss_pred CccCCcccccccccceEe----------------------ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcc
Q 027015 2 ASVGPIRLEKVDLAPFIR----------------------LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 59 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~----------------------~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i 59 (229)
+.||+|+||.||++.... ......|++|.+..........+.+|+..++.++ ||||
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~--h~ni 78 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS--HIHL 78 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC--CCCe
Confidence 469999999999985321 1122468999987655555567888999999999 9999
Q ss_pred cccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC
Q 027015 60 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139 (229)
Q Consensus 60 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~ 139 (229)
+++++++.++...++||||+++++|..++. .....+++..+..++.|+++|++|||+. |++|+||+|+||+++.
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 999999999999999999999999998883 2355788999999999999999999999 9999999999999975
Q ss_pred CC-------ceEEeccccccccCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHH-hCCCcccCccc
Q 027015 140 NF-------NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIV-SGRTAVDFDVQ 210 (229)
Q Consensus 140 ~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~-~g~~pf~~~~~ 210 (229)
++ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|+.||....+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 43 3799999987543221 12346778999998765 56899999999999999985 69999986544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=238.19 Aligned_cols=203 Identities=25% Similarity=0.404 Sum_probs=166.9
Q ss_pred CccCCcccccccccceEe-----ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-----LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||.||++.... ..++..+++|.+.... ....+.+.+|+..++.+ + ||||+++++++...+..++
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhcc--CCCchheeEEEecCCceEE
Confidence 579999999999995432 2345689999987442 34457788999999999 6 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc
Q 027015 75 VYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~ 142 (229)
+|||+++++|.+++..... ....++...+..++.|+++||.|||+. |++|+||||+||+++.++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~ 175 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNV 175 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCc
Confidence 9999999999999854211 123578889999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 143 PKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 143 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
++|+|||.+......... ......+++.|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999998766432211 1122334567999999988889999999999999999998 888987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=238.54 Aligned_cols=205 Identities=23% Similarity=0.359 Sum_probs=166.4
Q ss_pred CccCCcccccccccceEe-----ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-----LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||++.... ......+|+|.++... ......+.+|++.++.+. .||||+++++++.+.+..+++
T Consensus 18 ~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-KHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-CCCCeeeEEEEEccCCceEEE
Confidence 579999999999995432 2345679999987543 334467888999999883 299999999999988889999
Q ss_pred EEccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 76 YDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
+||+++++|.+++..... ....+++..+..++.|++.||.+||+. |++|+||+|+||++++++.+
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~ 173 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVM 173 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcE
Confidence 999999999999854211 224588999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCccc-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 144 KISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
+|+|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999987654322111 112233457999999988889999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=230.25 Aligned_cols=198 Identities=28% Similarity=0.393 Sum_probs=166.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|++|.||++ .... ++.|++|.+...... ....+.+|+++++.+. ||+|+++++++.+....++++||++
T Consensus 1 ~~lg~g~~g~v~~~--~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKG--VLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD--HPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEE--EEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCeEEEEEEEecCCCeEEEEEcCC
Confidence 46999999999999 4434 899999998765433 4567889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++. .....+++..+..++.+++.++++||++ +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 76 ~~~l~~~l~---~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 76 GGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 999999983 2344688999999999999999999999 9999999999999999999999999998754322111
Q ss_pred cc-ccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 161 IS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 161 ~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.. .....+..|+|||...+..++.++|+||||+++|++++ |..||.....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 11 11223556999999988889999999999999999998 8899976543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=234.73 Aligned_cols=194 Identities=27% Similarity=0.443 Sum_probs=169.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|++|.||++ ....+++.+++|.+.... ......+.+|++.++.+. ||||+++++.+..++..++++||++
T Consensus 7 ~~ig~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 7 GELGAGNSGVVSKV--LHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN--SPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred HHhcCCCCeEEEEE--EEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC--CCchhhhheeeecCCEEEEEEEecC
Confidence 57999999999999 667789999999987653 344567889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++. .....+++..+..++.|+++++.+||+ . |++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILK---EVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHH---HccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999983 222788999999999999999999999 8 999999999999999999999999998876532221
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
....++..|+|||...+..++.++|+||+|++++++++|+.||...
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1156788899999999889999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=236.98 Aligned_cols=194 Identities=24% Similarity=0.403 Sum_probs=169.3
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.||+|+||.||++ ....+|+.|++|.+..........+.+|+..++.++ |+||+++++.+......+++|||++++
T Consensus 27 ~lg~g~~g~v~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 27 KIGEGSTGIVCIA--TVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HcCCCCCeEEEEE--EEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC--CcchhheeeEEEeCCEEEEEEecCCCC
Confidence 5999999999999 667789999999987555555677889999999999 999999999999999999999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcccc
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 162 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (229)
+|.+++ ....+++..+..++.|++.++++||+. |++|+|++|.||++++++.++|+|||.+........ ..
T Consensus 103 ~L~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~ 173 (292)
T cd06657 103 ALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 173 (292)
T ss_pred cHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cc
Confidence 999877 234688999999999999999999999 999999999999999999999999998876543221 12
Q ss_pred ccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 163 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....+++.|+|||.+.+..++.++|+||+|+++|++++|+.||....
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 23457888999999888888999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=235.11 Aligned_cols=198 Identities=29% Similarity=0.481 Sum_probs=165.0
Q ss_pred CCccCCcccccccccceE--eccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEE
Q 027015 1 MASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILV 75 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv 75 (229)
++.||+|+||.||++.+. ...++..|++|.++... ......+.+|+++++.+. |||++++.+++.+. ...+++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEecCCCCceEEE
Confidence 367999999999998532 35678999999987553 334467889999999999 99999999988765 567899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||+++++|.+++. .....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 87 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 87 MEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEccCCCCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999983 2234689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcc--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCccc
Q 027015 156 ENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 156 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
..... ......++..|+|||.+.+..++.++|+||||+++|++++++.|+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 33211 1123446678999999988889999999999999999999876653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=231.69 Aligned_cols=191 Identities=24% Similarity=0.373 Sum_probs=159.5
Q ss_pred CccCCcccccccccceEeccCC----------cEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDG----------TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~ 71 (229)
..||+|+||.||++.. ..++ ..+++|.+...... ...+.+|+.+++.++ ||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~--~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~--h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVL--RVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLS--HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEE--eccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCC--CcchhheeeEEec-CC
Confidence 3699999999999944 3333 35888887644333 678889999999998 9999999999888 77
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-------ceE
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-------NPK 144 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-------~~~ 144 (229)
.++|+||+++++|.+++.. ....++...+..++.|++.+|+|||+. |++|+||+|+||+++.++ .++
T Consensus 75 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEE
Confidence 8999999999999999832 223789999999999999999999999 999999999999999887 799
Q ss_pred EeccccccccCCCCccccccccCCccccCccccccC--CCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 145 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
|+|||.+..... .....++..|+|||.+.+. .++.++|+||||+++|++++ |..||....
T Consensus 149 l~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 149 LSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred eCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 999999876433 1223456779999998876 78999999999999999999 578887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=233.93 Aligned_cols=204 Identities=25% Similarity=0.386 Sum_probs=163.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~ 73 (229)
+.||+|+||.||++.+........+|+|.++.. .....+.+.+|++.++.++ ||||+++++++... ...+
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD--HPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEccCCcccCCCCcE
Confidence 579999999999994433222236999998754 3444567888999999998 99999999976432 2468
Q ss_pred EEEEccCCCCHHHHHhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
+++||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999874321 2334588999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 152 KLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
..+...... ......+++.|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 876433211 1122345668999999998899999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=236.01 Aligned_cols=196 Identities=25% Similarity=0.387 Sum_probs=162.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ....+|+.+++|.+..... .....+.+|+..++.++ |+||+++.+++.+....++|+||+.
T Consensus 11 ~~ig~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 11 EKLGEGSYATVYKG--ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK--HANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred EEEEecCCEEEEEE--EEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC--CCCEeEEEEEEecCCeEEEEEeccc
Confidence 57999999999999 6677889999999875432 22346778999999999 9999999999999989999999995
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
++|.+++. .....+++..+..++.|+++||.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 87 -~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 87 -TDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred -CCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 67766652 3345678888999999999999999999 999999999999999999999999998865432211
Q ss_pred ccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+. .++.++|+||||+++|++++|+.||....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 11223467889999988754 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=232.50 Aligned_cols=199 Identities=27% Similarity=0.436 Sum_probs=165.1
Q ss_pred CccCCcccccccccceEeccCC---cEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDG---TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.. ..++ ..+++|.+.... ....+.+..|++.++.++ ||||+++.+++.+....+++||
T Consensus 11 ~~lg~g~~g~vy~~~~--~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 11 KVIGAGEFGEVFRGIL--KMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS--HHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred eEecCCCCccEEEEEE--ecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEccCCCcEEEEE
Confidence 5699999999999944 3333 379999987542 334567889999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++. .....+++..+..++.|++.|+++||+. |++|+|++|.||++++++.++|+|||.+......
T Consensus 87 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 87 YMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 999999999983 2346789999999999999999999999 9999999999999999999999999998765432
Q ss_pred Ccccc--ccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 158 TTHIS--TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
..... .....+..|+|||.+.+..++.++|+||||+++|++++ |+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 21111 11122456999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=235.73 Aligned_cols=196 Identities=23% Similarity=0.371 Sum_probs=163.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|++|.||++ ....+++.|++|.+..... .....+.+|+++++.++ ||||+++++++.++...++||||++
T Consensus 11 ~~lg~g~~~~vy~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 11 DKLGEGSYATVYKG--RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK--HANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred EEEeecCCeEEEEE--EEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC--CcceeeEEEEEecCCeEEEEEecCC
Confidence 57999999999999 6677889999999875432 22345678999999999 9999999999999999999999997
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+ +|.+++. .....+++..+..++.|+++||.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 87 ~-~L~~~~~---~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 87 T-DLKQYMD---DCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred C-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 5 8988873 2334788999999999999999999999 999999999999999999999999998865422111
Q ss_pred ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......++..|+|||...+ ..++.++|+||+|+++|++++|+.||....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1122245778999998875 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=248.69 Aligned_cols=187 Identities=22% Similarity=0.241 Sum_probs=160.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .+..+++.||+|.... ....+|+++++.++ |+||+++++++..++..++++|++ .
T Consensus 175 ~~Lg~G~~G~Vy~a--~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~--HpnIv~l~~~~~~~~~~~lv~e~~-~ 243 (461)
T PHA03211 175 RALTPGSEGCVFES--SHPDYPQRVVVKAGWY------ASSVHEARLLRRLS--HPAVLALLDVRVVGGLTCLVLPKY-R 243 (461)
T ss_pred EEEccCCCeEEEEE--EECCCCCEEEEecccc------cCHHHHHHHHHHCC--CCCCCcEEEEEEECCEEEEEEEcc-C
Confidence 46999999999999 6677889999996432 24568999999999 999999999999999999999999 4
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH- 160 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 160 (229)
++|.+++. .....+++..+..++.|++.+|.|||+. |++|+||||+||+++.++.++|+|||++.........
T Consensus 244 ~~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 SDLYTYLG---ARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 68888773 3345799999999999999999999999 9999999999999999999999999998765332211
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 205 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf 205 (229)
......||+.|+|||++.+..++.++|||||||++|++++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 122356899999999999999999999999999999999987654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=233.88 Aligned_cols=198 Identities=29% Similarity=0.470 Sum_probs=164.7
Q ss_pred CccCCcccccccccceE--eccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~e 77 (229)
+.||+|+||.||++... ...++..|++|.+........+.+.+|++.++.++ ||||+++.+++.. ....++|+|
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCeeEEEEEEccCCCCceEEEEE
Confidence 57999999999998532 45678899999997666666678899999999999 9999999997753 346789999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++. .....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 88 ~~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 88 YLPYGSLRDYLQ---KHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred ecCCCCHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999999983 2345689999999999999999999999 9999999999999999999999999998865432
Q ss_pred Cccc--cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 158 TTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 158 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.... .....++..|+|||...+..++.++|+||||++++++++|..|+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 2211 1112234569999999888899999999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=236.29 Aligned_cols=193 Identities=22% Similarity=0.336 Sum_probs=162.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ +...+|+.+++|.++.... .....+.+|++.++.++ ||||+++++++.+....++++||+
T Consensus 6 ~~l~~g~~~~vy~~--~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 6 EKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred EEecccCCeEEEEE--EECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC--CCCeeeHHHHhccCCceEEEEecC
Confidence 57999999999999 6677899999999875422 22356778999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+ ++|.+++. .....+++..+..++.|+++||.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 D-QDLKKYFD---SCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred C-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 6 57877763 3356799999999999999999999999 999999999999999999999999999876533221
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
. .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 1 1233567889999988764 47899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=236.19 Aligned_cols=196 Identities=27% Similarity=0.374 Sum_probs=166.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ ....+++.+|+|.+.... ....+.+.+|++.++.++ ||||+++++++.++...++|+||+
T Consensus 7 ~~lg~g~~~~vy~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 7 GLVGEGSYGMVMKC--KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR--HENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeeccCCCeEEEEE--EECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC--CcchhhHHHhcccCCeEEEEEecC
Confidence 57999999999999 556678999999886432 223456788999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.++. .....+++..+..++.|++++|+|||+. |++|+|++|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 83 DHTVLDDLE----KYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CccHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999888876 3445689999999999999999999999 999999999999999999999999999876543322
Q ss_pred cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......++..|+|||...+ ..++.++|+||+|+++|++++|+.||....
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 1223456788999998875 446789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=236.70 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=166.8
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++... ...++..+|+|.++... ....+.+.+|+++++++ + ||||+++++++...+..+++|
T Consensus 41 ~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred ceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccC--CCCcceEEEEEecCCceEEEE
Confidence 46899999999998542 23456689999987543 33346788999999999 6 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+.+++|.+++... ....+++.++..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 119 e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 119 EYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999998421 223489999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 157 NTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 157 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.... ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||....
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 3211 1122345678999999998889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=215.19 Aligned_cols=197 Identities=23% Similarity=0.377 Sum_probs=173.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
.+||+|.+|+||++ ++..+++.||+|.++.+ .........+|+-+++.++ |.||+++++....+....+|+|||
T Consensus 8 ekigegtygtvfka--rn~~t~eivalkrvrlddddegvpssalreicllkelk--hknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKA--RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred HhhcCCcceeeEec--ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh--hcceeehhhhhccCceeEEeHHHh
Confidence 47999999999999 66778999999999865 3444578899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
...|..++ .+.++.++.+....++.|++++|.++|+. ++.|||+||+|.+++.+|++||.|||+++.++-+..
T Consensus 84 -dqdlkkyf---dslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 -DQDLKKYF---DSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred -hHHHHHHH---HhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 66788777 57788999999999999999999999999 999999999999999999999999999998876654
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.... ..-|..|.||.++.+. -|+.+.|+||-|||+.|+.. |++.|++.+-
T Consensus 157 cysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 157 CYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred eeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 4333 2358899999999975 48899999999999999986 8888987653
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=231.30 Aligned_cols=194 Identities=22% Similarity=0.320 Sum_probs=160.5
Q ss_pred ccCCcccccccccceEe----------ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCce
Q 027015 3 SVGPIRLEKVDLAPFIR----------LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 72 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~ 72 (229)
.||+|+||.||++.... ......+++|.+..........+.+|+..+..++ ||||+++++++..+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~--hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS--HKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCCC
Confidence 68999999999995321 1223468999987655555567888999999999 99999999999998899
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc-------eEE
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-------PKI 145 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~-------~~l 145 (229)
+++|||+++++|..++. .....+++..+..++.|+++|++|||+. +++|+||+|+||+++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999988873 2345689999999999999999999999 9999999999999986664 899
Q ss_pred eccccccccCCCCccccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHH-hCCCcccCcc
Q 027015 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV-SGRTAVDFDV 209 (229)
Q Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~-~g~~pf~~~~ 209 (229)
+|||.+...... ....++..|+|||.+. +..++.++|+||||+++|+++ .|..||....
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999988654221 2234677899999876 567899999999999999998 5888887543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=233.78 Aligned_cols=201 Identities=25% Similarity=0.316 Sum_probs=165.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE-----cCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-----DGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (229)
+.||+|+||.||++ ....+++.+++|.+.... .....+.+|+..++.+. .||||+++++++. ++...+++|
T Consensus 24 ~~lg~g~~~~vy~~--~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 24 ETIGKGTYGKVFKV--LNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALS-DHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeccCCCcEEEEE--EECCCCceeEEEeecccc-chHHHHHHHHHHHHHHh-cCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 57999999999999 667788999999986432 23356778999998883 2999999999874 345679999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++.........+++..+..++.|++.++.+||+. +++|+|++|+||+++.++.++|+|||.+.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 99999999998754434556788999999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccccCCccccCcccccc-----CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... ......+++.|+|||.+.. ..++.++|+||+|+++|+|++|+.||.....
T Consensus 177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 177 TRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred CCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 221 1223457889999998753 4578899999999999999999999976543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=232.36 Aligned_cols=198 Identities=25% Similarity=0.400 Sum_probs=168.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhcc-CCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNV-CHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~-~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
..||+|+||.||++ +...+++.+++|.++.. .......+.+|+.+++.+.. .|||++++++++.++...+++|||+
T Consensus 7 ~~l~~g~~g~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 7 ELIGRGAYGAVYRG--KHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hheeccCCceEEEE--EEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 57999999999999 66778999999998755 33444667888888888852 2999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. . ..+++..+..++.|++++|.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 ~~~~L~~~~~----~-~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 85 EGGSVRTLMK----A-GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCCcHHHHHH----c-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999882 2 3789999999999999999999999 999999999999999999999999999877644332
Q ss_pred cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......++..|+|||...+ ..++.++|+||||+++|+|++|+.||.....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2233467889999998764 5578999999999999999999999976543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=234.27 Aligned_cols=202 Identities=26% Similarity=0.341 Sum_probs=166.4
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
..||+|+||.||++..... .+.+.+++|.+...... ....+.+|+++++.++ ||||+++++++.+....++|||
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS--HKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC--CcceeeeEEEECCCCcceEEEE
Confidence 5799999999999954322 24578999988654333 3467889999999999 9999999999998888999999
Q ss_pred ccCCCCHHHHHhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 78 YMPNNSLSQTLLGEEKR-----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|+++++|.+++...... ...+++..+..++.|++.+|+|||+. +++|+||+|+||+++.++.++++|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999998433211 12689999999999999999999999 99999999999999999999999999886
Q ss_pred ccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 208 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~ 208 (229)
..............+++.|+|||.+.+..++.++|+||||+++|++++ |..||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 543222222223345677999999888888999999999999999998 88899653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=235.90 Aligned_cols=201 Identities=28% Similarity=0.387 Sum_probs=162.6
Q ss_pred CccCCcccccccccceEeccCCc--EEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....++. .+++|.++.. .....+.+.+|++.+.++. .||||+++++++...+..++++||
T Consensus 8 ~~lg~g~~g~v~~~--~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 8 DVIGEGNFGQVIRA--MIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-HHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeecCCCcceEEEE--EecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc-CCCchhheEEEEccCCcceEEEEe
Confidence 57999999999999 4444443 5788888632 3344567889999999983 299999999999998899999999
Q ss_pred cCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 027015 79 MPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 146 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~ 146 (229)
+++++|.+++..... ....+++..++.++.|++.||++||+. |++|+||||+||++++++.++|+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 999999999854211 123588999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 147 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
|||++....... .......+..|+|||...+..++.++|+||||+++|+|++ |..||.....
T Consensus 162 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 162 DFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999875422111 1111223456999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=232.22 Aligned_cols=198 Identities=28% Similarity=0.443 Sum_probs=164.2
Q ss_pred CccCCcccccccccceEeccCCc----EEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT----IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++.+ ..+|. .+++|.+.... ......+.+|+..++.++ ||||+++++++.. ...++++
T Consensus 13 ~~ig~g~~g~v~~~~~--~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 13 KVLGSGAFGTVYKGVW--IPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD--HPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred ceecCCCCccEEEEEE--ecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEec-CceEEEE
Confidence 5799999999999944 33333 68999886553 334467889999999998 9999999999887 6789999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++. .....+++..+..++.|++.|+++||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 88 e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 88 QLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ecCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999983 3345689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccc-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 157 NTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
..... .....++..|+|||......++.++|+||+|+++|++++ |+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 22111 111223567999999888889999999999999999998 9999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=230.74 Aligned_cols=196 Identities=29% Similarity=0.485 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++.+ .++..+++|.+.... .....+.+|++.++.++ ||+++++++++......++++||+++
T Consensus 10 ~~ig~g~~g~v~~~~~---~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 10 QEIGSGQFGLVWLGYW---LEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLS--HPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred eeecCcccceEEEEEE---eCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCC--CCCeeeEEEEEccCCceEEEEEcCCC
Confidence 5799999999999833 346789999886432 23457889999999999 99999999999998999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+..........
T Consensus 84 ~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 84 GCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999883 2345688999999999999999999999 99999999999999999999999999887653322211
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.....++..|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 122334568999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=232.48 Aligned_cols=196 Identities=22% Similarity=0.379 Sum_probs=169.0
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
++.||+|+||.||++ ....+++.+|+|.+.... ......+.+|+..++.++ ||||+++++.+..+...++|+||+
T Consensus 9 ~~~ig~G~~~~vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 9 LEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred heeEeecCCeEEEEE--EECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC--CCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367999999999999 666788999999986443 333467888999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. ...+++..+..++.+++.++.+||+. |++|+|++|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999882 34688999999999999999999999 999999999999999999999999998876533221
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......++..|+|||.+.+..++.++|+||+|+++|++++|..||....
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 1223457888999999988888999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=230.87 Aligned_cols=200 Identities=28% Similarity=0.403 Sum_probs=170.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||.|++|+||++ ....++..+++|.+.... ......+.+|++.++.++ |+||+++++.+......++++|+++
T Consensus 7 ~~lg~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 7 EVIGVGATAVVYAA--ICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN--HPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred eeecCCCCeEEEEE--EEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC--CCCEEEEEEEEeeCCEEEEEEeccC
Confidence 57999999999999 556688999999987542 335578899999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++.... ....+++..+..++.|++.++++||+. |++|+|++|+||++++++.++|+|||.+.........
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999984221 135689999999999999999999999 9999999999999999999999999998765433221
Q ss_pred ---ccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ---ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......++..|+|||.+... .++.++|+||||++++++++|+.||....
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 22334578899999988766 78999999999999999999999997654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=233.28 Aligned_cols=199 Identities=28% Similarity=0.387 Sum_probs=166.8
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeeccc----chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++.... ..+|+.||+|.++... ....+.+.+|+.+++.+. .|++|+++++++..+...++|+
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc-cCCChhceeeEeecCCeEEEEE
Confidence 579999999999985422 3578999999987432 223356778999999985 3899999999999998999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++ .....+++..+..++.|++.+|.+||+. |++|+||+|+||++++++.++|+|||.+.....
T Consensus 85 e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 85 DYINGGELFTHL----SQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred ecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999998 4456788999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccCCccccCccccccC--CCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..........++..|+|||...+. .++.++|+||+|+++|++++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 322222345578899999988753 4678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=227.14 Aligned_cols=209 Identities=25% Similarity=0.370 Sum_probs=171.7
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
++.||.|..|.|+++ +...+|...|||.+... +++..++++..+.+..... ..|+|++.+++|..+...++.||.+
T Consensus 97 l~dlGsGtcG~V~k~--~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~-dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKM--RFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred HHhhcCCCccceEEE--EEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc-CCCeeeeeeeEEeeCchHHHHHHHH
Confidence 367999999999999 66778999999999755 4555577777777665543 2799999999999999999999987
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+..+..++. ...+++++..+-.+...+++||.||-... |++|||+||+||++|+.|++||||||.+-++-++..
T Consensus 174 -s~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 -STCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred -HHHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 555555552 45567999999999999999999998874 999999999999999999999999999887755443
Q ss_pred cccccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcc
Q 027015 160 HISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 222 (229)
.+..+|.+.|||||-+.- ..|+.++||||||+.++||.||+.||.+.+ .++++..++.+
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln 309 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLN 309 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHh
Confidence 345578899999998874 358899999999999999999999999854 34555555544
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=231.67 Aligned_cols=198 Identities=26% Similarity=0.362 Sum_probs=164.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~lv 75 (229)
+.||+|+||.||++ ....+++.+|+|.+.... .....+..|+..++.+. .||||+++++++... ...+++
T Consensus 12 ~~lg~g~~g~vy~~--~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 12 ELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYS-HHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred HheeecCCeEEEEE--EEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhc-CCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 46999999999999 667788999999987543 34457888999998883 299999999998753 357899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
+||+++++|.+++.. .....+++..+..++.|++.+++|||+. +++|+|++|.||++++++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 88 MEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999832 1335688999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCccccccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... ......++..|+|||++. ...++.++|+||+|+++|+|++|+.||....
T Consensus 163 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 163 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred cccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 3221 223456788999999886 3357889999999999999999999997543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=230.38 Aligned_cols=185 Identities=23% Similarity=0.343 Sum_probs=156.6
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCCC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~s 83 (229)
||+|+||.||++ .+..++..+++|.+........ |+.....+. .||||+++++.+...+..++||||+++++
T Consensus 24 lg~g~~g~v~~~--~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~-~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVL--KHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEE--EEcCCCcEEEEEEEehhhcchh-----hHHHHHHhh-cCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 599999999999 7778899999999874422111 222222221 39999999999999999999999999999
Q ss_pred HHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccccCCCCcccc
Q 027015 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFPENTTHIS 162 (229)
Q Consensus 84 L~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~ 162 (229)
|.+++ .....+++..+..++.|+++++.+||+. |++|+||+|.||+++.++ .++|+|||.+......
T Consensus 96 L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----- 163 (267)
T PHA03390 96 LFDLL----KKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----- 163 (267)
T ss_pred HHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----
Confidence 99998 3445899999999999999999999999 999999999999999888 9999999988765332
Q ss_pred ccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 163 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
....++..|+|||.+.+..++.++|+||+|+++|++++|+.||...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2235788899999999888999999999999999999999999854
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=230.44 Aligned_cols=196 Identities=30% Similarity=0.442 Sum_probs=163.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++. ..++..+++|.+... ......+.+|+++++.++ |+||+++.+.+.. ...++++||+++
T Consensus 12 ~~lg~g~~~~vy~~~---~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 12 KKLGAGQFGEVWMAT---YNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQ--HDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred eEecCccceEEEEEE---ecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcC--CCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 579999999999993 345677999988643 234467888999999998 9999999999877 678999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 85 GSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 9999998432 244678889999999999999999999 99999999999999999999999999987654332222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.....++..|+|||.+....++.++|+||||+++|++++ |+.||...+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 222334567999999988889999999999999999998 999998654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=229.94 Aligned_cols=198 Identities=25% Similarity=0.402 Sum_probs=169.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||++|++ ....+|+.+++|.+... .......+.+|+..++.++ ||||+++.+++...+..++|+||+
T Consensus 6 ~~lg~g~~g~~~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 6 KKIGEGSFGKAILV--KSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK--HPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred EEeccCCceEEEEE--EEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC--CCCeeeeEeeecCCCeEEEEEecC
Confidence 57999999999999 66778999999998754 2334467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++.. .....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999998831 1234678999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||...+..++.++|+||+|++++++++|+.||....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 1223457888999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=230.10 Aligned_cols=197 Identities=30% Similarity=0.429 Sum_probs=162.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..||+|++|.||++. . .++..+++|.+.... ...+.+.+|+++++.++ ||+++++++++.. ...+++|||+++
T Consensus 12 ~~ig~g~~~~v~~~~--~-~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 12 VKLGQGCFGEVWMGT--W-NGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLR--HDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred eeecCcCCCeEEEEE--E-cCCceEEEEEcccCC-ccHHHHHHHHHHHHhCC--CCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 469999999999983 2 344579999876433 23467888999999999 9999999988754 457899999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.||++||+. |++|+||+|+||++++++.++|+|||.+..........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 85 GSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 9999998422 234578999999999999999999999 99999999999999999999999999987654332222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....++..|+|||...+..++.++|+||||+++|++++ |+.||.....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 222335667999999988889999999999999999999 9999986543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=232.15 Aligned_cols=196 Identities=24% Similarity=0.394 Sum_probs=169.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++ ....+++.+++|.+..... ....+.+|++.++.++ |+|++++++.+......++++||+++
T Consensus 25 ~~l~~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 25 EKIGEGASGEVYKA--TDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCK--HPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred HhccCCCCeEEEEE--EEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCC--CCCeeEEEEEEEECCEEEEEEeccCC
Confidence 46899999999999 5566789999999976544 5667889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++.. ....+++..+..++.|++.+|.+||+. |++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 100 ~~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 100 GSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 999999932 123899999999999999999999999 999999999999999999999999998765433221 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||.+.+..++.++|+||||+++|++++|+.||....
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 123346788999999988889999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=235.51 Aligned_cols=199 Identities=28% Similarity=0.455 Sum_probs=162.7
Q ss_pred CCccCCcccccccccceEeccCCc----EEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGT----IVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
++.||+|+||.||++ ....+|. .+|+|.+..... .....+.+|+..++.+. ||||+++++++... ..+++
T Consensus 12 ~~~lg~G~~g~vy~~--~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 12 VKVLGSGAFGTVYKG--IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD--HPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred ccccccCCCccEEEE--EEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcccEEEEEcCC-Cceee
Confidence 367999999999999 4444554 578888865432 33346788999999998 99999999988754 46799
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
+||+++++|.+++. .....+++..+..++.|++.+|.|||+. |++|+||+|+||++++++.++|+|||.+....
T Consensus 87 ~e~~~~g~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 87 TQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred ehhcCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999983 2344688999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccc-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 156 ENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 156 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
...... .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 322211 122334668999999988899999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=233.77 Aligned_cols=197 Identities=22% Similarity=0.323 Sum_probs=165.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-----hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|++|.||++ ....+|+.|++|.+...... ....+..|++.++.++ |+||+++++++.+....++||
T Consensus 6 ~~lg~g~~~~vy~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 6 KKLGEGTYAVVYKA--RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK--HPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred eeeeeccccEEEEE--EECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC--CCCChhhhheeecCCEEEEEE
Confidence 46999999999999 66778999999999755322 2355678999999999 999999999999998999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+ +++|.+++.. ....+++..+..++.|+++||++||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 8999999832 223799999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... .....+++.|+|||.+.+ ..++.++|+||||++++++++|.+||.....
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 3211 122345778999998764 4678999999999999999999888876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=240.79 Aligned_cols=187 Identities=24% Similarity=0.328 Sum_probs=158.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....+++.||+|..... ....|+.+++.++ ||||+++++++......++|+|++ .
T Consensus 72 ~~lg~G~~g~Vy~~--~~~~~~~~valK~~~~~------~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~-~ 140 (357)
T PHA03209 72 KTLTPGSEGRVFVA--TKPGQPDPVVLKIGQKG------TTLIEAMLLQNVN--HPSVIRMKDTLVSGAITCMVLPHY-S 140 (357)
T ss_pred EEecCCCCeEEEEE--EECCCCceEEEEeCCcc------ccHHHHHHHHhCC--CCCCcChhheEEeCCeeEEEEEcc-C
Confidence 57999999999999 66677889999985422 2346899999999 999999999999999999999999 4
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||.+....... .
T Consensus 141 ~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~ 212 (357)
T PHA03209 141 SDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--A 212 (357)
T ss_pred CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--c
Confidence 57887773 3456789999999999999999999999 99999999999999999999999999986532211 1
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCC-CcccC
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVDF 207 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~-~pf~~ 207 (229)
.....|++.|+|||++.+..++.++|+|||||++|+|+++. .+|..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 22356889999999999989999999999999999999854 44443
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=232.95 Aligned_cols=203 Identities=25% Similarity=0.356 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++..... ..+..||+|.++... ......+.+|+..++.++ ||||+++++++.++...+++||
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT--CHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEcCCCCcEEEEe
Confidence 5799999999999855432 235589999886443 233456788999999999 9999999999998889999999
Q ss_pred ccCCCCHHHHHhhhhc------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
|+++++|.+++..... ....++...+..++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCcc
Confidence 9999999999954211 124556788899999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 152 KLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
........ .......++..|+|||.+.+..++.++|+||+|+++|++++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 75432211 11222334667999999988889999999999999999998 788997644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=233.01 Aligned_cols=203 Identities=28% Similarity=0.461 Sum_probs=166.9
Q ss_pred CccCCcccccccccceEec--------------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL--------------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC 66 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~--------------~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~ 66 (229)
+.||+|+||.||++..... ..+..||+|.+.... ......+.+|+++++.++ ||||+++++++
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~ 88 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS--DPNIARLLGVC 88 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC--CCCEeEEEEEE
Confidence 5799999999999854321 234568999987553 334567889999999999 99999999999
Q ss_pred EcCCceEEEEEccCCCCHHHHHhhhhc-------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC
Q 027015 67 IDGPCRILVYDYMPNNSLSQTLLGEEK-------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139 (229)
Q Consensus 67 ~~~~~~~lv~e~~~~~sL~~~~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~ 139 (229)
..+...++++|++++++|.+++..... ....+++..+..++.|++.||++||+. |++|+||+|+||+++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~ 165 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecC
Confidence 998999999999999999999843321 123689999999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh--CCCcccCcc
Q 027015 140 NFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFDV 209 (229)
Q Consensus 140 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~--g~~pf~~~~ 209 (229)
++.++|+|||.+........ .......+++.|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999876433221 12233445678999999988889999999999999999998 677886543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=226.57 Aligned_cols=195 Identities=26% Similarity=0.418 Sum_probs=172.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..||+|++|.||++ ....+++.+++|.+..........+.+|++.++.++ ||+++++.+++..+...++++||+++
T Consensus 6 ~~l~~g~~~~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 6 EKIGKGGFGEVYKA--RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK--HPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred eeeccCCceEEEEE--EECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCCeEEEEEecCCC
Confidence 57999999999999 556688999999998665556678999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.++.+||+. |++|+|++|+||+++.++.++|+|||.+........
T Consensus 82 ~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 82 GSLKDLLK---STNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CcHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999983 2226789999999999999999999998 999999999999999999999999999877644322
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.....++..|+|||...+..++.++|+||||++++++++|+.||...
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456788899999998888999999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=233.35 Aligned_cols=203 Identities=27% Similarity=0.423 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEe--------------ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEE
Q 027015 2 ASVGPIRLEKVDLAPFIR--------------LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC 66 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~--------------~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~ 66 (229)
+.||+|+||+||++++.. ..++..+|+|.++... ......+.+|++.++.++ |+||+++++++
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~~~~~~ 88 (296)
T cd05095 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK--DPNIIRLLAVC 88 (296)
T ss_pred eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEE
Confidence 579999999999985422 2234579999987543 334467889999999999 99999999999
Q ss_pred EcCCceEEEEEccCCCCHHHHHhhhhc-------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC
Q 027015 67 IDGPCRILVYDYMPNNSLSQTLLGEEK-------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139 (229)
Q Consensus 67 ~~~~~~~lv~e~~~~~sL~~~~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~ 139 (229)
.+++..+++|||+++++|.+++..... ....+++..+..++.|++.|+++||+. |++|+||+|+||+++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~ 165 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcC
Confidence 999999999999999999999854211 123477889999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh--CCCcccCcc
Q 027015 140 NFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFDV 209 (229)
Q Consensus 140 ~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~--g~~pf~~~~ 209 (229)
++.++|+|||.+..+...... ......++..|+|||...+..++.++|+||||+++|++++ |..||....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999998765332211 1122334567999998888889999999999999999998 778886543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=236.31 Aligned_cols=201 Identities=25% Similarity=0.340 Sum_probs=165.7
Q ss_pred CccCCcccccccccceEecc--CCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ--DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~l 74 (229)
+.||+|++|.||++ .... +++.||+|.+.... ........+|+.+++.++ ||||+++++++.+. ...++
T Consensus 6 ~~ig~g~~g~v~~~--~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 6 GCIGRGTYGRVYKA--KRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK--HENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred EEeccCCcEEEEEE--EecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC--CCCccceEEEEeCCCCceEEE
Confidence 57999999999999 4455 78999999997632 334467788999999999 99999999999988 78899
Q ss_pred EEEccCCCCHHHHHhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC----CCceEEeccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKR-RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ----NFNPKISDFG 149 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~----~~~~~l~dfg 149 (229)
|+||+++ +|.+.+...... ...+++..++.++.|++.++++||+. +++|+||+|+||+++. ++.++|+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999965 676666332222 24789999999999999999999999 9999999999999998 8999999999
Q ss_pred cccccCCCCc--cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 150 LSKLFPENTT--HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 150 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
++........ .......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 9876543322 11233457888999998775 4578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=232.25 Aligned_cols=195 Identities=24% Similarity=0.320 Sum_probs=160.2
Q ss_pred ccCCcccccccccceEecc-----CCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQ-----DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
.||+|+||.||++...... ....+++|.+........+.+.+|+..++.+. |||++++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~--h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS--HKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC--CCChhheeeEEEeCCCcEEEEe
Confidence 6999999999999442211 23458888886555555577888999999998 9999999999999888999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc--------eEEeccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--------PKISDFG 149 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~--------~~l~dfg 149 (229)
|+++++|.+++. .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLK---KNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999983 2334688999999999999999999999 9999999999999987665 6899999
Q ss_pred cccccCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhC-CCcccCccc
Q 027015 150 LSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQ 210 (229)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g-~~pf~~~~~ 210 (229)
.+..... .....+++.|+|||.+.+ ..++.++|+||||+++|++++| ..||.....
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 8765432 123456788999999876 4578999999999999999998 467665433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=248.13 Aligned_cols=194 Identities=25% Similarity=0.410 Sum_probs=170.5
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc----cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc--eEEEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC--RILVY 76 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~--~~lv~ 76 (229)
.||+|+|-+||+| .+..+|-.||=-.++.. .....+++..|+.+|+.|+ ||||+++++++.+... .-+|+
T Consensus 47 vLGrGafKtVYka--~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~--H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 47 VLGRGAFKTVYKA--FDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK--HPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred hcccccceeeeec--cccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC--CCceeeeeeheecCCCceeeeee
Confidence 4899999999999 66778888876555432 3444588999999999999 9999999999987654 66999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-CCCceEEeccccccccC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFP 155 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-~~~~~~l~dfg~~~~~~ 155 (229)
|.+.+|+|..|. .+.+.++...+..|++||++||.|||++ +|.|+|||||=+|||++ ..|.+||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999 7888999999999999999999999999 88999999999999997 56899999999999876
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.+.. ....|||.|||||++. ..|.+..||||+|+.+.||.|+..||.-..
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 5443 3378999999999877 789999999999999999999999998654
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=230.29 Aligned_cols=199 Identities=28% Similarity=0.396 Sum_probs=166.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~lv 75 (229)
+.||+|++|.||++ ....+++.+++|.+..... ....+.+|+.+++.+. .|+||+++++++.... ..+++
T Consensus 12 ~~l~~g~~~~v~~~--~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 12 EVIGEGTYGKVYKA--RHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYS-NHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eeecCCCCeEEEEE--EECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhc-CCCChheEEEEEEecCCCCcceEEEEE
Confidence 57999999999999 5666789999999875543 3467889999999983 2999999999997644 47899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||+++++|.+++.........+++..+..++.|++.||.+||+. +++|+||+|+||++++++.++|+|||.+....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 999999999999854433457899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCccccccccCCccccCcccccc-----CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.... ......++..|+|||.+.. ..++.++|+||||++++++++|+.||...
T Consensus 165 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 165 STLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred cchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 3222 2233457889999998753 34678999999999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=228.95 Aligned_cols=192 Identities=32% Similarity=0.499 Sum_probs=165.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|++|.||++.. .|+.|++|.+..... ..+++.+|+.+++.++ |+||+++++++.+....++||||+++
T Consensus 12 ~~ig~g~~g~v~~~~~----~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 12 ATIGKGEFGDVMLGDY----RGQKVAVKCLKDDST-AAQAFLAEASVMTTLR--HPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred eeeecCCCceEEEEEe----cCcEEEEEEeccchh-HHHHHHHHHHHHHhcC--CcceeeeEEEEcCCCCeEEEEEecCC
Confidence 5689999999999832 479999999975544 5678899999999999 99999999999988899999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999998322 223689999999999999999999999 999999999999999999999999999876532221
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
....+..|+|||.+....++.++|+||||++++++++ |+.||....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2234567999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=232.19 Aligned_cols=203 Identities=28% Similarity=0.412 Sum_probs=166.1
Q ss_pred CccCCcccccccccceEec----cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL----QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++..... .+++.+++|.+.... ......+.+|+..++.++ ||||+++++++.++...+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN--HPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC--CCCeeeEeeeecCCCCeEEEE
Confidence 4699999999999955332 133689999886443 234567889999999999 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-----ceEEecc
Q 027015 77 DYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-----NPKISDF 148 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-----~~~l~df 148 (229)
||+++++|.+++..... ....+++..+..++.|++.+|+|||+. +++|+|++|+||+++.++ .++|+||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999999854322 234578899999999999999999999 999999999999999877 8999999
Q ss_pred ccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 149 GLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 149 g~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
|++........ .......++..|+|||.+.+..++.++|+||||+++|++++ |+.||....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 99876532211 11122345678999999998889999999999999999998 999997543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=236.76 Aligned_cols=203 Identities=26% Similarity=0.401 Sum_probs=165.6
Q ss_pred CccCCcccccccccceEecc-----CCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-----DGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||.||++...... .+..+|+|.++... ....+.+.+|+++++++ + ||||+++++++...+..++
T Consensus 18 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~~~~~~~~~l 95 (334)
T cd05100 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYV 95 (334)
T ss_pred ceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcC--CCCeeeeeEEEccCCceEE
Confidence 57999999999999543321 23468999887442 33456788999999999 6 9999999999999989999
Q ss_pred EEEccCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc
Q 027015 75 VYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~ 142 (229)
++||+++++|.+++.... .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.
T Consensus 96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~ 172 (334)
T cd05100 96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNV 172 (334)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence 999999999999985421 1223578889999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 143 PKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 143 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999998765432211 1122233467999999999999999999999999999998 889997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=226.66 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=174.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||.|++|.||++ ....+++.+++|.+..... .....+.+|++.++.++ |||++++.+.+......++++||+
T Consensus 6 ~~l~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 6 KQIGKGSFGKVYLV--RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--HPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred eeeccCCCeEEEEE--EEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC--CCChhheEEEEecCCEEEEEEEec
Confidence 57999999999999 5566889999999976533 45577889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++.........+++..+..++.++++++.+||+. |++|+|++|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99999999854333357899999999999999999999999 99999999999999999999999999987654432
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......+++.|+|||...+..++.++|+||+|++++++++|+.||....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 12233567889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=250.24 Aligned_cols=199 Identities=21% Similarity=0.326 Sum_probs=176.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+-||.|+||+||+| .+..++-..|-|++...+.....+++-|+++|..+. ||+|+++++.|...+.++|+.|||.|
T Consensus 38 GELGDGAFGKVyKA--~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd--HP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKA--VNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD--HPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred hhhcCccchhhhhh--hcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC--ChHHHHHHHHHhccCceEEEEeecCC
Confidence 56899999999999 666777888999998888888899999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|-+...+. .-...+++..+.-+++|++.||.|||++ .|||||+|..||+++.+|.++|+|||.+..... ....
T Consensus 114 GAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 114 GAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred chHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 99998873 5677899999999999999999999999 999999999999999999999999998754322 2223
Q ss_pred cccccCCccccCcccccc-----CCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 162 STRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
...++|||.|||||+..+ .+|+.++||||||+++.+|..+.+|....++.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 456889999999998753 57999999999999999999999999876543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=241.02 Aligned_cols=204 Identities=26% Similarity=0.372 Sum_probs=166.4
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.+. ...+++.||+|.++... ....+.+.+|++++..+. .||||+++++.+...+..++|+|
T Consensus 43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG-PHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC-CCCCeEEEEEEEccCCCcEEEEe
Confidence 57999999999999543 23456789999997543 233457889999999985 49999999999999889999999
Q ss_pred ccCCCCHHHHHhhhhc----------------------------------------------------------------
Q 027015 78 YMPNNSLSQTLLGEEK---------------------------------------------------------------- 93 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~---------------------------------------------------------------- 93 (229)
|+++++|.+++.....
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 9999999999854311
Q ss_pred ------------------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 94 ------------------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 94 ------------------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
....+++..+..++.|++.||.|||+. +++|+||+|.||++++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~ 278 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLV 278 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEE
Confidence 112467778899999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 144 KISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
+|+|||++........ .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||....
T Consensus 279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999876432211 11122346778999999998889999999999999999998 899997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=270.45 Aligned_cols=208 Identities=28% Similarity=0.376 Sum_probs=177.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
.||.|.||+||.+ .+..+|.-.|+|.++.. .........+|..+++.++ |||+++++++=.+....+|.||||+
T Consensus 1242 ~Ig~G~fG~VYta--vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln--HpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTA--VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN--HPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred ccCCcceeeeEEe--ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc--CccccccCceeecHHHHHHHHHHhc
Confidence 5899999999999 88999999999998765 3334467889999999999 9999999999999889999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+|+|.+.+ ....-.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+..+...
T Consensus 1318 ~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1318 GGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred cCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 99999998 5666677778888889999999999999 9999999999999999999999999999887655322
Q ss_pred c---cccccCCccccCccccccC---CCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhccc
Q 027015 161 I---STRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSI 223 (229)
Q Consensus 161 ~---~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 223 (229)
. .+...||+-|||||++.+. ....++|||||||++.||+||+.||...+ .++.++-.+--+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d--ne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD--NEWAIMYHVAAG 1457 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc--chhHHHhHHhcc
Confidence 1 2346799999999999853 46789999999999999999999998643 355555544433
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=252.74 Aligned_cols=199 Identities=19% Similarity=0.294 Sum_probs=154.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEE------------------EeecccchhhHHHHHHHHHHhhhccCCCcccccc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVK------------------VLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 63 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK------------------~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~ 63 (229)
+.||+|+||+||++.... .++...+.| .+. ........+.+|+++++.++ ||||++++
T Consensus 154 ~~LG~G~fG~Vyl~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~--HpnIv~l~ 229 (501)
T PHA03210 154 DDLPAGAFGKIFICALRA-STEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLN--HENILKIE 229 (501)
T ss_pred eEecCCCCcceEEEEEec-cchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCC--CCCcCcEe
Confidence 579999999999984422 122222222 111 11223456789999999999 99999999
Q ss_pred eEEEcCCceEEEEEccCCCCHHHHHhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc
Q 027015 64 GGCIDGPCRILVYDYMPNNSLSQTLLGEE-KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142 (229)
Q Consensus 64 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~ 142 (229)
+++.+....+++++++ .++|.+++.... ..........+..++.|++.||+|||+. |++|+||||+||+++.++.
T Consensus 230 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 230 EILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred EEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 9999999999999998 456777663321 1123344667788999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCC-cccCc
Q 027015 143 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT-AVDFD 208 (229)
Q Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~-pf~~~ 208 (229)
++|+|||++..+............|+..|+|||++.+..++.++|||||||++|+|++|.. ||...
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 9999999998765443333344678999999999999999999999999999999999885 45433
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=239.30 Aligned_cols=193 Identities=25% Similarity=0.291 Sum_probs=163.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~ 73 (229)
+.||+|+||.||++ .+..+|+.||+|.+... .......+.+|+.+++.++ ||||+++++++... ...+
T Consensus 22 ~~lg~g~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 22 KPIGSGAQGIVCAA--YDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN--HKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred EEeccCCCEEEEEE--EECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC--CCCCcceeeeeccCCCccccCcEE
Confidence 57999999999999 77778999999998643 2333456778999999999 99999999988644 3568
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+|+||++ ++|.+.+. . .++...+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+..
T Consensus 98 lv~e~~~-~~l~~~~~----~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 98 LVMELMD-ANLCQVIQ----M--DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred EEEeccC-CCHHHHHh----h--cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999995 57887762 2 288999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 222 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH 222 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 543221 2234578889999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=228.97 Aligned_cols=199 Identities=26% Similarity=0.387 Sum_probs=159.6
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEE-cCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~-~~~~~~lv~e~ 78 (229)
+.||+|+||.||++..... .++..+|+|.+... .....+.+.+|+..++.++ ||||+++++++. .++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS--HPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC--CCCcceEEEEeecCCCCcEEEEec
Confidence 3689999999999955332 34568999998533 3344567888999999998 999999999765 45567899999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+.+++|.+++. .....+++..+..++.|+++||++||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 79 MKHGDLRNFIR---SETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999983 2234567788889999999999999999 99999999999999999999999999987543221
Q ss_pred c---cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCc
Q 027015 159 T---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 208 (229)
Q Consensus 159 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~ 208 (229)
. .......++..|+|||...+..++.++|+||||+++|++++ |.+||...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1 11112334667999999988889999999999999999999 56677653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=236.12 Aligned_cols=203 Identities=26% Similarity=0.364 Sum_probs=163.8
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC-CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-~~~~lv~ 76 (229)
+.||+|+||+||++.+. ...+++.||||.++... ......+.+|+..+..+. +||||+++++++... ...+++|
T Consensus 13 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~~~~~~lv~ 91 (343)
T cd05103 13 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIV 91 (343)
T ss_pred ccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc-CCccHhhhcceeecCCCceEEEE
Confidence 67999999999999543 34567899999997543 233467889999999995 289999999987654 4678999
Q ss_pred EccCCCCHHHHHhhhhc---------------------------------------------------------------
Q 027015 77 DYMPNNSLSQTLLGEEK--------------------------------------------------------------- 93 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~--------------------------------------------------------------- 93 (229)
||+++++|.+++.....
T Consensus 92 ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (343)
T cd05103 92 EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDL 171 (343)
T ss_pred eccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhh
Confidence 99999999999853210
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-ccccccCCcccc
Q 027015 94 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYL 172 (229)
Q Consensus 94 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~ 172 (229)
....+++..+..++.|+++||+|||+. |++|+||||+||++++++.++|+|||++......... ......++..|+
T Consensus 172 ~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 248 (343)
T cd05103 172 YKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 248 (343)
T ss_pred hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceE
Confidence 013467888899999999999999999 9999999999999999999999999998765322111 112233456799
Q ss_pred CccccccCCCCCcccchhHHHHHHHHHh-CCCcccCc
Q 027015 173 APEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 208 (229)
Q Consensus 173 aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~ 208 (229)
|||.+.+..++.++|+||||+++|++++ |..||...
T Consensus 249 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 9999988899999999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=230.89 Aligned_cols=197 Identities=27% Similarity=0.392 Sum_probs=161.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHH-HhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVAS-MANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ ....+|+.||+|.++... ......+..|+.. ++.+. ||||+++++++..++..++++||+
T Consensus 7 ~~ig~g~~g~v~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~--~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 7 EELGRGAYGVVDKM--RHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD--CPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred EEecccCCeEEEEE--EEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcC--CCCeeeeeEEEecCCcEEEEhhhh
Confidence 57999999999999 667789999999987552 2334455566665 45555 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+ ++|.+++.........+++..+..++.|++.+|++||+.. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 5 6888877544344567999999999999999999999742 899999999999999999999999999876533221
Q ss_pred cccccccCCccccCcccccc----CCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 160 HISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||..
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 122457788999998865 4568899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=240.18 Aligned_cols=198 Identities=26% Similarity=0.343 Sum_probs=174.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||.|+||.||-+ ....+|+-+|.|.+... .+..+.-.+.|..+++.++ .+.|+.+--.|+.....++|+..
T Consensus 191 RvlGkGGFGEV~ac--qvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~--s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 191 RVLGKGGFGEVCAC--QVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS--SPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred EEEecccccceeEE--EEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc--cCcEEEEeeeecCCCceEEEEEe
Confidence 56999999999998 66779999999998643 3444566788999999999 99999998889999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
|+||+|.-++.+ ..++.+++..+..++.+|+.||.+||+. +||+||+||+||++|+.|+++|+|+|+|..+.+..
T Consensus 267 MNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 267 MNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred ecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999888732 2346899999999999999999999999 99999999999999999999999999999886654
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ....||.+|||||++.+..|+.+.|.|||||++|+|+.|+.||.....
T Consensus 342 ~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 342 PI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred cc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 32 223799999999999998899999999999999999999999986543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=232.33 Aligned_cols=203 Identities=32% Similarity=0.421 Sum_probs=166.0
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.... ..++..+++|.+..... .....+.+|+..++.+. ||||+++++++.++...++++|
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--HPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC--CCchheEEEEEcCCCccEEEEe
Confidence 579999999999995422 23678999999875432 33466888999999999 9999999999999889999999
Q ss_pred ccCCCCHHHHHhhhh------------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC
Q 027015 78 YMPNNSLSQTLLGEE------------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~ 139 (229)
|+++++|.+++.... .....+++..+..++.|++.+|.+||+. +++|+||+|+||+++.
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~ 165 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGE 165 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecC
Confidence 999999999985321 1123578889999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 140 NFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 140 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
++.++|+|||.+........ ........+..|+|||...+..++.++|+||||+++|+|++ |..||....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999998875432211 11122234567999999998899999999999999999997 888986543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=231.12 Aligned_cols=197 Identities=24% Similarity=0.368 Sum_probs=165.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ +...+|+.|++|.++... ......+.+|++.+++++ ||||+++++++.++...+++|||+
T Consensus 6 ~~l~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 6 EKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred eeecCCCceEEEEE--EECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC--CCCCcchhhhcccCCcEEEEeecc
Confidence 57999999999999 667789999999987543 223357889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
. ++|.+++.. .....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 82 H-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred c-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 5 688888732 2345789999999999999999999999 999999999999999999999999999876533221
Q ss_pred cccccccCCccccCccccccCC-CCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||...+.. ++.++|+||||+++|++++|+.||..+.
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 112234577899999887644 6889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=230.46 Aligned_cols=200 Identities=25% Similarity=0.322 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~lv~ 76 (229)
+.||+|+||.||++ ....+++.+++|.+.... .....+.+|+..++.+. .|||++++++++... ...++|+
T Consensus 28 ~~l~~g~~~~vy~~--~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 28 ETIGKGTYGKVYKV--TNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLP-NHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred EEeecCCCeEEEEE--EECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhc-CCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 46899999999999 667789999999986432 23456778888888883 299999999998643 3578999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++.........+++..++.++.|++.+|++||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999999998854444556789999999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccccCCccccCccccccC-----CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
... ......++..|+|||.+... .++.++|+||+|+++|++++|+.||....
T Consensus 181 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 181 TRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred ccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 221 11234578889999987543 36889999999999999999999997653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=240.50 Aligned_cols=195 Identities=24% Similarity=0.322 Sum_probs=162.9
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
++.||+|+.++||++ ...+.+.+|+|.+... ......-+..|++.|.+|+ +|.+|+.++||-..++..|+||||
T Consensus 366 lk~iG~GGSSkV~kV---~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk-g~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKV---LNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLK-GHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred HHhhcCCCcceeeee---ecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc-CCceEEEEeeeeccCceEEEEeec
Confidence 478999999999998 3345567888877644 3334577999999999999 589999999999999999999996
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
- ..+|..++. +.....+...+..++.|++.++.++|+. ||||.||||.|+++- .|.+||+|||.|..+..+.
T Consensus 442 G-d~DL~kiL~---k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 442 G-DIDLNKILK---KKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred c-cccHHHHHH---hccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 5 778999983 3334444458889999999999999999 999999999999997 6799999999999887655
Q ss_pred cc-ccccccCCccccCccccccCC-----------CCCcccchhHHHHHHHHHhCCCcccC
Q 027015 159 TH-ISTRVAGTLGYLAPEYAISGR-----------LTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 159 ~~-~~~~~~~~~~~~aPE~~~~~~-----------~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.. ....-+||+.||+||.+.... .++++||||||||+|+|+.|+.||..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 44 334567999999999886432 46899999999999999999999974
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=225.51 Aligned_cols=197 Identities=26% Similarity=0.417 Sum_probs=168.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+++.+++|.+... .......+.+|++.++.++ |||++++++.+...+..++|+||+
T Consensus 6 ~~lg~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 6 RVVGRGAFGIVHLC--RRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS--HPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred EEecccCceEEEEE--EEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC--CCchhheeeeEecCCEEEEEEecC
Confidence 57999999999999 56668899999998754 2334567889999999999 999999999999899999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~~~~~ 158 (229)
++++|.+++... ....+++..+..++.+++.++++||++ |++|+||+|.||++++++ .++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999998421 234588999999999999999999999 999999999999998554 57999999988764332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....++..|+|||.+.+..++.++|+||+|+++|++++|+.||....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 1 223457888999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=230.53 Aligned_cols=199 Identities=25% Similarity=0.409 Sum_probs=166.3
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
++.||+|++|.||++ ++..+|+.|++|.++... ......+.+|+..++.++ ||||+++++++.+.+..++|+||+
T Consensus 5 ~~~l~~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 5 LEKLGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK--HENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred eeeeccCCceEEEEE--EECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc--CCCEeeeeeeEeeCCcEEEEEecC
Confidence 367999999999999 667789999999997553 233456778999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++ +|.+++... .....+++..+..++.|++.+|++||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~-~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTH-GVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhc-CCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 888877432 1235689999999999999999999999 999999999999999999999999999876533221
Q ss_pred cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||....
T Consensus 156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 122345778999998765 457889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=234.29 Aligned_cols=198 Identities=26% Similarity=0.398 Sum_probs=163.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchh--hHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (229)
+.||+|+||.||++ ....+|+.||+|.++...... .....+|+.+++.++ |+||+++++++.+. +..++|+|
T Consensus 13 ~~ig~g~~~~v~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 13 NRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR--HPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeeeecCCEEEEEE--EECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC--CCCCcceEEEEecCCCCeEEEEEe
Confidence 56999999999999 667789999999997553222 345668999999999 99999999998765 46799999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|++ ++|.+++. .....+++..+..++.|++.++++||+. |++|+||+|+||++++++.++|+|||.+......
T Consensus 89 ~~~-~~l~~~l~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 89 YCE-QDLASLLD---NMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred cCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 996 47888873 2346789999999999999999999999 9999999999999999999999999998776433
Q ss_pred CccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.. ......+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...+..
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 21 1122334678999998875 55789999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=226.72 Aligned_cols=198 Identities=30% Similarity=0.446 Sum_probs=172.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
..||+|++|.||++ .+..+++.+++|.+... .......+.+|++.++.++ |+||+++.+++.+....++|+||+
T Consensus 6 ~~i~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 6 KKLGKGSYGSVYKV--KRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN--HPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred eeecCCCceeEEEE--EECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC--CCCchhhhhhhccCCEEEEEehhc
Confidence 47899999999999 66778999999998754 2344567788999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++.........+++..+..++.|++.|+++||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 99999999855444457789999999999999999999999 99999999999999999999999999987664431
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||...+..++.++|+||||++++++++|+.||...+
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 122457788999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=224.64 Aligned_cols=194 Identities=29% Similarity=0.430 Sum_probs=168.9
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
||+|++|.||++ ....+++.+++|.+..... .....+..|+..++.++ ||||+++++.+..+...+++|||++
T Consensus 1 lg~G~~~~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLV--RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--HPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEE--EECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC--CCcHHHHHHHeecCCeeEEEEecCC
Confidence 799999999999 5566789999999875432 24467888999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++ .....+++..+..++.|+++++.++|+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 ~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~- 148 (250)
T cd05123 77 GGELFSHL----SKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS- 148 (250)
T ss_pred CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence 99999998 4445789999999999999999999999 999999999999999999999999999876543321
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......++..|+|||...+..++.++|+||||+++|++++|+.||....
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1233457788999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=242.02 Aligned_cols=214 Identities=26% Similarity=0.401 Sum_probs=187.9
Q ss_pred CccCCcccccccccceEeccCCc--EEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|-||.||++.++..+.|+ -||||..+.+ ...+.+.++.|+.+++.++ ||||+++++++.+.. .+||||.
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd--HphIikLIGv~~e~P-~WivmEL 471 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD--HPHIIKLIGVCVEQP-MWIVMEL 471 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC--Ccchhheeeeeeccc-eeEEEec
Confidence 47999999999999988775555 4889998865 4555688999999999999 999999999998775 7999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++-|.|..++. .+...++...+.-+++|++.+|+|||+. ..+||||-..||+|....-+||+|||+++.+....
T Consensus 472 ~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 472 APLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999993 5667899999999999999999999999 99999999999999999999999999999887766
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchhhhcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSIN 224 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 224 (229)
....+...-+..|||||.+.-..++.++|||.+|+.+||++. |..||.+-.+.+..-.++..++..
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP 612 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP 612 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC
Confidence 555555556778999999999999999999999999999885 999999988777777777766643
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=225.09 Aligned_cols=196 Identities=29% Similarity=0.432 Sum_probs=172.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ +...+++.+++|.+..... .....+.+|++.++.++ ||+++++.+++.+++..++++||+
T Consensus 6 ~~l~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 6 DLIGRGAFGVVYKG--LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--HPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred eEEcccCCeEEEEE--EEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC--CCCccEEEEEEEeCCEEEEEEecC
Confidence 57999999999999 6677889999999976543 45577899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++ .....+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998 4447899999999999999999999999 999999999999999999999999999887644332
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....++..|+|||...+..++.++|+||+|++++++++|+.||....
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 233457888999999888888999999999999999999999997543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=230.90 Aligned_cols=202 Identities=27% Similarity=0.443 Sum_probs=163.1
Q ss_pred CccCCcccccccccceEec----------cC--CcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRL----------QD--GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCID 68 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~----------~~--~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~ 68 (229)
+.||+|+||.||++..... .+ ...||+|.++... ......+.+|++.++.++ |||++++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~ 88 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK--NPNIIRLLGVCVS 88 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCcCeEEEEEcC
Confidence 5799999999999854221 11 2358999987553 333457889999999999 9999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHhhhhc--------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC
Q 027015 69 GPCRILVYDYMPNNSLSQTLLGEEK--------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140 (229)
Q Consensus 69 ~~~~~lv~e~~~~~sL~~~~~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~ 140 (229)
.+..++||||+++++|.+++..... ....+++..+..++.|++.|+++||+. |++|+||+|+||+++.+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~ 165 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNH 165 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCC
Confidence 9999999999999999999843211 113478889999999999999999999 99999999999999999
Q ss_pred CceEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh--CCCcccCc
Q 027015 141 FNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFD 208 (229)
Q Consensus 141 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~--g~~pf~~~ 208 (229)
+.++|+|||.+........ .......++..|+|||...+..++.++|+||||+++++|++ |..||...
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999876432211 11122334678999999988889999999999999999998 66788754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=230.07 Aligned_cols=199 Identities=30% Similarity=0.481 Sum_probs=166.7
Q ss_pred CccCCcccccccccceE--eccCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~ 76 (229)
+.||+|+||.||++... +..+++.+|+|.++..... ..+.+.+|++.++.+. ||||+++++++.. ....+++|
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~--~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD--HENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC--CCChheEEeeeecCCCCceEEEE
Confidence 57999999999999543 2345789999999865443 4678999999999998 9999999999877 55789999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++. .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 88 e~~~~~~l~~~l~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 88 EYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ecCCCCCHHHHHH---hCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999983 2233689999999999999999999999 999999999999999999999999999887643
Q ss_pred CCccc--cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 NTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..... .....++..|+|||...+..++.++|+||||++++++++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 22111 11223455699999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=228.91 Aligned_cols=204 Identities=23% Similarity=0.325 Sum_probs=165.9
Q ss_pred CccCCcccccccccceEecc--CCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEc-CCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ--DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-~~~~~lv~e 77 (229)
..||+|+||.||++.+.... ++..|++|.+... .......+.+|+..++.++ ||||+++++++.. +...+++++
T Consensus 12 ~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS--HQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred eeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEecCCCCCEEEEE
Confidence 46899999999999543311 3688999988744 3334567889999999998 9999999998765 467789999
Q ss_pred ccCCCCHHHHHhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 78 YMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
|+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999998443211 15689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 154 FPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
+...... ......++..|+|||.+.+..++.++|+||||+++|++++ |+.||....+
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 225 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence 5332211 1122335667999999988889999999999999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=229.39 Aligned_cols=197 Identities=26% Similarity=0.389 Sum_probs=166.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (229)
+.||+|++|.||++ ....+|+.+++|.+.... ......+.+|++.++.++ |||++++++++.+. +..++|+|
T Consensus 5 ~~l~~g~~~~vy~~--~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 5 AQIGEGTYGQVYKA--RNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR--HPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred EEeccCCCeEEEEE--EECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc--CCCeeeheeeEecCCCCcEEEEec
Confidence 57999999999999 666788999999998653 334467888999999999 99999999999887 78999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++ +|.+++. .....+++..++.++.|++.||++||+. |++|+||+|.||++++++.++|+|||.+......
T Consensus 81 ~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLD---SPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9964 8888872 2236799999999999999999999999 9999999999999999999999999998776443
Q ss_pred CccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.........++..|+|||.+.+ ..++.++|+||||+++|++++|+.||....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3212223345778999997765 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=226.87 Aligned_cols=198 Identities=23% Similarity=0.379 Sum_probs=165.7
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeeccc----------chhhHHHHHHHHHHhh-hccCCCcccccceEEEcC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVES----------KQGEKEFMSEVASMAN-VNVCHENLVKLHGGCIDG 69 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~~~~-l~~~~~~i~~~~~~~~~~ 69 (229)
+.||+|+||.||++ .... +++.+++|.+.... ......+..|+..+.. ++ ||||+++++++..+
T Consensus 6 ~~ig~G~~~~v~~~--~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~--h~~i~~~~~~~~~~ 81 (269)
T cd08528 6 EHLGSGAFGCVYKV--RKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR--HPNIVRYYKTFLEN 81 (269)
T ss_pred hhhcCCCCceEEEE--EEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCC--CCCeeeEEeeEccC
Confidence 57999999999999 4444 57899999886431 1223456667777764 56 99999999999999
Q ss_pred CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 027015 70 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDF 148 (229)
Q Consensus 70 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~df 148 (229)
+..++++||+++++|.+++.........+++..++.++.|++.++.+||+ . +++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999885444455679999999999999999999996 5 8999999999999999999999999
Q ss_pred ccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 149 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
|.+....... ......++..|+|||...+..++.++|+||||+++|++++|+.||...
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9987654332 223456788899999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=230.03 Aligned_cols=196 Identities=23% Similarity=0.343 Sum_probs=164.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch--hhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (229)
..||+|++|.||++ ....+++.+++|.++..... ....+.+|++.++.++ ||||+++++++... ...++++|
T Consensus 11 ~~lg~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 11 NRIEEGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ--HPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhcCCCCeEEEEE--EECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC--CCCEEEEEEEEEecCCCcEEEEeh
Confidence 57999999999999 56678899999999754322 2245678999999999 99999999998877 78999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|++ ++|.+++. .....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 ~~~-~~L~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 87 YVE-HDLKSLME---TMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hcC-cCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 996 48988873 2234689999999999999999999999 9999999999999999999999999998766443
Q ss_pred CccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.. ......+++.|+|||.+.+. .++.++|+||+|++++++++|+.||....
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11233467889999988754 46899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=228.97 Aligned_cols=198 Identities=26% Similarity=0.361 Sum_probs=163.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc------CCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------GPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~------~~~~~lv 75 (229)
..||+|+||.||++ ....+++.+++|.+.... .....+..|+..++.+. .||||+++++++.. ....+++
T Consensus 22 ~~lg~g~~~~v~~~--~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 22 EVVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYS-HHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred eeeccCCCeEEEEE--EEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhc-CCCcEEEEeeehhcccccCCCCEEEEE
Confidence 46899999999999 666788999999986543 23356778888888884 29999999999853 3567899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||+++++|.+++.. .....+++..+..++.|++++++|||+. |++|+|++|+||++++++.++|+|||.+....
T Consensus 98 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 98 MEFCGAGSVTDLVKN--TKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEeCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 999999999998842 2234578888999999999999999999 99999999999999999999999999987553
Q ss_pred CCCccccccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... ......+++.|+|||.+. ...++.++|+||||+++|+|++|..||....
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 173 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred cccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 2221 223356788999999876 3457889999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=244.26 Aligned_cols=213 Identities=25% Similarity=0.376 Sum_probs=178.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
++.||-|+||+|.++ ....+...||.|.+... .......+..|-.+|.... .+-|+++|-.|.++..+|+||+
T Consensus 634 ik~iGvGAFGeV~Lv--~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD--n~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLV--RKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD--NEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred EeeecccccceeEEE--eecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC--CcceEEEEEEeccCCceEEEEe
Confidence 378999999999999 77778899999998644 2334466778899999888 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC--
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-- 155 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~-- 155 (229)
|++||++-.++ -+.+-+.+..++.++..++.|+.++|.. |+|||||||+||++|.+|++||.|||+|.-+.
T Consensus 710 YIPGGDmMSLL----IrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLL----IRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHH----HHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999988 4667888999999999999999999999 99999999999999999999999999985431
Q ss_pred ---------CCCcc------------------------------ccccccCCccccCccccccCCCCCcccchhHHHHHH
Q 027015 156 ---------ENTTH------------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196 (229)
Q Consensus 156 ---------~~~~~------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 196 (229)
++... ..-...||+.|.|||++....++...|.||.|+|+|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 001134899999999999999999999999999999
Q ss_pred HHHhCCCcccCccccc-cccchhhhcccc
Q 027015 197 EIVSGRTAVDFDVQLG-EYHLVDKVRSIN 224 (229)
Q Consensus 197 ~l~~g~~pf~~~~~~~-~~~~~~~~~~~~ 224 (229)
+|+.|+.||-.+.+.+ .+.++.|-..++
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~ 891 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLH 891 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccc
Confidence 9999999998877644 455555544433
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=224.44 Aligned_cols=197 Identities=28% Similarity=0.404 Sum_probs=172.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (229)
+.||+|++|.||++ ....+++.+++|.+..... ...+.+.+|++.+++++ ||||+++++.+.+. ...++++|
T Consensus 6 ~~i~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 6 ELLGRGSFGSVYLA--LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ--HPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred eEeeecCceEEEEE--EECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC--CCCEeeEEEEEecCCCCeEEEEEE
Confidence 46899999999999 6666899999999976542 45678889999999999 99999999999988 78899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..+..++.|++.++.+||+. +++|+|++|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~~L~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 82 YVSGGSLSSLL----KKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred ecCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999998 3444899999999999999999999999 9999999999999999999999999998876544
Q ss_pred Ccc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
... ......++..|.|||...+...+.++|+||||++++++++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 1233457888999999988889999999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=236.87 Aligned_cols=205 Identities=25% Similarity=0.321 Sum_probs=173.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+..||.|+||+|-++ .+..+.+.+|||+++.+. ..+.+--+.|.++|.... +-|.++.+..+|+.-.+.|+|||
T Consensus 354 l~VlGKGSFGKVlLa--erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~-kppFL~qlHScFQTmDRLyFVME 430 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLA--ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFLVQLHSCFQTMDRLYFVME 430 (683)
T ss_pred EEEeccCccceeeee--cccCcchhhhhhhhccceeeecCcccceehhhhheecCC-CCchHHHHHHHhhhhhheeeEEE
Confidence 357999999999999 666677899999998652 223334455666666554 36789999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+.||.|-..+ +.-+.+.+..+..++..|+-+|-+||++ ||++||+|.+|++++.+|++||.|||.+..---.
T Consensus 431 yvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 431 YVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999998 6667888888889999999999999999 9999999999999999999999999998752111
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 216 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~ 216 (229)
.....+++|||.|.|||++...+|+.+.|.||+|+++||++.|++||++.+..+-++.
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a 561 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA 561 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 2233568999999999999999999999999999999999999999999876655543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=228.27 Aligned_cols=197 Identities=25% Similarity=0.368 Sum_probs=164.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||.|++|.||++ ....+|+.|++|.+.... ......+.+|++.++.++ ||+++++++++.+.+..++++||+
T Consensus 5 ~~l~~g~~~~vy~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 5 EKIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN--HPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred eEecCCCCeEEEEE--EEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC--CCCccCHhheeccCCeEEEEEecc
Confidence 57999999999999 666789999999987553 223356788999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+ ++|.+++... ....+++..+..++.|++.+|++||+. +++|+|++|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 6899888321 114689999999999999999999999 999999999999999999999999999875432211
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1222457789999987654 57899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=224.54 Aligned_cols=191 Identities=29% Similarity=0.460 Sum_probs=160.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE-cCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~-~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++.. .|..+++|.++... ..+.+.+|+..++.++ |++++++++++. .++..++++||++
T Consensus 12 ~~lg~g~~~~v~~~~~----~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 12 QTIGKGEFGDVMLGDY----RGNKVAVKCIKNDA--TAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred eeecccCCCeEEEEEE----cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCC--CCCeeeEEEEEEcCCCceEEEEECCC
Confidence 5799999999999832 47889999986332 3457889999999999 999999999754 5567899999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++... ....+++..+..++.|++.+|++||+. |++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999998421 233588999999999999999999999 99999999999999999999999999887543221
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.....+..|+|||...+..++.++|+||||+++|++++ |+.||....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 22234567999999988889999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=230.15 Aligned_cols=191 Identities=27% Similarity=0.398 Sum_probs=162.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
..||+|+||.||++ ....+|+.|++|.+.... ....+.+.+|++.++.++ ||||+++.+++.+....++|+||
T Consensus 21 ~~lg~g~~g~vy~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 21 REIGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR--HPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred eeecCCCCeEEEEE--EEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEEeCCeEEEEHHh
Confidence 57999999999999 666789999999986432 233456889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++ +++.+.+. .....+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 97 ~~-g~l~~~~~---~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 97 CL-GSASDILE---VHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred hC-CCHHHHHH---HcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 96 56777662 3345689999999999999999999999 9999999999999999999999999988654222
Q ss_pred ccccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
....++..|+|||.+. ...++.++|+||+|+++|++++|+.||...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 2345778899999874 356888999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=229.59 Aligned_cols=198 Identities=26% Similarity=0.402 Sum_probs=170.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|++|.||++ ....+|+.+++|++... .......+.+|.++++.+. .||||+++++++.++...+++||+
T Consensus 7 ~~lg~g~~~~vy~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 7 KIIGEGSFSTVVLA--KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-GHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eeecCCCceEEEEE--EEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-cCCCchhHHHHhcCCceEEEEEcC
Confidence 57999999999999 66678999999998643 2233466788889988886 599999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++++|.+||+. |++|+|++|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~l----~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 84 APNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999998 4455899999999999999999999999 99999999999999999999999999987654332
Q ss_pred c-------------------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 T-------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .......++..|+|||......++.++|+||||++++++++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 11223456788999999888889999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=227.84 Aligned_cols=201 Identities=24% Similarity=0.319 Sum_probs=166.7
Q ss_pred CccCCcccccccccceEeccC--CcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEc-CCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD--GTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-~~~~~lv~ 76 (229)
+.||+|.+|.||+|.-.+..+ .+.+|+|.++.+. +.......+|+..++.++ |||++.+..+|.. +...++++
T Consensus 30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~--h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK--HPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred ceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc--CCcchhHHHHHhccCceEEEEe
Confidence 679999999999994333333 3379999997553 233467889999999999 9999999998876 67889999
Q ss_pred EccCCCCHHHHHhh-hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC----CceEEeccccc
Q 027015 77 DYMPNNSLSQTLLG-EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN----FNPKISDFGLS 151 (229)
Q Consensus 77 e~~~~~sL~~~~~~-~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~----~~~~l~dfg~~ 151 (229)
||.+. +|...+.. ..+....++...+..++.||+.+++|||++ -++|||+||.||++..+ |.+||+|+|++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99965 56666643 445557899999999999999999999999 89999999999999876 89999999999
Q ss_pred cccCCCCccc--cccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 152 KLFPENTTHI--STRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
+.+....... .....-|..|.|||++.| ..||.+.|+|++|||+.||++-++.|.+.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9876543221 233556889999999886 46999999999999999999999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=228.81 Aligned_cols=200 Identities=23% Similarity=0.286 Sum_probs=163.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc-----eEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-----RIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~-----~~l 74 (229)
+.||+|+||.||++ ....+|+.||+|.++.... .....+.+|+.+++.+. .||||+++++++..... .++
T Consensus 7 ~~lg~g~~g~vy~~--~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 7 EKIGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEecccCCeEEEEE--EECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc-CCCCccceeeeEeecCCCCCceEEE
Confidence 46899999999999 6677899999999875432 23356788999999996 26999999999876655 799
Q ss_pred EEEccCCCCHHHHHhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-CCceEEecccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKR-RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSK 152 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~ 152 (229)
+|||+++ +|.+++...... ...+++..+..++.|++.+|.|||+. |++|+||+|+||+++. ++.++|+|||.+.
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 9999975 788887443222 45689999999999999999999999 9999999999999998 8899999999987
Q ss_pred ccCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||....
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 160 AFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred ecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 65332111 122345778999998765 557899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=235.25 Aligned_cols=195 Identities=26% Similarity=0.372 Sum_probs=164.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~l 74 (229)
+.||+|+||+||++ ++..+++.||+|.+... .......+.+|+..++.++ ||||+++++++... ...++
T Consensus 11 ~~lg~G~~~~vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 11 KPIGRGAYGIVCSA--KNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD--HENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred EEeccCCCeEEEEE--EecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC--CCCccchHHheecccccccCcEEE
Confidence 57999999999999 67788999999998743 2334456778999999998 99999999988654 24799
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
++||+. ++|.+++ .....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 87 v~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 87 VYELMD-TDLHQII----RSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEeCCC-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 999995 6888887 4556799999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 3321 12233456888999998764 568899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=233.45 Aligned_cols=197 Identities=26% Similarity=0.378 Sum_probs=164.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchh--------------hHHHHHHHHHHhhhccCCCcccccceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQG--------------EKEFMSEVASMANVNVCHENLVKLHGGCI 67 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~~~~l~~~~~~i~~~~~~~~ 67 (229)
+.||+|+||+||++ .+..+++.||+|.++...... ...+.+|++.++.++ ||||+++++++.
T Consensus 15 ~~ig~G~~g~vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 90 (335)
T PTZ00024 15 AHLGEGTYGKVEKA--YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK--HENIMGLVDVYV 90 (335)
T ss_pred hcccCCCceeEEEE--EECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC--CcceeeeeEEEe
Confidence 45999999999999 666789999999986542221 124778999999999 999999999999
Q ss_pred cCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 027015 68 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 147 (229)
Q Consensus 68 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~d 147 (229)
.....+++|||++ ++|.+++ .....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 91 EGDFINLVMDIMA-SDLKKVV----DRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred cCCcEEEEEeccc-cCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence 9999999999996 5888888 4556789999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC-------------ccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 148 FGLSKLFPENT-------------THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 148 fg~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
||.+....... ........+++.|+|||.+.+. .++.++|+||||+++|++++|+.||.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99987654110 0111223457789999988764 468999999999999999999999986653
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=230.83 Aligned_cols=198 Identities=25% Similarity=0.367 Sum_probs=161.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCC--------c
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--------C 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--------~ 71 (229)
+.||+|+||.||++ ....+++.||+|.+..... .......+|++.++.++ ||+|+++++++.... .
T Consensus 18 ~~lg~g~~~~v~~~--~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 18 AKIGQGTFGEVFKA--RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred EEeecCCCEEEEEE--EECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC--CCCccceEEEEecccccccCCCce
Confidence 57999999999999 6677899999999865422 22345678999999999 999999999886543 4
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
.++|+||+. ++|.+.+. .....+++..+..++.|+++||.+||+. |++|+||+|+||+++.++.++|+|||.+
T Consensus 94 ~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEEEcCCC-cCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 489999995 57877772 3344789999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCcc---ccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 152 KLFPENTTH---ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......... ......++..|+|||...+. .++.++|+||+|+++|+|++|+.||.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 765332211 11234467789999987654 468899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=224.55 Aligned_cols=198 Identities=24% Similarity=0.389 Sum_probs=168.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ ....+|..+++|.+.... ......+.+|+++++.++ |+||+++++.+.++...++++||+
T Consensus 6 ~~l~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 6 KKIGEGSFGKIYLA--KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK--HPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred EEecCCCcceEEEE--EEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC--CCChhhhhheeccCCeEEEEEecC
Confidence 57999999999999 667789999999987542 234457789999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc-eEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-PKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~-~~l~dfg~~~~~~~~~ 158 (229)
++++|.+++... ....+++..+..++.|+++++.+||+. +++|+|++|+||++++++. ++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999988321 233578999999999999999999999 9999999999999987764 6999999887654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|+|||...+..++.++|+||+|++++++++|+.||....
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 2223457888999999888889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=229.85 Aligned_cols=191 Identities=26% Similarity=0.403 Sum_probs=162.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ +...+|..+++|.+.... ......+.+|++.++.++ |||++++++++.++...++||||
T Consensus 31 ~~lg~G~~~~v~~~--~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 31 REIGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK--HPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred heeccCCCeEEEEE--EEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC--CCCEEEEEEEEeeCCeEEEEEeC
Confidence 57999999999999 666788999999987432 233457888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++ +|.+.+. .....+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 107 ~~g-~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 107 CLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCC-CHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 965 7777662 3356689999999999999999999999 999999999999999999999999998765322
Q ss_pred ccccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.....+++.|+|||.+. ...++.++|+||+|+++|+|++|+.||...
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 22345788899999874 456889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=228.37 Aligned_cols=199 Identities=29% Similarity=0.373 Sum_probs=166.1
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeeccc----chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|++|.||++.... ..+++.||+|.++... ......+.+|+++++.+. .||+|+++++.+..+...++||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-RCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc-CCcchhhhheeeecCCEEEEEE
Confidence 569999999999985433 3467899999987432 223356778999999994 3999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++ .....+++..+..++.|++++|.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~~----~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 85 DYVNGGELFTHL----YQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred ecCCCCcHHHHH----hhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999988 3445788999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccCCccccCccccccCC--CCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..........++..|+|||...+.. .+.++|+||||+++|++++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 3222223345788999999887654 788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=228.34 Aligned_cols=197 Identities=24% Similarity=0.342 Sum_probs=168.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+|+.+++|.++.... .....+.+|++.++.++ |++|+++++++.++...++++||+
T Consensus 5 ~~i~~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 5 GKIGEGTYGVVYKA--RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN--HPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred eeeecCCCceEEEE--EcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc--CCCcchHHHhhccCCCEEEEEecc
Confidence 57999999999999 6677899999999875432 24567888999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++ +|.+++. .....+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIK---DRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHH---hhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 65 8888773 2336889999999999999999999999 999999999999999999999999999877644331
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......++..|+|||...+. .++.++|+||||+++|++++|+.||...+.
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11224467789999988876 789999999999999999999999976553
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=227.19 Aligned_cols=196 Identities=22% Similarity=0.291 Sum_probs=161.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.+|+|.++... ........+|+..+.++. .|||++++++++.++ +..++|+||
T Consensus 5 ~~lg~g~~~~v~~~--~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 5 GKIGEGTFSEVLKA--QSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS-PHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred eeccccccceEEEE--EEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC-CCCCccceEEEEecCCCCcEEEEEec
Confidence 57999999999999 667789999999987542 222334557888888774 399999999999887 888999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++ ++|.+.+. .....+++..+..++.|++.||++||+. |++|+||+|+||+++. +.++|+|||.+.......
T Consensus 82 ~~-~~l~~~l~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 82 MD-MNLYELIK---GRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred CC-ccHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 96 57777772 2345789999999999999999999999 9999999999999998 999999999987654332
Q ss_pred ccccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. .....++..|+|||... +..++.++|+||+|+++|+|++|+.||...+.
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 2 12345788899999765 45578899999999999999999999986543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=229.99 Aligned_cols=197 Identities=27% Similarity=0.397 Sum_probs=162.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC---------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--------- 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--------- 70 (229)
+.||+|+||.||++ ....+|+.|++|.++... ......+.+|+++++.++ ||||+++++++.+..
T Consensus 13 ~~lg~g~~g~v~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 13 GQIGEGTYGQVYKA--RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN--HRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred eeecccCCEEEEEE--EECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC--CCCeeeeeheecCcchhhhccccC
Confidence 57899999999999 666788999999997543 233356778999999999 999999999887544
Q ss_pred -ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 027015 71 -CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 149 (229)
Q Consensus 71 -~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg 149 (229)
..++++||+++ ++...+. .....+++..+..++.|++.||++||+. |++|+||+|+||++++++.++|+|||
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLE---SGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred CcEEEEEcccCc-cHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999976 6666662 3345789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 150 LSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.+...............++..|+|||.+.+ ..++.++|+||||++++++++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 987654332212222345678999998765 457899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=222.95 Aligned_cols=191 Identities=28% Similarity=0.419 Sum_probs=160.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++. .+++.+++|.++... ....+.+|+..++.++ |||++++++++..+. .+++|||+++
T Consensus 12 ~~lg~g~~g~v~~~~----~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~-~~~v~e~~~~ 82 (254)
T cd05083 12 EIIGEGEFGAVLQGE----YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLH--HKNLVRLLGVILHNG-LYIVMELMSK 82 (254)
T ss_pred eeeccCCCCceEecc----cCCCceEEEeecCcc--hHHHHHHHHHHHHhCC--CCCcCeEEEEEcCCC-cEEEEECCCC
Confidence 569999999999883 367899999986432 3357888999999999 999999999987654 6899999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.++.+||+. |++|+|++|+||+++.++.++|+|||.+.......
T Consensus 83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999998432 234688999999999999999999999 99999999999999999999999999886542211
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 12233567999999988889999999999999999997 9999986543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=228.05 Aligned_cols=192 Identities=27% Similarity=0.386 Sum_probs=163.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ +...+|+.+++|.+.... ....+.+.+|++.++.++ |||++++.+++.+....+++|||
T Consensus 27 ~~lg~g~~g~v~~~--~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 27 HEIGHGSFGAVYFA--TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK--HPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred eeeccCCCeEEEEE--EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC--CCCCccEEEEEEeCCEEEEEEec
Confidence 56999999999999 667789999999987542 233456888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+. +++.+.+. .....+++..+..++.|++.++.+||+. |++|+|++|+||+++.++.++|+|||.+.....
T Consensus 103 ~~-~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 57777662 3345789999999999999999999999 999999999999999999999999998754321
Q ss_pred ccccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....++..|+|||.+. ...++.++|+||||+++|++++|+.||....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22346788899999874 3567889999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=232.66 Aligned_cols=194 Identities=27% Similarity=0.368 Sum_probs=161.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~lv 75 (229)
+.||+|++|.||++ ++..+|+.||+|.++.. .......+.+|+..++.++ ||||+++++++... ...+++
T Consensus 11 ~~lg~G~~g~vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 11 SYIGEGAYGMVCSA--THKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK--HENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred EEEEecCCeEEEEE--EEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC--CCCcCchhheeecccccccceEEEE
Confidence 46999999999999 66788999999998643 2334466788999999999 99999999987643 347899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
+||++ ++|.+.+ ....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 87 ~e~~~-~~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 87 QELME-TDLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ehhcc-cCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 99995 5777766 345689999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCcc--ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 156 ENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 156 ~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..... ......+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32211 1233467889999998654 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=209.81 Aligned_cols=198 Identities=25% Similarity=0.341 Sum_probs=169.3
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
-||+|++|.|-+. ++..+|+..|+|.+... ......+.++|+.+..+.. ..|+++.+++.....+..++.||.+ .
T Consensus 53 elGrGayG~vekm--rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~-~CPf~V~FyGa~~regdvwIcME~M-~ 128 (282)
T KOG0984|consen 53 ELGRGAYGVVEKM--RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTV-DCPFTVHFYGALFREGDVWICMELM-D 128 (282)
T ss_pred hhcCCccchhhhe--eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCC-CCCeEEEeehhhhccccEEEeHHHh-h
Confidence 4899999999888 78899999999999765 3445567888888877665 4899999999999999999999988 7
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
.||..+...--......++..+-.++..+..||.|||++. .++|||+||.||+++.+|++|+||||.+-.+.++...
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk- 205 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK- 205 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-
Confidence 7888877655577888999999999999999999999986 8999999999999999999999999998766554332
Q ss_pred cccccCCccccCcccccc----CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 162 STRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
+.-.|.-.|+|||.+.. ..|+.++|+||||+++.||.+++.||+.-
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 22356778999998873 46899999999999999999999999864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=233.19 Aligned_cols=197 Identities=27% Similarity=0.356 Sum_probs=168.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-----ceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----CRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-----~~~l 74 (229)
+.||+|++|.||++ +...+|+.+++|.+.... ....+.+.+|++.++.++ ||||+++.+++.... ..++
T Consensus 6 ~~ig~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 6 KPIGSGAYGVVCSA--VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR--HENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred eeecCCCCeEEEEE--EeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC--CcchhhhhhhhcccCcccccceEE
Confidence 57999999999999 666778999999987543 444578899999999999 999999999987764 7899
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
+|||++ ++|.+++ .....+++..+..++.+++.+|++||+. |++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 v~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVI----KSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999996 5788887 4455899999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCCc--cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... .......++..|+|||.+.+. .++.++|+||||+++|++++|+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 44321 112334567889999999877 789999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=227.42 Aligned_cols=197 Identities=24% Similarity=0.350 Sum_probs=161.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ ....+|+.|++|.+..... .....+.+|++.++.++ ||||+++++++.++...++|+||+
T Consensus 8 ~~l~~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 8 EKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--HGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred EEecCCCCEEEEEE--EecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc--CCCEeeEEEEEecCCeEEEEEecc
Confidence 46899999999999 6667899999999865422 23356788999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-CCceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~~~~~~~ 158 (229)
+ ++|.+.+.. .....+++..+..++.|++.||++||+. +++|+||+|+||+++. ++.++|+|||.+.......
T Consensus 84 ~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 5 577777622 1233467888999999999999999999 9999999999999985 5579999999987653322
Q ss_pred ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1122346788999998775 457899999999999999999999997654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=226.27 Aligned_cols=199 Identities=27% Similarity=0.373 Sum_probs=162.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ .+..+|+.+|+|.+.... ......+.+|+..+.++. .||||+++++++...+..+++||+++
T Consensus 10 ~~lg~G~~g~vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 10 GEIGRGAFGTVNKM--LHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHhCCCCceEEEEE--EECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-CCCCEeeeeeEEecCCcEEEEEeccc
Confidence 46999999999998 667789999999987543 334567888998888874 39999999999998889999999984
Q ss_pred CCCHHHHHhh-hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLG-EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~-~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
.++.++... .......+++..+..++.+++.||+|||+.. +++|+||+|+||+++.++.++|+|||++........
T Consensus 87 -~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 -ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 566554421 1223467999999999999999999999631 899999999999999999999999999876533221
Q ss_pred cccccccCCccccCccccccC---CCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 HISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.....++..|+|||.+.+. .++.++|+||+|+++|++++|+.||...
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 1223578889999998765 6889999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=232.49 Aligned_cols=196 Identities=25% Similarity=0.352 Sum_probs=164.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEc----CCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----~~~~~lv 75 (229)
..||+|++|.||++ +...+|+.|++|.+.... ......+.+|+.+++.++ ||||+++.+++.. ....++|
T Consensus 11 ~~lg~g~~g~v~~~--~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 11 ENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK--HDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeecCCCeEEEEE--EEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC--CCCccCHHHhccccCCCCceEEEE
Confidence 46899999999999 777889999999987542 233466788999999999 9999999998763 3467899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
+||+. ++|.+++ .....+++..+..++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 87 ~e~~~-~~l~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 87 MDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred Eehhh-hhHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99995 6888887 4556699999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCc---cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTT---HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 3221 11233467889999998765 458899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=230.68 Aligned_cols=199 Identities=31% Similarity=0.448 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhh-------HHHHHHHHHHhhhccCCCcccccceEEE-cCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGE-------KEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~e~~~~~~l~~~~~~i~~~~~~~~-~~~~~~ 73 (229)
..||+|+|+.||+| .++..++.||+|+-..+..+.. +...+|..+-+.|. ||.|+++|++|. +.+.+|
T Consensus 469 hLLGrGGFSEVyKA--FDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD--HpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKA--FDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD--HPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHhccccHHHHHHh--cccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC--cceeeeeeeeeeeccccce
Confidence 46899999999999 8888999999999765432221 45678999999999 999999999996 566788
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc---CCCceEEecccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGL 150 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~---~~~~~~l~dfg~ 150 (229)
-|+|||+|-+|.=++ ...+.+++.+++.|+.||+.||.||... ++.|||-|+||.||++. .-|.+||.|||+
T Consensus 545 TVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 999999999999888 7778999999999999999999999987 78999999999999995 346799999999
Q ss_pred ccccCCCCcc------ccccccCCccccCccccccC----CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 151 SKLFPENTTH------ISTRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 151 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
+..+...... .....+||-+|+|||.+.-. .++.+.||||+|+|+|+++.|+.||+.+-
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 9987543221 23457799999999977632 36789999999999999999999998653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=223.76 Aligned_cols=194 Identities=23% Similarity=0.312 Sum_probs=162.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC----CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~----~~~~lv~e 77 (229)
..||-|-.|+|-.+ .+..+|+++|+|++. +.....+|++.--... .||||+.++++|++. ....+|||
T Consensus 68 qvLG~GinGkV~~C--~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s-~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 68 QVLGAGINGKVVQC--VHKRTQEKFALKVLL-----DSPKARREVELHWMAS-GHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhccccCCceEEE--EeccchhhhHHHHHh-----cCHHHHhHhhhhhhhc-CCCceEEeehhhhhhccCceeeEeeee
Confidence 35899999999988 788899999999986 2345567777655555 499999999998754 34569999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEecccccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 154 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~~~~ 154 (229)
.++||.|++.+. ......+++.++.+|+.||..|++|||+. +|.|||+||+|++.+. |..+||+|||+++..
T Consensus 140 ~meGGeLfsriq--~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 140 CMEGGELFSRIQ--DRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred cccchHHHHHHH--HcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999983 22334699999999999999999999999 9999999999999963 456899999999875
Q ss_pred CCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..+ .....++-||.|.|||++....|+...|+||+|+++|-|++|.+||-....
T Consensus 215 ~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 215 QEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred CCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 432 234556789999999999988999999999999999999999999986543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=229.51 Aligned_cols=198 Identities=24% Similarity=0.308 Sum_probs=161.6
Q ss_pred ccCCc--ccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 3 SVGPI--RLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 3 ~lg~G--~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
.||.| +||+||++ .+..+|+.||+|...... ....+.+.+|+.+++.++ ||||+++++++..+...++++||
T Consensus 5 ~ig~g~~~~~~v~~a--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 5 EIGRGFCNLTSVYLA--RHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR--HPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HhCCcccCceeEEEE--EEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcceEeeeEecCCceEEEEec
Confidence 35666 88999999 677889999999987543 233467888999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+.+++|.+++... ....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++++||+.+.......
T Consensus 81 ~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 81 MAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred ccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 9999999988432 234588999999999999999999999 99999999999999999999999997654322111
Q ss_pred cc------ccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 TH------ISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~------~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.. ......++..|+|||++.+ ..++.++|+||+|+++|++++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 00 0111224567999999876 347899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=223.13 Aligned_cols=204 Identities=25% Similarity=0.368 Sum_probs=164.3
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ce
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~ 72 (229)
+.||+|+||.||++.... ..+++.+|+|.+..+ .....+.+.+|++.++.++ ||||+++++++.... ..
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD--HPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC--CCCcceEEEEEccCCCCCcccce
Confidence 579999999999995432 345789999998754 2334567888999999999 999999999886532 23
Q ss_pred EEEEEccCCCCHHHHHhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
+++++|+++++|.+++.... .....++...+..++.|++.+++|||+. |++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 68899999999998874321 2234578899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 151 SKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
+......... ......+++.|++||......++.++|+||||+++|++++ |+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence 8765332211 1122334567999999988889999999999999999998 8999976544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=224.78 Aligned_cols=217 Identities=23% Similarity=0.330 Sum_probs=176.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
++.||.|+||+|++- .+.++|+..|||.++.... .+++++..|.+...+.. ..|||+++|+.....+..++.||.+
T Consensus 69 lg~iG~G~fG~V~KM--~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKM--LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-NCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHhcCCcchhhhhh--hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-CCcHHHHHhhhhhcCCceeeeHHHH
Confidence 357999999999999 7889999999999987754 56678888888876665 4899999999999999999999998
Q ss_pred CCCCHHHHHh-hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLL-GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
..||.-+.. ...-....+++..+-.+....+.||.||-..+ .++|||+||+||+++..|.+||||||.+-.+.++.
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 667765442 23456678889988899888999999998875 89999999999999999999999999987665443
Q ss_pred ccccccccCCccccCccccc--cCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhccccccc
Q 027015 159 THISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMKL 227 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 227 (229)
. .+.-+|...|+|||-+. +..++.++|+||||+++||+.||+.|+..=+ ..++.+.++....+|.
T Consensus 223 A--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 223 A--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQVVIGDPPI 289 (361)
T ss_pred H--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHHHHcCCCCe
Confidence 2 23346778899999887 3458999999999999999999999997532 2555555555555543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=226.42 Aligned_cols=196 Identities=21% Similarity=0.206 Sum_probs=147.6
Q ss_pred CccCCcccccccccceEeccC---CcEEEEEEeecccchhh-----------HHHHHHHHHHhhhccCCCcccccceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD---GTIVAVKVLSVESKQGE-----------KEFMSEVASMANVNVCHENLVKLHGGCI 67 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~e~~~~~~l~~~~~~i~~~~~~~~ 67 (229)
+.||+|+||+||++. ...+ +..+++|.......... .....+...+..+. |+++++++++..
T Consensus 18 ~~LG~G~fG~Vy~~~--~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~--h~~i~~~~~~~~ 93 (294)
T PHA02882 18 KLIGCGGFGCVYETQ--CASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID--HLGIPKYYGCGS 93 (294)
T ss_pred eEEecCCCceEEEEE--EcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC--CCCCCcEEEeee
Confidence 469999999999994 3444 56777776543322111 11112233344555 999999998765
Q ss_pred cCC----ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 68 DGP----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 68 ~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
... ..+++++++ ..++.+.+ ......++..+..++.|++.|+++||+. +++||||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 94 FKRCRMYYRFILLEKL-VENTKEIF----KRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EecCCceEEEEEEehh-ccCHHHHH----HhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 443 336788876 45666666 3334467888999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCc------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 144 KISDFGLSKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
+|+|||++..+..... .......||+.|+|||...+..++.++|+||||+++++|++|+.||....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999876532211 11123468999999999999999999999999999999999999998763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=238.17 Aligned_cols=199 Identities=28% Similarity=0.463 Sum_probs=170.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhh-HHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
.+||+|-||.|.++ ....+..||||.++....+.. ..+.+|+++|.+++ ||||+.+++.|..+..+++|+||++
T Consensus 544 ekiGeGqFGEVhLC---eveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk--hPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 544 EKIGEGQFGEVHLC---EVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLK--HPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred hhhcCcccceeEEE---EecCceEEEEeecCcccchhHHHHHHHHHHHHhccC--CCCeeEEEeeeecCCchHHHHHHHh
Confidence 57999999999998 445579999999998755554 88999999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc-CCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~-~~~~~ 159 (229)
.|+|.+++....... +..+....++.||+++++||.+. +++|||+.+.|++++.++++||+|||.++.+ ....-
T Consensus 619 nGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred cCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999995443332 45556667999999999999999 9999999999999999999999999998754 23333
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHH--hCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV--SGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~--~g~~pf~~~~~ 210 (229)
....+..-+.+|||||.+....++.++|+|++|+++||++ +.+.||.....
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 3344555678999999999999999999999999999986 47889986543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=231.33 Aligned_cols=191 Identities=29% Similarity=0.378 Sum_probs=159.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~ 73 (229)
+.||+|+||.||++ ....+|+.||+|.+... .....+.+.+|++.++.++ ||||+++.+++... ...+
T Consensus 23 ~~lg~G~~g~v~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 23 SPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred EEeeecCCeEEEEE--EEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC--CCcccceeeeeeecccccccccEE
Confidence 56999999999999 66778999999998743 2233466788999999999 99999999988643 3467
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
++++++ +++|.+++ ....+++..+..++.|++.|+++||+. |++|+||+|+||++++++.++|+|||++..
T Consensus 99 lv~~~~-~~~L~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 99 LVTHLM-GADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEehhc-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 888876 88998877 234689999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... .....++..|+|||...+ ..++.++|+||+|+++|++++|+.||....
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322 123456788999998766 568899999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=219.38 Aligned_cols=182 Identities=22% Similarity=0.244 Sum_probs=153.7
Q ss_pred cccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCCCHHH
Q 027015 7 IRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQ 86 (229)
Q Consensus 7 G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 86 (229)
|.+|+||++ .+..+|+.+|+|.++.... ..+|...+.... ||||+++++++.+....+++|||+++++|.+
T Consensus 4 g~~~~v~~~--~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLV--MDTRTQQTFILKGLRKSSE-----YSRERLTIIPHC--VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEE--EEccCCcEEEEEeecchhh-----hhhHHHHHHhcC--CCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999 7788999999999975422 223444444445 9999999999999999999999999999999
Q ss_pred HHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcccccccc
Q 027015 87 TLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 166 (229)
Q Consensus 87 ~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 166 (229)
++ .....+++..+..++.|++++|.+||+. |++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 75 ~l----~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~ 143 (237)
T cd05576 75 HI----SKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEA 143 (237)
T ss_pred HH----HHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCC
Confidence 98 3445689999999999999999999999 99999999999999999999999999876543321 2233
Q ss_pred CCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 167 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 167 ~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
++..|+|||...+..++.++|+||+|+++|++++|+.||...
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 466799999998888899999999999999999999887653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=238.19 Aligned_cols=195 Identities=25% Similarity=0.322 Sum_probs=169.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc----ch----hhHHHHHHHHHHhhhccC-CCcccccceEEEcCCc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES----KQ----GEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPC 71 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~e~~~~~~l~~~-~~~i~~~~~~~~~~~~ 71 (229)
++++|+|+||+|++| ++..+...|+||.+..+. .+ ..-.+-.|++++..++.+ |+||++++++|++++.
T Consensus 566 lq~lG~GAyGkV~la--i~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~ 643 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLA--IHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY 643 (772)
T ss_pred eeeccccccceEEEe--eecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence 478999999999999 777788999999886441 11 123355789999998744 9999999999999999
Q ss_pred eEEEEEcc-CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 72 RILVYDYM-PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 72 ~~lv~e~~-~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
+|++||-. +|..|++++ ...+.+++.++..|+.|++.++.+||++ ||+|||||-+|+.++.+|-+||+|||.
T Consensus 644 yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 99999975 677899999 7889999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCccccCccccccCCCC-CcccchhHHHHHHHHHhCCCcccC
Q 027015 151 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
+...... +...+.||..|.|||++.|.+|- ..-|||+||+++|.++..+.||-+
T Consensus 717 aa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8765433 34568899999999999988864 678999999999999999999853
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=229.46 Aligned_cols=196 Identities=28% Similarity=0.386 Sum_probs=161.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcC--CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDG--PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~--~~~~lv~ 76 (229)
+.||+|+||.||++ +...+|+.+++|.+... .......+.+|+..++++ + ||||+++++++... ...++|+
T Consensus 13 ~~lg~g~~~~v~~~--~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 13 QKLGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--HPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HhhcCCCCeeEEEE--EEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcC--CCCccceeeeeccCCCceEEEEe
Confidence 57999999999999 66678899999988532 233345677899999999 7 99999999988643 3578999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||++ ++|.+++ ... .+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 89 e~~~-~~L~~~~----~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 89 EYME-TDLHAVI----RAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred cccc-cCHHHHH----hcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9996 5888887 222 788889999999999999999999 999999999999999999999999999876533
Q ss_pred CCc----cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTT----HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... .......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 221 12223457888999998764 5578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=227.60 Aligned_cols=198 Identities=26% Similarity=0.408 Sum_probs=160.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch--hhHHHHHHHHHHhhhccCCCcccccceEEEcCC--------c
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--------C 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--------~ 71 (229)
+.||+|++|.||++ ....+++.+++|.+...... ......+|++.++.++ ||||+++++.+.... .
T Consensus 14 ~~lg~g~~~~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 14 GKLGEGTFGEVYKA--RQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK--HPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEeccCCCEEEEEE--EECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC--CCCccchhhheecccccccccCce
Confidence 56999999999999 66778999999998654322 2346778999999999 999999999875433 4
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
.++++||+++ +|.+.+. .....+++..+..++.|++++|++||+. |++|+|++|+||++++++.++|+|||.+
T Consensus 90 ~~lv~~~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred EEEEEecCCc-CHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 5899999954 6666662 3455799999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccc----------cccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 152 KLFPENTTHI----------STRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|++||.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 7653322111 112345778999998765 4578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=231.13 Aligned_cols=195 Identities=25% Similarity=0.374 Sum_probs=161.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------------ 69 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------------ 69 (229)
+.||.|+||.||++ ....+|+.|++|.+........+.+.+|+++++.++ ||||+++++.+...
T Consensus 11 ~~Lg~g~~g~vy~~--~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 11 RPLGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred EEecCCCCEEEEEE--EECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC--CCcchhhHhhhccccccccccccccc
Confidence 57999999999999 777889999999997666666678889999999998 99999999876644
Q ss_pred --CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-CCCceEEe
Q 027015 70 --PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKIS 146 (229)
Q Consensus 70 --~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-~~~~~~l~ 146 (229)
...++++||++ ++|.+++ ....+++..+..++.|+++||.+||+. |++|+||+|+||+++ +++.++|+
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVL-----EQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccceEEEEeeccc-ccHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 24689999996 5888777 234688999999999999999999999 999999999999997 45578999
Q ss_pred ccccccccCCCCcc--ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 147 DFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 147 dfg~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
|||.+......... ......++..|+|||.+.+ ..++.++|+||||+++|++++|+.||....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765322111 1122346778999997654 567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=227.47 Aligned_cols=202 Identities=31% Similarity=0.486 Sum_probs=164.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----ceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~lv~e 77 (229)
..||+|+||+||+|.. +++.||||++... +.+.+..|-++++.....|+||+++++.-.... .+++|++
T Consensus 216 eli~~Grfg~V~KaqL----~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQL----DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred HHhhcCccceeehhhc----cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 4689999999999943 4599999999844 446788888888887777999999998765443 7899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------QPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~------~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
|.+.|||.+++ .....++.....++..+++||+|||+-. +++|+|||||..||++.+|++..|+|||++
T Consensus 289 fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 289 FHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999 5667999999999999999999999743 678999999999999999999999999999
Q ss_pred cccCCCCcc-ccccccCCccccCccccccCC-C-----CCcccchhHHHHHHHHHhCCCcccCccccccccc
Q 027015 152 KLFPENTTH-ISTRVAGTLGYLAPEYAISGR-L-----TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 216 (229)
Q Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~-----~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~ 216 (229)
..+...... ..-.-.||.+|||||++.+.. . -.+.||||+|.++||+++.-.-+.. +..++|.+
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yql 434 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQL 434 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccC
Confidence 887543222 122256999999999998643 2 2478999999999999987765543 34444444
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=222.94 Aligned_cols=196 Identities=28% Similarity=0.399 Sum_probs=167.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|++|.||++ +...+++.+++|.+.... ....+.+..|++.++.++ |++++++.+++.+....++|+||+
T Consensus 5 ~~ig~g~~~~vy~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 5 EKLGEGTYGVVYKA--RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK--HPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred hcccccCcceEEEe--eecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC--CCCHHHHHhhhhcCCceEEEecCc
Confidence 57999999999999 667789999999997653 333467788999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+ ++|.+++. .....+++..+..++.|++.+|++||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999983 2225799999999999999999999999 999999999999999999999999999876543322
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....++..|+|||.+.+. .++.++|+||||++++++++|+.||....
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 1223356779999988766 78899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=229.19 Aligned_cols=191 Identities=25% Similarity=0.352 Sum_probs=161.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~ 73 (229)
+.||+|+||.||++ ....+|..||+|.+.... ......+.+|+++++.++ ||||+++++++.... .++
T Consensus 21 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 21 KQVGSGAYGTVCSA--LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK--HENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred EEeeecCCeEEEEE--EECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCCccceeeeecCCccccccceEE
Confidence 57999999999999 667789999999986432 223456789999999999 999999999987553 358
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+|+|++ +++|.+++ ....+++..+..++.|++.|+++||+. |++|+||+|.||+++.++.++|+|||.+..
T Consensus 97 lv~e~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 97 LVMPFM-GTDLGKLM-----KHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 999998 77898887 235689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||....
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 53321 23356788999998875 457899999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=224.32 Aligned_cols=196 Identities=24% Similarity=0.287 Sum_probs=161.2
Q ss_pred cCCc--ccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 4 VGPI--RLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 4 lg~G--~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
||+| +.+.|+++ +...+++.||+|.++.. .......+.+|++.++.++ ||||+++++++.++...+++|||+
T Consensus 6 i~~~~~~~~~v~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 6 IGKCFEDLMIVHLA--KHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ--HPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhHhhcCCceEEEE--EecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC--CcchhhhhheeecCCeEEEEEecc
Confidence 4444 45666666 45558999999999755 3445578899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++... ....+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+||+.+........
T Consensus 82 ~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 82 AYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 999999998422 234688999999999999999999999 999999999999999999999999998765422111
Q ss_pred ------cccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 ------HISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11122346678999998875 35789999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=227.90 Aligned_cols=209 Identities=20% Similarity=0.279 Sum_probs=176.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCC----cccccceEEEcCCceEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE----NLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~----~i~~~~~~~~~~~~~~lv~ 76 (229)
++.+|+|.||+|-.+ .+..++..||||+++.- ..-.+..+-|++.++++....| .++.+.++|.-.++.|+|+
T Consensus 94 ~~~lGeGtFGkV~ec--~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivf 170 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVEC--WDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVF 170 (415)
T ss_pred hhhhcCCcccceEEE--eecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEE
Confidence 367999999999988 66667899999999733 2233566778999999964444 4788888999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-----------------
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ----------------- 139 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~----------------- 139 (229)
|.+ |-|+.+++. .+...+++...++.+.+|+++++.+||+. +++|.|+||+||++..
T Consensus 171 ell-G~S~~dFlk--~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 171 ELL-GLSTFDFLK--ENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ecc-ChhHHHHhc--cCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceec
Confidence 987 889999993 23556888999999999999999999999 9999999999999931
Q ss_pred ---CCceEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccc
Q 027015 140 ---NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 216 (229)
Q Consensus 140 ---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~ 216 (229)
+..++++|||.+....+.. .....|..|.|||++.+-+|+.+.||||+|||+.|+.+|...|......+...+
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred cCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 2348899999998765443 445678899999999999999999999999999999999999999988888888
Q ss_pred hhhhcc
Q 027015 217 VDKVRS 222 (229)
Q Consensus 217 ~~~~~~ 222 (229)
++.+.-
T Consensus 321 MerIlG 326 (415)
T KOG0671|consen 321 MERILG 326 (415)
T ss_pred HHHhhC
Confidence 887643
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=227.27 Aligned_cols=191 Identities=27% Similarity=0.354 Sum_probs=161.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEc-CCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-~~~~~lv~e~ 78 (229)
+.||.|+||.||++ ....+|+.||+|.+... .....+.+.+|+++++.++ ||||+++.+++.. ....++++||
T Consensus 16 ~~ig~g~~g~v~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 16 QPVGMGAFGLVCSA--RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR--HENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred EeecccCCeEEEEE--EECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC--CCCeeeEeeeEecCCCcEEEEeeh
Confidence 57999999999999 67778999999988643 2334467888999999999 9999999999875 4578899999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+ +++|.+++ ....+++..+..++.|++++|++||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 92 ~-~~~L~~~~-----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 92 L-GTDLHRLL-----TSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred h-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 8 66888877 234678888999999999999999999 99999999999999999999999999887543211
Q ss_pred ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||....
T Consensus 163 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 163 ----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred ----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22346778999998765 678999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=224.78 Aligned_cols=191 Identities=26% Similarity=0.404 Sum_probs=162.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|++|.||++ +...+++.+++|.+... .....+.+.+|++.++.++ |+|++++.+++......++|+||
T Consensus 21 ~~lg~g~~g~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 21 REIGHGSFGAVYFA--RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HheeeCCCEEEEEE--EEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC--CCCcccEEEEEEcCCeeEEEEEc
Confidence 57999999999999 66678899999998643 2233456788999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+. ++|.+.+. .....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 97 CL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred cC-CCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 96 57777662 3345689999999999999999999999 9999999999999999999999999988654322
Q ss_pred ccccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
....+++.|+|||.+. ...++.++|+||||+++|++++|..||...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2345778899999875 345788999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=220.91 Aligned_cols=196 Identities=25% Similarity=0.345 Sum_probs=173.9
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+..||+|++++|-++ +...+.+.+|+|+++.+ ..++......|....++.. +||.++.+..+|...++.++|.|
T Consensus 255 l~vigrgsyakvl~~--~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as-n~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLV--RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred eeeecCcchhhhhhe--ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-CCCeEEehhhhhcccceEEEEEE
Confidence 467999999999999 55667899999999865 4555667778888887776 59999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|++||.|-=.+ +....++++.++.+...|.-||.|||+. ||++||+|.+|++++..|++||.|+|.++.--.+
T Consensus 332 yv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 332 YVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999987766 6778899999999999999999999999 9999999999999999999999999998753222
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.....+++|||.|.|||++.+..|..+.|.|+||+++++|+.|+.||+.
T Consensus 405 -gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 405 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred -CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 2345678999999999999999999999999999999999999999975
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=220.92 Aligned_cols=198 Identities=26% Similarity=0.378 Sum_probs=161.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch--hhHHHHHHHHHHhhhcc-CCCcccccceEEEcCCc-----eE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNV-CHENLVKLHGGCIDGPC-----RI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~~~~l~~-~~~~i~~~~~~~~~~~~-----~~ 73 (229)
+.||+|+||.||++ ....+++.+|+|.++..... ....+.+|+..++.+.. .|||++++++++.+... .+
T Consensus 5 ~~l~~g~~~~v~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 5 AEIGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEecccCceEEEEE--EECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 56899999999999 55557899999999754222 23455567777666631 29999999999987766 89
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+++||+. ++|.+++... ....+++..+..++.|+++||++||+. +++|+|++|+||+++.++.++|+|||.+..
T Consensus 83 l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 83 LVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999996 4788887322 223689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 533321 122346778999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=225.34 Aligned_cols=199 Identities=27% Similarity=0.312 Sum_probs=160.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC----CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~----~~~~lv 75 (229)
+.||+|+||.||++......++..+|+|.+... .....+.+.+|++.++.+. .||||+++++..... ...+++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-GHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCChheeeeeeeeccccCCcEEEE
Confidence 579999999999994433323889999998643 2223467788999999884 399999999875422 456788
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
+++++ ++|.+++ .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 85 ~e~~~-~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 85 EELME-ADLHQII----RSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred Eeccc-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 99884 6898888 4566799999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcc---ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTH---ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ......+++.|+|||...+ ..++.++|+||+|+++|++++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 32211 1223467889999998765 568899999999999999999999998644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=229.30 Aligned_cols=192 Identities=28% Similarity=0.383 Sum_probs=162.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc------eE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC------RI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~------~~ 73 (229)
+.||+|++|.||++ ....+++.||+|.+... .......+.+|+.+++.+. |||++++.+++..... .+
T Consensus 21 ~~ig~g~~g~vy~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 21 SPVGSGAYGQVCSA--FDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD--HENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred EEeccCCceEEEEE--EECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc--CCCHHHHHHHhhccccccccccEE
Confidence 57999999999999 66778899999998643 2333466778999999998 9999999998866544 79
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+|+||+ +++|.+++. ...+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+..
T Consensus 97 lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 97 LVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 999998 679999882 35689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... .....++..|+|||...+ ..++.++|+||||+++|++++|+.||.....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 5332 223456788999998765 4678999999999999999999999986544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=220.17 Aligned_cols=198 Identities=28% Similarity=0.366 Sum_probs=163.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|++|+||++ +...+++.|++|.+..... .......+|+..++.++ .|||++++++++.+++..++||||+
T Consensus 5 ~~ig~g~~g~v~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 5 KQLGDGTFGSVYLA--RNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-EHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeeccCCceEEEEE--EECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc-CCCCchhHHHHhhcCCcEEEEEecC-
Confidence 57999999999999 6666789999999864422 23334566888888775 4999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++... ....+++..+..++.|++++|.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 78898887322 134789999999999999999999999 999999999999999999999999999876543221
Q ss_pred ccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 161 ISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....++..|+|||.+. ...++.++|+||+|++++++++|+.||.....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 12345678899999875 45578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=223.97 Aligned_cols=187 Identities=30% Similarity=0.409 Sum_probs=157.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----ceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~lv~e 77 (229)
+.||+|+||.||++.| .|+.||||++... +++...+|.++++..-.+|+||+.+++.-..+. +.++|++
T Consensus 217 e~IGkGRyGEVwrG~w----rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRW----RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEecCccccceeeccc----cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 5799999999999977 5799999999743 456788999999887777999999998765443 5689999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-----IQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-----~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|.+.|||.|++ .+..++.+...+++..+++||++||.. .+|.|.|||||..||+|.+++..-|+|+|+|.
T Consensus 290 YHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 290 YHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred cccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 99999999999 447899999999999999999999974 37789999999999999999999999999998
Q ss_pred ccCCCC---ccccccccCCccccCccccccCC------CCCcccchhHHHHHHHHHh
Q 027015 153 LFPENT---THISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVS 200 (229)
Q Consensus 153 ~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~i~~~l~~ 200 (229)
...... .-......||-+|||||++...- --..+||||+|.++||+..
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 764432 12345577999999999987532 2257999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=243.99 Aligned_cols=218 Identities=24% Similarity=0.405 Sum_probs=186.9
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||.|-||.|+.++... -+....||||.++.. ..+...+|+.|+.++-++. ||||+++.++........||.|||
T Consensus 635 ~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd--HPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 635 KVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC--CCcEEEEEEEEecCceeEEEhhhh
Confidence 469999999999996532 123457999999866 4556688999999999999 999999999999998889999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++|+|..++. .+.+.++.-++..+++.|++++.||-+. ++|||||-..||+++.+-..|++|||+++.+.++..
T Consensus 713 ENGsLDsFLR---~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 713 ENGSLDSFLR---QNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hCCcHHHHHh---hcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 9999999995 4457799999999999999999999999 999999999999999999999999999987765542
Q ss_pred cccccc--cCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchhhhccccccc
Q 027015 160 HISTRV--AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSINMKL 227 (229)
Q Consensus 160 ~~~~~~--~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 227 (229)
...+.. .-+.+|.|||.+....++.++||||+|++|||.++ |+.||...++.+...-+++.-++.+|+
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 211111 12468999999999999999999999999999885 999999988888888888877777664
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=220.23 Aligned_cols=194 Identities=26% Similarity=0.382 Sum_probs=157.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|++|.||++ ....+++.||+|.++... ......+..|+..+.... .||||+++++++.+....+++|||+
T Consensus 21 ~~lg~g~~~~v~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~- 96 (296)
T cd06618 21 GEIGSGTCGQVYKM--RFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYGYFITDSDVFICMELM- 96 (296)
T ss_pred eEeeccCCeEEEEE--EECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc-CCCchHhhheeeecCCeEEEEeecc-
Confidence 57999999999999 556678999999997542 223345566666555543 3999999999999999999999998
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.++.. .....+++..+..++.|++.+++|||+ . |++|+||+|+||++++++.++|+|||.+..+.....
T Consensus 97 ~~~l~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 97 STCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred CcCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 457777663 234578999999999999999999997 5 899999999999999999999999999876533222
Q ss_pred cccccccCCccccCccccccCC----CCCcccchhHHHHHHHHHhCCCcccC
Q 027015 160 HISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.....++..|+|||.+.+.. ++.++|+||||+++|++++|+.||..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 12234677899999987553 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=217.10 Aligned_cols=198 Identities=23% Similarity=0.339 Sum_probs=163.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc-----cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++ .....+..+++|.++.. ..........|+.+++.++ ||||+++++++.+....++++
T Consensus 6 ~~ig~g~~g~v~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 6 QRLGKGSFGTVYLV--KDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD--HPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred eeecCCCCceEEEE--EecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC--CCcHHHHHHHHhcCCceEEEE
Confidence 57999999999999 44444555666665421 1223345667889999998 999999999999888999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++.........+++..+..++.|+++++.+||+. |++|+|++|+||+++. +.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998865445567899999999999999999999999 9999999999999974 6799999999876533
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
... ......+++.|+|||...+..++.++|+||+|+++|++++|..||...
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 221 223345788899999988888899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=225.70 Aligned_cols=190 Identities=26% Similarity=0.350 Sum_probs=158.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~ 73 (229)
..||+|+||.||++ +...+|+.||+|.+.... ......+.+|+++++.++ ||||+++++++.... .++
T Consensus 21 ~~ig~g~~g~v~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 21 KQVGSGAYGSVCSA--IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--HENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred EEeeecCCeEEEEE--EeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC--CCCccchhheecccccCCCCceEE
Confidence 46999999999999 666789999999986432 222356789999999998 999999999987542 458
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+++||+. .+|..+. ...+++..+..++.|++.|+++||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 97 lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 97 LVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 9999985 4666554 23688999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322 122356778999998875 468899999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=217.14 Aligned_cols=208 Identities=25% Similarity=0.424 Sum_probs=170.2
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEc--------CC
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID--------GP 70 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--------~~ 70 (229)
++.||+|.||.||+| +...+|+.||+|..-.+. ..-.....+|+.+++.++ |+|++.+++.|.. ..
T Consensus 22 ~~kigqGtfgeVFkA--r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk--Henv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKA--RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHhcCCchHHHHHHH--hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc--chhHHHHHHHHhhccCCcccccc
Confidence 367999999999999 667788999999775442 223467889999999999 9999999987742 23
Q ss_pred ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 71 ~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
..|+||.+| ..+|...+ ......++..++..++.+++++|.|+|+. .|+|||+||.|++++.+|.++|+|||+
T Consensus 98 t~ylVf~~c-ehDLaGlL---sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFC-EHDLAGLL---SNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHh-hhhHHHHh---cCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 478999999 45788888 24447899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccc---cccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhh
Q 027015 151 SKLFPENTTHI---STRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 219 (229)
Q Consensus 151 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 219 (229)
++.+....... -+...-|..|.+||.+.| ..++++.|+|+-||++.+|++|.+.|.+++......++..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 97764332111 122334889999998886 5689999999999999999999999998876665555443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=234.80 Aligned_cols=215 Identities=24% Similarity=0.362 Sum_probs=183.6
Q ss_pred CccCCcccccccccceEeccCCcE--EEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTI--VAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~--vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
..||+|.||.|+++.|.. .+|+. ||||+++..... ...+|.+|+..+.+++ ||+++++|++..+ ...-+|||.
T Consensus 116 e~LG~GsFgvV~rg~Wt~-psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~--H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQ-PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ--HPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHhcCcceeeEeeccccC-CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc--CcceeEEeeeecc-chhhHHhhh
Confidence 469999999999999976 66664 899999877554 5588999999999999 9999999999988 457799999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++.|||.+.+.. ..+..|-...+..++.||+.|++||.++ +.||||+-..|+++-....+||||||+.+.++...
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999964 4667888999999999999999999999 99999999999999888899999999998876554
Q ss_pred ccc--cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchhhhccccc
Q 027015 159 THI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSINM 225 (229)
Q Consensus 159 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 225 (229)
... .....-...|.|||.+....++.++|+|++|+++|||++ |+.||.+.......+.++..+++..
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR 336 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR 336 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC
Confidence 332 111223557999999999999999999999999999997 8999999887777777766555443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=208.65 Aligned_cols=213 Identities=30% Similarity=0.364 Sum_probs=175.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
..||+|++|.||++ ....+++.+++|.+...... ..+.+.+|++.++.++ |++++++++++......++++|+++
T Consensus 5 ~~i~~g~~~~v~~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~--~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 5 KKLGEGAFGKVYLA--RDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK--HPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred eEeecCCCeEEEEE--EEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC--CCChhhheeeeecCCceEEEEeccC
Confidence 46899999999999 55667899999999866544 5678889999999998 9999999999998889999999999
Q ss_pred CCCHHHHHhhhhccccC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAK-FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~-l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++. .... +++..+..++.+++.++++||+. +++|+|++|.|++++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLR----KKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999983 3333 88999999999999999999999 999999999999999999999999999877644321
Q ss_pred cccccccCCccccCcccc-ccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcccccc
Q 027015 160 HISTRVAGTLGYLAPEYA-ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 226 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (229)
.......++..|++||.. ....++.++|+|+||++++++++|+.||... ......+.+.+....++
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGE-GEFTSLLSDVWSFGVPL 220 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcccc-chhHHHHHHHHhcCCcc
Confidence 112234567789999988 6677888999999999999999999999651 22333444444444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=204.20 Aligned_cols=187 Identities=20% Similarity=0.326 Sum_probs=159.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC--ceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 79 (229)
+.+|+|.++.||.+ ++..++++|+||++++.. .+.+.+|+.+++.++ ++|||+++++...++. ...+|+||+
T Consensus 44 rk~GRGKYSEVFeg--~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~-gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 44 RKVGRGKYSEVFEG--INITNNEKCVIKILKPVK---KKKIKREIKILQNLR-GGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred HHHcCccHhhHhcc--cccCCCceEEEeeechHH---HHHHHHHHHHHHhcc-CCCCeeehhhhhcCccccCchhHhhhh
Confidence 46899999999999 778899999999998543 357899999999998 6999999999998764 456999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-CCceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~~~~~~~ 158 (229)
++.+...+. ..++...+...+.++++||.|+|+. ||.|||+||+|++++. .-.++|+|+|+|.+.....
T Consensus 118 ~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 118 NNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred ccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 988876655 5688899999999999999999999 9999999999999984 4569999999998875543
Q ss_pred ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCccc
Q 027015 159 THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
.. .....+..|.-||++.. ..++.+.|+|||||++..|+..+.||=
T Consensus 188 eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 188 EY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred ee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 32 12234667899998875 458899999999999999999999884
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=228.90 Aligned_cols=188 Identities=28% Similarity=0.372 Sum_probs=160.0
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.+|.|+|+.|-.+ .+..+++..++|++... ..+..+|+..+.... .||||+++.+.+.++...++|||.+.|+
T Consensus 329 ~~~~gs~s~~~~~--~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~-~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 329 ELGEGSFSAVKYC--ESSPTDQEPAVKIISKR----ADDNQDEIPISLLVR-DHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred ccCCCCccceeee--eccccccchhheecccc----ccccccccchhhhhc-CCCcceeecceecCCceeeeeehhcccc
Confidence 5899999999888 77888999999999744 233455665555554 4999999999999999999999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE-cCCCceEEeccccccccCCCCccc
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-DQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~-~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
-+.+.+ .....++ ..+.+|+.+|++++.+||++ |++|||+||+||++ +..++++|+|||.+......
T Consensus 402 ell~ri----~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 402 ELLRRI----RSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred HHHHHH----HhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 988877 3334444 78888999999999999999 99999999999999 58999999999998765443
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....+-|..|.|||+.....+++++|+||||+++|+|++|+.||....
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 233456888999999999999999999999999999999999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=247.16 Aligned_cols=185 Identities=28% Similarity=0.495 Sum_probs=154.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..||+|+||.||++ ....+|..||+|.++.... ...+|++.+++++ ||||+++++++.+....++||||+++
T Consensus 696 ~~ig~G~~g~Vy~~--~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~--HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 696 NVISRGKKGASYKG--KSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQ--HPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred cEEccCCCeeEEEE--EECCCCcEEEEEEccCCcc----ccHHHHHHHhhCC--CCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 35899999999999 6667899999999863322 1234588888988 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .+++..+..++.|+++|++|||....++++|||+||+||+++.++..++. ++.......
T Consensus 768 g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 768 KNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 99999982 37899999999999999999995444499999999999999988877765 554332211
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.....+++.|+|||+..+..++.++||||+|+++||+++|+.||+.
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1223578899999999999999999999999999999999999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=242.62 Aligned_cols=189 Identities=28% Similarity=0.417 Sum_probs=154.9
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEc-----------
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----------- 68 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----------- 68 (229)
++.||+|+||.|+++ ++.-||+.||||.+... +...-..+.+|+..+.+++ ||||++++..+..
T Consensus 484 L~lLGkGGFG~VvkV--RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn--HpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKV--RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN--HPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred HHHhcCCCCceEEEE--eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC--CcceeeeehhhhccCCcccccccc
Confidence 357999999999999 88999999999999866 3444477899999999999 9999999775320
Q ss_pred --------------------------------------------------------------------------------
Q 027015 69 -------------------------------------------------------------------------------- 68 (229)
Q Consensus 69 -------------------------------------------------------------------------------- 68 (229)
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence
Q ss_pred --------------------C--------CceEEEEEccCCCCHHHHHhhhhccccCC-CHHHHHHHHHHHHHHHHHHhh
Q 027015 69 --------------------G--------PCRILVYDYMPNNSLSQTLLGEEKRRAKF-GWKARREIIMGIGRGLAYIHE 119 (229)
Q Consensus 69 --------------------~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~l-~~~~~~~~~~~i~~~l~~lH~ 119 (229)
. ...||-||||+..++.+++ ..+... .....|.++++|+.||.|+|+
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI----~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDII----RRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHH----HhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1247889999888888877 233322 577899999999999999999
Q ss_pred cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC---C--------------CCccccccccCCccccCccccccC--
Q 027015 120 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP---E--------------NTTHISTRVAGTLGYLAPEYAISG-- 180 (229)
Q Consensus 120 ~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~---~--------------~~~~~~~~~~~~~~~~aPE~~~~~-- 180 (229)
+ |+|||||||.|||++.++.+||+|||++.... . ......+...||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998721 0 111123456799999999999864
Q ss_pred -CCCCcccchhHHHHHHHHHh
Q 027015 181 -RLTRKSDVYSFGVLLLEIVS 200 (229)
Q Consensus 181 -~~~~~~Dv~slG~i~~~l~~ 200 (229)
.|+.|+|+||||++++||+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999984
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=227.61 Aligned_cols=212 Identities=28% Similarity=0.389 Sum_probs=182.9
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
+||-|.+|.||.+.|.... -.||||.++ +..-....|+.|+.+++.+. |||+++++++|.....+|||+|||..|
T Consensus 274 KLGGGQYGeVYeGvWKkys--lTvAVKtLK-EDtMeveEFLkEAAvMKeik--HpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 274 KLGGGQYGEVYEGVWKKYS--LTVAVKTLK-EDTMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred ccCCCcccceeeeeeeccc--eeeehhhhh-hcchhHHHHHHHHHHHHhhc--CccHHHHhhhhccCCCeEEEEecccCc
Confidence 6999999999999886544 789999997 44556688999999999999 999999999999999999999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcccc
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 162 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (229)
+|.+|+... ++..++.-.+.+++.||.+|+.||... ++||||+-..|++|.++..+|+.|||+++.+..+..-..
T Consensus 349 NLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 349 NLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 999999433 445677788999999999999999999 999999999999999999999999999998855432111
Q ss_pred ccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchhhhcccc
Q 027015 163 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSIN 224 (229)
Q Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 224 (229)
.-..-++.|.|||-+....++.++|||++|+++||+.| |-.||.+-+-...|.+.++.-++.
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD 486 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc
Confidence 11123567999999999999999999999999999997 889999988888888887766654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=217.76 Aligned_cols=206 Identities=22% Similarity=0.315 Sum_probs=173.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-----ceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----CRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-----~~~l 74 (229)
++||.|+||.||-+ .+-.+|+.|++|.+..- +-...+.+.+|++++..++ |.|++..+|+....+ ..|+
T Consensus 59 RPIGYGAFGVVWsV--TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk--HdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSV--TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR--HDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CcccccceeEEEec--cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc--cccHHHHHHhcCCCCchHHHHHHH
Confidence 58999999999999 67889999999998532 3445578999999999999 999999999876543 4467
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
++|.+ ..+|...+ -....++...+.-+++||+++|.|||+. +|.||||||.|.+++.+-.+||||||+++..
T Consensus 135 ~TELm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 77776 55666666 5677899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhh
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 219 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 219 (229)
........+.-.-|..|.|||++.| ..|+.+.||||+|||+.||+..+..|...++.+..+++..
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 5444444444456789999999886 4689999999999999999999999999888777766544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=235.16 Aligned_cols=140 Identities=24% Similarity=0.329 Sum_probs=125.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.||+|+++... ......+.+|+..+..++ ||+|+++++.+......++||||
T Consensus 10 ~~LG~G~fg~Vy~a--~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 10 KPISRGAFGKVYLG--RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEecCCCeEEEEE--EECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC--CCCcCeEEEEEEECCEEEEEEeC
Confidence 57999999999999 667789999999997432 223467888999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
+++++|.+++ .....+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~g~~L~~li----~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999998 4455788999999999999999999999 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=230.18 Aligned_cols=197 Identities=25% Similarity=0.371 Sum_probs=169.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE-----cCCceEEEEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-----DGPCRILVYD 77 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~-----~~~~~~lv~e 77 (229)
.||.|.+|+||++ ++..+++..|+|+.....+.+ +.+..|.++++.+. .|||++.++++|. .++.+++|||
T Consensus 26 vig~Gtygkv~k~--k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~-~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 26 VIGNGTYGKVYKG--RHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYS-HHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEeeccceeEEEE--eeeecCceeeeEeecCCcccc-HHHHHHHHHHHhcc-CCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 5899999999999 777889999999987665443 46777888888887 5999999999886 3468899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
||.+||..|++.+.. ...+.+..+..|++.++.++.+||.+ .++|||+|-.||+++.++.+||+|||++...-.
T Consensus 102 fC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds- 175 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS- 175 (953)
T ss_pred ccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec-
Confidence 999999999996553 77899999999999999999999999 999999999999999999999999999765532
Q ss_pred CccccccccCCccccCccccccC-----CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+..||+.|||||++.+. .|+.++|+||||++..||--|.+|+-...
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 33344667899999999999854 36789999999999999999999997654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=224.70 Aligned_cols=203 Identities=22% Similarity=0.220 Sum_probs=170.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCC----cccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE----NLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~----~i~~~~~~~~~~~~~~lv~e 77 (229)
+..|.|-|++|..| .....|+.||||++..+ ...-+.=+.|+++|+.|+...| +++.++.+|...+++|+|||
T Consensus 438 ~~~GkGvFs~Vvra--~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE 514 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRA--RDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFE 514 (752)
T ss_pred eccccceeeeeeec--cccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEeh
Confidence 56799999999999 55667789999999743 3233556789999999984433 89999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccccCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFPE 156 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~~~ 156 (229)
.+ ..+|.+.+... ..+..|....+..+++|++-||..|-.. |++|+||||+||+|++.. .+||||||.|...+.
T Consensus 515 ~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 515 PL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred hh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccccccc
Confidence 88 88999999665 5566788999999999999999999998 999999999999998654 579999999987655
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccccccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 215 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~ 215 (229)
+.. ++..-+..|.|||++.|.+|+...|+||+||++|||.||+..|++.++.....
T Consensus 590 nei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 590 NEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 432 33344567999999999999999999999999999999999999876554443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-33 Score=230.66 Aligned_cols=214 Identities=28% Similarity=0.389 Sum_probs=181.5
Q ss_pred CccCCcccccccccceEeccC--CcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD--GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++.|+-..+ .-+||+|++... ..+..+.+++|+-++.+++ |||++++++++..+. .-||++|
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld--Hpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD--HPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC--CchHHHHhhhcccch-HHHHHHh
Confidence 689999999999996643211 236888888644 4555688999999999999 999999999987665 6799999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++|+|.++++ ..+..+....+..|++||++|+.|||.+ .++||||-..|++|+....+|+.|||+++......
T Consensus 779 mP~G~LlDyvr---~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVR---EHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHH---HhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999994 4667788899999999999999999999 99999999999999999999999999998875443
Q ss_pred cccc-ccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchhhhcccc
Q 027015 159 THIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSIN 224 (229)
Q Consensus 159 ~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 224 (229)
.... ....-.+.|+|-|.+....++.++||||+|+++||++| |+.|+.+....+..++.+...++.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs 920 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS 920 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC
Confidence 3222 22234567999999999999999999999999999998 999999998888888888877743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=202.53 Aligned_cols=187 Identities=30% Similarity=0.477 Sum_probs=163.5
Q ss_pred ccccccccceEeccCCcEEEEEEeecccchh-hHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCCCHHH
Q 027015 8 RLEKVDLAPFIRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQ 86 (229)
Q Consensus 8 ~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 86 (229)
+||.||++ +...+|+.+++|.+....... .+.+.+|++.++.++ |++++++.+.+......++++|++++++|.+
T Consensus 1 ~~g~v~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLA--RDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLK--HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEE--EECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCC--CCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 57899999 556678999999997654444 678899999999998 9999999999999889999999999999999
Q ss_pred HHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcccccccc
Q 027015 87 TLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 166 (229)
Q Consensus 87 ~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 166 (229)
++. ....++...+..++.+++.++++||+. +++|+|++|.||+++.++.++|+|||.+....... ......
T Consensus 77 ~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 147 (244)
T smart00220 77 LLK----KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV 147 (244)
T ss_pred HHH----hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence 983 333489999999999999999999999 99999999999999999999999999988764432 223345
Q ss_pred CCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 167 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 167 ~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
++..|+|||...+..++.++|+||+|++++++++|..||..
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 67889999999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=223.59 Aligned_cols=202 Identities=29% Similarity=0.390 Sum_probs=169.1
Q ss_pred CccCCcccccccccceEeccC-----CcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD-----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|.||.|+++....... ...||||.++.. ...+.+.+..|++.++.+. .|+||+.+++.+...+..++|
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g-~H~niv~llG~~t~~~~~~~v 380 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG-KHPNIVNLLGACTQDGPLYVI 380 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc-CCcchhhheeeeccCCceEEE
Confidence 379999999999997654432 457999999855 3445688999999999997 599999999999998899999
Q ss_pred EEccCCCCHHHHHhhhh---ccc---------cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 76 YDYMPNNSLSQTLLGEE---KRR---------AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~---~~~---------~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
+||++.|+|.+++.... ... ..++..++..+..||+.|++||++. +++|||+-..||++.++..+
T Consensus 381 ~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 381 VEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEE
Confidence 99999999999995443 101 2389999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCcccccccc--CCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccC
Q 027015 144 KISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDF 207 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~ 207 (229)
|++|||+++.............. -+..|||||.+....++.++||||+|+++||+++ |..||.+
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999864333222211111 2456999999999999999999999999999998 9999987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=221.87 Aligned_cols=195 Identities=21% Similarity=0.217 Sum_probs=136.5
Q ss_pred CccCCcccccccccceEeccC----CcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceE------EEcCCc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------CIDGPC 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~------~~~~~~ 71 (229)
+.||+|+||.||++ +...+ +..||+|.+...... +....+ .++... +.++..+... ......
T Consensus 138 ~~LG~G~FG~VYka--~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~--~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 138 KKLGEGAFGVVYKA--SLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRAC--PNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred EEEeeCCCeEEEEE--EEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhc--hhhHHHHHHhhhcccccccCCc
Confidence 56999999999999 55666 899999987632211 111111 111111 2233322222 134567
Q ss_pred eEEEEEccCCCCHHHHHhhhhc----------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCE
Q 027015 72 RILVYDYMPNNSLSQTLLGEEK----------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~----------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni 135 (229)
.++|+||+++++|.+++..... .........+..++.|++.+|.|||+. +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 8999999999999998843210 011122345678999999999999999 999999999999
Q ss_pred EEcC-CCceEEeccccccccCCCCccccccccCCccccCccccccCC----------------------CCCcccchhHH
Q 027015 136 LLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR----------------------LTRKSDVYSFG 192 (229)
Q Consensus 136 ~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----------------------~~~~~Dv~slG 192 (229)
+++. ++.++|+|||++..+............+++.|+|||.+.... ++.++||||+|
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 578999999999766443333445567899999999764322 23456999999
Q ss_pred HHHHHHHhCCCcccC
Q 027015 193 VLLLEIVSGRTAVDF 207 (229)
Q Consensus 193 ~i~~~l~~g~~pf~~ 207 (229)
|++|+|+++..|++.
T Consensus 367 viL~el~~~~~~~~~ 381 (566)
T PLN03225 367 LIFLQMAFPNLRSDS 381 (566)
T ss_pred HHHHHHHhCcCCCch
Confidence 999999998766543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=214.36 Aligned_cols=201 Identities=20% Similarity=0.208 Sum_probs=146.1
Q ss_pred CccCCcccccccccceE--------------eccCCcEEEEEEeecccchhhHH--------------HHHHHHHHhhhc
Q 027015 2 ASVGPIRLEKVDLAPFI--------------RLQDGTIVAVKVLSVESKQGEKE--------------FMSEVASMANVN 53 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--------------~~~~~~~vavK~~~~~~~~~~~~--------------~~~e~~~~~~l~ 53 (229)
+.||+|+||+||++... ...+++.||||.++.......+. ...|+.++..++
T Consensus 151 ~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~ 230 (507)
T PLN03224 151 DKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIK 230 (507)
T ss_pred eEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhh
Confidence 46999999999998431 12356789999987543322222 334666666666
Q ss_pred cCCC-----cccccceEEEc--------CCceEEEEEccCCCCHHHHHhhhhc--------------------cccCCCH
Q 027015 54 VCHE-----NLVKLHGGCID--------GPCRILVYDYMPNNSLSQTLLGEEK--------------------RRAKFGW 100 (229)
Q Consensus 54 ~~~~-----~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~--------------------~~~~l~~ 100 (229)
|. +++++++++.. .+..++|+||+++++|.+++..... ....+++
T Consensus 231 --~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 231 --RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred --cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 44 34677777643 3567999999999999998853211 1123467
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccccccccCCccccCccccccC
Q 027015 101 KARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 180 (229)
Q Consensus 101 ~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 180 (229)
..+..++.|++.+|.++|+. +++|+||||+||+++.++.++|+|||++..+............+++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 78889999999999999999 999999999999999999999999999876543322222223347899999987643
Q ss_pred C----------------------CCCcccchhHHHHHHHHHhCCC-cccC
Q 027015 181 R----------------------LTRKSDVYSFGVLLLEIVSGRT-AVDF 207 (229)
Q Consensus 181 ~----------------------~~~~~Dv~slG~i~~~l~~g~~-pf~~ 207 (229)
. ...+.|+||+||++++|++|.. ||..
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 2 1234799999999999999985 7753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=201.42 Aligned_cols=197 Identities=25% Similarity=0.342 Sum_probs=166.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------Cce
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCR 72 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~ 72 (229)
++++|.|.- .|.-+ .+.-.+++|++|....+ .....++..+|...+..++ |+||++++.+|... ...
T Consensus 22 L~p~~~g~~-~v~~a--~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~--~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAA--FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN--HKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred ecccCCCCc-eEEec--chhhccCceehhhhcCccccCccchhhhhhhhhhhhhc--ccceeeeeeccCccccHHHHHhH
Confidence 467788887 55555 45667899999988654 3444577889999999999 99999999999644 356
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|+|||++ ..+|.+.+. ..++-.++..+++|++.|+++||+. ||+|||+||+||++..+..+|++|||++.
T Consensus 97 y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 8999999 778888873 6688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 214 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~ 214 (229)
..... ...+....+..|.|||++.+..+.+.+||||+||++.||++|+..|.+.+..+.+
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~ 226 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQW 226 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHH
Confidence 75443 3456677788999999999999999999999999999999999999976654444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=218.04 Aligned_cols=197 Identities=25% Similarity=0.289 Sum_probs=158.0
Q ss_pred ccCCccccc-ccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEK-VDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~-v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
.+|.|+-|+ ||++ .-+|+.||||.+-.+ ......+|+..++..+ .||||++++..-.+.+..||..|.| .
T Consensus 516 ilG~Gs~Gt~Vf~G----~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD-~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRG----VYEGREVAVKRLLEE---FFDFAQREIQLLQESD-EHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred HcccCCCCcEEEEE----eeCCceehHHHHhhH---hHHHHHHHHHHHHhcc-CCCceEEEEeeccCCceEEEEehHh-h
Confidence 368888876 5766 347899999998633 2346678999999887 5999999998888888999999999 7
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---C--CceEEeccccccccCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---N--FNPKISDFGLSKLFPE 156 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~--~~~~l~dfg~~~~~~~ 156 (229)
.+|.+++...............+..+.|+++||++||+. +|+|||+||+||+++. + .+++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 799999943201111111255678899999999999998 9999999999999975 3 4589999999998855
Q ss_pred CCcc--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhC-CCcccCcccc
Q 027015 157 NTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQL 211 (229)
Q Consensus 157 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g-~~pf~~~~~~ 211 (229)
.... ......||.+|+|||++....-+.++||+||||++|+.++| .+||+....+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 4332 24557799999999999988888999999999999999985 8999986655
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=182.30 Aligned_cols=184 Identities=35% Similarity=0.539 Sum_probs=157.7
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
||+|++|.||++ ....+|+.+++|.+...... ....+.+|++.++.+. |++++++++++......++++|+++++
T Consensus 1 l~~g~~~~v~~~--~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLA--RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN--HPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEE--EecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC--CCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 799999999999 55556899999999855432 3567899999999999 999999999999988999999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-CCceEEeccccccccCCCCccc
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
+|.+++.. ....++...+..++.++++++++||+. |++|+|++|.||+++. ++.++|+||+.+........ .
T Consensus 77 ~l~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~ 149 (215)
T cd00180 77 SLKDLLKE---NEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-L 149 (215)
T ss_pred cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-h
Confidence 99999831 115789999999999999999999999 9999999999999998 89999999999876544321 1
Q ss_pred cccccCCccccCccccccC-CCCCcccchhHHHHHHHH
Q 027015 162 STRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEI 198 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l 198 (229)
.....+...|++||..... ..+.++|+|++|++++++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 2334567789999998876 788999999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=191.50 Aligned_cols=210 Identities=19% Similarity=0.328 Sum_probs=164.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceE-EEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG-CIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~-~~~~~~~~lv~e~~~ 80 (229)
+.||+|.||++-++ .+.++++.+++|.+..+- ....++.+|...--.|. .|.||+.-|+. |+..+.+++++||++
T Consensus 30 k~lgeG~FgkIlL~--eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls-~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 30 KQLGEGRFGKILLA--EHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLS-PHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred HHhcccceeeEEee--eccCCceEEEeeccCcch-hhHHHHHHHhccceeec-cchhhhHHHHHHhhcCceEEEeeccCc
Confidence 46899999999999 667788999999986442 23456777776655554 48899987775 566678889999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc--CCCceEEeccccccccCCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~--~~~~~~l~dfg~~~~~~~~~ 158 (229)
-|+|.+-+ ....+.+..-..++.|+++|+.|+|+. +++|||||.+||++- +.-++||||||.....+...
T Consensus 106 ~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 106 RGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred cchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999877 346788899999999999999999999 999999999999994 34479999999887643322
Q ss_pred ccccccccCCccccCccccccC-----CCCCcccchhHHHHHHHHHhCCCcccCc--cccccccchhhhccccccc
Q 027015 159 THISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFD--VQLGEYHLVDKVRSINMKL 227 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~ 227 (229)
.. .--...|.+||+.... ...+.+|+|.+|++++.+++|..||+-. .......+.++.++.++++
T Consensus 178 ~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 178 KY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred hh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 11 1224458899877632 2467899999999999999999999843 3445667777777777665
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=196.81 Aligned_cols=129 Identities=22% Similarity=0.306 Sum_probs=109.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCC------CcccccceEEEc----CCc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH------ENLVKLHGGCID----GPC 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~------~~i~~~~~~~~~----~~~ 71 (229)
++||=|.|++||++ .+.++.+.||+|+.+.. ..-.+..+.|+.+|++++... ..|++++|.|.. +.+
T Consensus 84 rKLGWGHFSTVWLa--wDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 84 RKLGWGHFSTVWLA--WDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred EeccccccceeEEE--eeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 58999999999999 77888899999999743 223356788999999997543 379999999974 457
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~ 138 (229)
.|+|+|++ |.+|..++. ......++...+.+|++|++.||.|||+.+ ||||.||||+||++.
T Consensus 161 VCMVfEvL-GdnLLklI~--~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIK--YSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred EEEEehhh-hhHHHHHHH--HhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 89999998 888888883 246678999999999999999999999986 999999999999993
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=179.91 Aligned_cols=210 Identities=20% Similarity=0.267 Sum_probs=172.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+++||+|+||.+|++ .+..+|..||+|+-+..... .++..|..+++.++ .-..|..+..+..+...-++||+..
T Consensus 20 vrkiGsGSFGdIy~~--~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~-~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLG--ISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQ-GGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred EEeecCCchhheeee--eeccCCceEEEEeecccCCC--cchhHHHHHHHHhc-cCCCCchhhhhccccccceeeeecc-
Confidence 368999999999999 88889999999998644333 46788999999998 3456777777777777889999988
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc---CCCceEEeccccccccCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~---~~~~~~l~dfg~~~~~~~~ 157 (229)
|-||.+++. -....++..++.-++.|++.-+.|+|.. +++||||||+|+++. ...++.|+|||+++.+.+.
T Consensus 94 GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 94 GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 889999883 3556788899999999999999999999 999999999999995 3456899999999887543
Q ss_pred Ccc------ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhcc
Q 027015 158 TTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222 (229)
Q Consensus 158 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 222 (229)
... ......||..|.+-..+.+..-+++.|+-|+|.++.++-.|..||++.......+-.+.+.+
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 221 13346689999998888888889999999999999999999999998766555555555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=191.12 Aligned_cols=193 Identities=26% Similarity=0.367 Sum_probs=160.1
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
.+||+|.|+.||++..... ..+..||+|.+...+. ...+..|++++..+. ++.||+++.+++-.++...+|+||++
T Consensus 42 ~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~g-G~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 42 NKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLG-GSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred ccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhc-cchhhhcchhhhccCCeeEEEecccC
Confidence 4799999999999965442 1568899999865443 357899999999998 59999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-CCCceEEeccccccccCC---
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPE--- 156 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-~~~~~~l~dfg~~~~~~~--- 156 (229)
+....++. ..++...+.++++.++.||+++|.+ ||+||||||.|++.+ ..++-.|+|||++.....
T Consensus 119 H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 119 HDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred ccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 99998887 4566899999999999999999999 999999999999997 566789999999872100
Q ss_pred -----C-----Cc------------------------------cccccccCCccccCcccccc-CCCCCcccchhHHHHH
Q 027015 157 -----N-----TT------------------------------HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLL 195 (229)
Q Consensus 157 -----~-----~~------------------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~ 195 (229)
. .. ......+||++|.|||++.. ...+.+.|+||.|+|+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 00 00112348999999999885 4568899999999999
Q ss_pred HHHHhCCCcccC
Q 027015 196 LEIVSGRTAVDF 207 (229)
Q Consensus 196 ~~l~~g~~pf~~ 207 (229)
..+++++.||=.
T Consensus 269 Lslls~~~PFf~ 280 (418)
T KOG1167|consen 269 LSLLSRRYPFFK 280 (418)
T ss_pred ehhhcccccccc
Confidence 999999999953
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=207.69 Aligned_cols=194 Identities=24% Similarity=0.336 Sum_probs=173.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..+|+|.+|.||++ ++..+++..|+|.++.+...+...+.+|+-+++..+ ||||+.+++.+....+.++.||||.+
T Consensus 21 qrvgsgTygdvyKa--Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~--h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKA--RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR--HPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred eeecCCcccchhhh--cccccCchhhheeeeccCCccccccccceeeeecCC--CcChHHHHhhhhhhcCcEEEEEecCC
Confidence 46899999999999 667789999999999998888889999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|.+.. .-.+++++-++...++..++++.|||++ |-+|||||-.||++++.|.+++.|||.+-.+..... .
T Consensus 97 gslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-K 168 (829)
T KOG0576|consen 97 GSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-K 168 (829)
T ss_pred Cccccee----eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh-h
Confidence 9999987 7889999999999999999999999999 999999999999999999999999999876544322 2
Q ss_pred cccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 162 STRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
...+.||+.|||||+.. ...|....|+|++|....++-.-++|.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd 217 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD 217 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence 35578999999999875 34588999999999999988777765443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=180.61 Aligned_cols=197 Identities=21% Similarity=0.282 Sum_probs=167.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
++||+|+||.++.+ .++-++++||||.....+ ..-++..|.+.++.|. ..++|...+-+-..+-+-.+|+|.+ |
T Consensus 34 kKIGeGsFG~lf~G--~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~-g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 34 KKIGEGSFGVLFLG--KNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLG-GTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cccccCcceeeecc--cccccCceEEEEeccccC--CcchHHHHHHHHHHHc-CCCCCCceeeeccccchhhhhhhhh-C
Confidence 58999999999999 778899999999875333 3457888999999998 5789988875555555667999988 8
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-----CceEEeccccccccCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-----FNPKISDFGLSKLFPE 156 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-----~~~~l~dfg~~~~~~~ 156 (229)
-||.|++ +-....++..++..++.|++.-++++|+. .+|+|||||+|+++... +.+.++|||+++...+
T Consensus 108 PSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 108 PSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred cCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8999998 46678899999999999999999999999 99999999999999643 3489999999998765
Q ss_pred CCccc------cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHI------STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
+.... .....||.+||+-..+.|..-+++.|+-|||.++++++.|..||.+..-
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 43322 2335699999999999999999999999999999999999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=184.80 Aligned_cols=201 Identities=19% Similarity=0.213 Sum_probs=162.0
Q ss_pred CccCCcccccccccceEeccC-CcEEEEEEeecccchhhHHHHHHHHHHhhhcc--CCCcccccceEE-EcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNV--CHENLVKLHGGC-IDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~--~~~~i~~~~~~~-~~~~~~~lv~e 77 (229)
+.||+|+||.||++ .+..+ ...+|+|............+..|..++..+.. ..+++..+++.. ......++||+
T Consensus 24 ~~iG~G~fG~V~~v--~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 24 KKIGEGGFGAVYLV--SDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred eeccccCCceEEEE--EecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 57999999999999 44444 36799999876544433377788888888872 235888888888 46677899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-----CceEEecccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-----FNPKISDFGLSK 152 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-----~~~~l~dfg~~~ 152 (229)
.+ |.+|.++..... ...++..+...++.|++.+|.++|+. |++||||||.|+++... ..+.|.|||++.
T Consensus 102 l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred cc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 77 999999874332 57899999999999999999999999 99999999999999754 358999999998
Q ss_pred --ccCCCC----ccc---cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 153 --LFPENT----THI---STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 153 --~~~~~~----~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.+.... ... .....||..|.++..+.+...+++.|+||++.++.++..|..||.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 321111 111 2335699999999999999999999999999999999999999976543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=181.00 Aligned_cols=157 Identities=18% Similarity=0.160 Sum_probs=120.0
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeecc-----cchhhHHHHHHHHHHhhhccCCCcccc-cceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVK-LHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~~i~~-~~~~~~~~~~~~l 74 (229)
+.||+|+||+||+| +... +++.+|||.+... .....+.+.+|+++++.++ |+++++ +++ .+..++
T Consensus 24 ~~IG~G~fg~Vy~a--~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~--h~~iv~~l~~----~~~~~L 95 (365)
T PRK09188 24 AVLKRDVFSTVERG--YFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR--GIGVVPQLLA----TGKDGL 95 (365)
T ss_pred cEEeecCcEEEEEE--EEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc--CCCCCcEEEE----cCCcEE
Confidence 56999999999999 4444 6788899987533 1223466889999999999 999885 433 246799
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCC-CCCCEEEcCCCceEEeccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI-KTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di-~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
||||++|++|.... ... ...++.+++++|.+||+. |++|||| ||.||+++.++.++|+|||++..
T Consensus 96 VmE~~~G~~L~~~~-----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 96 VRGWTEGVPLHLAR-----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEccCCCCHHHhC-----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 99999999996321 111 146788999999999999 9999999 99999999899999999999987
Q ss_pred cCCCCccc-------cccccCCccccCccccccC
Q 027015 154 FPENTTHI-------STRVAGTLGYLAPEYAISG 180 (229)
Q Consensus 154 ~~~~~~~~-------~~~~~~~~~~~aPE~~~~~ 180 (229)
+....... -....+++.|.|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 64432111 1234567789999988743
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=200.06 Aligned_cols=145 Identities=19% Similarity=0.168 Sum_probs=111.5
Q ss_pred C-CcccccceEE-------EcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEE
Q 027015 56 H-ENLVKLHGGC-------IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127 (229)
Q Consensus 56 ~-~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h 127 (229)
| +||+.++++| ......+.++|++ +++|.+++. .....+++..+..++.||++||+|||++ ||+|
T Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 31 HIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLD---NPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred HHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHh---cccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 5 6788888877 2334567888877 779999993 2345699999999999999999999999 9999
Q ss_pred cCCCCCCEEEcCCCc-------------------eEEeccccccccCCCCc---------------cccccccCCccccC
Q 027015 128 RDIKTSNILLDQNFN-------------------PKISDFGLSKLFPENTT---------------HISTRVAGTLGYLA 173 (229)
Q Consensus 128 ~di~p~ni~~~~~~~-------------------~~l~dfg~~~~~~~~~~---------------~~~~~~~~~~~~~a 173 (229)
|||||+||+++..+. ++++|||++........ .......+|+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999965444 45555555543211000 00011347888999
Q ss_pred ccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 174 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 174 PE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
||++.+..++.++|||||||++|||++|..|+..
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 9999999999999999999999999999998864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=160.61 Aligned_cols=138 Identities=14% Similarity=0.151 Sum_probs=108.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch--h------------------------hHHHHHHHHHHhhhccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--G------------------------EKEFMSEVASMANVNVC 55 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~~~~l~~~ 55 (229)
+.||+|++|.||+| ... +|+.||+|+++..... . ......|++.+..+.
T Consensus 3 ~~ig~G~~~~Vy~a--~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 77 (190)
T cd05147 3 GCISTGKEANVYHA--TTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-- 77 (190)
T ss_pred CccccccceEEEEE--ECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 68999999999999 443 8999999999754211 1 012235899999998
Q ss_pred CCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEcCCCCCC
Q 027015 56 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI-HEEIQPHVVHRDIKTSN 134 (229)
Q Consensus 56 ~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-H~~~~~~i~h~di~p~n 134 (229)
++++.....+... ..++||||++++++.... .....++...+..++.|++.+|.++ |+. |++|+||||.|
T Consensus 78 ~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~----~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~N 148 (190)
T cd05147 78 TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPR----LKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYN 148 (190)
T ss_pred HCCCCCCcEEEec--CCEEEEEEeCCCCCcchh----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHH
Confidence 7776544433222 238999999988776543 2345788999999999999999999 788 99999999999
Q ss_pred EEEcCCCceEEecccccccc
Q 027015 135 ILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 135 i~~~~~~~~~l~dfg~~~~~ 154 (229)
|+++ ++.++|+|||++...
T Consensus 149 Ili~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 149 LLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEE-CCcEEEEEccccccC
Confidence 9998 578999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=172.29 Aligned_cols=216 Identities=18% Similarity=0.214 Sum_probs=167.3
Q ss_pred cCCcccccccccceEecc---CCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-CceEEEEEc
Q 027015 4 VGPIRLEKVDLAPFIRLQ---DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVYDY 78 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-~~~~lv~e~ 78 (229)
+-+|.||.||.+.|+..+ +.+.|.+|.++.. +.-....++.|.-.+..+. |||+..+.++.... ...++++++
T Consensus 292 lqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s--H~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 292 LQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS--HPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc--CCCccceeEEEeeccCcceEEEec
Confidence 468999999999665432 3456777877633 2333456777887787877 99999999987654 466899999
Q ss_pred cCCCCHHHHHhhhh----ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 79 MPNNSLSQTLLGEE----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 79 ~~~~sL~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
..-++|..++.... +....++..++..++.|++.|+++||+. |++|.||-..|+.+++.-++||+|=.+++..
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcccc
Confidence 99999999995321 2223566778888999999999999999 9999999999999999999999998777653
Q ss_pred C-CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchhhhcccc
Q 027015 155 P-ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSIN 224 (229)
Q Consensus 155 ~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 224 (229)
- .+.......--.+..||+||.+....++.++|+||+|+++|||++ |+.|+..-++.+.+.......++.
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla 518 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA 518 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence 2 211111111123567999999999999999999999999999998 999999888888777777665543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=162.80 Aligned_cols=163 Identities=17% Similarity=0.214 Sum_probs=123.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHH---------HHHHHHHHhhhccCCCcccccceEEEcC---
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKE---------FMSEVASMANVNVCHENLVKLHGGCIDG--- 69 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~~~~l~~~~~~i~~~~~~~~~~--- 69 (229)
+.||.|+||.||++.. ++..+|+|++.......... +.+|+..+.++. ||+|..+.+++...
T Consensus 37 ~~l~~~~f~~v~l~~~----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~--~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 37 KVFRNIDDTKVSLIDT----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR--SEGLASLNDFYLLAERK 110 (232)
T ss_pred EEecCCCceEEEEEec----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH--HCCCCcceEeeeecccc
Confidence 5789999999998622 46789999997654333322 578888999998 99999999987643
Q ss_pred -----CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceE
Q 027015 70 -----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144 (229)
Q Consensus 70 -----~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~ 144 (229)
+..+++|||++|.+|.++. .+++ ....++..++..+|+. |++|+|++|.||+++.+| ++
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 3578999999999998874 1222 2455889999999999 999999999999999888 99
Q ss_pred EeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHH
Q 027015 145 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199 (229)
Q Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~ 199 (229)
|+|||........... . .......+..++|+||||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~-------d------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------D------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-------H------HHHHHhHhcccccccceeEeehHHH
Confidence 9999977544221110 0 0223344567899999998876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=154.94 Aligned_cols=141 Identities=14% Similarity=0.134 Sum_probs=110.5
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccch---------------------h-----hHHHHHHHHHHhhhcc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ---------------------G-----EKEFMSEVASMANVNV 54 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~~~~l~~ 54 (229)
.+.||+|++|.||++ ... +|+.||||+++..... . ......|.+.+..+.
T Consensus 2 ~~~ig~G~~~~Vy~a--~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 77 (190)
T cd05145 2 NGCISTGKEANVYHA--RTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY- 77 (190)
T ss_pred CceeecCCCcEEEEE--EcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-
Confidence 478999999999999 443 8999999999754211 0 122357888899998
Q ss_pred CCCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCC
Q 027015 55 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTS 133 (229)
Q Consensus 55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ 133 (229)
++++.....+... ..++||||++|+++.... .....++......++.|++.++.++|+ . |++|+||||.
T Consensus 78 -~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~----l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~ 147 (190)
T cd05145 78 -EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPR----LKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEY 147 (190)
T ss_pred -hCCCCCceEEEec--CCEEEEEEecCCCchhhh----hhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChh
Confidence 8887655444333 248999999888654432 133567888999999999999999999 8 9999999999
Q ss_pred CEEEcCCCceEEeccccccccCC
Q 027015 134 NILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 134 ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++ ++.++|+|||++.....
T Consensus 148 NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE-CCCEEEEEcccceecCC
Confidence 99999 88999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-23 Score=164.25 Aligned_cols=194 Identities=32% Similarity=0.495 Sum_probs=164.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch---hhHHHHHHHHHHhhhccCCC-cccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~~~~l~~~~~-~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||.|.|+.||++... ..+++|.+...... ....+.+|+..+..+. |+ +++++.+.+......+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 6 RKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSKEVERFLREIQILASLN--HPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred EeecCCCCeEEEEEEec-----cEEEEEeechhhccchhHHHHHHHHHHHHHHcc--CCcceeeEEEEEecCCEEEEEEe
Confidence 47899999999999443 78999998755322 3678899999999999 77 79999999977777899999
Q ss_pred ccCCCCHHHHHhhhhccc---cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccc
Q 027015 78 YMPNNSLSQTLLGEEKRR---AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKL 153 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~ 153 (229)
++.++++.+++ ... ..++......++.|++.++.++|+. +++|+|++|+|++++..+ .++++|||.+..
T Consensus 79 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 79 YVDGGSLEDLL----KKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred cCCCCcHHHHH----HhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 99999999666 233 3799999999999999999999999 999999999999999888 699999999875
Q ss_pred cCCCCcc-----ccccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTH-----ISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....... ......++..|.+||...+ ...+...|+||+|++++++++|..||....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5433221 2355678999999999987 578899999999999999999999977654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=182.85 Aligned_cols=189 Identities=17% Similarity=0.133 Sum_probs=153.7
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
-||+|++|+||+| .... |+.||+|+-++.+.+..--..+-.++|+ .. .-+.|..+...+.-.+..++|++|.+.|
T Consensus 705 e~G~g~y~~vy~a--~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~-~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 705 EIGEGSYGSVYVA--THSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ-MLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred eeccccceEEEEe--ecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh-hhcchHHHHHHHccCCcceeeeeccccc
Confidence 5899999999999 3333 9999999998877776533333333333 21 1577888877777778889999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-------CCCceEEeccccccccC
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-------QNFNPKISDFGLSKLFP 155 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-------~~~~~~l~dfg~~~~~~ 155 (229)
+|.+++ +..+.+++.....++.|++..+..||.. +||||||||+|+++. ..-.++|+|||.+..+.
T Consensus 780 tlld~~----N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 780 TLLDLI----NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred cHHHhh----ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999 5888899999999999999999999999 999999999999994 23348999999987653
Q ss_pred CCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCC
Q 027015 156 ENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203 (229)
Q Consensus 156 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 203 (229)
-.... .....++|-.|..+|...|++|++..|.|.|+.+++.|+.|+.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 22111 2234567888999999999999999999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=150.17 Aligned_cols=107 Identities=23% Similarity=0.239 Sum_probs=93.2
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|.+++. .....+++..++.++.|++.||+|||+. + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILE---VRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 67888883 2355799999999999999999999998 6 999999999999999 99887653321
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..|++.|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25789999999999999999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=158.13 Aligned_cols=200 Identities=19% Similarity=0.211 Sum_probs=132.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhcc-C-------CCcccccceEEE---
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNV-C-------HENLVKLHGGCI--- 67 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~-~-------~~~i~~~~~~~~--- 67 (229)
+.||.|+++.||.+ ++..+|+.+++|++.... ....+++.+|......+.. . |-.++..++...
T Consensus 18 ~~i~~g~~~~v~~v--~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 18 RIIGKGGFSIVFEV--TDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEETTEEEEEE--EETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred cccccCCceEEEEE--EEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 36899999999999 888899999999987553 2233566666666555331 0 223344444332
Q ss_pred ------cC---C-----ceEEEEEccCCCCHHHHHhh---hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCC
Q 027015 68 ------DG---P-----CRILVYDYMPNNSLSQTLLG---EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130 (229)
Q Consensus 68 ------~~---~-----~~~lv~e~~~~~sL~~~~~~---~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di 130 (229)
.. . ..+++|+-+ .++|.+.+.. .......+.......+..|+++.+++||.. |++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11 1 235677766 7788877533 222223444555667778999999999999 9999999
Q ss_pred CCCCEEEcCCCceEEeccccccccCCCCccccccccCCccccCccccccC--------CCCCcccchhHHHHHHHHHhCC
Q 027015 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG--------RLTRKSDVYSFGVLLLEIVSGR 202 (229)
Q Consensus 131 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Dv~slG~i~~~l~~g~ 202 (229)
+|+|++++++|.+.|+||+.....+..... ...+..|.|||..... .++.+.|.|+||+++|.|++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999887765443221 2234678999977542 4688999999999999999999
Q ss_pred CcccCcccc
Q 027015 203 TAVDFDVQL 211 (229)
Q Consensus 203 ~pf~~~~~~ 211 (229)
.||+.....
T Consensus 248 lPf~~~~~~ 256 (288)
T PF14531_consen 248 LPFGLSSPE 256 (288)
T ss_dssp -STCCCGGG
T ss_pred CCCCCCCcc
Confidence 999976543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=144.84 Aligned_cols=186 Identities=17% Similarity=0.087 Sum_probs=136.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchh----hHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQG----EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
..|++|+||+|+.+ . ..+.+++.+.+....... ...+.+|+++++++. .++++.+++++ +..+++||
T Consensus 8 ~~l~~~~f~~v~~~---~-~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~-~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 8 EPLKSDTFGRILLV---R-GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLD-GLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred eeecCCCcceEEEe---e-cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcC-CCCCCCEEEEE----cCEEEEEe
Confidence 46899999999976 2 267888888876442211 125788999999997 25789998886 45799999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCC-CCCCEEEcCCCceEEeccccccccCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI-KTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di-~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
|++|.+|..... . . ...++.|+..++.++|+. |++|+|| +|.||+++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~----~-~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPP----R-G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhh----h-h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999999875441 1 1 124678899999999999 9999999 79999999999999999999985433
Q ss_pred CCcc----c--------cccccCCccccCccccccC-CCC-CcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTH----I--------STRVAGTLGYLAPEYAISG-RLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~----~--------~~~~~~~~~~~aPE~~~~~-~~~-~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... . ..-...++.+++|+..... ..+ ...+.++.|+-+|.++|+..++-.+..
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 2210 0 0011145667777755432 344 566788889999999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=146.46 Aligned_cols=135 Identities=17% Similarity=0.238 Sum_probs=104.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhcc---CCCcccccceEEEcCC---ceE-E
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV---CHENLVKLHGGCIDGP---CRI-L 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~---~~~~i~~~~~~~~~~~---~~~-l 74 (229)
..||+|+||.||. +..++.. +||++........+.+.+|+..++.+.. .||||++++++++++. ..+ +
T Consensus 8 ~~LG~G~~~~Vy~----hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 8 SPLGTGRHRKCYA----HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred ceecCCCceEEEE----CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4799999999995 3445555 6999876655566789999999999942 2799999999998874 334 7
Q ss_pred EEEc--cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEEcCCCCCCEEEcCC----CceEEec
Q 027015 75 VYDY--MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL-AYIHEEIQPHVVHRDIKTSNILLDQN----FNPKISD 147 (229)
Q Consensus 75 v~e~--~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l-~~lH~~~~~~i~h~di~p~ni~~~~~----~~~~l~d 147 (229)
|+|| +.+++|.+++. . ..+++. ..++.+++.++ +|||++ +|+|+||||+||+++.+ ..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~----~-~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAE----Q-CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHH----c-ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 55799999992 2 235555 35567777777 999999 99999999999999743 3799999
Q ss_pred cccc
Q 027015 148 FGLS 151 (229)
Q Consensus 148 fg~~ 151 (229)
++.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-23 Score=175.11 Aligned_cols=198 Identities=24% Similarity=0.314 Sum_probs=156.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhh----HHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGE----KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
..+|.|++|.|+.+ ......+..+.|.+... ..... ..+..|.-+-..+. |||++..+..+.+.....-.
T Consensus 324 ~~~g~ga~g~~~~~--~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~--h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 324 RVLGSGAYGSVRIA--KRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS--HPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred ceeeecccCceEEE--EecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc--CCchhhhHHHHhhcccchhh
Confidence 35788999977776 55555565666655321 11111 22445666666667 99998888877766666656
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
||||++ +|+..+ .....++..++-.++.|++.|++|+|.. |+.|||+||+|++++.+|.++|+|||.+..+.
T Consensus 400 mE~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 400 MEYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeec
Confidence 999999 999988 4556899999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCc---cccccccCCccccCccccccCCCC-CcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 156 ENTT---HISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 156 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.... .......|+..|+|||++.+..|. +..|+||.|+++..|.+|+.||....+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 4332 334556789999999999999987 5789999999999999999999865443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.9e-23 Score=175.65 Aligned_cols=194 Identities=24% Similarity=0.308 Sum_probs=150.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
..||+++|=+|.++.+ .+ ..|+||++-... .-..+.+.++++-.+..-.++||.+++..+-+.+...|+|-+|.
T Consensus 29 ~~LGstRFlKv~r~k~---~e-G~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv- 103 (1431)
T KOG1240|consen 29 ENLGSTRFLKVARAKD---RE-GLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV- 103 (1431)
T ss_pred cccCchhhhhhhhccC---CC-ceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH-
Confidence 4699999999999832 33 459999986443 33344555555444433334999999998888888888999998
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc--CCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT 158 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~--~~~~ 158 (229)
..+|.|.+ +.++-+..-+..+++.|++.|+..+|.. ||+|||||.+||+++.-+.+.|.||...+.. ..++
T Consensus 104 khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 67899999 7888899999999999999999999999 9999999999999999999999999865432 2211
Q ss_pred cc----ccccccCCccccCccccccC----------C-CCCcccchhHHHHHHHHHh-CCCcccC
Q 027015 159 TH----ISTRVAGTLGYLAPEYAISG----------R-LTRKSDVYSFGVLLLEIVS-GRTAVDF 207 (229)
Q Consensus 159 ~~----~~~~~~~~~~~~aPE~~~~~----------~-~~~~~Dv~slG~i~~~l~~-g~~pf~~ 207 (229)
.. ...+.....+|.|||-+... + .+++.||||+||++.||++ |++||+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 11 11222345689999977642 1 5788999999999999987 8999974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-21 Score=144.99 Aligned_cols=138 Identities=17% Similarity=0.112 Sum_probs=107.4
Q ss_pred CccCCcccccccccceE-eccCCcEEEEEEeecccch------------------------hhHHHHHHHHHHhhhccCC
Q 027015 2 ASVGPIRLEKVDLAPFI-RLQDGTIVAVKVLSVESKQ------------------------GEKEFMSEVASMANVNVCH 56 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~~~~l~~~~ 56 (229)
.+||+|++|.||+| . +..+|+.||+|.++..... ....+..|+..+..+. +
T Consensus 34 ~~Lg~G~~g~Vy~a--~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~--~ 109 (237)
T smart00090 34 GCISTGKEANVYHA--LDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY--E 109 (237)
T ss_pred CeeccCcceeEEEE--EecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH--h
Confidence 57999999999999 5 5678999999998754210 0123567999999997 4
Q ss_pred C--cccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEEcCCCCC
Q 027015 57 E--NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-VVHRDIKTS 133 (229)
Q Consensus 57 ~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-i~h~di~p~ 133 (229)
. .+.++++ . ...++||||+++.+|.... .....+.......++.|++.++++||+. | ++|+|++|+
T Consensus 110 ~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeE---e-cCceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 3 2333333 2 2458999999998887654 2344566677789999999999999999 9 999999999
Q ss_pred CEEEcCCCceEEeccccccccC
Q 027015 134 NILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 134 ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999887543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-22 Score=166.23 Aligned_cols=190 Identities=27% Similarity=0.283 Sum_probs=158.6
Q ss_pred ccCCcccccccccceE-eccCCcEEEEEEeecccchh--hHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 3 SVGPIRLEKVDLAPFI-RLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~-~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
.+|+|.+|+|++++-. ....|.-+++|+++...... ......|..++...+ .||.++++...++.+...+++.++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~-~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH-NTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc-CCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999998633 34557889999987543221 224455666666665 4999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
.++.|...+ .....+++.........++-+++++|+. +++|+|+|++||+++.+|++++.|||+++..-+...
T Consensus 80 rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 80 RGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred ccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999998887 5667777888888888999999999999 999999999999999999999999999876543322
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.+|+.-|+|||++. ....++|.||+|++++++++|..||..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27899999999988 667889999999999999999999997
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-20 Score=140.17 Aligned_cols=135 Identities=20% Similarity=0.250 Sum_probs=112.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccch--------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCce
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 72 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~ 72 (229)
++.||+|++|.||++.+ +|..+++|........ ......+|++.+..+. ++++.....++.+....
T Consensus 1 ~~~l~~G~~~~vy~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR--KAGVNVPAVYFVDPENF 74 (211)
T ss_pred CcccccCceEEEEEEee----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH--HCCCCCCeEEEEeCCCC
Confidence 47899999999999933 6788999987643211 1245778999999998 99988887777777888
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
+++|||++|.+|.+.+. ... . ....++.+++.++.++|+. |++|+|++|.||+++ ++.++++|||.+.
T Consensus 75 ~lv~e~~~G~~L~~~~~----~~~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 75 IIVMEYIEGEPLKDLIN----SNG---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EEEEEEeCCcCHHHHHH----hcc---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 99999999999999883 111 1 7888999999999999999 999999999999999 7889999999876
Q ss_pred c
Q 027015 153 L 153 (229)
Q Consensus 153 ~ 153 (229)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 5
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=133.83 Aligned_cols=130 Identities=20% Similarity=0.242 Sum_probs=105.3
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccc--------hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~l 74 (229)
.||+|++|.||++. .+|..+++|....... .....+.+|++.+..+. ++++.....++......++
T Consensus 1 ~ig~G~~~~vy~~~----~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGD----FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR--KAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEee----cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH--HCCCCCCEEEEEECCCCEE
Confidence 38999999999994 3678999998653311 11255678999999998 8776666556666777899
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+|||++|++|.+.+. .... .++.+++.+|.++|+. |++|+|++|.||+++ ++.++++|||.+..
T Consensus 75 v~e~~~g~~l~~~~~----~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 75 VMEYIEGKPLKDVIE----EGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEECCccHHHHHh----hcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999998872 1111 7889999999999999 999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=139.64 Aligned_cols=194 Identities=20% Similarity=0.348 Sum_probs=151.2
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+|.+...|..|+++| .|..++.|+++.. +....+++.+|.-.++.+. ||||+++++.+.......++..|++
T Consensus 197 kl~e~hsgelwrgrw----qgndivakil~vr~~t~risrdfneefp~lrifs--hpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 197 KLAESHSGELWRGRW----QGNDIVAKILNVREVTARISRDFNEEFPALRIFS--HPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhccCCCcccccccc----cCcchhhhhhhhhhcchhhcchhhhhCcceeeec--CCchhhhhhhccCCCCceEeeeecc
Confidence 456667788888866 4577888988754 2333477889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
.+||.+.++. +...-.+..++..++.+++++++|||+. .+-+.--.++..+++++++.+.+|.--+.-..+...
T Consensus 271 ~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe~--- 344 (448)
T KOG0195|consen 271 FGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV--- 344 (448)
T ss_pred chHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeecc---
Confidence 9999999952 3455677888899999999999999997 334445579999999998877665432222212111
Q ss_pred ccccccCCccccCccccccCCCC---CcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~---~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
-..-.|.|++||.+..++.+ +++|+||+++++|||-|.+.||....+.
T Consensus 345 ---gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 345 ---GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred ---ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 12346789999998876643 5799999999999999999999876654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=128.88 Aligned_cols=133 Identities=20% Similarity=0.209 Sum_probs=101.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch----------------------hhHHHHHHHHHHhhhccCCCc-
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ----------------------GEKEFMSEVASMANVNVCHEN- 58 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~~~~l~~~~~~- 58 (229)
..||+|+||.||++ .. .+|+.+|||+++..... .......|...+..+. +++
T Consensus 21 ~~i~~G~~g~Vy~~--~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i 95 (198)
T cd05144 21 NQIGVGKESDVYLA--LD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY--EEGF 95 (198)
T ss_pred CccccCcceEEEEE--Ec-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH--HcCC
Confidence 46999999999998 33 47999999987643210 1123567888888887 663
Q ss_pred -ccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 027015 59 -LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137 (229)
Q Consensus 59 -i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~ 137 (229)
+...++ ....+++|||++|++|..... . .....++.+++.++.++|+. |++|+|++|.||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV----L------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc----c------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 333333 345689999999999876541 0 33457888999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCC
Q 027015 138 DQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 138 ~~~~~~~l~dfg~~~~~~~ 156 (229)
++++.++|+|||.+.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999865433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=144.98 Aligned_cols=131 Identities=18% Similarity=0.251 Sum_probs=105.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cc------hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~ 73 (229)
+.||+|+||+||++.+ .+..+++|..... .. ...+.+.+|++.++.++ |+++.....+..+....+
T Consensus 339 ~~iG~G~~g~Vy~~~~----~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 339 HLIGKGAEADIKKGEY----LGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR--RAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ceeccCCcEEEEEEee----cCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc--ccCCCeeEEEEEeCCCCE
Confidence 4689999999999843 2334455443211 11 12356788999999999 999988877777777789
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||+++++|.+++. ....++.+++.+|.+||+. |++|+|+||.||++ .++.++|+|||++..
T Consensus 413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999882 3467899999999999999 99999999999999 577899999999875
Q ss_pred c
Q 027015 154 F 154 (229)
Q Consensus 154 ~ 154 (229)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=122.50 Aligned_cols=137 Identities=20% Similarity=0.212 Sum_probs=94.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchh--hHH----------------------HHHHHHHHhhhccCCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQG--EKE----------------------FMSEVASMANVNVCHE 57 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~~~~l~~~~~ 57 (229)
+.||+|+||.||++ .. .+|+.||||+++...... ... ...|...+..+.....
T Consensus 3 ~~lg~G~~g~Vy~a--~~-~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 3 GPIGTGKEADVYLA--LD-GDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred cccccccceeEEEE--EC-CCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 67999999999999 33 378999999987542211 111 1245555555541112
Q ss_pred cccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEE
Q 027015 58 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNIL 136 (229)
Q Consensus 58 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~ 136 (229)
.+.+++.. ...+++|||++++.+..... ..... ...+..++.+++.++.++|. . +++|+|++|+||+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l----~~~~~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRL----KDVRL-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhh----hhhhh-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 23344332 24589999999854321110 00001 16677889999999999999 8 9999999999999
Q ss_pred EcCCCceEEecccccccc
Q 027015 137 LDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 137 ~~~~~~~~l~dfg~~~~~ 154 (229)
++ ++.++++|||.+...
T Consensus 148 i~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EE-CCcEEEEECcccccc
Confidence 99 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=118.82 Aligned_cols=136 Identities=16% Similarity=0.135 Sum_probs=109.9
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
++.||+|.++.||++.. ++..+++|....... ...+.+|+..++.+......+.+++.+...++..++++||++
T Consensus 3 ~~~i~~g~~~~v~~~~~----~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 3 IKLLKGGLTNRVYLLGT----KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred ceecccccccceEEEEe----cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 36799999999999832 337899999865433 467889999999998211588888888877788999999998
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+.++... +......++.+++++++.+|.....+++|+|++|.|+++++++.++++||+.+..
T Consensus 77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8766543 4566677889999999999986333799999999999999889999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-16 Score=120.24 Aligned_cols=134 Identities=18% Similarity=0.159 Sum_probs=99.8
Q ss_pred ccC-CcccccccccceEeccCCcEEEEEEeeccc-------------chhhHHHHHHHHHHhhhccCCCcc--cccceEE
Q 027015 3 SVG-PIRLEKVDLAPFIRLQDGTIVAVKVLSVES-------------KQGEKEFMSEVASMANVNVCHENL--VKLHGGC 66 (229)
Q Consensus 3 ~lg-~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~~~~l~~~~~~i--~~~~~~~ 66 (229)
.|| .|+-|+||.+.. ++..++||.+.... ........+|++.+..+. +++| +..++..
T Consensus 38 ~lg~~~g~gtv~~v~~----~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~--~~gi~vP~pl~~~ 111 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT----PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY--EAGLPVPRPIAAR 111 (239)
T ss_pred eeecCCCCccEEEEEe----CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH--hCCCCCceeEeee
Confidence 366 788888888622 36889999875311 122356788999999999 7664 5666654
Q ss_pred EcC-C---ceEEEEEccCC-CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC
Q 027015 67 IDG-P---CRILVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141 (229)
Q Consensus 67 ~~~-~---~~~lv~e~~~~-~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~ 141 (229)
... . ..++|+|+++| .+|.+++. ...++.. .+.+++.++.++|+. |++|+|++|.||+++.++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQ-----EAPLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHh-----cCCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 332 2 22599999997 68988872 2344444 356889999999999 999999999999999888
Q ss_pred ceEEecccccccc
Q 027015 142 NPKISDFGLSKLF 154 (229)
Q Consensus 142 ~~~l~dfg~~~~~ 154 (229)
.++|+|||.+...
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999988653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.1e-18 Score=137.64 Aligned_cols=123 Identities=25% Similarity=0.417 Sum_probs=104.8
Q ss_pred ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 71 ~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
..+|.|++|+..+|.+++... ......+......++.|++.++.| + +.+|+|++|.||++..+..++|+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 468999999999999999432 233356678889999999999999 6 899999999999999999999999999
Q ss_pred ccccCCCC-----ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh
Q 027015 151 SKLFPENT-----THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200 (229)
Q Consensus 151 ~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 200 (229)
........ ....+...||..||+||++.+..|+.++||||||++++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 88764433 222345668999999999999999999999999999999998
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.7e-16 Score=128.37 Aligned_cols=168 Identities=16% Similarity=0.206 Sum_probs=132.0
Q ss_pred EeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccC
Q 027015 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAK 97 (229)
Q Consensus 18 ~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~ 97 (229)
....++.+|.|...+...........+-++.++.++ ||+|+++++.++..+..|+|+|.+ ..|..++. .
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlR--HP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk-------~ 100 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLR--HPNILSYLDTTEEEGTLYLVTERV--RPLETVLK-------E 100 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhcc--CchhhhhhhhhcccCceEEEeecc--ccHHHHHH-------H
Confidence 567789999999998776655677888999999999 999999999999999999999987 44666662 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccccccccCCccccCcccc
Q 027015 98 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 177 (229)
Q Consensus 98 l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 177 (229)
+........+.||+.||.|||..+ +++|++|.-+.+||+..|..+|++|.++........ .......--.|..|+.+
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI 177 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence 237778888999999999998653 999999999999999999999999998865433221 11111222345666654
Q ss_pred ccCCCCCcccchhHHHHHHHHHhC
Q 027015 178 ISGRLTRKSDVYSFGVLLLEIVSG 201 (229)
Q Consensus 178 ~~~~~~~~~Dv~slG~i~~~l~~g 201 (229)
.... ...|.|.|||++++++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 3332 346999999999999999
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=129.08 Aligned_cols=165 Identities=30% Similarity=0.541 Sum_probs=130.6
Q ss_pred hhhccCCCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-EEc
Q 027015 50 ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV-VHR 128 (229)
Q Consensus 50 ~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i-~h~ 128 (229)
+.+. |.|+.++++.+.+++..++|.+||.-|+|.+.+. .....+++.....++++++.++.|+|.. .+ .|+
T Consensus 2 ~~l~--h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~---~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg 73 (484)
T KOG1023|consen 2 RQLD--HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS---NEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHG 73 (484)
T ss_pred cccc--hhhhhhheeeEecCCceEEEEeeecCccHHhHHh---ccccCccHHHHHHHHHHHHHHHHHHhcC---cceeee
Confidence 4556 9999999999999999999999999999999993 3567899999999999999999999998 44 999
Q ss_pred CCCCCCEEEcCCCceEEeccccccccCCC-CccccccccCCccccCccccccCC-------CCCcccchhHHHHHHHHHh
Q 027015 129 DIKTSNILLDQNFNPKISDFGLSKLFPEN-TTHISTRVAGTLGYLAPEYAISGR-------LTRKSDVYSFGVLLLEIVS 200 (229)
Q Consensus 129 di~p~ni~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Dv~slG~i~~~l~~ 200 (229)
.++..|++++..-.+||.|||+....... .........-..-|.|||.+.+.. .+.+.|+||+|++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999998765320 001111111344689999988631 4678999999999999999
Q ss_pred CCCcccCcccccc-ccchhhhcc
Q 027015 201 GRTAVDFDVQLGE-YHLVDKVRS 222 (229)
Q Consensus 201 g~~pf~~~~~~~~-~~~~~~~~~ 222 (229)
.+.||+....... ..++..+++
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred ccCccccccccCChHHHHHHHHh
Confidence 9999997433222 344444444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=122.62 Aligned_cols=145 Identities=24% Similarity=0.336 Sum_probs=111.0
Q ss_pred CCCcccccceEEEc---------------------------CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHH
Q 027015 55 CHENLVKLHGGCID---------------------------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 107 (229)
Q Consensus 55 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~ 107 (229)
.||||+.+...|.+ +...|+||..+ ..+|.+++ .....+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl-----~~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYL-----WTRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHH-----hcCCCchHHHHHHH
Confidence 39999999888752 34568999887 66898888 44556677788899
Q ss_pred HHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc--CCC--ceEEeccccccccCCCC-----ccccccccCCccccCccccc
Q 027015 108 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNF--NPKISDFGLSKLFPENT-----THISTRVAGTLGYLAPEYAI 178 (229)
Q Consensus 108 ~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~--~~~--~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~ 178 (229)
.|+++++.+||++ |+.|||+|.+||++. .|+ .+.+.|||-+-.-.... ....-..-|+...+|||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999994 333 37899999664322211 11122234677899999887
Q ss_pred cCC------CCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 179 SGR------LTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 179 ~~~------~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..+ --.++|.|+.|.+.||+++...||-..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 433 135899999999999999999999863
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=126.56 Aligned_cols=142 Identities=20% Similarity=0.240 Sum_probs=96.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhh----------------------------------------HH
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGE----------------------------------------KE 41 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~ 41 (229)
.+||.|++|.||+| .+.+|+.||||+.++...... -+
T Consensus 123 ~plasaSigQVh~A---~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 123 KPLAAASIAQVHRA---RLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred cceeeeehhheEEE---EecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 47999999999999 356899999999865421111 12
Q ss_pred HHHHHHHHhhhccC---CCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHH-HHHHH
Q 027015 42 FMSEVASMANVNVC---HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR-GLAYI 117 (229)
Q Consensus 42 ~~~e~~~~~~l~~~---~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~-~l~~l 117 (229)
+.+|+..+..+... ++++.-..-+.......++||||++|.+|.+..... ....+ ...++.+++. .+..+
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHH
Confidence 34455555555311 333322222222344578999999999998876321 11222 2334444444 46788
Q ss_pred hhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 118 H~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|.. |++|+|++|.||+++.+++++++|||.+..+.
T Consensus 274 ~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 988 99999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.3e-17 Score=140.42 Aligned_cols=202 Identities=25% Similarity=0.331 Sum_probs=158.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
.+||+|+|+.|-..... ......+++|.+.... .........|...-+.+. .|+|++.+++...+....++.+++.
T Consensus 26 ~~ig~gs~~~~~~~~~~-~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s-~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNS-RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS-KHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccchhhhhhhc-CCCcceeeccCCCCCCCccchhhhcCcccccccccc-ccccccccCCccCCCcccccccCcc
Confidence 57899999999877321 2234556777665432 223344445666666665 3999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccccCC-
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH-EEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFPE- 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~~~- 156 (229)
+|+++.+-.. .......+.......+.|+..++.|+| .. ++.|+|++|+|.+++..+ .+++.|||++..+..
T Consensus 104 ~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 104 DGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9999988762 122236777788889999999999999 87 999999999999999999 999999999988765
Q ss_pred -CCccccccccC-CccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 -NTTHISTRVAG-TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 -~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.........+| ++.|+|||...+. ...+..|+||+|+++..+++|..||.....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 23333445667 9999999998885 446889999999999999999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=137.70 Aligned_cols=164 Identities=22% Similarity=0.270 Sum_probs=115.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.|-.|++|-||++ ++..+.+++|+|.-+ ++ .+.+- ++.... .|.++
T Consensus 89 klisngAygavylv--rh~~trqrfa~kiNk-q~-----lilRn--ilt~a~--npfvv--------------------- 135 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLV--RHKETRQRFAMKINK-QN-----LILRN--ILTFAG--NPFVV--------------------- 135 (1205)
T ss_pred EeeccCCCCceeee--eccccccchhhcccc-cc-----hhhhc--cccccC--Cccee---------------------
Confidence 56778999999999 555566888984432 11 01110 222222 33333
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC----
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---- 157 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~---- 157 (229)
|+-...+ ..-++++... +.++.|||+. ||+|+|+||+|.+++.-|++|+.|||+.+.....
T Consensus 136 gDc~tll----k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 GDCATLL----KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred chhhhhc----ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 2222222 2323443333 6789999999 9999999999999999999999999987653211
Q ss_pred ----------CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccccc
Q 027015 158 ----------TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213 (229)
Q Consensus 158 ----------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~ 213 (229)
........+||+.|.|||++....|....|.|++|+|+|+.+.|..||.++.+++-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 11123346799999999999999999999999999999999999999999855443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.5e-14 Score=102.90 Aligned_cols=139 Identities=14% Similarity=0.069 Sum_probs=99.5
Q ss_pred CccCCcccccccccceEecc------CCcEEEEEEeeccc----------------------chhhHHH----HHHHHHH
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ------DGTIVAVKVLSVES----------------------KQGEKEF----MSEVASM 49 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~----~~e~~~~ 49 (229)
++||.|.=+.||.+. ... ++..+|||+.+... ....+.+ .+|...|
T Consensus 3 g~i~~GKEa~V~~~~--~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 3 GCISTGKESVVLHAN--GGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CccccCcceEEEEEe--cCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 689999999999993 322 35799999874310 0111222 3799999
Q ss_pred hhhccCCCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEc
Q 027015 50 ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI-HEEIQPHVVHR 128 (229)
Q Consensus 50 ~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-H~~~~~~i~h~ 128 (229)
+++...--.+.+++++ ...++||||+++..+.... .....++......+..+++.++..+ |+. |++|+
T Consensus 81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK----LKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh----hhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9988333455566553 4568999999765442211 1223455566777889999999988 888 99999
Q ss_pred CCCCCCEEEcCCCceEEecccccccc
Q 027015 129 DIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 129 di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
|+++.||+++ ++.+.++|||.+...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 568999999988765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.4e-15 Score=123.47 Aligned_cols=143 Identities=16% Similarity=0.178 Sum_probs=90.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchh----------------------------------h------HH
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQG----------------------------------E------KE 41 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~----------------------------------~------~~ 41 (229)
.+||+|++|.||+| +...+|+.||||+.++..... . -+
T Consensus 125 ~PlasaSiaQVh~A--~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD 202 (537)
T PRK04750 125 KPLASASIAQVHFA--RLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELD 202 (537)
T ss_pred hhhcCCCccEEEEE--EECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhC
Confidence 47999999999999 444459999999997542111 0 12
Q ss_pred HHHHHHHHhhhccC--CCcccccceEEEc-CCceEEEEEccCCCCHHHHHhh--hhccccCCCHHHHHHHHHHHHHHHHH
Q 027015 42 FMSEVASMANVNVC--HENLVKLHGGCID-GPCRILVYDYMPNNSLSQTLLG--EEKRRAKFGWKARREIIMGIGRGLAY 116 (229)
Q Consensus 42 ~~~e~~~~~~l~~~--~~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~--~~~~~~~l~~~~~~~~~~~i~~~l~~ 116 (229)
+.+|+....++... +...+.+-..+.+ ....++||||++|+.+.+.-.- .......+....+..++.|++
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 33344444444311 2222222222222 4456899999999999875311 101112344444444455543
Q ss_pred HhhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccccccccCC
Q 027015 117 IHEEIQPHVVHRDIKTSNILLDQNF----NPKISDFGLSKLFPE 156 (229)
Q Consensus 117 lH~~~~~~i~h~di~p~ni~~~~~~----~~~l~dfg~~~~~~~ 156 (229)
.. |++|+|++|.||+++.++ +++++|||.+..+..
T Consensus 278 --~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 --RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999888 999999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-14 Score=102.32 Aligned_cols=127 Identities=15% Similarity=0.102 Sum_probs=93.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCccc-ccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV-KLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~-~~~~~~~~~~~~~lv~e~~~ 80 (229)
++|+.|.++.||+++. +++.+++|....... .......|+..++.+. +.+++ +++... ....++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~----~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~--~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEV----ANKKYVVRIPGNGTE-LLINRENEAENSKLAA--EAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEE----CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHH--HhCCCCceEEEe--CCCCeEEEEecC
Confidence 5789999999998732 478999999864432 2335678899999887 44443 444432 334579999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-----VVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-----i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
|.++.+.. . .......+++.+++.||+. + ++|+|++|.||+++ ++.++++||+.+..
T Consensus 75 G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~---~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTED---------F---SDPENLEKIAKLLKKLHSS---PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCcccccc---------c---cCHHHHHHHHHHHHHHhCC---CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98875420 1 1123567889999999998 6 59999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-13 Score=112.49 Aligned_cols=198 Identities=21% Similarity=0.223 Sum_probs=156.5
Q ss_pred CccCC--cccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGP--IRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~--G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.+|. |.+|.+|.++.....++..+|+|.-+.. .......-.+|+...+.+. .|++.++....++..+..++-+|
T Consensus 120 ~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~-~~~~~v~~~~~~e~~~~lfiqtE 198 (524)
T KOG0601|consen 120 SRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID-SHENPVRDSPAWEGSGILFIQTE 198 (524)
T ss_pred cccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC-ccccccccCcccccCCcceeeec
Confidence 45788 9999999996655788899999984433 2233445566777777776 59999998888999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEEcCCCCCCEEEcCC-CceEEecccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR----GLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSK 152 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~----~l~~lH~~~~~~i~h~di~p~ni~~~~~-~~~~l~dfg~~~ 152 (229)
.+ +.+|..+.. .....++...++..+.+..+ |+.++|+. +++|.|++|.|++...+ ...+++|||+..
T Consensus 199 ~~-~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 199 LC-GESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cc-cchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeE
Confidence 88 577777762 44455788888888888888 99999999 99999999999999988 789999999998
Q ss_pred ccCCCCcc----ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 153 LFPENTTH----ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 153 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.++..... ......+...|++||... ..++...|++++|.++.+...+..++...
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 87654311 122335778899999654 45688899999999999998888776654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.5e-12 Score=91.21 Aligned_cols=131 Identities=22% Similarity=0.275 Sum_probs=100.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--------cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~ 73 (229)
..+++|+=+.++.+.+ -|.++++|.=.++ .+-...+-.+|+.++..+. ...|...+-++.+.....
T Consensus 2 ~~i~~GAEa~i~~~~~----~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~--~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF----LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR--EAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeec----cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH--HcCCCCCeEEEEcCCCCE
Confidence 5688999999998855 2345777764322 1111245667999999988 667777777777888889
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
|+|||++|..|.+.+. .. ...++..+-.-+.-||.. |++|+|++++|+.+..+ .+.++|||++..
T Consensus 76 I~me~I~G~~lkd~l~----~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALE----EA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHH----hc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 9999999999998882 22 245667777778899999 99999999999999854 499999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.6e-12 Score=89.62 Aligned_cols=141 Identities=21% Similarity=0.233 Sum_probs=105.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--------cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~ 73 (229)
..|-+|+=+.|+++ ..+|+.++||.-.+. ..-..++..+|++.+.++. --.|.-..-+|.+...-.
T Consensus 13 ~likQGAEArv~~~----~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~--~~GI~~P~l~~~D~~~~~ 86 (229)
T KOG3087|consen 13 ELIKQGAEARVPRG----SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR--ALGIPAPRLIFIDTYGGQ 86 (229)
T ss_pred eeeeccceeeEeee----ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH--HhCCCCceEEEEecCCCe
Confidence 34667888888876 447899999975322 1222366778999999988 667777777888888889
Q ss_pred EEEEccCC-CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc---eEEeccc
Q 027015 74 LVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFG 149 (229)
Q Consensus 74 lv~e~~~~-~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~---~~l~dfg 149 (229)
++|||++| .++.+++... .....+.......+.++-+.+.-||.. +++|+|++.+||++..++. +.++|||
T Consensus 87 i~ME~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred EEEEeccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeec
Confidence 99999977 4677777432 223333444478888999999999999 9999999999999964443 5899999
Q ss_pred cccc
Q 027015 150 LSKL 153 (229)
Q Consensus 150 ~~~~ 153 (229)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 8764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.6e-12 Score=95.82 Aligned_cols=143 Identities=17% Similarity=0.201 Sum_probs=102.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcC---CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~---~~~~lv~e 77 (229)
.+|+.|..+.+|+++. .+|+.+++|....... .....+..|.+.++.+...+..+.+++.+.... +..+++||
T Consensus 4 ~~l~~G~~n~~~~v~~---~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTA---GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEe---cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 5789999999999832 4468999999764322 234678899999999983334456666665543 25689999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------------------------------------ 121 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~------------------------------------ 121 (229)
|++|.++.+.+. ...++......++.+++++|..||+..
T Consensus 81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999988876541 134555666666666666666666421
Q ss_pred -----------------CCCeEEcCCCCCCEEEcC--CCceEEecccccc
Q 027015 122 -----------------QPHVVHRDIKTSNILLDQ--NFNPKISDFGLSK 152 (229)
Q Consensus 122 -----------------~~~i~h~di~p~ni~~~~--~~~~~l~dfg~~~ 152 (229)
...++|+|++|.||+++. ++.+.++||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 235799999999999998 5668999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.4e-12 Score=99.33 Aligned_cols=154 Identities=26% Similarity=0.350 Sum_probs=118.6
Q ss_pred HHHhhhccCCCcccccceEEEcC-----CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC
Q 027015 47 ASMANVNVCHENLVKLHGGCIDG-----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 121 (229)
Q Consensus 47 ~~~~~l~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 121 (229)
..+-++. |.||+++..|+.+. .+..++.||+..+++..++.........+......+|+.||++||.|||+.
T Consensus 119 dnllqlv--HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 119 DNLLQLV--HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHH--HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 3344555 99999999888643 456899999999999999987777778899999999999999999999997
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC----ccccccccCCccccCccccccCCCCCcccchhHHHHHHH
Q 027015 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT----THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197 (229)
Q Consensus 122 ~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~ 197 (229)
++.++|++++-+.+++..+|-+|++--.- .....+. ......-.+.++|.+||.-....-+-++|||++|+...+
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 88999999999999999888777654321 1111110 111122335678999997666667788999999999999
Q ss_pred HHhCCCc
Q 027015 198 IVSGRTA 204 (229)
Q Consensus 198 l~~g~~p 204 (229)
+..+..-
T Consensus 275 mailEiq 281 (458)
T KOG1266|consen 275 MAILEIQ 281 (458)
T ss_pred HHHheec
Confidence 8877753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.1e-11 Score=94.07 Aligned_cols=192 Identities=11% Similarity=0.114 Sum_probs=127.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccc----cceEEE--cCC-ceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK----LHGGCI--DGP-CRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~----~~~~~~--~~~-~~~l 74 (229)
.+||+|+-+.+|.. .+-...+-|+..........+.. +.+...- .||-+.. ...... +.+ ..-+
T Consensus 17 r~LgqGgea~ly~l-----~e~~d~VAKIYh~Pppa~~aqk~---a~la~~p-~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 17 RPLGQGGEADLYTL-----GEVRDQVAKIYHAPPPAAQAQKV---AELAATP-DAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred ccccCCccceeeec-----chhhchhheeecCCCchHHHHHH---HHhccCC-CCcchhhhhcccHHHhhCCCccceeEE
Confidence 47999999999865 33345567777644333222222 2222221 1442222 111111 122 2457
Q ss_pred EEEccCCCC-HHHHHhh--hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 75 VYDYMPNNS-LSQTLLG--EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 75 v~e~~~~~s-L~~~~~~--~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
+|+.+.+.- ...+... ..+......+..+....+.++.+.+.||.. |.+-+|++++|++|++++.+.|.|=+..
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 888876653 2232211 223445678899999999999999999999 9999999999999999999999996654
Q ss_pred cccCCCCccccccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhC-CCcccC
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSG-RTAVDF 207 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g-~~pf~~ 207 (229)
..- .+........|.+.|.+||... +...+...|.|.||+++++++.| ++||.+
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 332 1122234456889999999876 34567889999999999999876 899976
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=95.33 Aligned_cols=169 Identities=22% Similarity=0.319 Sum_probs=129.4
Q ss_pred ccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE----cCCceEEEEEccCC-CCH
Q 027015 10 EKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI----DGPCRILVYDYMPN-NSL 84 (229)
Q Consensus 10 ~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~----~~~~~~lv~e~~~~-~sL 84 (229)
.+.|++ ...-||..|++|.++............-++.++++. |+|++++-++|. .+...++|++|.++ .+|
T Consensus 290 ~Ttyk~--~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~--h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 290 ITTYKA--TSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLC--HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ceeEee--eeccCCceeeeeeeccccccCcccchHHHHHHHHhc--cCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 455676 788899999999995443333445566789999999 999999999886 44577899999865 467
Q ss_pred HHHHhhhh-----------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 85 SQTLLGEE-----------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 85 ~~~~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
.+...... ......++..+|.++.|++.||.++|+. |+..+-+.|.+|+++.+.+++|...|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 77654432 2334678899999999999999999999 999999999999999888999999887765
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCC
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 203 (229)
...+.. +| +.+ ..+.|.=.||.++..|.+|..
T Consensus 443 l~~d~~-------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPT-------------EP--LES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCCC-------------cc--hhH---HhhhhHHHHHHHHHHHhhccc
Confidence 433220 01 111 234688999999999999853
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.1e-10 Score=88.86 Aligned_cols=126 Identities=11% Similarity=0.036 Sum_probs=91.7
Q ss_pred cCCcEEEEEEeecccch-----------hhHHHHHHHHHHhhhccCCCccc--ccceEEEc-----CCceEEEEEccCCC
Q 027015 21 QDGTIVAVKVLSVESKQ-----------GEKEFMSEVASMANVNVCHENLV--KLHGGCID-----GPCRILVYDYMPNN 82 (229)
Q Consensus 21 ~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~~~~l~~~~~~i~--~~~~~~~~-----~~~~~lv~e~~~~~ 82 (229)
.+|+.+.||........ ......+|...+..+. ..+|. +++.+.+. ....++|+|++++.
T Consensus 43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~--~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~ 120 (268)
T PRK15123 43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH--EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPT 120 (268)
T ss_pred ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH--HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCC
Confidence 36788999976432211 1124778889888887 43433 33445443 23468999999886
Q ss_pred -CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-------CCceEEeccccccc
Q 027015 83 -SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-------NFNPKISDFGLSKL 153 (229)
Q Consensus 83 -sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-------~~~~~l~dfg~~~~ 153 (229)
+|.+++... ...+.+......++.+++..+..||+. |++|+|+++.||+++. +..+.|+||+.+..
T Consensus 121 ~sL~~~~~~~--~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 121 ISLEDYCADW--ATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 898887321 124556677889999999999999999 9999999999999975 46799999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.1e-11 Score=86.87 Aligned_cols=126 Identities=21% Similarity=0.203 Sum_probs=76.9
Q ss_pred ccccceEeccCCcEEEEEEeeccc--------------------------chhhHHHHHHHHHHhhhccCCCcccccceE
Q 027015 12 VDLAPFIRLQDGTIVAVKVLSVES--------------------------KQGEKEFMSEVASMANVNVCHENLVKLHGG 65 (229)
Q Consensus 12 v~~~~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~ 65 (229)
||.| ...+|..+|+|..+... ........+|.+.|..+...--++.+++++
T Consensus 2 Vy~~---~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 2 VYHA---IDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEE---EECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred EEEE---ECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 6666 33678899999874310 001245677999999998222245566544
Q ss_pred EEcCCceEEEEEccC--CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEEcCCCCCCEEEcCCCc
Q 027015 66 CIDGPCRILVYDYMP--NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA-YIHEEIQPHVVHRDIKTSNILLDQNFN 142 (229)
Q Consensus 66 ~~~~~~~~lv~e~~~--~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~-~lH~~~~~~i~h~di~p~ni~~~~~~~ 142 (229)
...++||||++ |..+..+.. ..++......++.+++..+. -+|.. |++|||+++.||+++++ .
T Consensus 79 ----~~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 ----NRNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ----ETTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred ----eCCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence 24579999998 655544331 11113344556666666444 45788 99999999999999976 9
Q ss_pred eEEecccccccc
Q 027015 143 PKISDFGLSKLF 154 (229)
Q Consensus 143 ~~l~dfg~~~~~ 154 (229)
+.++|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-10 Score=87.49 Aligned_cols=131 Identities=18% Similarity=0.153 Sum_probs=94.7
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc------------------c----chhhHHHHHHHHHHhhhccCCC--c
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE------------------S----KQGEKEFMSEVASMANVNVCHE--N 58 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~------------------~----~~~~~~~~~e~~~~~~l~~~~~--~ 58 (229)
.||-|.=|.||.+ ..++|.+++||.-+.. . ........+|.+.|+.|. .. .
T Consensus 98 ~IGvGKEsdVY~~---~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~--~~G~~ 172 (304)
T COG0478 98 KIGVGKESDVYVA---IDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY--PEGVK 172 (304)
T ss_pred ccccCccceEEEE---ECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh--hcCCC
Confidence 6899999999998 4467999999975321 0 011245677889999986 33 5
Q ss_pred ccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc
Q 027015 59 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138 (229)
Q Consensus 59 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~ 138 (229)
+.+.+++ ++.++|||+++|..|...- ++......++..|+.-+.-+-.. |++|||+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7777664 6778999999987665432 23344444444555545544466 999999999999999
Q ss_pred CCCceEEecccccccc
Q 027015 139 QNFNPKISDFGLSKLF 154 (229)
Q Consensus 139 ~~~~~~l~dfg~~~~~ 154 (229)
++|.+.++||..+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.7e-12 Score=102.90 Aligned_cols=189 Identities=21% Similarity=0.165 Sum_probs=142.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
..||.|.|+.|+... ++..++..|++|..... ...+...-+.|+-+...+. .|.+++.++..+......++=.|||
T Consensus 271 ~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~-~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVS-KRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILG-SHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred EEccCCccccceeee-ecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhh-cccccCCCCCCccccccccCchhhh
Confidence 468999999999885 45578899999987543 2333344556666666666 3788888777777777777999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-CceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-~~~~l~dfg~~~~~~~~~ 158 (229)
+++++.... ....-+++...+.+..|++.++.++|+. .++|.|++|.||++..+ +..+++||+....+.-.
T Consensus 349 ~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 349 EGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee-
Confidence 999887766 4455677888899999999999999999 99999999999999876 77889999987542111
Q ss_pred ccccccccCCcccc--CccccccCCCCCcccchhHHHHHHHHHhCCC
Q 027015 159 THISTRVAGTLGYL--APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203 (229)
Q Consensus 159 ~~~~~~~~~~~~~~--aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 203 (229)
.......-.+. ++.......+..++|++|||.-+.+..++..
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 11112222334 4555556778899999999999998888774
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.6e-11 Score=97.98 Aligned_cols=144 Identities=19% Similarity=0.210 Sum_probs=96.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch----------------------------------------hhHH
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ----------------------------------------GEKE 41 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~ 41 (229)
.+|+.++.|.||+| .+.+|+.||||+.++.-.. .+-+
T Consensus 131 ~PiAsASIaQVH~A---~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD 207 (517)
T COG0661 131 EPIASASIAQVHRA---VLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD 207 (517)
T ss_pred CchhhhhHhhheeE---EecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence 37889999999999 5566999999997542111 1123
Q ss_pred HHHHHHHHhhhccC---CCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh
Q 027015 42 FMSEVASMANVNVC---HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 118 (229)
Q Consensus 42 ~~~e~~~~~~l~~~---~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 118 (229)
+.+|+....+++.. .|++.-.-=+++-.+...++|||++|..+.+... ......+...+.....++. +..+=
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~---l~~~g~d~k~ia~~~~~~f--~~q~~ 282 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA---LKSAGIDRKELAELLVRAF--LRQLL 282 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH---HHhcCCCHHHHHHHHHHHH--HHHHH
Confidence 44555555555422 3444433333444567799999999999988852 2234555444444443332 22222
Q ss_pred hcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 119 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 119 ~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
.. |+.|+|.+|.||+++.+|++.+.|||....+.+
T Consensus 283 ~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 34 999999999999999999999999998876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.6e-11 Score=104.98 Aligned_cols=202 Identities=19% Similarity=0.219 Sum_probs=140.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+++-+|.++.++.+. -..+|...+.|+.... .+.+.+....+-....... +|.++...-.+......+++++|
T Consensus 810 ~p~qS~sp~ss~p~~--pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~--~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPAS--PAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR--SPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred ccccCCCCcccccCC--ccccccccchhhhccchhhccccccccCCccCccccCC--CCceecccCCCCCCCCcchhhHH
Confidence 456778888887773 2334434444443211 1111222222222222222 56666555444445567899999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC---
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP--- 155 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~--- 155 (229)
..+++|...+ ...+..+.+.....+..+..++.+||.. .+.|+|++|+|.+...++..++.||+.....+
T Consensus 886 ~~~~~~~Skl----~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 886 LNGGDLPSKL----HNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hccCCchhhh----hcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999888 4455677777777788888999999998 78999999999999999999999997332210
Q ss_pred ------------------CCC---------ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 156 ------------------ENT---------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 156 ------------------~~~---------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
... ........+++.|.+||...+......+|.|+.|.++++.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 000 01122345889999999999999999999999999999999999999987
Q ss_pred cccccc
Q 027015 209 VQLGEY 214 (229)
Q Consensus 209 ~~~~~~ 214 (229)
.+...+
T Consensus 1039 tpq~~f 1044 (1205)
T KOG0606|consen 1039 TPQQIF 1044 (1205)
T ss_pred chhhhh
Confidence 765555
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.6e-09 Score=80.03 Aligned_cols=125 Identities=18% Similarity=0.157 Sum_probs=90.9
Q ss_pred CCcEEEEEEeeccc-------chhhHHHHHHHHHHhhhccCCCcccccceEEEcC----CceEEEEEccCCC-CHHHHHh
Q 027015 22 DGTIVAVKVLSVES-------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PCRILVYDYMPNN-SLSQTLL 89 (229)
Q Consensus 22 ~~~~vavK~~~~~~-------~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~-sL~~~~~ 89 (229)
.++.+.+|...... ........+|...+..+....-...+++.+.+.. ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666532111 1234567788888888873333344555555432 2447999999874 7999883
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC---ceEEeccccccc
Q 027015 90 GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGLSKL 153 (229)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~---~~~l~dfg~~~~ 153 (229)
.....+......++.+++..++-||.. |++|+|+++.||+++.++ .+.++||+.+..
T Consensus 111 ----~~~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 ----QWEQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred ----hhcccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 323377778889999999999999999 999999999999999887 799999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=9.7e-09 Score=76.00 Aligned_cols=139 Identities=14% Similarity=0.092 Sum_probs=100.5
Q ss_pred CCcccccccccceEeccCCcEEEEEEeecc------cchhhHHHHHHHHHHhhhccCCCcccccceEEE---cC--CceE
Q 027015 5 GPIRLEKVDLAPFIRLQDGTIVAVKVLSVE------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI---DG--PCRI 73 (229)
Q Consensus 5 g~G~~~~v~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~---~~--~~~~ 73 (229)
|+|+.|.|+... .+|+.+.+|.-... .......+.+|...++.+....-.+.++. ++. .. .+.+
T Consensus 27 ~rgG~SgV~r~~----~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 27 RRNGMSGVQCVE----RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CCCCcceEEEEE----eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 568888888752 24567999975411 13345789999999999984433344444 322 11 2346
Q ss_pred EEEEccC-CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc--eEEecccc
Q 027015 74 LVYDYMP-NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDFGL 150 (229)
Q Consensus 74 lv~e~~~-~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~--~~l~dfg~ 150 (229)
||+|-++ ..+|.+++.. ....+.+......++.+++..++.||+. |+.|+|+.+.||+++.++. +.++||.-
T Consensus 102 LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 9999764 3688888721 1233567788889999999999999999 9999999999999986667 99999986
Q ss_pred ccc
Q 027015 151 SKL 153 (229)
Q Consensus 151 ~~~ 153 (229)
+..
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.8e-10 Score=96.84 Aligned_cols=120 Identities=27% Similarity=0.409 Sum_probs=90.6
Q ss_pred HHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc--------cccccCCccccCccccc
Q 027015 107 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI--------STRVAGTLGYLAPEYAI 178 (229)
Q Consensus 107 ~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~ 178 (229)
+.+++.|+.++|+.. ++||++|.|++|.++.++.+||+.|+++.........+ .....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344558999999984 99999999999999999999999999987654421111 01111345799999999
Q ss_pred cCCCCCcccchhHHHHHHHHH-hCCCcccCccccccccchhhhcccccccC
Q 027015 179 SGRLTRKSDVYSFGVLLLEIV-SGRTAVDFDVQLGEYHLVDKVRSINMKLY 228 (229)
Q Consensus 179 ~~~~~~~~Dv~slG~i~~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (229)
+..-+.++|++|+|+++|.+. .|+.-+...+....+......-..+...|
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~ 233 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGY 233 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccc
Confidence 988899999999999999999 68888887766666665555444444333
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.1e-08 Score=73.99 Aligned_cols=141 Identities=13% Similarity=0.063 Sum_probs=84.1
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
+||+|..+.||+. .|..+++|...... ......+|.+.++.+...---+.+++++..+.+...++||+++|.
T Consensus 8 ~i~~G~t~~~y~~------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 8 QTGEGGNGESYTH------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eecCCCCcceeEe------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 6899999999974 24578899886433 334578899999998721223567777777777788999999986
Q ss_pred C-HHHHH--------------hh----hhcc-ccCCCHHHHHH-HHH----------HHHH-HHHHHhhc-CCCCeEEcC
Q 027015 83 S-LSQTL--------------LG----EEKR-RAKFGWKARRE-IIM----------GIGR-GLAYIHEE-IQPHVVHRD 129 (229)
Q Consensus 83 s-L~~~~--------------~~----~~~~-~~~l~~~~~~~-~~~----------~i~~-~l~~lH~~-~~~~i~h~d 129 (229)
. +...+ .. .-.- ........... +.. .+.. ..++|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 21111 00 0000 00111111000 000 0011 11222211 123678999
Q ss_pred CCCCCEEEcCCCceEEecccccc
Q 027015 130 IKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 130 i~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
+.|.|+++++++ +.++||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999877 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.92 E-value=9.1e-09 Score=76.45 Aligned_cols=114 Identities=17% Similarity=0.214 Sum_probs=74.3
Q ss_pred cCCcEEEEEEeecccchhhHHHH---------HHHHHHhhhccCCCccc---ccceEEE-----cCCceEEEEEccCCCC
Q 027015 21 QDGTIVAVKVLSVESKQGEKEFM---------SEVASMANVNVCHENLV---KLHGGCI-----DGPCRILVYDYMPNNS 83 (229)
Q Consensus 21 ~~~~~vavK~~~~~~~~~~~~~~---------~e~~~~~~l~~~~~~i~---~~~~~~~-----~~~~~~lv~e~~~~~s 83 (229)
-+|+.+++|..+......++.+. +.+.....++ ...+. .++-..+ -....+++|||++|..
T Consensus 52 i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~--~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~ 129 (229)
T PF06176_consen 52 IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIR--NEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVE 129 (229)
T ss_pred ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHH--HcCccccccceeeeeeeeccceeEEEEEEEEecCee
Confidence 36788999998765443333322 3444444443 22222 2222222 2234568999999998
Q ss_pred HHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 84 L~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|.+... +++ .+...+.+++..+|+. |+.|+|.+|.|++++++ .++++|++...
T Consensus 130 l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 130 LNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred cccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 877641 222 2445566778999999 99999999999999854 59999997554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.1e-08 Score=74.53 Aligned_cols=139 Identities=16% Similarity=0.181 Sum_probs=92.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-------------------h-----hHHHHHHHHHHhhhccCCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-------------------G-----EKEFMSEVASMANVNVCHE 57 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-------------------~-----~~~~~~e~~~~~~l~~~~~ 57 (229)
++|.+|.-++||+|. ..++..+|+|+++..... + .....+|...|.++...+=
T Consensus 54 g~istGKEA~Vy~a~---~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 54 GCISTGKEANVYLAE---TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eeecCCcceEEEeec---cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 578899999999982 366899999998642111 0 1224457777777763333
Q ss_pred cccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEE
Q 027015 58 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNIL 136 (229)
Q Consensus 58 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~ 136 (229)
.+.+.+.+. .-.+|||++.....- .......+++..+...+..++++.+.-|-. . +++|+|++.-||+
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~p----AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL 199 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLP----APRLKDVPLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNIL 199 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCC----CCCcccCCcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheE
Confidence 444554432 346999999544110 001122334444566667777777776665 5 9999999999999
Q ss_pred EcCCCceEEeccccccccC
Q 027015 137 LDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 137 ~~~~~~~~l~dfg~~~~~~ 155 (229)
+. ++.+.++|++.+....
T Consensus 200 ~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 200 VH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred EE-CCeEEEEECccccccC
Confidence 99 8899999999987654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.8e-08 Score=84.41 Aligned_cols=145 Identities=19% Similarity=0.202 Sum_probs=92.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-------------------------------------hhHHHHH
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-------------------------------------GEKEFMS 44 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~ 44 (229)
.+||.-+.|.|++| .+.+|+.||||+=++.-+. .+-++..
T Consensus 167 ~piaaASlaQVhrA---~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 167 EPIAAASLAQVHRA---RLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred chhhhcchhheEEE---EecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 36888999999999 6677999999986432111 1123444
Q ss_pred HHHHHhhhccC--CCcc---cccceEEE-cCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh
Q 027015 45 EVASMANVNVC--HENL---VKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 118 (229)
Q Consensus 45 e~~~~~~l~~~--~~~i---~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 118 (229)
|++..++++.. |-+. +.+-.++. -....+++|||++|..+.+.- .-....++...+..-+.+.. ++
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~---~i~~~gi~~~~i~~~l~~~~-----~~ 315 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLD---AIDKRGISPHDILNKLVEAY-----LE 315 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHH---HHHHcCCCHHHHHHHHHHHH-----HH
Confidence 44444444321 3331 11222222 234678999999999887764 23455566665554444432 22
Q ss_pred hcCCCCeEEcCCCCCCEEEcC----CCceEEeccccccccCCC
Q 027015 119 EEIQPHVVHRDIKTSNILLDQ----NFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 119 ~~~~~~i~h~di~p~ni~~~~----~~~~~l~dfg~~~~~~~~ 157 (229)
+....|++|+|.+|.||+++. ++.+.+.|||+...+...
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 222239999999999999983 677999999998776543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.72 E-value=3e-07 Score=70.70 Aligned_cols=78 Identities=10% Similarity=-0.042 Sum_probs=55.0
Q ss_pred CccCCccc-ccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRL-EKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~-~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
..|-.|.. +.||+. .. ++..+++|...... ...+.+|++.++.+.. +--+.+++.+...++..++|||+++
T Consensus 4 ~~~~~g~~~~~v~~~---~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~-~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 4 ERVTEGQSGATVYRL---DG-KNPGLYLKIAPSGP---TYELEREAERLRWLAG-KLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred eecCCCCCcCeEEEE---cC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHh-cCCCCeEEEEEecCCccEEEEEeeC
Confidence 35666666 677876 22 34688999876433 3457789999988873 3446677777766667789999999
Q ss_pred CCCHHHH
Q 027015 81 NNSLSQT 87 (229)
Q Consensus 81 ~~sL~~~ 87 (229)
|.++...
T Consensus 76 G~~l~~~ 82 (244)
T cd05150 76 GVPAAAL 82 (244)
T ss_pred CccHhHh
Confidence 9887754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.59 E-value=5e-07 Score=68.70 Aligned_cols=145 Identities=15% Similarity=0.135 Sum_probs=81.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE---cCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI---DGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~---~~~~~~lv~e~ 78 (229)
..|+.|..+.||+. ...+ ..+++|..... .....+.+|...++.+......+.+++.... .....+++|++
T Consensus 3 ~~l~~G~~n~~~~v---~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 3 RPLSGGFSNRVYRV---TTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEESSSSEEEEE---EETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred ccCCCCCeeeEEEE---EECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 46888999999987 3333 69999997644 4556778889998888732223555655432 23346899999
Q ss_pred cCCCCHHH----------------HHhhhhcc---ccCCCHHH---------HHHH------------HHHHHH-HHHHH
Q 027015 79 MPNNSLSQ----------------TLLGEEKR---RAKFGWKA---------RREI------------IMGIGR-GLAYI 117 (229)
Q Consensus 79 ~~~~sL~~----------------~~~~~~~~---~~~l~~~~---------~~~~------------~~~i~~-~l~~l 117 (229)
++|..+.. .+....+. ..++.... .... ...+.. .++.+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99998877 11110011 01111100 0000 011222 23333
Q ss_pred hhc----CCCCeEEcCCCCCCEEEc-CCCceEEecccccc
Q 027015 118 HEE----IQPHVVHRDIKTSNILLD-QNFNPKISDFGLSK 152 (229)
Q Consensus 118 H~~----~~~~i~h~di~p~ni~~~-~~~~~~l~dfg~~~ 152 (229)
++. ....++|+|++|.||+++ +++.+.++||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 321 123799999999999999 66667899998664
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.5e-06 Score=62.29 Aligned_cols=126 Identities=15% Similarity=0.152 Sum_probs=87.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCccc-ccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV-KLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~-~~~~~~~~~~~~~lv~e~~~ 80 (229)
+-||.|.+|.||++++ .|..+|+|+-+.++ ....+..|+++++.+. -.++. +++.+- ..++.|||++
T Consensus 28 ~~L~KG~~s~Vyl~~~----~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~--g~~~~p~vy~yg----~~~i~me~i~ 95 (201)
T COG2112 28 KELAKGTTSVVYLGEW----RGGEVALKVRRRDS--PRRNLEKEAKILEILA--GEGVTPEVYFYG----EDFIRMEYID 95 (201)
T ss_pred hhhhcccccEEEEeec----cCceEEEEEecCCc--chhhHHHHHHHHHHhh--hcCCCceEEEec----hhhhhhhhhc
Confidence 4589999999999866 45699999876443 3467889999999988 54444 344332 2345699999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCC-CCCEEEcCCCceEEeccccccc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK-TSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~-p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
|.+|.+.... .+... +..++....-|-.. ||-|+.++ |....+.+++.+.|+||..|+.
T Consensus 96 G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIG-------GDRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhc-------ccHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9898877621 12232 33444445556666 99999886 5566666677999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.48 E-value=7.1e-06 Score=60.79 Aligned_cols=129 Identities=15% Similarity=0.165 Sum_probs=91.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc----------------chhhHHHHHHHHHHhhhc-cC---CCcccc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES----------------KQGEKEFMSEVASMANVN-VC---HENLVK 61 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~~~~l~-~~---~~~i~~ 61 (229)
..||+|+.-.||. .++....+||+..... .....+..+|+..+..+. .. +..|.+
T Consensus 7 ~~i~~G~~R~cy~-----HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 7 DLIAQGGERDCYQ-----HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred cccccCCCceEEE-----CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3689999998875 3566788999997665 222355666777766665 22 678999
Q ss_pred cceEEEcCCceEEEEEccC------CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCE
Q 027015 62 LHGGCIDGPCRILVYDYMP------NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135 (229)
Q Consensus 62 ~~~~~~~~~~~~lv~e~~~------~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni 135 (229)
++++.+++-..-+|+|.+. ..+|.+++ ....++. .+.+.+.++ .++|-+. +|+.+|++|+||
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-----~~~~~~~-~~~~~L~~f---~~~l~~~---~Iv~~dl~~~NI 149 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYL-----KEGGLTE-ELRQALDEF---KRYLLDH---HIVIRDLNPHNI 149 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHH-----HcCCccH-HHHHHHHHH---HHHHHHc---CCeecCCCcccE
Confidence 9999999988889999762 33677777 3344555 444444444 4567777 999999999999
Q ss_pred EEcCCC----ceEEec
Q 027015 136 LLDQNF----NPKISD 147 (229)
Q Consensus 136 ~~~~~~----~~~l~d 147 (229)
++..+. .+.|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 996332 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.4e-06 Score=64.49 Aligned_cols=75 Identities=13% Similarity=0.095 Sum_probs=45.7
Q ss_pred CccCCccccc-ccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCC-CcccccceEEEcC---CceEEEE
Q 027015 2 ASVGPIRLEK-VDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDG---PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~-v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~-~~i~~~~~~~~~~---~~~~lv~ 76 (229)
.+|+.|+... ||+. +..+++|..... .....+.+|.+.++.+.... --+.+++...... ...+++|
T Consensus 3 ~~~~~gG~~n~vy~~-------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL-------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc-------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 4678777775 8865 135778876532 23457888999998886211 1233333322221 2347899
Q ss_pred EccCCCCHH
Q 027015 77 DYMPNNSLS 85 (229)
Q Consensus 77 e~~~~~sL~ 85 (229)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1e-07 Score=80.24 Aligned_cols=180 Identities=18% Similarity=0.117 Sum_probs=120.9
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCc-ccccceEEEcCCceEEEEEccCCC
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~-i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.++|+++++++.+. ..+ +....+.+.. .....-++++|.+++ ||| .+..++-+..+....+.++++.++
T Consensus 250 fvK~altknpKkRp--tae-klL~h~fvs~-----~l~~rl~~eLLdK~n--~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 250 FVKGALTKNPKKRP--TAE-KLLQHPFVSQ-----TLSRRLAIELLDKVN--NPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHhcCCCccCC--Chh-hheeceeecc-----chhhHHHHHHHHHcc--CCCCcccccccCCcccccchhhhhhcCC
Confidence 46788888998832 222 2222444431 134455788999999 999 566666555566778999998766
Q ss_pred -CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 83 -SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 83 -sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
+-.... ....-.+.......+++.-++.++++|+. --+|+| ||+..+ +..+..||+....+.... .
T Consensus 320 rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 320 RSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred ccccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--c
Confidence 222111 01222344455556677778889999987 446666 776664 678999999876654332 2
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
.....+++.++|||+.....+....|.|+++.-..++--|.+|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 355678999999999999999999999999976666666666543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.9e-06 Score=60.83 Aligned_cols=106 Identities=18% Similarity=0.172 Sum_probs=82.6
Q ss_pred HHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 027015 43 MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 122 (229)
Q Consensus 43 ~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 122 (229)
..|..+++.+.. .+++.+++|+| ..+++.||...+++.+.. .........+|..+..++.+++..+.+++....
T Consensus 7 ~~E~lll~~l~~-~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQG-SEPFPKLLGSC----GRFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCC-CCCCCCeeeEC----CCEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 347888888883 35899999987 346899999877664320 000233467899999999999999999998655
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 123 ~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
..+..+|++|+|+-++++++++++|.+.+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 56888999999999999999999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.7e-05 Score=71.44 Aligned_cols=78 Identities=13% Similarity=0.175 Sum_probs=52.1
Q ss_pred ccCCcccccccccceEeccCC---cEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCc--ccccceEEEcC---CceE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDG---TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN--LVKLHGGCIDG---PCRI 73 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~--i~~~~~~~~~~---~~~~ 73 (229)
.++.|.+..+|+.+. .++ ..+++|...... ......+.+|.++++.+.. |++ +.+++.++.+. +..+
T Consensus 45 ~l~gG~sn~ty~l~~---~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~-~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 45 QFGHGQSNPTFLLEV---GNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGE-HTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EeCCCCcCceEEEEE---CCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhh-cCCCCCCcEEEEecCCCcCCCce
Confidence 577888888888632 222 467788764332 2234578899999999852 444 46666666554 4678
Q ss_pred EEEEccCCCCH
Q 027015 74 LVYDYMPNNSL 84 (229)
Q Consensus 74 lv~e~~~~~sL 84 (229)
+||||++|..+
T Consensus 121 lVME~v~G~~~ 131 (822)
T PLN02876 121 YIMEYLEGRIF 131 (822)
T ss_pred EEEEecCCccc
Confidence 99999988753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.2e-05 Score=61.26 Aligned_cols=77 Identities=6% Similarity=-0.067 Sum_probs=54.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCC-CcccccceEEEc---CCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCID---GPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~-~~i~~~~~~~~~---~~~~~lv~e 77 (229)
.+||.|..+.||.. ...++ .+++|..+. ......+..|.+.++.+.... -.+.++++++.+ .+..++|||
T Consensus 20 ~~i~~G~~~~vy~~---~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 20 ECISEQPYAALWAL---YDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eecCCccceeEEEE---EcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 57999999999985 32333 577787542 113357889999999987322 357777776654 366899999
Q ss_pred ccCCCCH
Q 027015 78 YMPNNSL 84 (229)
Q Consensus 78 ~~~~~sL 84 (229)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.9e-05 Score=62.13 Aligned_cols=138 Identities=17% Similarity=0.199 Sum_probs=95.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---------------------cchh-----hHHHHHHHHHHhhhccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---------------------SKQG-----EKEFMSEVASMANVNVC 55 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---------------------~~~~-----~~~~~~e~~~~~~l~~~ 55 (229)
+||-.|.=++||.| ...+|..+|||+++.. .+.. ......|++.|.++.
T Consensus 150 GCiSTGKEANVYHa---t~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-- 224 (520)
T KOG2270|consen 150 GCISTGKEANVYHA---TEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-- 224 (520)
T ss_pred cccccCccceeEee---ecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH--
Confidence 67888999999998 5577889999987431 0111 123445777788777
Q ss_pred CCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCE
Q 027015 56 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135 (229)
Q Consensus 56 ~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni 135 (229)
...|.-.--+... ..+|||+++....-. ........++...+..+-.+++..++-|-+.+ ++||.||+--|+
T Consensus 225 ~aGIP~PePIlLk--~hVLVM~FlGrdgw~----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~ 296 (520)
T KOG2270|consen 225 NAGIPCPEPILLK--NHVLVMEFLGRDGWA----APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNL 296 (520)
T ss_pred hcCCCCCCceeee--cceEeeeeccCCCCc----CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhh
Confidence 5555433333222 347999998432211 11134556777778888888888888877764 999999999999
Q ss_pred EEcCCCceEEeccccccc
Q 027015 136 LLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 136 ~~~~~~~~~l~dfg~~~~ 153 (229)
++. +|.+.++|.+.+..
T Consensus 297 Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred eEE-CCEEEEEEcccccc
Confidence 997 77999999887654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.6e-05 Score=59.81 Aligned_cols=145 Identities=12% Similarity=0.110 Sum_probs=81.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceE------EEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------CIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~------~~~~~~~~lv 75 (229)
..|..|....+|+. .. ++..+++|.... .....+..|+++++.+....-.+.+++.. ...++..+++
T Consensus 20 ~~i~~G~~n~~y~v---~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 20 EGISAGIENTNYFV---TT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred ecccCccccceEEE---Ee-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 35667777788875 22 345789998764 23345677888888886222124444331 2334567899
Q ss_pred EEccCCCCHHH-----------HH---hhhhcc-cc------CCCHHHH--H--------HHHHHHHHHHHHHhh----c
Q 027015 76 YDYMPNNSLSQ-----------TL---LGEEKR-RA------KFGWKAR--R--------EIIMGIGRGLAYIHE----E 120 (229)
Q Consensus 76 ~e~~~~~sL~~-----------~~---~~~~~~-~~------~l~~~~~--~--------~~~~~i~~~l~~lH~----~ 120 (229)
++|++|..+.. .+ +..... .. ...+... . .....+..++..+.+ .
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99999876532 00 000000 00 0010000 0 001112233344432 1
Q ss_pred CCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 121 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 121 ~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
...+++|+|++|.|+++++++.+.|+||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 123799999999999999877678999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=9.8e-05 Score=59.12 Aligned_cols=32 Identities=22% Similarity=0.293 Sum_probs=26.5
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 122 ~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
..++||+|++|+||+++.+....++||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 34899999999999998665558999998753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.10 E-value=7.2e-05 Score=57.10 Aligned_cols=73 Identities=15% Similarity=0.131 Sum_probs=46.4
Q ss_pred CccCCcccccccccceEeccC--CcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCc-ccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~-i~~~~~~~~~~~~~~lv~e~ 78 (229)
..|..|-...+|+. ...+ ++.+++|....... ......+|...++.+. ... ..+++..+ . + .+++||
T Consensus 4 ~~l~gG~tN~~~~v---~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~--~~gl~P~v~~~~-~-~--~~l~e~ 73 (235)
T cd05157 4 KRFTGGITNKLVKV---SNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLS--KHGLAPKLYATF-Q-N--GLIYEF 73 (235)
T ss_pred EEcCCcccceEEEE---EcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHH--hCCCCCeEEEEe-C-C--cEEEEe
Confidence 46778888889886 3332 57899998754322 2234457888888886 333 33443332 2 2 389999
Q ss_pred cCCCCH
Q 027015 79 MPNNSL 84 (229)
Q Consensus 79 ~~~~sL 84 (229)
++|.++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00019 Score=57.15 Aligned_cols=145 Identities=11% Similarity=0.110 Sum_probs=78.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceE------EEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------CIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~------~~~~~~~~lv 75 (229)
+.++.|....+|+. ... +..+++|...... ....+..|.+.++.+....-.+.+++.. ....+..+++
T Consensus 28 ~~~~~G~~n~~y~v---~t~-~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 28 KGIAEGVENSNYLL---TTD-VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred cccCCccccceEEE---EeC-CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 35667777788876 223 4468889875422 2334556777777775222123444332 1234567899
Q ss_pred EEccCCCCHH-----------HH---Hhhhhccc-c------CCC-HHHHH------------HHHHHHHHHHHHHhh--
Q 027015 76 YDYMPNNSLS-----------QT---LLGEEKRR-A------KFG-WKARR------------EIIMGIGRGLAYIHE-- 119 (229)
Q Consensus 76 ~e~~~~~sL~-----------~~---~~~~~~~~-~------~l~-~~~~~------------~~~~~i~~~l~~lH~-- 119 (229)
++|++|..+. .. ++...... . ..+ +.... .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 9999886532 11 11000000 0 000 00000 001112233444432
Q ss_pred --cCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 120 --EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 120 --~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
....+++|+|+++.|+++++++...++||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123489999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00012 Score=56.65 Aligned_cols=140 Identities=11% Similarity=0.042 Sum_probs=78.0
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcc-cccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL-VKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i-~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
.+..|....+|+.. .+++.+++|........-.....+|.+.++.+. ...+ .+++.. +. -++|+||++|
T Consensus 3 ~~~~G~tn~~y~~~----~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~--~~g~~P~~i~~--~~--~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE----HPGISFVWRPQSPVCKALGVDRQREYQILQALS--ALGLAPKPILV--NE--HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE----eCCccEEEeeCCcccccccCcHHHHHHHHHHHH--hcCCCCceEEE--eC--CEEEEEeccC
Confidence 56778888899762 457789999865332221124577888888887 3323 233332 22 3689999998
Q ss_pred CCHHHH--------------Hhh---hhccccCCCHH-HHHHHHHHH---------HHHHHHHhhc-----CCCCeEEcC
Q 027015 82 NSLSQT--------------LLG---EEKRRAKFGWK-ARREIIMGI---------GRGLAYIHEE-----IQPHVVHRD 129 (229)
Q Consensus 82 ~sL~~~--------------~~~---~~~~~~~l~~~-~~~~~~~~i---------~~~l~~lH~~-----~~~~i~h~d 129 (229)
..+... +.. ......+++.. .+.....++ ...+..+-.. ....++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 765321 110 00111122221 111111111 1112222111 012589999
Q ss_pred CCCCCEEEcCCCceEEeccccccc
Q 027015 130 IKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 130 i~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+.|.||++++++ +.++||+.+..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999776 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.1e-05 Score=63.42 Aligned_cols=132 Identities=12% Similarity=0.048 Sum_probs=89.5
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc-----------------cch-----hhHHHHHHHHHHhhhccCCCccc
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-----------------SKQ-----GEKEFMSEVASMANVNVCHENLV 60 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-----------------~~~-----~~~~~~~e~~~~~~l~~~~~~i~ 60 (229)
.||-|.=+.||++ ...+|++.++|.-+.. ... +.....+|...++.|..+---+.
T Consensus 99 qIGVGKESDIY~v---~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVP 175 (465)
T KOG2268|consen 99 QIGVGKESDIYVV---ADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVP 175 (465)
T ss_pred ccccccccceEEE---ecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCC
Confidence 5888888999997 5577899999964321 000 11335567888888762112244
Q ss_pred ccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC
Q 027015 61 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140 (229)
Q Consensus 61 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~ 140 (229)
+.++ .++.++|||.++|..|...- .-.+...+. ..++..+--|-.. |+||||.+-=||+++++
T Consensus 176 kpiD----~~RH~Vvmelv~g~Pl~~v~-------~v~d~~~ly---~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 176 KPID----HNRHCVVMELVDGYPLRQVR-------HVEDPPTLY---DDLMGLIVRLANH---GLIHGDFNEFNIMVKDD 238 (465)
T ss_pred Cccc----ccceeeHHHhhcccceeeee-------ecCChHHHH---HHHHHHHHHHHHc---CceecccchheeEEecC
Confidence 5544 46789999999887775432 223334333 3344444555566 99999999999999999
Q ss_pred CceEEecccccccc
Q 027015 141 FNPKISDFGLSKLF 154 (229)
Q Consensus 141 ~~~~l~dfg~~~~~ 154 (229)
+.++++||..+...
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 99999999877554
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00059 Score=50.51 Aligned_cols=121 Identities=27% Similarity=0.363 Sum_probs=81.0
Q ss_pred CccCCccc-ccccccceEeccCCcEEEEEEeec---ccc------------------hhhHHHHHHHHHHhhhccC-CCc
Q 027015 2 ASVGPIRL-EKVDLAPFIRLQDGTIVAVKVLSV---ESK------------------QGEKEFMSEVASMANVNVC-HEN 58 (229)
Q Consensus 2 ~~lg~G~~-~~v~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~~~~l~~~-~~~ 58 (229)
.-||.|.- |.||+++. +|+.+|+|++.. ... .-...+..|-+.+.+|+.. +..
T Consensus 43 efLg~g~~~~~V~kv~I----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~ 118 (207)
T PF13095_consen 43 EFLGHGSHDGYVFKVEI----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREG 118 (207)
T ss_pred eecCCCCceeEEEEEEE----CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccC
Confidence 45899999 99999843 678999999421 100 1123466788887777743 334
Q ss_pred c--cccceEEEcC------------------CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh
Q 027015 59 L--VKLHGGCIDG------------------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 118 (229)
Q Consensus 59 i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 118 (229)
+ +++++|..=. ....||.||++... .++.. -+.++.+-+..+|
T Consensus 119 ~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 119 LWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred ceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHHHHHH
Confidence 5 8888887311 12357777764432 23333 3455666678899
Q ss_pred hcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 119 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 119 ~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
.. ||+-+|+++.|.. + -+|+||+.+
T Consensus 182 k~---gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 KL---GIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HC---CeeeccCcccccc---C--CEEEecccC
Confidence 99 9999999999997 3 478999854
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00056 Score=54.33 Aligned_cols=77 Identities=16% Similarity=0.138 Sum_probs=46.9
Q ss_pred CccCCcccccccccceEe----ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcc-cccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR----LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL-VKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i-~~~~~~~~~~~~~~lv~ 76 (229)
..|..|-...+|+.+... ...++.+++|+..... .......+|.+.++.+. ...+ .+++..+. + .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~--~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLS--ERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHH--hCCCCCceEEEeC-C---Cchh
Confidence 346666677888762210 0125789999976433 23356678888888887 3333 34444432 2 2589
Q ss_pred EccCCCCHH
Q 027015 77 DYMPNNSLS 85 (229)
Q Consensus 77 e~~~~~sL~ 85 (229)
+|++|.++.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=1.2e-05 Score=74.47 Aligned_cols=162 Identities=12% Similarity=0.009 Sum_probs=119.3
Q ss_pred HHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh
Q 027015 42 FMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 119 (229)
Q Consensus 42 ~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 119 (229)
...|....+... |+++...+.-..+. ..-+..++++.+|.+++.+.+...+..+++.......-.+.+....-+|+
T Consensus 1276 ll~e~de~~~~~--h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAK--HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhh--ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 334444455556 88887766654432 34478999999999999997766666777666665555554666666666
Q ss_pred cCCCC--eEEcCCCCCCEEEcCCCceEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHH
Q 027015 120 EIQPH--VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197 (229)
Q Consensus 120 ~~~~~--i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~ 197 (229)
+.+.| .+|.++++.|.++..+-.++++++|+.+. ..+.........+++.|+.|++.....++.++|+|..++.+|.
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKI-knp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKI-KNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccc-cCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 53222 57899999999999888899999999872 2333333455667888999998888888988999999999999
Q ss_pred HHhCCCccc
Q 027015 198 IVSGRTAVD 206 (229)
Q Consensus 198 l~~g~~pf~ 206 (229)
+..|..+|.
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 988888774
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.001 Score=52.17 Aligned_cols=30 Identities=27% Similarity=0.511 Sum_probs=25.0
Q ss_pred CeEEcCCCCCCEEEcCCCc-eEEeccccccc
Q 027015 124 HVVHRDIKTSNILLDQNFN-PKISDFGLSKL 153 (229)
Q Consensus 124 ~i~h~di~p~ni~~~~~~~-~~l~dfg~~~~ 153 (229)
.++|+|++|.|+++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999997555 46999997753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0036 Score=51.58 Aligned_cols=77 Identities=14% Similarity=0.019 Sum_probs=51.7
Q ss_pred CccCCcccccccccceEeccCC-cEEEEEEeeccc-------chhhHHHHHHHHHHhhhccCC-CcccccceEEEcCCce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDG-TIVAVKVLSVES-------KQGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~e~~~~~~l~~~~-~~i~~~~~~~~~~~~~ 72 (229)
..||.|.+..||++ ...+| +.++||.-.+.. .-...+...|.+.|+.+.... ..+.+++.+ +....
T Consensus 32 ~elggGn~N~VyrV---~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 32 REIGDGNLNLVFRV---SDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA 106 (401)
T ss_pred eEcCCCceEEEEEE---EeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence 46899999999997 23455 589999864221 223456777888888875322 345566555 45567
Q ss_pred EEEEEccCCCC
Q 027015 73 ILVYDYMPNNS 83 (229)
Q Consensus 73 ~lv~e~~~~~s 83 (229)
++||||+++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 89999997643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00053 Score=62.24 Aligned_cols=154 Identities=22% Similarity=0.241 Sum_probs=107.1
Q ss_pred HHHHHHHHHHhhhccCCCcccccceEEEcCC----ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHH
Q 027015 40 KEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 115 (229)
Q Consensus 40 ~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 115 (229)
+...-|++.+.... |+|+..++.+-...- ...+..+++...++.+.+ +.-...+....+.+..+..+++.
T Consensus 227 ~~~E~e~~~l~k~~--~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 227 QTTEIELESLSKIA--HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHHHHhhc--cccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHH
Confidence 44445666677777 999999988765432 223566778888888888 67788889999999999999999
Q ss_pred HHhhcCCCCeEEcCCCCC---CEEEcCCCceEEe--ccccccccCCCCccccccccCCccccCccccccCCCC--Ccccc
Q 027015 116 YIHEEIQPHVVHRDIKTS---NILLDQNFNPKIS--DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT--RKSDV 188 (229)
Q Consensus 116 ~lH~~~~~~i~h~di~p~---ni~~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~Dv 188 (229)
++|+. ...|.-+... +...+..+.+... ||+.............. .-+..+.++|........ ..+|+
T Consensus 301 ~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 301 YLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHH
Confidence 99998 5555555544 3333445555555 88877665443322222 123446788877766554 45899
Q ss_pred hhHHHHHHHHHhCCCc
Q 027015 189 YSFGVLLLEIVSGRTA 204 (229)
Q Consensus 189 ~slG~i~~~l~~g~~p 204 (229)
|.+|.....+..|..+
T Consensus 376 ~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHHHHhhhhhcCcc
Confidence 9999999999887753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.003 Score=50.31 Aligned_cols=29 Identities=28% Similarity=0.360 Sum_probs=25.5
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 123 ~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
.+++|+|+++.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0026 Score=50.80 Aligned_cols=32 Identities=19% Similarity=0.308 Sum_probs=28.3
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 122 ~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
..+++|+|+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999888999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.003 Score=50.89 Aligned_cols=75 Identities=9% Similarity=0.087 Sum_probs=44.7
Q ss_pred ccCCcccccccccceEec-cCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCccc-ccceEEEcCCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV-KLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~-~~~~~~~~~~~~~lv~e~~~ 80 (229)
+|..|-...+|+...... .++..|++|+...... ....-.+|..+++.+. .-++. +++.++ .++ +|.+|++
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~--~~gl~P~~l~~~-~~G---~i~~fi~ 93 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLS--AAGFGAKLLGVF-GNG---MIQSFIN 93 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHH--hcCCCCceeEEe-CCc---Eeehhhc
Confidence 455566777787632111 1134899998864433 3344567888888887 44443 445444 222 5889988
Q ss_pred CCCH
Q 027015 81 NNSL 84 (229)
Q Consensus 81 ~~sL 84 (229)
+..|
T Consensus 94 g~~l 97 (330)
T PLN02421 94 ARTL 97 (330)
T ss_pred CCCC
Confidence 7765
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0098 Score=47.79 Aligned_cols=131 Identities=16% Similarity=0.280 Sum_probs=72.7
Q ss_pred eccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCccc-c---cceEE--EcCC--ceEEEEEccCCCCHHH-H--
Q 027015 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV-K---LHGGC--IDGP--CRILVYDYMPNNSLSQ-T-- 87 (229)
Q Consensus 19 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~-~---~~~~~--~~~~--~~~lv~e~~~~~sL~~-~-- 87 (229)
...+|+. ++|+.... .....+..|.+.+..+...-.-+. + .-+-. .-+. +.+.+++|++|..+.. .
T Consensus 45 ~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~ 121 (331)
T COG2334 45 QTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNA 121 (331)
T ss_pred EecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcH
Confidence 3344444 99998755 455677788888888873311111 2 11111 1223 6789999999988772 1
Q ss_pred ------------Hhhhhcccc--------CCCHHH----H---------HHHHHHHHHHHHHHhhcC----CCC---eEE
Q 027015 88 ------------LLGEEKRRA--------KFGWKA----R---------REIIMGIGRGLAYIHEEI----QPH---VVH 127 (229)
Q Consensus 88 ------------~~~~~~~~~--------~l~~~~----~---------~~~~~~i~~~l~~lH~~~----~~~---i~h 127 (229)
++....... ...+.. . .....++...+..+.+.. ..+ +||
T Consensus 122 ~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH 201 (331)
T COG2334 122 EQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIH 201 (331)
T ss_pred HHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeee
Confidence 100001100 111110 0 011223333344443322 223 899
Q ss_pred cCCCCCCEEEcCCCc-eEEecccccc
Q 027015 128 RDIKTSNILLDQNFN-PKISDFGLSK 152 (229)
Q Consensus 128 ~di~p~ni~~~~~~~-~~l~dfg~~~ 152 (229)
+|+.|+||+++.+.. +.++||+-+.
T Consensus 202 ~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 202 GDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999998775 8899999764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.015 Score=46.75 Aligned_cols=67 Identities=16% Similarity=0.101 Sum_probs=40.7
Q ss_pred ccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC-CCcccccc---e--EEEcCCceEEEEEccCCCC
Q 027015 12 VDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLH---G--GCIDGPCRILVYDYMPNNS 83 (229)
Q Consensus 12 v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~-~~~i~~~~---~--~~~~~~~~~lv~e~~~~~s 83 (229)
||.. ...+|+.+++|+.+.. ......+..|.+.+..+... -| ++... + ....++..+.++++++|..
T Consensus 41 vy~v---~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 41 VYQF---GDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred EEEE---ecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 5553 4456788999988633 23455677788888877632 22 22211 1 2233456788999998764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0067 Score=49.12 Aligned_cols=74 Identities=15% Similarity=0.059 Sum_probs=48.5
Q ss_pred ccCCcccccccccceEeccCC-cEEEEEEeecc-------cchhhHHHHHHHHHHhhhccCCCc-ccccceEEEcCCceE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDG-TIVAVKVLSVE-------SKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRI 73 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~e~~~~~~l~~~~~~-i~~~~~~~~~~~~~~ 73 (229)
-||.|...-||++. . ++| +.++||.-.+. ..-...+...|.+.|+.....-|. +.+++. .+.....
T Consensus 2 EigdGnlN~VfrV~--~-~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVY--D-QEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAV 76 (370)
T ss_pred cCCCCceEEEEEEE--c-CCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccce
Confidence 37999999999983 2 333 68999975321 233446667788888777643453 444433 3555667
Q ss_pred EEEEccCC
Q 027015 74 LVYDYMPN 81 (229)
Q Consensus 74 lv~e~~~~ 81 (229)
+|||+++.
T Consensus 77 ~vMEdL~~ 84 (370)
T TIGR01767 77 TVMEDLSH 84 (370)
T ss_pred ehHhhCcc
Confidence 99999853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.004 Score=50.51 Aligned_cols=144 Identities=14% Similarity=0.164 Sum_probs=78.7
Q ss_pred ccCCcccccccccceEec--cCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCccc-ccceEEEcCCceEEEEEcc
Q 027015 3 SVGPIRLEKVDLAPFIRL--QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV-KLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~-~~~~~~~~~~~~~lv~e~~ 79 (229)
+|..|-.-.+|++..... ..++.+++|....... ......+|..+++.+. ..++. ++++.+.. + .|.+|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~--~~gl~P~~~~~~~~-g---~v~efi 115 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMS--RHGQGPRLLGRFPN-G---RVEEFI 115 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHH--HcCCCCceEEEECC-c---eEEEee
Confidence 455677778888632111 1246899998865432 3234477888888887 43333 44555432 2 579999
Q ss_pred CCCCHHHH--------------H---hhhhccc-c-CCCHHHHHHHHHHH-----------------HHHHHHHh----h
Q 027015 80 PNNSLSQT--------------L---LGEEKRR-A-KFGWKARREIIMGI-----------------GRGLAYIH----E 119 (229)
Q Consensus 80 ~~~sL~~~--------------~---~~~~~~~-~-~l~~~~~~~~~~~i-----------------~~~l~~lH----~ 119 (229)
++.++... + +...... . ......+..+..++ ...+..|. .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87776421 0 0000000 0 11122222222111 11111121 1
Q ss_pred -cCCCCeEEcCCCCCCEEEcC-CCceEEeccccccc
Q 027015 120 -EIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL 153 (229)
Q Consensus 120 -~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~~ 153 (229)
.....++|+|+++.||++++ ++.+.++||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11226899999999999986 46799999988754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0031 Score=50.84 Aligned_cols=71 Identities=21% Similarity=0.220 Sum_probs=56.2
Q ss_pred ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 71 ~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
..|++|++. |+++.. ...-..+++..++.+.++.++-+.... ..-|+++.-+||+++ +|++.|+||-.
T Consensus 300 y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 446788876 555532 234457788889999999888888764 788999999999999 89999999998
Q ss_pred ccc
Q 027015 151 SKL 153 (229)
Q Consensus 151 ~~~ 153 (229)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 873
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0087 Score=47.70 Aligned_cols=30 Identities=27% Similarity=0.502 Sum_probs=26.9
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 124 ~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
.++|+|+++.|++++.++.+-+.||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 579999999999999888899999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.008 Score=47.38 Aligned_cols=73 Identities=16% Similarity=0.130 Sum_probs=45.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC-CCcccccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+++.|....+|.. . .+++.+.||.-. ......+..|.+-|+.+... .-.+.+++.+...++..++++||++.
T Consensus 24 ~v~GG~i~~a~~~---~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 24 PVSGGDINEAYRL---D-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EE--SSSSEEEEE---E-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred ecCCCChhheEEE---E-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 5677777888875 2 678899999976 33335678888888888532 34577888887777777999999987
Q ss_pred C
Q 027015 82 N 82 (229)
Q Consensus 82 ~ 82 (229)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.019 Score=47.34 Aligned_cols=74 Identities=9% Similarity=0.012 Sum_probs=47.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-------chhhHHHHHHHHHHhhhccCCC-cccccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-------KQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~~~~l~~~~~-~i~~~~~~~~~~~~~~ 73 (229)
+.||.|....||+. .. +++.++||.-.+.. .....+...|.+.|+.+....| .+.+++.+.. ...+
T Consensus 38 ~eiggGn~N~VyrV--~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 38 KEVGDGNLNFVYIV--VS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred EEcCCCceeeEEEE--Ec--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 35788888889986 22 34679999865221 1244555666777776652223 6667766654 4467
Q ss_pred EEEEccCC
Q 027015 74 LVYDYMPN 81 (229)
Q Consensus 74 lv~e~~~~ 81 (229)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0075 Score=49.47 Aligned_cols=76 Identities=16% Similarity=-0.004 Sum_probs=50.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc------cchhhHHHHHHHHHHhhhccCCCc-ccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE------SKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~~~~l~~~~~~-i~~~~~~~~~~~~~~l 74 (229)
..||.|...-||++.. ..+++.++||.-.+. ..-...+...|.+.|+....--|. +.+++. .+.....+
T Consensus 35 ~eigdGnlN~VfrV~~--~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWD--EQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCC 110 (409)
T ss_pred eEcCCCceEEEEEEee--CCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhH
Confidence 4689999999999833 223568999975322 233457777888888887644554 444543 35555678
Q ss_pred EEEccCC
Q 027015 75 VYDYMPN 81 (229)
Q Consensus 75 v~e~~~~ 81 (229)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9998753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.041 Score=51.07 Aligned_cols=31 Identities=32% Similarity=0.469 Sum_probs=25.6
Q ss_pred CCeEEcCCCCCCEEEcCCC--ceE-Eeccccccc
Q 027015 123 PHVVHRDIKTSNILLDQNF--NPK-ISDFGLSKL 153 (229)
Q Consensus 123 ~~i~h~di~p~ni~~~~~~--~~~-l~dfg~~~~ 153 (229)
.++||+|++++||+++.++ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3799999999999998775 454 999997654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.022 Score=42.70 Aligned_cols=30 Identities=27% Similarity=0.475 Sum_probs=21.2
Q ss_pred CeEEcCCCCCCEEE-cCCCceEEeccccccc
Q 027015 124 HVVHRDIKTSNILL-DQNFNPKISDFGLSKL 153 (229)
Q Consensus 124 ~i~h~di~p~ni~~-~~~~~~~l~dfg~~~~ 153 (229)
.++|+|+.|.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58899999999999 7889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.022 Score=46.86 Aligned_cols=61 Identities=16% Similarity=0.103 Sum_probs=37.8
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~ 139 (229)
..++=+|..|.++..++ .....+++....++.-.+.|+-.+--- .+.+|.|++|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v-----~~~~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFV-----KWKSQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhh-----hcccChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence 35666788888988888 233333344444444334444332221 17999999999999953
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.032 Score=42.32 Aligned_cols=61 Identities=16% Similarity=0.181 Sum_probs=43.6
Q ss_pred CCcEEEEEEeecccchhhHHHHHHHHHHhhhccC-CCcccccceEEEcCCceEEEEEccCCCCHH
Q 027015 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYDYMPNNSLS 85 (229)
Q Consensus 22 ~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 85 (229)
...++.||+-. ......+..|+.-|+.+.+. .-.+.+++.+-.+..+.|+|+||++.+.+.
T Consensus 38 g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 35678888854 33446677888888887722 245667777777788899999999876554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0058 Score=45.97 Aligned_cols=38 Identities=29% Similarity=0.298 Sum_probs=32.8
Q ss_pred HHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 027015 111 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 149 (229)
Q Consensus 111 ~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg 149 (229)
+++|..+|+. ..+.+|||.+|+||+.+..|.+||.|=+
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChh
Confidence 4677888965 4589999999999999999999999954
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.037 Score=45.54 Aligned_cols=29 Identities=28% Similarity=0.268 Sum_probs=24.4
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 124 ~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
..+|.|+.+.||+.+ ++.+.++||..+..
T Consensus 228 VfCHNDL~~gNIL~~-~~~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDF-NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEec-CCCEEEEEeccccC
Confidence 679999999999976 45699999987753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.096 Score=44.01 Aligned_cols=76 Identities=8% Similarity=0.020 Sum_probs=44.3
Q ss_pred CccCCcccccccccceEec------cCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCccc-ccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV-KLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~-~~~~~~~~~~~~~l 74 (229)
++|..|-.-.+|++..... ..++.|++|+.-.... ......+|...++.+. ..+|. ++++.+. + ..
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te-~lIdR~~E~~v~~~ls--~~gi~P~l~~~f~-g---g~ 183 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD-ELYNPISEFEVYKTMS--KYRIAPQLLNTFS-G---GR 183 (442)
T ss_pred EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc-ceeCHHHHHHHHHHHH--HCCCCCceEEEeC-C---CE
Confidence 3556666777777632110 1146899999864433 2234566777777777 43433 4444432 2 36
Q ss_pred EEEccCCCCH
Q 027015 75 VYDYMPNNSL 84 (229)
Q Consensus 75 v~e~~~~~sL 84 (229)
|.+|++|.+|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 8899988744
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 229 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 334 bits (860), Expect = e-117
Identities = 85/206 (41%), Positives = 128/206 (62%), Gaps = 5/206 (2%)
Query: 19 RLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
RL DGT+VAVK L E QG E +F +EV ++ H NL++L G C+ R+LVY
Sbjct: 50 RLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYP 107
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
YM N S++ L + + W R+ I +G RGLAY+H+ P ++HRD+K +NILL
Sbjct: 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
D+ F + DFGL+KL TH++T V GT+G++APEY +G+ + K+DV+ +GV+LLE
Sbjct: 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
Query: 198 IVSGRTAVDFDVQLGE--YHLVDKVR 221
+++G+ A D + L+D V+
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVK 253
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-104
Identities = 90/205 (43%), Positives = 126/205 (61%), Gaps = 6/205 (2%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
L+DG VA+K + ES QG +EF +E+ +++ H +LV L G C + IL+Y Y
Sbjct: 59 VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR--HPHLVSLIGFCDERNEMILIYKY 116
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M N +L + L G + W+ R EI +G RGL Y+H ++HRD+K+ NILLD
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLD 173
Query: 139 QNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
+NF PKI+DFG+SK E + TH+ST V GTLGY+ PEY I GRLT KSDVYSFGV+L E
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 198 IVSGRTAVDFDVQLGEYHLVDKVRS 222
++ R+A+ + +L +
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVE 258
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = e-100
Identities = 83/205 (40%), Positives = 118/205 (57%), Gaps = 14/205 (6%)
Query: 22 DGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ T VAVK L+ + +++ +++F E+ MA HENLV+L G DG LVY
Sbjct: 53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ--HENLVELLGFSSDGDDLCLVYV 110
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
YMPN SL L + W R +I G G+ ++HE H +HRDIK++NILL
Sbjct: 111 YMPNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166
Query: 138 DQNFNPKISDFGLSKLFPEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
D+ F KISDFGL++ + T +++R+ GT Y+APE + G +T KSD+YSFGV+LL
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLL 225
Query: 197 EIVSGRTAVDFDVQLGEYHLVDKVR 221
EI++G AVD L+D
Sbjct: 226 EIITGLPAVDEH--REPQLLLDIKE 248
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-65
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC----RILVYD 77
VAVK+ ++ KQ + EV S+ + HEN+++ G G L+
Sbjct: 46 LNEYVAVKIFPIQDKQSW-QNEYEVYSLPGMK--HENILQFIGAEKRGTSVDVDLWLITA 102
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ-------PHVVHRDI 130
+ SLS L + W I + RGLAY+HE+I P + HRDI
Sbjct: 103 FHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISG-----RLTR 184
K+ N+LL N I+DFGL+ F + + GT Y+APE
Sbjct: 158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 185 KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222
+ D+Y+ G++L E+ S TA D V +++
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 9e-54
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-----LVY 76
D VAVKV S ++Q F++E + H+N+ + G LV
Sbjct: 35 DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------QPHVVHRDI 130
+Y PN SL + L W + + + RGLAY+H E+ +P + HRD+
Sbjct: 92 EYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENT-------THISTRVAGTLGYLAPEYA------ 177
+ N+L+ + ISDFGLS N + + GT+ Y+APE
Sbjct: 147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL 206
Query: 178 -ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 216
++ D+Y+ G++ EI T + + EY +
Sbjct: 207 RDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-53
Identities = 61/183 (33%), Positives = 97/183 (53%), Gaps = 7/183 (3%)
Query: 23 GTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G+ VAVK+L + + EF+ EVA M + H N+V G P +V +Y+
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR--HPNIVLFMGAVTQPPNLSIVTEYLS 117
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
SL + LL + R + + R + + +G+ Y+H P +VHR++K+ N+L+D+
Sbjct: 118 RGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKK 175
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ K+ DFGLS+ +T S AGT ++APE KSDVYSFGV+L E+ +
Sbjct: 176 YTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 201 GRT 203
+
Sbjct: 235 LQQ 237
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-51
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 28/197 (14%)
Query: 21 QDGTIVAVKVLSVESKQGE-------KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73
+D ++VA+K L + +GE +EF EV M+N+N H N+VKL+G + P
Sbjct: 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN--HPNIVKLYGLMHNPPR-- 97
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+V +++P L LL + W + +++ I G+ Y+ + P +VHRD+++
Sbjct: 98 MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSP 153
Query: 134 NILLDQ-----NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL---TRK 185
NI L K++DFGLS+ + H + + G ++APE I T K
Sbjct: 154 NIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPE-TIGAEEESYTEK 208
Query: 186 SDVYSFGVLLLEIVSGR 202
+D YSF ++L I++G
Sbjct: 209 ADTYSFAMILYTILTGE 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-50
Identities = 53/182 (29%), Positives = 89/182 (48%), Gaps = 12/182 (6%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+K + ES+ K F+ E+ ++ VN H N+VKL+G C++ C LV +Y
Sbjct: 31 AKDVAIKQIESESE--RKAFIVELRQLSRVN--HPNIVKLYGACLNPVC--LVMEYAEGG 84
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
SL +L + + + +G+AY+H ++HRD+K N+LL
Sbjct: 85 SL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143
Query: 143 -PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
KI DFG + + T G+ ++APE + K DV+S+G++L E+++
Sbjct: 144 VLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR 199
Query: 202 RT 203
R
Sbjct: 200 RK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-50
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 23 GTIVAVKVL----SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
G VAVK + Q + E A + H N++ L G C+ P LV ++
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--HPNIIALRGVCLKEPNLCLVMEF 87
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
L++ L + + I RG+ Y+H+E ++HRD+K+SNIL+
Sbjct: 88 ARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILIL 142
Query: 139 QNFNP--------KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYS 190
Q KI+DFGL++ + T AG ++APE + ++ SDV+S
Sbjct: 143 QKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWS 199
Query: 191 FGVLLLEIVSGRT 203
+GVLL E+++G
Sbjct: 200 YGVLLWELLTGEV 212
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-48
Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 15/183 (8%)
Query: 26 VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
VAVK+L+V + Q + F +EV + H N++ G I V + +S
Sbjct: 49 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYSTAPQLAI-VTQWCEGSS 105
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L KF K +I RG+ Y+H ++HRD+K++NI L ++
Sbjct: 106 LYHHL---HASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTV 159
Query: 144 KISDFGLSKLFPE-NTTHISTRVAGTLGYLAPE---YAISGRLTRKSDVYSFGVLLLEIV 199
KI DFGL+ + +H +++G++ ++APE S + +SDVY+FG++L E++
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 200 SGR 202
+G+
Sbjct: 220 TGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-48
Identities = 43/188 (22%), Positives = 81/188 (43%), Gaps = 20/188 (10%)
Query: 23 GTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL--VYDY 78
G + VKVL V S + ++F E + + H N++ + G C P + +
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS--HPNVLPVLGACQSPPAPHPTLITHW 90
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
MP SL L E + + + RG+A++H +P + + + ++++D
Sbjct: 91 MPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMID 147
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVL 194
++ +IS + F S ++APE A+ + R +D++SF VL
Sbjct: 148 EDMTARISMADVKFSF------QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVL 200
Query: 195 LLEIVSGR 202
L E+V+
Sbjct: 201 LWELVTRE 208
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-46
Identities = 55/198 (27%), Positives = 83/198 (41%), Gaps = 28/198 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI----LVYDY 78
G VAVKV E + E V + HEN++ I G L+ DY
Sbjct: 60 GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIKTS 133
N SL L + K+ ++ GL ++H EI +P + HRD+K+
Sbjct: 117 HENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYLAPEYAISGRL-------T 183
NIL+ +N I+D GL+ F +T + GT Y+ PE + L
Sbjct: 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSY 230
Query: 184 RKSDVYSFGVLLLEIVSG 201
+D+YSFG++L E+
Sbjct: 231 IMADMYSFGLILWEVARR 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-46
Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 26/197 (13%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI----LVYDY 78
G VAVK+ S + EK + E V + HEN++ + L+ Y
Sbjct: 31 GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIKTS 133
SL L + + I++ I GLA++H EI +P + HRD+K+
Sbjct: 88 HEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYLAPE------YAISGRLTR 184
NIL+ +N I+D GL+ + ++T + + GT Y+APE +
Sbjct: 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK 202
Query: 185 KSDVYSFGVLLLEIVSG 201
+ D+++FG++L E+
Sbjct: 203 RVDIWAFGLVLWEVARR 219
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-46
Identities = 43/192 (22%), Positives = 78/192 (40%), Gaps = 24/192 (12%)
Query: 26 VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
VA++++ +E ++ K F EV + HEN+V G C+ P ++ +
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTR--HENVVLFMGACMSPPHLAIITSLCKGRT 115
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L + + R+I I +G+ Y+H ++H+D+K+ N+ D N
Sbjct: 116 LYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKV 168
Query: 144 KISDFGLSKL----FPENTTHISTRVAGTLGYLAPE---------YAISGRLTRKSDVYS 190
I+DFGL + G L +LAPE ++ SDV++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 191 FGVLLLEIVSGR 202
G + E+ +
Sbjct: 229 LGTIWYELHARE 240
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-45
Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 21/197 (10%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
+ G ++ +K L ++ ++ F+ EV M + H N++K G + +Y+
Sbjct: 33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE--HPNVLKFIGVLYKDKRLNFITEYIK 90
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
+L + +++ W R I G+AY+H +++HRD+ + N L+ +N
Sbjct: 91 GGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVREN 144
Query: 141 FNPKISDFGLSKLFPENTTH-------------ISTRVAGTLGYLAPEYAISGRLTRKSD 187
N ++DFGL++L + T V G ++APE K D
Sbjct: 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD 204
Query: 188 VYSFGVLLLEIVSGRTA 204
V+SFG++L EI+ A
Sbjct: 205 VFSFGIVLCEIIGRVNA 221
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-43
Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 28/199 (14%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVYD 77
G VAVK+ S + E+ + E V + HEN++ LV D
Sbjct: 64 RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ-----PHVVHRDIKT 132
Y + SL L R + ++ + GLA++H EI P + HRD+K+
Sbjct: 121 YHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYLAPEYAISGRL------- 182
NIL+ +N I+D GL+ T I GT Y+APE + +
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFES 234
Query: 183 TRKSDVYSFGVLLLEIVSG 201
+++D+Y+ G++ EI
Sbjct: 235 FKRADIYAMGLVFWEIARR 253
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-36
Identities = 53/184 (28%), Positives = 92/184 (50%), Gaps = 12/184 (6%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDY 78
G +VAVK L +++ ++F E+ + ++ H+N+VK G C R L+ +Y
Sbjct: 37 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGRRNLKLIMEY 94
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+P SL L +K + + + I +G+ Y+ + +HRD+ T NIL++
Sbjct: 95 LPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVE 148
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLL 196
KI DFGL+K+ P++ + G + APE + + SDV+SFGV+L
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 197 EIVS 200
E+ +
Sbjct: 209 ELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-36
Identities = 53/184 (28%), Positives = 93/184 (50%), Gaps = 12/184 (6%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDY 78
G +VAVK L +++ ++F E+ + ++ H+N+VK G C R L+ +Y
Sbjct: 68 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+P SL L +K + + + I +G+ Y+ + +HRD+ T NIL++
Sbjct: 126 LPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVE 179
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLL 196
KI DFGL+K+ P++ + + G + APE + + SDV+SFGV+L
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 197 EIVS 200
E+ +
Sbjct: 240 ELFT 243
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 16/184 (8%)
Query: 22 DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
D T+VAVK + +F+ E + + H N+V+L G C +V + +
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLIGVCTQKQPIYIVMELVQ 195
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
L A+ K +++ G+ Y+ + +HRD+ N L+ +
Sbjct: 196 GGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEK 249
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGY----LAPEYAISGRLTRKSDVYSFGVLLL 196
KISDFG+S+ + G APE GR + +SDV+SFG+LL
Sbjct: 250 NVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 197 EIVS 200
E S
Sbjct: 307 ETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-35
Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 21 QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--ILVYD 77
G VAVK L E + E+ + N+ HEN+VK G C + L+ +
Sbjct: 48 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICTEDGGNGIKLIME 105
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
++P+ SL + L K + K K + + + I +G+ Y+ VHRD+ N+L+
Sbjct: 106 FLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV 159
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVLL 195
+ KI DFGL+K + + + + + APE + + SDV+SFGV L
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 196 LEIVS 200
E+++
Sbjct: 220 HELLT 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-35
Identities = 45/179 (25%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 24 TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+K L S + KE + E MA+V+ + ++ +L G C+ ++ + MP
Sbjct: 45 IPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTSTVQL-ITQLMPFG 101
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
L + + + G + + I +G+ Y+ + +VHRD+ N+L+ +
Sbjct: 102 CLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155
Query: 143 PKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
KI+DFGL+KL + ++A E + T +SDV+S+GV + E+++
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-35
Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 12/184 (6%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDY 78
G +VAVK L +++F E+ + ++ + +VK G + LV +Y
Sbjct: 50 NTGALVAVKQLQHSGPDQQRDFQREIQILKALH--SDFIVKYRGVSYGPGRQSLRLVMEY 107
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+P+ L L ++ RA+ I +G+ Y+ VHRD+ NIL++
Sbjct: 108 LPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVE 161
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLL 196
+ KI+DFGL+KL P + + R G + APE +R+SDV+SFGV+L
Sbjct: 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 221
Query: 197 EIVS 200
E+ +
Sbjct: 222 ELFT 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-35
Identities = 59/183 (32%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 23 GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDYM 79
G +VAVK L + Q + E+ + + HE+++K G C D LV +Y+
Sbjct: 60 GEMVAVKALKADAGPQHRSGWKQEIDILRTLY--HEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
P SL L R G I G+AY+H + H +HRD+ N+LLD
Sbjct: 118 PLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDN 169
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLLE 197
+ KI DFGL+K PE + R G + APE + SDV+SFGV L E
Sbjct: 170 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 198 IVS 200
+++
Sbjct: 230 LLT 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-34
Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 13/186 (6%)
Query: 19 RLQDGTI-VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
R++ I VA+KVL +++ + E M E M ++ + +V+L G C + V
Sbjct: 32 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQAEALML-VM 88
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+ L + L+ +R + E++ + G+ Y+ E+ + VHRD+ N+L
Sbjct: 89 EMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVL 142
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVL 194
L KISDFGLSK + ++ + R AG + APE + + +SDV+S+GV
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202
Query: 195 LLEIVS 200
+ E +S
Sbjct: 203 MWEALS 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-34
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 14/181 (7%)
Query: 24 TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
VAVK+L E + E ++E M ++ + +V++ G C + V +
Sbjct: 45 KTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGICEAESWML-VMEMAEL 101
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
L++ L ++ K E++ + G+ Y+ E + VHRD+ N+LL
Sbjct: 102 GPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH 154
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
KISDFGLSK + + + G + APE + + KSDV+SFGVL+ E
Sbjct: 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
Query: 200 S 200
S
Sbjct: 215 S 215
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-34
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 18/189 (9%)
Query: 21 QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR----IL 74
+ VA L +K + F E + + H N+V+ + +L
Sbjct: 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKKCIVL 106
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V + M + +L L KR K R I +GL ++H P ++HRD+K N
Sbjct: 107 VTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDN 161
Query: 135 ILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
I + + KI D GL+ L + V GT ++APE + DVY+FG+
Sbjct: 162 IFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM-YEEKYDESVDVYAFGM 217
Query: 194 LLLEIVSGR 202
+LE+ +
Sbjct: 218 CMLEMATSE 226
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-33
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 26 VAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VAVK L + + +F+ EV +M +++ H NL++L+G + P ++ V + P
Sbjct: 49 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVLTPPMKM-VTELAPLG 105
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
SL L K + F + + G+ Y+ + +HRD+ N+LL
Sbjct: 106 SLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL 159
Query: 143 PKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
KI DFGL + P+N H + + + APE + + SD + FGV L E+ +
Sbjct: 160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 19 RLQDGTI-VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
R++ I VA+KVL K +E M E M ++ + +V+L G C + V
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQAEALML-VM 414
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+ L + L+ +R + E++ + G+ Y+ E+ + VHR++ N+L
Sbjct: 415 EMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVL 468
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEYAISGRLTRKSDVYSFGVL 194
L KISDFGLSK + ++ + R AG APE + + +SDV+S+GV
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 195 LLEIVS 200
+ E +S
Sbjct: 529 MWEALS 534
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 43/179 (24%), Positives = 83/179 (46%), Gaps = 11/179 (6%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+K L + E + E MA+V+ + ++ +L G C+ ++ + MP
Sbjct: 45 IPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTSTVQL-ITQLMPFG 101
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
L + + + G + + I +G+ Y+ + +VHRD+ N+L+ +
Sbjct: 102 CLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155
Query: 143 PKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
KI+DFGL+KL + ++A E + T +SDV+S+GV + E+++
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-33
Identities = 45/179 (25%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 24 TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
V +KV+ +S +Q + + ++ +++ H ++V+L G C ++ V Y+P
Sbjct: 43 IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD--HAHIVRLLGLCPGSSLQL-VTQYLPLG 99
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
SL + + R G + + I +G+ Y+ E +VHR++ N+LL
Sbjct: 100 SLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQ 153
Query: 143 PKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+++DFG++ L P + + A T + ++A E G+ T +SDV+S+GV + E+++
Sbjct: 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-33
Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 16/189 (8%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ VA+K + + E++F+ E M ++ H LV+L+G C++ LV ++
Sbjct: 28 YWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICLVTEF 84
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M + LS L +R F + + + + G+AY+ E V+HRD+ N L+
Sbjct: 85 MEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVG 138
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGRLTRKSDVYSFGVLL 195
+N K+SDFG+++ ++ T GT + +PE R + KSDV+SFGVL+
Sbjct: 139 ENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195
Query: 196 LEIVS-GRT 203
E+ S G+
Sbjct: 196 WEVFSEGKI 204
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-32
Identities = 47/189 (24%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
L DG VA+K + + K + E+ + +N H N++K + I+ +V
Sbjct: 53 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIKYYASFIEDNELNIV 110
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+ LS+ + +K++ + + + + L ++H V+HRDIK +N+
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANV 167
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
+ K+ D GL + F TT + V GT Y++PE KSD++S G LL
Sbjct: 168 FITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLL 226
Query: 196 LEIVSGRTA 204
E+ + ++
Sbjct: 227 YEMAALQSP 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+K L V + ++ +F+ E + M + H N+++L G ++V +YM N
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
SL L K A+F ++ GI G+ Y+ + VHRD+ NIL++ N
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLV 185
Query: 143 PKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYAISGRLTRKSDVYSFGVLLLEIVS 200
K+SDFGL ++ ++ T G + +PE + T SDV+S+G++L E++S
Sbjct: 186 CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-32
Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 21 QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
+ VAVK + + +++FMSE M N++ H ++VKL G + P I + +
Sbjct: 38 GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD--HPHIVKLIGIIEEEPTWI-IMELY 94
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
P L L E+ + + I + +AY+ + VHRDI NIL+
Sbjct: 95 PYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVAS 148
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGRLTRKSDVYSFGVLLL 196
K+ DFGLS+ + + + T +++PE R T SDV+ F V +
Sbjct: 149 PECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMW 205
Query: 197 EIVS 200
EI+S
Sbjct: 206 EILS 209
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-32
Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+K L + ++ +F+SE + M + H N+++L G G ++V +YM N
Sbjct: 78 VPVAIKALKAGYTERQRRDFLSEASIMGQFD--HPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
SL L +F ++ G+G G+ Y+ + VHRD+ N+L+D N
Sbjct: 136 SLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189
Query: 143 PKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYAISGRLTRKSDVYSFGVLLLEIVS 200
K+SDFGLS++ ++ T G + APE + SDV+SFGV++ E+++
Sbjct: 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-32
Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ + VA+K++ S E EF+ E M N++ HE LV+L+G C ++ +Y
Sbjct: 44 KWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLS--HEKLVQLYGVCTKQRPIFIITEY 100
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M N L L + R +F + E+ + + Y+ + +HRD+ N L++
Sbjct: 101 MANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVN 154
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGRLTRKSDVYSFGVLL 195
K+SDFGLS+ ++ T G+ + PE + + + KSD+++FGVL+
Sbjct: 155 DQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 196 LEIVS 200
EI S
Sbjct: 212 WEIYS 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-32
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 28/221 (12%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 70
VDL L DG A+K + +Q +E E N H N+++L C+
Sbjct: 44 YVDLV--EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN--HPNILRLVAYCLRER 99
Query: 71 CR----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 126
L+ + +L + + + +++GI RGL IH
Sbjct: 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYA 156
Query: 127 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--------GTLGYLAPE--- 175
HRD+K +NILL P + D G + + T+ Y APE
Sbjct: 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216
Query: 176 ---YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213
+ + + ++DV+S G +L ++ G D Q G+
Sbjct: 217 VQSHCV---IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-32
Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 11/178 (6%)
Query: 26 VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84
VA+K L + ++ +F+ E M + H N+++L G +++ +YM N +L
Sbjct: 76 VAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144
+ L ++ +F ++ GI G+ Y+ + VHRD+ NIL++ N K
Sbjct: 134 DKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCK 187
Query: 145 ISDFGLSKLFPENTTHISTRVAGTLGY--LAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+SDFGLS++ ++ T G + APE + T SDV+SFG+++ E+++
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-31
Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 15/185 (8%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ + VAVK++ E E EF E +M ++ H LVK +G C +V +Y
Sbjct: 28 KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLS--HPKLVKFYGVCSKEYPIYIVTEY 84
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+ N L L E+ + G+A++ +HRD+ N L+D
Sbjct: 85 ISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVD 138
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGRLTRKSDVYSFGVLL 195
++ K+SDFG+++ ++ GT + APE + + KSDV++FG+L+
Sbjct: 139 RDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
Query: 196 LEIVS 200
E+ S
Sbjct: 196 WEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 23 GTIVAVKVLSVESKQG---EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
VAVK L K+ +EF+ E A M + H NLV+L G C P ++ ++M
Sbjct: 245 SLTVAVKTL----KEDTMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYIITEFM 298
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
+L L E R + + I + Y+ ++ + +HR++ N L+ +
Sbjct: 299 TYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGE 353
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
N K++DFGLS+L +T + + APE + + KSDV++FGVLL EI
Sbjct: 354 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413
Query: 200 S 200
+
Sbjct: 414 T 414
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-31
Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 10/178 (5%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+K + + +F+ E +M + H ++VKL G + P I + +
Sbjct: 44 LAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVITENPVWI-IMELCTLG 100
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
L L R+ + + LAY+ + VHRDI N+L+ N
Sbjct: 101 ELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC 154
Query: 143 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
K+ DFGLS+ ++T + +++ + ++APE R T SDV+ FGV + EI+
Sbjct: 155 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 16/189 (8%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
T VAVK + + F++E M + H+ LVKLH P I + ++
Sbjct: 208 TYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQ--HDKLVKLHAVVTKEPIYI-ITEF 263
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M SL L + +K + I G+A+I + + +HRD++ +NIL+
Sbjct: 264 MAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 318
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLG---YLAPEYAISGRLTRKSDVYSFGVLL 195
+ KI+DFGL+++ +N T G + APE G T KSDV+SFG+LL
Sbjct: 319 ASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 196 LEIVS-GRT 203
+EIV+ GR
Sbjct: 376 MEIVTYGRI 384
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 19/185 (10%)
Query: 23 GTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYM 79
G VAVK + K + F++E + M + H NLV+L G + + +V +YM
Sbjct: 216 GNKVAVKCI----KNDATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
SL L + R+ G + + + + Y+ + VHRD+ N+L+ +
Sbjct: 270 AKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSE 324
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
+ K+SDFGL+K ++T + ++ + + APE + + KSDV+SFG+LL EI
Sbjct: 325 DNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 200 S-GRT 203
S GR
Sbjct: 381 SFGRV 385
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-31
Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 40/242 (16%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS-----------------VESKQGEKEFMSEVASMANVN 53
K+ L +D A+K + K +F +E+ + ++
Sbjct: 46 KIILC----EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101
Query: 54 VCHENLVKLHGGCIDGPCRI-LVYDYMPN----NSLSQTLLGEEKRRAKFGWKARREIIM 108
+E + G I + ++Y+YM N + ++ + + II
Sbjct: 102 --NEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 109 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 168
+ +YIH + ++ HRD+K SNIL+D+N K+SDFG S+ + S GT
Sbjct: 159 SVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGT 213
Query: 169 LGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINM 225
++ PE S + K D++S G+ L + F +++ L + +R+ N+
Sbjct: 214 YEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP--FSLKISLVELFNNIRTKNI 270
Query: 226 KL 227
+
Sbjct: 271 EY 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-31
Identities = 48/218 (22%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 70
+V A D A+K + ++ +SEV +A++N H+ +V+ + ++
Sbjct: 21 QVVKA--RNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN--HQYVVRYYAAWLERR 75
Query: 71 CRI-------------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 117
+ + +Y N +L + + I L+YI
Sbjct: 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEALSYI 132
Query: 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-------------TR 164
H + ++HRD+K NI +D++ N KI DFGL+K + + T
Sbjct: 133 HSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 165 VAGTLGYLAPE-YAISGRLTRKSDVYSFGVLLLEIVSG 201
GT Y+A E +G K D+YS G++ E++
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-31
Identities = 45/188 (23%), Positives = 88/188 (46%), Gaps = 10/188 (5%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+DG +K +++ S + +E EVA +AN+ H N+V+ + +V
Sbjct: 45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--HPNIVQYRESFEENGSLYIVM 102
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
DY L + + ++ F + + I L ++H+ ++HRDIK+ NI
Sbjct: 103 DYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIF 157
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
L ++ ++ DFG++++ + GT YL+PE + KSD+++ G +L
Sbjct: 158 LTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 197 EIVSGRTA 204
E+ + + A
Sbjct: 217 ELCTLKHA 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 10/178 (5%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+K + + +F+ E +M + H ++VKL G + P I + +
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVITENPVWI-IMELCTLG 475
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
L L + R+ + + LAY+ + VHRDI N+L+ N
Sbjct: 476 ELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC 529
Query: 143 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
K+ DFGLS+ ++T + +++ + ++APE R T SDV+ FGV + EI+
Sbjct: 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-30
Identities = 46/187 (24%), Positives = 70/187 (37%), Gaps = 13/187 (6%)
Query: 18 IRLQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
+DG + AVK + ++EV S V H V+L +G L
Sbjct: 77 RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV-GQHPCCVRLEQAWEEGGILYLQ 135
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+ SL Q E A + LA++H + +VH D+K +NI
Sbjct: 136 TELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANI 188
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
L K+ DFGL + G Y+APE + G +DV+S G+ +
Sbjct: 189 FLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTI 245
Query: 196 LEIVSGR 202
LE+
Sbjct: 246 LEVACNM 252
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-30
Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 25/196 (12%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
QD +VAVK L S+ ++F E + + H+++V+ G C +G ++V++YM
Sbjct: 69 QDKMLVAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCTEGRPLLMVFEYMR 126
Query: 81 NNSLSQTLLGEEKRRAKFGWKARRE-----------IIMGIGRGLAYIHEEIQPHVVHRD 129
+ L++ L + + G+ Y+ H VHRD
Sbjct: 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRD 183
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTR 184
+ T N L+ Q KI DFG+S+ RV G L PE + + T
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRV-GGRTMLPIRWMPPESILYRKFTT 239
Query: 185 KSDVYSFGVLLLEIVS 200
+SDV+SFGV+L EI +
Sbjct: 240 ESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
+D +VAVK L + K+F E + N+ HE++VK +G C DG I+V++YM
Sbjct: 43 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDGDPLIMVFEYMK 100
Query: 81 NNSLSQTLLGEEKRRAKFGWKARRE------------IIMGIGRGLAYIHEEIQPHVVHR 128
+ L++ L R+ I I G+ Y+ + H VHR
Sbjct: 101 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHR 157
Query: 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLT 183
D+ T N L+ N KI DFG+S+ + G L PE + + T
Sbjct: 158 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFT 213
Query: 184 RKSDVYSFGVLLLEIVS 200
+SDV+SFGV+L EI +
Sbjct: 214 TESDVWSFGVILWEIFT 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-30
Identities = 63/191 (32%), Positives = 90/191 (47%), Gaps = 20/191 (10%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
T VAVK L S F++E M + H+ LV+L+ P I + +Y
Sbjct: 33 YYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQ--HQRLVRLYAVVTQEPIYI-ITEY 88
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M N SL L + K ++ I G+A+I E + +HRD++ +NIL+
Sbjct: 89 MENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 143
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGV 193
+ KI+DFGL++L +N T G APE G T KSDV+SFG+
Sbjct: 144 DTLSCKIADFGLARLIEDNEY---TAREGAK--FPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 194 LLLEIVS-GRT 203
LL EIV+ GR
Sbjct: 199 LLTEIVTHGRI 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-30
Identities = 55/186 (29%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 24 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
VAVK L ++ + +EF+ E A M + H NLV+L G C P ++ ++M +
Sbjct: 39 LTVAVKTLKEDTME-VEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGN 95
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L E R + + I + Y+ ++ + +HRD+ N L+ +N
Sbjct: 96 LLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150
Query: 144 KISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEI 198
K++DFGLS+L +T A APE + + KSDV++FGVLL EI
Sbjct: 151 KVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 199 VS-GRT 203
+ G +
Sbjct: 206 ATYGMS 211
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 9/182 (4%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
T VA+K L + F+ E M + HE LV+L+ + P I V +Y
Sbjct: 287 TWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR--HEKLVQLYAVVSEEPIYI-VTEY 342
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M SL L + + ++ I G+AY+ + VHRD++ +NIL+
Sbjct: 343 MSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG 397
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+N K++DFGL++L +N + + APE A+ GR T KSDV+SFG+LL E+
Sbjct: 398 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 199 VS 200
+
Sbjct: 458 TT 459
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 9/182 (4%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
T VA+K L + F+ E M + HE LV+L+ + P I V +Y
Sbjct: 204 TWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR--HEKLVQLYAVVSEEPIYI-VTEY 259
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M SL L + + ++ I G+AY+ + VHRD++ +NIL+
Sbjct: 260 MSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG 314
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+N K++DFGL++L +N + + APE A+ GR T KSDV+SFG+LL E+
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 199 VS 200
+
Sbjct: 375 TT 376
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-30
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL-- 74
R DG I+ K L ++ ++ +SEV + + H N+V+ + ID L
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIIDRTNTTLYI 84
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE--EIQPHVVHRDIKT 132
V +Y L+ + K R + ++ + L H + V+HRD+K
Sbjct: 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 144
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
+N+ LD N K+ DFGL+++ +T+ T V GT Y++PE KSD++S G
Sbjct: 145 ANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 193 VLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222
LL E+ + F + L K+R
Sbjct: 204 CLLYELCALMPP--FTAF-SQKELAGKIRE 230
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-30
Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 12/181 (6%)
Query: 25 IVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
VA+K + + ++ E K F EV + + ++ H+N+V + + C LV +Y+
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLS--HQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
+LS+ + + I G+ + H+ +VHRDIK NIL+D N
Sbjct: 96 PTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNK 148
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
KI DFG++K E + + V GT+ Y +PE A +D+YS G++L E++ G
Sbjct: 149 TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208
Query: 202 R 202
Sbjct: 209 E 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-30
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
V LA Q+ I+A+KVL +E + E + E+ +++ H N+++++
Sbjct: 29 NVYLA--REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR--HPNILRMYN-YF 83
Query: 68 DGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 126
RI L+ ++ P L + L ++ +F + + + L Y HE V+
Sbjct: 84 HDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER---KVI 136
Query: 127 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRK 185
HRDIK N+L+ KI+DFG S P T + GTL YL PE I G+ K
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE-MIEGKTHDEK 192
Query: 186 SDVYSFGVLLLEIVSGRT 203
D++ GVL E + G
Sbjct: 193 VDLWCAGVLCYEFLVGMP 210
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-30
Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 19/185 (10%)
Query: 23 GTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-LVYDYM 79
G VAVK + K + F++E + M + H NLV+L G ++ + +V +YM
Sbjct: 44 GNKVAVKCI----KNDATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYIVTEYM 97
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
SL L + R+ G + + + + Y+ + VHRD+ N+L+ +
Sbjct: 98 AKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSE 152
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
+ K+SDFGL+K ++T + ++ + + APE + + KSDV+SFG+LL EI
Sbjct: 153 DNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
Query: 200 S-GRT 203
S GR
Sbjct: 209 SFGRV 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-30
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
V LA Q I+A+KVL +E E + EV +++ H N+++L+G
Sbjct: 24 NVYLA--REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFH 79
Query: 68 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127
D L+ +Y P ++ + L ++ +KF + I + L+Y H + V+H
Sbjct: 80 DATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIH 132
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKS 186
RDIK N+LL KI+DFG S P + + GTL YL PE I GR+ K
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE-MIEGRMHDEKV 188
Query: 187 DVYSFGVLLLEIVSGRT 203
D++S GVL E + G+
Sbjct: 189 DLWSLGVLCYEFLVGKP 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-29
Identities = 45/187 (24%), Positives = 79/187 (42%), Gaps = 24/187 (12%)
Query: 24 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
T V +KVL + + F + M+ ++ H++LV +G C+ G ILV +++ S
Sbjct: 41 TEVLLKVLDKAHRNYSESFFEAASMMSKLS--HKHLVLNYGVCVCGDENILVQEFVKFGS 98
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L +K + + E+ + + ++ E ++H ++ NILL + +
Sbjct: 99 LDTYL---KKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDR 152
Query: 144 --------KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGV 193
K+SD G+S + R+ PE I L +D +SFG
Sbjct: 153 KTGNPPFIKLSDPGISITV-LPKDILQERIPWV----PPE-CIENPKNLNLATDKWSFGT 206
Query: 194 LLLEIVS 200
L EI S
Sbjct: 207 TLWEICS 213
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 21/189 (11%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T VA+K ++ + E+ EF++E + M N ++V+L G G +++ + M
Sbjct: 56 TRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSQGQPTLVIMELMTRG 113
Query: 83 SLSQTLLGEEKRRAKFGWKARR------EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
L L A A ++ I G+AY++ VHRD+ N +
Sbjct: 114 DLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSF 191
+ ++F KI DFG+++ E + G G L +PE G T SDV+SF
Sbjct: 171 VAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226
Query: 192 GVLLLEIVS 200
GV+L EI +
Sbjct: 227 GVVLWEIAT 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 43/197 (21%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 21 QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ I A+K +++E Q + +E+A + + + +++L+ I +V +
Sbjct: 31 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
N L+ L K++ R+ + + IH+ +VH D+K +N L+
Sbjct: 91 -GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 142
Query: 139 QNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAPE-----------YAISGRLTRKS 186
K+ DFG++ +TT + GT+ Y+ PE +++ KS
Sbjct: 143 DG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201
Query: 187 DVYSFGVLLLEIVSGRT 203
DV+S G +L + G+T
Sbjct: 202 DVWSLGCILYYMTYGKT 218
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 43/197 (21%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 21 QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ I A+K +++E Q + +E+A + + + +++L+ I +V +
Sbjct: 50 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 109
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
N L+ L K++ R+ + + IH+ +VH D+K +N L+
Sbjct: 110 G-NIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 161
Query: 139 QNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAPE-----------YAISGRLTRKS 186
K+ DFG++ +TT + GT+ Y+ PE +++ KS
Sbjct: 162 DG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 187 DVYSFGVLLLEIVSGRT 203
DV+S G +L + G+T
Sbjct: 221 DVWSLGCILYYMTYGKT 237
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 19/185 (10%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVYDYMPN 81
AVK L+ + GE +F++E M + + H N++ L G C+ ++V YM +
Sbjct: 54 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSPLVVLPYMKH 111
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
L + K + + +G+ Y+ + VHRD+ N +LD+ F
Sbjct: 112 GDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKF 165
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYL------APEYAISGRLTRKSDVYSFGVLL 195
K++DFGL++ + + V G A E + + T KSDV+SFGVLL
Sbjct: 166 TVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222
Query: 196 LEIVS 200
E+++
Sbjct: 223 WELMT 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-29
Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 13/182 (7%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVYDYMPN 81
A+K LS ++ + F+ E M +N H N++ L G + ++ YM +
Sbjct: 50 IQCAIKSLSRITEMQQVEAFLREGLLMRGLN--HPNVLALIGIMLPPEGLPHVLLPYMCH 107
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
L Q + + K + + RG+ Y+ E+ VHRD+ N +LD++F
Sbjct: 108 GDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESF 161
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
K++DFGL++ + + + + A E + R T KSDV+SFGVLL E+
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221
Query: 199 VS 200
++
Sbjct: 222 LT 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-29
Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
L + +A+K + + + E+A ++ H+N+V+ G + + + +
Sbjct: 44 LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK--HKNIVQYLGSFSENGFIKIFMEQV 101
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYIHEEIQPHVVHRDIKTSN 134
P SLS L R+K+G E +G I GL Y+H+ +VHRDIK N
Sbjct: 102 PGGSLSALL------RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDN 152
Query: 135 ILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL---TRKSDVYS 190
+L++ + KISDFG SK T GTL Y+APE I + +D++S
Sbjct: 153 VLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE-IIDKGPRGYGKAADIWS 210
Query: 191 FGVLLLEIVSGR 202
G ++E+ +G+
Sbjct: 211 LGCTIIEMATGK 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-29
Identities = 44/198 (22%), Positives = 85/198 (42%), Gaps = 25/198 (12%)
Query: 21 QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ I A+K +++E Q + +E+A + + + +++L+ I +V +
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
N L+ L K++ R+ + + IH+ +VH D+K +N L+
Sbjct: 138 -GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189
Query: 139 QNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAPEYAISGR------------LTRK 185
K+ DFG++ +TT + G + Y+ PE AI ++ K
Sbjct: 190 DG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSRENGKSKSKISPK 247
Query: 186 SDVYSFGVLLLEIVSGRT 203
SDV+S G +L + G+T
Sbjct: 248 SDVWSLGCILYYMTYGKT 265
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-28
Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 29/200 (14%)
Query: 21 QDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGC--IDGPCRILVYD 77
VAVK+L + E MSE+ + ++ H N+V L G C GP ++V +
Sbjct: 55 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIV-E 112
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARRE----------IIMG--IGRGLAYIHEEIQPHV 125
+ +LS L + + I + +G+ ++
Sbjct: 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 169
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISG 180
+HRD+ NILL + KI DFGL++ ++ V L APE
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLPLKWMAPETIFDR 225
Query: 181 RLTRKSDVYSFGVLLLEIVS 200
T +SDV+SFGVLL EI S
Sbjct: 226 VYTIQSDVWSFGVLLWEIFS 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 23/191 (12%)
Query: 24 TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRILVY 76
VAVK + ++ S++ +EF+SE A M + + H N+++L G CI+ P +++
Sbjct: 63 LKVAVKTMKLDNSSQREIEEFLSEAACMKDFS--HPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--IGRGLAYIHEEIQPHVVHRDIKTSN 134
+M L LL + + I G+ Y+ + +HRD+ N
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARN 177
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVY 189
+L + ++DFGLSK + G + + A E T KSDV+
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVW 233
Query: 190 SFGVLLLEIVS 200
+FGV + EI +
Sbjct: 234 AFGVTMWEIAT 244
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 18/187 (9%)
Query: 25 IVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLH-GGCIDGPCRILVY---D 77
VAVKVL + + F E + A +N H +V ++ G + P L Y +
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETPAGPLPYIVME 96
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
Y+ +L + K E+I + L + H+ ++HRD+K +NI++
Sbjct: 97 YVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMI 149
Query: 138 DQNFNPKISDFGLSKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
K+ DFG+++ ++ + + V GT YL+PE A + +SDVYS G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 196 LEIVSGR 202
E+++G
Sbjct: 210 YEVLTGE 216
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 21 QDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
++ VAVK+L ++ + + + +SE+ M + H+N++ L G C ++ +Y
Sbjct: 65 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYA 123
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARRE----------IIMG--IGRGLAYIHEEIQPHVVH 127
+L + L ++ + R + + RG+ Y+ + +H
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRL 182
RD+ N+L+ +N KI+DFGL++ T G L APE
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNI----DYYKKTTNGRLPVKWMAPEALFDRVY 236
Query: 183 TRKSDVYSFGVLLLEIVS 200
T +SDV+SFGVL+ EI +
Sbjct: 237 THQSDVWSFGVLMWEIFT 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-28
Identities = 48/195 (24%), Positives = 77/195 (39%), Gaps = 27/195 (13%)
Query: 24 TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+K L + +EF E A + H N+V L G +++ Y +
Sbjct: 40 QAVAIKTLKDKAEGPLREEFRHEAMLRARLQ--HPNVVCLLGVVTKDQPLSMIFSYCSHG 97
Query: 83 SLSQTLLGEEKRRAKFGWKARRE------------IIMGIGRGLAYIHEEIQPHVVHRDI 130
L + L+ R ++ I G+ Y+ HVVH+D+
Sbjct: 98 DLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDL 154
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRK 185
T N+L+ N KISD GL + + L APE + G+ +
Sbjct: 155 ATRNVLVYDKLNVKISDLGLFREVYAADYY----KLLGNSLLPIRWMAPEAIMYGKFSID 210
Query: 186 SDVYSFGVLLLEIVS 200
SD++S+GV+L E+ S
Sbjct: 211 SDIWSYGVVLWEVFS 225
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 17/184 (9%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVYDYMPN 81
AVK L+ + GE +F++E M + + H N++ L G C+ ++V YM +
Sbjct: 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSPLVVLPYMKH 175
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
L + K + + +G+ ++ + VHRD+ N +LD+ F
Sbjct: 176 GDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKF 229
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLL 196
K++DFGL++ + T L A E + + T KSDV+SFGVLL
Sbjct: 230 TVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287
Query: 197 EIVS 200
E+++
Sbjct: 288 ELMT 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 34/200 (17%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VAVK+L + E+ MSE+ ++ + H N+V L G C G +++ +Y
Sbjct: 54 MTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHMNIVNLLGACTIGGPTLVITEYCCYG 112
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMG-----------------IGRGLAYIHEEIQPHV 125
L L ++R F IM + +G+A++ + +
Sbjct: 113 DLLNFLR---RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NC 166
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISG 180
+HRD+ NILL KI DFGL++ + S V L APE +
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKND----SNYVVKGNARLPVKWMAPESIFNC 222
Query: 181 RLTRKSDVYSFGVLLLEIVS 200
T +SDV+S+G+ L E+ S
Sbjct: 223 VYTFESDVWSYGIFLWELFS 242
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-28
Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 24/195 (12%)
Query: 21 QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCR 72
VAVK+L + + +EF+ E A M + H ++ KL G + P
Sbjct: 49 GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD--HPHVAKLVGVSLRSRAKGRLPIP 106
Query: 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--IGRGLAYIHEEIQPHVVHRDI 130
+++ +M + L LL F + + I G+ Y+ + +HRD+
Sbjct: 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDL 163
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRK 185
N +L ++ ++DFGLS+ + G L A E T
Sbjct: 164 AARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVH 219
Query: 186 SDVYSFGVLLLEIVS 200
SDV++FGV + EI++
Sbjct: 220 SDVWAFGVTMWEIMT 234
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-28
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 29/200 (14%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI---- 73
DG +K + ++ + EV ++A ++ H N+V +G
Sbjct: 31 KHRIDGKTYVIKRVKYNNE----KAEREVKALAKLD--HVNIVHYNGCWDGFDYDPETSS 84
Query: 74 ------------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 121
+ ++ +L Q + E++R K E+ I +G+ YIH +
Sbjct: 85 KNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKGVDYIHSK- 141
Query: 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 181
+++RD+K SNI L KI DFGL +N + GTL Y++PE S
Sbjct: 142 --KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRSK-GTLRYMSPEQISSQD 197
Query: 182 LTRKSDVYSFGVLLLEIVSG 201
++ D+Y+ G++L E++
Sbjct: 198 YGKEVDLYALGLILAELLHV 217
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 46/189 (24%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 20 LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-L 74
+ A K++ ++ Q EK E++ ++ H+++V HG + + +
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA--HQHVVGFHG-FFEDNDFVFV 118
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V + SL + KRR R + I G Y+H V+HRD+K N
Sbjct: 119 VLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGN 171
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGV 193
+ L+++ KI DFGL+ + + GT Y+APE +S + + + DV+S G
Sbjct: 172 LFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSKKGHSFEVDVWSIGC 229
Query: 194 LLLEIVSGR 202
++ ++ G+
Sbjct: 230 IMYTLLVGK 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-28
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 24/193 (12%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VAVK+L + EK MSE+ M+++ HEN+V L G C G +++ +Y
Sbjct: 77 LKVAVKMLKSTAHADEKEALMSELKIMSHLG-QHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 83 SLSQTLLGEEKRRAKFGWKAR-------REIIM---GIGRGLAYIHEEIQPHVVHRDIKT 132
L L + + A R+++ + +G+A++ + + +HRD+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSD 187
N+LL KI DFGL++ + S + L APE T +SD
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMND----SNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248
Query: 188 VYSFGVLLLEIVS 200
V+S+G+LL EI S
Sbjct: 249 VWSYGILLWEIFS 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-28
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 32/203 (15%)
Query: 19 RLQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ ++ VAVK+L ++ + + + +SE+ M + H+N++ L G C ++ +
Sbjct: 109 KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVE 167
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMG---------------IGRGLAYIHEEIQ 122
Y +L + L RR + + + RG+ Y+ +
Sbjct: 168 YASKGNLREYLR---ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-- 222
Query: 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYA 177
+HRD+ N+L+ +N KI+DFGL++ T G L APE
Sbjct: 223 -KCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DYYKKTTNGRLPVKWMAPEAL 277
Query: 178 ISGRLTRKSDVYSFGVLLLEIVS 200
T +SDV+SFGVL+ EI +
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-28
Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 21/190 (11%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
D VAVK + + EV + + H N+++ D + + +
Sbjct: 47 DNRDVAVKRIL---PECFSFADREVQLLRESDE-HPNVIRYFCTEKDRQFQYIAIELCAA 102
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---- 137
+L + + E++ ++ GLA++H ++VHRD+K NIL+
Sbjct: 103 -TLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPN 155
Query: 138 -DQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEY---AISGRLTRKSDVYSF 191
ISDFGL K S R V GT G++APE T D++S
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 192 GVLLLEIVSG 201
G + ++S
Sbjct: 216 GCVFYYVISE 225
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-28
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 30/197 (15%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T VAVK+L ++ + + + +SE+ M + H+N++ L G C ++ +Y
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKG 160
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMG--------------IGRGLAYIHEEIQPHVVHR 128
+L + L +R + + RG+ Y+ + +HR
Sbjct: 161 NLREYLQ--ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 215
Query: 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLT 183
D+ N+L+ ++ KI+DFGL++ T G L APE T
Sbjct: 216 DLAARNVLVTEDNVMKIADFGLARDIHHI----DYYKKTTNGRLPVKWMAPEALFDRIYT 271
Query: 184 RKSDVYSFGVLLLEIVS 200
+SDV+SFGVLL EI +
Sbjct: 272 HQSDVWSFGVLLWEIFT 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 21/189 (11%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VAVK L + ++ +F+ E ++ N H+N+V+ G + R ++ + M
Sbjct: 102 LQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNIVRCIGVSLQSLPRFILLELMAGG 159
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNILLD- 138
L L R ++ A +++ I G Y+ E H +HRDI N LL
Sbjct: 160 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTC 216
Query: 139 --QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSF 191
KI DFG+++ G L PE + G T K+D +SF
Sbjct: 217 PGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 192 GVLLLEIVS 200
GVLL EI S
Sbjct: 273 GVLLWEIFS 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-27
Identities = 46/189 (24%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 20 LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-L 74
+ A K++ ++ Q EK E++ ++ H+++V HG + + +
Sbjct: 37 ADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA--HQHVVGFHG-FFEDNDFVFV 92
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V + SL + KRR R + I G Y+H V+HRD+K N
Sbjct: 93 VLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGN 145
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGV 193
+ L+++ KI DFGL+ + + GT Y+APE +S + + + DV+S G
Sbjct: 146 LFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSKKGHSFEVDVWSIGC 203
Query: 194 LLLEIVSGR 202
++ ++ G+
Sbjct: 204 IMYTLLVGK 212
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 53/189 (28%), Positives = 80/189 (42%), Gaps = 21/189 (11%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VAVK L + ++ +F+ E ++ N H+N+V+ G + R ++ + M
Sbjct: 61 LQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNIVRCIGVSLQSLPRFILMELMAGG 118
Query: 83 SLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLD- 138
L L R ++ A +++ I G Y+ E H +HRDI N LL
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTC 175
Query: 139 --QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSF 191
KI DFG+++ S G L PE + G T K+D +SF
Sbjct: 176 PGPGRVAKIGDFGMARDIYRA----SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231
Query: 192 GVLLLEIVS 200
GVLL EI S
Sbjct: 232 GVLLWEIFS 240
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-27
Identities = 43/228 (18%), Positives = 82/228 (35%), Gaps = 35/228 (15%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRI---- 73
D A+K + + +++ +E M EV ++A + H +V+ ++
Sbjct: 26 NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFNAWLEKNTTEKLQP 83
Query: 74 --------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 125
+ +L + + I + I + ++H + +
Sbjct: 84 SSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GL 139
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLF-----------PENTTHISTRVAGTLGYLAP 174
+HRD+K SNI + K+ DFGL P T GT Y++P
Sbjct: 140 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222
E + K D++S G++L E+ F Q+ + VR+
Sbjct: 200 EQIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTDVRN 242
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-27
Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 18/189 (9%)
Query: 20 LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-LV 75
+ G VA+K++ + + +EV + H ++++L+ + + LV
Sbjct: 33 IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK--HPSILELYN-YFEDSNYVYLV 89
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFG-WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
+ N +++ L + R F +AR + I G+ Y+H ++HRD+ SN
Sbjct: 90 LEMCHNGEMNRYL---KNRVKPFSENEARH-FMHQIITGMLYLHSH---GILHRDLTLSN 142
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGV 193
+LL +N N KI+DFGL+ T + GT Y++PE + +SDV+S G
Sbjct: 143 LLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IATRSAHGLESDVWSLGC 200
Query: 194 LLLEIVSGR 202
+ ++ GR
Sbjct: 201 MFYTLLIGR 209
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 35/203 (17%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T VAVK+L + E + +SE + VN H +++KL+G C +L+ +Y
Sbjct: 54 TTVAVKMLKENASPSELRDLLSEFNVLKQVN--HPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 83 SL------------SQTLLGEEKRRAKFGWKARREIIMG--------IGRGLAYIHEEIQ 122
SL G + + R + MG I +G+ Y+ E
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-- 169
Query: 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYA 177
+VHRD+ NIL+ + KISDFGLS+ E + V + G + A E
Sbjct: 170 -KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE----DSYVKRSQGRIPVKWMAIESL 224
Query: 178 ISGRLTRKSDVYSFGVLLLEIVS 200
T +SDV+SFGVLL EIV+
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 41/206 (19%)
Query: 24 TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
T+VAVK+L E S + +F E A MA + + N+VKL G C G L+++YM
Sbjct: 78 TMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLGVCAVGKPMCLLFEYMAYG 135
Query: 83 SLSQTLLGEEKRRAKFGWKARRE-----------------------IIMGIGRGLAYIHE 119
L++ L I + G+AY+ E
Sbjct: 136 DLNEFLR---SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192
Query: 120 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----AP 174
VHRD+ T N L+ +N KI+DFGLS+ N A + P
Sbjct: 193 R---KFVHRDLATRNCLVGENMVVKIADFGLSR----NIYSADYYKADGNDAIPIRWMPP 245
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVS 200
E R T +SDV+++GV+L EI S
Sbjct: 246 ESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-26
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 30/199 (15%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
A+K + + + + +F E+ + + H N++ L G C L +Y P+
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHG 111
Query: 83 SLSQTL----LGEEKRRAKFGWKARREIIM--------GIGRGLAYIHEEIQPHVVHRDI 130
+L L + E + + RG+ Y+ ++ +HRD+
Sbjct: 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDL 168
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAISGRLTRK 185
NIL+ +N+ KI+DFGLS+ V T+G L A E T
Sbjct: 169 AARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 221
Query: 186 SDVYSFGVLLLEIVS-GRT 203
SDV+S+GVLL EIVS G T
Sbjct: 222 SDVWSYGVLLWEIVSLGGT 240
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 24 TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VAVK+L ++ E+ MSE+ M + HEN+V L G C L+++Y
Sbjct: 76 IQVAVKMLKEKADSSEREALMSELKMMTQLG-SHENIVNLLGACTLSGPIYLIFEYCCYG 134
Query: 83 SL-----------SQTLLGEEKRRAKFGWKARREIIMG--------IGRGLAYIHEEIQP 123
L S+ + E ++ + + + +G+ ++ +
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--- 191
Query: 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAI 178
VHRD+ N+L+ KI DFGL++ + S V L APE
Sbjct: 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD----SNYVVRGNARLPVKWMAPESLF 247
Query: 179 SGRLTRKSDVYSFGVLLLEIVS 200
G T KSDV+S+G+LL EI S
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFS 269
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 51/191 (26%), Positives = 77/191 (40%), Gaps = 20/191 (10%)
Query: 23 GTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLH------GGCIDGPCRILV 75
G VA+K E +E + E+ M +N H N+V +L
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLN--HPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+Y L + L + + R ++ I L Y+HE ++HRD+K NI
Sbjct: 97 MEYCEGGDLRK-YLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENI 152
Query: 136 LLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSF 191
+L KI D G +K + + V GTL YLAPE + + T D +SF
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAPE-LLEQKKYTVTVDYWSF 209
Query: 192 GVLLLEIVSGR 202
G L E ++G
Sbjct: 210 GTLAFECITGF 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 33/234 (14%), Positives = 65/234 (27%), Gaps = 51/234 (21%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKE----------------------------F 42
A + G V V + F
Sbjct: 88 AYLEA--TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145
Query: 43 MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN--SLSQTLLGEEKRRAKFGW 100
+ + + V+L + R +Y M +N + + LL
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205
Query: 101 KARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160
AR ++ + + R LA +H +VH ++ +I+LDQ ++ F
Sbjct: 206 HARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV- 261
Query: 161 ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRT 203
+ + G+ PE +T D ++ G+++ I
Sbjct: 262 ----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 34/234 (14%), Positives = 64/234 (27%), Gaps = 38/234 (16%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKE----------------------------FMSEVASMA 50
+ G V V + F+ +
Sbjct: 99 DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158
Query: 51 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNN--SLSQTLLGEEKRRAKFGWKARREIIM 108
+ V+L + R +Y M +N + + LL AR ++ +
Sbjct: 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTL 218
Query: 109 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 168
+ R LA +H +VH ++ +I+LDQ ++ F + R
Sbjct: 219 QVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAP 275
Query: 169 LGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 217
A +T D ++ G+ + I D LG +
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-26
Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
Q G AVK + +E + + E+ + A ++ +V L+G +GP + + +
Sbjct: 80 KQTGFQCAVKKVRLEVFR-----VEELVACAGLS--SPRIVPLYGAVREGPWVNIFMELL 132
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
SL Q + K+ + GL Y+H ++H D+K N+LL
Sbjct: 133 EGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSS 185
Query: 140 NFNP-KISDFGLSKLFPENTTHISTR----VAGTLGYLAPEYAISGR-LTRKSDVYSFGV 193
+ + + DFG + + S + GT ++APE + G+ K D++S
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCC 244
Query: 194 LLLEIVSGR 202
++L +++G
Sbjct: 245 MMLHMLNGC 253
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-26
Identities = 44/209 (21%), Positives = 78/209 (37%), Gaps = 29/209 (13%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDG 69
V + G + A+KV + S + M E + +N H+N+VKL +
Sbjct: 24 NVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--HKNIVKLFA-IEEE 78
Query: 70 PCRILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 126
++ P SL +L E ++ + G+ ++ E +V
Sbjct: 79 TTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIV 134
Query: 127 HRDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 182
HR+IK NI+ D K++DFG ++ ++ + GT YL P+ +
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDM-YERAV 191
Query: 183 TR---------KSDVYSFGVLLLEIVSGR 202
R D++S GV +G
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-26
Identities = 42/182 (23%), Positives = 71/182 (39%), Gaps = 14/182 (7%)
Query: 26 VAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHG-GCIDGPCRILVYDYMPN 81
VA+K++S E + + ++V +H G IDG + +
Sbjct: 62 VALKLMSETLSSDPVFRTRMQREARTAGRLQ--EPHVVPIHDFGEIDG-QLYVDMRLING 118
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
L+ L +R+ I+ IG L H HRD+K NIL+ +
Sbjct: 119 VDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADD 171
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
+ DFG++ + GTL Y+APE T ++D+Y+ +L E ++G
Sbjct: 172 FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231
Query: 202 RT 203
Sbjct: 232 SP 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 46/208 (22%), Positives = 82/208 (39%), Gaps = 27/208 (12%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDG 69
V + G + A+KV + S + M E + +N H+N+VKL +
Sbjct: 24 NVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--HKNIVKLFAIEEET 79
Query: 70 PCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127
R +L+ ++ P SL +L E ++ + G+ ++ E +VH
Sbjct: 80 TTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVH 135
Query: 128 RDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 183
R+IK NI+ D K++DFG ++ ++ + GT YL P+ +
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDM-YERAVL 192
Query: 184 R---------KSDVYSFGVLLLEIVSGR 202
R D++S GV +G
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 41/187 (21%), Positives = 70/187 (37%), Gaps = 24/187 (12%)
Query: 22 DGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKL-----HGGCIDGPCRILV 75
+G V +K L + M+E +A V H ++V++ H P +V
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV--HPSIVQIFNFVEHTDRHGDPVGYIV 162
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+Y+ SL + K ++ I L+Y+H +V+ D+K NI
Sbjct: 163 MEYVGGQSLK------RSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENI 213
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
+L + K+ D G + GT G+ APE T +D+Y+ G L
Sbjct: 214 MLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEIV-RTGPTVATDIYTVGRTL 266
Query: 196 LEIVSGR 202
+
Sbjct: 267 AALTLDL 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-25
Identities = 41/208 (19%), Positives = 78/208 (37%), Gaps = 33/208 (15%)
Query: 18 IRLQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
++ DG I A+K + E+ + EV + A + H ++V+ + ++
Sbjct: 31 VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-QHSHVVRYFSAWAEDDHMLIQ 89
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+Y SL+ + + + F +++++ +GRGL YIH +VH DIK SNI
Sbjct: 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNI 146
Query: 136 LLDQNFNP-------------------KISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 176
+ + P KI D G G +LA E
Sbjct: 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----GDSRFLANE- 200
Query: 177 AISGRL--TRKSDVYSFGVLLLEIVSGR 202
+ K+D+++ + ++
Sbjct: 201 VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-25
Identities = 40/228 (17%), Positives = 79/228 (34%), Gaps = 46/228 (20%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 70
V A + G A+K L ++ + + EV M ++ H N+V+ G
Sbjct: 43 FVYEA--QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-HPNIVQFCSAASIGK 99
Query: 71 ----------------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 114
C+ + +++ S+ L + F + R +
Sbjct: 100 EESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIF-----YQTC----RAV 149
Query: 115 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA-------- 166
++H + +P ++HRD+K N+LL K+ DFG + + +
Sbjct: 150 QHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 167 ---GTLGYLAPE-YAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD 208
T Y PE + K D+++ G +L + + F+
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FE 254
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-24
Identities = 45/181 (24%), Positives = 88/181 (48%), Gaps = 12/181 (6%)
Query: 23 GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
G ++A K++ +E K + + E+ + N +V +G + ++M
Sbjct: 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
SL Q L K+ + + ++ + + +GL Y+ E+ ++HRD+K SNIL++
Sbjct: 116 GSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRG 169
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
K+ DFG+S + ++ GT Y++PE + +SD++S G+ L+E+ G
Sbjct: 170 EIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 202 R 202
R
Sbjct: 227 R 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 12/177 (6%)
Query: 23 GTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
G +K ++ S+ ++ +E+ + +++ H N++K+ D +V +
Sbjct: 47 GLERVIKTINKDRSQVPMEQIEAEIEVLKSLD--HPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---D 138
L + ++ + R E++ + LAY H + HVVH+D+K NIL
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTS 161
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
+ KI DFGL++LF + T AGT Y+APE +T K D++S GV++
Sbjct: 162 PHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-24
Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 21 QDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G AVKV+S V+ K ++ + EV + ++ H N++KL+ D LV +
Sbjct: 49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD--HPNIMKLYEFFEDKGYFYLVGE 106
Query: 78 YMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
G E R +F II + G+ Y+H+ +VHRD+K
Sbjct: 107 VYT---------GGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKP 154
Query: 133 SNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 189
N+LL ++ N +I DFGLS F + GT Y+APE + G K DV+
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPE-VLHGTYDEKCDVW 211
Query: 190 SFGVLLLEIVSGR 202
S GV+L ++SG
Sbjct: 212 STGVILYILLSGC 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-24
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 17/190 (8%)
Query: 21 QDGTIVAVKVLSVESKQGE-KEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
G I+AVK + E K + ++ SM V+ V +G + +
Sbjct: 30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD--CPFTVTFYGALFREGDVWICMEL 87
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M + SL + + +I + I + L ++H ++ V+HRD+K SN+L++
Sbjct: 88 M-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLIN 144
Query: 139 QNFNPKISDFGLSKLFPENTTHIS-TRVAGTLGYLAPEYAISGRLTR-----KSDVYSFG 192
K+ DFG+S ++ AG Y+APE I+ L + KSD++S G
Sbjct: 145 ALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPE-RINPELNQKGYSVKSDIWSLG 200
Query: 193 VLLLEIVSGR 202
+ ++E+ R
Sbjct: 201 ITMIELAILR 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-24
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 56/229 (24%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---------------------VESKQGEKEFMS----- 44
V LA D T A+KVLS +
Sbjct: 28 VVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ 85
Query: 45 EVASMANVNVCHENLVKLHGGCIDGPCR---ILVYDYMPNNSL----SQTLLGEEKRRAK 97
E+A + ++ H N+VKL +D P +V++ + + + L E++ R
Sbjct: 86 EIAILKKLD--HPNVVKLVE-VLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142
Query: 98 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157
F +++I GI Y+H + ++HRDIK SN+L+ ++ + KI+DFG+S F +
Sbjct: 143 F-----QDLIKGI----EYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 158 TTHISTRVAGTLGYLAPEYAISGRLT----RKSDVYSFGVLLLEIVSGR 202
+S GT ++APE ++S + DV++ GV L V G+
Sbjct: 191 DALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-24
Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 14/189 (7%)
Query: 21 QDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
G I+AVK + + E K+ + ++ + + +V+ +G + + M
Sbjct: 45 PSGQIMAVKRIRSTVDEKEQKQLLMDL-DVVMRSSDCPYIVQFYGALFREGDCWICMELM 103
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
+ + +I + + L ++ E + ++HRDIK SNILLD+
Sbjct: 104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDR 161
Query: 140 NFNPKISDFGLSKLFPENTTHIS-TRVAGTLGYLAPEYAISGRLTR-----KSDVYSFGV 193
+ N K+ DFG+S + I+ TR AG Y+APE I +R +SDV+S G+
Sbjct: 162 SGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPE-RIDPSASRQGYDVRSDVWSLGI 217
Query: 194 LLLEIVSGR 202
L E+ +GR
Sbjct: 218 TLYELATGR 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-24
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 30/202 (14%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 68
KV LA + G VA+K++ + ++ EV M +N H N+VKL I+
Sbjct: 30 KVKLA--RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--HPNIVKLFE-VIE 84
Query: 69 GPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 122
+ L+ +Y + L + E++ R+KF R+I+ + Y H++
Sbjct: 85 TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-----RQIVSAV----QYCHQK-- 133
Query: 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 182
+VHRD+K N+LLD + N KI+DFG S F + G Y APE G+
Sbjct: 134 -RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPE-LFQGKK 189
Query: 183 --TRKSDVYSFGVLLLEIVSGR 202
+ DV+S GV+L +VSG
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGS 211
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 7e-24
Identities = 24/216 (11%), Positives = 54/216 (25%), Gaps = 38/216 (17%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKLHGGCI------- 67
++ A+KV ++ ++ E + A + + +
Sbjct: 82 RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141
Query: 68 --------------DGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIM 108
D MP S+ LL R G A +
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 109 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 168
+ R A + + +VH N+ + + + D +
Sbjct: 202 QLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVP 254
Query: 169 LGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 202
+ Y E+ + T + + G+ + +
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-23
Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 34/206 (16%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
G VAVK + + E+ + H N+++ + + + N
Sbjct: 38 QGRPVAVKRML---IDFCDIALMEIKLLTES-DDHPNVIRYYCSETTDRFLYIALELC-N 92
Query: 82 NSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+L + + ++ ++ I G+A++H ++HRD+K NIL+
Sbjct: 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVS 149
Query: 139 -------------QNFNPKISDFGLSKLFPENTTHISTR---VAGTLGYLAPE------- 175
+N ISDFGL K + T +GT G+ APE
Sbjct: 150 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNN 209
Query: 176 YAISGRLTRKSDVYSFGVLLLEIVSG 201
RLTR D++S G + I+S
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-23
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 17/190 (8%)
Query: 18 IRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
A+K++ S + + EVA + ++ H N++KL+ D LV
Sbjct: 57 RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD--HPNIMKLYDFFEDKRNYYLV 114
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+ L ++ R KF II + G+ Y+H+ ++VHRD+K N+
Sbjct: 115 MECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENL 167
Query: 136 LL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
LL +++ KI DFGLS +F GT Y+APE + + K DV+S G
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIG 224
Query: 193 VLLLEIVSGR 202
V+L +++G
Sbjct: 225 VILFILLAGY 234
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-23
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 49/230 (21%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMS------EVASMANVNVCHENLVKLHG 64
V IR+ D VA+K + + E + EV + V+ +++L
Sbjct: 58 SVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115
Query: 65 GCIDGPCRIL-----------VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 113
+ P + ++D++ L EE R+ F +++ +
Sbjct: 116 -WFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFF-----WQVLEAV--- 162
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYL 172
+ H V+HRDIK NIL+D N K+ DFG L + GT Y
Sbjct: 163 -RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYS 215
Query: 173 APEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD----VQLGEYHL 216
PE+ I R + V+S G+LL ++V G + F+ + G+
Sbjct: 216 PPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFF 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-23
Identities = 53/214 (24%), Positives = 79/214 (36%), Gaps = 45/214 (21%)
Query: 11 KVDLAPFIRLQDGTIVAVKVL------SVESKQGEKEFMSEVASMANVNVC--HENLVKL 62
V RL D VA+KV+ EVA + V H +++L
Sbjct: 46 TVFAG--HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103
Query: 63 HGGCIDGPCRIL-----------VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 111
+ + ++DY+ + LGE R F +++ I
Sbjct: 104 LD-WFETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFF-----GQVVAAI- 152
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLG 170
+ H VVHRDIK NIL+D + K+ DFG L + GT
Sbjct: 153 ---QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRV 203
Query: 171 YLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 202
Y PE+ IS + V+S G+LL ++V G
Sbjct: 204 YSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-23
Identities = 31/134 (23%), Positives = 50/134 (37%), Gaps = 21/134 (15%)
Query: 78 YMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
+L + E R +I + ++H + ++HRD+K SN
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLHSK---GLMHRDLKPSN 194
Query: 135 ILLDQNFNPKISDFGLSK-----------LFPENTTHISTRVAGTLGYLAPEYAISGRLT 183
I + K+ DFGL L P T GT Y++PE +
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254
Query: 184 RKSDVYSFGVLLLE 197
K D++S G++L E
Sbjct: 255 HKVDIFSLGLILFE 268
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-23
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 29/196 (14%)
Query: 18 IRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
AVKV++ ++K + EV + ++ H N++KL D +
Sbjct: 42 KDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLD--HPNIMKLFEILEDSSSFYI 98
Query: 75 VYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
V + G E +R +F II + G+ Y+H+ ++VHRD
Sbjct: 99 VGELYT---------GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRD 146
Query: 130 IKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS 186
+K NILL +++ + KI DFGLS F +N GT Y+APE + G K
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE-VLRGTYDEKC 203
Query: 187 DVYSFGVLLLEIVSGR 202
DV+S GV+L ++SG
Sbjct: 204 DVWSAGVILYILLSGT 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-23
Identities = 47/192 (24%), Positives = 80/192 (41%), Gaps = 33/192 (17%)
Query: 23 GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73
AVK++ E ++ + + EV + V+ H N+++L
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG-HPNIIQLKDTYETNTFFF 100
Query: 74 LVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
LV+D M GE + + K R+I+ + + +H+ ++VHRD
Sbjct: 101 LVFDLMKK--------GELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRD 149
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE------YAISGRLT 183
+K NILLD + N K++DFG S + GT YLAPE
Sbjct: 150 LKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPSYLAPEIIECSMNDNHPGYG 207
Query: 184 RKSDVYSFGVLL 195
++ D++S GV++
Sbjct: 208 KEVDMWSTGVIM 219
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-23
Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 25/181 (13%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
A K + + F E+ M +++ H N+++L+ D LV +
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD--HPNIIRLYETFEDNTDIYLVMELCT-- 89
Query: 83 SLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
G E + F I+ + +AY H+ +V HRD+K N L
Sbjct: 90 -------GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLF 139
Query: 138 ---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ K+ DFGL+ F GT Y++P+ + G + D +S GV+
Sbjct: 140 LTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVM 196
Query: 195 L 195
+
Sbjct: 197 M 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-23
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 18 IRLQDGTIVAVKVLS-------------VESKQGEKEFMSEVASMANVNVCHENLVKLHG 64
+ A+KV+ ++ +E +E++ + +++ H N++KL
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD--HPNIIKLFD 113
Query: 65 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 124
D LV ++ L + ++ R KF I+ I G+ Y+H+ +
Sbjct: 114 VFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKH---N 166
Query: 125 VVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 181
+VHRDIK NILL + N KI DFGLS F ++ + GT Y+APE + +
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPE-VLKKK 223
Query: 182 LTRKSDVYSFGVLLLEIVSGR 202
K DV+S GV++ ++ G
Sbjct: 224 YNEKCDVWSCGVIMYILLCGY 244
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 8e-23
Identities = 42/199 (21%), Positives = 66/199 (33%), Gaps = 25/199 (12%)
Query: 18 IRLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
G V V+ +++E+ E E+ N H N+V I +V
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELWVV 104
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR----GLAYIHEEIQPHVVHRDIK 131
+M S + F I I + L YIH VHR +K
Sbjct: 105 TSFMAYGSAKDLI------CTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVK 155
Query: 132 TSNILLDQNFNPKISDFGLS-KLFPE----NTTH-ISTRVAGTLGYLAPEYAISGRL--T 183
S+IL+ + +S + + H L +L+PE
Sbjct: 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215
Query: 184 RKSDVYSFGVLLLEIVSGR 202
KSD+YS G+ E+ +G
Sbjct: 216 AKSDIYSVGITACELANGH 234
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-22
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKLHGGCIDG 69
+V LA + VAVK++ ++ E + E+ +N HEN+VK +G
Sbjct: 22 EVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYG-HRRE 76
Query: 70 PCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 123
L +Y L + E + F +++ G+ Y+H
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-----HQLMAGV----VYLH---GI 124
Query: 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT--HISTRVAGTLGYLAPEYAISGR 181
+ HRDIK N+LLD+ N KISDFGL+ +F N ++ GTL Y+APE + R
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLKRR 182
Query: 182 L--TRKSDVYSFGVLLLEIVSGR 202
DV+S G++L +++G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-22
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKLHGGCIDG 69
+V LA + VAVK++ ++ E + E+ +N HEN+VK +G
Sbjct: 22 EVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYG-HRRE 76
Query: 70 PCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 123
L +Y L + E + F +++ G+ Y+H
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-----HQLMAGV----VYLH---GI 124
Query: 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT--HISTRVAGTLGYLAPEYAISGR 181
+ HRDIK N+LLD+ N KISDFGL+ +F N ++ GTL Y+APE + R
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLKRR 182
Query: 182 L--TRKSDVYSFGVLLLEIVSGR 202
DV+S G++L +++G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-22
Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 25/181 (13%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G + A+K + + +E+A + + HEN+V L LV +
Sbjct: 34 GKLFALKCIKKSPAFRDSSLENEIAVLKKIK--HENIVTLEDIYESTTHYYLVMQLVS-- 89
Query: 83 SLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
G E R + K +I + + Y+HE +VHRD+K N+L
Sbjct: 90 -------GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLY 139
Query: 138 ---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
++N I+DFGLSK+ + GT GY+APE ++ D +S GV+
Sbjct: 140 LTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
Query: 195 L 195
Sbjct: 197 T 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-22
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 28/214 (13%)
Query: 23 GTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
VA++++S +E+ + +N H ++K+ D +
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN--HPCIIKIKN-FFDAEDYYI 216
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V + M L ++ + + + + Y+HE ++HRD+K N
Sbjct: 217 VLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPEN 269
Query: 135 ILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE---YAISGRLTRKSDV 188
+LL +++ KI+DFG SK+ E + + T GT YLAPE + R D
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDC 327
Query: 189 YSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222
+S GV+L +SG F + L D++ S
Sbjct: 328 WSLGVILFICLSGYPP--FSEHRTQVSLKDQITS 359
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-22
Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 29/184 (15%)
Query: 23 GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
AVKV++ ++K + EV + ++ H N++KL D +V +
Sbjct: 47 QQEYAVKVINKASAKNKDTST-ILREVELLKKLD--HPNIMKLFEILEDSSSFYIVGELY 103
Query: 80 PNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
G E +R +F II + G+ Y+H+ ++VHRD+K N
Sbjct: 104 T---------GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPEN 151
Query: 135 ILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
ILL +++ + KI DFGLS F +NT GT Y+APE + G K DV+S
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGTYDEKCDVWSA 208
Query: 192 GVLL 195
GV+L
Sbjct: 209 GVIL 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-22
Identities = 48/190 (25%), Positives = 92/190 (48%), Gaps = 23/190 (12%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G VAVK++ + +Q + +EV M + H N+V+++ + G ++ +
Sbjct: 65 REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HFNVVEMYKSYLVGEELWVLME 122
Query: 78 YMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
++ +L+ Q L EE+ + + + LAY+H + V+HRDIK+
Sbjct: 123 FLQGGALTDIVSQVRLNEEQIAT---------VCEAVLQALAYLHAQ---GVIHRDIKSD 170
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTRKSDVYSF 191
+ILL + K+SDFG + + + R + GT ++APE + D++S
Sbjct: 171 SILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSL 227
Query: 192 GVLLLEIVSG 201
G++++E+V G
Sbjct: 228 GIMVIEMVDG 237
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-22
Identities = 44/213 (20%), Positives = 79/213 (37%), Gaps = 45/213 (21%)
Query: 11 KVDLAPFIRLQDGTIVAVKVL--------SVESKQGEKEFMSEVASMANVNVCHENLVKL 62
V A + + V VK + + E+A ++ V H N++K+
Sbjct: 39 FVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE--HANIIKV 94
Query: 63 HGGCIDGPCRI-LV----------YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 111
+ LV + ++ L E F R+++ +
Sbjct: 95 LD-IFENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIF-----RQLVSAV- 143
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 171
Y+ + ++HRDIK NI++ ++F K+ DFG + T GT+ Y
Sbjct: 144 ---GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYT-FCGTIEY 195
Query: 172 LAPEYAISGRLTR--KSDVYSFGVLLLEIVSGR 202
APE + G R + +++S GV L +V
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 7e-22
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 23/190 (12%)
Query: 23 GTIVAVKVLS---VESKQGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRI-LVYD 77
G + A+K L ++ KQGE ++E ++ V+ +V + P ++ + D
Sbjct: 214 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY-AFHTPDKLSFILD 272
Query: 78 YMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
M L L +F + A EII+G L ++H VV+RD+K +N
Sbjct: 273 LMNGGDLHYHLSQHGVFSEADMRF-YAA--EIILG----LEHMHNR---FVVYRDLKPAN 322
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS-DVYSFGV 193
ILLD++ + +ISD GL+ F + H V GT GY+APE G S D +S G
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 194 LLLEIVSGRT 203
+L +++ G +
Sbjct: 380 MLFKLLRGHS 389
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-22
Identities = 37/181 (20%), Positives = 71/181 (39%), Gaps = 14/181 (7%)
Query: 23 GTIVAVKV-----LSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G AVK+ + ++ E + + H ++V+L +V++
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK--HPHIVELLETYSSDGMLYMVFE 106
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+M L ++ + + I L Y H+ +++HRD+K +LL
Sbjct: 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLL 163
Query: 138 ---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ + K+ FG++ E+ RV GT ++APE + DV+ GV+
Sbjct: 164 ASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 195 L 195
L
Sbjct: 223 L 223
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-22
Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 15/181 (8%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ + AVK++S K+ E E+ ++ H N+VKLH D LV +
Sbjct: 31 VHKKSNQAFAVKIIS---KRMEANTQKEITALKLCE-GHPNIVKLHEVFHDQLHTFLVME 86
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+ L + + ++ F I+ + ++++H+ VVHRD+K N+L
Sbjct: 87 LLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLF 139
Query: 138 ---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ N KI DFG ++L P + + T TL Y APE D++S GV+
Sbjct: 140 TDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVI 198
Query: 195 L 195
L
Sbjct: 199 L 199
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-22
Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 19/188 (10%)
Query: 23 GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-LVYDY 78
G + A K L+ ++ ++G + M E +A V+ +V L + + LV
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--SRFIVSLAY-AFETKTDLCLVMTI 266
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
M + + ++ F +I+ G L ++H+ ++++RD+K N
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPEN 319
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+LLD + N +ISD GL+ T GT G++APE + D ++ GV
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 195 LLEIVSGR 202
L E+++ R
Sbjct: 379 LYEMIAAR 386
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-21
Identities = 45/190 (23%), Positives = 90/190 (47%), Gaps = 23/190 (12%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ + G VA++ ++++ + ++ ++E+ M + N+V + G +V +
Sbjct: 40 MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVME 97
Query: 78 YMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
Y+ SL+ +T + E + A + + L ++H V+HRDIK+
Sbjct: 98 YLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALEFLHSN---QVIHRDIKSD 145
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTRKSDVYSF 191
NILL + + K++DFG + T S R + GT ++APE K D++S
Sbjct: 146 NILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 192 GVLLLEIVSG 201
G++ +E++ G
Sbjct: 203 GIMAIEMIEG 212
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 2e-21
Identities = 33/200 (16%), Positives = 65/200 (32%), Gaps = 26/200 (13%)
Query: 20 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVYDY 78
++ +KV + EF M + +K + + +LV +
Sbjct: 92 AKNKQKFVLKV---QKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148
Query: 79 MPNNSLSQTL-LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+L + L + M + + +H+ ++H DIK N +L
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFIL 205
Query: 138 -----------DQNFNPKISDFGLS---KLFPENTTHISTRVAGTLGYLAPEYAISGRL- 182
D + + D G S KLFP+ T + T G+ E +S +
Sbjct: 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA--KCETSGFQCVE-MLSNKPW 262
Query: 183 TRKSDVYSFGVLLLEIVSGR 202
+ D + + ++ G
Sbjct: 263 NYQIDYFGVAATVYCMLFGT 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-21
Identities = 46/189 (24%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
I + +VA+K++ +E + E E E+ ++ + + K +G + ++
Sbjct: 42 IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKDTKLWIIM 99
Query: 77 DYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
+Y+ S L E + I+ I +GL Y+H E +HRDIK
Sbjct: 100 EYLGGGSALDLLEPGPLDETQIAT---------ILREILKGLDYLHSE---KKIHRDIKA 147
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
+N+LL ++ K++DFG++ + +T V GT ++APE K+D++S G
Sbjct: 148 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLG 206
Query: 193 VLLLEIVSG 201
+ +E+ G
Sbjct: 207 ITAIELARG 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-21
Identities = 42/192 (21%), Positives = 82/192 (42%), Gaps = 23/192 (11%)
Query: 21 QDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
A+K+L ++ + E M+ ++ H VKL+ D
Sbjct: 53 ATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLD--HPFFVKLYFTFQDDEKLYFGL 109
Query: 77 DYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
Y N L + + +F + A EI+ + Y+H + ++HRD+K
Sbjct: 110 SYAKNGEL-LKYIRKIGSFDETCTRF-YTA--EIVSALE----YLHGK---GIIHRDLKP 158
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAPEYAISGRLTRKSDVYSF 191
NILL+++ + +I+DFG +K+ + GT Y++PE + SD+++
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 218
Query: 192 GVLLLEIVSGRT 203
G ++ ++V+G
Sbjct: 219 GCIIYQLVAGLP 230
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-21
Identities = 46/191 (24%), Positives = 77/191 (40%), Gaps = 32/191 (16%)
Query: 23 GTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
G AVK++ + ++ + E + V H +++ L L
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG-HPHIITLIDSYESSSFMFL 177
Query: 75 VYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
V+D M GE + + K R I+ + ++++H ++VHRD+
Sbjct: 178 VFDLMRK--------GELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDL 226
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE------YAISGRLTR 184
K NILLD N ++SDFG S + GT GYLAPE +
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 185 KSDVYSFGVLL 195
+ D+++ GV+L
Sbjct: 285 EVDLWACGVIL 295
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-21
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV + G VAVK+L+ + S + E+ ++ H +++KL+ I
Sbjct: 26 KVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR--HPHIIKLYQ-VI 80
Query: 68 DGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 121
P +V +Y+ L + + E + R F ++I+ + Y H
Sbjct: 81 STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-----QQILSAV----DYCH--- 128
Query: 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 181
+ VVHRD+K N+LLD + N KI+DFGLS + + + T G+ Y APE ISGR
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT-SCGSPNYAAPE-VISGR 185
Query: 182 L--TRKSDVYSFGVLLLEIVSGR 202
L + D++S GV+L ++ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-21
Identities = 45/219 (20%), Positives = 75/219 (34%), Gaps = 55/219 (25%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLH--- 63
KV + + AVK+L GE E+ + + H+N+++L
Sbjct: 20 KVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR--HKNVIQLVDVL 75
Query: 64 ----------------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 107
G + + D +P + F ++I
Sbjct: 76 YNEEKQKMYMVMEYCVCGMQE------MLDSVPEKRFP-----VCQAHGYF-----CQLI 119
Query: 108 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVA 166
G+ Y+H +VH+DIK N+LL KIS G+++
Sbjct: 120 DGL----EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 167 GTLGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGR 202
G+ + PE +G T K D++S GV L I +G
Sbjct: 173 GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-21
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 36/218 (16%)
Query: 23 GTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
VA+K++S +E+ + +N H ++K+ D +
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN--HPCIIKIKN-FFDAEDYYI 91
Query: 75 VYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
V + M GE +K + + + + Y+HE ++HRD+
Sbjct: 92 VLELMEG--------GELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDL 140
Query: 131 KTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE---YAISGRLTR 184
K N+LL +++ KI+DFG SK+ E + + T GT YLAPE + R
Sbjct: 141 KPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLAPEVLVSVGTAGYNR 198
Query: 185 KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 222
D +S GV+L +SG F + L D++ S
Sbjct: 199 AVDCWSLGVILFICLSGYPP--FSEHRTQVSLKDQITS 234
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-21
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 27/194 (13%)
Query: 21 QDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+ A+K ++ VE + E+ M + H LV L D +V
Sbjct: 38 DTKKMYAMKYMNKQKCVERNEVR-NVFKELQIMQGLE--HPFLVNLWYSFQDEEDMFMVV 94
Query: 77 DYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
D + L + L + K + E++M L Y+ + ++HRD+K
Sbjct: 95 DLLLGGDL-RYHLQQNVHFKEETVKL-FIC--ELVMA----LDYLQNQ---RIIHRDMKP 143
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL---TRKSDVY 189
NILLD++ + I+DF ++ + P T + +AGT Y+APE S + + D +
Sbjct: 144 DNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKGAGYSFAVDWW 201
Query: 190 SFGVLLLEIVSGRT 203
S GV E++ GR
Sbjct: 202 SLGVTAYELLRGRR 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-21
Identities = 62/191 (32%), Positives = 91/191 (47%), Gaps = 28/191 (14%)
Query: 23 GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-LVYDY 78
G + A K L ++ ++GE ++E + VN +V L + + LV
Sbjct: 209 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVSLAY-AYETKDALCLVLTL 265
Query: 79 MPNNSL-------SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
M L Q E RA F + A EI G L +H E +V+RD+K
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEA--RAVF-YAA--EICCG----LEDLHRE---RIVYRDLK 313
Query: 132 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
NILLD + + +ISD GL+ PE T I RV GT+GY+APE + R T D ++
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 192 GVLLLEIVSGR 202
G LL E+++G+
Sbjct: 372 GCLLYEMIAGQ 382
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-20
Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 15/195 (7%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
VA+K +++E Q + + E+ +M+ + H N+V + + LV
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH--HPNIVSYYTSFVVKDELWLVM 92
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR----GLAYIHEEIQPHVVHRDIKT 132
+ S+ + + I I R GL Y+H+ +HRD+K
Sbjct: 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKA 149
Query: 133 SNILLDQNFNPKISDFGLS-KLFPENTTHISTR---VAGTLGYLAPEYAISGRL-TRKSD 187
NILL ++ + +I+DFG+S L + GT ++APE R K+D
Sbjct: 150 GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209
Query: 188 VYSFGVLLLEIVSGR 202
++SFG+ +E+ +G
Sbjct: 210 IWSFGITAIELATGA 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-20
Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 12/175 (6%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G A K + + ++ E+ +M+ + H LV LH D +++Y++M
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142
L + + E K E + + +GL ++HE + VH D+K NI+ +
Sbjct: 240 ELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRS 293
Query: 143 P--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
K+ DFGL+ + GT + APE A + +D++S GVL
Sbjct: 294 NELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-20
Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 21 QDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
+ G ++AVK + + E K + ++ + + +V+ G I + + M
Sbjct: 48 KTGHVIAVKQMRRSGNKEENKRILMDLDVVLK-SHDCPYIVQCFGTFITNTDVFIAMELM 106
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
+ + + + ++ + I + L Y+ E+ V+HRD+K SNILLD+
Sbjct: 107 -GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDE 160
Query: 140 NFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPE-----YAISGRLTRKSDVYSFGV 193
K+ DFG+S +L R AG Y+APE ++DV+S G+
Sbjct: 161 RGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 194 LLLEIVSGR 202
L+E+ +G+
Sbjct: 218 SLVELATGQ 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-20
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 25/198 (12%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRI--- 73
++ G + A+KV+ V E+E E+ + H N+ +G I
Sbjct: 44 RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKY--SHHRNIATYYGAFIKKNPPGMDD 100
Query: 74 ---LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
LV ++ S++ + + K W A I I RGL+++H+ V+HRDI
Sbjct: 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQH---KVIHRDI 155
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTR---- 184
K N+LL +N K+ DFG+S + + R GT ++APE
Sbjct: 156 KGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 212
Query: 185 -KSDVYSFGVLLLEIVSG 201
KSD++S G+ +E+ G
Sbjct: 213 FKSDLWSLGITAIEMAEG 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-20
Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 11/181 (6%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
+ G IVA+K + VES +E + E++ M + ++VK +G +V +Y
Sbjct: 52 ETGQIVAIKQVPVESD--LQEIIKEISIMQQCD--SPHVVKYYGSYFKNTDLWIVMEYCG 107
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
S+S ++ + A I+ +GL Y+H +HRDIK NILL+
Sbjct: 108 AGSVS-DIIRLRNKTLTEDEIAT--ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTE 161
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ K++DFG++ + +T + GT ++APE +D++S G+ +E+
Sbjct: 162 GHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 201 G 201
G
Sbjct: 221 G 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-20
Identities = 38/181 (20%), Positives = 67/181 (37%), Gaps = 24/181 (13%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G + K ++ + +E++ M ++ H L+ LH D +L+ +++
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDKYEMVLILEFLS-- 131
Query: 83 SLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
G E K + GL ++HE +VH DIK NI+
Sbjct: 132 -------GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIM 181
Query: 137 LDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ KI DFGL+ + T + APE + +D+++ GVL
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
Query: 195 L 195
Sbjct: 240 G 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-20
Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 24/193 (12%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
I L AVK++ + EV + H N+++L + LV++
Sbjct: 33 INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-GHRNVLELIEFFEEEDRFYLVFE 91
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
M S+ L +R F ++ + L ++H + HRD+K NIL
Sbjct: 92 KMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILC 144
Query: 138 ---DQNFNPKISDFGLSKLFPEN-------TTHISTRVAGTLGYLAPE-----YAISGRL 182
+Q KI DF L N T + T G+ Y+APE +
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIY 203
Query: 183 TRKSDVYSFGVLL 195
++ D++S GV+L
Sbjct: 204 DKRCDLWSLGVIL 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-20
Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 31/202 (15%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 70
L +VAVK + + E E+ + ++ H N+V+ I P
Sbjct: 35 VARLM--RDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLR--HPNIVRFKE-VILTP 88
Query: 71 CRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 124
+ ++ +Y L + + E++ R F ++++ G+ +Y H
Sbjct: 89 THLAIIMEYASGGELYERICNAGRFSEDEARFFF-----QQLLSGV----SYCHSM---Q 136
Query: 125 VVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 182
+ HRD+K N LLD + P KI DFG SK + + + V GT Y+APE + +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPE-VLLRQE 193
Query: 183 --TRKSDVYSFGVLLLEIVSGR 202
+ +DV+S GV L ++ G
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGA 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-20
Identities = 40/191 (20%), Positives = 89/191 (46%), Gaps = 18/191 (9%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ G + A KV+ +S++ ++++ E+ +A + H +VKL G ++ +
Sbjct: 39 KNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYIVKLLGAYYHDGKLWIMIE 96
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+ P ++ ++ E R + + L ++H + ++HRD+K N+L+
Sbjct: 97 FCPGGAVD-AIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK---RIIHRDLKAGNVLM 150
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTR-----KSDVYS 190
+ +++DFG+S +N + R GT ++APE + + K+D++S
Sbjct: 151 TLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 207
Query: 191 FGVLLLEIVSG 201
G+ L+E+
Sbjct: 208 LGITLIEMAQI 218
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 8e-20
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 31/203 (15%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV + G VAVK+L+ + S + E+ ++ H +++KL+ I
Sbjct: 31 KVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR--HPHIIKLYQ-VI 85
Query: 68 DGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 121
P I +V +Y+ L + L E++ R F ++I+ G+ Y H
Sbjct: 86 STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF-----QQILSGV----DYCH--- 133
Query: 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 181
+ VVHRD+K N+LLD + N KI+DFGLS + + + T G+ Y APE ISGR
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPE-VISGR 190
Query: 182 L--TRKSDVYSFGVLLLEIVSGR 202
L + D++S GV+L ++ G
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGT 213
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-20
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 25/184 (13%)
Query: 23 GTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G A K L + E + E+A + ++ LH + IL+ +Y
Sbjct: 54 GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-SCPRVINLHEVYENTSEIILILEYAA 112
Query: 81 NNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
GE + +I I G+ Y+H+ ++VH D+K N
Sbjct: 113 G--------GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQN 161
Query: 135 ILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
ILL + KI DFG+S+ + + GT YLAPE +T +D+++
Sbjct: 162 ILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM-GTPEYLAPEILNYDPITTATDMWNI 219
Query: 192 GVLL 195
G++
Sbjct: 220 GIIA 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 40/181 (22%), Positives = 77/181 (42%), Gaps = 24/181 (13%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
G +A K++ + ++E +E++ M ++ H NL++L+ +LV +Y+
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLD--HANLIQLYDAFESKNDIVLVMEYVD-- 169
Query: 83 SLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
G E + I G+ ++H+ +++H D+K NIL
Sbjct: 170 -------GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENIL 219
Query: 137 LDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
KI DFGL++ + + GT +LAPE ++ +D++S GV+
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
Query: 195 L 195
Sbjct: 278 A 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-19
Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 26/183 (14%)
Query: 23 GTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G A K+++ + S + ++ E + H N+V+LH + LV+D +
Sbjct: 31 GLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFHYLVFDLVT 88
Query: 81 NNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
G E R + I I +AY H +VHR++K N+
Sbjct: 89 ---------GGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENL 136
Query: 136 LL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
LL + K++DFGL+ ++ AGT GYL+PE ++ D+++ G
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 194
Query: 193 VLL 195
V+L
Sbjct: 195 VIL 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-19
Identities = 41/183 (22%), Positives = 72/183 (39%), Gaps = 25/183 (13%)
Query: 23 GTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G A +++ + S + ++ E + H N+V+LH + L++D +
Sbjct: 36 GQEYAAMIINTKKLSARDHQKLEREARICRLLK--HPNIVRLHDSISEEGHHYLIFDLVT 93
Query: 81 NNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
G E R + I I + + H+ VVHR++K N+
Sbjct: 94 ---------GGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENL 141
Query: 136 LL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
LL + K++DFGL+ GT GYL+PE + D+++ G
Sbjct: 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPYGKPVDLWACG 200
Query: 193 VLL 195
V+L
Sbjct: 201 VIL 203
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-19
Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 24/195 (12%)
Query: 21 QDGTIVAVKVLSVES--KQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ A+K+L+ K+ E F E + N + + + LH D LV D
Sbjct: 97 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--SKWITTLHYAFQDDNNLYLVMD 154
Query: 78 YMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
Y L L E R A+F + A E+++ I +H+ H VHRDIK
Sbjct: 155 YYVGGDLLTLLSKFEDRLPEEMARF-YLA--EMVIAID----SVHQL---HYVHRDIKPD 204
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE-----YAISGRLTRKSDV 188
NIL+D N + +++DFG E+ T S+ GT Y++PE GR + D
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 189 YSFGVLLLEIVSGRT 203
+S GV + E++ G T
Sbjct: 265 WSLGVCMYEMLYGET 279
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 40/207 (19%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 66
KV LA + VA+K +S +S + E++ + + H +++KL+
Sbjct: 24 KVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLR--HPHIIKLYD-V 77
Query: 67 IDGPCRI-LV--------YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 117
I P I +V +DY+ + + + E++ R F ++II I Y
Sbjct: 78 ITTPTDIVMVIEYAGGELFDYI----VEKKRMTEDEGRRFF-----QQIICAI----EYC 124
Query: 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 177
H + +VHRD+K N+LLD N N KI+DFGLS + + + T G+ Y APE
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT-SCGSPNYAAPE-V 178
Query: 178 ISGRL--TRKSDVYSFGVLLLEIVSGR 202
I+G+L + DV+S G++L ++ GR
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-19
Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 27/182 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
AVK++ +SK+ E E+ + H N++ L DG +V + M
Sbjct: 47 NMEFAVKIID-KSKRDPTE---EIEILLRY-GQHPNIITLKDVYDDGKYVYVVTELMKGG 101
Query: 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-DQNF 141
L +L R+ F + ++ I + + Y+H + VVHRD+K SNIL D++
Sbjct: 102 ELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESG 154
Query: 142 NP---KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS-----DVYSFGV 193
NP +I DFG +K + T T ++APE L R+ D++S GV
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEV-----LERQGYDAACDIWSLGV 208
Query: 194 LL 195
LL
Sbjct: 209 LL 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-19
Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 26/183 (14%)
Query: 23 GTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G A K+++ + S + ++ E + H N+V+LH + LV+D +
Sbjct: 54 GLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFHYLVFDLVT 111
Query: 81 NNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
G E R + I I +AY H +VHR++K N+
Sbjct: 112 ---------GGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENL 159
Query: 136 LL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
LL + K++DFGL+ ++ AGT GYL+PE ++ D+++ G
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217
Query: 193 VLL 195
V+L
Sbjct: 218 VIL 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-19
Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 25/194 (12%)
Query: 21 QDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+ A+K+LS ++ F E MA N +V+L D +V
Sbjct: 92 STRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFAN--SPWVVQLFYAFQDDRYLYMVM 148
Query: 77 DYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+YMP L L+ + A+F + A E+++ + IH +HRD+K
Sbjct: 149 EYMPGGDLV-NLMSNYDVPEKWARF-YTA--EVVLALD----AIHSM---GFIHRDVKPD 197
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE----YAISGRLTRKSDVY 189
N+LLD++ + K++DFG + GT Y++PE G R+ D +
Sbjct: 198 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257
Query: 190 SFGVLLLEIVSGRT 203
S GV L E++ G T
Sbjct: 258 SVGVFLYEMLVGDT 271
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 9e-19
Identities = 49/228 (21%), Positives = 77/228 (33%), Gaps = 53/228 (23%)
Query: 23 GTIVAVKV-----LSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
I A+K+ + + + + +EV M ++ H N+ +L+ D LV +
Sbjct: 51 RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH--HPNIARLYEVYEDEQYICLVME 108
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKAR---------------------------------- 103
L L
Sbjct: 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREK 168
Query: 104 --REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL--DQNFNPKISDFGLSKLFPENTT 159
I+ I L Y+H + + HRDIK N L +++F K+ DFGLSK F +
Sbjct: 169 LISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 160 HISTR---VAGTLGYLAPE--YAISGRLTRKSDVYSFGVLLLEIVSGR 202
AGT ++APE + K D +S GVLL ++ G
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-19
Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 26/181 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
A+KVL +K +E+ + ++ H N++KL LV + +
Sbjct: 78 QKPYALKVLK--KTVDKKIVRTEIGVLLRLS--HPNIIKLKEIFETPTEISLVLELVT-- 131
Query: 83 SLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
G E + + + + + I +AY+HE +VHRD+K N+L
Sbjct: 132 -------GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLY 181
Query: 138 ---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ KI+DFGLSK+ V GT GY APE + D++S G++
Sbjct: 182 ATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239
Query: 195 L 195
Sbjct: 240 T 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-18
Identities = 41/187 (21%), Positives = 73/187 (39%), Gaps = 29/187 (15%)
Query: 23 GTIVAVKVLSV------ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
G A K + +E EV+ + V H N++ LH + +L+
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL--HHNVITLHDVYENRTDVVLIL 94
Query: 77 DYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
+ + GE + ++ + I I G+ Y+H + + H D+K
Sbjct: 95 ELVSG--------GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKP 143
Query: 133 SNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDV 188
NI+L P K+ DFGL+ + + GT ++APE L ++D+
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 189 YSFGVLL 195
+S GV+
Sbjct: 202 WSIGVIT 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 39/180 (21%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PCRILVYDY 78
G A+K+L + EV + ++V + + C +++ +
Sbjct: 54 GQKCALKLLY---DS--PKARQEVDHHWQASG-GPHIVCILDVYENMHHGKRCLLIIMEC 107
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL- 137
M L + E+ F + EI+ IG + ++H ++ HRD+K N+L
Sbjct: 108 MEGGELFSRIQ--ERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYT 162
Query: 138 --DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
+++ K++DFG +K +N + T T Y+APE + + D++S GV++
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-18
Identities = 27/181 (14%), Positives = 63/181 (34%), Gaps = 25/181 (13%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
K + V + E++ + H N++ LH +++++++
Sbjct: 30 KKTYMAKFVKV-KGTDQVLVKKEISILNIAR--HRNILHLHESFESMEELVMIFEFIS-- 84
Query: 83 SLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
G + + + + + L ++H ++ H DI+ NI+
Sbjct: 85 -------GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENII 134
Query: 137 LDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+ KI +FG ++ + Y APE ++ +D++S G L
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 195 L 195
+
Sbjct: 193 V 193
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-18
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 26/197 (13%)
Query: 21 QDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
Q G + A+K+++ + + F E + N + + +LH D LV +
Sbjct: 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--RRWITQLHFAFQDENYLYLVME 141
Query: 78 YMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
Y L L +R A+F + A EI+M I +H VHRDIK
Sbjct: 142 YYVGGDLLTLLSKFGERIPAEMARF-YLA--EIVMAID----SVHRL---GYVHRDIKPD 191
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE-------YAISGRLTRKS 186
NILLD+ + +++DFG + T S GT YL+PE +G +
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPEC 251
Query: 187 DVYSFGVLLLEIVSGRT 203
D ++ GV E+ G+T
Sbjct: 252 DWWALGVFAYEMFYGQT 268
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-18
Identities = 41/188 (21%), Positives = 70/188 (37%), Gaps = 31/188 (16%)
Query: 23 GTIVAVKVL------SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
G A K + S ++ EV+ + + H N++ LH + IL+
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITLHEVYENKTDVILIL 93
Query: 77 DYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+ + G E + + E + I G+ Y+H + H D+K
Sbjct: 94 ELVA---------GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLK 141
Query: 132 TSNILL----DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 187
NI+L KI DFGL+ + GT ++APE L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEAD 199
Query: 188 VYSFGVLL 195
++S GV+
Sbjct: 200 MWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-18
Identities = 41/187 (21%), Positives = 73/187 (39%), Gaps = 29/187 (15%)
Query: 23 GTIVAVKVLSV------ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
G A K + +E EV+ + V H N++ LH + +L+
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL--HPNIITLHDVYENRTDVVLIL 94
Query: 77 DYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
+ + GE + ++ + I I G+ Y+H + + H D+K
Sbjct: 95 ELVSG--------GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKP 143
Query: 133 SNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDV 188
NI+L P K+ DFGL+ + + GT ++APE L ++D+
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 189 YSFGVLL 195
+S GV+
Sbjct: 202 WSIGVIT 208
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-18
Identities = 52/191 (27%), Positives = 88/191 (46%), Gaps = 26/191 (13%)
Query: 21 QDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+ G A+K+L V+ KQ E ++E + VN LVKL D +V
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVN--FPFLVKLEFSFKDNSNLYMVM 120
Query: 77 DYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
+Y+ + + L R A+F + A +I++ Y+H +++RD+K
Sbjct: 121 EYVAGGEMF-SHLRRIGRFSEPHARF-YAA--QIVLT----FEYLHSL---DLIYRDLKP 169
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
N+L+DQ +++DFG +K T T + GT LAPE +S + D ++ G
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT---WT-LCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 193 VLLLEIVSGRT 203
VL+ E+ +G
Sbjct: 226 VLIYEMAAGYP 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 6e-18
Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 20 LQDGTIVAVKVLSVES-KQGEKEFMS----EVASMANVNVC-HENLVKL----HGGCIDG 69
G VA+K + V + G EVA + + H N+V+L D
Sbjct: 31 PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90
Query: 70 PCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128
++ LV++++ + L L ++ + ++++ RGL ++H +VHR
Sbjct: 91 EIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHR 144
Query: 129 DIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISGRLTRKS 186
D+K NIL+ K++DFGL++++ T V TL Y APE +
Sbjct: 145 DLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TLWYRAPEVLLQSTYATPV 200
Query: 187 DVYSFGVLLLEIVSGR 202
D++S G + E+ +
Sbjct: 201 DMWSVGCIFAEMFRRK 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 7e-18
Identities = 39/188 (20%), Positives = 70/188 (37%), Gaps = 31/188 (16%)
Query: 23 GTIVAVKVL------SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
G A K + S +E EV + + H N++ LH + +L+
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR--HPNIITLHDIFENKTDVVLIL 87
Query: 77 DYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+ + G E + + + I G+ Y+H + + H D+K
Sbjct: 88 ELVS---------GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLK 135
Query: 132 TSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 187
NI+L P K+ DFG++ + GT ++APE L ++D
Sbjct: 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEAD 193
Query: 188 VYSFGVLL 195
++S GV+
Sbjct: 194 MWSIGVIT 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 8e-18
Identities = 49/191 (25%), Positives = 89/191 (46%), Gaps = 22/191 (11%)
Query: 18 IRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
+++ +VA+K +S KQ ++ + EV + + H N ++ G + L
Sbjct: 74 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWL 131
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V +Y ++ LL K+ + A + G +GLAY+H +++HRD+K N
Sbjct: 132 VMEYCLGSAS--DLLEVHKKPLQEVEIAA--VTHGALQGLAYLHSH---NMIHRDVKAGN 184
Query: 135 ILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRLTR---KSDVYS 190
ILL + K+ DFG + + P N+ GT ++APE ++ + K DV+S
Sbjct: 185 ILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWS 238
Query: 191 FGVLLLEIVSG 201
G+ +E+
Sbjct: 239 LGITCIELAER 249
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 8e-18
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 40/208 (19%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLV 60
KV L+ + + AVK+L VE EK ++ L
Sbjct: 356 KVMLS---ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-------PPFLT 405
Query: 61 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAY 116
+LH C R+ V +Y+ L + + A F + A EI +G L +
Sbjct: 406 QLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAA--EIAIG----LFF 457
Query: 117 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAP 174
+ + +++RD+K N++LD + KI+DFG+ K ++ TT T GT Y+AP
Sbjct: 458 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-FCGTPDYIAP 511
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVSGR 202
E + D ++FGVLL E+++G+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 1e-17
Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 26/191 (13%)
Query: 21 QDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+G A+KVL V KQ E E ++ V H ++++ G D ++
Sbjct: 29 HNGRYYAMKVLKKEIVVRLKQVE-HTNDERLMLSIVT--HPFIIRMWGTFQDAQQIFMIM 85
Query: 77 DYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
DY+ L +LL + +R AKF + A E+ + L Y+H + +++RD+K
Sbjct: 86 DYIEGGELF-SLLRKSQRFPNPVAKF-YAA--EVCLA----LEYLHSK---DIIYRDLKP 134
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 192
NILLD+N + KI+DFG +K P+ T T + GT Y+APE + + D +SFG
Sbjct: 135 ENILLDKNGHIKITDFGFAKYVPDVT---YT-LCGTPDYIAPEVVSTKPYNKSIDWWSFG 190
Query: 193 VLLLEIVSGRT 203
+L+ E+++G T
Sbjct: 191 ILIYEMLAGYT 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 58/210 (27%)
Query: 20 LQDGTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH------GGCIDGPC 71
G +VA+K VL +K F + E+ M ++ H N+V+L G D
Sbjct: 76 CDSGELVAIKKVLQ------DKRFKNRELQIMRKLD--HCNIVRLRYFFYSSGEKKDEVY 127
Query: 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--------IGRGLAYIHEEIQP 123
LV DY+P +T+ R A+ +A++ + + + R LAYIH
Sbjct: 128 LNLVLDYVP-----ETV----YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--- 175
Query: 124 HVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLAPE---- 175
+ HRDIK N+LLD + K+ DFG +K N ++I +R Y APE
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFG 230
Query: 176 ---YAISGRLTRKSDVYSFGVLLLEIVSGR 202
Y T DV+S G +L E++ G+
Sbjct: 231 ATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-17
Identities = 39/186 (20%), Positives = 74/186 (39%), Gaps = 32/186 (17%)
Query: 23 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI----LVYDY 78
A+K+L K EV + ++V++ + +V +
Sbjct: 87 QEKFALKMLQDCPKARR-----EVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMEC 140
Query: 79 MPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
+ GE ++ F + EI+ IG + Y+H ++ HRD+K
Sbjct: 141 LDG--------GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 189
Query: 133 SNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 189
N+L N K++DFG +K + + ++T T Y+APE + + D++
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMW 247
Query: 190 SFGVLL 195
S GV++
Sbjct: 248 SLGVIM 253
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 4e-17
Identities = 49/193 (25%), Positives = 92/193 (47%), Gaps = 26/193 (13%)
Query: 23 GTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVC-HENLVKL----HGGCIDGPCR 72
G VA+K + V++ +E M EVA + ++ H N+V+L D +
Sbjct: 37 GRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 73 I-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+ LV++++ + L+ L ++ + ++++ + RGL ++H VVHRD+K
Sbjct: 94 LTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLK 147
Query: 132 TSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 189
NIL+ + K++DFGL++++ T V TL Y APE + D++
Sbjct: 148 PQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-TLWYRAPEVLLQSSYATPVDLW 203
Query: 190 SFGVLLLEIVSGR 202
S G + E+ +
Sbjct: 204 SVGCIFAEMFRRK 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-16
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 40/208 (19%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLV 60
KV L+ + + AVK+L VE EK ++ L
Sbjct: 35 KVMLS---ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-------PPFLT 84
Query: 61 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAY 116
+LH C R+ V +Y+ L + + A F + A EI +G L +
Sbjct: 85 QLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAA--EIAIG----LFF 136
Query: 117 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAP 174
+ + +++RD+K N++LD + KI+DFG+ K ++ TT T GT Y+AP
Sbjct: 137 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDYIAP 190
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVSGR 202
E + D ++FGVLL E+++G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-16
Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 21/164 (12%)
Query: 20 LQDGTIVAVKVLSVESKQGEKE---FMS--EVASMANVNVCHENLVKLHGGCIDGPCRIL 74
IVA+K + + + K+ + E+ + ++ H N++ L L
Sbjct: 32 KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFGHKSNISL 89
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V+D+M + L + + + ++ +GL Y+H+ ++HRD+K +N
Sbjct: 90 VFDFMETD-LEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNN 142
Query: 135 ILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 175
+LLD+N K++DFGL+K F P TH +V T Y APE
Sbjct: 143 LLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TRWYRAPE 182
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-16
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 23 GTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G IVA+K + S + K +K M E+ + + HENLV L C LV++++
Sbjct: 50 GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--HENLVNLLEVCKKKKRWYLVFEFV- 106
Query: 81 NNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
T+L + E ++ ++ + I G+ + H +++HRDIK NIL+ Q
Sbjct: 107 ----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQ 159
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 175
+ K+ DFG ++ VA T Y APE
Sbjct: 160 SGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-16
Identities = 50/195 (25%), Positives = 97/195 (49%), Gaps = 37/195 (18%)
Query: 23 GTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G IVA+K + +++ E E + E++ + ++ H N+V L C LV++
Sbjct: 45 GRIVALKRIRLDA---EDEGIPSTAIREISLLKELH--HPNIVSLIDVIHSERCLTLVFE 99
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+M + L + L ++ + + + + RG+A+ H+ ++HRD+K N+L+
Sbjct: 100 FMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLI 152
Query: 138 DQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE-------YAISGRLTRKSD 187
+ + K++DFGL++ F P + TH V TL Y AP+ Y+ S D
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPDVLMGSKKYSTS------VD 202
Query: 188 VYSFGVLLLEIVSGR 202
++S G + E+++G+
Sbjct: 203 IWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-16
Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 14/156 (8%)
Query: 23 GTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
G IVA+K + S + +K + E+ + + H NLV L LV++Y
Sbjct: 28 GQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--HPNLVNLLEVFRRKRRLHLVFEYC- 84
Query: 81 NNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
T+L E ++ + + I + + + H+ + +HRD+K NIL+ +
Sbjct: 85 ----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITK 137
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 175
+ K+ DFG ++L + + VA T Y +PE
Sbjct: 138 HSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 44/210 (20%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLV 60
KV L RL+ I A++V+ ++ Q EK + ++ H LV
Sbjct: 67 KVLLV---RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-------HPFLV 116
Query: 61 KLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGL 114
LH C R+ V +Y+ L Q L EE A+F + A EI + L
Sbjct: 117 GLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSA--EISLA----L 166
Query: 115 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYL 172
Y+HE +++RD+K N+LLD + K++D+G+ K L P +TT GT Y+
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPNYI 220
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
APE D ++ GVL+ E+++GR
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-16
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 44/210 (20%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLV 60
KV L RL+ I A+KV+ ++ Q EK + ++ H LV
Sbjct: 24 KVLLV---RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------HPFLV 73
Query: 61 KLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGL 114
LH C R+ V +Y+ L Q L EE A+F + A EI + L
Sbjct: 74 GLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSA--EISLA----L 123
Query: 115 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYL 172
Y+HE +++RD+K N+LLD + K++D+G+ K L P +TT T GT Y+
Sbjct: 124 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNYI 177
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
APE D ++ GVL+ E+++GR
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-16
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 23 GTIVAVKVLSVESKQGEKEFMS----EVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
G VA+K + ++S++G S E++ M + HEN+V+L+ LV+++
Sbjct: 30 GVYVALKEVKLDSEEG---TPSTAIREISLMKELK--HENIVRLYDVIHTENKLTLVFEF 84
Query: 79 MPNNSLSQTL--LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
M N+ L + + + + +GLA+ HE ++HRD+K N+L
Sbjct: 85 MDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLL 140
Query: 137 LDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 175
+++ K+ DFGL++ F P NT + V TL Y AP+
Sbjct: 141 INKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPD 178
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 3e-16
Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 23/161 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G +VA+K + +++ E E + E++ + +N H N+VKL LV++
Sbjct: 28 GEVVALKKIRLDT---ETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTENKLYLVFE 82
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
++ + L + + + + + + +GLA+ H V+HRD+K N+L+
Sbjct: 83 FLHQD-LKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLI 136
Query: 138 DQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 175
+ K++DFGL++ F P T TH V TL Y APE
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPE 173
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-16
Identities = 36/163 (22%), Positives = 75/163 (46%), Gaps = 24/163 (14%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENLVKLHGGCIDGPCRILV 75
+ IVA+K + ++ + E + E+ + + H+N+V+LH LV
Sbjct: 25 ETHEIVALKRVRLDD---DDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLV 79
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+++ + L + + + + + + +GL + H +V+HRD+K N+
Sbjct: 80 FEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNL 132
Query: 136 LLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 175
L+++N K+++FGL++ F P + V TL Y P+
Sbjct: 133 LINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPD 171
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-16
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 23/160 (14%)
Query: 23 GTIVAVKVLSVESKQGEKEF----MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+VA+K + +E ++G + EV+ + ++ H N+V LH LV++Y
Sbjct: 27 DNLVALKEIRLEHEEG---APCTAIREVSLLKDLK--HANIVTLHDIIHTEKSLTLVFEY 81
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
+ + L Q L + + + + RGLAY H + V+HRD+K N+L++
Sbjct: 82 LDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLIN 134
Query: 139 QNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 175
+ K++DFGL++ P T + V TL Y P+
Sbjct: 135 ERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPD 170
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-16
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 40/208 (19%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLV 60
KV LA + A+K L VE EK +S H L
Sbjct: 32 KVFLA---EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-------HPFLT 81
Query: 61 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAY 116
+ + V +Y+ L + K RA F + A EII+G+ +
Sbjct: 82 HMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-YAA--EIILGLQ----F 133
Query: 117 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAP 174
+H + +V+RD+K NILLD++ + KI+DFG+ K + + T +T GT Y+AP
Sbjct: 134 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT-FCGTPDYIAP 187
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVSGR 202
E + + D +SFGVLL E++ G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 6e-16
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV L I D + A+KVL + + E + VN H +VKLH
Sbjct: 39 KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIVKLHY-AF 95
Query: 68 DGPCRI-LVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQ 122
++ L+ D++ L T L +E KF + A E+ + L ++H
Sbjct: 96 QTEGKLYLILDFLRGGDLF-TRLSKEVMFTEEDVKF-YLA--ELALA----LDHLHSL-- 145
Query: 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISG 180
+++RD+K NILLD+ + K++DFGLSK + E + + GT+ Y+APE
Sbjct: 146 -GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--S-FCGTVEYMAPEVVNRR 201
Query: 181 RLTRKSDVYSFGVLLLEIVSGR 202
T+ +D +SFGVL+ E+++G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGT 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-16
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 40/208 (19%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLV 60
KV LA R+++ G + AVKVL VE EK +S + H L
Sbjct: 38 KVMLA---RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------HPFLT 87
Query: 61 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAY 116
+L C P R+ V +++ L + + RA+F + A EII L +
Sbjct: 88 QLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAA--EIISA----LMF 139
Query: 117 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAP 174
+H++ +++RD+K N+LLD + K++DFG+ K + TT +T GT Y+AP
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPDYIAP 193
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVSGR 202
E D ++ GVLL E++ G
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 7e-16
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCHENLVKLHGGC 66
KV L + + G A+K+L E + E ++E + N H L L
Sbjct: 163 KVILV---KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTALKY-S 216
Query: 67 IDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQ 122
R+ V +Y L L E RA+F + A EI+ L Y+H E
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGA--EIVSA----LDYLHSEKN 269
Query: 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 182
VV+RD+K N++LD++ + KI+DFGL K ++ + T GT YLAPE
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 326
Query: 183 TRKSDVYSFGVLLLEIVSGR 202
R D + GV++ E++ GR
Sbjct: 327 GRAVDWWGLGVVMYEMMCGR 346
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 9e-16
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 37/195 (18%)
Query: 23 GTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G A+K + +E E E + E++ + + H N+VKL+ +LV++
Sbjct: 26 GETFALKKIRLEK---EDEGIPSTTIREISILKELK--HSNIVKLYDVIHTKKRLVLVFE 80
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
++ + L + L + + ++ + G+AY H+ V+HRD+K N+L+
Sbjct: 81 HLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLI 133
Query: 138 DQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE-------YAISGRLTRKSD 187
++ KI+DFGL++ F P TH + TL Y AP+ Y+ + D
Sbjct: 134 NREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDVLMGSKKYSTT------ID 183
Query: 188 VYSFGVLLLEIVSGR 202
++S G + E+V+G
Sbjct: 184 IWSVGCIFAEMVNGT 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-16
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 36/166 (21%)
Query: 56 HENLVKLH------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 109
H N+V L G D LV +Y+P +T+ R ++ K ++ + M
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETV----YRASRHYAKLKQTMPML 141
Query: 110 --------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PEN 157
+ R LAYIH + HRDIK N+LLD K+ DFG +K+ N
Sbjct: 142 LIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 158 TTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 202
++I +R Y APE T D++S G ++ E++ G+
Sbjct: 199 VSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 9e-16
Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 28/159 (17%)
Query: 56 HENLVKLHGGCIDGPCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 107
H+N++ L + P + LV + M N L Q + + + + ++
Sbjct: 120 HKNIISLLN--VFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLL 170
Query: 108 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTR 164
+ G+ ++H ++HRD+K SNI++ + KI DFGL++ + T ++ TR
Sbjct: 171 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 165 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
Y APE + D++S G ++ E+V +
Sbjct: 228 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 61/208 (29%), Positives = 84/208 (40%), Gaps = 41/208 (19%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLV 60
KV L R + G A+K+L V E + N H L
Sbjct: 20 KVILV---REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--------NTRHPFLT 68
Query: 61 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAY 116
L R+ V +Y L L E RA+F + A EI+ L Y
Sbjct: 69 ALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIVSA----LEY 120
Query: 117 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAP 174
+H VV+RDIK N++LD++ + KI+DFGL K + T T GT YLAP
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-FCGTPEYLAP 174
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVSGR 202
E R D + GV++ E++ GR
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 63/207 (30%), Positives = 88/207 (42%), Gaps = 38/207 (18%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCHENLVK 61
KV LA + AVKVL + E+ + + NV H LV
Sbjct: 53 KVLLAR--HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-------NVKHPFLVG 103
Query: 62 LHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYI 117
LH ++ V DY+ L L E RA+F + A EI +G Y+
Sbjct: 104 LHF-SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAA--EIASALG----YL 155
Query: 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPE 175
H ++V+RD+K NILLD + ++DFGL K + +TT ST GT YLAPE
Sbjct: 156 HSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAPE 209
Query: 176 YAISGRLTRKSDVYSFGVLLLEIVSGR 202
R D + G +L E++ G
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-15
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 27/203 (13%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVL---SVESKQGEKEF-MSEVASMANVNVCHENLVKLHGG 65
KV + + G I A+KVL + + +E + V H +V L
Sbjct: 32 KVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK--HPFIVDLIY- 88
Query: 66 CIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEI 121
++ L+ +Y+ L L E A F + A EI M L ++H++
Sbjct: 89 AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLA--EISMA----LGHLHQK- 140
Query: 122 QPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAIS 179
+++RD+K NI+L+ + K++DFGL K + TH T GT+ Y+APE +
Sbjct: 141 --GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--T-FCGTIEYMAPEILMR 195
Query: 180 GRLTRKSDVYSFGVLLLEIVSGR 202
R D +S G L+ ++++G
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGA 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-15
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT- 168
+ +G+ ++ +HRD+ NILL + KI DFGL++ ++ ++ A
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 169 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
L ++APE T +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 43/203 (21%), Positives = 81/203 (39%), Gaps = 38/203 (18%)
Query: 20 LQDGTIVAVK-VLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR----- 72
G VA+K V+ + E + M ++A + H N+V+L
Sbjct: 45 KSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH-----HPNIVQLQS-YFYTLGERDRRD 98
Query: 73 ---ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--------IGRGLAYIHEEI 121
+V +Y+P TL R + ++ + + R + +H
Sbjct: 99 IYLNVVMEYVP-----DTL----HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP- 148
Query: 122 QPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 180
+V HRDIK N+L++ + K+ DFG +K + +++ + + Y APE
Sbjct: 149 SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY-IC-SRYYRAPELIFGN 206
Query: 181 RL-TRKSDVYSFGVLLLEIVSGR 202
+ T D++S G + E++ G
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-15
Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGT 168
G+ ++H ++HRD+K SNI++ + KI DFGL++ + T ++ TR
Sbjct: 138 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 191
Query: 169 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
Y APE + D++S G ++ E++ G
Sbjct: 192 --YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-14
Identities = 45/209 (21%), Positives = 82/209 (39%), Gaps = 48/209 (22%)
Query: 21 QDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRI-L 74
+D A+K + S E + E+ H N++ L + ++ L
Sbjct: 46 KDDKDYALKQIEGTGISMSACREIALLRELK--------HPNVISLQKVFLSHADRKVWL 97
Query: 75 VYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
++DY ++ L + K+ + + ++ I G+ Y+H V+HRD
Sbjct: 98 LFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRD 153
Query: 130 IKTSNILLDQNFNP----KISDFGLSKLF--PENT-THISTRVAGTLGYLAPE------- 175
+K +NIL+ KI+D G ++LF P + V T Y APE
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARH 212
Query: 176 Y--AISGRLTRKSDVYSFGVLLLEIVSGR 202
Y AI D+++ G + E+++
Sbjct: 213 YTKAI--------DIWAIGCIFAELLTSE 233
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-14
Identities = 18/181 (9%), Positives = 46/181 (25%), Gaps = 44/181 (24%)
Query: 26 VAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82
VA+ + + + +E +S ++ ++ + ++ ++V +++
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRID--KPGVARVLDVVHTRAGGLVVAEWIRGG 116
Query: 83 SLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
SL + A + + H V S +
Sbjct: 117 SLQEVADTSPSPVGA-------IRAMQSLAAAADAAHRA---GVALSIDHPSRVR----- 161
Query: 142 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 201
+S G L + + D+ G L ++
Sbjct: 162 ---VSIDGDVVL-------------AYPATMPDA-------NPQDDIRGIGASLYALLVN 198
Query: 202 R 202
R
Sbjct: 199 R 199
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 38/166 (22%), Positives = 66/166 (39%), Gaps = 30/166 (18%)
Query: 23 GTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
VA+K + +E E+E + EV+ + + H N+++L L+++
Sbjct: 59 NETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQ--HRNIIELKSVIHHNHRLHLIFE 113
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
Y L + + + + + G+ + H +HRD+K N+LL
Sbjct: 114 YA-----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLL 165
Query: 138 DQNFNP-----KISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 175
+ KI DFGL++ F P TH + TL Y PE
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPE 207
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 24/139 (17%)
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMGIGRGLAYIHEEIQPHV 125
++ +Y+P TL + K ++ R I I + R + +IH +
Sbjct: 115 VIMEYVP-----DTL----HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGI 162
Query: 126 VHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-T 183
HRDIK N+L++ N K+ DFG +K + ++ + + Y APE + T
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY-IC-SRFYRAPELMLGATEYT 220
Query: 184 RKSDVYSFGVLLLEIVSGR 202
D++S G + E++ G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 37/210 (17%)
Query: 11 KVDLAPFIRLQD-GTIVAVKVLS----------VESKQGEKEFMSEVASMANVNVCHENL 59
KV L I D G + A+KVL E + E++ + + L
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-------SPFL 121
Query: 60 VKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGL 114
V LH ++ L+ DY+ L T L + +R + + EI++ L
Sbjct: 122 VTLHY-AFQTETKLHLILDYINGGELF-THLSQRERFTEHEVQI-YVG--EIVLA----L 172
Query: 115 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 174
++H+ +++RDIK NILLD N + ++DFGLSK F + T + GT+ Y+AP
Sbjct: 173 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 175 EYAISGRL--TRKSDVYSFGVLLLEIVSGR 202
+ G + D +S GVL+ E+++G
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-14
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 30/173 (17%)
Query: 20 LQDGTIVAVKVLSVESKQGEKE---FMS--EVASMANVNVCHENLVKLHGGCIDGPCRI- 73
+ G VA+K + +E+ EKE + E+ + + HEN+V L C
Sbjct: 39 RKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLK--HENVVNLIEICRTKASPYN 93
Query: 74 -------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 126
LV+D+ ++ L+ L KF + ++ + GL YIH ++
Sbjct: 94 RCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KIL 146
Query: 127 HRDIKTSNILLDQNFNPKISDFGLSKLF----PENTTHISTRVAGTLGYLAPE 175
HRD+K +N+L+ ++ K++DFGL++ F + RV TL Y PE
Sbjct: 147 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-14
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 33/161 (20%)
Query: 56 HENLVKLHGGCIDGPCRI--------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARR 104
HEN++ L + P LV +M + E+ +
Sbjct: 82 HENVIGLLD--VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY--------- 130
Query: 105 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHIST 163
++ + +GL YIH VVHRD+K N+ ++++ KI DFGL++ E T ++ T
Sbjct: 131 -LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186
Query: 164 RVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 203
R Y APE +S + D++S G ++ E+++G+T
Sbjct: 187 RW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 32/94 (34%), Positives = 56/94 (59%), Gaps = 10/94 (10%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLG 170
+GL YIH ++HRD+K N+ ++++ KI DFGL++ E T ++ TR
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 171 YLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 203
Y APE ++ R T+ D++S G ++ E+++G+T
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-13
Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 10/94 (10%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLG 170
RGL YIH ++HRD+K SN+ ++++ KI DFGL++ E T +++TR
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 171 YLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 203
Y APE ++ + D++S G ++ E+++GRT
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGT 168
GL +HE VVHRD+ NILL N + I DF L++ + T +++ R
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW--- 198
Query: 169 LGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 203
Y APE + T+ D++S G ++ E+ + +
Sbjct: 199 --YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 44/193 (22%), Positives = 87/193 (45%), Gaps = 26/193 (13%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--ILV 75
I + + V VK+L K K+ E+ + N+ N++ L D R LV
Sbjct: 56 INITNNEKVVVKILKPVKK---KKIKREIKILENLR-GGPNIITLADIVKDPVSRTPALV 111
Query: 76 YDYMPN---NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
++++ N L QTL + R + I + L Y H ++HRD+K
Sbjct: 112 FEHVNNTDFKQLYQTLTDYDIRF----------YMYEILKALDYCH---SMGIMHRDVKP 158
Query: 133 SNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS-DVYS 190
N+++D ++ ++ D+GL++ + + + RVA + + PE + ++ S D++S
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPELLVDYQMYDYSLDMWS 216
Query: 191 FGVLLLEIVSGRT 203
G +L ++ +
Sbjct: 217 LGCMLASMIFRKE 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 16/100 (16%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN-------TTHISTR 164
RGL YIH +V+HRD+K SN+LL+ + KI DFGL+++ + T +++TR
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 165 VAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 203
Y APE ++ T+ D++S G +L E++S R
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-11
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 17/103 (16%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG- 170
R + +H +V+HRD+K SN+L++ N + K+ DFGL+++ E+ S G
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 171 --------YLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGR 202
Y APE + S + +R DV+S G +L E+ R
Sbjct: 180 VEFVATRWYRAPE--VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-11
Identities = 30/97 (30%), Positives = 56/97 (57%), Gaps = 9/97 (9%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLF---PENTTHISTRVAG 167
RGL YIH +V+HRD+K +N+ ++ ++ KI DFGL+++ + H+S +
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV- 186
Query: 168 TLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRT 203
T Y +P +S T+ D+++ G + E+++G+T
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 22/73 (30%), Positives = 37/73 (50%), Gaps = 4/73 (5%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLG 170
G +IHE ++HRD+K +N LL+Q+ + K+ DFGL+ + E T+I +
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 171 YLAPEYAISGRLT 183
+ +LT
Sbjct: 197 PGPHNKNLKKQLT 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-10
Identities = 20/72 (27%), Positives = 32/72 (44%), Gaps = 3/72 (4%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 171
+ + Y+H ++HRD+K SNILL+ + K++DFGLS+ F +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 172 LAPEYAISGRLT 183
LT
Sbjct: 177 TENFDDDQPILT 188
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-10
Identities = 42/207 (20%), Positives = 85/207 (41%), Gaps = 37/207 (17%)
Query: 20 LQDGTIVAVKVL-SVES--KQGEKE-----FMSEVASMANVNVCHENLVKL------HGG 65
+ + T VA+K++ + + E E +++ + ++ +++KL G
Sbjct: 41 MVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 100
Query: 66 CIDGPCRILVYDYMPNNSLSQTLLGEEKRR--AKFGWKARREIIMGIGRGLAYIHEEIQP 123
+V++ L + LL K+ ++I + GL Y+H
Sbjct: 101 NGVHVV--MVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-- 151
Query: 124 HVVHRDIKTSNILLD------QNFNPKISDFGLSKLFPEN-TTHISTRVAGTLGYLAPEY 176
++H DIK N+L++ KI+D G + + E+ T I TR Y +PE
Sbjct: 152 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE-----YRSPEV 206
Query: 177 AISGRLTRKSDVYSFGVLLLEIVSGRT 203
+ +D++S L+ E+++G
Sbjct: 207 LLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-10
Identities = 28/144 (19%), Positives = 53/144 (36%), Gaps = 32/144 (22%)
Query: 23 GTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI----LVYD 77
A+K+L + E E + ++V++ + +V +
Sbjct: 43 QEKFALKMLQDCPKARREVELHWRASQ-------CPHIVRIVDVYENLYAGRKCLLIVME 95
Query: 78 YMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+ GE ++ F + EI+ IG + Y+H ++ HRD+K
Sbjct: 96 CLDG--------GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVK 144
Query: 132 TSNILL---DQNFNPKISDFGLSK 152
N+L N K++DFG +K
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAK 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-09
Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 112 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 171
G+ Y+H ++HRD+K +N L++Q+ + K+ DFGL++ S
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 172 LAPE 175
Sbjct: 224 DMNL 227
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-09
Identities = 46/260 (17%), Positives = 86/260 (33%), Gaps = 73/260 (28%)
Query: 20 LQDGTIVAVKVLSVESKQG-----EKEFMSEVASMANVNVCHENLVKLHGG-CIDGP--- 70
+Q VA+KV+ E + V + + E +V+L I G
Sbjct: 59 IQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT 118
Query: 71 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128
C +V++ + + L + ++ + ++II + +GL Y+H + ++H
Sbjct: 119 HIC--MVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLDYLHTKC--RIIHT 171
Query: 129 DIKTSNILL-------------------------------------------------DQ 139
DIK NILL +
Sbjct: 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
KI+D G + ++ T T Y + E I +D++S + E+
Sbjct: 232 KLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287
Query: 200 SGRTAVDFDVQLGEYHLVDK 219
+G F+ GE + D+
Sbjct: 288 TGDYL--FEPHSGEEYTRDE 305
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 8e-09
Identities = 33/229 (14%), Positives = 69/229 (30%), Gaps = 50/229 (21%)
Query: 22 DGTIVAVKVLSVESK--------QGEKEFMSEVASM-------ANVNVCHENLVKLHGGC 66
D T VA+K++++E + +E + E+ V E + L+
Sbjct: 42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101
Query: 67 I----DGPCRILVYDYMPNNSLSQ---------------------TLLGEEKRRAKFGWK 101
P + +D+ + S + E+ R
Sbjct: 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLA 161
Query: 102 ARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161
+ I+ + LA + HRD+ N+LL + K+ K + +
Sbjct: 162 TAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL 219
Query: 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210
+ +Y +S V+ + ++ +G FD+
Sbjct: 220 QVSII--------DYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIY 260
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-09
Identities = 41/198 (20%), Positives = 76/198 (38%), Gaps = 25/198 (12%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
L VA+K+ E + + + + +++ G +V +
Sbjct: 29 KNLYTNEYVAIKL---EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85
Query: 78 YM-PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+ P SL L R F K I + + + Y+H + ++++RD+K N L
Sbjct: 86 LLGP--SLED-LFDLCDR--TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFL 137
Query: 137 LDQNFNPK-----ISDFGLSKLF--PENTTHISTR----VAGTLGYLAPEYAISGR-LTR 184
+ + N I DF L+K + PE HI R + GT Y G+ +R
Sbjct: 138 IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY-MSINTHLGKEQSR 196
Query: 185 KSDVYSFGVLLLEIVSGR 202
+ D+ + G + + + G
Sbjct: 197 RDDLEALGHMFMYFLRGS 214
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 11/103 (10%)
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPEN-TTH 160
R+ I + L +H+ ++H D+K NILL Q K+ DFG S + T+
Sbjct: 203 RKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259
Query: 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
I +R Y APE + R D++S G +L E+++G
Sbjct: 260 IQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 33/202 (16%), Positives = 69/202 (34%), Gaps = 39/202 (19%)
Query: 26 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG------------GCIDGPCRI 73
++K+ ++K G A + KL+ G R
Sbjct: 78 FSLKL---DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF 134
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
LV + SL Q+ L + ++ ++ + L ++HE VH ++
Sbjct: 135 LVLPSL-GRSL-QSALDVSPKH-VLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188
Query: 134 NILLDQNFNPKI--SDFGLSKLFPENTTHISTR------VAGTLGYLAPEYA-----ISG 180
NI +D ++ + +G + + + H++ G E+
Sbjct: 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGC 243
Query: 181 RLTRKSDVYSFGVLLLEIVSGR 202
+R+SD+ S G +L+ + G
Sbjct: 244 GPSRRSDLQSLGYCMLKWLYGF 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 45/210 (21%), Positives = 74/210 (35%), Gaps = 34/210 (16%)
Query: 18 IRLQDGTIVAVKVLSVESKQG-----EKEFMSEVASMANVNVCHENLVKLHGG------- 65
A V+ VE ++ E +F VA + E + G
Sbjct: 57 FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116
Query: 66 ----CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 121
R +V + + L + + F ++ + + L YIHE
Sbjct: 117 GLTEFKGRSYRFMVMERL-GIDLQKIS----GQNGTFKKSTVLQLGIRMLDVLEYIHEN- 170
Query: 122 QPHVVHRDIKTSNILLDQNFNPKI--SDFGLSKLFPENTTHI------STRVAGTLGYLA 173
VH DIK +N+LL ++ +D+GLS + N H GT+ +
Sbjct: 171 --EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF-T 227
Query: 174 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 202
A G L+R+SDV G +L + G+
Sbjct: 228 SLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-07
Identities = 26/103 (25%), Positives = 45/103 (43%), Gaps = 9/103 (8%)
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPEN-TTH 160
R+ + L ++ + ++H D+K NILL KI DFG S + +
Sbjct: 160 RKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 218
Query: 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 203
I +R Y +PE + D++S G +L+E+ +G
Sbjct: 219 IQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 8e-07
Identities = 37/217 (17%), Positives = 73/217 (33%), Gaps = 62/217 (28%)
Query: 53 NVCHENLVKLHGGCIDGPCRILV---------------YDYMPNNSLSQTLLGEEKRR-- 95
NV + + C+IL+ ++ + S TL +E +
Sbjct: 252 NVQNAKAWNA----FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 96 AKF-GWKA---RREIIMGIGRGLAYIHEEIQPHVVHRD-------------IKTS-NILL 137
K+ + RE++ R L+ I E I+ + D I++S N+L
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY---AISGRLTRKSDV------ 188
+ +FP + HI T + + + + + +L + S V
Sbjct: 368 PAEYRKMFDRLS---VFPPS-AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 189 --YSFGVLLLEIVSGRTAVDFDVQLGEYH--LVDKVR 221
S + LE+ + ++ + L H +VD
Sbjct: 424 STISIPSIYLEL---KVKLENEYAL---HRSIVDHYN 454
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-06
Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 21/102 (20%)
Query: 114 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI--SDFGLSKLF--PENTTHISTR----V 165
L YIHE VH DIK SN+LL+ ++ D+GL+ + +
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 166 AGTLGYLAPEYA-IS---GR-LTRKSDVYSFGVLLLEIVSGR 202
GT E+ I G +R+ D+ G +++ ++G
Sbjct: 222 DGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-06
Identities = 43/199 (21%), Positives = 73/199 (36%), Gaps = 29/199 (14%)
Query: 18 IRLQDGTIVAVKVLSVESKQG----EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73
+ G VA+K+ V++K E + + + + +G +
Sbjct: 29 TDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGI-------PTIRWCGAEGDYNV 81
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+V + + SL KF K + + + YIH + + +HRD+K
Sbjct: 82 MVMELL-GPSLEDLF---NFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPD 134
Query: 134 NILLDQNFNPK---ISDFGLSKLF--PENTTHISTR----VAGTLGYLAPEYAISGR-LT 183
N L+ I DFGL+K + HI R + GT Y A G +
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINTHLGIEQS 193
Query: 184 RKSDVYSFGVLLLEIVSGR 202
R+ D+ S G +L+ G
Sbjct: 194 RRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 16/99 (16%)
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPK-----ISDFGLSKLF--PENTTHISTR---- 164
IHE+ +V+RDIK N L+ + + + DFG+ K + P HI R
Sbjct: 121 SIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 165 VAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 202
++GT Y GR +R+ D+ + G + + + G
Sbjct: 178 LSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 4e-06
Identities = 45/199 (22%), Positives = 76/199 (38%), Gaps = 29/199 (14%)
Query: 18 IRLQDGTIVAVKVLSVESK----QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73
+Q VA+K+ +V++K E + + + + ++G +
Sbjct: 27 TNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGI-------PNVRWFGVEGDYNV 79
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
LV D + SL L R K K + + + ++H + +HRDIK
Sbjct: 80 LVMDLL-GPSLED-LFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPD 132
Query: 134 NILLDQNFNPK---ISDFGLSKLF--PENTTHISTR----VAGTLGYLAPEYAISGR-LT 183
N L+ I DFGL+K + HI R + GT Y A G +
Sbjct: 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHLGIEQS 191
Query: 184 RKSDVYSFGVLLLEIVSGR 202
R+ D+ S G +L+ + G
Sbjct: 192 RRDDLESLGYVLMYFLRGS 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 5e-04
Identities = 29/128 (22%), Positives = 45/128 (35%), Gaps = 44/128 (34%)
Query: 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-------------------K 144
R + + L ++HE + H D+K NIL + +
Sbjct: 126 RHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 145 ISDFGLSKLFPEN-TTHISTRVAGTLGYLAPE--------YAISGRLTRKSDVYSFGVLL 195
++DFG + E+ TT ++TR Y PE DV+S G +L
Sbjct: 183 VADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQPC--------DVWSIGCIL 229
Query: 196 LEIVSGRT 203
E G T
Sbjct: 230 FEYYRGFT 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 229 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.35 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.69 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.6 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.27 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.08 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.93 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.92 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.53 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.22 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.86 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 95.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.44 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=349.21 Aligned_cols=198 Identities=24% Similarity=0.394 Sum_probs=179.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| ++..+|+.||||+++.......+.+.+|+++++.++ ||||++++++|.+++..|+|||||+|
T Consensus 80 ~~iG~G~fG~V~~a--~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 80 IKIGEGSTGIVCIA--TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred EEeecCcCeEEEEE--EECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 46999999999999 778899999999998776666678899999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|.+++. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||++..+..... .
T Consensus 156 g~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 156 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 99999882 35699999999999999999999999 999999999999999999999999999987654322 2
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 277 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 345789999999999999999999999999999999999999998765443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=344.23 Aligned_cols=198 Identities=24% Similarity=0.370 Sum_probs=179.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+| ++..+|+.||+|+++.. .....+.+.+|+++++.++ ||||++++++|++++..|+||||
T Consensus 38 ~~lG~G~fg~V~~a--~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 38 KILGEGSFSTVVLA--RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--HPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEecccCeEEEEE--EECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEEEEEEec
Confidence 57999999999999 78889999999999754 2334577999999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++||+|.+++ ...+.+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++..+....
T Consensus 114 ~~gG~L~~~i----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 114 AKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999 5667899999999999999999999999 99999999999999999999999999998764332
Q ss_pred -ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 -THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234567899999999999999999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=345.87 Aligned_cols=199 Identities=24% Similarity=0.401 Sum_probs=170.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ ++..+|+.||||+++.. .....+.+.+|+++++.++ ||||+++++++.+++..|+|||||
T Consensus 30 ~~lG~G~fg~V~~a--~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 30 QKIGEGSFGKAILV--KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--HPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEC------CEEEE--EETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC--CCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999 77889999999999755 3334577899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+||+|.+++.. .....+++..++.++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||++.......
T Consensus 106 ~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 106 EGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp TTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999932 2345678999999999999999999999 99999999999999999999999999998653321
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 230 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 122446799999999999999999999999999999999999999987653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=350.78 Aligned_cols=198 Identities=24% Similarity=0.396 Sum_probs=179.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| ++..+|+.||||+++.......+.+.+|+++++.++ ||||++++++|.+++.+|+|||||+|
T Consensus 157 ~~iG~G~fG~V~~a--~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 157 IKIGEGSTGIVCIA--TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEeccCcCcEEEEE--EECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC--CCCCCceEEEEEECCEEEEEEeCCCC
Confidence 56999999999999 778899999999998776666678999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|.+++ ....+++..+..++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||++..+..... .
T Consensus 233 G~L~~~i-----~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 233 GALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp EEHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CcHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 9999988 235699999999999999999999999 999999999999999999999999999987644322 2
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 345789999999999999999999999999999999999999998765443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=337.29 Aligned_cols=195 Identities=22% Similarity=0.294 Sum_probs=170.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++ ++..+|+.||||+++.+.. ..+|+.+++.++ ||||+++++++.+++..|+||||++|
T Consensus 64 ~~lG~G~fG~Vy~a--~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~--HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 64 PRVGRGSFGEVHRM--KDKQTGFQCAVKKVRLEVF-----RVEELVACAGLS--SPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEETTTC-----CTHHHHTTTTCC--CTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEeccCCCeEEEEE--EECCCCCEEEEEEECHHHh-----HHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEeccCC
Confidence 35999999999999 7788999999999975422 246999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccccCCCCcc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 160 (229)
++|.+++ ...+.+++..+..++.|++.||+|||++ ||+||||||+|||++.+| .+||+|||++..+......
T Consensus 135 g~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 135 GSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999 4567899999999999999999999999 999999999999999887 6999999999876432211
Q ss_pred ----ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 161 ----ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 161 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 1234679999999999999999999999999999999999999998765443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=337.70 Aligned_cols=201 Identities=27% Similarity=0.346 Sum_probs=168.8
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+|+... ..+++.||+|+++... ......+.+|+++++.++ ||||+++++++.+++..|+||||
T Consensus 30 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC--CTTEECEEEEEEETTEEEEEECC
T ss_pred EEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECCEEEEEEEc
Confidence 579999999999994422 3468899999997542 223456888999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
|+||+|.+++ .....+++..+..++.|++.||+|||++ ||+||||||+||+++.+|.+||+|||++.......
T Consensus 108 ~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 108 LRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp CTTCEEHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999 5567899999999999999999999999 99999999999999999999999999997653322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 233 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH
Confidence 22345689999999999999999999999999999999999999998765433
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=334.94 Aligned_cols=206 Identities=30% Similarity=0.460 Sum_probs=175.4
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+|++.. ..++..||||.++.......+.+.+|++++++++ ||||+++++++.+++..++||||
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSSSEEEEEEC
T ss_pred eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC--CCCCccEEEEEeeCCEEEEEEEc
Confidence 469999999999996543 3468899999998766666788999999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhh---------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 027015 79 MPNNSLSQTLLGEE---------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 149 (229)
Q Consensus 79 ~~~~sL~~~~~~~~---------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg 149 (229)
+++|+|.+++.... .....+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcc
Confidence 99999999995432 2345799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 150 LSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9986543322 22334568999999999999999999999999999999998 999998765443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=326.85 Aligned_cols=195 Identities=28% Similarity=0.426 Sum_probs=161.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ++..+|+.||+|+++... ......+.+|+++++.++ ||||+++++++.+++..|+||||
T Consensus 19 ~~lG~G~fg~V~~~--~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 19 KTLGEGSFGKVKLA--YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR--HPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp EEEEC---CCEEEE--ECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCcCeEEEEE--EECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECCEEEEEEeC
Confidence 57999999999999 778899999999997542 233467899999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+ +|+|.+++ .....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~-~g~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 95 A-GNELFDYI----VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp C-CEEHHHHH----HHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred C-CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 9 67999998 5567899999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~ 217 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 217 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 2345679999999999998876 5799999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=325.66 Aligned_cols=191 Identities=26% Similarity=0.400 Sum_probs=167.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEc----CCceEEEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVY 76 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----~~~~~lv~ 76 (229)
.||+|+||+||+| ++..++..||+|.+... .....+.+.+|+++++.++ ||||++++++|.+ ....++||
T Consensus 33 ~iG~G~fg~Vy~a--~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 33 EIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEECSSEEEEEE--EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEecCcCcEEEEE--EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4999999999999 77889999999999754 3334577899999999999 9999999999875 34578999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEc-CCCceEEeccccccc
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLD-QNFNPKISDFGLSKL 153 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~ni~~~-~~~~~~l~dfg~~~~ 153 (229)
|||++|+|.+++ .....+++..+..++.|+++||+|||++ + |+||||||+|||++ .++.+||+|||++..
T Consensus 109 Ey~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999 4567899999999999999999999998 7 99999999999997 578999999999975
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 182 ~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4332 2345689999999998865 5999999999999999999999999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=334.11 Aligned_cols=207 Identities=28% Similarity=0.440 Sum_probs=170.2
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+|++. ...+++.||||.++.......+.+.+|++++++++ ||||+++++++.+.+..++||||
T Consensus 47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEEc
Confidence 35999999999999654 23568899999998666666788999999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhh-----------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 027015 79 MPNNSLSQTLLGEE-----------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 147 (229)
Q Consensus 79 ~~~~sL~~~~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~d 147 (229)
+++|+|.+++.... ....++++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence 99999999985432 1235799999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccc
Q 027015 148 FGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 213 (229)
Q Consensus 148 fg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~ 213 (229)
||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99998654332 222344678999999999999999999999999999999998 9999987654443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=327.55 Aligned_cols=206 Identities=25% Similarity=0.353 Sum_probs=174.0
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||+|.+.. ..+++.||||.++... ....+.+.+|+.++++++ ||||+++++++.+++..++|||
T Consensus 32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~--HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ--HPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC--CCCCCCcceEEEECCEEEEEEE
Confidence 469999999999996532 3467899999997553 334578999999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 78 YMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
|+++|+|.+++.... .....+++..+..++.|+++||+|||+. +++||||||.||++++++.+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEE
Confidence 999999999995432 1235699999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 146 SDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 146 ~dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
+|||+++...... ........||+.|+|||++.+..++.++||||+||++|||+| |+.||.+....+
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999997653322 222345678999999999999999999999999999999998 899998765443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=317.26 Aligned_cols=194 Identities=26% Similarity=0.422 Sum_probs=161.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++.+ ...||||+++.. .....+.+.+|++++++++ ||||+++++++.+ +..++|||||
T Consensus 42 ~~iG~G~fG~Vy~~~~-----~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~--HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 42 TRIGSGSFGTVYKGKW-----HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR--HVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp EECCCCSSSEEEEEES-----SSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECS-SSCEEEEECC
T ss_pred eEEeeCCCcEEEEEEE-----CCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEC-CeEEEEEEcC
Confidence 4699999999999943 136999998754 3344578999999999999 9999999998754 5689999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT- 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 158 (229)
++|+|.+++. .....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||++.......
T Consensus 114 ~gGsL~~~l~---~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 114 EGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp SSCBHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999983 3456799999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........||+.|+|||++.+ .+++.++|||||||++|||++|+.||....
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 223345679999999999864 358999999999999999999999998654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=314.43 Aligned_cols=195 Identities=21% Similarity=0.339 Sum_probs=157.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---------- 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~---------- 70 (229)
+.||+|+||+||+| ++..+|+.||||.++.... ...+.+.+|+++++.++ ||||+++++++.+.+
T Consensus 11 ~~lG~G~fg~V~~a--~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 11 QCLGRGGFGVVFEA--KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEECC--EEEEE--EETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEEC----------
T ss_pred eEEecCCCeEEEEE--EECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEecCccccccccCC
Confidence 57999999999999 7788999999999976543 34467899999999999 999999999987544
Q ss_pred --ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 027015 71 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 148 (229)
Q Consensus 71 --~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~df 148 (229)
..|+|||||++++|.+++... ......++..+..++.|+++||+|||++ ||+||||||+||+++.++.+||+||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 368999999999999999432 1223456677889999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcc-----------ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 149 GLSKLFPENTTH-----------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 149 g~~~~~~~~~~~-----------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
|++......... .....+||+.|+|||++.+..++.++|||||||++|+|++ ||..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999876432211 1233579999999999999999999999999999999996 7764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=335.28 Aligned_cols=206 Identities=24% Similarity=0.310 Sum_probs=174.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHH---HHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSE---VASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e---~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||+||+| ++..+|+.||+|+++... ........+| +.+++.++ ||||++++++|.+....|+|
T Consensus 195 k~LG~G~fG~V~la--~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~--HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 195 RIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD--CPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC--CTTBCCEEEEEECSSEEEEE
T ss_pred EEEecccCeEEEEE--EECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC--CCCEeEEEEEEEECCEEEEE
Confidence 57999999999999 778899999999997431 2223334444 45555666 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||++||+|.+++ ...+.+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++..+.
T Consensus 271 mEy~~GGdL~~~l----~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 271 LDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp ECCCCSCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999 5567899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCccccccccchhhhc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVR 221 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~ 221 (229)
... ....+||+.|+|||++. +..++.++|+|||||++|+|++|+.||..........+...+.
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~ 407 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence 432 24568999999999986 5679999999999999999999999998765554444444433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=322.05 Aligned_cols=200 Identities=25% Similarity=0.351 Sum_probs=171.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEc------CCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------GPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~------~~~~~ 73 (229)
+.||+|+||+||+| ++..+|+.||||+++.. .....+.+.+|+++++.++ ||||+++++++.. .+..|
T Consensus 60 ~~lG~G~fG~V~~a--~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 60 ETIGNGAYGVVSSA--RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK--HDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSSCTTTCCCEE
T ss_pred EEEecccCeEEEEE--EECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC--CCCcceEeeeeecccccccCCEEE
Confidence 57999999999999 77889999999999744 2334567889999999999 9999999998753 35789
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||++ |+|.+++ .....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus 136 ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 136 VVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 9999995 6799988 5677899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC---ccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcccccc
Q 027015 154 FPENT---THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213 (229)
Q Consensus 154 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~ 213 (229)
+.... .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~ 271 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ 271 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH
Confidence 64321 2233457899999999998875 568999999999999999999999987654443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=315.72 Aligned_cols=204 Identities=25% Similarity=0.354 Sum_probs=172.3
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcC-CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-~~~~lv~ 76 (229)
+.||+|+||+||+|.+... .+++.||||.++.... ...+.+.+|++++.+++ +||||++++++|.+. +..++||
T Consensus 70 ~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~-hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 70 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECCTTSCCEEEE
T ss_pred eEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC-CCCcEEEEEEEEEecCCEEEEEE
Confidence 4699999999999965432 3457899999975533 34567999999999998 249999999998664 5689999
Q ss_pred EccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceE
Q 027015 77 DYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~ 144 (229)
|||++|+|.+++..... ....+++..+..++.|+++||+|||++ +++||||||.||++++++.+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEE
Confidence 99999999999964322 234589999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 145 ISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 145 l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 999999987644322 22345678999999999999999999999999999999998 999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=305.52 Aligned_cols=195 Identities=27% Similarity=0.355 Sum_probs=155.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----ceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~lv~e 77 (229)
+.||+|+||+||+|.+ +|+.||||.++.... .......|+..+..++ ||||+++++++.+++ ..++|||
T Consensus 9 ~~iG~G~fG~Vy~~~~----~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~--HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKW----RGEEVAVKIFSSREE-RSWFREAEIYQTVMLR--HENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEECSSSEEEEEEE----TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEeeCCCeEEEEEEE----CCEEEEEEEECccch-hhHHHHHHHHHHhcCC--CCCCCcEEEEEEecCCCceEEEEEec
Confidence 4699999999999943 689999999974422 2222334555666777 999999999997654 4689999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|+++|+|.+++. ..++++..+..++.|+++||+|||++. .++|+||||||+|||++.++.+||+|||++.
T Consensus 82 y~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999993 356899999999999999999999752 3489999999999999999999999999997
Q ss_pred ccCCCCcc---ccccccCCccccCccccccC------CCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 153 LFPENTTH---ISTRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 153 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 76433221 12345799999999998764 3677999999999999999998877543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=326.16 Aligned_cols=199 Identities=23% Similarity=0.349 Sum_probs=178.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++ ++..+|+.||+|.+........+.+.+|+++++.++ ||||++++++|.+....++||||++|
T Consensus 163 ~~lG~G~fg~V~~~--~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 163 EELGTGAFGVVHRV--TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC--CTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred EEEeeccCeEEEEE--EECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEEEeecCC
Confidence 46999999999999 778899999999998766666778999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC--CCceEEeccccccccCCCCc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~--~~~~~l~dfg~~~~~~~~~~ 159 (229)
|+|.+++. .....+++..+..++.|++.||.|||++ ||+||||||+||+++. .+.+||+|||++..+....
T Consensus 239 g~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 239 GELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred CcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 99999982 3456799999999999999999999999 9999999999999974 4889999999998765432
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~ 363 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 2244679999999999999999999999999999999999999998765443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=306.19 Aligned_cols=194 Identities=24% Similarity=0.335 Sum_probs=163.7
Q ss_pred CccCCcccccccccceE-eccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFI-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||+|... +..+++.||+|.+.... ...++.+|+++++.+. .||||++++++|.+.+..|+||||++
T Consensus 27 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~-~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 27 DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAG-GQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTC-SBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhc-CCCCCceEEEEEEECCEEEEEEeCCC
Confidence 47999999999999543 23567899999986442 3456889999999884 39999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-CceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++ ..+++.++..++.|+++||+|||++ ||+||||||+||+++.+ +.+||+|||++........
T Consensus 104 g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 104 HESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred cccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999988 2589999999999999999999999 99999999999999866 7999999999976533211
Q ss_pred ---------------------------cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 ---------------------------HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ---------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
......+||+.|+|||++.+. .++.++|+||+||++|+|++|+.||...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 112335799999999998875 5899999999999999999999999643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=284.41 Aligned_cols=196 Identities=21% Similarity=0.368 Sum_probs=176.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++ .+..+|+.||+|.+........+.+.+|+..++.++ ||||+++++++.+.+..++||||+++
T Consensus 26 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 26 EKIGQGASGTVYTA--MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp EEEEEETTEEEEEE--EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeccCCCeEEEEE--EECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCC--CCCCCeEeEEEEECCEEEEEEECCCC
Confidence 57999999999999 677899999999998776666778899999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. ...+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++........ .
T Consensus 102 ~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 102 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 99999983 34689999999999999999999999 999999999999999999999999999877644322 2
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 221 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3446789999999999999999999999999999999999999976543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=289.59 Aligned_cols=197 Identities=28% Similarity=0.329 Sum_probs=174.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||+|+++.. .......+.+|+.+++.++ ||||+++++++.+....++||||
T Consensus 11 ~~lG~G~fg~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 11 KLLGKGTFGKVILV--REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC--CCcCcceEEEEEeCCEEEEEEeC
Confidence 57999999999999 67788999999999754 2334567889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 87 ~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 87 ANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999998 4567899999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 223456789999999999999999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=288.68 Aligned_cols=196 Identities=30% Similarity=0.431 Sum_probs=174.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+..+|+.||+|++... .....+.+.+|+++++.++ ||||+++++++.+.+..++||||+
T Consensus 21 ~~lG~G~~g~V~~a--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 21 KTIGKGNFAKVKLA--RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--HPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEeeCCCEEEEEE--EECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCEEEEEEECC
Confidence 57999999999999 77889999999999754 3344567889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++ .....+++..+..++.|+++||+|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 97 SGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp TTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999998 4557799999999999999999999999 99999999999999999999999999997654332
Q ss_pred cccccccCCccccCccccccCCCC-CcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......|++.|+|||++.+..++ .++|+||||+++|+|++|+.||.....
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 23456799999999999988775 799999999999999999999987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=292.06 Aligned_cols=199 Identities=25% Similarity=0.319 Sum_probs=170.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ +...+|+.||+|+++.. .........+|..+++.+. .||||+++++++.+....++||||
T Consensus 29 ~~lG~G~fg~V~~~--~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~-~hp~Iv~l~~~~~~~~~~~lv~E~ 105 (353)
T 3txo_A 29 RVLGKGSFGKVMLA--RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLFCCFQTPDRLFFVMEF 105 (353)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEeeCCCEEEEEE--EEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCEEEEEEeC
Confidence 57999999999999 67788999999999754 2334466788999998873 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 106 ~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~- 177 (353)
T 3txo_A 106 VNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN- 177 (353)
T ss_dssp CCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence 9999999999 4557899999999999999999999999 9999999999999999999999999998753222
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 22234567999999999999999999999999999999999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=282.49 Aligned_cols=197 Identities=28% Similarity=0.429 Sum_probs=169.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+++.||+|.+.... ....+.+.+|+..++.++ ||||+++++++.+.+..++||||
T Consensus 17 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 17 DKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS--HQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEETTEEEEEE--EETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC--BTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEccCCCEEEEEE--EECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC--CCCCceEEEeeeeCCeEEEEEeC
Confidence 57999999999999 677889999999986442 233467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.+|++||+. |++|+||||+||+++.++.++|+|||.+.......
T Consensus 93 ~~g~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 93 IEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp CCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999 4556899999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 333445678999999999999999999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=289.70 Aligned_cols=202 Identities=25% Similarity=0.389 Sum_probs=176.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.||+|.+... .....+.+.+|+++++.++ ||||+++++++.+....++||||
T Consensus 21 ~~LG~G~fG~V~~~--~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 21 RAIGKGSFGKVCIV--QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--HPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEECCTTCCEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCCEEEEEEec
Confidence 57999999999999 77888999999999754 2334567889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 97 LLGGDLRYHL----QQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CTTEEHHHHH----HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999 5567899999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccccccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCccccccccc
Q 027015 159 THISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 216 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~ 216 (229)
......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||..........+
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~ 228 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH
Confidence 2345679999999999874 4589999999999999999999999986554443333
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=297.61 Aligned_cols=200 Identities=27% Similarity=0.329 Sum_probs=174.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ++..+++.||+|+++.. .......+.+|+.+++.++ ||||+++++++.+....++||||
T Consensus 75 ~~LG~G~fG~V~~~--~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 75 KVIGRGAFGEVQLV--RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEcCCCEEEEEE--EECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEEEeC
Confidence 57999999999999 67788999999999743 2223356889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 151 ~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 151 MPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999882 34689999999999999999999999 99999999999999999999999999998765544
Q ss_pred ccccccccCCccccCccccccCC----CCCcccchhHHHHHHHHHhCCCcccCcccccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~ 213 (229)
.......+||+.|+|||++.+.. ++.++|+||||+++|+|++|+.||...+..+.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 281 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence 33345678999999999998765 78999999999999999999999987654433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=284.73 Aligned_cols=194 Identities=27% Similarity=0.432 Sum_probs=173.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ +...+|+.||+|+++... ....+.+.+|..+++.++ ||||+++++++.+....++||||
T Consensus 12 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 12 RTLGTGSFGRVHLI--RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--HPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--BTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeCCCEEEEEE--EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC--CCCCceEeEEEEeCCEEEEEEeC
Confidence 57999999999999 677889999999997542 234567888999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.+||+. |++||||||+||+++.++.++|+|||++......
T Consensus 88 ~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 88 IEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999 4556799999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....||+.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 208 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 2345789999999999999999999999999999999999999987544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=286.79 Aligned_cols=198 Identities=26% Similarity=0.333 Sum_probs=173.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++ +...+|+.||+|.++... .........|..++..+ + ||||+++++++.+....++|||
T Consensus 23 ~~lG~G~fg~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~--hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 23 KMLGKGSFGKVFLA--EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEECSSSEEEEE--EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT--CTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCC--CCCCCcEEEEEEeCCEEEEEEe
Confidence 57999999999999 667889999999997542 33446678888888877 6 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 99 ~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 99 YLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp CCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999 4556799999999999999999999999 9999999999999999999999999998754322
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
. ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 172 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (345)
T 1xjd_A 172 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred C-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH
Confidence 1 1234567999999999999999999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=297.35 Aligned_cols=202 Identities=26% Similarity=0.328 Sum_probs=175.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ +...+++.||+|+++... ......+.+|..++..++ ||||+++++++.+....++||||
T Consensus 80 ~~LG~G~fG~V~~~--~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~--hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 80 KVIGRGAFGEVAVV--KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--SKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC--TTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEeCCCEEEEEE--EEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999 667789999999997432 222345888999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 156 ~~gg~L~~~l~---~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 156 YVGGDLLTLLS---KFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHH---HccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999993 2356799999999999999999999999 99999999999999999999999999997765544
Q ss_pred ccccccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCcccccc
Q 027015 159 THISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~ 213 (229)
.......+||+.|+|||++. ...++.++|+||||+++|+|++|+.||...+..+.
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 289 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH
Confidence 43445567999999999987 45689999999999999999999999987654433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=290.08 Aligned_cols=196 Identities=26% Similarity=0.348 Sum_probs=171.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ +...+++.||+|+++... ......+.+|..+++.+. .||||+++++++.+....++||||
T Consensus 58 ~~LG~G~fG~V~~~--~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~-~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 58 RVIGRGSYAKVLLV--RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC-CCCCcCeeEEEEEECCEEEEEEEc
Confidence 57999999999999 677889999999997542 233456788999988873 299999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|..++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 135 ~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 135 VNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp CTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 9999999998 4557899999999999999999999999 9999999999999999999999999999753222
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 22234567999999999999999999999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=285.60 Aligned_cols=197 Identities=23% Similarity=0.334 Sum_probs=174.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||+||++ .+..+|+.||+|.++..... ..+.+.+|+.+++.++ ||||+++++++.+....++|
T Consensus 18 ~~LG~G~fg~V~~~--~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 18 EELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL--HPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeCcCEEEEEE--EECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC--CcCCCcEEEEEEeCCEEEEE
Confidence 46999999999999 77788999999999755322 2467899999999999 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKISDFGLS 151 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~----~~~l~dfg~~ 151 (229)
|||+++++|.+++ .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++
T Consensus 94 ~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 94 LELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999 5567899999999999999999999999 999999999999998776 7999999999
Q ss_pred cccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
....... ......||+.|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~ 224 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 8764432 223457999999999999999999999999999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=277.69 Aligned_cols=198 Identities=25% Similarity=0.424 Sum_probs=174.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++ .+..+++.||+|.+........+.+.+|+++++.++ ||||+++++++.++...++||||+++
T Consensus 16 ~~lG~G~~g~V~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 16 EVLGKGCFGQAIKV--THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE--HPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEECCSSEEEEEE--EETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ceecCCCCEEEEEE--EECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CcCcccEEEEEecCCeeEEEEEecCC
Confidence 46999999999999 777889999999987666666788999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|+++||+|||+. |++|+||||+||+++.++.++|+|||.+..........
T Consensus 92 ~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 92 GTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CBHHHHHH---HCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999993 3356799999999999999999999999 99999999999999999999999999997754322211
Q ss_pred -------------cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 -------------STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 -------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 114568999999999999999999999999999999999999997644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=285.82 Aligned_cols=195 Identities=25% Similarity=0.356 Sum_probs=174.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||+|+++... ....+.+.+|+.+++.++ ||||+++++++.+....++||||
T Consensus 47 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 47 KTLGTGSFGRVMLV--KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--FPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeecCcCcEEEEE--EECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEcCCEEEEEEcC
Confidence 57999999999999 677889999999997542 234567889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 123 ~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 123 VAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999 4456799999999999999999999999 9999999999999999999999999999876432
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.....||+.|+|||++.+..++.++|+||||+++|+|++|+.||......
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 244 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH
Confidence 23457899999999999999999999999999999999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=293.29 Aligned_cols=202 Identities=25% Similarity=0.303 Sum_probs=174.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ +...+|+.||+|+++.. .......+.+|..++..++ ||||+++++++.+.+..++||||
T Consensus 67 ~~lG~G~fG~V~~~--~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~--hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 67 KVIGRGAFSEVAVV--KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--RRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC--TTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC--CCCeeeEEEEEeeCCEEEEEEcC
Confidence 57999999999999 66789999999999743 2223456888999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 143 ~~gg~L~~~l~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 143 YVGGDLLTLLS---KFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp CCSCBHHHHHH---HHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999993 2234799999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccccccccCCccccCccccc-------cCCCCCcccchhHHHHHHHHHhCCCcccCcccccc
Q 027015 159 THISTRVAGTLGYLAPEYAI-------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~ 213 (229)
.......+||+.|+|||++. ...++.++|+|||||++|+|++|+.||...+..+.
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 33334567999999999987 35689999999999999999999999987654443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=286.22 Aligned_cols=199 Identities=24% Similarity=0.307 Sum_probs=173.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||+|+++.. .....+.+..|..++..+. .||+|+++++++.+....++||||
T Consensus 26 ~~lG~G~fg~V~~~--~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-~hp~iv~l~~~~~~~~~~~lv~E~ 102 (353)
T 2i0e_A 26 MVLGKGSFGKVMLS--ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQTMDRLYFVMEY 102 (353)
T ss_dssp EEEEEETTEEEEEE--EETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEeeCCCEEEEEE--EECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC-CCCEEeeEEEEEEcCCEEEEEEeC
Confidence 57999999999999 66778899999999754 2334467788999998873 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 103 ~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 103 VNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp CCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 9999999999 4556799999999999999999999999 99999999999999999999999999987542221
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 2234567999999999999999999999999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=282.78 Aligned_cols=194 Identities=27% Similarity=0.365 Sum_probs=171.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++ +...+|+.||+|+++... ....+.+.+|..+++.+ + ||||+++++++.+....++|||
T Consensus 15 ~~lG~G~fg~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~--hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 15 RVIGRGSYAKVLLV--RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTT--CTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEecCCeEEEEE--EECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCC--CCccCeEEEEEEeCCEEEEEEe
Confidence 57999999999999 667889999999997542 23346678899999887 6 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..++.++.|++.||+|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 91 ~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 91 YVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred CCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999998 4556799999999999999999999999 9999999999999999999999999998754222
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 1 223456799999999999999999999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=281.82 Aligned_cols=199 Identities=21% Similarity=0.330 Sum_probs=174.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-----chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++ .+..+|+.||+|++.... ....+.+.+|+.+++.++ ||||+++++++.+++..++||
T Consensus 30 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 30 EVIGKGPFSVVRRC--INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK--HPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeeCCCEEEEEE--EECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999 778899999999996432 123567899999999999 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc---eEEeccccccc
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKL 153 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~---~~l~dfg~~~~ 153 (229)
||+++++|.+.+.........+++..+..++.|++.||+|||+. |++|+||||+||+++.++. ++|+|||++..
T Consensus 106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999998865544556799999999999999999999999 9999999999999986554 99999999987
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
...... ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 183 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 183 LGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 654322 234457899999999999999999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=281.14 Aligned_cols=197 Identities=26% Similarity=0.397 Sum_probs=172.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||+|.+.... ......+.+|+..++.++ ||||+++++++.+....++||||
T Consensus 15 ~~lG~G~~g~V~~a--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 15 ETLGEGSFGKVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR--HPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEEEEEEEC
Confidence 57999999999999 778899999999997542 223467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+ +++|.+++ .....+++..+..++.|+++||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 91 ~-~g~l~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 91 A-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp C-CEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred C-CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9 78898888 4557799999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
......|++.|+|||++.+..+ +.++|+||||+++|+|++|+.||.......
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 2244578999999999988776 689999999999999999999998764433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=277.49 Aligned_cols=195 Identities=25% Similarity=0.407 Sum_probs=175.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
..||+|+||.||++ ....+|+.||||.+........+.+.+|+..++.++ ||||+++++++......++||||+++
T Consensus 51 ~~lg~G~~g~V~~a--~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 51 VKIGEGSTGIVCLA--REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred EEeccCCCeEEEEE--EECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEECCEEEEEEecCCC
Confidence 36999999999999 667789999999998776666778999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++ ....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||++........ .
T Consensus 127 ~~L~~~l-----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 127 GALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CBHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCHHHHH-----HhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 9999988 235699999999999999999999999 999999999999999999999999999877644322 2
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 244578999999999999999999999999999999999999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=286.31 Aligned_cols=198 Identities=32% Similarity=0.375 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHH-HhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVAS-MANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++ ++..+++.||+|+++... ......+.+|... ++.++ ||||+++++++.+....++|||
T Consensus 44 ~~lG~G~fg~V~~~--~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~--hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 44 KVIGKGSFGKVLLA--RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--HPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEECCTTCEEEEE--EETTTCCEEEEEEEEGGGBC-------------CCBCCCC--CTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEE--EEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC--CCCCCCEEEEEEeCCEEEEEEe
Confidence 57999999999999 677889999999997543 2233456666666 45667 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++ .....+++..++.++.|++.||+|||+. |++||||||+||+++.+|.++|+|||++......
T Consensus 120 ~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 120 YINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999998 4556789999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
. ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 245 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 245 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 2 2234567999999999999999999999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=277.58 Aligned_cols=196 Identities=23% Similarity=0.329 Sum_probs=174.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||++ .+..+|+.||+|.++..... ..+.+.+|+.+++.++ ||||+++++++.+....++|
T Consensus 17 ~~lG~G~~g~V~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 17 EELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEECCSSEEEEEE--EETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeCCCeEEEEE--EECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCCEEEEE
Confidence 46999999999999 77788999999999754322 3567899999999999 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKISDFGLS 151 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~----~~~l~dfg~~ 151 (229)
|||+++++|.+++ .....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++
T Consensus 93 ~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 93 LELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EECCCSCBHHHHH----TTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEcCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999 4567899999999999999999999999 999999999999998877 7999999999
Q ss_pred cccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
....... ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 8764322 12345689999999999989999999999999999999999999986543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=277.43 Aligned_cols=205 Identities=45% Similarity=0.703 Sum_probs=177.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++. ..+|+.||+|.+........+.+.+|++.++.++ ||||+++++++.+.+..++||||+++
T Consensus 45 ~~lg~G~~g~Vy~~~---~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 45 FLIGHGVFGKVYKGV---LRDGAKVALKRRTPESSQGIEEFETEIETLSFCR--HPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCBCSSSEEEEEE---CTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCC--CTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ceeecCCCeeEEEEE---ECCCCEEEEEEecccChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 579999999999993 3578999999988766666788999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC-cc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-TH 160 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 160 (229)
++|.+++.........+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999854433445799999999999999999999999 99999999999999999999999999987653322 22
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 214 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~ 214 (229)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....+.+..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~ 250 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH
Confidence 223455889999999999889999999999999999999999999876554443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=282.37 Aligned_cols=196 Identities=24% Similarity=0.378 Sum_probs=173.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ .+..+|+.||+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+.+..++||||+
T Consensus 35 ~~lG~G~~g~V~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~lv~e~~ 110 (362)
T 2bdw_A 35 EELGKGAFSVVRRC--VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFHYLVFDLV 110 (362)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEecCCCeEEEEE--EECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEEEEEEecC
Confidence 46999999999999 777889999999997542 334567889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC---ceEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~---~~~l~dfg~~~~~~~ 156 (229)
++++|.+++ .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++.....
T Consensus 111 ~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 111 TGGELFEDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CSCBHHHHH----TTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred CCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999998 4567799999999999999999999999 999999999999997544 599999999976643
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 32 22345789999999999998999999999999999999999999986543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=289.74 Aligned_cols=197 Identities=22% Similarity=0.334 Sum_probs=172.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+..+|+.+|+|.+.... ....+.+.+|+++++.++ ||||+++++++.+.+..++||||+
T Consensus 17 ~~LG~G~fg~V~~~--~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 17 EELGKGAFSVVRRC--VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK--HPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEC--CEEEEE--EETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC--BTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeccCCCeEEEEE--EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CcCCCeEEEEEEECCEEEEEEEeC
Confidence 57999999999999 778899999999997553 334467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc---CCCceEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~---~~~~~~l~dfg~~~~~~~ 156 (229)
++++|.+.+ .....+++..+..++.|+++||.|||+. |++||||||+||+++ +++.++|+|||++.....
T Consensus 93 ~gg~L~~~i----~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 93 TGGELFEDI----VAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp BCCBHHHHH----HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred CCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999998 4567799999999999999999999999 999999999999998 567899999999976644
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 322 22346799999999999999999999999999999999999999977553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=292.39 Aligned_cols=200 Identities=24% Similarity=0.307 Sum_probs=176.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ +...+|+.||+|+++... ....+.+.+|+.+++.++ ||||+++++++.+....++||||
T Consensus 191 ~~LG~G~fG~Vy~a--~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 191 RVLGRGGFGEVFAC--QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--SRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeCCCeEEEEE--EECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC--CCCEeeEEEEEeeCCEEEEEEEe
Confidence 46999999999999 667889999999997542 233467889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++|++|.+++.........+++..+..++.|++.||.|||+. |++||||||+||+++.+|.++|+|||++.......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 999999999854444456799999999999999999999999 99999999999999999999999999998764432
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 344 ~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 344 T-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp C-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred c-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 2 2234579999999999999999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=276.49 Aligned_cols=194 Identities=25% Similarity=0.373 Sum_probs=152.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .+..+|+.||+|.+... ......+|+..++.+. .||||+++++++.+....++||||+++
T Consensus 17 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~-~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKC--VHKKSNQAFAVKIISKR---MEANTQKEITALKLCE-GHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEE--EETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEE--EECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhc-CCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 57999999999999 77788999999999743 3456778999999886 499999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC---ceEEeccccccccCCCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGLSKLFPENT 158 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~---~~~l~dfg~~~~~~~~~ 158 (229)
++|.+++ .....+++..+..++.|++.+|+|||+. |++|+||||+||+++.++ .++|+|||++.......
T Consensus 91 ~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 91 GELFERI----KKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CBHHHHH----HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 9999999 4567899999999999999999999999 999999999999998665 79999999997654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 164 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 164 Q-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred C-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 2 2244567999999999999999999999999999999999999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=278.50 Aligned_cols=199 Identities=24% Similarity=0.348 Sum_probs=163.2
Q ss_pred CccCCcccccccccceE-eccCCcEEEEEEeeccc----chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI-RLQDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~-~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++... ...+|+.||+|+++... ......+.+|+.+++.++ ||||+++++++.+.+..++||
T Consensus 23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK--HPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC--CTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC--CCCccceeEEEEcCCEEEEEE
Confidence 57999999999998432 13689999999997542 233456788999999999 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++ .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 101 e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 101 EYLSGGELFMQL----EREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp ECCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred eCCCCCcHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999998 4556789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 21 122345789999999999999999999999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=279.61 Aligned_cols=197 Identities=28% Similarity=0.447 Sum_probs=170.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||++ .+..+++.||+|++.... ....+.+.+|+.+++.++ ||||+++++++.+.+..++||||++
T Consensus 13 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 13 QTLGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECC-------CHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eEEecCCCEEEEEE--EECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC--CCCCCeEEEEEecCCeEEEEEEcCC
Confidence 57999999999999 777889999999997543 233467889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC-c
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-T 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 159 (229)
+++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++..+.... .
T Consensus 89 ~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 89 GGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999998 5667799999999999999999999999 99999999999999999999999999997653222 2
Q ss_pred cccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......|++.|+|||++.+..+ +.++|+||||+++|+|++|+.||....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 22345678999999999987775 778999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=280.83 Aligned_cols=205 Identities=25% Similarity=0.400 Sum_probs=172.9
Q ss_pred CccCCcccccccccceEe-----ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-----LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||.||++++.. ..++..||+|.++... ....+.+.+|+++++.+ + ||||+++++++.+.+..++
T Consensus 87 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCC--CTTBCCEEEEECSSSSCEE
T ss_pred eEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcC--CCCEeeEEEEEccCCCEEE
Confidence 469999999999996542 2456789999997553 33457789999999999 6 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc
Q 027015 75 VYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~ 142 (229)
||||+++++|.+++..... ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 241 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 241 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCC
Confidence 9999999999999954321 124588999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 143 PKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 143 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
++|+|||++........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||......
T Consensus 242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999986643322 12233456788999999999999999999999999999999 99999875543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=291.86 Aligned_cols=197 Identities=28% Similarity=0.331 Sum_probs=164.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+|+.||+|+++.. .......+.+|+.+++.++ ||||+++++++.+.+..++||||
T Consensus 154 ~~lG~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 154 KLLGKGTFGKVILV--KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEHHHHC-------------CCCCCS--CTTSCCEEEEEEETTEEEEEECC
T ss_pred EEEeeCcCEEEEEE--EEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC--CCeEeeEEEEEeeCCEEEEEEee
Confidence 57999999999999 77889999999999754 2334466788999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+ . |++||||||+||+++.++.++|+|||++......
T Consensus 230 ~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 230 ANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CSSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999998 455689999999999999999999998 8 9999999999999999999999999998754332
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. .......||+.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 2 223446799999999999999999999999999999999999999987543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=277.58 Aligned_cols=201 Identities=41% Similarity=0.748 Sum_probs=175.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++. ..+|+.||+|.+.... ......+.+|+++++.++ ||||+++++++.+....++||||++
T Consensus 36 ~~lg~G~~g~V~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 110 (326)
T 3uim_A 36 NILGRGGFGKVYKGR---LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPYMA 110 (326)
T ss_dssp TEEECCSSSEEEEEC---CSSSCCEEEEECCC-----CCCHHHHHHHGGGTCC--CTTBCCCCEEECCSSCCEEEEECCT
T ss_pred eeEecCCCcEEEEEE---ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc--CCCccceEEEEecCCceEEEEEecc
Confidence 579999999999993 4578999999997553 223347899999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++.........+++..+..++.|++.||++||+...+|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (326)
T 3uim_A 111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190 (326)
T ss_dssp TCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc
Confidence 99999999655455567999999999999999999999976668999999999999999999999999999876544444
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||+.
T Consensus 191 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence 44556689999999999988899999999999999999999999963
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=280.03 Aligned_cols=196 Identities=23% Similarity=0.325 Sum_probs=169.2
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.||+|+||.||++ ....+|+.||+|+++.......+.+.+|+++++.++ ||||+++++++.+.+..++||||++++
T Consensus 96 ~lG~G~~g~Vy~a--~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 96 ILGGGRFGQVHKC--EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD--HANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp ECC-----CEEEE--EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEecCcCEEEEEE--EEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 5999999999999 677889999999998766566778999999999999 999999999999999999999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE--cCCCceEEeccccccccCCCCcc
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL--DQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+|.+++. .....+++..+..++.|++.||+|||+. |++|+||||+||++ +.++.++|+|||++........
T Consensus 172 ~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRII---DESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHH---HTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 9999883 3445799999999999999999999999 99999999999999 5677899999999987643322
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2334689999999999988899999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=282.51 Aligned_cols=197 Identities=21% Similarity=0.309 Sum_probs=174.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .+..+|+.+|+|.+..........+.+|+++++.++ ||||+++++++.+....++||||+++
T Consensus 57 ~~LG~G~~g~Vy~~--~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 57 EELGSGAFGVVHRC--VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--STTBCCEEEEEECSSEEEEEEECCCC
T ss_pred EEEecCCCEEEEEE--EECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCC--CcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 46999999999999 777889999999998666556678899999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc--CCCceEEeccccccccCCCCc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~--~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++|.+++. .....+++..+..++.|++.||+|||+. |++|+||||+||+++ .++.++|+|||++........
T Consensus 133 g~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 133 GELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999983 3345799999999999999999999999 999999999999997 456799999999987644322
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....||+.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 255 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence 2334689999999999999999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=277.13 Aligned_cols=201 Identities=18% Similarity=0.238 Sum_probs=173.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||++ .+..+|+.||||.+..... ...+.+|+++++.+ . ||||+++++++.+....++||||+
T Consensus 15 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~--h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 15 KKIGCGNFGELRLG--KNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGS--GDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp EECCC-CTTSEEEE--EETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCS--CTTSCCEEEEEEETTEEEEEEECC-
T ss_pred EEeeccCCceEEEE--EECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhC--CCCCCEEEEEEecCCccEEEEEeC-
Confidence 57999999999999 6778999999999875432 34688999999999 6 999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc-----eEEeccccccccC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-----PKISDFGLSKLFP 155 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~-----~~l~dfg~~~~~~ 155 (229)
+++|.+++. .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++. ++|+|||++....
T Consensus 88 ~~~L~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 GPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 999999983 2256899999999999999999999999 9999999999999998887 9999999998754
Q ss_pred CCCcc------ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccccccc
Q 027015 156 ENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 215 (229)
Q Consensus 156 ~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~ 215 (229)
..... ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~ 227 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence 33221 1245678999999999999999999999999999999999999999765444333
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=276.87 Aligned_cols=196 Identities=15% Similarity=0.267 Sum_probs=173.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .+..+++.+|+|.+... ......+.+|+.+++.++ ||||+++++++.+....++||||+++
T Consensus 11 ~~lG~G~~g~Vy~~--~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 11 EDLGRGEFGIVHRC--VETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIAR--HRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSC--CTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEecCCCeEEEEE--EECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCC--CCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 56999999999999 77788999999999744 344567889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC--CCceEEeccccccccCCCCc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~--~~~~~l~dfg~~~~~~~~~~ 159 (229)
++|.+++. .....+++..+..++.|++.||+|||+. |++|+||||+||+++. ++.++|+|||.+.......
T Consensus 86 ~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 86 LDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 99999982 3345799999999999999999999999 9999999999999986 7899999999998764432
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 22345689999999999988889999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=273.67 Aligned_cols=201 Identities=23% Similarity=0.374 Sum_probs=164.4
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
++.||+|+||+||++ .+..+|+.||+|.++... ....+.+.+|+++++.++ ||||+++++++.+++..++||||+
T Consensus 10 ~~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 10 LEKLGNGTYATVYKG--LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK--HENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp ---------CEEEEE--ECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC--BTTBCCEEEEECCTTEEEEEEECC
T ss_pred eeEECCCCCEEEEEE--EECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC--CCCcceEEEEEEECCeEEEEEEec
Confidence 367999999999999 667789999999997653 333467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 80 PNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 80 ~~~sL~~~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
+ ++|.+++.... .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+......
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 7 58999885432 1224689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||.....
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 22 2234568999999999876 4689999999999999999999999987554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=280.06 Aligned_cols=201 Identities=15% Similarity=0.105 Sum_probs=166.4
Q ss_pred CccCCcccccccccce---EeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC-CCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPF---IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~-~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++.+ .+..+++.||+|.++.... ..+..|++.++.+... |+||+++++++...+..++|||
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 3699999999999943 1456789999999975433 3455566665555422 8999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-----------CCceEE
Q 027015 78 YMPNNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-----------NFNPKI 145 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-----------~~~~~l 145 (229)
|+++++|.+++..... ....+++..+..++.|++.||+|||+. |++||||||+||+++. ++.++|
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEE
Confidence 9999999999954322 456799999999999999999999999 9999999999999988 899999
Q ss_pred eccccccccCCC-CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 146 SDFGLSKLFPEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 146 ~dfg~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
+|||++..+... .........||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 999999764321 222334567999999999999999999999999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=286.27 Aligned_cols=196 Identities=27% Similarity=0.413 Sum_probs=173.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||||+++... ......+.+|+.+++.++ ||||+++++++.+....++||||
T Consensus 22 ~~LG~G~fg~V~~a--~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 22 DTLGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR--HPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEECCSSSCEEEE--EETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEeC
Confidence 57999999999999 777899999999997542 223467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 98 VSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999 5567899999999999999999999999 99999999999999999999999999998764432
Q ss_pred ccccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....+|++.|+|||++.+..+ +.++|+||||+++|+|++|+.||.....
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 2244578999999999988765 6899999999999999999999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=267.90 Aligned_cols=197 Identities=27% Similarity=0.426 Sum_probs=171.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ...++..||+|.++.... ..+.+.+|++.++.++ ||||+++++++.+....++||||+++
T Consensus 14 ~~lg~G~~g~V~~~---~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 14 KELGSGQFGVVKLG---KWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLS--HPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp EEEEEETTEEEEEE---EETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred eeeccCCCceEEEE---EecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCceEEEEEccCC
Confidence 57999999999998 334677899999975433 3467899999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..++.++.|++++|++||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 88 ~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 88 GCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CBHHHHHH---HHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CcHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 99999983 3345699999999999999999999999 99999999999999999999999999998765544333
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 344456778999999999899999999999999999998 9999986543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=276.87 Aligned_cols=198 Identities=27% Similarity=0.404 Sum_probs=164.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCce----EE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR----IL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~----~l 74 (229)
+.||+|+||.||++ .+..+++.||+|+++.... .....+.+|+..++.++ ||||+++++++...... ++
T Consensus 18 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 18 EILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC--CTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEccCCCEEEEEE--EECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC--CCCcceEEEeeeccCCCCcccEE
Confidence 57999999999999 6778899999999976532 23357889999999998 99999999998765443 89
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
||||+++++|.+++ .....+++..+..++.|++.+|+|||+. |++|+||||+||+++.++.++|+|||.+...
T Consensus 94 v~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 94 VMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 99999999999999 4556799999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc--cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 43321 122335689999999999999999999999999999999999999987543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=272.08 Aligned_cols=198 Identities=31% Similarity=0.500 Sum_probs=162.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++++ +|+.||+|++.... ....+.+.+|+++++.++ ||||+++++++.+.+..++||||+
T Consensus 43 ~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 43 EKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR--HPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp EEEEECSSEEEEEEEE----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSTTCCEEEEECC
T ss_pred eEeecCCCeEEEEEEE----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCceEEEEecC
Confidence 4699999999999932 67899999997553 334467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
++++|.+++... .....+++..+..++.|+++||++||+. | ++|+||||+||+++.++.++|+|||++......
T Consensus 117 ~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 117 SRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp TTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999422 1223499999999999999999999999 8 999999999999999999999999998754332
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 123345689999999999999999999999999999999999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=268.60 Aligned_cols=197 Identities=29% Similarity=0.483 Sum_probs=171.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .. .+++.||+|.+..... ..+.+.+|++.++.++ ||||+++++++.+.+..++||||+++
T Consensus 16 ~~lg~G~~g~V~~~--~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 16 QEIGSGQFGLVHLG--YW-LNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp EEEEECSSCEEEEE--EE-TTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred heecCCCccEEEEE--Ee-cCCCeEEEEEeccccc-CHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCceEEEEEeCCC
Confidence 57999999999999 33 3578899999975432 3467899999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..++.++.|++++|++||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 90 ~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 90 GCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHH---hcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999983 3445799999999999999999999999 99999999999999999999999999998664433333
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 344556778999999999999999999999999999999 9999987544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=296.48 Aligned_cols=199 Identities=24% Similarity=0.307 Sum_probs=174.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+++.||||+++.. .....+....|..++..+. .||+|+++++++.+....|+||||
T Consensus 347 ~~LG~G~fG~V~~~--~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~-~~~~i~~l~~~~~~~~~~~lV~E~ 423 (674)
T 3pfq_A 347 MVLGKGSFGKVMLS--ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQTMDRLYFVMEY 423 (674)
T ss_dssp EESSBTTTBCEEEE--EESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT-CCTTBCCEEEECBCSSEEEEEEEC
T ss_pred EEEccCCCEEEEEE--EECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEEEeCCEEEEEEeC
Confidence 47999999999999 66778999999999754 2334567888999988874 399999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 424 ~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 424 VNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp CCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred cCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 9999999999 4556799999999999999999999999 99999999999999999999999999997643222
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~ 548 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH
Confidence 2234567999999999999999999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=272.08 Aligned_cols=198 Identities=23% Similarity=0.335 Sum_probs=166.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++ .+..+++.||||.+..........+.+|++.+.++. .||||+++++++.+.+..++||||+++
T Consensus 19 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (316)
T 2ac3_A 19 DVLGEGAHARVQTC--INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-GHRNVLELIEFFEEEDRFYLVFEKMRG 95 (316)
T ss_dssp CCCCCCSSEEEEEE--ECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ceecCCceEEEEEE--EEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence 46999999999999 667789999999998665556678899999998853 299999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc---eEEeccccccccCCCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPENT 158 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~---~~l~dfg~~~~~~~~~ 158 (229)
++|.+++ .....+++..+..++.|++.||++||+. |++|+||||+||+++.++. ++|+|||++.......
T Consensus 96 ~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 96 GSILSHI----HKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred CcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999 4456799999999999999999999999 9999999999999987776 9999999987653211
Q ss_pred ------ccccccccCCccccCcccccc-----CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 ------THISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ------~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 111223458999999999875 557899999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=268.07 Aligned_cols=192 Identities=21% Similarity=0.360 Sum_probs=165.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+..+|+.||+|.++... ......+.+|+.+++.++ ||||+++++++.++...++||||+
T Consensus 8 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 8 EKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEecCCCCeEEEEE--EECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC--CCCEeeEEeEEEeCCEEEEEEecC
Confidence 57999999999999 777889999999997553 333467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++ ++.+.+. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+........
T Consensus 84 ~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 84 DQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred CC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 76 5555542 4467899999999999999999999999 999999999999999999999999999987643322
Q ss_pred cccccccCCccccCccccccCC-CCCcccchhHHHHHHHHHhCCCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAV 205 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~pf 205 (229)
......+|+.|+|||++.+.. ++.++|+||||+++|+|++|..||
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 234456899999999988765 799999999999999999988875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=289.80 Aligned_cols=197 Identities=28% Similarity=0.356 Sum_probs=173.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+|+.||+|.+... .......+.+|+++++.++ ||||+++++++.+....++||||
T Consensus 190 ~~LG~G~fG~Vy~a--~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 190 RVLGKGGFGEVCAC--QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeCCCEEEEEE--EECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC--CCCEeeEEEEEeeCCEEEEEEEc
Confidence 57999999999999 67789999999999754 2334466889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++|++|.+++... ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 266 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 266 MNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999988321 234599999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. .....||+.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 341 ~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 341 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp C--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred c--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 2 233579999999999999889999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=277.50 Aligned_cols=195 Identities=24% Similarity=0.344 Sum_probs=160.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++ ++..+++.||+|.+.... .....+.+|+..++.++ ||||+++++++.+....++||||+++
T Consensus 26 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 26 KDIGSGNFGVARLM--RDKLTKELVAVKYIERGA-AIDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp EEESSSTTSSEEEE--EETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeccCCCEEEEEE--EECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCC--CCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 57999999999999 777899999999997443 23367889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc--eEEeccccccccCCCCc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDFGLSKLFPENTT 159 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~ 159 (229)
++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++. ++|+|||++......
T Consensus 101 ~~L~~~l----~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 101 GELYERI----CNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 9999998 4556799999999999999999999999 9999999999999987665 999999998743222
Q ss_pred cccccccCCccccCccccccCCCCCc-ccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRK-SDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.......||+.|+|||++.+..++.+ +|+||||+++|+|++|+.||.....
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 12234568999999999988887655 8999999999999999999986543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=277.65 Aligned_cols=200 Identities=23% Similarity=0.257 Sum_probs=172.1
Q ss_pred CccCCc--ccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPI--RLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G--~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+| +||+||++ .+..+|+.||+|.++... ....+.+.+|+.+++.++ ||||+++++++.+.+..++|||
T Consensus 31 ~~lG~G~~~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 31 TVIGKGFEDLMTVNLA--RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEETTTTEEEEEE--EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEE
T ss_pred ecccCCcCCceEEEEE--EEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC--CCCCCcEeEEEEECCEEEEEEE
Confidence 579999 99999999 777789999999998653 334467888999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++.. .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||.+......
T Consensus 107 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 107 FMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp CCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred ccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999832 2236699999999999999999999999 9999999999999999999999999987654221
Q ss_pred ------CccccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 ------TTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ------~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.........|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 1112233468899999999987 6789999999999999999999999986543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=270.34 Aligned_cols=198 Identities=21% Similarity=0.319 Sum_probs=166.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---------- 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~---------- 70 (229)
+.||+|+||.||++ ++..+|+.||||.++... ....+.+.+|+++++.++ ||||+++++++.+..
T Consensus 12 ~~lG~G~~g~V~~a--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 12 QCMGRGGFGVVFEA--KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEECC-CSEEEEE--EETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC--CTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred eEecCCCCeEEEEE--EEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC--CCCEeeEEEEEEEeccchhhhhhhh
Confidence 57999999999999 677789999999997553 334578999999999999 999999999986543
Q ss_pred -----------------------------------------------ceEEEEEccCCCCHHHHHhhhhccccCCCHHHH
Q 027015 71 -----------------------------------------------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 103 (229)
Q Consensus 71 -----------------------------------------------~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~ 103 (229)
..++||||+++++|.+++... ......++..+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~ 166 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREHGVC 166 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhhHHH
Confidence 278999999999999999543 23345677789
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc-----------cccccccCCcccc
Q 027015 104 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-----------HISTRVAGTLGYL 172 (229)
Q Consensus 104 ~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~~ 172 (229)
+.++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++........ .......||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 99999999999999999 999999999999999999999999999987654321 1223356899999
Q ss_pred CccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 173 aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
|||++.+..++.++|+||||+++|+|++|..|+..
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~ 278 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence 99999999999999999999999999999887753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=270.82 Aligned_cols=198 Identities=24% Similarity=0.378 Sum_probs=166.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+ .+|+.||+|.++... ......+.+|+++++.++ ||||+++++++.+....++||||+
T Consensus 27 ~~lG~G~~g~V~~~--~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 27 EKVGEGTYGVVYKA--KD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--HPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEECSSCEEEEE--EE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCC--CTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhccCCCCeEEEEE--EE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcC--CCCEeeeeeEEccCCEEEEEEcCC
Confidence 57999999999999 33 468999999997543 223467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++ +|.+.+. .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+........
T Consensus 102 ~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 102 EK-DLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp SE-EHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CC-CHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 75 7777773 4456699999999999999999999999 999999999999999999999999999987643322
Q ss_pred cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||......+
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 2234568999999999876 568999999999999999999999998765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=274.68 Aligned_cols=202 Identities=28% Similarity=0.447 Sum_probs=168.6
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++.+... ..+..||||.++.. .....+.+.+|+.+++.++ ||||+++++++.+.+..++||||+
T Consensus 55 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD--HPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECGGGCCEEEEECC
T ss_pred eEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCCccEEEeeCC
Confidence 4699999999999944221 23446999999865 3444567899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|++.||.+||+. |++|+||||+||+++.++.++|+|||++........
T Consensus 133 ~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 133 ENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp TTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 9999999983 3446799999999999999999999999 999999999999999999999999999987644322
Q ss_pred c--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 160 H--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 160 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
. ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 261 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 1 1222345678999999998999999999999999999999 99999775443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=279.75 Aligned_cols=206 Identities=26% Similarity=0.342 Sum_probs=171.1
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||++.+. +..+++.||||.++.. .......+.+|+.+++.++ ||||+++++++.+....++|||
T Consensus 77 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC--CCCCCeEEEEEecCCCCEEEEE
Confidence 46999999999999543 4457889999999754 3444567889999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC---ceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~---~~~l~dfg~~ 151 (229)
|+++++|.+++.... .....+++..++.++.|+++||+|||+. |++||||||+||+++.++ .++|+|||++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 999999999995432 1224689999999999999999999999 999999999999998555 4999999998
Q ss_pred cccCCC-CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 152 KLFPEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 152 ~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
...... .........+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~ 294 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 754221 1122334567889999999999999999999999999999998 999998765433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=268.97 Aligned_cols=195 Identities=27% Similarity=0.377 Sum_probs=164.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--------------------------hhhHHHHHHHHHHhhhccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--------------------------QGEKEFMSEVASMANVNVC 55 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~~~~l~~~ 55 (229)
+.||+|+||.||++ .+..+|+.||+|++..... ...+.+.+|+++++.++
T Consensus 19 ~~lG~G~~g~Vy~a--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 94 (298)
T 2zv2_A 19 DEIGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD-- 94 (298)
T ss_dssp EEEEC--CCEEEEE--EETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC--
T ss_pred eEEeecCCEEEEEE--EECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC--
Confidence 57999999999999 7788899999999975421 12356889999999999
Q ss_pred CCcccccceEEEc--CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCC
Q 027015 56 HENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133 (229)
Q Consensus 56 ~~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ 133 (229)
||||+++++++.+ ....++||||+++++|.++. ....+++..+..++.|++.||++||+. |++|+||||+
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999986 55789999999999998765 446799999999999999999999999 9999999999
Q ss_pred CEEEcCCCceEEeccccccccCCCCccccccccCCccccCccccccCC---CCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 134 ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
||+++.++.++|+|||++........ ......|++.|+|||++.+.. .+.++|+||||+++|+|++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999987644322 223457899999999988665 3678999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=265.02 Aligned_cols=194 Identities=22% Similarity=0.312 Sum_probs=173.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .+..++..+|+|.+........+.+.+|+++++.++ ||||+++++++.+....++||||+++
T Consensus 15 ~~lg~G~~g~V~~~--~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 15 NTIGRGSWGEVKIA--VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD--HPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eEEeecCCEEEEEE--EeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCeEEEEEeccCC
Confidence 57999999999999 677788999999998766666788999999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccccCCCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~---~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++|.+++ .....+++..+..++.|++.+|++||+. |++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 91 ~~L~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 91 GELFERV----VHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred CcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999988 4556799999999999999999999999 99999999999999 788899999999987764332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+. ++.++|+||||+++|+|++|+.||....
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 22345689999999988654 8999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=278.73 Aligned_cols=199 Identities=27% Similarity=0.378 Sum_probs=160.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC--ceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--~~~lv~e 77 (229)
+.||+|+||.||++ .+..+|+.||+|.+... .....+...+|+..++.+. .||||+++++++...+ ..++|||
T Consensus 15 ~~lG~G~~g~V~~~--~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~~~~~~lv~e 91 (388)
T 3oz6_A 15 KKLGKGAYGIVWKS--IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-GHENIVNLLNVLRADNDRDVYLVFD 91 (388)
T ss_dssp EC-------CEEEE--EETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECTTSSCEEEEEE
T ss_pred EEeeeCCCeEEEEE--EECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc-CCCCCCeeeeEEecCCCCEEEEEec
Confidence 57999999999999 77889999999998643 3445577889999999986 4999999999997544 6799999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|++ ++|.+++. ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..+...
T Consensus 92 ~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 92 YME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred ccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 996 58988882 35789999999999999999999999 9999999999999999999999999999765321
Q ss_pred C--------------------ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 158 T--------------------THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 158 ~--------------------~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 111234578999999999886 678999999999999999999999998765443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=269.09 Aligned_cols=197 Identities=22% Similarity=0.297 Sum_probs=168.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC--ceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+|+.||+|+++... ....+.+.+|+++++.++ ||||+++++++.... ..++||||
T Consensus 15 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 15 DILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--HKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEecCCCCeEEEEE--EECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC--CCCcceEEEEeecCCCceEEEEEeC
Confidence 46999999999999 667789999999997543 334567789999999999 999999999998665 67999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----cCCCceEEecccccccc
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF 154 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~----~~~~~~~l~dfg~~~~~ 154 (229)
+++++|.+++... .....+++..++.++.|+++||+|||+. |++|+||||+||++ +.++.++|+|||.+...
T Consensus 91 ~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 91 CPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999432 2223499999999999999999999999 99999999999999 77778999999999876
Q ss_pred CCCCccccccccCCccccCccccc--------cCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAI--------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..... .....+++.|+|||++. +..++.++|+||||+++|+|++|+.||...
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 44322 23456899999999886 467899999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=266.86 Aligned_cols=196 Identities=31% Similarity=0.447 Sum_probs=170.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+++.||+|.+.... ......+.+|+..++.++ ||||+++++++.+....++||||
T Consensus 15 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 15 RPLGKGKFGNVYLA--REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEecCCCeEEEEE--EEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC--CCCCcchhheEecCCEEEEEEec
Confidence 56999999999999 777889999999996442 223467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 91 ~~~~~l~~~l----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 91 APLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp CTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 9999999998 4556799999999999999999999999 9999999999999999999999999988654322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 213 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence 223456899999999999999999999999999999999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=270.54 Aligned_cols=196 Identities=23% Similarity=0.347 Sum_probs=173.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||++ .+..+|+.||+|.++..... ..+.+.+|+.+++.++ ||||+++++++.+....++|
T Consensus 18 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 18 EELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL--HHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEE
T ss_pred eEeeecCCEEEEEE--EECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC--CCCcceEEEEEecCCEEEEE
Confidence 57999999999999 67788999999999754322 3467899999999999 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKISDFGLS 151 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~----~~~l~dfg~~ 151 (229)
|||+++++|.+++ .....+++..+..++.|++.||++||+. |++|+||+|+||+++.++ .++|+|||.+
T Consensus 94 ~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 94 LELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp ECCCCSCBHHHHH----HTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999 4566789999999999999999999999 999999999999999887 7999999999
Q ss_pred cccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........ .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 87644322 2345689999999999999999999999999999999999999986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=276.12 Aligned_cols=193 Identities=24% Similarity=0.362 Sum_probs=166.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++ .+..+|+.||+|.+..... ...+|++.+.++. .||||+++++++.+....++||||+++
T Consensus 28 ~~lG~G~~g~V~~~--~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~-~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 28 EDIGVGSYSVCKRC--IHKATNMEFAVKIIDKSKR----DPTEEIEILLRYG-QHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEETTTC----CCHHHHHHHHHHT-TSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeCCCEEEEEE--EECCCCCEEEEEEEEcccC----ChHHHHHHHHHhc-CCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 57999999999999 7778899999999975432 3356788887773 299999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC----CceEEeccccccccCCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN----FNPKISDFGLSKLFPEN 157 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~----~~~~l~dfg~~~~~~~~ 157 (229)
++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||++..+ +.++|+|||++......
T Consensus 101 g~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 101 GELLDKI----LRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CBHHHHH----HTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999998 4567799999999999999999999999 99999999999998533 34999999999876443
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.. ......+|+.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 174 NG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp TC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred CC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 22 2344678999999999988888999999999999999999999998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=267.79 Aligned_cols=197 Identities=27% Similarity=0.439 Sum_probs=168.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ...++..||+|.++.... ..+.+.+|++.++.++ ||||+++++++.+.+..++||||+++
T Consensus 30 ~~lg~G~~g~V~~~---~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 30 KELGTGQFGVVKYG---KWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLS--HEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp EECC---CEEEEEE---EETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred hhcCCCCCceEEEE---EEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCC--CCCEeeEEEEEecCCCeEEEEeccCC
Confidence 57999999999998 334677899999975432 3467889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 104 ~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 104 GCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CBHHHHHH---CGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 99999983 3356799999999999999999999999 99999999999999999999999999998664433222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 333456778999999999999999999999999999998 9999987543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=267.25 Aligned_cols=201 Identities=27% Similarity=0.381 Sum_probs=175.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....++..||+|.+... ....+.+.+|++.++.++ ||||+++++++.+....++||||+++
T Consensus 19 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~~ 93 (288)
T 3kfa_A 19 HKLGGGQYGEVYEG--VWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYIITEFMTY 93 (288)
T ss_dssp EESGGGTTCSEEEE--EEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred eecCCCCceeEEEe--EecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 46999999999999 66778899999999743 345578899999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++.. .....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 94 ~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 94 GNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp EEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred CcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 999999832 2345699999999999999999999999 99999999999999999999999999998765444333
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~ 220 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 344556788999999999999999999999999999999 999998765443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=281.41 Aligned_cols=201 Identities=25% Similarity=0.333 Sum_probs=171.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ....+++.||+|.++... ....+.+.+|+++++.++ ||||+++++++.+....++||||++
T Consensus 120 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 120 EQIGRGNFGEVFSG--RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC--CTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEeccCCCCeEEEE--EEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEecCCCcEEEEEcCC
Confidence 46999999999999 566789999999997543 233467889999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++. .....+++..+..++.|+++||+|||+. |++|+||+|+||+++.++.++|+|||++.........
T Consensus 196 ~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 196 GGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp TCBHHHHHH---HHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999983 3345689999999999999999999999 9999999999999999999999999998764332211
Q ss_pred c-cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 161 I-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 161 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
. .....+++.|+|||.+.+..++.++|+||||+++|++++ |+.||.......
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~ 323 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 112234678999999998889999999999999999998 999998765433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=268.88 Aligned_cols=197 Identities=22% Similarity=0.260 Sum_probs=162.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+++.||+|++..... ...+.+.+|+..++.++ ||||+++++++.+++..++++||
T Consensus 40 ~~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 40 RLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ--EPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEECSSSEEEEE--EETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEcCCCCeeEEEE--EEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC--CCCeeEEEEEEeeCCeEEEEEEe
Confidence 57999999999999 6677899999999975422 22367889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 116 ~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 116 INGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CCCEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred cCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999 4456799999999999999999999999 99999999999999999999999999987664433
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 333344568999999999999899999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=267.09 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=164.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+ .+|+.||+|.+..... .....+.+|+++++.++ ||||+++++++.+.+..++||||+
T Consensus 8 ~~lg~G~~g~V~~~--~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 8 EKIGEGTYGVVYKA--QN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp EEEEEETTEEEEEE--EE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC--CTTBCCEEEEEECSSCEEEEEECC
T ss_pred hhcccCCCEEEEEE--Ec-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC--CCCEeeeeeEEccCCeEEEEEEec
Confidence 57999999999999 44 6789999999975532 22367889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++ +|.+++. .....+++..+..++.|+++||++||+. |++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 83 DQ-DLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp SE-EHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred CC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 75 8888883 3446799999999999999999999999 999999999999999999999999999876543222
Q ss_pred cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2233467999999999876 458999999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=263.30 Aligned_cols=198 Identities=27% Similarity=0.400 Sum_probs=152.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+|+.||+|.+.... ....+.+.+|+..++.++ ||||+++++++.+.+..++||||
T Consensus 17 ~~lg~G~~g~Vy~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 17 NLLGKGSFAGVYRA--ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK--HPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeecCCCceEEEEE--EEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC--CCCeEeEEEEEccCCeEEEEEec
Confidence 56999999999999 667789999999997542 222467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..++.++.|+++||.+||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 93 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 93 CHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred CCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999983 3346799999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 2 12335688999999999988899999999999999999999999986543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=269.75 Aligned_cols=199 Identities=21% Similarity=0.282 Sum_probs=168.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+..+|+.||+|.+..... ...+.+.+|+++++.++ ||||+++++++.+.+..++||||+
T Consensus 9 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 9 GKIGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--HPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeecCCeEEEEE--EeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC--CCCccchhheeecCCeEEEEEEeC
Confidence 57999999999999 6777899999999865432 23466789999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++ .....+++..+..++.|+++||++||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 ~~~~l~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 85 DHTVLHELD----RYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp SEEHHHHHH----HTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCchHHHHH----hhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999887 5567799999999999999999999999 999999999999999999999999999977643322
Q ss_pred cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 160 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 2234568999999999876 678999999999999999999999998765443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=264.45 Aligned_cols=198 Identities=26% Similarity=0.377 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||++ ....++..+|+|.+.... ....+.+.+|+++++.++ ||||+++++++.+....++||||++
T Consensus 28 ~~lg~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 28 RKLGSGAFGDVHLV--EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD--HPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEECCCS
T ss_pred ceeccCCCeEEEEE--EEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC--CchHHhHHHheecCCeEEEEEEeCC
Confidence 57999999999999 677889999999997653 334578899999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccccCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~---~~~~~~~l~dfg~~~~~~~~ 157 (229)
+++|.+++.........+++..+..++.|++.||++||+. |++|+||+|+||++ +.++.++|+|||.+......
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 9999999866555667899999999999999999999999 99999999999999 45678999999999765432
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|+|||.+. ..++.++|+||||+++|+|++|+.||....
T Consensus 181 ~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 181 E--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 2 223456899999999875 568899999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=285.12 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=174.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....++..||||.++... ...+.+.+|+++++.++ ||||+++++++.+....++||||+++
T Consensus 226 ~~lG~G~fg~Vy~~--~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 226 HKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp EESGGGTTSSEEEE--EEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEecCCCCeEEEEE--EEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcC--CCCEeeEEEEEecCCcEEEEEEccCC
Confidence 46999999999999 556678999999997543 34578999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..........
T Consensus 301 g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 301 GNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp CBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 9999999421 345689999999999999999999999 99999999999999999999999999998764433222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEY 214 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~ 214 (229)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.........
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 233446778999999998899999999999999999999 99999876544433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=276.06 Aligned_cols=205 Identities=27% Similarity=0.401 Sum_probs=172.8
Q ss_pred CccCCcccccccccceEec-----cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL-----QDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||.||++.+... .++..||+|.++... ....+.+.+|+++++.+ + ||||+++++++.+.+..++
T Consensus 75 ~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEE
T ss_pred eEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcC--CchhhhheeeeccCCceEE
Confidence 4699999999999954321 334689999997653 33457789999999999 6 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc
Q 027015 75 VYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~ 142 (229)
||||+++++|.+++..... ....+++..+..++.|++.||++||+. |++|+||||+||+++.++.
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 229 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNV 229 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCc
Confidence 9999999999999954321 124699999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 143 PKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 143 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 230 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999986643321 22333456788999999999999999999999999999999 99999876433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=273.51 Aligned_cols=193 Identities=24% Similarity=0.340 Sum_probs=156.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....+++.||+|.++... ..+.+.+|+++++.++ ||||+++++++.+....++||||+++
T Consensus 59 ~~lG~G~~g~Vy~~--~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 59 SELGRGATSIVYRC--KQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLS--HPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEC------------CHHHHHCC--CTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEeeCCCEEEEEE--EECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCC--CCCCcceeeeEecCCeEEEEEEeCCC
Confidence 46999999999999 667788999999997443 3456788999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEeccccccccCCCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~~~~~~~~ 158 (229)
++|.+++ .....+++..+..++.|++.||.|||+. |++|+||||+||+++. ++.++|+|||++.......
T Consensus 133 ~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 133 GELFDRI----VEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CBHHHHH----TTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999998 4566799999999999999999999999 9999999999999975 8899999999987653321
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 2234568999999999999999999999999999999999999997644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=263.52 Aligned_cols=196 Identities=24% Similarity=0.382 Sum_probs=172.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ .+..+|+.||+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+.+..++||||+
T Consensus 12 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 12 EELGKGAFSVVRRC--VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhcCcCCeEEEEE--EEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC--CCCcCeEEEEEEcCCEEEEEEecC
Confidence 57999999999999 777889999999997553 334467889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc---eEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~---~~l~dfg~~~~~~~ 156 (229)
++++|.+.+ .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 88 ~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 88 TGGELFEDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999988 4557799999999999999999999999 9999999999999986655 99999999976644
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 322 2345689999999999999999999999999999999999999976543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=269.10 Aligned_cols=207 Identities=29% Similarity=0.363 Sum_probs=174.0
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.... ..+++.||+|.++... ....+.+.+|+++++.++ ||||+++++++.+.+..++|||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred eeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC--CCceeeEEEEEecCCceEEEEe
Confidence 469999999999995533 3456899999997543 344577899999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhc--------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 027015 78 YMPNNSLSQTLLGEEK--------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~--------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~ 137 (229)
|+++++|.+++..... ....+++..++.++.|++.||++||+. |++|+||||+||++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli 183 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILV 183 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEE
Confidence 9999999999954322 124589999999999999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccc
Q 027015 138 DQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 213 (229)
Q Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~ 213 (229)
+.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||........
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999998766433221 2233456788999999999889999999999999999999 9999987654433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=271.27 Aligned_cols=194 Identities=22% Similarity=0.291 Sum_probs=170.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--------hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~ 73 (229)
+.||+|+||+||++ ++..+|+.||+|.++.... .....+.+|+++++.++ ||||+++++++.+.+..+
T Consensus 30 ~~lG~G~~g~Vy~a--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 30 SPLGSGAFGFVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE--HANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EECSSSSSCSEEEE--EETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC--CTTBCCEEEEEECSSEEE
T ss_pred eEEEecCCEEEEEE--EECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC--CCCEeeEEEEEeeCCEEE
Confidence 57999999999999 7788999999999975421 13346778999999998 999999999999999999
Q ss_pred EEEEccCCC-CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 74 LVYDYMPNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 74 lv~e~~~~~-sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
+||||+.++ +|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+.
T Consensus 106 lv~e~~~~g~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEECCTTSCBHHHHH----HTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999998666 999998 5666899999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
....... .....|++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...
T Consensus 179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 7644322 234568999999999988776 78999999999999999999999763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=264.13 Aligned_cols=195 Identities=28% Similarity=0.414 Sum_probs=172.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|.+.... ......+.+|++.++.++ ||||+++++++.+.+..++||||
T Consensus 20 ~~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 20 RPLGKGKFGNVYLA--REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR--HPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred heecCCCCeEEEEE--EEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC--CCCEeeEEEEEEcCCEEEEEEEe
Confidence 46999999999999 677789999999997542 223467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 96 APRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999998 4456799999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 217 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH
Confidence 2345689999999999999999999999999999999999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=268.53 Aligned_cols=199 Identities=27% Similarity=0.478 Sum_probs=167.5
Q ss_pred CccCCcccccccccceE--eccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (229)
+.||+|+||+||++++. +..+++.||+|.+........+.+.+|+++++.++ ||||+++++++... ...++|||
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECHHHHTSCEEEEE
T ss_pred heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCCCceEEEEE
Confidence 57999999999999432 56688999999998666666678999999999999 99999999998643 56899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+......
T Consensus 94 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 94 YLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp CCTTCBHHHHHH---HCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred eCCCCCHHHHHH---hcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 999999999993 3345699999999999999999999999 9999999999999999999999999999876433
Q ss_pred Cc--cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 158 TT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 158 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 21 1223345677899999999999999999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=263.31 Aligned_cols=196 Identities=23% Similarity=0.349 Sum_probs=173.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+++.+|+|.+.... ....+.+.+|+..++.++ ||||+++++++.+.+..++||||
T Consensus 21 ~~lg~G~~g~Vy~~--~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 21 RFLGKGGFAKCFEI--SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA--HQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEeecCCEEEEEE--EECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC--CCCEeeeeeeeccCCEEEEEEec
Confidence 46999999999999 677789999999997542 234567889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 97 CRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CTTCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999988 4556899999999999999999999999 99999999999999999999999999987754322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2234568999999999999889999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=268.89 Aligned_cols=196 Identities=23% Similarity=0.349 Sum_probs=173.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+++.+|+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+.+..++||||
T Consensus 47 ~~lg~G~~g~Vy~~--~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 47 RFLGKGGFAKCFEI--SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA--HQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEecCCeEEEEEec
Confidence 46999999999999 677789999999997542 334567889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 123 ~~~~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 123 CRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CTTCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999988 4557899999999999999999999999 99999999999999999999999999998764322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 2 2234568999999999999999999999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=283.38 Aligned_cols=193 Identities=25% Similarity=0.280 Sum_probs=162.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~ 73 (229)
+.||+|+||+||++ ++..+|+.||||++... .....+.+.+|+.+++.++ ||||+++++++.... ..+
T Consensus 68 ~~lG~G~~g~V~~a--~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 68 KPIGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEECSSCEEEEE--EETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EEeecCCCeEEEEE--EECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC--CCCCCcEEEEEccCCccccCCeEE
Confidence 57999999999999 77888999999999754 3444577889999999999 999999999997553 469
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||++++ |.+.+. ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..
T Consensus 144 lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 144 LVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999654 666551 2489999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 54322 23446789999999999999999999999999999999999999987653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=272.05 Aligned_cols=202 Identities=28% Similarity=0.284 Sum_probs=167.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc-----cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++ .+..+++.||+|.+... .....+.+.+|+++++.++ ||||+++++++.+.+..++||
T Consensus 32 ~~lG~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 32 GAIGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH--HPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEE
T ss_pred ceeeecCCeEEEEE--EECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC--CCCcceeehhhccCCeEEEEE
Confidence 57999999999999 77888999999999754 2344578899999999999 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhc------------------------------------cccCCCHHHHHHHHHHHHHHHHHHhhc
Q 027015 77 DYMPNNSLSQTLLGEEK------------------------------------RRAKFGWKARREIIMGIGRGLAYIHEE 120 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~------------------------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~ 120 (229)
||+++++|.+++..... ....+++..++.++.|++.||++||+.
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999998842100 123346788899999999999999999
Q ss_pred CCCCeEEcCCCCCCEEEcCCC--ceEEeccccccccCCCC---ccccccccCCccccCcccccc--CCCCCcccchhHHH
Q 027015 121 IQPHVVHRDIKTSNILLDQNF--NPKISDFGLSKLFPENT---THISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGV 193 (229)
Q Consensus 121 ~~~~i~h~di~p~ni~~~~~~--~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~ 193 (229)
|++|+||+|+||+++.++ .++|+|||.+..+.... ........|++.|+|||.+.+ ..++.++||||||+
T Consensus 188 ---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 188 ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp ---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred ---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999998776 89999999997653321 112344668999999999875 67899999999999
Q ss_pred HHHHHHhCCCcccCccc
Q 027015 194 LLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 194 i~~~l~~g~~pf~~~~~ 210 (229)
++|+|++|+.||.....
T Consensus 265 il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVND 281 (345)
T ss_dssp HHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHCCCCCCCCCh
Confidence 99999999999976543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=265.83 Aligned_cols=199 Identities=27% Similarity=0.410 Sum_probs=169.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
.||+|+||.||++.+....++..||+|.++... ....+.+.+|+++++.++ ||||+++++++ ..+..++||||+++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC--CCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 699999999999966566678999999998653 345577899999999998 99999999999 45568999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH- 160 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 160 (229)
++|.+++. .....+++..+..++.|+++||.+||+. |++|+||+|+||+++.++.++|+|||.+.........
T Consensus 94 ~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 94 GPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp EEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 99999983 3456799999999999999999999999 9999999999999999999999999999876443222
Q ss_pred -ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 161 -ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 161 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 1233446788999999998889999999999999999998 9999987554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=268.32 Aligned_cols=194 Identities=26% Similarity=0.401 Sum_probs=169.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .+..+|+.||+|.++.........+.+|+..++.++ ||||+++++++.+....++||||+++
T Consensus 15 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (304)
T 2jam_A 15 EVLGSGAFSEVFLV--KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK--HENIVTLEDIYESTTHYYLVMQLVSG 90 (304)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEECC------HHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeccCCCCceEEEE--EECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC--CCCeeehhhhcccCCEEEEEEEcCCC
Confidence 57999999999999 667789999999998665555567889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccccCCCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~---~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++|.+++ .....+++..+..++.|++.||.+||+. |++|+||+|+||++ +.++.++|+|||.+......
T Consensus 91 ~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 91 GELFDRI----LERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred ccHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999998 4456799999999999999999999999 99999999999999 77889999999998654322
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1233458999999999999999999999999999999999999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=265.87 Aligned_cols=201 Identities=24% Similarity=0.326 Sum_probs=157.8
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++.+... ..+..||+|.++... ....+.+.+|+..++.++ ||||+++++++. ++..++||||+
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~-~~~~~lv~e~~ 97 (281)
T 1mp8_A 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVIT-ENPVWIIMELC 97 (281)
T ss_dssp EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEC-SSSCEEEEECC
T ss_pred eEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCccceEEEEEc-cCccEEEEecC
Confidence 4699999999999954332 235679999987543 334567889999999998 999999999974 45689999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+........
T Consensus 98 ~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 98 TLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp TTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred CCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 9999999983 3345799999999999999999999999 999999999999999999999999999987654433
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
.......+++.|+|||.+.+..++.++|+||||+++|++++ |..||......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~ 224 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence 33334456788999999999999999999999999999996 99999875543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=274.82 Aligned_cols=200 Identities=28% Similarity=0.372 Sum_probs=169.2
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeeccc----chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||+++... ..+|+.||||+++... ......+.+|+++++.++ .||||+++++++.+....++||
T Consensus 60 ~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-TCTTBCCEEEEEEETTEEEEEE
T ss_pred EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc-CCCceeEEEEEEeeCceEEEEe
Confidence 469999999999994322 3578999999986432 233456778999999984 3999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++ .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 139 e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 139 DYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp CCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 999999999999 4456799999999999999999999999 999999999999999999999999999986644
Q ss_pred CCccccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 33333445679999999999885 347899999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=261.20 Aligned_cols=197 Identities=28% Similarity=0.447 Sum_probs=172.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ .+..+++.||+|.+.... ....+.+.+|+..++.++ ||||+++++++.+.+..++|+||++
T Consensus 13 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 13 QTLGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEeecCCCcEEEEE--EECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC--CCCceeeeeEEEcCCEEEEEEEecC
Confidence 57999999999999 677789999999997553 344577889999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC-c
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-T 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 159 (229)
+++|.+++ .....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 89 ~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 89 GGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp TEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999988 5566799999999999999999999999 99999999999999999999999999987653322 1
Q ss_pred cccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 22344568999999999987665 678999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=273.03 Aligned_cols=192 Identities=27% Similarity=0.374 Sum_probs=162.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~ 73 (229)
+.||+|+||.||++ .+..+|+.||||.+... .....+.+.+|+++++.++ ||||+++++++.... ..+
T Consensus 31 ~~lG~G~~g~V~~a--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 31 QPVGSGAYGAVCSA--VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEC------CEEEE--EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--BTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEeeecCCeEEEEE--EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC--CcCCCCceeeEecCCccccCceEE
Confidence 57999999999999 77889999999998643 2334567889999999999 999999999997653 459
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||+ +++|.+++. ...+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++..
T Consensus 107 lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 999999 889999883 25789999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... .....+|+.|+|||++.+ ..++.++|+|||||++++|++|+.||.+.+.
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5432 234568999999999887 6799999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=272.57 Aligned_cols=204 Identities=31% Similarity=0.416 Sum_probs=171.4
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.+... .+++.||+|.++... ....+.+.+|+.+++.++ ||||+++++++.+.+..++|||
T Consensus 53 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEccCCceEEEEe
Confidence 4699999999999955322 456899999998653 334567899999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhcc--------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 027015 78 YMPNNSLSQTLLGEEKR--------------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~--------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~ 137 (229)
|+++++|.+++...... ...+++..++.++.|+++||.+||+. |++|+||||+||++
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEE
Confidence 99999999999543211 26799999999999999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 138 DQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
+.++.++|+|||.+........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9999999999999876533221 12234557889999999999999999999999999999999 9999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=274.16 Aligned_cols=204 Identities=25% Similarity=0.357 Sum_probs=170.7
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-ceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-~~~lv~ 76 (229)
+.||+|+||.||++.+. +..+++.||||.++... ....+.+.+|++++..+. .||||+++++++.+.+ ..++||
T Consensus 28 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc-CCcceeeeeeeeecCCCceEEEE
Confidence 46999999999999543 45677899999997653 334467899999999994 2999999999998765 489999
Q ss_pred EccCCCCHHHHHhhhhcc--------------------------------------------------------------
Q 027015 77 DYMPNNSLSQTLLGEEKR-------------------------------------------------------------- 94 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~-------------------------------------------------------------- 94 (229)
||+++++|.+++......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 999999999999543221
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc-cccccccCCccccC
Q 027015 95 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLA 173 (229)
Q Consensus 95 ~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~a 173 (229)
...+++..++.++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+........ .......+++.|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 12289999999999999999999999 999999999999999999999999999986543322 22344567889999
Q ss_pred ccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 174 PEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 174 PE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
||++.+..++.++||||||+++|+|++ |+.||....
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 999999999999999999999999998 999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=270.55 Aligned_cols=198 Identities=23% Similarity=0.325 Sum_probs=170.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC---CCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC---HENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~---~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+++.||+|+++. ..........|+++++.+... ||||+++++++......++||||
T Consensus 41 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 117 (360)
T 3llt_A 41 RKMGDGTFGRVLLC--QHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117 (360)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCCeEEEEE--EECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcC
Confidence 57999999999999 6778899999999963 233445677788888888532 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-------------------
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ------------------- 139 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~------------------- 139 (229)
+ +++|.+++... ....+++..+..++.|++.||+|||+. |++|+||||+||+++.
T Consensus 118 ~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 118 L-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp C-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred C-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 9 99999998422 234699999999999999999999999 9999999999999975
Q ss_pred ------CCceEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 140 ------NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 140 ------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 266 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence 788999999999764332 234568999999999999999999999999999999999999998765433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=282.18 Aligned_cols=195 Identities=29% Similarity=0.403 Sum_probs=170.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+..+|+.||+|++... .......+.+|+++++.++ ||||+++++++.+....++||||+
T Consensus 28 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~ 103 (486)
T 3mwu_A 28 CMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLFEILEDSSSFYIVGELY 103 (486)
T ss_dssp EEEECCSSSEEEEE--EETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEeecCCEEEEEE--EECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC--CCCcCeEEEEEEcCCEEEEEEEcC
Confidence 57999999999999 67788999999999743 2344578899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc---CCCceEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~---~~~~~~l~dfg~~~~~~~ 156 (229)
++++|.+.+ .....+++..+..++.|++.||.|||+. |++||||||+||+++ .++.++|+|||++.....
T Consensus 104 ~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 104 TGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred CCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999988 4556899999999999999999999999 999999999999995 456799999999976543
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32 2234568999999999876 589999999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=274.90 Aligned_cols=194 Identities=22% Similarity=0.294 Sum_probs=158.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc----CCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----~~~~~lv~e 77 (229)
+.||+|+||+||++ .+..+|+.||||+++. .....+|++.+.++. .||||+++++++.. ....++|||
T Consensus 68 ~~LG~G~~g~V~~~--~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~-~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 68 QVLGLGINGKVLQI--FNKRTQEKFALKMLQD-----CPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHT-TSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeeeccCeEEEEE--EECCCCCEEEEEEeCc-----chhHHHHHHHHHHhc-CCCCcceEeEEEeecccCCcEEEEEEE
Confidence 36999999999999 7788899999999862 245667888775543 39999999999875 556799999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEecccccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 154 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~~~~ 154 (229)
|+++++|.+++.. .....+++..+..++.|++.||.|||+. |++||||||+||+++. ++.++|+|||++...
T Consensus 140 ~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 140 CLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp CCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 9999999999932 1234699999999999999999999999 9999999999999987 788999999999865
Q ss_pred CCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 215 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 215 TSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp C-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred CCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4322 22345789999999999999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=268.10 Aligned_cols=197 Identities=25% Similarity=0.370 Sum_probs=167.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ .+..+|+.||+|.+..... ...+.+.+|+.+++.++ ||||+++++++.+.+..++||||+
T Consensus 31 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 31 GLVGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--HENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEGGGGTTSSEEEE--EETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeecCCEEEEEE--EECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC--CCCEeeEEEEeecCCEEEEEEecC
Confidence 57999999999999 6778899999999865432 23456789999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.++. .....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 107 ~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 107 DHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp SEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999998887 4566799999999999999999999999 999999999999999999999999999976543322
Q ss_pred cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
......+++.|+|||++.+. .++.++|+||||+++|+|++|+.||.....
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 22345689999999998865 789999999999999999999999987653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=261.22 Aligned_cols=196 Identities=21% Similarity=0.327 Sum_probs=170.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||++ ....+|+.||+|.++..... ..+.+.+|+..++.++ ||||+++++++.+....++|
T Consensus 11 ~~lg~G~~g~V~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 11 EELGSGQFAIVRKC--RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR--HPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEE
T ss_pred HhhcccCceEEEEE--EEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC--CCCeeehhheecCCCeEEEE
Confidence 57999999999999 67778999999999754221 3567899999999999 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKISDFGLS 151 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~----~~~l~dfg~~ 151 (229)
|||+++++|.+++ .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++ .++|+|||.+
T Consensus 87 ~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 87 LELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EeecCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999 4556799999999999999999999999 999999999999998777 7999999998
Q ss_pred cccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........ .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 87643321 2334688999999999989999999999999999999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=275.08 Aligned_cols=201 Identities=27% Similarity=0.435 Sum_probs=160.0
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++.... ..++..||||.++... ....+.+.+|+.+++.++ ||||+++++++.+....++||||+
T Consensus 51 ~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp EEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCCceEEEEeCC
Confidence 579999999999995431 1457789999997653 334567899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|+++||+|||+. |++|+||||+||+++.++.++|+|||++........
T Consensus 129 ~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 129 ENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp TTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 9999999993 3345799999999999999999999999 999999999999999999999999999877643322
Q ss_pred cc--cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.. .....+++.|+|||.+.+..++.++||||||+++|++++ |+.||.....
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 11 112234678999999999999999999999999999997 9999976543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=263.50 Aligned_cols=198 Identities=20% Similarity=0.229 Sum_probs=170.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ .+..+|+.||+|.+.... ....+.+|+..++.+. .|++++++++++.+....++||||+ +
T Consensus 16 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 16 RRIGEGSFGVIFEG--TNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA-GCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEECSSCEEEEE--EETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTT-TCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEeecCCEEEEEE--EECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHh-cCCCCCeEEeecCCCceeEEEEEec-C
Confidence 46999999999999 667899999999986432 3356788999999994 2999999999999999999999999 9
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc-----eEEeccccccccCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-----PKISDFGLSKLFPE 156 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~-----~~l~dfg~~~~~~~ 156 (229)
++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++. ++|+|||.+.....
T Consensus 90 ~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 90 PSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp CBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred CCHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 99999993 2345699999999999999999999999 9999999999999987766 99999999987644
Q ss_pred CCc------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 157 NTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 157 ~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 322 1234456899999999999999999999999999999999999999875443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=270.24 Aligned_cols=192 Identities=25% Similarity=0.397 Sum_probs=167.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ .+..+|+.||||.+.... ....+.+.+|+++++.++ ||||+++++++.+.+..++||||
T Consensus 60 ~~lG~G~~g~Vy~a--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 60 REIGHGSFGAVYFA--RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEccCCCEEEEEE--EEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCeEEEEEec
Confidence 46999999999999 677899999999997543 223367889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++ ++|.+++. .....+++..+..++.|+++||++||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 136 ~~-g~l~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 136 CL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp CS-EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred CC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 96 67887773 3456799999999999999999999999 999999999999999999999999999876532
Q ss_pred ccccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....|++.|+|||++. ...++.++||||||+++|+|++|+.||....
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23456899999999885 4678999999999999999999999997654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=279.38 Aligned_cols=197 Identities=21% Similarity=0.292 Sum_probs=153.9
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceE
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRI 73 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~ 73 (229)
.+.||+|+||+||++ ++..+|+.||||.+... .....+.+.+|+.+++.++ ||||+++++++... ...|
T Consensus 58 ~~~lG~G~~g~V~~~--~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEA--YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN--HDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp CCC-------CEEEE--EECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCTTTCCCEE
T ss_pred eeEeeecCCeEEEEE--EECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC--CCCCCceEEEEecCCcccCceEE
Confidence 367999999999999 67778999999999643 3334577889999999998 99999999998433 5689
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+|||++ +++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..
T Consensus 134 lv~e~~-~~~L~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLF----RTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEECCC-SEEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEecc-ccchhhhc----ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 999998 67899988 5567899999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc--------------------------cccccccCCccccCcccc-ccCCCCCcccchhHHHHHHHHHh------
Q 027015 154 FPENTT--------------------------HISTRVAGTLGYLAPEYA-ISGRLTRKSDVYSFGVLLLEIVS------ 200 (229)
Q Consensus 154 ~~~~~~--------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~------ 200 (229)
...... .......||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 542211 112345679999999976 46679999999999999999998
Q ss_pred -----CCCcccCcc
Q 027015 201 -----GRTAVDFDV 209 (229)
Q Consensus 201 -----g~~pf~~~~ 209 (229)
|+++|.+.+
T Consensus 286 ~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 286 AYHADRGPLFPGSS 299 (458)
T ss_dssp SSGGGCCCSCC---
T ss_pred cccccccccCCCCc
Confidence 777776543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=263.46 Aligned_cols=200 Identities=25% Similarity=0.345 Sum_probs=165.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-----hhhHHHHHHHHHHhhhcc-CCCcccccceEEEcCC-----
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-----QGEKEFMSEVASMANVNV-CHENLVKLHGGCIDGP----- 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~~~~l~~-~~~~i~~~~~~~~~~~----- 70 (229)
+.||+|+||+||++ ++..+|+.||+|.+..... .......+|++.++.++. .||||+++++++....
T Consensus 15 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~ 92 (308)
T 3g33_A 15 AEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92 (308)
T ss_dssp EEECCSSSCCEEEE--ECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred EEEecCCCeEEEEE--EECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence 57999999999999 6778899999999974421 112456666666665531 2999999999998765
Q ss_pred ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 71 ~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
..+++|||++ ++|.+++.. .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.
T Consensus 93 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 93 KVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred eEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 4789999996 599998832 1223499999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 151 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
+....... ......+|+.|+|||++.+..++.++|+||||+++|+|++|+.||......
T Consensus 167 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 167 ARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp TTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred ccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 97654332 224457899999999999999999999999999999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=269.35 Aligned_cols=199 Identities=25% Similarity=0.353 Sum_probs=167.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEc--------CCc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID--------GPC 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--------~~~ 71 (229)
+.||+|+||+||++ .+..+|+.||+|.+.... ......+.+|+++++.++ ||||+++++++.. .+.
T Consensus 23 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 23 AKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EECSSCSTTSEEEE--EETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC--CTTBCCEEEEEEEC--------CE
T ss_pred EEEecCCCcEEEEE--EECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc--CCCcccHhheeeccccccccCCce
Confidence 57999999999999 777899999999986543 223467889999999999 9999999999876 346
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
.++||||+++ +|.+.+. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+
T Consensus 99 ~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp EEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 7999999975 6776662 4446799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 152 KLFPENT---THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 152 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
..+.... ........+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 235 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 8764221 122234568999999998876 55899999999999999999999999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=263.27 Aligned_cols=195 Identities=22% Similarity=0.381 Sum_probs=173.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ++..+++.||+|.+.... ....+.+.+|+..++.+. ||||+++++++.+....++||||++
T Consensus 28 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 28 EKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhcccCCeEEEEE--EECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCCeEEEEEEeCC
Confidence 56999999999999 677889999999997653 344578899999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++ ....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 104 ~~~L~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 104 GGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp TEEHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCcHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 99999998 235799999999999999999999999 999999999999999999999999999977644322
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 2244568999999999999999999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=281.36 Aligned_cols=195 Identities=28% Similarity=0.393 Sum_probs=166.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ ++..++..||+|++.... ......+.+|+.+++.++ ||||+++++++.+....++||||+
T Consensus 43 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 43 KKLGSGAYGEVLLC--RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD--HPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEECC---EEEEE--EETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEecCCCEEEEEE--EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEEEEEEecC
Confidence 57999999999999 777889999999997542 334577899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC---CceEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~---~~~~l~dfg~~~~~~~ 156 (229)
++++|.+.+ .....+++..+..++.|+++||.|||+. |++||||||+||+++.. +.++|+|||++.....
T Consensus 119 ~~g~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 119 KGGELFDEI----IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred CCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999988 4557799999999999999999999999 99999999999999754 4599999999877644
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.....
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32 224457899999999876 5689999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=271.99 Aligned_cols=198 Identities=24% Similarity=0.360 Sum_probs=162.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ....+++.||+|.++..... ....+.+|+++++.++ ||||+++++++.+.+..++||||++
T Consensus 8 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 8 DKLGEGTYATVYKG--KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEECC------CCCCCCCHHHHSCCC--CTTBCCEEEEEECSSCEEEEEECCS
T ss_pred EEEcCCCCEEEEEE--EECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC--CCCCCeeeeEEeeCCEEEEEecccc
Confidence 57999999999999 67778999999999754322 2234567999999999 9999999999999999999999996
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+........
T Consensus 84 -~~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 84 -KDLKQYLD---DCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp -EEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred -cCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 58888873 3445799999999999999999999999 999999999999999999999999999876543222
Q ss_pred ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 161 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE 207 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 2233467999999999876 56899999999999999999999999876543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=277.39 Aligned_cols=200 Identities=19% Similarity=0.174 Sum_probs=157.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhcc-CCCcccccc-------eEEEcCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNV-CHENLVKLH-------GGCIDGP 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~-~~~~i~~~~-------~~~~~~~ 70 (229)
+.||+|+||.||++ +...+|+.||||++... .....+.+.+|+++++.+.. .||||++++ +++.+.+
T Consensus 79 ~~lG~G~~g~V~~a--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 79 TVLGQEDPYAYLEA--TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEETTEEEEEE--EC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred ceeecCCCEEEEEE--EECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 57999999999999 55678999999999743 33455778899955544431 299999998 6666554
Q ss_pred c-----------------eEEEEEccCCCCHHHHHhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCC
Q 027015 71 C-----------------RILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130 (229)
Q Consensus 71 ~-----------------~~lv~e~~~~~sL~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di 130 (229)
. .+++|||+ +++|.+++..... ....+++..+..++.|++.||+|||+. |++|+||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 3 78999999 6799999943211 112344588889999999999999999 9999999
Q ss_pred CCCCEEEcCCCceEEeccccccccCCCCccccccccCCccccCccccccC-----------CCCCcccchhHHHHHHHHH
Q 027015 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-----------RLTRKSDVYSFGVLLLEIV 199 (229)
Q Consensus 131 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Dv~slG~i~~~l~ 199 (229)
||+||+++.++.++|+|||++..... ......| +.|+|||++.+. .++.++||||||+++|+|+
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 99999999999999999999876432 2234456 899999999887 8999999999999999999
Q ss_pred hCCCcccCccccc
Q 027015 200 SGRTAVDFDVQLG 212 (229)
Q Consensus 200 ~g~~pf~~~~~~~ 212 (229)
+|+.||.......
T Consensus 308 tg~~Pf~~~~~~~ 320 (377)
T 3byv_A 308 CADLPITKDAALG 320 (377)
T ss_dssp HSSCCC------C
T ss_pred HCCCCCccccccc
Confidence 9999998765433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=267.42 Aligned_cols=204 Identities=24% Similarity=0.380 Sum_probs=157.7
Q ss_pred CccCCcccccccccceEeccCCc---EEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCce----
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT---IVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR---- 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~---- 72 (229)
+.||+|+||.||++.+ ..++. .||+|.++.. .....+.+.+|+++++.++ ||||+++++++......
T Consensus 29 ~~lg~G~~g~Vy~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 29 RMLGKGEFGSVREAQL--KQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD--HPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp EEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCC--CTTBCCCCEEEECC-------
T ss_pred ceecccCCeEEEEEEE--cccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC--CCceehhhceeeccccccCCC
Confidence 5799999999999943 33443 8999999755 3445678999999999998 99999999999877655
Q ss_pred --EEEEEccCCCCHHHHHhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 027015 73 --ILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 148 (229)
Q Consensus 73 --~lv~e~~~~~sL~~~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~df 148 (229)
+++|||+++++|.+++.... .....+++..+..++.|+++||++||+. |++|+||||+||+++.++.++|+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence 89999999999999985432 2223699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 149 GLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 149 g~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
|.+........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||......+
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 99976543322 12233446778999999999999999999999999999999 999998765433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=270.63 Aligned_cols=203 Identities=24% Similarity=0.422 Sum_probs=167.2
Q ss_pred CccCCcccccccccceEeccCCcE----EEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTI----VAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++ ....+++. |++|.+.... ....+.+.+|+..++.++ ||||+++++++. +...++|+
T Consensus 19 ~~lG~G~~g~Vy~~--~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 19 KVLGSGVFGTVHKG--VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD--HAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEECCSSCEEEEE--EECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC--CTTBCCEEEEEC-BSSEEEEE
T ss_pred eeeeecCCceEEEE--EEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEc-CCccEEEE
Confidence 57999999999999 55556665 7777775332 333466788999999998 999999999886 45688999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++. .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 94 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 94 QYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp ECCTTCBSHHHHH---SSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EeCCCCCHHHHHH---HccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 9999999999983 3346789999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccccc
Q 027015 157 NTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 215 (229)
Q Consensus 157 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~ 215 (229)
.... ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||..........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 228 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH
Confidence 3222 2234557779999999999999999999999999999999 999998765444333
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=266.39 Aligned_cols=199 Identities=28% Similarity=0.388 Sum_probs=169.2
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
.||+|+||.||++.+....+++.||+|.++... ....+.+.+|++.++.++ ||||+++++++ .....++||||++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~-~~~~~~lv~e~~~ 100 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGIC-EAESWMLVMEMAE 100 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC--CTTBCCEEEEE-ESSSEEEEEECCT
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC--CCCEEEEEEEE-CCCCcEEEEEeCC
Confidence 799999999999977667778999999997543 333577899999999998 99999999998 5567899999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++ .....+++..++.++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+.........
T Consensus 101 ~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 101 LGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp TEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCHHHHH----HhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999999 4456799999999999999999999999 9999999999999999999999999999876443322
Q ss_pred c--cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 161 I--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 161 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||......
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 227 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 1 222345688999999998889999999999999999999 99999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=282.52 Aligned_cols=195 Identities=30% Similarity=0.404 Sum_probs=172.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+|+.||||++.... ......+.+|+++++.++ ||||+++++++.+.+..++||||
T Consensus 32 ~~lg~G~~g~V~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 32 RVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD--HPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEecCCCEEEEEE--EECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCCEEEEEEec
Confidence 46999999999999 777899999999997542 344578999999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccccC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~---~~~~~~~l~dfg~~~~~~ 155 (229)
+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||++ +.++.++|+|||++....
T Consensus 108 ~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 108 YTGGELFDEI----ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCSCBHHHHH----HTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999998 4567899999999999999999999999 99999999999999 567889999999997764
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 432 2234568999999998876 689999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=272.88 Aligned_cols=194 Identities=24% Similarity=0.378 Sum_probs=170.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ .+..+|+.||+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+++..++||||++
T Consensus 39 ~~lg~G~~g~V~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 39 SELGAGNGGVVFKV--SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC--CTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeecCCCCeEEEEE--EECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC--CCCEEEEeEEEEECCEEEEEEECCC
Confidence 57999999999999 677889999999998653 334577899999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++ .....+++..+..++.|++.+|.+||+ . |++|+||+|+||+++.++.++|+|||.+......
T Consensus 115 ~~~L~~~l----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 115 GGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp TCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999 455679999999999999999999998 5 8999999999999999999999999998654221
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999998654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=269.84 Aligned_cols=201 Identities=25% Similarity=0.397 Sum_probs=162.9
Q ss_pred CccCCcccccccccceEeccCCcE----EEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTI----VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++ +...+|+. ||+|.++.. .....+.+.+|+.+++.++ ||||+++++++.++. .++++
T Consensus 21 ~~lG~G~~g~Vy~~--~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 21 KVLGSGAFGTVYKG--LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEETTEEEEEE--EECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC--BTTBCCEEEEEESSS-EEEEE
T ss_pred eEEeeCCCeEEEEE--EEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCC-eEEEE
Confidence 57999999999999 44555554 577877543 3344578899999999999 999999999998764 78999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
+++++++|.+++. .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 96 e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 96 QLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp ECCTTCBHHHHHH---HSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999983 3456799999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccc
Q 027015 157 NTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 213 (229)
Q Consensus 157 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~ 213 (229)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||........
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 228 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH
Confidence 3222 2233456778999999999999999999999999999999 9999987654443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=269.63 Aligned_cols=196 Identities=22% Similarity=0.340 Sum_probs=161.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ ++..+|+.||+|.++.... .....+.+|+++++.++ ||||+++++++.+....++||||+
T Consensus 40 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 40 TKLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ--HRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEECSSSEEEEE--EETTTTEEEEEEECCCCC--------CHHHHHHGGGCC--CTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEecCCeEEEEE--EECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC--CCCcceEEEEEecCCEEEEEEecC
Confidence 57999999999999 7788999999999975532 22456779999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-----CCCceEEecccccccc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-----QNFNPKISDFGLSKLF 154 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-----~~~~~~l~dfg~~~~~ 154 (229)
+ ++|.+++ .....+++..+..++.|++.||++||+. |++|+||||+||+++ +++.++|+|||.+...
T Consensus 116 ~-~~L~~~~----~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 116 E-NDLKKYM----DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp S-EEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred C-CCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 7 5999998 4556799999999999999999999999 999999999999994 4555999999999776
Q ss_pred CCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.....
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 43322 22345679999999998874 589999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=259.22 Aligned_cols=192 Identities=26% Similarity=0.391 Sum_probs=166.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEc----CCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----~~~~~lv 75 (229)
+.||+|+||.||++ .+..++..||+|.+... .....+.+.+|+.+++.++ ||||+++++++.. ....++|
T Consensus 32 ~~lg~G~~g~Vy~~--~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 32 IEIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEESSSCEEEEEE
T ss_pred eeccCCCCeEEEEe--EecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC--CCCeeeeeeeeccccCCCceEEEE
Confidence 35999999999999 77788999999999754 3344577889999999999 9999999999875 3457899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEc-CCCceEEecccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLD-QNFNPKISDFGLSK 152 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~ni~~~-~~~~~~l~dfg~~~ 152 (229)
|||+++++|.+++ .....+++..+..++.|++.||.+||+. + ++|+||+|+||+++ .++.++|+|||.+.
T Consensus 108 ~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 108 TELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEecCCCCHHHHH----HHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999 4557799999999999999999999999 8 99999999999997 78999999999987
Q ss_pred ccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
...... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||...
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 543332 234568999999998764 5899999999999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=267.26 Aligned_cols=199 Identities=23% Similarity=0.324 Sum_probs=169.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ ....+|+.||+|+++... ......+.+|+..++.+. .||||+++++++.+....++||||+
T Consensus 35 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~iv~~~~~~~~~~~~~lv~e~~ 111 (327)
T 3lm5_A 35 KELGRGKFAVVRQC--ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-SCPRVINLHEVYENTSEIILILEYA 111 (327)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceeCCCCCeEEEEE--EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc-CCCCEEEEEEEEEeCCeEEEEEEec
Confidence 46999999999999 778889999999997542 333577889999999986 3799999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~~~~~~ 156 (229)
++++|.+++.. .....+++..++.++.|++.||++||+. |++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 112 ~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 112 AGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp TTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred CCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999998721 2346799999999999999999999999 9999999999999987 78999999999987643
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 187 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 187 ACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 321 2345689999999999999999999999999999999999999987544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=261.15 Aligned_cols=196 Identities=29% Similarity=0.468 Sum_probs=170.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++. . .+++.||+|.+..... ..+.+.+|++.++.++ ||||+++++++.+.+..+++|||+++
T Consensus 14 ~~lg~G~~g~V~~~~--~-~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 14 QEIGSGQFGLVHLGY--W-LNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp EEEEEETTEEEEEEE--E-TTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred eEecCCCceeEEEEE--e-cCCCeEEEEEccccCC-CHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 469999999999993 3 3678999999975433 3467899999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++++|++||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 88 ~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 88 GCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHh---hCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999983 3345789999999999999999999999 99999999999999999999999999987654332222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.....+++.|+|||++.+..++.++|+||||+++|+|++ |+.||....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 233456778999999998999999999999999999999 899998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=290.64 Aligned_cols=206 Identities=27% Similarity=0.372 Sum_probs=172.1
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
.||+|+||.||++.+....+++.||||+++... ....+.+.+|+++++.++ ||||+++++++.++ ..++||||++
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~-~~~lv~E~~~ 452 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGICEAE-SWMLVMEMAE 452 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC--CTTBCCEEEEEESS-SEEEEEECCT
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecC-CEEEEEEccC
Confidence 599999999999977666778999999997543 233578999999999999 99999999998654 5789999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc-
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT- 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 159 (229)
+++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..+.....
T Consensus 453 ~g~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999 4567799999999999999999999999 999999999999999999999999999987644322
Q ss_pred -cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccchh
Q 027015 160 -HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVD 218 (229)
Q Consensus 160 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~ 218 (229)
.......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 12233446788999999999999999999999999999998 999998766544443333
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=275.24 Aligned_cols=194 Identities=22% Similarity=0.288 Sum_probs=163.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~l 74 (229)
+.||+|+||.||++ ++..+|+.||||.++.. .....+.+.+|+.+++.++ ||||+++++++... ...++
T Consensus 32 ~~lG~G~~g~V~~a--~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 32 HLIGRGSYGYVYLA--YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK--SDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEETTEEEEEE--EETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEeecCCEEEEEE--EECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC--CCCcceEEEEEecCCCCcCCeEEE
Confidence 57999999999999 77888999999999753 3344578899999999999 99999999998765 56899
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
||||++ ++|.+++ .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++...
T Consensus 108 v~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 108 VLEIAD-SDLKKLF----KTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEECCS-EEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCC-cCHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 999985 5999998 5567799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc---------------------cccccccCCccccCcccc-ccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 155 PENTT---------------------HISTRVAGTLGYLAPEYA-ISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 155 ~~~~~---------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
..... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 43221 112456789999999986 566799999999999999999986655543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=263.74 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=170.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~e 77 (229)
+.||+|+||.||++ ....+|+.||+|.+.... ....+.+.+|+..++.++ ||||+++++++.+ ....++|||
T Consensus 12 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 12 YTIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred hhccCCCCcEEEEE--EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC--CCCCCeEEEEEecCCCceEEEEEe
Confidence 57999999999999 677889999999997543 334567889999999998 9999999998754 567899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-----VVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-----i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|+++++|.+++.........+++..++.++.|++.+|.+||+. + ++|+||+|+||+++.++.++|+|||.+.
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999965545556799999999999999999999999 8 9999999999999999999999999987
Q ss_pred ccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 6543321 1233468899999999999899999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=264.44 Aligned_cols=198 Identities=29% Similarity=0.463 Sum_probs=168.3
Q ss_pred CccCCcccccccccceE--eccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~ 76 (229)
+.||+|+||.||++.+. +..+++.||+|.++... ....+.+.+|+++++.++ ||||+++++++.+. ...++||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC--CTTBCCEEEEEEC---CCEEEEE
T ss_pred hccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC--CCCeeeeeeEEecCCCceEEEEE
Confidence 57999999999999421 46689999999997553 334577899999999999 99999999999876 6689999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++. .....+++..+..++.|++.+|++||+. |++|+||||+||+++.++.++|+|||.+.....
T Consensus 105 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 105 EFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp ECCTTCBHHHHHH---HHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EeCCCCcHHHHHH---hccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 9999999999983 3445699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc--cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 157 NTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 157 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+..
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 332 223445678889999999999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=261.73 Aligned_cols=201 Identities=25% Similarity=0.333 Sum_probs=166.2
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++.+... .++..||+|.+... .....+.+.+|+..++.++ ||||+++++++.++ ..++||||+
T Consensus 18 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~-~~~~v~e~~ 94 (281)
T 3cc6_A 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD--HPHIVKLIGIIEEE-PTWIIMELY 94 (281)
T ss_dssp EEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC--CTTBCCEEEEECSS-SCEEEEECC
T ss_pred EEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC--CCCcceEEEEEcCC-CCEEEEecC
Confidence 4699999999999955432 23457999999765 3345578899999999998 99999999998654 568999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|+++||++||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 95 ~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 95 PYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp TTCBHHHHHH---HHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred CCCCHHHHHH---hccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 9999999983 3345689999999999999999999999 999999999999999999999999999887654333
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
.......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||......
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~ 221 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH
Confidence 33344556788999999999999999999999999999998 99999765443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=287.52 Aligned_cols=204 Identities=26% Similarity=0.380 Sum_probs=170.0
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
.||+|+||+||++.+....++..||||.++... ....+.+.+|+++++.++ ||||+++++++.+ ...++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC--CTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC--CCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 589999999999976655677889999997653 345678999999999998 9999999999976 468999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..........
T Consensus 420 g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 420 GPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp CBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred CcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 99999983 3456799999999999999999999999 99999999999999999999999999998764332211
Q ss_pred --cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccccc
Q 027015 162 --STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 215 (229)
Q Consensus 162 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~ 215 (229)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+...
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~ 550 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 122335678999999999999999999999999999998 999998765544333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=279.32 Aligned_cols=196 Identities=29% Similarity=0.406 Sum_probs=168.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-------------hhhHHHHHHHHHHhhhccCCCcccccceEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-------------QGEKEFMSEVASMANVNVCHENLVKLHGGCID 68 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~ 68 (229)
+.||+|+||+||++ .+..+++.||+|++..... ...+.+.+|+.+++.++ ||||+++++++.+
T Consensus 42 ~~lG~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~ 117 (504)
T 3q5i_A 42 RKLGSGAYGEVLLC--KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD--HPNIIKLFDVFED 117 (504)
T ss_dssp EEEEC--CEEEEEE--EETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC--CTTBCCEEEEEEC
T ss_pred eEecccCCeEEEEE--EECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEc
Confidence 57999999999999 6778899999999975421 23467889999999999 9999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC---ceEE
Q 027015 69 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKI 145 (229)
Q Consensus 69 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~---~~~l 145 (229)
....++||||+++++|.+++ .....+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQI----INRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred CCEEEEEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999998 4557799999999999999999999999 999999999999998766 6999
Q ss_pred eccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
+|||++....... ......|++.|+|||++. ..++.++|+||||+++|+|++|+.||......
T Consensus 191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 253 (504)
T 3q5i_A 191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253 (504)
T ss_dssp CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998764432 224456899999999876 46899999999999999999999999876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=267.20 Aligned_cols=195 Identities=26% Similarity=0.424 Sum_probs=169.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--------hhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--------QGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~ 72 (229)
+.||+|+||.||++ ....+|+.||||+++.... ...+.+.+|+.+++.+ . ||||+++++++......
T Consensus 100 ~~lg~G~~g~Vy~a--~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 100 DVIGRGVSSVVRRC--VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG--HPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT--CTTBCCEEEEEEBSSEE
T ss_pred eEEecCCCEEEEEE--EECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC--CCCEeEEEEEEeeCCEE
Confidence 47999999999999 6677899999999975431 1135678899999998 6 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
++||||+++++|.+++ .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||++.
T Consensus 176 ~lv~e~~~g~~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEEECCCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 9999999999999998 4556799999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCccccccccCCccccCccccccC------CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
...... ......|++.|+|||++.+. .++.++|+||||+++|+|++|+.||....
T Consensus 249 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 249 HLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 764332 22346789999999988643 57889999999999999999999997654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=261.97 Aligned_cols=192 Identities=24% Similarity=0.243 Sum_probs=159.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+|+.||||.+.... .........|+..+..+ . ||||+++++++.+.+..++||||
T Consensus 63 ~~LG~G~~g~Vy~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~--h~~iv~l~~~~~~~~~~~lv~e~ 138 (311)
T 3p1a_A 63 SRLGHGSYGEVFKV--RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ--HPCCVRLEQAWEEGGILYLQTEL 138 (311)
T ss_dssp EEEEEETTEEEEEE--EETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEEC
T ss_pred heeccCCCeEEEEE--EECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcC--CCcEEEEEEEEEeCCEEEEEEec
Confidence 46999999999999 677789999999986542 23334555566666555 5 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+ +++|.+++. .....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 139 ~-~~~L~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 139 C-GPSLQQHCE---AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp C-CCBHHHHHH---HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred c-CCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9 778988873 3345799999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2234568999999998876 789999999999999999999776654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=259.32 Aligned_cols=192 Identities=30% Similarity=0.526 Sum_probs=164.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchh-------hHHHHHHHHHHhhhccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQG-------EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||+||++ ....+++.||+|.+....... .+.+.+|+++++.++ ||||+++++++.+.. ++
T Consensus 25 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 25 KQIGKGGFGLVHKG--RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN--HPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EECCCCSSSCEEEE--EETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC--CTTBCCEEEEETTTT--EE
T ss_pred hccccCCceeEEEE--EEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC--CCCchhhheeecCCC--eE
Confidence 46999999999999 667889999999986543221 167889999999998 999999999986655 69
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEcCCCc-----eEEec
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFN-----PKISD 147 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~ni~~~~~~~-----~~l~d 147 (229)
||||+++++|.+.+. .....+++..+..++.|++.+|++||+. | ++|+||||+||+++.++. ++|+|
T Consensus 99 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 999999999998883 4456799999999999999999999999 8 999999999999987776 99999
Q ss_pred cccccccCCCCccccccccCCccccCccccc--cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 148 FGLSKLFPENTTHISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
||.+..... ......+++.|+|||++. ...++.++|+||||+++|+|++|+.||....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999875432 223456899999999984 4557889999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=279.44 Aligned_cols=198 Identities=30% Similarity=0.444 Sum_probs=168.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++.+ .++..||||.++... ...+.+.+|+++++.++ ||||+++++++. ....++||||+++
T Consensus 194 ~~lG~G~fg~V~~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 194 KKLGAGQFGEVWMATY---NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQ--HDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp EEEECCSSEEEEEEEE---TTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCC--CTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred EEcccCCceEEEEEEE---CCccEEEEEEecCCC-ccHHHHHHHHHHHhhCC--CCCEeeEEEEEe-CCccEEEEeecCC
Confidence 4699999999999933 457889999997543 34678999999999999 999999999886 5578999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..........
T Consensus 267 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 267 GSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 9999999422 234688999999999999999999999 99999999999999999999999999998764332222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 233346778999999998999999999999999999999 99999875443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=261.01 Aligned_cols=197 Identities=26% Similarity=0.358 Sum_probs=168.2
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.||+|+||.||++ .+..+++.||+|.+........+.+.+|+..++.++ ||||+++++++.+.+..++||||++++
T Consensus 29 ~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 29 VLGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK--HKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp EEEECSSSEEEEE--EETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEeecCcEEEEEE--EECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCC--CCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 6999999999999 667889999999998766666678999999999998 999999999999999999999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-CCceEEeccccccccCCCCccc
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
+|.+++... .....+++..+..++.|++.||++||+. |++|+||+|+||+++. ++.++|+|||.+........ .
T Consensus 105 ~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~ 179 (295)
T 2clq_A 105 SLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-C 179 (295)
T ss_dssp EHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-c
Confidence 999998432 2234567899999999999999999999 9999999999999987 88999999999876543221 2
Q ss_pred cccccCCccccCccccccCC--CCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 162 STRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.....+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 23456899999999987643 789999999999999999999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=262.47 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=162.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+|+.||+|.++.. .......+.+|+..++.++ ||||+++++++.+.+..++||||
T Consensus 38 ~~lg~G~~g~Vy~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 38 KKIGRGQFSEVYRA--ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEECC--CEEEEE--EETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEEEEC
T ss_pred EeecCCCCceEEEE--EEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCcEEEEEec
Confidence 56999999999999 66778999999999753 2334567889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++.........+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999999999965545567899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 191 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 191 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred c-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 1 223356889999999999999999999999999999999999999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=267.53 Aligned_cols=203 Identities=27% Similarity=0.377 Sum_probs=168.5
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++.+.. ..++..||+|.++.. .....+.+.+|+.+++.+ . ||||+++++++.+.+..++||
T Consensus 51 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEE
T ss_pred eeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcC--CCCeeeEEEEEeeCCccEEEE
Confidence 469999999999995432 345678999999754 233457889999999999 7 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhcc-------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 027015 77 DYMPNNSLSQTLLGEEKR-------------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~-------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~ 137 (229)
||+++++|.+++...... ...+++..+..++.|++.||++||+. |++|+||||+||++
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll 205 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV 205 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEE
Confidence 999999999999533211 13489999999999999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 138 DQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
+.++.++|+|||.+........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||....
T Consensus 206 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999976543322 12234456788999999999999999999999999999998 999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=263.92 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=168.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE----cCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI----DGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~----~~~~~~lv~e 77 (229)
+.||+|+||.||++ .+..+|+.||+|.+........+.+.+|+++++.++ ||||+++++++. .....++|+|
T Consensus 35 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 35 QKLGEGGFSYVDLV--EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN--HPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEC--CEEEEEE--EETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEecCCCCeEEEEE--EecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC--CCCeeeEEEEEEeccCCCceeEEEEE
Confidence 57999999999999 667889999999997766666788999999999998 999999999987 3346789999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++.........+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 9999999999965545567899999999999999999999999 9999999999999999999999999988754321
Q ss_pred Ccc--------ccccccCCccccCccccccCC---CCCcccchhHHHHHHHHHhCCCcccC
Q 027015 158 TTH--------ISTRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 158 ~~~--------~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
... ......|++.|+|||++.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 110 012234688999999987554 68999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=261.26 Aligned_cols=195 Identities=27% Similarity=0.384 Sum_probs=169.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....+|+.||+|.+.... ..+.+.+|+..++.++ ||||+++++++.+.+..++||||+++
T Consensus 35 ~~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (314)
T 3com_A 35 EKLGEGSYGSVYKA--IHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD--SPHVVKYYGSYFKNTDLWIVMEYCGA 108 (314)
T ss_dssp EECC----CEEEEE--EETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeccCCCeEEEEE--EECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCC--CCCCccEEEEEEeCCEEEEEeecCCC
Confidence 57999999999999 667789999999997543 3467889999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 109 ~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 109 GSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp EEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 99999983 3456799999999999999999999999 999999999999999999999999999876644322 2
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999999899999999999999999999999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=266.97 Aligned_cols=197 Identities=31% Similarity=0.443 Sum_probs=163.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----ceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~lv~e 77 (229)
+.||+|+||+||++++ .++.||||.+.... .......+|+..++.++ ||||+++++++.+.. ..++|||
T Consensus 30 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 30 EVKARGRFGCVWKAQL----LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMK--HENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEECSTTCEEEEEEE----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred heecccCceEEEEEEE----CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCC--CCCchhhcceeccCCCCCceEEEEEe
Confidence 5799999999999933 37999999997543 33345666888899998 999999999998754 3689999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC-------CCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-------QPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-------~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
|+++++|.+++. ...+++..+..++.|++.||+|||+.. ..|++|+||||+||+++.++.++|+|||.
T Consensus 103 ~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 103 FHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999983 245999999999999999999999751 22899999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccCCccccCccccccC-----CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 151 SKLFPENTTH-ISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
+......... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.....
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 9776443222 22335689999999998863 456688999999999999999999987544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=263.17 Aligned_cols=192 Identities=25% Similarity=0.344 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEeccCC-------cEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDG-------TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||+||++.. ..++ ..||+|.+........+.+.+|+..++.++ ||||+++++++.+.+..++
T Consensus 14 ~~lg~G~~g~V~~~~~--~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 14 ESLGQGTFTKIFKGVR--REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS--HKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEETTEEEEEEEE--EEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC--CTTBCCEEEEECCTTCCEE
T ss_pred eeeccCCCceEEEEEE--ecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEEeCCCCEE
Confidence 5799999999999944 4444 579999997666666788999999999999 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc--------eEEe
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--------PKIS 146 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~--------~~l~ 146 (229)
||||+++++|.+++. .....+++..+..++.|+++||++||+. |++|+||||+||+++.++. ++|+
T Consensus 90 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEECCTTCBHHHHHH---HTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEECCCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 999999999999993 2334599999999999999999999999 9999999999999988877 9999
Q ss_pred ccccccccCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhC-CCcccCc
Q 027015 147 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSG-RTAVDFD 208 (229)
Q Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g-~~pf~~~ 208 (229)
|||.+...... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++| ..||...
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence 99998654221 23457888999999887 7789999999999999999995 4555543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=265.94 Aligned_cols=204 Identities=25% Similarity=0.409 Sum_probs=169.4
Q ss_pred CccCCcccccccccceEe-----ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-----LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||.||++.+.. ..++..||+|.++... ....+.+.+|+++++.+ + ||||+++++++.+.+..++
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSCCEE
T ss_pred eEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhc--CCCEeeEEEEEccCCceEE
Confidence 579999999999995431 2467899999997553 33457788999999999 6 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc
Q 027015 75 VYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~ 142 (229)
||||+++++|.+++..... ....+++..++.++.|+++||.+||+. |++|+||||+||+++.++.
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 195 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCC
Confidence 9999999999999954321 123589999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 143 PKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 143 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
++|+|||.+........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999987644322 12233456788999999998889999999999999999999 9999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=274.82 Aligned_cols=194 Identities=29% Similarity=0.448 Sum_probs=165.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-ceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-~~~lv~e~~~ 80 (229)
+.||+|+||+||++.+ .|+.||||.++... ..+.+.+|+++++.++ ||||+++++++.+.. ..++||||++
T Consensus 199 ~~lG~G~fg~V~~~~~----~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 199 QTIGKGEFGDVMLGDY----RGNKVAVKCIKNDA--TAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp EEEEECSSEEEEEEEE----TTEEEEEEEESSCT--TSHHHHHHHHHHHTCC--CTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred eeecCcCCeeEEEEEe----cCCeEEEEEeCCch--HHHHHHHHHHHHHhcc--CCCEEEEEEEEEcCCCceEEEEEecC
Confidence 5799999999999843 47899999997543 4578999999999999 999999999987665 7899999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++... ....+++..+..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++......
T Consensus 271 ~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 271 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 99999999422 223478999999999999999999999 9999999999999999999999999998754322
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 122356788999999999999999999999999999998 999998765443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=273.88 Aligned_cols=194 Identities=25% Similarity=0.373 Sum_probs=158.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--------chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~ 73 (229)
+.||+|+||.||++ .+..+++.||+|++.... ......+.+|+++++.++ ||||+++++++..+ ..+
T Consensus 141 ~~LG~G~~g~V~~a--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~-~~~ 215 (419)
T 3i6u_A 141 KTLGSGACGEVKLA--FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN--HPCIIKIKNFFDAE-DYY 215 (419)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC--CTTBCCCCEEEESS-EEE
T ss_pred eEEeeCCCeEEEEE--EECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC--CCCEeeEEEEEecC-ceE
Confidence 46999999999999 778899999999997542 112235789999999998 99999999998654 578
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC---ceEEecccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGL 150 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~---~~~l~dfg~ 150 (229)
+||||+++++|.+++ .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||+
T Consensus 216 lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 216 IVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 999999999999988 5667899999999999999999999999 999999999999997544 499999999
Q ss_pred ccccCCCCccccccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 151 SKLFPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
+....... ......|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 289 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 289 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred ceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 98764322 2244678999999999863 567889999999999999999999998643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=266.09 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=172.6
Q ss_pred CccCCcccccccccceE--eccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE--cCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~--~~~~~~lv~e 77 (229)
+.||+|+||.||++++. +..+++.||+|.+........+.+.+|+++++.++ ||||+++++++. +....++|||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH--SDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC--CCceeEEEEEEecCCCceEEEEEe
Confidence 57999999999999432 46688999999998766666678999999999998 999999999887 4456789999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+......
T Consensus 107 ~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 107 YLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp CCTTCBHHHHHH---HHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred ecCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 999999999993 2345699999999999999999999999 9999999999999999999999999999876433
Q ss_pred Ccc--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 TTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 221 2334557888999999999889999999999999999999999997543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=270.31 Aligned_cols=195 Identities=23% Similarity=0.358 Sum_probs=162.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++ .+ .+++.||||.+.... ....+.+.+|+++++.++..||||+++++++......++||| +
T Consensus 62 ~~LG~G~fg~Vy~~--~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~ 137 (390)
T 2zmd_A 62 KQIGSGGSSKVFQV--LN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 137 (390)
T ss_dssp EEEECCSSEEEEEE--EC-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-C
T ss_pred EEEccCCCeEEEEE--Ec-CCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-c
Confidence 57999999999998 33 348999999997553 334577899999999998446999999999999999999999 5
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
.+++|.+++ .....+++..+..++.|++.||.|||+. |++||||||+||+++ ++.++|+|||++..+.....
T Consensus 138 ~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 138 GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp CSEEHHHHH----HHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred CCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 688999998 4556889999999999999999999999 999999999999996 68999999999987643322
Q ss_pred c-ccccccCCccccCcccccc-----------CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 H-ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~-~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 1 2344679999999999875 36889999999999999999999999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=263.71 Aligned_cols=203 Identities=25% Similarity=0.393 Sum_probs=172.5
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++.+. +..+++.||+|.++.... ...+.+.+|+..++.+ + ||||+++++++.+.+..++||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEE
T ss_pred HhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhccc--CCCeeeEEEEEecCCCcEEEE
Confidence 46999999999999543 346778999999975533 3457789999999999 7 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhc--------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc
Q 027015 77 DYMPNNSLSQTLLGEEK--------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 142 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~ 142 (229)
||+++++|.+++..... ....+++..++.++.|+++||++||+. |++|+||+|+||+++.++.
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 183 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCC
Confidence 99999999999854321 123589999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 143 PKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 143 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||....
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999876443221 2233456788999999999999999999999999999998 999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=258.17 Aligned_cols=195 Identities=26% Similarity=0.396 Sum_probs=163.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+|+.||+|.+.... ....+.+.+|+..++.++ ||||+++++++.+....++||||
T Consensus 17 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 17 DTLGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR--HPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeecCCCCeEEEEE--EECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC--CCCEeEEEEEEecCCeEEEEEec
Confidence 57999999999999 667789999999997542 233467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 93 ~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 93 VSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred cCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999 4456799999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||....
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 1233468899999999987765 589999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=270.72 Aligned_cols=192 Identities=29% Similarity=0.372 Sum_probs=151.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~ 73 (229)
+.||+|+||.||++ .+..+|+.||||.+... .....+.+.+|+.+++.++ ||||+++++++... ...+
T Consensus 35 ~~lG~G~~g~V~~a--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 35 SPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EECC----CCEEEE--EETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeecCCeEEEEE--EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEecCCccccCCeEE
Confidence 57999999999999 77889999999998653 3334577889999999999 99999999998754 5679
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+++|++ +++|.+++. ...+++..+..++.|+++||.|||+. |++|+||||+||+++.++.++|+|||++..
T Consensus 111 lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 111 LVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 999998 789988872 35799999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... .....+|+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5332 234568999999999886 6789999999999999999999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=257.46 Aligned_cols=195 Identities=22% Similarity=0.325 Sum_probs=167.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ ....+++.||+|.++.. .......+.+|+..+..+ + ||||+++++++.+.+..++||||
T Consensus 17 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~--h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 17 EKIGSGEFGSVFKC--VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCS--CTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhcCCCceEEEEE--EEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCC--CCCeeeeeeeeecCCeEEEEEEe
Confidence 57999999999999 67778999999999754 344557788899999998 6 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC------------------
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN------------------ 140 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~------------------ 140 (229)
+++++|.+++.........+++..++.++.|++.||++||+. |++|+||||+||+++.+
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 999999999965544457799999999999999999999999 99999999999999844
Q ss_pred -CceEEeccccccccCCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 141 -FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 141 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..++|+|||.+...... ....+++.|+|||.+.+. .++.++|+||||+++|++++|..|+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 47999999998775432 223589999999998865 5668999999999999999999877543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=266.40 Aligned_cols=195 Identities=24% Similarity=0.361 Sum_probs=161.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ .. .+++.||+|.+.... ....+.+.+|+++++.++..||||+++++++.+....++||| +
T Consensus 15 ~~lG~G~~g~Vy~~--~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 90 (343)
T 3dbq_A 15 KQIGSGGSSKVFQV--LN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 90 (343)
T ss_dssp EEESCCSSEEEEEE--EC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEecCCCeEEEEE--Ee-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence 57999999999998 33 568999999997553 333467889999999998323999999999999999999999 5
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
.+++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||+++ ++.++|+|||++........
T Consensus 91 ~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 91 GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp CSEEHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 588999999 4567899999999999999999999999 999999999999997 67899999999987643322
Q ss_pred c-ccccccCCccccCcccccc-----------CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 H-ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~-~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 1 2334578999999999875 66889999999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=269.67 Aligned_cols=195 Identities=22% Similarity=0.311 Sum_probs=164.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------------ 69 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------------ 69 (229)
+.||+|+||+||++ .+..+|+.||+|.+..... ...+|+++++.++ ||||+++++++...
T Consensus 13 ~~lG~G~fg~V~~a--~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 13 KTLGTGSFGIVCEV--FDIESGKRFALKKVLQDPR----YKNRELDIMKVLD--HVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp EEEECC-CEEEEEE--EETTTCCEEEEEEEECCTT----SCCHHHHHHTTCC--CTTBCCEEEEEEEC------------
T ss_pred EEEEeccCEEEEEE--EECCCCCEEEEEEEecCcc----hHHHHHHHHHHcC--CCCccchhheeeecCccccccccccc
Confidence 57999999999999 7788999999999864422 2347999999999 99999999998543
Q ss_pred --------------------------CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 027015 70 --------------------------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 123 (229)
Q Consensus 70 --------------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 123 (229)
...++||||++ ++|.+.+.........+++..+..++.|++.||+|||+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--- 160 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34789999997 588888765556678899999999999999999999999
Q ss_pred CeEEcCCCCCCEEEc-CCCceEEeccccccccCCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhC
Q 027015 124 HVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSG 201 (229)
Q Consensus 124 ~i~h~di~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g 201 (229)
|++|+||||+||+++ +++.++|+|||.+........ .....+++.|+|||++.+. .++.++|+||+||++|+|++|
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 999999999999997 688999999999987643322 2345678999999998865 489999999999999999999
Q ss_pred CCcccCccc
Q 027015 202 RTAVDFDVQ 210 (229)
Q Consensus 202 ~~pf~~~~~ 210 (229)
+.||.....
T Consensus 239 ~~pf~~~~~ 247 (383)
T 3eb0_A 239 KPLFSGETS 247 (383)
T ss_dssp SCSSCCSSH
T ss_pred CCCCCCCCh
Confidence 999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=258.53 Aligned_cols=198 Identities=41% Similarity=0.620 Sum_probs=169.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc----cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.. +++.||+|.+... .....+.+.+|+..++.++ ||||+++++++.+.+..++|||
T Consensus 37 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ--HENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp CEEEECSSEEEEEEES----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred CccccCCCeEEEEEEE----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC--CCCeEEEEEEEecCCceEEEEE
Confidence 4699999999999832 6899999998643 2334577889999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++... .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 111 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 111 YMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp CCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 99999999998432 2345799999999999999999999999 9999999999999999999999999998765443
Q ss_pred Cc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. .......|++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.....
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 22 12334568999999998765 478999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=267.06 Aligned_cols=198 Identities=28% Similarity=0.351 Sum_probs=168.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~lv 75 (229)
+.||+|+||.||++ .+..+++.||+|.+.... ....+.+.+|+++++.++ ||||+++++++... ...++|
T Consensus 33 ~~lG~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 33 SYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC--CTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEeecCCCeEEEEE--EECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC--CCCCccceeEEecCCccccceEEEE
Confidence 57999999999999 777889999999997543 334477889999999999 99999999999654 367999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
+|+++ ++|.+++ ....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+....
T Consensus 109 ~e~~~-~~L~~~l-----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 109 QDLME-TDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EECCS-EEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EcccC-cCHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99996 5898888 234699999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcc--ccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 156 ENTTH--ISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 156 ~~~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
..... ......||+.|+|||++. +..++.++|+||||+++|+|++|+.||......+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 32211 124457899999999866 4558999999999999999999999998765433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=265.65 Aligned_cols=201 Identities=25% Similarity=0.393 Sum_probs=162.6
Q ss_pred CccCCcccccccccceEeccCCcEE----EEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIV----AVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||.||++ ....+++.+ ++|.+... .....+.+.+|+.+++.++ ||||+++++++.++. .++++
T Consensus 21 ~~lG~G~~g~Vy~~--~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 21 KVLGSGAFGTVYKG--LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEECSSEEEEEE--EECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC--BTTBCCCCEEEESSS-EEEEE
T ss_pred EEeeeCCCeEEEEE--EEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC--CCCeeEEEEEEecCC-ceEEE
Confidence 57999999999999 555666654 66666533 3445578899999999999 999999999998765 78999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
+++++++|.+++. .....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+.....
T Consensus 96 ~~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 96 QLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CCCSSCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 9999999999983 3456799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccc
Q 027015 157 NTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 213 (229)
Q Consensus 157 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~ 213 (229)
... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||........
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 228 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 322 12233446778999999999999999999999999999999 9999987654443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=268.22 Aligned_cols=199 Identities=20% Similarity=0.262 Sum_probs=159.2
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeecccchh-----------hHHHHHHHHHHhhhccCCCcccccceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVESKQG-----------EKEFMSEVASMANVNVCHENLVKLHGGCI 67 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~~~~-----------~~~~~~e~~~~~~l~~~~~~i~~~~~~~~ 67 (229)
+.||+|+||.||++.+... ..++.||+|.+....... ......|+..+..++ ||||+++++++.
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~ 118 (364)
T 3op5_A 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK--YLGVPKYWGSGL 118 (364)
T ss_dssp EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS--CCCSCCEEEEEE
T ss_pred EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc--CCCCCeEEeeee
Confidence 4699999999999944221 136899999987543211 012233444555666 999999999987
Q ss_pred cC----CceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc--CCC
Q 027015 68 DG----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNF 141 (229)
Q Consensus 68 ~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~--~~~ 141 (229)
.. ...++||||+ +++|.+++. .....+++..+..++.|++.||+|||+. |++||||||+||+++ .++
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~---~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYE---ANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHH---HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 64 4478999999 999999983 3346799999999999999999999999 999999999999998 889
Q ss_pred ceEEeccccccccCCCCcc------ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 142 NPKISDFGLSKLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 142 ~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.++|+|||++..+...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9999999999765432111 1133458999999999999999999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=262.67 Aligned_cols=197 Identities=21% Similarity=0.353 Sum_probs=166.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++ ....+|+.||+|.+........+.+.+|++.++.++ ||||+++++++.+++..++||||+++
T Consensus 25 ~~lg~G~~g~V~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 25 GELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEECSTTCCEEEE--EETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCC--CTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred ceeccCCCeEEEEE--EEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCC--CCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 56999999999999 667789999999998666666788999999999998 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 101 ~~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 101 GAVDAIML---ELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred CcHHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 99999883 3356799999999999999999999999 9999999999999999999999999987543211 111
Q ss_pred cccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.....+++.|+|||++. +..++.++|+||||+++|+|++|+.||....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 23346889999999884 5678899999999999999999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=266.48 Aligned_cols=195 Identities=21% Similarity=0.278 Sum_probs=158.6
Q ss_pred CccCCcccccccccceEecc---CCcEEEEEEeecccch-----------hhHHHHHHHHHHhhhccCCCcccccceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ---DGTIVAVKVLSVESKQ-----------GEKEFMSEVASMANVNVCHENLVKLHGGCI 67 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~ 67 (229)
+.||+|+||.||++ .... ++..+|+|........ ....+.+|+..++.++ ||||+++++++.
T Consensus 43 ~~lg~G~~g~Vy~~--~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~--h~ni~~~~~~~~ 118 (345)
T 2v62_A 43 KKIGSGGFGLIYLA--FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD--YLGIPLFYGSGL 118 (345)
T ss_dssp EEC------CEEEE--EESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS--CCCCCCEEEEEE
T ss_pred eeEeecCCeEEEEE--EecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc--ccCcceeecccc
Confidence 47999999999999 4444 6789999998754321 1133556778888888 999999999998
Q ss_pred c----CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC--
Q 027015 68 D----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-- 141 (229)
Q Consensus 68 ~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-- 141 (229)
. ....++||||+ +++|.+++ .....+++..++.++.|++.||+|||+. |++|+||||+||+++.++
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKIS----GQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHC----BGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccCCCcEEEEEEecc-CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 7 67889999999 99999998 4455899999999999999999999999 999999999999998877
Q ss_pred ceEEeccccccccCCCC------ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 142 NPKISDFGLSKLFPENT------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 142 ~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.++|+|||++..+.... ........|++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999999997653321 11124457899999999999999999999999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=264.50 Aligned_cols=200 Identities=28% Similarity=0.393 Sum_probs=165.9
Q ss_pred CccCCcccccccccceEeccCCcEE--EEEEeecc-cchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIV--AVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++ ....+|..+ ++|.++.. .....+.+.+|+++++.+ + ||||+++++++.+.+..++|||
T Consensus 31 ~~lg~G~~g~Vy~~--~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 31 DVIGEGNFGQVLKA--RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp EEEECGGGCEEEEE--EEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCC--CTTBCCEEEEEEETTEEEEEEC
T ss_pred eeeecCCCceEEEE--EEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccC--CCchhhhceeeeeCCceEEEEe
Confidence 46999999999999 555677755 99998743 334456788999999999 6 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 78 YMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
|+++++|.+++.... .....+++..++.++.|++.||++||+. |++|+||+|+||+++.++.++|
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999985432 2235799999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
+|||++...... .......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 999998643221 11233446788999999998889999999999999999998 9999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=271.93 Aligned_cols=197 Identities=22% Similarity=0.293 Sum_probs=167.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC--ceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--~~~lv~e~ 78 (229)
+.||+|+||+||++ ....+|+.||+|+++... ....+.+.+|+++++.++ ||||+++++++.+.. ..++||||
T Consensus 15 ~~LG~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 15 DILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--HKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECTTTCCEEEEECC
T ss_pred EEEEcCCCeEEEEE--EECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC--CCCCCeEEEeeccCCCCeeEEEEec
Confidence 46999999999999 667789999999997543 334567789999999999 999999999998765 67999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----cCCCceEEecccccccc
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF 154 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~----~~~~~~~l~dfg~~~~~ 154 (229)
+++++|.+++... .....+++..++.++.|++.||+|||+. |++|+||||+||++ +.++.++|+|||.+...
T Consensus 91 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 91 CPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred CCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999999998432 2223499999999999999999999999 99999999999999 77778999999999875
Q ss_pred CCCCccccccccCCccccCcccccc--------CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAIS--------GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.... ......|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4332 2234568999999998875 45778999999999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=267.89 Aligned_cols=197 Identities=24% Similarity=0.329 Sum_probs=166.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-----hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++ .+..+|+.||+|.++..... ..+.+.+|+++++.++ ||||+++++++.+....++||
T Consensus 16 ~~lg~G~~g~Vy~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 16 DFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp EEEEEETTEEEEEE--ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC--CTTBCCEEEEECCTTCCEEEE
T ss_pred eEEeecCCEEEEEE--EECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC--CCCCCeEEEEEeeCCceEEEE
Confidence 57999999999999 66778999999999754221 1356789999999999 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++ +|.+++. .....+++..+..++.|+++||+|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 92 e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 92 DFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp ECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99976 8888872 3445788999999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 165 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 165 PNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp CCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Ccc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 322 2234568999999999875 4588999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=258.12 Aligned_cols=197 Identities=31% Similarity=0.441 Sum_probs=167.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++. ..+++.||+|.++... ...+.+.+|++.++.++ ||||+++++++.+ +..++||||+++
T Consensus 19 ~~lg~G~~g~Vy~~~---~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 19 ERLGAGQFGEVWMGY---YNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQ--HQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp EEEEEETTEEEEEEE---ETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred eeecCCCCeEEEEEE---EcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCC--CcCcceEEEEEcC-CCcEEEEecCCC
Confidence 579999999999993 3467789999997543 34567899999999998 9999999998764 458999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.||++||+. |++|+||+|+||++++++.++|+|||.+..........
T Consensus 92 ~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999998321 223799999999999999999999999 99999999999999999999999999998765443333
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 334456778999999998889999999999999999999 9999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=276.90 Aligned_cols=198 Identities=31% Similarity=0.465 Sum_probs=162.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++.+ .++..||||.++... ...+.+.+|+++++.++ ||||+++++++.+ ...++||||+++
T Consensus 190 ~~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 190 VKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp EEEEECSSCEEEEEEE---TTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred eeecCCCCeEEEEEEE---CCCceEEEEEeccCC-CCHHHHHHHHHHHHhCC--CCCEeeEEEEEcC-CceEEEehhhcC
Confidence 4699999999999933 345779999997543 34567899999999999 9999999999876 678999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++..........
T Consensus 263 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 263 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 9999999321 235689999999999999999999999 99999999999999999999999999998764432222
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 233446788999999999999999999999999999999 99999875543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=257.35 Aligned_cols=203 Identities=21% Similarity=0.275 Sum_probs=168.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEE-EcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC-IDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~-~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||++ .+..+++.||+|.+..... ...+.+|+++++.++ |++++..+..+ .+....++||||+
T Consensus 15 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~--~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 15 RKIGSGSFGDIYLG--TDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEECSSSEEEEE--EETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHT--TSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eeecCCCCeEEEEE--EEcCCCceEEEEeeccccc--chHHHHHHHHHHHhc--CCCCCCeeeeecCCCCceEEEEEcc-
Confidence 56999999999999 6778999999998764432 246788999999999 87766666655 5667789999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccccCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~---~~~~~~~l~dfg~~~~~~~~ 157 (229)
+++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||++ +.++.++|+|||.+......
T Consensus 88 ~~~L~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 88 GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHH---HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999999983 2356799999999999999999999999 99999999999999 78899999999999876443
Q ss_pred Cc------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccccccch
Q 027015 158 TT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 217 (229)
Q Consensus 158 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 217 (229)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||............
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 22 1223467899999999999999999999999999999999999999876554443333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=258.12 Aligned_cols=201 Identities=27% Similarity=0.348 Sum_probs=166.0
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCce-EEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR-ILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~-~lv~e~ 78 (229)
+.||+|+||.||++.+... .++..||+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+.... ++++||
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN--HPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEECCSSSCCEEEECC
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEecCCCCcEEEEec
Confidence 4699999999999954332 233479999987543 344577889999999998 99999999999876655 899999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+.+++|.+++. .....+++..+..++.|+++||++||+. |++|+||||+||+++.++.++|+|||.+.......
T Consensus 105 ~~~~~L~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 105 MCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred ccCCCHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999983 3456789999999999999999999999 99999999999999999999999999997653321
Q ss_pred ---ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCC-CcccCccc
Q 027015 159 ---THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVDFDVQ 210 (229)
Q Consensus 159 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~-~pf~~~~~ 210 (229)
........+++.|+|||.+.+..++.++|+||||+++|+|++|. +||.....
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 11223355788999999999999999999999999999999955 55554443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=256.77 Aligned_cols=191 Identities=31% Similarity=0.463 Sum_probs=156.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc----hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK----QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++. . .|+.||+|.++.... ...+.+.+|++.++.++ ||||+++++++.+.+..++|||
T Consensus 13 ~~lg~G~~g~V~~~~--~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 13 EIIGIGGFGKVYRAF--W--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--HPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp EEEEEETTEEEEEEE--E--TTEEEEEEEC----------CHHHHHHHHHHHHHCC--CTTBCCEEEEECCC--CEEEEE
T ss_pred eeeccCCCeEEEEEE--E--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC--CCCEeeEEEEEecCCceEEEEE
Confidence 479999999999993 3 478999999875422 22467889999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC---eEEcCCCCCCEEEcC--------CCceEEe
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH---VVHRDIKTSNILLDQ--------NFNPKIS 146 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---i~h~di~p~ni~~~~--------~~~~~l~ 146 (229)
|+++++|.+++ ....+++..+..++.|++++|++||+. | ++|+||+|+||+++. ++.++|+
T Consensus 87 ~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 87 FARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp CCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred cCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999988 345799999999999999999999999 8 999999999999985 6789999
Q ss_pred ccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 147 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
|||.+........ ....+++.|+|||.+.+..++.++|+||||+++|++++|+.||....
T Consensus 159 Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 159 DFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876543322 23468999999999999999999999999999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=268.09 Aligned_cols=193 Identities=24% Similarity=0.283 Sum_probs=159.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~ 73 (229)
+.||+|+||.||++ .+..+|+.||||.+... .....+.+.+|+.+++.++ ||||+++++++.... ..+
T Consensus 31 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 31 KPIGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeeEecCCEEEEEE--EECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC--CCCccceEEeeccccccccccceE
Confidence 56999999999999 77788999999999754 2334467889999999999 999999999997654 679
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||+++ +|.+.+. ..+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||++..
T Consensus 107 lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999964 7877772 3588999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 54322 22345689999999999999999999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=264.71 Aligned_cols=201 Identities=27% Similarity=0.418 Sum_probs=169.5
Q ss_pred CccCCcccccccccceEeccCC-----cEEEEEEeeccc-chhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDG-----TIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||.||++ ....++ ..||+|.++... ....+.+.+|+.+++.+ + ||||+++++++.+.+..++
T Consensus 52 ~~lG~G~~g~Vy~~--~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 52 KTLGAGAFGKVVEA--TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ--HENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEEECSSEEEEEE--EETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEE
T ss_pred eEeccCCCcceEEE--EecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcC--CCCeeeEEEEEecCCceEE
Confidence 46999999999999 444333 489999997553 33456788999999999 7 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhc----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceE
Q 027015 75 VYDYMPNNSLSQTLLGEEK----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~ 144 (229)
||||+++++|.+++..... ....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence 9999999999999854322 134689999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 145 ISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 145 l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
|+|||++........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||....
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999999976533222 12233456778999999999999999999999999999998 999998654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=269.09 Aligned_cols=195 Identities=9% Similarity=0.043 Sum_probs=149.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccc-------eEEEcCC-
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLH-------GGCIDGP- 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~-------~~~~~~~- 70 (229)
+.||+|+||.||++ .+..+|+.||+|++..... ...+.+.+|+.+++.++..||||++++ +.+...+
T Consensus 68 ~~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 68 EPLRVGDRSVVFLV--RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred eeccCCCCEEEEEE--EECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 46999999999999 6677899999999986532 334567778555555532399988755 4554332
Q ss_pred ----------------ceEEEEEccCCCCHHHHHhhhhccccCCCHHHH------HHHHHHHHHHHHHHhhcCCCCeEEc
Q 027015 71 ----------------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR------REIIMGIGRGLAYIHEEIQPHVVHR 128 (229)
Q Consensus 71 ----------------~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~------~~~~~~i~~~l~~lH~~~~~~i~h~ 128 (229)
..++||||++ ++|.+++... ...++...+ ..++.|+++||+|||+. |++||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 3799999998 8999999432 334455555 67779999999999999 99999
Q ss_pred CCCCCCEEEcCCCceEEeccccccccCCCCccccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCccc
Q 027015 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 129 di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
||||+||+++.++.++|+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998653321 13456799999999987 779999999999999999999999998
Q ss_pred Ccc
Q 027015 207 FDV 209 (229)
Q Consensus 207 ~~~ 209 (229)
...
T Consensus 295 ~~~ 297 (371)
T 3q60_A 295 LVT 297 (371)
T ss_dssp BCC
T ss_pred CcC
Confidence 764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=262.30 Aligned_cols=197 Identities=31% Similarity=0.482 Sum_probs=167.3
Q ss_pred CccCCcccccccccce--EeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPF--IRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~--~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~ 76 (229)
+.||+|+||+||++.+ .+..+|+.||+|.++... ....+.+.+|+++++.++ ||||+++++++.+. ...++||
T Consensus 37 ~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY--HEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTTTEEEEEE
T ss_pred heecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC--CcchhhEEEEEecCCCceEEEEE
Confidence 5799999999977643 455688999999998653 334577899999999999 99999999999874 5678999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||+++++|.+++ ....+++..++.++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 115 e~~~~~~L~~~l-----~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 115 EYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp CCCTTCBHHHHG-----GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ecccCCcHHHHH-----hhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999998 234599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc--cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 157 NTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 157 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
... .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 322 1233455788899999999989999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=255.70 Aligned_cols=196 Identities=27% Similarity=0.385 Sum_probs=170.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---------chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~ 72 (229)
+.||+|+||.||++ .+..+|+.||+|.+.... ....+.+.+|+++++.+. .||||+++++++.+....
T Consensus 23 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~~~ 99 (298)
T 1phk_A 23 EILGRGVSSVVRRC--IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-GHPNIIQLKDTYETNTFF 99 (298)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEE
T ss_pred eeecCCCceEEEEE--EEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc-CCCCEeeeeeeeccCCeE
Confidence 46999999999999 777889999999997543 122356788999999984 399999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
++||||+++++|.+++ .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+.
T Consensus 100 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 100 FLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999 4456899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCccccccccCCccccCccccc------cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAI------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
...... ......+++.|+|||++. ...++.++|+||||+++|+|++|+.||....
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 754332 223456899999999885 4467899999999999999999999997654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=264.13 Aligned_cols=201 Identities=25% Similarity=0.410 Sum_probs=163.0
Q ss_pred CccCCcccccccccceEecc--CCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ--DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++...... .+..||+|.++... ......+.+|+..++.++ ||||+++++++.+.+..++||||
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSEEEEEEC
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEecCCCcEEEEeC
Confidence 46999999999999543221 23469999997553 334467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 128 ~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 128 MENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp CTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 99999999983 3346799999999999999999999999 99999999999999999999999999998764332
Q ss_pred cc--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 159 TH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 159 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 11 1122345778999999998999999999999999999998 9999976543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=270.42 Aligned_cols=197 Identities=20% Similarity=0.244 Sum_probs=168.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhcc----CCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV----CHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~----~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++ .+..+++.||||.++.. ......+.+|+.+++.++. .|+||+++++++......++|||
T Consensus 103 ~~LG~G~fg~V~~a--~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 179 (429)
T 3kvw_A 103 KVIGKGSFGQVVKA--YDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179 (429)
T ss_dssp EEEEESSSEEEEEE--EETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred EEcccCccEEEEEE--EECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence 57999999999999 77788999999999743 3334567778888888752 27799999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc--eEEeccccccccC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDFGLSKLFP 155 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~--~~l~dfg~~~~~~ 155 (229)
|++ ++|.+++.. .....+++..+..++.|++.||+|||+. |++||||||+||+++.++. ++|+|||++....
T Consensus 180 ~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 180 LLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp CCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred ccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 995 689988832 2234589999999999999999999999 9999999999999998887 9999999987643
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.. .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 254 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 254 QR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp CC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred Cc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 32 23457899999999999999999999999999999999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=259.89 Aligned_cols=192 Identities=27% Similarity=0.398 Sum_probs=158.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC----CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~----~~~~lv~e 77 (229)
+.||+|+||+||++.+ +|+.||||++... ......+|.+++......||||+++++++... ...++|||
T Consensus 14 ~~lg~G~~g~V~~~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 14 ECVGKGRYGEVWRGSW----QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp EEEEECSSEEEEEEEE----TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred EeeccCCCcEEEEEEE----CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 5799999999999833 6899999998643 33456667777766333399999999987543 45789999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--------EEIQPHVVHRDIKTSNILLDQNFNPKISDFG 149 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--------~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg 149 (229)
|+++++|.+++ ....+++..+..++.|+++||+||| +. |++|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~g~L~~~l-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 87 YHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp CCTTCBHHHHH-----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred hccCCCHHHHH-----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence 99999999999 3457999999999999999999999 88 99999999999999999999999999
Q ss_pred cccccCCCCccc---cccccCCccccCccccccC------CCCCcccchhHHHHHHHHHhC----------CCcccCc
Q 027015 150 LSKLFPENTTHI---STRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSG----------RTAVDFD 208 (229)
Q Consensus 150 ~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~i~~~l~~g----------~~pf~~~ 208 (229)
++.......... .....||+.|+|||++.+. .++.++||||||+++|+|++| +.||...
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 987654332221 2334789999999998876 445789999999999999999 8888653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=270.54 Aligned_cols=199 Identities=22% Similarity=0.318 Sum_probs=152.7
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~e~~~ 80 (229)
.||+|+||+||++......+++.||+|.+.... ....+.+|+++++.++ ||||+++++++.. ....++||||++
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELK--HPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCC--CTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcC--CCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 699999999999954455678999999986432 2356889999999999 9999999999954 567899999995
Q ss_pred CCCHHHHHhhhhc-----cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----cCCCceEEeccccc
Q 027015 81 NNSLSQTLLGEEK-----RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLS 151 (229)
Q Consensus 81 ~~sL~~~~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~----~~~~~~~l~dfg~~ 151 (229)
++|.+++..... ....+++..++.++.|++.||+|||+. |++||||||+||++ +.++.++|+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 578777743221 223599999999999999999999999 99999999999999 67789999999999
Q ss_pred cccCCCCc--cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 152 KLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 152 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 87643221 223446789999999998874 58999999999999999999999997643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=255.15 Aligned_cols=198 Identities=22% Similarity=0.296 Sum_probs=167.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEE-EcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC-IDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~-~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ++..+|+.||+|++..... ...+.+|+.+++.++ |++++..+..+ ......++||||+
T Consensus 15 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~--~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 15 RKIGSGSFGDIYLG--TDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEETTEEEEEE--EETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHT--TSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEccCCCeEEEEE--EEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhh--cCCCCCccccccCCCCceEEEEEec-
Confidence 57999999999999 6778999999999875432 346889999999999 88766666655 5666779999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccccCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~---~~~~~~~l~dfg~~~~~~~~ 157 (229)
+++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||++ +.++.++|+|||.+......
T Consensus 88 ~~~L~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999999983 2456799999999999999999999999 99999999999999 47889999999999876443
Q ss_pred Ccc------ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 158 TTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 158 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence 221 1244578999999999999999999999999999999999999998755433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=262.14 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=171.0
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.+... .+++.||+|.+.... ......+.+|+.+++.++ ||||+++++++.+....++|||
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred eEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC--CCCEeeeEEEEccCCccEEEEE
Confidence 4699999999999965421 457889999997543 334467889999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhc------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
|+++++|.+++..... ....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccc
Confidence 9999999999854321 124678999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 152 KLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 76533221 12233456788999999999999999999999999999999 899998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=261.01 Aligned_cols=201 Identities=23% Similarity=0.357 Sum_probs=152.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++ ....+++.||+|.+.... ......+.+|+..++.++ ||||+++++++...+..++||||++
T Consensus 21 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 21 EVIGSGATAVVQAA--YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH--HPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp EECC---CCCEEEE--EC----CEEEEECCC----------------CCCCCC--CTTBCCEEEEEESSSCEEEEEECCT
T ss_pred heeccccceEEEEE--EECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC--CCCEeeEEEEEeecCCcEEEehhcc
Confidence 57999999999999 666788999999987543 334567889999999998 9999999999999999999999999
Q ss_pred CCCHHHHHhhhh----ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 81 NNSLSQTLLGEE----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 81 ~~sL~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
+++|.+++.... .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 999999985321 1345699999999999999999999999 999999999999999999999999999876543
Q ss_pred CC----ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 157 NT----THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 157 ~~----~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.. ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 21 111234568999999999875 578999999999999999999999998654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=262.27 Aligned_cols=204 Identities=25% Similarity=0.357 Sum_probs=170.0
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-ceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-~~~lv~ 76 (229)
+.||+|+||.||++.+. +..+++.||+|.++.... ...+.+.+|+..++.+. .||||+++++++...+ ..++||
T Consensus 33 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECCTTSCCEEEE
T ss_pred eEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc-cCCCeeeEEEEEecCCCceEEEE
Confidence 46999999999999543 345778999999975533 34467889999999994 2999999999987654 589999
Q ss_pred EccCCCCHHHHHhhhhcc------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceE
Q 027015 77 DYMPNNSLSQTLLGEEKR------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~ 144 (229)
||+++++|.+++...... ...+++..+..++.|+++||++||+. |++|+||+|+||+++.++.++
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEE
Confidence 999999999999543221 12388999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 145 ISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 145 l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
|+|||.+........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||....
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999976543322 22334557888999999999999999999999999999998 999998654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=262.13 Aligned_cols=204 Identities=26% Similarity=0.359 Sum_probs=165.5
Q ss_pred CccCCcccccccccceE---eccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI---RLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~---~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.+. +..+++.||+|.+... .......+.+|+..++.++ ||||+++++++.+....++|||
T Consensus 36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC--CCCCCeEEEEEcCCCCcEEEEe
Confidence 57999999999999543 4567889999999744 3445567889999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~ 151 (229)
|+++++|.+++..... ....+++..++.++.|++.||.+||+. |++|+||+|+||+++. +..++|+|||.+
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccc
Confidence 9999999999954321 124589999999999999999999999 9999999999999984 445999999998
Q ss_pred cccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 152 KLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 152 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
....... ........+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 7543222 122334557889999999999999999999999999999998 9999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=260.22 Aligned_cols=194 Identities=25% Similarity=0.383 Sum_probs=164.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--------chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~ 73 (229)
+.||+|+||.||++ .+..+++.||||.+.... ......+.+|+++++.++ ||||+++++++.... .+
T Consensus 16 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~-~~ 90 (322)
T 2ycf_A 16 KTLGSGACGEVKLA--FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN--HPCIIKIKNFFDAED-YY 90 (322)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECC---------------CHHHHHHHHHHCC--CTTBCCEEEEEESSS-EE
T ss_pred eEEecCCCEEEEEE--EEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC--CCCCceEeeEEcCCc-eE
Confidence 57999999999999 777889999999986432 122345789999999998 999999999987665 89
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc---eEEecccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGL 150 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~---~~l~dfg~ 150 (229)
+||||+++++|.+++ .....+++..+..++.|++.||++||+. |++|+||+|+||+++.++. ++|+|||.
T Consensus 91 lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 91 IVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 999999999999988 5567899999999999999999999999 9999999999999987655 99999999
Q ss_pred ccccCCCCccccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 151 SKLFPENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
+....... ......|++.|+|||++. ...++.++|+||||+++|+|++|+.||....
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred ceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 97764322 123356899999999874 4668899999999999999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=267.25 Aligned_cols=202 Identities=25% Similarity=0.372 Sum_probs=158.9
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEc-CCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-~~~~~lv~e~ 78 (229)
+.||+|+||+||++.+.... .+..||+|.++.. .....+.+.+|+.+++.++ ||||+++++++.. ++..++||||
T Consensus 95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC--CTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCCCeEEEEEC
Confidence 46999999999999554322 1346899998644 3445578999999999998 9999999998754 4577999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..+..++.|+++||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 173 ~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 173 MKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp CTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999993 3445688999999999999999999999 99999999999999999999999999997653322
Q ss_pred c---cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 159 T---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 159 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||......
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 1 11223456778999999999999999999999999999999 78888765443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=258.01 Aligned_cols=205 Identities=24% Similarity=0.364 Sum_probs=160.6
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC-----ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~-----~~~ 73 (229)
+.||+|+||.||++..... .++..||+|.++... ....+.+.+|+..++.++ ||||+++++++.+.. ..+
T Consensus 40 ~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS--HPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC--CTTBCCCCEEEEC-------CEE
T ss_pred cceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC--CCCeeeeeEEEeeccccCCcccE
Confidence 4699999999999954332 245689999997552 334467889999999999 999999999998654 348
Q ss_pred EEEEccCCCCHHHHHhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
+||||+++++|.+++.... .....+++..++.++.|+++||.+||+. |++|+||+|+||+++.++.++|+|||.+
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcc
Confidence 9999999999999984332 3446799999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 152 KLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 76543321 12233456788999999999999999999999999999999 99999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=261.70 Aligned_cols=198 Identities=27% Similarity=0.476 Sum_probs=169.9
Q ss_pred CccCCcccccccccceE--eccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC--ceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFI--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~--~~~lv~e 77 (229)
+.||+|+||.||++.+. +..+|+.||+|.+........+.+.+|++.++.++ ||||+++++++.... ..++|||
T Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC--CTTBCCEEEEECC----CCEEEEC
T ss_pred eeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEecCCCceEEEEE
Confidence 56999999999999432 45678999999998766666788999999999998 999999999887554 6799999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++. .....+++..+..++.|+++||++||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 125 ~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 125 YLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CCTTCBHHHHHH---HSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred CCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 999999999993 3345699999999999999999999999 9999999999999999999999999999876443
Q ss_pred Ccc--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 158 TTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 158 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 221 12334567789999999988899999999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=263.28 Aligned_cols=197 Identities=22% Similarity=0.366 Sum_probs=168.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchh-----------------hHHHHHHHHHHhhhccCCCcccccce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQG-----------------EKEFMSEVASMANVNVCHENLVKLHG 64 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~~~~l~~~~~~i~~~~~ 64 (229)
+.||+|+||.||++ .. +|+.||+|.+....... .+.+.+|++.++.++ ||||+++++
T Consensus 37 ~~lg~G~~g~V~~~--~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~ 110 (348)
T 2pml_X 37 RTLNQGKFNKIILC--EK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK--NEYCLTCEG 110 (348)
T ss_dssp EEEECCSSCCEEEE--EE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC--CTTBCCCSE
T ss_pred EEEcCCCCeEEEEE--Ec--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC--CCCcceEEE
Confidence 46999999999999 33 89999999997542211 178899999999999 999999999
Q ss_pred EEEcCCceEEEEEccCCCCHHHHHhh----hhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcC
Q 027015 65 GCIDGPCRILVYDYMPNNSLSQTLLG----EEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQ 139 (229)
Q Consensus 65 ~~~~~~~~~lv~e~~~~~sL~~~~~~----~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~ 139 (229)
++.+.+..++||||+++++|.+++.. .......+++..++.++.|++.||++||+ . |++|+||+|+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence 99999999999999999999998211 11125789999999999999999999999 8 9999999999999999
Q ss_pred CCceEEeccccccccCCCCccccccccCCccccCccccccC-CCCC-cccchhHHHHHHHHHhCCCcccCccc
Q 027015 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTR-KSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
++.++|+|||.+...... ......+++.|+|||.+.+. .++. ++|+||||+++|+|++|+.||.....
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999998875433 23445689999999999877 5665 99999999999999999999986543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=254.44 Aligned_cols=191 Identities=27% Similarity=0.408 Sum_probs=166.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc-------------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------------- 68 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~------------- 68 (229)
+.||+|+||.||++ ....+|+.||+|.++... ..+.+|+++++.++ ||||+++++++..
T Consensus 17 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 17 ELIGSGGFGQVFKA--KHRIDGKTYVIKRVKYNN----EKAEREVKALAKLD--HVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp EEEECSSSCCEEEE--EETTTCCEEEEEEEECCS----GGGHHHHHHHHHCC--CTTBCCEEEEEEEEEEC---------
T ss_pred eeeccCCceEEEEE--EEcCCCeEEEEEEecccc----HHHHHHHHHHHhCC--CCCEEEEeeeEeccccCccccccccc
Confidence 57999999999999 667789999999997543 35678999999999 9999999998864
Q ss_pred ---CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 69 ---GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 69 ---~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
....++||||+++++|.+++... ....+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEE
Confidence 34578999999999999999422 345799999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 164 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 164 GDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp CCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred Ccchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999877644322 2345689999999999999999999999999999999999998854
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=256.55 Aligned_cols=188 Identities=20% Similarity=0.323 Sum_probs=164.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ ++..+++.||+|+++.. ..+.+.+|+++++.++ .||||+++++++.+ ....++||||+
T Consensus 42 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 42 RKLGRGKYSEVFEA--INITNNEKVVVKILKPV---KKKKIKREIKILENLR-GGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHT-TSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEecccCCeEEEEE--EECCCCcEEEEEEeccc---chHHHHHHHHHHHHcC-CCCCEEEeeeeeccCCCCceEEEEecc
Confidence 57999999999999 77889999999998733 3467889999999996 49999999999987 56789999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~~~~~ 158 (229)
++++|.+++ ..+++..+..++.|++.||++||+. |++|+||||+||+++.++ .++|+|||.+.......
T Consensus 116 ~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 116 NNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred CchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999999987 2488999999999999999999999 999999999999999766 89999999997654332
Q ss_pred ccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 159 THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
. .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 2 234568899999999886 6789999999999999999999999954
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=268.23 Aligned_cols=194 Identities=26% Similarity=0.321 Sum_probs=161.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~lv 75 (229)
+.||+|+||+||++ +...+|+.||||.+.... ....+|+++++.++ ||||+++++++... ...++|
T Consensus 60 ~~lG~G~fg~Vy~~--~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~--hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 60 KVIGNGSFGVVYQA--KLCDSGELVAIKKVLQDK----RFKNRELQIMRKLD--HCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEECCT----TSCCHHHHHHHTCC--CTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred eEEeeCCCEEEEEE--EECCCCcEEEEEEecccc----hhHHHHHHHHHHcC--CCCccceeeEEeccCCCCcceeEEee
Confidence 56999999999999 667789999999986432 22347999999999 99999999988532 235799
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-CceEEecccccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLF 154 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-~~~~l~dfg~~~~~ 154 (229)
|||+++ +|.+.+.........+++..+..++.|++.||+|||+. |++||||||+||+++.+ +.+||+|||++...
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999965 67776654445667899999999999999999999999 99999999999999955 56899999999875
Q ss_pred CCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 43322 2345689999999998764 78999999999999999999999998765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=258.07 Aligned_cols=196 Identities=24% Similarity=0.354 Sum_probs=161.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE--------------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-------------- 67 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~-------------- 67 (229)
+.||+|+||.||++ .+..+|+.||+|.+........+.+.+|+++++.++ ||||+++++++.
T Consensus 17 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 17 KPLGCGGNGLVFSA--VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EECC-----CEEEE--EETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECTTSCBCCC----CC
T ss_pred EEeccCCCeEEEEE--EECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC--CCCeeEEEEecccccccccccccccc
Confidence 57999999999999 677789999999998766666788999999999999 999999999874
Q ss_pred cCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-CCCceEEe
Q 027015 68 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKIS 146 (229)
Q Consensus 68 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-~~~~~~l~ 146 (229)
+....++||||++ ++|.+++ ....+++..+..++.|++.||++||+. |++|+||+|+||+++ +++.++|+
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVL-----EQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccCceeEEeeccC-CCHHHHh-----hcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3457789999997 5999988 345789999999999999999999999 999999999999997 56789999
Q ss_pred ccccccccCCCCc--cccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 147 DFGLSKLFPENTT--HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 147 dfg~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
|||.+........ .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 9999886543211 12233456889999998875 6789999999999999999999999987653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=261.43 Aligned_cols=199 Identities=22% Similarity=0.293 Sum_probs=156.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc-------eEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-------RIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~-------~~l 74 (229)
+.||+|+||.||++ .+..+|+.||||.+... ........++++.+..++ ||||+++++++...+. .++
T Consensus 29 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 29 RMAGQGTFGTVQLG--KEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLH--HPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp ----------CEEE--EETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHC--CTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcC--CCCcccHHHhhhccccccccceeEEE
Confidence 57999999999999 67788999999998643 223346677888888888 9999999999975433 789
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEEcCCCCCCEEEcC-CCceEEeccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--EEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLS 151 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~ 151 (229)
||||+++ +|...+.........+++..+..++.|++.+|.+|| +. |++|+||||+||+++. ++.++|+|||++
T Consensus 104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 9999965 566555444456778999999999999999999999 88 9999999999999996 899999999999
Q ss_pred cccCCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
........ .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||......
T Consensus 180 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 180 KKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp BCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 87644322 2345689999999998755 4899999999999999999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=256.94 Aligned_cols=194 Identities=29% Similarity=0.453 Sum_probs=153.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++.. ...+|+|.++... ....+.+.+|++.++.++ ||||++++++. .....++||||+
T Consensus 30 ~~lG~G~~g~Vy~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~-~~~~~~lv~e~~ 101 (289)
T 3og7_A 30 QRIGSGSFGTVYKGKW-----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYS-TAPQLAIVTQWC 101 (289)
T ss_dssp EEEEECSSEEEEEEES-----SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEE-CSSSCEEEEECC
T ss_pred eEecCCCCeEEEEEEE-----cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCC--CCcEEEEEeec-cCCccEEEEEec
Confidence 4699999999999832 2469999997553 334577899999999999 99999999954 556689999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT- 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 158 (229)
++++|.+++. .....+++..+..++.|++.+|++||+. |++|+||||+||+++.++.++|+|||.+.......
T Consensus 102 ~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 102 EGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred CCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999999983 3456799999999999999999999999 99999999999999999999999999987653321
Q ss_pred ccccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
........|++.|+|||.+. +..++.++|+||||+++|+|++|+.||....
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 22223456899999999986 5678889999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=256.14 Aligned_cols=197 Identities=24% Similarity=0.317 Sum_probs=154.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-hh-hHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-QG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ .+..+|+.||+|.++.... .. .+.+.++...++.++ ||||+++++++.+.+..++||||+
T Consensus 13 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~--h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 13 MELGRGAYGVVEKM--RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD--CPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSSEEEEEECC
T ss_pred HhcCCCCCeEEEEE--EecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCC--CCeEEEEeeeeeccCCEEEEEehh
Confidence 57999999999999 6778999999999975522 22 233445555577777 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+ ++|.+++.........+++..+..++.|++.||++||+.. |++|+||||+||+++.++.++|+|||.+........
T Consensus 89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 6 5888887655556778999999999999999999999842 899999999999999999999999999876543322
Q ss_pred cccccccCCccccCcccc----ccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 160 HISTRVAGTLGYLAPEYA----ISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
.....+++.|+|||++ .+..++.++|+||||+++|+|++|+.||..
T Consensus 166 --~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 166 --KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred --ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 2334688999999996 466789999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=256.38 Aligned_cols=201 Identities=25% Similarity=0.376 Sum_probs=163.8
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEE-cCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~-~~~~~~lv~e~ 78 (229)
+.||+|+||.||++..... .....+|+|.++... ....+.+.+|+.+++.++ ||||+++++++. .++..++||||
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEECCSSSCCEEEEEC
T ss_pred ceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC--CCCEeeeeeEEEcCCCceEEEEeC
Confidence 4699999999999954322 223468999987543 344577889999999999 999999999864 45678999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. .....+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+.......
T Consensus 109 ~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 109 MKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp CTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred CCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 99999999993 3456789999999999999999999999 99999999999999999999999999997654322
Q ss_pred c---cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 159 T---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 159 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||.....
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 1 12233456788999999999999999999999999999999 6677776543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=260.66 Aligned_cols=200 Identities=19% Similarity=0.253 Sum_probs=153.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEE--------cCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI--------DGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~--------~~~~~~ 73 (229)
+.||+|+||.||++ .+..+|+.||+|.+........+.+.+|+..++.+. .||||+++++++. .....+
T Consensus 34 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 110 (337)
T 3ll6_A 34 RVLAEGGFAFVYEA--QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-GHPNIVQFCSAASIGKEESDTGQAEFL 110 (337)
T ss_dssp EEEECCSSEEEEEE--EETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT-TSTTBCCEEEEEEECTTTSTTSSEEEE
T ss_pred EEEccCCceEEEEE--EECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc-cCCChhhccccccccccccccCCceEE
Confidence 57999999999999 667789999999997666666778899999999994 3999999999984 233578
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
+++||++ ++|.+++... .....+++..++.++.|++.||++||+. | ++|+||||+||+++.++.++|+|||.+
T Consensus 111 lv~e~~~-g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEECCS-EEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEecC-CCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 9999995 7898888432 2345799999999999999999999999 8 999999999999999999999999999
Q ss_pred cccCCCCcc-----------ccccccCCccccCcccc---ccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 152 KLFPENTTH-----------ISTRVAGTLGYLAPEYA---ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 152 ~~~~~~~~~-----------~~~~~~~~~~~~aPE~~---~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......... ......+++.|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 876432211 11134588999999998 46678899999999999999999999997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=257.80 Aligned_cols=198 Identities=26% Similarity=0.364 Sum_probs=162.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc------CCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------GPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~------~~~~~lv 75 (229)
+.||+|+||.||++ ....+|+.||+|.+.... .....+.+|+..++.+. .||||+++++++.. ....++|
T Consensus 30 ~~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 30 ELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYS-HHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHC-CSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEeccCCCEEEEEE--EECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhcc-CCCCeeeeeeEEeeccCccccceEEEE
Confidence 57999999999999 667789999999997543 34567889999999983 29999999999976 4578999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||+++++|.+++... ....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 106 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 9999999999998422 346789999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... ......+++.|+|||++. +..++.++|+||||+++|+|++|+.||....
T Consensus 181 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 181 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 3221 223456899999999987 5668899999999999999999999997654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=278.75 Aligned_cols=198 Identities=31% Similarity=0.465 Sum_probs=167.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||.||++.+ .++..||||.++... ...+.+.+|+++++.++ ||||+++++++.+ ...++||||+++
T Consensus 273 ~~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 273 VKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp EEEEECSSEEEEEEEE---TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred eecccCCCeEEEEEEE---CCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCC--CCCEeeEEEEEee-ccceEeeehhcC
Confidence 4699999999999933 345789999997543 33567899999999999 9999999999876 678999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++..........
T Consensus 346 gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 346 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp EEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred CcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 9999999321 234689999999999999999999999 99999999999999999999999999997654322212
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 223446778999999999999999999999999999999 99999875443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=258.34 Aligned_cols=196 Identities=23% Similarity=0.282 Sum_probs=167.0
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCC------cccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE------NLVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~------~i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||+||++ .+ ..+|+.||+|+++.. ....+.+.+|+++++.++ |+ +++++++++.+.+..++
T Consensus 20 ~~lg~G~~g~V~~~--~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~--~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 20 DTLGEGAFGKVVEC--IDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLN--TTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp EEEEEETTEEEEEE--EETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHH--HHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred EEEecCCCeEEEEE--EecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhh--hcCCCCceeeEeeecccccCCcEEE
Confidence 57999999999999 55 457899999999743 334567888999999887 54 59999999999999999
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---------------
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--------------- 139 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~--------------- 139 (229)
||||+ +++|.+++.. .....+++..+..++.|++.||++||+. |++|+||||+||+++.
T Consensus 95 v~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 95 VFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 99999 8899998832 2224689999999999999999999999 9999999999999987
Q ss_pred ----CCceEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 140 ----NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 140 ----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
++.++|+|||.+...... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 667999999998764332 234568999999999999999999999999999999999999998765443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=261.80 Aligned_cols=190 Identities=28% Similarity=0.377 Sum_probs=162.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCce------E
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR------I 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~------~ 73 (229)
+.||+|+||.||++ .+..+|+.||+|.+.... ....+.+.+|+..++.++ ||||+++++++...+.. +
T Consensus 48 ~~lG~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 48 THVGSGAYGSVCSA--IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSSTTCCCCE
T ss_pred eEEecCCCeEEEEE--EECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC--CCCchhhhhheeccCCcccceeEE
Confidence 46999999999999 778899999999997542 333577889999999999 99999999999877654 9
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||++ ++|.+.+ ...+++..+..++.|++.||++||+. |++|+||||+||+++.++.++|+|||.+..
T Consensus 124 lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 9999996 6787776 23489999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5332 234567999999999887 788999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=263.30 Aligned_cols=193 Identities=15% Similarity=0.176 Sum_probs=162.1
Q ss_pred CccCCcccccccccceEecc--------CCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccc------------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ--------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK------------ 61 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~------------ 61 (229)
+.||+|+||.||++. ... +++.||+|.+... ..+.+|+++++.++ ||||++
T Consensus 48 ~~lg~G~~g~Vy~~~--~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 48 SFQTRDNQGILYEAA--PTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAA--KPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEETTEEEEEEE--ECC-----------CEEEEEEETT-----STHHHHHHHHHHHC--CHHHHHHHHHHTTCTTCS
T ss_pred EEecCCCCeEEEEEe--ecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhc--ccchhhhhhhhccCCccC
Confidence 579999999999994 443 4889999998743 46889999999999 999988
Q ss_pred ---cceEEEc-CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 027015 62 ---LHGGCID-GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137 (229)
Q Consensus 62 ---~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~ 137 (229)
+++++.. +...++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. |++|+||||+||++
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 5666665 66789999999 99999999421 247899999999999999999999999 99999999999999
Q ss_pred cCCC--ceEEeccccccccCCCCc------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 138 DQNF--NPKISDFGLSKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 138 ~~~~--~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
+.++ .++|+|||++..+..... .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9988 899999999976543211 11233578999999999999999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=251.42 Aligned_cols=191 Identities=20% Similarity=0.334 Sum_probs=163.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (229)
+.||+|+||.||++.+ +|+.||+|.++... ....+.+.+|+..++.++ ||||+++++++.+. ...++|||
T Consensus 16 ~~lg~G~~g~V~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 16 TKLNENHSGELWKGRW----QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS--HPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp EEEEEETTEEEEEEEE----TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS--CTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhcCCCcceEEEEEE----CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcC--CCchhheEEEEccCCCCCeEeeec
Confidence 5799999999999943 48999999997653 334567899999999998 99999999999877 77899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|+++++|.+++.. .....+++..+..++.|+++||+|||+. + ++|+||+|+||+++.++.++++|||+.....
T Consensus 90 ~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp CCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999932 1223689999999999999999999998 8 9999999999999999999999999875432
Q ss_pred CCCccccccccCCccccCccccccCCCCC---cccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTR---KSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. ....+++.|+|||.+.+..++. ++|+||||+++|+|++|+.||....
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2 2245789999999998765544 7999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=258.82 Aligned_cols=195 Identities=25% Similarity=0.335 Sum_probs=169.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||++ ++..+|+.||+|.+...... ....+.+|+.+++.++..||||+++++++.+.+..++|
T Consensus 49 ~~lg~G~~g~Vy~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv 126 (320)
T 3a99_A 49 PLLGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126 (320)
T ss_dssp EECSSSSSCEEEEE--EETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEEeeCCCeEEEEE--EECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence 57999999999999 77788999999999755321 23567789999999974469999999999999999999
Q ss_pred EEccCC-CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-CCCceEEeccccccc
Q 027015 76 YDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKL 153 (229)
Q Consensus 76 ~e~~~~-~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-~~~~~~l~dfg~~~~ 153 (229)
+|++.+ ++|.+++ .....+++..+..++.|++.||++||+. |++|+||+|+||+++ +++.++|+|||.+..
T Consensus 127 ~e~~~~~~~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 127 LERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEcCCCCccHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 999976 8999998 4567899999999999999999999999 999999999999998 788999999999887
Q ss_pred cCCCCccccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..... .....+++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...
T Consensus 200 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 200 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 64332 234568999999999887765 68899999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=253.83 Aligned_cols=198 Identities=23% Similarity=0.306 Sum_probs=165.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc----chhhHHHHHHHHHHhhhccCCCcccccceEEE--cCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~--~~~~~~lv 75 (229)
+.||+|+||.||++ .+..+++.||+|.++... ......+.+|++.++.++ ||||+++++++. +....++|
T Consensus 11 ~~lg~G~~g~V~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 11 DLLGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR--HKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp CEEEECSSCEEEEE--EBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEECC---CEEEE
T ss_pred eEEecCCCeEEEEE--EECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC--CCCeeEEEEEEEcCCCCeEEEE
Confidence 57999999999999 677889999999997542 234577899999999999 999999999984 44578999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||++++ |.+++.. .....+++..+..++.|+++||.+||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 87 ~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999776 7676632 2356799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC-ccccccccCCccccCccccccCCC--CCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENT-THISTRVAGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~-~~~~~~~~~~~~~~aPE~~~~~~~--~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
... ........+++.|+|||++.+... +.++|+||||+++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 322 222234568999999999876543 779999999999999999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=253.22 Aligned_cols=194 Identities=29% Similarity=0.403 Sum_probs=168.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ ....+++.||+|++.... ....+.+.+|++.++.++ ||||+++++++.+....++|+||+
T Consensus 28 ~~lg~G~~g~V~~~--~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~ 103 (287)
T 2wei_A 28 CMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLFEILEDSSSFYIVGELY 103 (287)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEcCCCCEEEEEE--EEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc--CCCccEEEEEEeCCCeEEEEEEcc
Confidence 57999999999999 667789999999997542 334578899999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC---CceEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~---~~~~l~dfg~~~~~~~ 156 (229)
++++|.+++ .....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 104 ~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 104 TGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred CCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999988 3456799999999999999999999999 99999999999999754 4699999999876543
Q ss_pred CCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
... .....+++.|+|||.+.+. ++.++|+||||+++|+|++|+.||....
T Consensus 177 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 177 NTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp CSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 322 2234578899999988764 8999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=255.55 Aligned_cols=192 Identities=30% Similarity=0.449 Sum_probs=155.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++.+ .++.||+|.+... ...+.+.+|++.++.++ ||||+++++++.+ ..++||||+++
T Consensus 14 ~~lg~G~~g~V~~~~~----~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 14 EVVGRGAFGVVCKAKW----RAKDVAIKQIESE--SERKAFIVELRQLSRVN--HPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp EEEECCSSSEEEEEEE----TTEEEEEEECSST--THHHHHHHHHHHHHHCC--CTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred eEeecCCCceEEEEEE----CCeeEEEEEecCh--hHHHHHHHHHHHHhcCC--CCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 4699999999999833 4789999998633 34567899999999998 9999999998764 47899999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc-eEEeccccccccCCCCcc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-PKISDFGLSKLFPENTTH 160 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~-~~l~dfg~~~~~~~~~~~ 160 (229)
++|.+++... .....++...+..++.|+++||++||+....|++|+||||+||+++.++. ++|+|||.+.......
T Consensus 84 ~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 9999999432 22235789999999999999999999921119999999999999988886 7999999987653321
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 2345899999999999999999999999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=266.29 Aligned_cols=199 Identities=21% Similarity=0.293 Sum_probs=168.0
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCC-CcccccceEEEcCCceEEEEEcc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~-~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
.+.||+|+||.||++ .+..+++.||||++..... ...+.+|+++++.+. | +++..+..++......++||||+
T Consensus 12 ~~~LG~G~fG~Vy~a--~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~--~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLG--TNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp CCCCEECSSCEEEEE--EETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTT--TSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeeCCCEEEEEE--EECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhc--CCCCCCeEEEEEeeCCEEEEEEECC
Confidence 367999999999999 6778899999999875433 245788999999998 6 55556666667777889999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccccCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~---~~~~~~~l~dfg~~~~~~~ 156 (229)
+++|.+++. .....+++..++.++.|++.||.|||+. |++|+||||+||++ +.++.++|+|||++.....
T Consensus 86 -g~sL~~ll~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 86 -GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp -CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999983 2356799999999999999999999999 99999999999999 5888999999999987644
Q ss_pred CCcc------ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 157 NTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 157 ~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 3221 1235678999999999999999999999999999999999999998765433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=259.68 Aligned_cols=195 Identities=23% Similarity=0.311 Sum_probs=164.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~lv 75 (229)
+.||+|+||.||++ .+..+|+.||||.+.... ......+.+|+++++.++ ||||+++++++... ...++|
T Consensus 17 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 17 SLLGEGAYGVVCSA--THKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK--HENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEcCCCCeEEEEE--EECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc--CCCcCCeeeeecccccCccceEEEE
Confidence 57999999999999 677789999999997443 334467889999999999 99999999987654 678999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||++ ++|.+++. ...+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 93 ~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 93 QELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp ECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99996 68988882 35799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcc---------ccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 156 ENTTH---------ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 156 ~~~~~---------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ......|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32211 1223468999999998764 778999999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=261.82 Aligned_cols=194 Identities=25% Similarity=0.293 Sum_probs=157.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc------eEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC------RILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~------~~lv 75 (229)
+.||+|+||+||++ ....++ .+|+|.+..... ...+|+++++.++ ||||+++++++...+. .++|
T Consensus 46 ~~lG~G~~g~V~~a--~~~~~~-~~aikk~~~~~~----~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 46 KVIGNGSFGVVFQA--KLVESD-EVAIKKVLQDKR----FKNRELQIMRIVK--HPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEETTEEEEEE--EETTTE-EEEEEEEECCTT----SCCHHHHHHHTCC--CTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred EEEeeCCCeEEEEE--EECCCC-eEEEEEEecCcc----hHHHHHHHHHhCC--CCCcceEEEEEEecCCCCCceEEEEE
Confidence 57999999999999 444444 488888753322 2236999999999 9999999999965433 7899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-CCCceEEecccccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLF 154 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-~~~~~~l~dfg~~~~~ 154 (229)
|||++++ +...+.........+++..+..++.|++.||+|||+. |++||||||+||+++ .++.++|+|||++...
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999764 4444433334567899999999999999999999999 999999999999998 7999999999999875
Q ss_pred CCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 43322 2345679999999998764 589999999999999999999999987653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=262.08 Aligned_cols=198 Identities=22% Similarity=0.306 Sum_probs=165.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC------CCcccccceEEE----cCCc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC------HENLVKLHGGCI----DGPC 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~------~~~i~~~~~~~~----~~~~ 71 (229)
+.||+|+||+||++ ++..+++.||+|+++.. ....+.+.+|+.+++.++.. |+||+++++++. +...
T Consensus 43 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 119 (397)
T 1wak_A 43 RKLGWGHFSTVWLS--WDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119 (397)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred EEeeecCCeeEEEE--EecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence 46999999999999 77888999999999743 33456788999999998621 678999999987 4567
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC----------
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---------- 141 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~---------- 141 (229)
.++||||+ +++|.+.+.. .....+++..+..++.|++.||+|||+.. |++||||||+||+++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 89999999 6666666521 23357999999999999999999999852 899999999999998775
Q ss_pred ---------------------------------------ceEEeccccccccCCCCccccccccCCccccCccccccCCC
Q 027015 142 ---------------------------------------NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 182 (229)
Q Consensus 142 ---------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 182 (229)
.++|+|||.+...... .....||+.|+|||++.+..+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCC
Confidence 7999999999775433 233468999999999999999
Q ss_pred CCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 183 TRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 183 ~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
+.++|||||||++|+|++|+.||......
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~ 299 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGE 299 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence 99999999999999999999999875543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=252.54 Aligned_cols=192 Identities=29% Similarity=0.454 Sum_probs=157.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-CceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-~~~~lv~e~~~ 80 (229)
+.||+|+||+||++.+ +|+.||+|.++... ..+.+.+|++.++.++ ||||+++++++.+. +..++||||++
T Consensus 27 ~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 27 QTIGKGEFGDVMLGDY----RGNKVAVKCIKNDA--TAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp EEEEECSSCEEEEEEE----TTEEEEEEECCCCC----HHHHHTHHHHTTCC--CTTBCCEEEEECCC--CCEEEECCCT
T ss_pred eEEecCCCceEEEEEE----cCCEEEEEEecchh--HHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCCceEEEEecCC
Confidence 4699999999999833 57899999987442 4567899999999999 99999999987654 47899999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+++|.+++... ....+++..+..++.|++.+|++||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 99 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 99 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999998422 223488999999999999999999999 99999999999999999999999999987543321
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 23356788999999999999999999999999999998 9999986543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=278.01 Aligned_cols=200 Identities=24% Similarity=0.333 Sum_probs=165.0
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||++.+... ..+..||+|.++... ....+.+.+|+..++.++ ||||+++++++. ++..++||||+
T Consensus 396 ~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEC-SSSCEEEEECC
T ss_pred eEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEe-cCceEEEEEcC
Confidence 4699999999999955332 235679999987543 334477899999999999 999999999985 45689999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++........
T Consensus 473 ~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 473 TLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp TTCBHHHHHH---HTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred CCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 9999999983 2345789999999999999999999999 999999999999999999999999999987654433
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
.......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 33344556788999999999999999999999999999997 9999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=254.83 Aligned_cols=197 Identities=27% Similarity=0.393 Sum_probs=164.5
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeecccc--hhhHHHHHHHHHHhhh---ccCCCcccccceEEE-----cCC
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVESK--QGEKEFMSEVASMANV---NVCHENLVKLHGGCI-----DGP 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l---~~~~~~i~~~~~~~~-----~~~ 70 (229)
+.||+|+||.||++ .+. .+|+.||+|.++.... .....+.+|+..++.+ . ||||+++++++. ...
T Consensus 17 ~~lg~G~~g~V~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 17 AEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE--HPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEETTEEEEEE--EETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTC--CTTBCCEEEEEEEEECSSEE
T ss_pred eeecccccEEEEEE--EecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccC--CCCeEeeeeeeeecccCCCc
Confidence 57999999999999 553 5788999999975432 2234566788777776 6 999999999987 456
Q ss_pred ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 71 ~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
..++||||++ ++|.+++... ....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred eEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcc
Confidence 7789999997 6999988322 234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 151 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
+....... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 87653321 22345689999999999998999999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=259.22 Aligned_cols=194 Identities=23% Similarity=0.282 Sum_probs=156.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-----------hhHHHHHHHHHHhhhccCCCcccccceEEEc--
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-----------GEKEFMSEVASMANVNVCHENLVKLHGGCID-- 68 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-- 68 (229)
+.||+|+||.||++ .+ .+|+.||||.+...... ..+.+.+|+++++.++ ||||+++++++..
T Consensus 28 ~~lg~G~~g~V~~~--~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 28 RFISSGSYGAVCAG--VD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH--HPNILGLRDIFVHFE 102 (362)
T ss_dssp EEEEEETTEEEEEE--EC-TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEEEECC
T ss_pred EEeccCCCEEEEEE--EC-CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC--CcCccceeeeEEecc
Confidence 57999999999999 33 45899999998643221 1267899999999999 9999999999854
Q ss_pred ---CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 69 ---GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 69 ---~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
....++||||++ ++|.+.+. .....+++..+..++.|++.||.+||+. |++|+||||+||+++.++.++|
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEE
Confidence 235799999996 67888773 4455799999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
+|||.+....... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 176 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 176 CDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999987543322 2234568899999998876 678999999999999999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=257.55 Aligned_cols=190 Identities=28% Similarity=0.378 Sum_probs=161.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc------eE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC------RI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~------~~ 73 (229)
+.||+|+||.||++ ++..+|+.||||.+.... ......+.+|+..++.++ ||||+++++++..... .+
T Consensus 30 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 30 THVGSGAYGSVCSA--IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eeEecCCCeEEEEE--EECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCCcccHhheEecccccccceeEE
Confidence 46999999999999 777889999999997542 233467889999999999 9999999999987654 49
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||++ ++|.+++ ...+++..+..++.|++.||++||+. |++|+||+|+||+++.++.++|+|||.+..
T Consensus 106 lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEECCS-EEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEecccc-CCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 9999996 5777766 23489999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322 233567899999998886 678999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=258.74 Aligned_cols=198 Identities=21% Similarity=0.245 Sum_probs=164.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCC-----cccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-----NLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~-----~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||++ .+..+++.||||+++.. .........|+.+++.++. |+ +|+++++++......++||
T Consensus 60 ~~lG~G~~g~V~~~--~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~-~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 60 SLIGKGSFGQVVKA--YDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNK-HDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEETTEEEEEE--EETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHH-CSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEeecCCEEEEEE--EEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHh-cccccceeEEEeeeeeccCCceEEEE
Confidence 46999999999999 77788999999999733 2334567778888887762 33 5999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc--CCCceEEecccccccc
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLF 154 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~--~~~~~~l~dfg~~~~~ 154 (229)
||++ ++|.+++... ....+++..+..++.|++.||.+||+. ..|++||||||+||+++ .++.++|+|||++...
T Consensus 136 e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp ECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred ecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 9995 5999988422 235689999999999999999999942 12999999999999995 4778999999999876
Q ss_pred CCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 212 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 212 GQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp TCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 432 23456899999999999999999999999999999999999999976543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=251.07 Aligned_cols=199 Identities=26% Similarity=0.409 Sum_probs=158.0
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||++.+.... .+..||+|.++.. .....+.+.+|++.++.++ ||||+++++++.+.. .++|+|
T Consensus 24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSS-CEEEEE
T ss_pred eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC--CCCcccEEEEEccCC-ceeeEe
Confidence 57999999999999543221 2236999998754 2344578889999999998 999999999988765 889999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++. .....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 101 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 101 LAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CCTTCBHHHHHH---HHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred cccCCCHHHHHH---hccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 999999999984 3346799999999999999999999999 9999999999999999999999999998876443
Q ss_pred Ccc--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 158 TTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 158 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||....
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 221 2233456778999999998889999999999999999999 999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=255.03 Aligned_cols=192 Identities=27% Similarity=0.352 Sum_probs=160.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----ceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~lv~e 77 (229)
+.||+|+||.||++.+ +|+.||+|.++.. ....+.+|.+++..+...||||+++++++.... ..++|||
T Consensus 48 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e 120 (342)
T 1b6c_B 48 ESIGKGRFGEVWRGKW----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120 (342)
T ss_dssp EEEEEETTEEEEEEEE----TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred eeecCCCCcEEEEEEE----cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence 4699999999999933 5899999999643 345677888888874333999999999998776 7899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--------EEIQPHVVHRDIKTSNILLDQNFNPKISDFG 149 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--------~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg 149 (229)
|+++++|.+++. ...+++..++.++.|++.+|.+|| +. |++|+||||+||+++.++.++|+|||
T Consensus 121 ~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 121 YHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999993 346899999999999999999999 77 99999999999999999999999999
Q ss_pred cccccCCCCcc---ccccccCCccccCccccccCC------CCCcccchhHHHHHHHHHhC----------CCcccCc
Q 027015 150 LSKLFPENTTH---ISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSG----------RTAVDFD 208 (229)
Q Consensus 150 ~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~i~~~l~~g----------~~pf~~~ 208 (229)
.+......... ......+++.|+|||++.+.. ++.++|+||||+++|+|++| +.||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 98765433221 224456899999999987653 33689999999999999999 7888754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=255.16 Aligned_cols=196 Identities=19% Similarity=0.279 Sum_probs=164.8
Q ss_pred CccCCcccccccccceEeccCC-cEEEEEEeecccchhhHHHHHHHHHHhhhccCCCc------ccccceEEEcCCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDG-TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN------LVKLHGGCIDGPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~------i~~~~~~~~~~~~~~l 74 (229)
+.||+|+||+||++ .+..++ +.||+|+++.. ....+.+.+|+.+++.++ |++ ++.+++++...+..++
T Consensus 25 ~~lg~G~~g~V~~~--~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~--~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 25 GNLGEGTFGKVVEC--LDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIK--EKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp EEEEEETTEEEEEE--EETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHH--HHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEeeccCCeEEEEE--EecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHh--hcCCCCceeEEEeeeeeeeCCeEEE
Confidence 56999999999999 555565 68999999743 334567788999999988 554 8899999999999999
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE-----------------
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----------------- 137 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~----------------- 137 (229)
||||+ +++|.+++.. .....+++..+..++.|++.||++||+. |++|+||||+||++
T Consensus 100 v~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 99999 6667776632 2335799999999999999999999999 99999999999999
Q ss_pred --cCCCceEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 138 --DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 138 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
+.++.++|+|||.+...... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||......+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56788999999998764332 234568999999999999999999999999999999999999998765443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=249.34 Aligned_cols=188 Identities=26% Similarity=0.388 Sum_probs=156.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc-------------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------------- 68 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~------------- 68 (229)
+.||+|+||.||++ .+..+|+.||+|.+... ....+.+.+|+..++.++ ||||+++++++.+
T Consensus 12 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 12 AVLGQGAFGQVVKA--RNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLN--HQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEECCCCCC------C
T ss_pred heeccCCcEEEEEE--EEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcC--chHHHHHHHHHHhhcchhhhhccccc
Confidence 57999999999999 67788999999999643 344577889999999999 9999999998865
Q ss_pred CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 027015 69 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 148 (229)
Q Consensus 69 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~df 148 (229)
....++||||+++++|.+++. .....+++..++.++.|++.||++||+. |++|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHH---HSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred CCceEEEEecCCCCCHHHhhh---ccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence 346789999999999999993 3445788899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC-------------ccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHh
Q 027015 149 GLSKLFPENT-------------THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVS 200 (229)
Q Consensus 149 g~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~ 200 (229)
|.+....... ........+++.|+|||.+.+. .++.++|+||||+++|+|++
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9987654221 1112345688999999998864 68999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=255.00 Aligned_cols=193 Identities=27% Similarity=0.356 Sum_probs=161.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc------hhhHHHHHHHHHHhhh----ccCCCcccccceEEEcCCc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK------QGEKEFMSEVASMANV----NVCHENLVKLHGGCIDGPC 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~~~~l----~~~~~~i~~~~~~~~~~~~ 71 (229)
+.||+|+||.||++ .+..+|+.||+|.+..... .....+.+|+..+..+ + ||||+++++++.+.+.
T Consensus 37 ~~lg~G~~g~Vy~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~--h~~i~~~~~~~~~~~~ 112 (312)
T 2iwi_A 37 PLLGKGGFGTVFAG--HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG--HPGVIRLLDWFETQEG 112 (312)
T ss_dssp EEEEEETTEEEEEE--ECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCC--CSSBCCEEEEC-----
T ss_pred eEEEcCCCEEEEEE--EEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCC--CCCeeeEEEEEecCCe
Confidence 56999999999999 6777899999999975432 1234466789999888 6 9999999999999899
Q ss_pred eEEEEEc-cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc-CCCceEEeccc
Q 027015 72 RILVYDY-MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFG 149 (229)
Q Consensus 72 ~~lv~e~-~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~-~~~~~~l~dfg 149 (229)
.++|+|+ +++++|.+++ .....+++..+..++.|++.||++||+. |++|+||+|+||+++ .++.++|+|||
T Consensus 113 ~~~v~e~~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 113 FMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp CEEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 9999999 7899999999 4456799999999999999999999999 999999999999998 88999999999
Q ss_pred cccccCCCCccccccccCCccccCccccccCCCC-CcccchhHHHHHHHHHhCCCcccCc
Q 027015 150 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.+....... .....+++.|+|||++.+..+. .++|+||||+++|+|++|+.||...
T Consensus 186 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 186 SGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp SCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 988764432 2345689999999998877664 5899999999999999999999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=250.05 Aligned_cols=188 Identities=30% Similarity=0.431 Sum_probs=152.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC----CceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~----~~~~lv~e 77 (229)
+.||+|+||.||++.+ .|+.||||++... ......+|.+++......||||+++++++.+. ...++|||
T Consensus 43 ~~lg~G~~g~V~~~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 115 (337)
T 3mdy_A 43 KQIGKGRYGEVWMGKW----RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115 (337)
T ss_dssp EEEEEETTEEEEEEEE----TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred eEeecCCCeEEEEEEE----CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence 5799999999999933 4899999998633 23445556666666533499999999999877 67899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|+++++|.+++. ...+++..+..++.|++.||.|||+.. ..|++|+||||+||+++.++.++|+|||.+.
T Consensus 116 ~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 116 YHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp CCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 999999999982 346999999999999999999999651 2289999999999999999999999999997
Q ss_pred ccCCCCcc---ccccccCCccccCccccccCCCCCc------ccchhHHHHHHHHHhC
Q 027015 153 LFPENTTH---ISTRVAGTLGYLAPEYAISGRLTRK------SDVYSFGVLLLEIVSG 201 (229)
Q Consensus 153 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~------~Dv~slG~i~~~l~~g 201 (229)
........ ......|++.|+|||++.+...+.. +||||||+++|+|++|
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 65433221 1234578999999999987776665 9999999999999999
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=250.70 Aligned_cols=195 Identities=24% Similarity=0.361 Sum_probs=160.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ .+ .+++.||+|.+.... ....+.+.+|++.++.++..||||+++++++.+.+..+++|| +
T Consensus 34 ~~lg~G~~g~Vy~~--~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 109 (313)
T 3cek_A 34 KQIGSGGSSKVFQV--LN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 109 (313)
T ss_dssp EEEECCSSEEEEEE--EC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEecCCCCEEEEEE--Ec-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence 57999999999999 33 458999999997543 334577889999999998446999999999999999999999 5
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
.+++|.+++ .....+++..+..++.|+++||++||+. |++|+||+|+||+++ ++.++|+|||.+........
T Consensus 110 ~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 110 GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp CSEEHHHHH----HHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred CCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 688999999 4556899999999999999999999999 999999999999997 58999999999876543322
Q ss_pred c-ccccccCCccccCcccccc-----------CCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 H-ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ~-~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 1 2234568999999999875 46788999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=262.37 Aligned_cols=196 Identities=23% Similarity=0.305 Sum_probs=152.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||.+ ...+|+.||||.+..+. .+...+|+++++.+ + ||||+++++++.+....++||||++
T Consensus 21 ~~LG~G~~g~V~~~---~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~--HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 21 KILGYGSSGTVVFQ---GSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDD--HPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEECSTTCEEEE---EESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTT--STTBCCEEEEEECSSEEEEEECCCS
T ss_pred CeEeeCCCeEEEEE---EEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccC--CCCcCeEEEEEecCCeEEEEEecCC
Confidence 46999999999864 45679999999987432 34677899999876 6 9999999999999999999999995
Q ss_pred CCCHHHHHhhhhccccC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-------------CceE
Q 027015 81 NNSLSQTLLGEEKRRAK---FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-------------FNPK 144 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-------------~~~~ 144 (229)
++|.+++......... .++..++.++.|++.||+|||+. |++|+||||+||+++.+ +.++
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999432211111 13335678999999999999999 99999999999999754 4799
Q ss_pred EeccccccccCCCCcc---ccccccCCccccCcccccc-------CCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 145 ISDFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 145 l~dfg~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
|+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999876543221 1234578999999999875 568999999999999999998 999997643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=256.06 Aligned_cols=195 Identities=29% Similarity=0.445 Sum_probs=152.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHH--HhhhccCCCcccccceEEEc-----CCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVAS--MANVNVCHENLVKLHGGCID-----GPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--~~~l~~~~~~i~~~~~~~~~-----~~~~~l 74 (229)
+.||+|+||.||+++ . +++.||||+++... ......|.++ +..++ ||||+++++.+.. ...+++
T Consensus 19 ~~lg~G~~g~Vy~~~--~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~--h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 19 ELIGRGRYGAVYKGS--L--DERPVAVKVFSFAN---RQNFINEKNIYRVPLME--HDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp EEEEECSSEEEEEEE--E--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eecccCCCeEEEEEE--E--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc--CcchhhheecccccccCCCceEEE
Confidence 579999999999983 2 78999999997443 2333444444 44466 9999999986542 235689
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEEcCCCCCCEEEcCCCceEEecc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------QPHVVHRDIKTSNILLDQNFNPKISDF 148 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~------~~~i~h~di~p~ni~~~~~~~~~l~df 148 (229)
||||+++++|.+++. ....++..+..++.|+++||+|||+.. .+|++|+||||+||+++.++.++|+||
T Consensus 90 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHh-----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999999982 334588999999999999999999762 228999999999999999999999999
Q ss_pred ccccccCCCC-------ccccccccCCccccCcccccc-------CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 149 GLSKLFPENT-------THISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 149 g~~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
|++..+.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 9998764321 112234568999999999886 3566789999999999999999877654433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=251.43 Aligned_cols=198 Identities=25% Similarity=0.353 Sum_probs=147.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHH-HHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~-~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ ....+|+.||+|.++... ......+..|+. .++.++ ||||+++++++.+.+..++||||+
T Consensus 28 ~~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~--h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 28 GEIGRGAYGSVNKM--VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD--CPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp CEEEECSSEEEEEE--EETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCC--CTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeccCCCEEEEEE--EEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCC--CCcEeeeeeEEEeCCceEEEEeec
Confidence 57999999999999 677789999999997653 233345555555 666677 999999999999999999999999
Q ss_pred CCCCHHHHHhhh-hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~-~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++ +|.+++... ......+++..+..++.|++.||.+||+.. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 75 888877432 123578999999999999999999999852 89999999999999999999999999987654332
Q ss_pred ccccccccCCccccCcccc----ccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYA----ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
. .....|++.|+|||++ .+..++.++|+||||+++|+|++|+.||...
T Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 1 2234688999999998 4567899999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=255.06 Aligned_cols=192 Identities=21% Similarity=0.298 Sum_probs=139.1
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc----CCceEEEEEc
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVYDY 78 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----~~~~~lv~e~ 78 (229)
.||+|+||+||++ .+..+|+.||+|++.... ....+....++.+. ||||+++++++.. ....++||||
T Consensus 36 ~lG~G~~g~V~~~--~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~--h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 36 VLGLGVNGKVLEC--FHRRTGQKCALKLLYDSP----KARQEVDHHWQASG--GPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp EEEEETTEEEEEE--EETTTCCEEEEEEEESSH----HHHHHHHHHHHHTT--STTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeeeCCCeEEEEE--EECCCCCEEEEEEecCcH----HHHHHHHHHHHhcC--CCChHHHHHHHhhccCCCceEEEEEec
Confidence 4899999999999 777889999999986321 12222233345555 9999999999875 3457899999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEeccccccccC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLFP 155 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~~~~~ 155 (229)
+++++|.+++... ....+++..++.++.|++.||++||+. |++|+||+|+||+++. ++.++|+|||.+....
T Consensus 108 ~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 108 MEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp CTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999421 234799999999999999999999999 9999999999999975 4459999999987654
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 183 QNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 322 2345679999999999888899999999999999999999999976543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=269.77 Aligned_cols=197 Identities=27% Similarity=0.374 Sum_probs=169.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEc------CCceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------GPCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~------~~~~~l 74 (229)
+.||+|+||.||++ .+..+|+.||+|.++.. .....+.+.+|+++++.++ ||||+++++++.. .+..++
T Consensus 20 ~~LG~G~fG~Vyla--~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 20 ERLGTGGFGYVLRW--IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN--HPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp CCCCBCSSSBCCCC--CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC--BTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred EEEeeCCCeEEEEE--EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC--CCCCCceeeeecccccccCCCeEEE
Confidence 67999999999999 66778999999998754 3444577899999999999 9999999998755 667799
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCc---eEEeccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLS 151 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~---~~l~dfg~~ 151 (229)
||||+++++|.+++... .....+++..++.++.|++.||+|||+. |++|+||+|+||+++.++. ++|+|||.+
T Consensus 96 VmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp EEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 99999999999998432 2233688999999999999999999999 9999999999999997765 899999999
Q ss_pred cccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 172 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 172 KELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 8764432 224457899999999999999999999999999999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=246.92 Aligned_cols=194 Identities=23% Similarity=0.340 Sum_probs=146.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-hh-HHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-GE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++ ....+|+.||+|.+...... .. +.+.++...++.++ ||||+++++++.+....++||||+
T Consensus 31 ~~lg~G~~g~V~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~--h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 31 GEMGSGTCGQVWKM--RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD--CPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEC------CEEEE--EETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT--CTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceeeecCCeeEEEE--EEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCceeeEEEEEecCCcEEEEEecc
Confidence 57999999999999 66778999999999755322 22 33444555677777 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++++..+.. .....+++..+..++.|++.||.+||+ . |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 107 -~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 107 -GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp -SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred -CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 556655552 235679999999999999999999998 6 99999999999999999999999999987654322
Q ss_pred ccccccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 159 THISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
......+++.|+|||++. ...++.++|+||||+++|+|++|+.||...
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 123356889999999984 456889999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=253.70 Aligned_cols=196 Identities=22% Similarity=0.303 Sum_probs=161.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC---------CCcccccceEEEcCC--
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC---------HENLVKLHGGCIDGP-- 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~---------~~~i~~~~~~~~~~~-- 70 (229)
+.||+|+||+||++ .+..+|+.||+|++... ......+.+|+..++.+... ||||+++++++...+
T Consensus 25 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 101 (373)
T 1q8y_A 25 RKLGWGHFSTVWLA--KDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101 (373)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EeeeecCCeEEEEE--EecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence 57999999999999 67788999999999743 33446678889888887622 789999999997643
Q ss_pred --ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc------CCCc
Q 027015 71 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD------QNFN 142 (229)
Q Consensus 71 --~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~------~~~~ 142 (229)
..+++||++ +++|.+++... ....+++..+..++.|++.||++||+.. |++|+||||+||+++ ..+.
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 102 GVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred CceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcce
Confidence 678999999 99999998422 2456999999999999999999999842 899999999999994 3447
Q ss_pred eEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 143 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
++|+|||++...... .....+|+.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 177 ~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 177 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999765432 233468999999999999999999999999999999999999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=270.80 Aligned_cols=187 Identities=23% Similarity=0.298 Sum_probs=159.4
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCc-----eEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-----RIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~-----~~l 74 (229)
+.||+|+||.||++ .+.. +|+.||||.+.... ......+.+|+++++.++ ||||+++++++...+. .++
T Consensus 86 ~~lg~G~~g~Vy~a--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 86 GCIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV--HPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEETTEEEEEE--EEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC--CTTBCCEEEEEEEECTTSCEEEEE
T ss_pred EEEeeCCCeEEEEE--EEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC--CCCcCeEeeeEeecCCCCCceeEE
Confidence 46999999999999 5544 78999999986443 334467889999999999 9999999999987665 699
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
||||+++++|.+++ .. .+++..+..++.|++++|.|||+. |++|+||||+||+++.+ .++|+|||++...
T Consensus 162 v~E~~~g~~L~~~~----~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 162 VMEYVGGQSLKRSK----GQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEECCCCEECC--------C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEeCCCCcHHHHH----hC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 99999999998876 22 799999999999999999999999 99999999999999975 8999999999765
Q ss_pred CCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||...
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence 432 3456899999999887654 88999999999999999999998764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=256.69 Aligned_cols=192 Identities=23% Similarity=0.287 Sum_probs=152.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+|+. ....+|+.||||.+..+.. ....+|+++++.+ + ||||+++++++.+....++|||+++
T Consensus 30 ~~LG~G~~G~V~~---~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~--HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 30 DVLGHGAEGTIVY---RGMFDNRDVAVKRILPECF---SFADREVQLLRESDE--HPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEECGGGCEEE---EEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCC--CTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CeeecCcCEEEEE---EEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccC--CCCcCeEEEEEecCCEEEEEEECCC
Confidence 4699999999763 3566899999999974432 3456799999988 5 9999999999999999999999995
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC-----CceEEeccccccccC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-----FNPKISDFGLSKLFP 155 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~-----~~~~l~dfg~~~~~~ 155 (229)
++|.+++. .......+..+..++.|+++||+|||+. |++||||||+||+++.+ ..++|+|||++....
T Consensus 102 -g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 102 -ATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp -EEHHHHHH---SSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred -CCHHHHHH---hcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 59999984 2333455556678999999999999999 99999999999999532 257899999998764
Q ss_pred CCCc--cccccccCCccccCccccc---cCCCCCcccchhHHHHHHHHHh-CCCcccCc
Q 027015 156 ENTT--HISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 208 (229)
Q Consensus 156 ~~~~--~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~ 208 (229)
.... .......||+.|+|||++. ...++.++|||||||++|++++ |..||...
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 3221 2234467899999999987 4567889999999999999999 99999754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=248.71 Aligned_cols=194 Identities=24% Similarity=0.378 Sum_probs=159.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||.||++.+ +..+++|.++... ....+.+.+|+..++.++ ||||+++++++.+....+++|||+
T Consensus 39 ~~lg~G~~g~V~~~~~-----~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 39 ELIGKGRFGQVYHGRW-----HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR--HENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CBCCCSSSSEEEEEEE-----SSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCC--CTTBCCCCEEEECSSCEEEECBCC
T ss_pred eEeccCCceEEEEEEE-----cCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCC--CCCEeEEEEEEecCCceEEEeecc
Confidence 5799999999999833 2359999987542 233456788999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC--
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN-- 157 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~-- 157 (229)
++++|.+++. .....+++..+..++.|++.||++||+. |++|+||+|+||+++ ++.++|+|||.+......
T Consensus 112 ~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 112 KGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CSEEHHHHTT---SSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999983 3345799999999999999999999999 999999999999998 679999999987654321
Q ss_pred --CccccccccCCccccCcccccc---------CCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 158 --TTHISTRVAGTLGYLAPEYAIS---------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 158 --~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.........|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1112233458899999999874 347889999999999999999999998654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=253.26 Aligned_cols=187 Identities=17% Similarity=0.154 Sum_probs=152.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--------hhhHHHHHHHHHHhhhcc-------CCCccc------
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--------QGEKEFMSEVASMANVNV-------CHENLV------ 60 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~~~~l~~-------~~~~i~------ 60 (229)
+.||+|+||+||++. . +|+.||||.++.... ...+.+.+|+.+++.++. .||||+
T Consensus 26 ~~lG~G~~g~V~~~~--~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 26 EKIGEGVFGEVFQTI--A--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp EEEEEETTEEEEEEE--E--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred eeecccCceEEEEEE--e--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 579999999999993 3 789999999976532 223678889888888751 155554
Q ss_pred -----------ccceEEEc-------------CCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHH
Q 027015 61 -----------KLHGGCID-------------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 116 (229)
Q Consensus 61 -----------~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 116 (229)
++++++.+ ....++||||++++++.+.+ ....+++..+..++.|++.||+|
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~-----~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG-----TTTCCCHHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH-----HhcCCCHHHHHHHHHHHHHHHHH
Confidence 44444443 67889999999999776666 22568999999999999999999
Q ss_pred Hh-hcCCCCeEEcCCCCCCEEEcCCC--------------------ceEEeccccccccCCCCccccccccCCccccCcc
Q 027015 117 IH-EEIQPHVVHRDIKTSNILLDQNF--------------------NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 175 (229)
Q Consensus 117 lH-~~~~~~i~h~di~p~ni~~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE 175 (229)
|| +. |++||||||+||+++.++ .+||+|||++...... ...||+.|+|||
T Consensus 177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE 247 (336)
T 2vuw_A 177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED 247 (336)
T ss_dssp HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence 99 89 999999999999999887 8999999999865432 346899999999
Q ss_pred ccccCCCCCcccchhHHHH-HHHHHhCCCcccC
Q 027015 176 YAISGRLTRKSDVYSFGVL-LLEIVSGRTAVDF 207 (229)
Q Consensus 176 ~~~~~~~~~~~Dv~slG~i-~~~l~~g~~pf~~ 207 (229)
++.+.. +.++||||++++ .++++.|..||..
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 998776 889999998766 7788899999965
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=253.44 Aligned_cols=198 Identities=19% Similarity=0.176 Sum_probs=153.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCC-Cccccc---------ceE---
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCH-ENLVKL---------HGG--- 65 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~-~~i~~~---------~~~--- 65 (229)
+.||+|+||+||++ .+..+|+.||||+++.... ...+.+.+|+..++.+. | ++.... .+.
T Consensus 84 ~~LG~G~fG~Vy~a--~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~--~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 84 TVLGQEDPYAYLEA--TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR--GIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST--TCCSHHHHHHHTCBCCCCEEEEC
T ss_pred cccccCCCEEEEEE--EecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc--cCCCHHHHHHhcccccchhhccc
Confidence 46999999999999 6788899999999874422 23577889999999887 5 221111 111
Q ss_pred ---------EEc-----CCceEEEEEccCCCCHHHHHhhh---hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEc
Q 027015 66 ---------CID-----GPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128 (229)
Q Consensus 66 ---------~~~-----~~~~~lv~e~~~~~sL~~~~~~~---~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~ 128 (229)
+.. ...++++|+.+ +++|.+++... ......+++..+..++.|+++||+|||+. |++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 111 12456777765 78999888432 23355688889999999999999999999 99999
Q ss_pred CCCCCCEEEcCCCceEEeccccccccCCCCccccccccCCccccCcccc----------ccCCCCCcccchhHHHHHHHH
Q 027015 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA----------ISGRLTRKSDVYSFGVLLLEI 198 (229)
Q Consensus 129 di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Dv~slG~i~~~l 198 (229)
||||+||+++.++.+||+|||++...... .....| +.|+|||++ ....++.++|||||||++|+|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999998765332 234567 899999998 455578899999999999999
Q ss_pred HhCCCcccCccccc
Q 027015 199 VSGRTAVDFDVQLG 212 (229)
Q Consensus 199 ~~g~~pf~~~~~~~ 212 (229)
++|+.||.......
T Consensus 311 ltg~~Pf~~~~~~~ 324 (413)
T 3dzo_A 311 WCADLPNTDDAALG 324 (413)
T ss_dssp HHSSCCCCTTGGGS
T ss_pred HHCCCCCCCcchhh
Confidence 99999998765433
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=237.30 Aligned_cols=170 Identities=9% Similarity=0.044 Sum_probs=147.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||.||++ .+..+|+.||+|++..... ...+.+.+|+..+..++ ||||+++++++.+++..++||||
T Consensus 37 ~~lg~G~~g~Vy~a--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 37 IFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID--KPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEBSTTCEEEEE--EETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEcccCCeEEEEE--EecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC--CCCcceeeEEEEECCcEEEEEEe
Confidence 57999999999999 6677899999999976532 23367889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++. . . .....+..++.|++.||+|||+. |++|+||||+||+++.++.++|++++.
T Consensus 113 ~~g~~L~~~l~----~-~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~-------- 175 (286)
T 3uqc_A 113 IRGGSLQEVAD----T-S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT-------- 175 (286)
T ss_dssp CCEEEHHHHHT----T-C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred cCCCCHHHHHh----c-C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence 99999999982 2 2 35667889999999999999999 999999999999999999999985432
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
++ +++.++|+||||+++|+|++|+.||.......
T Consensus 176 -------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 176 -------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp -------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred -------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 22 26888999999999999999999999765543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=234.75 Aligned_cols=172 Identities=21% Similarity=0.318 Sum_probs=144.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc----CCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----~~~~~lv~e 77 (229)
+.||+|+||.||++ .+..+|+.||+|.++. .....+|++.+.++. .||||+++++++.+ ....++|||
T Consensus 24 ~~lg~G~~g~V~~~--~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 24 QVLGLGINGKVLQI--FNKRTQEKFALKMLQD-----CPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHT-TSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cccccCCCeEEEEE--EEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhc-cCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 35999999999999 7778899999999863 245677888874443 29999999999876 667899999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEecccccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 154 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~~~~ 154 (229)
|+++++|.+++.. .....+++..+..++.|++.||++||+. |++|+||||+||+++. ++.++|+|||++...
T Consensus 96 ~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 96 CLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp CCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 9999999999942 1234699999999999999999999999 9999999999999997 788999999988543
Q ss_pred CCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
. +..++.++|+||||+++|+|++|+.||....
T Consensus 171 ~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 171 T-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp T-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred c-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 2 1335678999999999999999999997654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=251.13 Aligned_cols=187 Identities=14% Similarity=0.118 Sum_probs=133.0
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeeccc----------chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceE
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES----------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~ 73 (229)
.+.|+.|....+ ++.-.|+.+++|.+.... ....+.+.+|+++|+++. .|+||+++++++++++..|
T Consensus 242 ~~~~~~~~h~~~--rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~-~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 242 PYAGAGLAHKRS--RRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP-AGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp -C--------CC--EEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC-TTCCCCCEEEEEECSSEEE
T ss_pred cccCCccccccc--ccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEECCEEE
Confidence 566777777777 667788999999996431 122356889999999995 3999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
|||||++|++|.+++ ....+++.. .++.||++||+|+|++ ||+||||||+|||++.+|.+||+|||+++.
T Consensus 319 LVMEyv~G~~L~d~i----~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 319 LVMEKLPGRLLSDML----AAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EEEECCCSEEHHHHH----HTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EEEecCCCCcHHHHH----HhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCee
Confidence 999999999999999 556677665 4789999999999999 999999999999999999999999999987
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 205 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf 205 (229)
...... .....+||+.|+|||++.+. +..++|+||+|++.+.+.++..+|
T Consensus 389 ~~~~~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 389 TPQDCS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCCc-cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 644322 23446799999999998764 567899999999888776655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=215.57 Aligned_cols=182 Identities=18% Similarity=0.126 Sum_probs=143.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--------hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~ 73 (229)
+.||+|+||+||++ ...++.+++|....... ...+.+.+|+++++.++ ||||+++..++......+
T Consensus 342 ~~LG~G~fg~Vy~~----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 342 HLIGKGAEADIKRD----SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK--DFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ------CCEEEEEE----ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG--GGTCCCCCEEEEETTTTE
T ss_pred CEEeeCCCEEEEEE----EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC--CCCcCceEEEEEeCCccE
Confidence 46999999999998 23568899998753311 11345789999999999 999997767777777889
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||+++++|.+++.. +..++.|++++|+|||+. |++||||||+||+++. .++|+|||++..
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999999832 568999999999999999 9999999999999997 999999999987
Q ss_pred cCCCCcc------ccccccCCccccCcccccc--CCCCCcccchhHHHHHHHHHhCCCccc
Q 027015 154 FPENTTH------ISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 154 ~~~~~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
....... ......||+.|+|||++.. ..|+...|+|+...-..+-+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 6443211 1235678999999999986 567888899998888888777776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=175.53 Aligned_cols=128 Identities=15% Similarity=0.085 Sum_probs=103.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc------------------hhhHHHHHHHHHHhhhccCCCcccccc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK------------------QGEKEFMSEVASMANVNVCHENLVKLH 63 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~~~~l~~~~~~i~~~~ 63 (229)
+.||+|+||.||++ .. .+|+.||+|.++.... .....+.+|+++++.++ | +++.
T Consensus 96 ~~iG~G~~g~Vy~~--~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~---~~v~ 167 (282)
T 1zar_A 96 KLMGEGKESAVFNC--YS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G---LAVP 167 (282)
T ss_dssp EEEEECSSEEEEEE--EE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T---SSSC
T ss_pred CEeccCCCceEEEE--Ee-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C---CCcC
Confidence 57999999999999 45 7899999999964321 13456889999999997 4 4444
Q ss_pred eEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 64 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 64 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
+++.. +..++||||++|++|.+ +. . .....++.|++.++.+||+. |++|+||||+||+++ ++.+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEE
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcE
Confidence 44433 55699999999999987 41 1 22446999999999999999 999999999999999 9999
Q ss_pred EEeccccccc
Q 027015 144 KISDFGLSKL 153 (229)
Q Consensus 144 ~l~dfg~~~~ 153 (229)
+|+|||++..
T Consensus 232 kl~DFG~a~~ 241 (282)
T 1zar_A 232 WIIDFPQSVE 241 (282)
T ss_dssp EECCCTTCEE
T ss_pred EEEECCCCeE
Confidence 9999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.1e-22 Score=152.46 Aligned_cols=133 Identities=15% Similarity=0.138 Sum_probs=102.0
Q ss_pred CccCCcccccccccceEeccCCcE--EEEEEeecccch------------------------hhHHHHHHHHHHhhhccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTI--VAVKVLSVESKQ------------------------GEKEFMSEVASMANVNVC 55 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~~~~l~~~ 55 (229)
+.||+|+||.||++ ....+|+. ||||+++..... ....+.+|+..+..+.
T Consensus 53 ~~ig~G~~g~Vy~a--~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 128 (258)
T 1zth_A 53 GVISTGKEANVFYA--DGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK-- 128 (258)
T ss_dssp EEEEECSSEEEEEE--EEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH--
T ss_pred CEEeecceEEEEEE--EEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH--
Confidence 46999999999999 55568889 999997543111 1136788999999998
Q ss_pred CCcc--cccceEEEcCCceEEEEEccCC-C----CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEE
Q 027015 56 HENL--VKLHGGCIDGPCRILVYDYMPN-N----SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH-EEIQPHVVH 127 (229)
Q Consensus 56 ~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~~~~i~h 127 (229)
|+++ ..+++. ...++||||+.+ + +|.+... . .++..+..++.|++.++.+|| +. |++|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~---~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----E---LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----G---GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----c---cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 7754 333332 356899999942 3 6776542 1 224567789999999999999 88 9999
Q ss_pred cCCCCCCEEEcCCCceEEecccccccc
Q 027015 128 RDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 128 ~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
+||||.||+++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999997 8999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-19 Score=144.25 Aligned_cols=133 Identities=13% Similarity=0.131 Sum_probs=92.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch--------------hhHH--------HHHHHHHHhhhccCCCcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ--------------GEKE--------FMSEVASMANVNVCHENL 59 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~e~~~~~~l~~~~~~i 59 (229)
++||+|++|.||+| .. .+|+.||||+++..... .... ..+|...+.++. ++++
T Consensus 101 ~~IG~Gk~a~VY~a--~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~--~~gv 175 (397)
T 4gyi_A 101 SRIGVGKESDIMIV--AD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY--EEGF 175 (397)
T ss_dssp EEEEECSSEEEEEE--EC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred CEeeeCCceEEEEE--EC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH--hcCC
Confidence 57999999999999 33 57999999997532100 0011 123455555554 3333
Q ss_pred cccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC
Q 027015 60 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139 (229)
Q Consensus 60 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~ 139 (229)
....-+.. ...++||||++|.+|..+. . ......++.|++.++.++|+. |++||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~----~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVS----S------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCC----C------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhc----c------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 22211111 2347999999998875543 1 123356789999999999999 9999999999999987
Q ss_pred CC----------ceEEecccccccc
Q 027015 140 NF----------NPKISDFGLSKLF 154 (229)
Q Consensus 140 ~~----------~~~l~dfg~~~~~ 154 (229)
++ .+.++||+.+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=5.3e-14 Score=108.13 Aligned_cols=136 Identities=15% Similarity=0.035 Sum_probs=103.5
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
.++.|+.+.||++ . .+++.+++|............+.+|++.++.+.. +..+.+++++..+.+..++||||++|.
T Consensus 21 ~~~g~s~~~v~~~--~--~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 21 DTEGMSPAKVYKL--V--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp CCSCCSSSEEEEE--E--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred eccCCCCCeEEEE--E--CCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-CCCCCeEEEEEecCCceEEEEEecCCe
Confidence 4567777889987 2 2468999999875432334568899999999973 667888999988888899999999999
Q ss_pred CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 027015 83 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI----------------------------------------- 121 (229)
Q Consensus 83 sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~----------------------------------------- 121 (229)
+|.+.+. +......++.++..+++.||+..
T Consensus 96 ~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 96 LCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred ehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9987641 11223467788889999999810
Q ss_pred ---------------CCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 122 ---------------QPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 122 ---------------~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0258999999999999865556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=3.6e-12 Score=97.49 Aligned_cols=131 Identities=15% Similarity=0.075 Sum_probs=93.5
Q ss_pred ccC-CcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCc--ccccceEEEcCCceEEEEEcc
Q 027015 3 SVG-PIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 3 ~lg-~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~--i~~~~~~~~~~~~~~lv~e~~ 79 (229)
.++ .|..+.||++ ...+|+.+++|..... ....+.+|++.++.+. +.+ +.+++.+...++..++||||+
T Consensus 26 ~~~~gg~~~~v~~~---~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~--~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 26 QQTIGCSDAAVFRL---SAQGRPVLFVKTDLSG---ALNELQDEAARLSWLA--TTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp ECSCTTSSCEEEEE---ECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHH--TTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred ecccCCCCceEEEE---ecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHH--hCCCCCCeEEEeccCCCCCEEEEEec
Confidence 354 4555889987 3456788999997643 2356788999999997 333 556888888777889999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-------------------------------------- 121 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-------------------------------------- 121 (229)
+|.+|. .. . .+ ...++.++...++.||+..
T Consensus 98 ~G~~l~--~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998874 21 1 11 1245566667777777641
Q ss_pred -----------------CCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 122 -----------------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 122 -----------------~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998765567999998643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.5e-12 Score=102.42 Aligned_cols=142 Identities=14% Similarity=0.135 Sum_probs=103.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEee--ccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcC---CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLS--VES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~---~~~~lv 75 (229)
..|+.|.++.+|+.. . ++..+++|... ... ......+.+|..+++.+...+..+.+++.++.+. +..++|
T Consensus 44 ~~l~~G~sn~~y~v~---~-~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLV---T-PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EECCC-CCSCEEEEE---C-SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEcCCcccceEEEEE---E-CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 468899999999872 2 34688899875 332 2234578889999999984345577888887665 457899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI---------------------------------- 121 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---------------------------------- 121 (229)
|||++|..+.+. ....++......++.++...|+.||+..
T Consensus 120 me~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999877432 1234678888899999999999999731
Q ss_pred ---------------------CCCeEEcCCCCCCEEEcCCCc--eEEeccccccc
Q 027015 122 ---------------------QPHVVHRDIKTSNILLDQNFN--PKISDFGLSKL 153 (229)
Q Consensus 122 ---------------------~~~i~h~di~p~ni~~~~~~~--~~l~dfg~~~~ 153 (229)
...++|+|++|.||+++.++. +.++||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 137999999999999987653 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=96.38 Aligned_cols=189 Identities=14% Similarity=0.116 Sum_probs=118.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCc--ccccceEEEcCC---ceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLHGGCIDGP---CRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~--i~~~~~~~~~~~---~~~lv~ 76 (229)
..++.|....||+.. ..+++|..... .....+.+|.+.++.+.. +.. +.+++....... ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~-~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-------RDFIFKFPKHS--RGSTNLFNEVNILKRIHN-KLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-------TSEEEEEESSH--HHHHHHHHHHHHHHHHTT-SSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-------CEEEEEecCCc--chHHHHHHHHHHHHHHHh-cCCCCCCceEeecCCCCCCCcceEEE
Confidence 356788888888762 46899986532 345678899999988852 322 333333322222 347899
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI----------------------------------- 121 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~----------------------------------- 121 (229)
++++|.+|.+.. ...++..+...++.++...++.||+..
T Consensus 96 ~~i~G~~l~~~~------~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 96 TKIKGVPLTPLL------LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp ECCCCEECCHHH------HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred cccCCeECCccc------cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999999886533 134666777777778877777777510
Q ss_pred --------------------CCCeEEcCCCCCCEEEcC--CCceEEeccccccccCCCCccccccccCCccccCccccc-
Q 027015 122 --------------------QPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI- 178 (229)
Q Consensus 122 --------------------~~~i~h~di~p~ni~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~- 178 (229)
...++|+|++|.||++++ +..+.++||+.+..- ........ ......-.+|+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~~Dl~~-~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPDNDFIS-LMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTTHHHHT-TCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChHHHHHH-HHhhccccCHHHHHH
Confidence 125799999999999997 455789999987542 11110000 00000001222111
Q ss_pred ---cCCC----------CCcccchhHHHHHHHHHhCCCcccCc
Q 027015 179 ---SGRL----------TRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 179 ---~~~~----------~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.... ..-.+.|+++.++|.+.+|..+|-..
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHH
Confidence 1110 11258999999999999999988654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=2.6e-08 Score=76.53 Aligned_cols=134 Identities=13% Similarity=0.036 Sum_probs=90.4
Q ss_pred Ccccc-cccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCCCH
Q 027015 6 PIRLE-KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 84 (229)
Q Consensus 6 ~G~~~-~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 84 (229)
.|..+ .||+. ....++..+++|..... ....+.+|...++.+.. +--+.+++.+..+.+..++|||+++|.++
T Consensus 34 ~G~S~~~v~rl--~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~-~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 34 VGQSGATIYRL--YGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTA-FMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp CSSSSCEEEEE--ECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred CCCcCCeEEEE--EecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhcc-CCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34443 46664 33446678999987633 34567889999998873 33367788888888889999999999988
Q ss_pred HHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 027015 85 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------------------------------------------- 121 (229)
Q Consensus 85 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~------------------------------------------- 121 (229)
.+..... ......+..++...|+.||+..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765211 1112234444455555555321
Q ss_pred ------------CCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 122 ------------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 122 ------------~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
...++|+|+++.||+++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01268999999999999776677999997653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=8.2e-08 Score=75.25 Aligned_cols=136 Identities=16% Similarity=0.167 Sum_probs=85.2
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCC-cccccceEEE-cCCceEEEEEccC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-NLVKLHGGCI-DGPCRILVYDYMP 80 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~-~i~~~~~~~~-~~~~~~lv~e~~~ 80 (229)
.++.|....||+. |..+++|... .......+.+|.+.++.+....+ .+.+++.+.. ..+..+++||+++
T Consensus 26 ~l~~G~~n~v~~v-------g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 26 SLGEGFRNYAILV-------NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEECSSEEEEEE-------TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred ecCCCcceeEEEE-------CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 4566776777764 4678899853 23345678899999999983212 3455555553 3456789999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE---------------------------------------- 120 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---------------------------------------- 120 (229)
|.++.+... ..++......+..++...|+.||+.
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988866310 1122223333333333333333321
Q ss_pred -----------------CCCCeEEcCCCCCCEEEcC---CCce-EEeccccccc
Q 027015 121 -----------------IQPHVVHRDIKTSNILLDQ---NFNP-KISDFGLSKL 153 (229)
Q Consensus 121 -----------------~~~~i~h~di~p~ni~~~~---~~~~-~l~dfg~~~~ 153 (229)
....++|+|++|.|++++. ++.+ .|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 4554 7999997754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=4.3e-08 Score=78.41 Aligned_cols=83 Identities=8% Similarity=-0.039 Sum_probs=53.0
Q ss_pred cc-CCcccccccccceEecc----CCcEEEEEEeeccc---chhhHHHHHHHHHHhhhccC-CCcccccceEEEcC---C
Q 027015 3 SV-GPIRLEKVDLAPFIRLQ----DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDG---P 70 (229)
Q Consensus 3 ~l-g~G~~~~v~~~~~~~~~----~~~~vavK~~~~~~---~~~~~~~~~e~~~~~~l~~~-~~~i~~~~~~~~~~---~ 70 (229)
.| +.|....+|+....... +++.+++|...... ......+.+|+..++.+... .-.+.+++.+..+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 35 67778888876321001 25789999875432 11235678888988888732 23466677766554 3
Q ss_pred ceEEEEEccCCCCHH
Q 027015 71 CRILVYDYMPNNSLS 85 (229)
Q Consensus 71 ~~~lv~e~~~~~sL~ 85 (229)
..++|||+++|.++.
T Consensus 107 ~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 107 TPFFLMDYVEGVVPP 121 (357)
T ss_dssp SCEEEEECCCCBCCC
T ss_pred CceEEEEecCCCChh
Confidence 568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.52 E-value=7.4e-07 Score=70.54 Aligned_cols=31 Identities=29% Similarity=0.424 Sum_probs=27.5
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 123 ~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
..++|+|+++.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4899999999999998778899999997743
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=4.9e-07 Score=73.35 Aligned_cols=77 Identities=13% Similarity=0.059 Sum_probs=48.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc-------hhhHHHHHHHHHHhhhccCCCccc-ccceEEEcCCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK-------QGEKEFMSEVASMANVNVCHENLV-KLHGGCIDGPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~~~~l~~~~~~i~-~~~~~~~~~~~~~ 73 (229)
..||.|..+.||++ ....+++.+++|....... ........|.+.++.+....|..+ +++.+ +....+
T Consensus 36 ~~lg~G~~n~vyrv--~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 36 QEIGDGNLNYVFHI--YDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EECCSSSSEEEEEE--EC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EECCCCceEEEEEE--EECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46899999999988 2233568899998653211 123456788999888862224333 44432 445568
Q ss_pred EEEEccCCC
Q 027015 74 LVYDYMPNN 82 (229)
Q Consensus 74 lv~e~~~~~ 82 (229)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.27 E-value=6e-06 Score=64.72 Aligned_cols=76 Identities=13% Similarity=0.052 Sum_probs=57.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccC-CCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~-~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
.+|+.|....+|+.. .++..+++|..... ....+..|.+.++.+... ...+.+++.+....+..++||||++
T Consensus 42 ~~l~gG~~n~~y~v~----~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIN----DEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEECCSSSSEEEEEE----SSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred EEeCCccceeeeEEE----ECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 357888889999862 25678999987633 345678899999888632 3567788888777788899999999
Q ss_pred CCCH
Q 027015 81 NNSL 84 (229)
Q Consensus 81 ~~sL 84 (229)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.18 E-value=9.3e-06 Score=62.84 Aligned_cols=76 Identities=20% Similarity=0.198 Sum_probs=53.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCC-cccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~-~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
..+|.|..+.||+. ...||+.+++|............+..|++.++.+....+ -+.+++.+ + ..++||||++
T Consensus 21 ~~~g~G~~~~vyrv---~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~ 93 (288)
T 3f7w_A 21 AERGHSHRWHLYRV---ELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVD 93 (288)
T ss_dssp EEEEEETTEEEEEE---EETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCC
T ss_pred EecCCCCCeEEEEE---EECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeec
Confidence 45788999999996 668899999998765544444567889999998862222 23333332 2 3478999998
Q ss_pred CCCH
Q 027015 81 NNSL 84 (229)
Q Consensus 81 ~~sL 84 (229)
+...
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.8e-05 Score=61.68 Aligned_cols=71 Identities=10% Similarity=0.016 Sum_probs=43.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcc-cccceEEEcCCceEEEEEcc-
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL-VKLHGGCIDGPCRILVYDYM- 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i-~~~~~~~~~~~~~~lv~e~~- 79 (229)
.+|+.|....+|+. +.+++|....... ......+|...++.+. ...+ .+++.. +...-++++||+
T Consensus 24 ~~l~gG~tN~~~~~--------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~--~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 24 LERLGGLTNLVFRA--------GDLCLRIPGKGTE-EYINRANEAVAAREAA--KAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp EEEESCSSEEEEEE--------TTEEEEEECC-----CCCHHHHHHHHHHHH--HTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eEcCCcccccccee--------eeEEEECCCCCcc-ceeCHHHHHHHHHHHH--HcCCCCceEEE--ECCCCEEEEeecC
Confidence 45777888888875 5688998864321 1223456888888776 2233 344433 343457899999
Q ss_pred CCCCHH
Q 027015 80 PNNSLS 85 (229)
Q Consensus 80 ~~~sL~ 85 (229)
+|.++.
T Consensus 91 ~g~~l~ 96 (301)
T 3dxq_A 91 GAQTMS 96 (301)
T ss_dssp TCEECC
T ss_pred CCccCC
Confidence 766553
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-05 Score=63.06 Aligned_cols=29 Identities=21% Similarity=0.400 Sum_probs=26.0
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 124 ~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
.++|+|++|.||+++.++ +.++||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 899999999999998766 99999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.93 E-value=6.2e-05 Score=59.38 Aligned_cols=31 Identities=32% Similarity=0.376 Sum_probs=26.6
Q ss_pred CCeEEcCCCCCCEEEcCC----CceEEeccccccc
Q 027015 123 PHVVHRDIKTSNILLDQN----FNPKISDFGLSKL 153 (229)
Q Consensus 123 ~~i~h~di~p~ni~~~~~----~~~~l~dfg~~~~ 153 (229)
..++|+|+++.||+++.+ +.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 379999999999999864 6789999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.92 E-value=8.7e-05 Score=58.14 Aligned_cols=145 Identities=10% Similarity=0.061 Sum_probs=75.1
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceE------EEcCCceEEEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------CIDGPCRILVY 76 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~------~~~~~~~~lv~ 76 (229)
.|+.|....+|+. ...+ ..+++|..... .....+..|...++.+....-.+.+++.. ....+..++++
T Consensus 29 ~i~~G~~n~~~~v---~~~~-g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 29 GIAEGVENSNFLL---HTTK-DPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EECC---EEEEEE---EESS-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred ccCCCcccceEEE---EeCC-ccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 4566777778876 2233 47889988642 12335566778777776321112333321 12345678999
Q ss_pred EccCCCCHHH-----------H---Hhhhhcc-ccC----CC---HHHHHH------------HHHHHHHHHHHHhhc--
Q 027015 77 DYMPNNSLSQ-----------T---LLGEEKR-RAK----FG---WKARRE------------IIMGIGRGLAYIHEE-- 120 (229)
Q Consensus 77 e~~~~~sL~~-----------~---~~~~~~~-~~~----l~---~~~~~~------------~~~~i~~~l~~lH~~-- 120 (229)
+|++|..+.. . ++..... ..+ .. +..... +...+...++.+...
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998865311 0 1110000 000 11 111000 001133344444432
Q ss_pred --CCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 121 --IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 121 --~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
...+++|+|+++.||+++.++.+.++||+.+..
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123799999999999998765568999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00015 Score=56.99 Aligned_cols=75 Identities=9% Similarity=-0.058 Sum_probs=46.1
Q ss_pred cCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceE-----EEcCCceEEEEEc
Q 027015 4 VGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG-----CIDGPCRILVYDY 78 (229)
Q Consensus 4 lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~-----~~~~~~~~lv~e~ 78 (229)
|+ |....||+. ...+|+.+++|..+... .....+..|...++.+....-.+.+++.. ....+..++++++
T Consensus 34 l~-g~~n~~y~v---~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 34 LN-SYENRVYQF---QDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EC-CSSSEEEEE---CCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred ec-CcccceEEE---EcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 44 666677765 33467789999987432 23456677888888876321123344332 2234556789999
Q ss_pred cCCCC
Q 027015 79 MPNNS 83 (229)
Q Consensus 79 ~~~~s 83 (229)
++|..
T Consensus 109 i~G~~ 113 (328)
T 1zyl_A 109 VGGRQ 113 (328)
T ss_dssp CCCEE
T ss_pred cCCCC
Confidence 98754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00029 Score=56.67 Aligned_cols=145 Identities=15% Similarity=0.104 Sum_probs=78.2
Q ss_pred ccCCcccccccccceEe-----ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 3 SVGPIRLEKVDLAPFIR-----LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
.|..|....+|+...-. ..+++.+++|..... ........+|.++++.+.. +.-..+++..+.+ .+|+|
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~-~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAE-RSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHH-TTSSCCEEEEETT----EEEEE
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHh-cCCCCeEEEEcCC----ccEEE
Confidence 45667777778762210 113578999996432 2234566689999988873 2223555555433 28999
Q ss_pred ccCCCCHHH--------------HHhhhhcc----ccCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 027015 78 YMPNNSLSQ--------------TLLGEEKR----RAKFG--WKARREIIMGIGR-------------------GLAYIH 118 (229)
Q Consensus 78 ~~~~~sL~~--------------~~~~~~~~----~~~l~--~~~~~~~~~~i~~-------------------~l~~lH 118 (229)
|++|.+|.. .+...-.. ..... +..+..+..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998865531 11100000 11111 2344444433321 122222
Q ss_pred ----hc-CCCCeEEcCCCCCCEEEcCC----CceEEeccccccc
Q 027015 119 ----EE-IQPHVVHRDIKTSNILLDQN----FNPKISDFGLSKL 153 (229)
Q Consensus 119 ----~~-~~~~i~h~di~p~ni~~~~~----~~~~l~dfg~~~~ 153 (229)
.. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 11 12268999999999999876 6899999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0011 Score=52.47 Aligned_cols=30 Identities=27% Similarity=0.372 Sum_probs=26.8
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 124 ~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
.++|+|+.+.|++++.++.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 799999999999999778899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0011 Score=54.62 Aligned_cols=73 Identities=7% Similarity=-0.047 Sum_probs=43.6
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcc-cccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL-VKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i-~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
.|+.|....+|+.. ...++..+++|+...... ......+|...++.+. ..++ .++++.+ .+ .+|+||++|
T Consensus 115 ~lsgG~tN~~y~v~--~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~--~~gl~P~ll~~~--~~--G~v~e~I~G 185 (458)
T 2qg7_A 115 IINGGITNILIKVK--DMSKQAKYLIRLYGPKTD-EIINREREKKISCILY--NKNIAKKIYVFF--TN--GRIEEFMDG 185 (458)
T ss_dssp EECC--CEEEEEEE--ETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHT--TSSSBCCEEEEE--TT--EEEEECCCS
T ss_pred EcCCCeEeEEEEEE--ECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHH--hcCCCCCEEEEe--CC--eEEEEeeCC
Confidence 56777778888862 211247899998753321 2222367888888887 3333 4566655 22 259999987
Q ss_pred CCH
Q 027015 82 NSL 84 (229)
Q Consensus 82 ~sL 84 (229)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00047 Score=55.14 Aligned_cols=75 Identities=8% Similarity=-0.026 Sum_probs=41.8
Q ss_pred ccCCcccccccccceEec------cCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCc-ccccceEEEcCCceEEE
Q 027015 3 SVGPIRLEKVDLAPFIRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILV 75 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~-i~~~~~~~~~~~~~~lv 75 (229)
.|+.|....+|+...... ..++.+++|+...... .......|.+.++.+. ..+ ..+++..+ . -++|
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~--~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMS--KYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHH--HTTSSCCEEEEE--T--TEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHH--hcCCCCceEEec--C--CcEE
Confidence 566777778887632110 0136889998754322 2223467888888887 333 34555443 2 3689
Q ss_pred EEccCCCCH
Q 027015 76 YDYMPNNSL 84 (229)
Q Consensus 76 ~e~~~~~sL 84 (229)
++|++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00096 Score=54.59 Aligned_cols=76 Identities=14% Similarity=0.084 Sum_probs=45.9
Q ss_pred CccCCcccccccccceEe-----ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-----LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
..|+.|....+|++..-. ..+++.+++|+..... ....+.+|...++.+.. +.-..++++.+. + .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~-~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSE-RHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHH-TTSSSCEEEEET--T--EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHh-CCCCCcEEEEeC--C--CEEE
Confidence 356778788888872210 0125789999984321 11355578999888872 222345555443 2 2899
Q ss_pred EccCCCCH
Q 027015 77 DYMPNNSL 84 (229)
Q Consensus 77 e~~~~~sL 84 (229)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0023 Score=46.99 Aligned_cols=100 Identities=12% Similarity=0.084 Sum_probs=64.8
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
..||.+.+ .....+++++++|.++.|.+..|..+-..- .-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL---~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEIL---RLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHH---HHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHH---HHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc--------
Confidence 45799998 367789999999999999999988762210 112344567889999998887664 1110
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 200 (229)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122356787642 344677789999999998663
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.014 Score=47.59 Aligned_cols=76 Identities=3% Similarity=-0.036 Sum_probs=44.2
Q ss_pred ccCCcccccccccceEec-c----CCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 3 SVGPIRLEKVDLAPFIRL-Q----DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~-~----~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
.+..|....+|+...-.. . .++.+++|...... ....+..+|...++.+.. +.-..++++.+ . -++|++
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~-~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSN-INIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHH-TTSSCCEEEEE--T--TEEEEE
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHh-cCCCCCEEEEc--C--CCEEEE
Confidence 455666677777632100 0 15889999975332 222345678888888862 22234555432 2 268999
Q ss_pred ccCCCCH
Q 027015 78 YMPNNSL 84 (229)
Q Consensus 78 ~~~~~sL 84 (229)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.029 Score=41.05 Aligned_cols=117 Identities=9% Similarity=0.064 Sum_probs=77.8
Q ss_pred CCCcccccceEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCC
Q 027015 55 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134 (229)
Q Consensus 55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~n 134 (229)
.+|++++. .+-++.+.+.+.++.-+ +..++ ..-..++....+.++.+++....+++.. .|.-++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f-----~~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPF-----DNIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEG-----GGGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCH-----HHHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 48888876 45556665445444332 22222 2235688899999999998877555533 788999999
Q ss_pred EEEcCCCceEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 135 i~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
++++.++.+++.-.|+...+ +|. ..+...=+-.+=|++..+++++..|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999998864322 111 112222344556888888999888864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.1 Score=38.26 Aligned_cols=115 Identities=9% Similarity=0.089 Sum_probs=75.5
Q ss_pred CCCcccccceEEEcCCceEEEEEccCCC-CHHHHHhhhhccccCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEEcCCCC
Q 027015 55 CHENLVKLHGGCIDGPCRILVYDYMPNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA-YIHEEIQPHVVHRDIKT 132 (229)
Q Consensus 55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~-~lH~~~~~~i~h~di~p 132 (229)
.+|++ --.+-.+.+.+.+.++.-++. ++. .+ ..++....+..+.+++.... +++ .-.|.-++|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 48888 334446666666666654333 333 22 46788899999999887665 444 347889999
Q ss_pred CCEEEcCCCceEEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccC
Q 027015 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 207 (229)
Q Consensus 133 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~ 207 (229)
+|++++.++.+++.-.|+...+ +|.- .+...=+-.+=|++..++.++..|+.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred ceEEEeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999999998864322 2211 11112233556788888888877764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.44 E-value=0.18 Score=40.67 Aligned_cols=29 Identities=31% Similarity=0.453 Sum_probs=24.5
Q ss_pred eEEcCCCCCCEEE------cCCCceEEeccccccc
Q 027015 125 VVHRDIKTSNILL------DQNFNPKISDFGLSKL 153 (229)
Q Consensus 125 i~h~di~p~ni~~------~~~~~~~l~dfg~~~~ 153 (229)
++|+|+.+.||++ ++++.+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 3466799999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 229 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-53
Identities = 45/187 (24%), Positives = 87/187 (46%), Gaps = 12/187 (6%)
Query: 18 IRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
G ++A K++ +E K + + E+ + N +V +G +
Sbjct: 26 SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISICM 83
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
++M SL Q L K+ + + ++ + + +GL Y+ E + ++HRD+K SNIL
Sbjct: 84 EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
++ K+ DFG+S ++ GT Y++PE + +SD++S G+ L+
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 194
Query: 197 EIVSGRT 203
E+ GR
Sbjct: 195 EMAVGRY 201
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 7e-53
Identities = 51/183 (27%), Positives = 93/183 (50%), Gaps = 15/183 (8%)
Query: 26 VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 83
VAVK+L+V + Q + F +EV + H N++ G P +V + +S
Sbjct: 33 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYS-TAPQLAIVTQWCEGSS 89
Query: 84 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143
L L KF +I +G+ Y+H ++HRD+K++NI L ++
Sbjct: 90 LYHHL---HIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTV 143
Query: 144 KISDFGLSKLFPE-NTTHISTRVAGTLGYLAPEYA---ISGRLTRKSDVYSFGVLLLEIV 199
KI DFGL+ + + +H +++G++ ++APE + +SDVY+FG++L E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 200 SGR 202
+G+
Sbjct: 204 TGQ 206
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-51
Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 9/184 (4%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
T VAVK L + F++E M + H+ LV+L+ P ++ +Y
Sbjct: 33 YYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQ--HQRLVRLYAVVTQEP-IYIITEY 88
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M N SL L + K ++ I G+A+I E + +HRD++ +NIL+
Sbjct: 89 MENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVS 143
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+ KI+DFGL++L +N + + APE G T KSDV+SFG+LL EI
Sbjct: 144 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 199 VSGR 202
V+
Sbjct: 204 VTHG 207
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-50
Identities = 53/184 (28%), Positives = 93/184 (50%), Gaps = 9/184 (4%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ VA+K + E E++F+ E M ++ H LV+L+G C++ LV+++
Sbjct: 25 YWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICLVFEF 81
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M + LS +R F + + + + G+AY+ E V+HRD+ N L+
Sbjct: 82 MEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVG 135
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+N K+SDFG+++ ++ ST + + +PE R + KSDV+SFGVL+ E+
Sbjct: 136 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 195
Query: 199 VSGR 202
S
Sbjct: 196 FSEG 199
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-48
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 9/192 (4%)
Query: 18 IRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL- 74
R DG I+ K L S + ++ +SEV + + H N+V+ + ID L
Sbjct: 24 RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIIDRTNTTLY 81
Query: 75 -VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE--EIQPHVVHRDIK 131
V +Y L+ + K R + ++ + L H + V+HRD+K
Sbjct: 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141
Query: 132 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 191
+N+ LD N K+ DFGL+++ +T+ + GT Y++PE KSD++S
Sbjct: 142 PANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200
Query: 192 GVLLLEIVSGRT 203
G LL E+ +
Sbjct: 201 GCLLYELCALMP 212
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-48
Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 9/182 (4%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
+ + VA+K++ E E EF+ E M N++ HE LV+L+G C ++ +Y
Sbjct: 24 KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLS--HEKLVQLYGVCTKQRPIFIITEY 80
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M N L L + R +F + E+ + + Y+ +HRD+ N L++
Sbjct: 81 MANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVN 134
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
K+SDFGLS+ ++ S + + PE + + + KSD+++FGVL+ EI
Sbjct: 135 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 194
Query: 199 VS 200
S
Sbjct: 195 YS 196
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 4e-48
Identities = 39/190 (20%), Positives = 83/190 (43%), Gaps = 14/190 (7%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ + A KV+ +S++ +++M E+ +A+ + H N+VKL ++ +
Sbjct: 32 QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIE 89
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+ ++ + + + + L Y+H+ ++HRD+K NIL
Sbjct: 90 FCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILF 143
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFG 192
+ + K++DFG+S + + GT ++APE + K+DV+S G
Sbjct: 144 TLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLG 202
Query: 193 VLLLEIVSGR 202
+ L+E+
Sbjct: 203 ITLIEMAEIE 212
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-48
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 9/184 (4%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78
T VA+K L + F+ E M + HE LV+L+ + P +V +Y
Sbjct: 37 TWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR--HEKLVQLYAVVSEEPI-YIVTEY 92
Query: 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 138
M SL + + ++ I G+AY+ + + VHRD++ +NIL+
Sbjct: 93 MSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVG 147
Query: 139 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 198
+N K++DFGL++L +N + + APE A+ GR T KSDV+SFG+LL E+
Sbjct: 148 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 207
Query: 199 VSGR 202
+
Sbjct: 208 TTKG 211
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-47
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 18 IRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
Q I+A+KVL +E E + EV +++ H N+++L+G D L
Sbjct: 26 REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRVYL 83
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
+ +Y P ++ + L ++ +KF + I + L+Y H + V+HRDIK N
Sbjct: 84 ILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPEN 136
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
+LL KI+DFG S P + + GTL YL PE K D++S GVL
Sbjct: 137 LLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 193
Query: 195 LLEIVSGRTAVDFDVQLGEYHLVDKVR 221
E + G+ + + Y + +V
Sbjct: 194 CYEFLVGKPPFEANTYQETYKRISRVE 220
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 2e-47
Identities = 44/192 (22%), Positives = 85/192 (44%), Gaps = 20/192 (10%)
Query: 18 IRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
+++ +VA+K +S KQ ++ + EV + + H N ++ G + L
Sbjct: 35 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWL 92
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V +Y ++ + + G +GLAY+H +++HRD+K N
Sbjct: 93 VMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGN 145
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSF 191
ILL + K+ DFG + + + + GT ++APE ++ G+ K DV+S
Sbjct: 146 ILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 192 GVLLLEIVSGRT 203
G+ +E+ +
Sbjct: 201 GITCIELAERKP 212
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-46
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 69
+V LA + VAVK++ ++ + + E+ +N HEN+VK +G +G
Sbjct: 20 EVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREG 75
Query: 70 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
+ L +Y L + + + + G+ Y+H + HRD
Sbjct: 76 NIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 128
Query: 130 IKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAISGRL-TRKSD 187
IK N+LLD+ N KISDFGL+ +F N + ++ GTL Y+APE D
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 188 VYSFGVLLLEIVSGRTAVDFD 208
V+S G++L +++G D
Sbjct: 189 VWSCGIVLTAMLAGELPWDQP 209
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-46
Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 18/192 (9%)
Query: 18 IRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPC 71
+ + VA L +K + F E + + H N+V+ + C
Sbjct: 29 LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKKC 86
Query: 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+LV + M + +L L KR K R I +GL ++H P ++HRD+K
Sbjct: 87 IVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLK 141
Query: 132 TSNILL-DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYS 190
NI + + KI D GL+ L + V GT ++APE + DVY+
Sbjct: 142 CDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM-YEEKYDESVDVYA 197
Query: 191 FGVLLLEIVSGR 202
FG+ +LE+ +
Sbjct: 198 FGMCMLEMATSE 209
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (386), Expect = 3e-46
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80
+ VAVK L ++ + E EF+ E A M + H NLV+L G C P ++ ++M
Sbjct: 40 KYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYIITEFMT 96
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
+L L E R + + I + Y+ + + +HRD+ N L+ +N
Sbjct: 97 YGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGEN 151
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
K++DFGLS+L +T + + APE + + KSDV++FGVLL EI +
Sbjct: 152 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211
Query: 201 GRTAVDFDVQLGE-YHLVDK 219
+ + L + Y L++K
Sbjct: 212 YGMSPYPGIDLSQVYELLEK 231
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-46
Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ + G VA++ ++++ + ++ ++E+ M + N+V + G +V +
Sbjct: 40 MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVME 97
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
Y+ SL+ + + + L ++H V+HRDIK+ NILL
Sbjct: 98 YLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILL 149
Query: 138 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
+ + K++DFG + ST V GT ++APE K D++S G++ +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
Query: 198 IVSGR 202
++ G
Sbjct: 209 MIEGE 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-44
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDG 69
V + + VA+KVL +++ + +E M E M ++ + +V+L G
Sbjct: 24 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIG-VCQA 80
Query: 70 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
+LV + L + L+G +R + E++ + G+ Y+ + + VHRD
Sbjct: 81 EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRD 134
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTRKSD 187
+ N+LL KISDFGLSK + ++ + R L + APE + + +SD
Sbjct: 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 194
Query: 188 VYSFGVLLLEIVS 200
V+S+GV + E +S
Sbjct: 195 VWSYGVTMWEALS 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-44
Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 22 DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-LVYDYMP 80
G VAVK + + + F++E + M + H NLV+L G ++ + +V +YM
Sbjct: 29 RGNKVAVKCIK--NDATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYIVTEYMA 84
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
SL L + R+ G + + + + Y+ + VHRD+ N+L+ ++
Sbjct: 85 KGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSED 139
Query: 141 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
K+SDFGL+K + + APE + + KSDV+SFG+LL EI S
Sbjct: 140 NVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
Query: 201 GR 202
Sbjct: 196 FG 197
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-44
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCID 68
V + + VAVK+L E+ E ++E M ++ + +V++ G +
Sbjct: 22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIG-ICE 78
Query: 69 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128
+LV + L++ L ++ K E++ + G+ Y+ + + VHR
Sbjct: 79 AESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHR 131
Query: 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTRKS 186
D+ N+LL KISDFGLSK + + + + + APE + + KS
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 187 DVYSFGVLLLEIVSGR 202
DV+SFGVL+ E S
Sbjct: 192 DVWSFGVLMWEAFSYG 207
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 4e-44
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 69
+ + + T+VAVK+L E S + +F E A MA + + N+VKL G C G
Sbjct: 31 QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLGVCAVG 88
Query: 70 PCRILVYDYMPNNSLSQTLLGEEKR--------------------RAKFGWKARREIIMG 109
L+++YM L++ L + I
Sbjct: 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148
Query: 110 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGT 168
+ G+AY+ E VHRD+ T N L+ +N KI+DFGLS+ ++ + A
Sbjct: 149 VAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 205
Query: 169 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 202
+ ++ PE R T +SDV+++GV+L EI S
Sbjct: 206 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-43
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 19 RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ VAVK+L ++ E+E MSE+ M + HEN+V L G C L+++
Sbjct: 63 KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-SHENIVNLLGACTLSGPIYLIFE 121
Query: 78 YMPNNSLSQTL-------------------LGEEKRRAKFGWKARREIIMGIGRGLAYIH 118
Y L L L EE+ ++ + +G+ ++
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181
Query: 119 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYA 177
VHRD+ N+L+ KI DFGL++ ++ + + + ++APE
Sbjct: 182 F---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238
Query: 178 ISGRLTRKSDVYSFGVLLLEIVSG 201
G T KSDV+S+G+LL EI S
Sbjct: 239 FEGIYTIKSDVWSYGILLWEIFSL 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-43
Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 26/200 (13%)
Query: 21 QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PCRILVY 76
G VAVK+ S + E+ + E V + HEN++ LV
Sbjct: 24 WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIK 131
DY + SL L R + ++ + GLA++H EI +P + HRD+K
Sbjct: 81 DYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 135
Query: 132 TSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLGYLAPEYAIS------GRL 182
+ NIL+ +N I+D GL+ T I GT Y+APE
Sbjct: 136 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 195
Query: 183 TRKSDVYSFGVLLLEIVSGR 202
+++D+Y+ G++ EI
Sbjct: 196 FKRADIYAMGLVFWEIARRC 215
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-43
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDG 69
+ I+ VAVK+L + E+E MSE+ ++ + H N+V L G C G
Sbjct: 41 EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHMNIVNLLGACTIG 99
Query: 70 PCRILVYDYMPNNSLSQTLLGE--------------EKRRAKFGWKARREIIMGIGRGLA 115
+++ +Y L L + E + + +G+A
Sbjct: 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 116 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAP 174
++ + + +HRD+ NILL KI DFGL++ ++ + + + ++AP
Sbjct: 160 FLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 175 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208
E + T +SDV+S+G+ L E+ S ++
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 147 bits (371), Expect = 2e-43
Identities = 45/188 (23%), Positives = 80/188 (42%), Gaps = 12/188 (6%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
G A K + + ++ E+ +M+ + H LV LH D +++Y+
Sbjct: 46 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDDNEMVMIYE 103
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+M L + + K E + + +GL ++HE + VH D+K NI+
Sbjct: 104 FMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMF 157
Query: 138 DQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
+ K+ DFGL+ + T GT + APE A + +D++S GVL
Sbjct: 158 TTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 215
Query: 196 LEIVSGRT 203
++SG +
Sbjct: 216 YILLSGLS 223
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-43
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 13/186 (6%)
Query: 23 GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGP-CRILVYDYMP 80
AVK L+ + GE +F++E M + + H N++ L G C+ ++V YM
Sbjct: 55 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSPLVVLPYMK 112
Query: 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 140
+ L K + + +G+ ++ VHRD+ N +LD+
Sbjct: 113 HGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEK 166
Query: 141 FNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
F K++DFGL++ + + H T + ++A E + + T KSDV+SFGVLL E
Sbjct: 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226
Query: 198 IVSGRT 203
+++
Sbjct: 227 LMTRGA 232
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 5e-43
Identities = 49/185 (26%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 21 QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
+ VA+K L +++ ++F+SE + M + H N++ L G +++ ++M
Sbjct: 52 KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNVIHLEGVVTKSTPVMIITEFM 109
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N SL + +F ++ GI G+ Y+ + VHRD+ NIL++
Sbjct: 110 ENGSLDSF---LRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNS 163
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVA----GTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
N K+SDFGLS+ ++T+ + A + + APE + T SDV+S+G+++
Sbjct: 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223
Query: 196 LEIVS 200
E++S
Sbjct: 224 WEVMS 228
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-41
Identities = 48/196 (24%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 21 QDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
+ VA+K L + ++ +F+ E M + H N+++L G +++ +YM
Sbjct: 34 KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISKYKPMMIITEYM 91
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
N +L + ++ +F ++ GI G+ Y+ + VHRD+ NIL++
Sbjct: 92 ENGALDKF---LREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNS 145
Query: 140 NFNPKISDFGLSKLFPEN--TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 197
N K+SDFGLS++ ++ T+ ++ + + APE + T SDV+SFG+++ E
Sbjct: 146 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205
Query: 198 IVSGRTAVDFDVQLGE 213
+++ +++ E
Sbjct: 206 VMTYGERPYWELSNHE 221
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-41
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 13/190 (6%)
Query: 18 IRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
L A+K+L + + E M+ ++ H VKL+ D
Sbjct: 28 RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--HPFFVKLYFTFQDDEKLYF 85
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
Y N L + + ++ F R I L Y+H ++HRD+K N
Sbjct: 86 GLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPEN 138
Query: 135 ILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
ILL+++ + +I+DFG +K+ PE+ + GT Y++PE + SD+++ G
Sbjct: 139 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198
Query: 194 LLLEIVSGRT 203
++ ++V+G
Sbjct: 199 IIYQLVAGLP 208
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 142 bits (359), Expect = 2e-41
Identities = 40/188 (21%), Positives = 74/188 (39%), Gaps = 12/188 (6%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ G + K ++ + +E++ M ++ H L+ LH D +L+ +
Sbjct: 49 VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDKYEMVLILE 106
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
++ L + K + GL ++HE +VH DIK NI+
Sbjct: 107 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMC 160
Query: 138 DQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
+ KI DFGL+ + T T + APE + +D+++ GVL
Sbjct: 161 ETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLG 218
Query: 196 LEIVSGRT 203
++SG +
Sbjct: 219 YVLLSGLS 226
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-41
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 19/205 (9%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 69
+V A + A+K + SK ++F E+ + + H N++ L G C
Sbjct: 25 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHR 83
Query: 70 PCRILVYDYMPNNSLSQTLLGE------------EKRRAKFGWKARREIIMGIGRGLAYI 117
L +Y P+ +L L + + + RG+ Y+
Sbjct: 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143
Query: 118 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 177
Q +HRD+ NIL+ +N+ KI+DFGLS+ T + ++A E
Sbjct: 144 S---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESL 198
Query: 178 ISGRLTRKSDVYSFGVLLLEIVSGR 202
T SDV+S+GVLL EIVS
Sbjct: 199 NYSVYTTNSDVWSYGVLLWEIVSLG 223
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-41
Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 14/185 (7%)
Query: 21 QDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
VAVK L + + +F+ EV +M +++ H NL++L+G + P ++ V +
Sbjct: 34 GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVLTPPMKM-VTE 90
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
P SL K + F + + G+ Y+ +HRD+ N+LL
Sbjct: 91 LAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLL 144
Query: 138 DQNFNPKISDFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
KI DFGL + P+N H + + APE + + SD + FGV L
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 196 LEIVS 200
E+ +
Sbjct: 205 WEMFT 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-41
Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 11/182 (6%)
Query: 23 GTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81
VA+K L S + KE + E MA+V+ + ++ +L G C+ + L+ MP
Sbjct: 38 KIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTSTVQ-LITQLMPF 94
Query: 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 141
L L + + G + + I +G+ Y+ +VHRD+ N+L+
Sbjct: 95 GCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQ 148
Query: 142 NPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 200
+ KI+DFGL+KL E + + + ++A E + T +SDV+S+GV + E+++
Sbjct: 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208
Query: 201 GR 202
Sbjct: 209 FG 210
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-40
Identities = 45/184 (24%), Positives = 78/184 (42%), Gaps = 10/184 (5%)
Query: 21 QDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79
VA+K + +E F+ E +M + H ++VKL G + ++ +
Sbjct: 33 NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVITEN-PVWIIMELC 89
Query: 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 139
L + R+ + + LAY+ VHRDI N+L+
Sbjct: 90 TLGELRSF---LQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSS 143
Query: 140 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 199
N K+ DFGLS+ ++T + +++ + ++APE R T SDV+ FGV + EI+
Sbjct: 144 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203
Query: 200 SGRT 203
Sbjct: 204 MHGV 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (346), Expect = 1e-39
Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 15/190 (7%)
Query: 18 IRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRI 73
+ G + A+K L ++ KQGE ++E ++ V+ +V +
Sbjct: 24 RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+ D M L L + F R I GL ++H VV+RD+K +
Sbjct: 84 FILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPA 136
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFG 192
NILLD++ + +ISD GL+ F + H S GT GY+APE G +D +S G
Sbjct: 137 NILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLG 193
Query: 193 VLLLEIVSGR 202
+L +++ G
Sbjct: 194 CMLFKLLRGH 203
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (339), Expect = 2e-39
Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 18 IRLQDGTIVAVKVLSV---------ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 68
I AVK++ V E ++ + + EV + V+ H N+++L
Sbjct: 23 IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-GHPNIIQLKDTYET 81
Query: 69 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128
LV+D M L L + K R+I+ + + +H+ ++VHR
Sbjct: 82 NTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHR 134
Query: 129 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL------ 182
D+K NILLD + N K++DFG S V GT YLAPE
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGY 192
Query: 183 TRKSDVYSFGVLLLEIVSGRT 203
++ D++S GV++ +++G
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSP 213
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (332), Expect = 5e-38
Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 9/186 (4%)
Query: 18 IRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+ +VA+K ++ ++ +G E +E+A + + H N+V L G L+
Sbjct: 29 EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK--HPNIVALDDIYESGGHLYLIM 86
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+ L + + + + +I + + Y+H+ H +
Sbjct: 87 QLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
LD++ ISDFGLSK+ + + GT GY+APE ++ D +S GV+
Sbjct: 143 LDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200
Query: 197 EIVSGR 202
++ G
Sbjct: 201 ILLCGY 206
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-37
Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 18/198 (9%)
Query: 19 RLQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ T VAVK+L + +++ + +SE+ M + H+N++ L G C ++ +
Sbjct: 41 KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVE 99
Query: 78 YMPNNSLSQTL------------LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 125
Y +L + L + K + RG+ Y+
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKC 156
Query: 126 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV-AGTLGYLAPEYAISGRLTR 184
+HRD+ N+L+ ++ KI+DFGL++ + T + ++APE T
Sbjct: 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216
Query: 185 KSDVYSFGVLLLEIVSGR 202
+SDV+SFGVLL EI +
Sbjct: 217 QSDVWSFGVLLWEIFTLG 234
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-37
Identities = 28/188 (14%), Positives = 69/188 (36%), Gaps = 13/188 (6%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
+ K + V+ + E++ + H N++ LH +++++
Sbjct: 25 VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR--HRNILHLHESFESMEELVMIFE 81
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
++ + + + + + + + L ++H ++ H DI+ NI+
Sbjct: 82 FISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIY 135
Query: 138 DQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
+ KI +FG ++ Y APE ++ +D++S G L+
Sbjct: 136 QTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
Query: 196 LEIVSGRT 203
++SG
Sbjct: 194 YVLLSGIN 201
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 3e-37
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 16/188 (8%)
Query: 18 IRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
+G A+KVL V + + E ++ V H ++++ G D +
Sbjct: 24 RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--HPFIIRMWGTFQDAQQIFM 81
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
+ DY+ L ++ +F + + L Y+H +++RD+K N
Sbjct: 82 IMDYIEGGELFS----LLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPEN 134
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
ILLD+N + KI+DFG +K P+ T + GT Y+APE + + D +SFG+L
Sbjct: 135 ILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL 190
Query: 195 LLEIVSGR 202
+ E+++G
Sbjct: 191 IYEMLAGY 198
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-37
Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 13/193 (6%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
++ + T VA+K ++ + E+ EF++E + M N ++V+L G G +++
Sbjct: 45 VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSQGQPTLVIM 102
Query: 77 DYMPNNSLSQTL------LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
+ M L L + A ++ I G+AY++ VHRD+
Sbjct: 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDL 159
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 189
N ++ ++F KI DFG+++ E + + + +++PE G T SDV+
Sbjct: 160 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 219
Query: 190 SFGVLLLEIVSGR 202
SFGV+L EI +
Sbjct: 220 SFGVVLWEIATLA 232
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-36
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 12/189 (6%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 74
+ A+K L + + + M E ++ H L +
Sbjct: 22 EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHMFCTFQTKENLFF 80
Query: 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 134
V +Y+ L + + KF I GL ++H +V+RD+K N
Sbjct: 81 VMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDN 133
Query: 135 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 194
ILLD++ + KI+DFG+ K +T GT Y+APE + + D +SFGVL
Sbjct: 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHSVDWWSFGVL 192
Query: 195 LLEIVSGRT 203
L E++ G++
Sbjct: 193 LYEMLIGQS 201
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-36
Identities = 46/194 (23%), Positives = 73/194 (37%), Gaps = 17/194 (8%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKE------FMSEVASMANVNVCHENLVKLHGGCIDGPC 71
IR+ D VA+K + + E EV + V+ +++L
Sbjct: 24 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83
Query: 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
+L+ + + R + R + + + H V+HRDIK
Sbjct: 84 FVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIK 137
Query: 132 TSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVY 189
NIL+D N K+ DFG L + T GT Y PE+ R R + V+
Sbjct: 138 DENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVW 194
Query: 190 SFGVLLLEIVSGRT 203
S G+LL ++V G
Sbjct: 195 SLGILLYDMVCGDI 208
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-36
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 19 RLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVY 76
+ VAVK+L + E + MSE+ + ++ H N+V L G C G +++
Sbjct: 39 KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIV 97
Query: 77 DYMPNNSLSQTL------------LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 124
++ +LS L E+ + + + +G+ ++
Sbjct: 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RK 154
Query: 125 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLT 183
+HRD+ NILL + KI DFGL++ ++ ++ L ++APE T
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 184 RKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213
+SDV+SFGVLL EI S + V++ E
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-35
Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 10/189 (5%)
Query: 19 RLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILV 75
G VA+K + V++ + + EVA + ++ H N+V+L C
Sbjct: 29 LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88
Query: 76 YDYMPNNSLSQTLLG--EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+ + Q L ++ + ++++ + RGL ++H VVHRD+K
Sbjct: 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQ 145
Query: 134 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV 193
NIL+ + K++DFGL++++ T V TL Y APE + D++S G
Sbjct: 146 NILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 203
Query: 194 LLLEIVSGR 202
+ E+ +
Sbjct: 204 IFAEMFRRK 212
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (312), Expect = 3e-35
Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 18/194 (9%)
Query: 18 IRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKLHGGCID----GP 70
L+ VAVKVL + + F E + A +N H +V ++ GP
Sbjct: 27 RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETPAGP 84
Query: 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 130
+V +Y+ +L + K E+I + L + H+ ++HRD+
Sbjct: 85 LPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDV 137
Query: 131 KTSNILLDQNFNPKISDFGLSKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDV 188
K +NI++ K+ DFG+++ ++ + + V GT YL+PE A + +SDV
Sbjct: 138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 197
Query: 189 YSFGVLLLEIVSGR 202
YS G +L E+++G
Sbjct: 198 YSLGCVLYEVLTGE 211
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-35
Identities = 46/209 (22%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENLVKLHGGCIDGPCR 72
IVA+K + + + K+ + E+ + ++ H N++ L
Sbjct: 18 RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFGHKSNI 75
Query: 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 132
LV+D+M + + + ++ +GL Y+H+ ++HRD+K
Sbjct: 76 SLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKP 128
Query: 133 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSF 191
+N+LLD+N K++DFGL+K F + +V T Y APE R+ D+++
Sbjct: 129 NNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYGVGVDMWAV 187
Query: 192 GVLLLEIVSGRTAVDFDVQLGEYHLVDKV 220
G +L E++ + D L + + +
Sbjct: 188 GCILAELLLRVPFLPGDSDLDQLTRIFET 216
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-34
Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 10/189 (5%)
Query: 18 IRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+ VA+K +S Q + + E+ + HEN++ ++ +
Sbjct: 28 YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGINDIIRAPTIEQMKD 85
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
Y+ + + L K + + I RGL YIH +V+HRD+K SN+L
Sbjct: 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLL 141
Query: 137 LDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLAPEYAISGRL-TRKSDVYSFGV 193
L+ + KI DFGL+++ + H T T Y APE ++ + T+ D++S G
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201
Query: 194 LLLEIVSGR 202
+L E++S R
Sbjct: 202 ILAEMLSNR 210
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-34
Identities = 38/187 (20%), Positives = 76/187 (40%), Gaps = 10/187 (5%)
Query: 18 IRLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
G +VA+K + E++ + E++ + +N H N+VKL LV
Sbjct: 22 RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTENKLYLV 79
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
++++ + + + + + +GLA+ H V+HRD+K N+
Sbjct: 80 FEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNL 133
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
L++ K++DFGL++ F + V + D++S G +
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 196 LEIVSGR 202
E+V+ R
Sbjct: 194 AEMVTRR 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (302), Expect = 1e-33
Identities = 35/220 (15%), Positives = 75/220 (34%), Gaps = 21/220 (9%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77
L + VA+K S + E + + C + ++ +G +LV D
Sbjct: 25 TNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCT-GIPNVYYFGQEGLHNVLVID 81
Query: 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137
+ + + KF K + + IH + +V+RDIK N L+
Sbjct: 82 LLGPSLEDL----LDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLI 134
Query: 138 DQNFNP-----KISDFGLSKLFPENTTHI------STRVAGTLGYLAPEYAISGRLTRKS 186
+ + + DFG+ K + + T ++GT Y++ + +R+
Sbjct: 135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD 194
Query: 187 DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 226
D+ + G + + + G +++
Sbjct: 195 DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 118 bits (296), Expect = 6e-33
Identities = 37/204 (18%), Positives = 84/204 (41%), Gaps = 11/204 (5%)
Query: 19 RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
+ G A+K + +E + + E++ + + H N+VKL+ +LV+
Sbjct: 22 QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKLYDVIHTKKRLVLVF 79
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+++ + + ++ + G+AY H+ V+HRD+K N+L
Sbjct: 80 EHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLL 132
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 196
+++ KI+DFGL++ F + + S + + D++S G +
Sbjct: 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFA 192
Query: 197 EIVSGRTAVDFDVQLGEYHLVDKV 220
E+V+G + + + ++
Sbjct: 193 EMVNGTPLFPGVSEADQLMRIFRI 216
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (296), Expect = 7e-33
Identities = 40/219 (18%), Positives = 78/219 (35%), Gaps = 21/219 (9%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVY 76
+ G VA+K+ V++K + E + + C +G ++V
Sbjct: 27 TDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNVMVM 82
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
+ + + KF K + + + YIH + + +HRD+K N L
Sbjct: 83 ELLGPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFL 135
Query: 137 ---LDQNFNPKISDFGLSKLFPENTTHI------STRVAGTLGYLAPEYAISGRLTRKSD 187
+ I DFGL+K + + TH + + GT Y + + +R+ D
Sbjct: 136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDD 195
Query: 188 VYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 226
+ S G +L+ G + +++ M
Sbjct: 196 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 9e-33
Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 21/195 (10%)
Query: 18 IRLQDGTIVAVKVLSVESKQGE------KEFMSEVASMANVNVCHENLVKLHGGCIDGPC 71
G A K + + ++ EV+ + + H N++ LH +
Sbjct: 30 REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITLHEVYENKTD 87
Query: 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
IL+ + + L + + E + I G+ Y+H + H D+K
Sbjct: 88 VILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLK 140
Query: 132 TSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 187
NI+L P KI DFGL+ + GT ++APE L ++D
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEAD 198
Query: 188 VYSFGVLLLEIVSGR 202
++S GV+ ++SG
Sbjct: 199 MWSIGVITYILLSGA 213
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-32
Identities = 55/196 (28%), Positives = 79/196 (40%), Gaps = 15/196 (7%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 67
KV L G A+K+L + +K ++E + N H L L
Sbjct: 20 KVILV--REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQ 75
Query: 68 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127
V +Y L L R F + R I L Y+H VV+
Sbjct: 76 THDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RDVVY 128
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 187
RDIK N++LD++ + KI+DFGL K + + T GT YLAPE R D
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVD 187
Query: 188 VYSFGVLLLEIVSGRT 203
+ GV++ E++ GR
Sbjct: 188 WWGLGVVMYEMMCGRL 203
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-31
Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 18/192 (9%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI------DGPC 71
G +VA+K + Q ++ E+ M ++ H N+V+L D
Sbjct: 40 KLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD--HCNIVRLRYFFYSSGEKKDEVY 93
Query: 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 131
LV DY+P + + + + + + R LAYIH + HRDIK
Sbjct: 94 LNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIK 149
Query: 132 TSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYS 190
N+LLD + K+ DFG +K ++ + + + T DV+S
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELIFGATDYTSSIDVWS 208
Query: 191 FGVLLLEIVSGR 202
G +L E++ G+
Sbjct: 209 AGCVLAELLLGQ 220
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 1e-30
Identities = 38/193 (19%), Positives = 79/193 (40%), Gaps = 20/193 (10%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRI 73
+ A+K+L Q + EV + ++V++ + C +
Sbjct: 32 FNKRTQEKFALKML-----QDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLL 85
Query: 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 133
+V + + L + +++ F + EI+ IG + Y+H ++ HRD+K
Sbjct: 86 IVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 140
Query: 134 NILLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYS 190
N+L K++DFG +K + + + T Y+APE + + D++S
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMWS 198
Query: 191 FGVLLLEIVSGRT 203
GV++ ++ G
Sbjct: 199 LGVIMYILLCGYP 211
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-30
Identities = 45/217 (20%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 18 IRLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI-- 73
+ G VA+K + +E+++ + E+ + + HEN+V L C
Sbjct: 30 RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKASPYNR 87
Query: 74 ------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127
LV+D+ ++ KF + ++ + GL YIH ++H
Sbjct: 88 CKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILH 140
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTT---HISTRVAGTLGYLAPEYAISGRL-T 183
RD+K +N+L+ ++ K++DFGL++ F + T TL Y PE + R
Sbjct: 141 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 200
Query: 184 RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 220
D++ G ++ E+ + + + + + L+ ++
Sbjct: 201 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-30
Identities = 34/187 (18%), Positives = 77/187 (41%), Gaps = 11/187 (5%)
Query: 18 IRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
+ IVA+K + ++ + + E+ + + H+N+V+LH LV
Sbjct: 22 KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLV 79
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
+++ + + + + + + +GL + H +V+HRD+K N+
Sbjct: 80 FEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNL 132
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
L+++N K+++FGL++ F S V + + D++S G +
Sbjct: 133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192
Query: 196 LEIVSGR 202
E+ +
Sbjct: 193 AELANAG 199
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (279), Expect = 6e-30
Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKLHGGCI 67
+V L + G A+K+L + K+ ++E + VN LVKL
Sbjct: 56 RVMLV--KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--FPFLVKLEFSFK 111
Query: 68 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 127
D +V +Y+ + L +R +F R I Y+H +++
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIY 164
Query: 128 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 187
RD+K N+L+DQ +++DFG +K T + GT LAPE +S + D
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVD 220
Query: 188 VYSFGVLLLEIVSGR 202
++ GVL+ E+ +G
Sbjct: 221 WWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-29
Identities = 44/188 (23%), Positives = 82/188 (43%), Gaps = 10/188 (5%)
Query: 18 IRLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
+ + G VA+K L +S+ K E+ + ++ HEN++ L
Sbjct: 38 VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLLDVFTPDETLDDF 95
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
D+ T LG+ + K G + ++ + +GL YIH ++HRD+K N+
Sbjct: 96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNL 152
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 195
++++ KI DFGL++ T V R T+ D++S G ++
Sbjct: 153 AVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209
Query: 196 LEIVSGRT 203
E+++G+T
Sbjct: 210 AEMITGKT 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (256), Expect = 7e-27
Identities = 37/190 (19%), Positives = 78/190 (41%), Gaps = 20/190 (10%)
Query: 18 IRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--ILV 75
I + + V VK+L K K+ E+ + N+ N++ L D R LV
Sbjct: 55 INITNNEKVVVKILKPVKK---KKIKREIKILENLR-GGPNIITLADIVKDPVSRTPALV 110
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
++++ N Q R + I + L Y H ++HRD+K N+
Sbjct: 111 FEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNV 160
Query: 136 LLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGV 193
++D ++ ++ D+GL++ + + + + PE + ++ D++S G
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 218
Query: 194 LLLEIVSGRT 203
+L ++ +
Sbjct: 219 MLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-26
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 14/189 (7%)
Query: 21 QDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76
G + A+KVL V+ + + +E + ++ LV LH L+
Sbjct: 50 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTETKLHLIL 108
Query: 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 136
DY+ L L +R +F + + I L ++H+ +++RDIK NIL
Sbjct: 109 DYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENIL 161
Query: 137 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVL 194
LD N + ++DFGLSK F + T + GT+ Y+AP+ G + D +S GVL
Sbjct: 162 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221
Query: 195 LLEIVSGRT 203
+ E+++G +
Sbjct: 222 MYELLTGAS 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 2e-24
Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 12/189 (6%)
Query: 18 IRLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75
+ G VAVK LS +S K E+ + ++ HEN++ L
Sbjct: 38 FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFTPARSLEEF 95
Query: 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 135
D L L + K + +I I RGL YIH ++HRD+K SN+
Sbjct: 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNL 152
Query: 136 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVL 194
++++ KI DFGL++ + T T Y APE ++ + D++S G +
Sbjct: 153 AVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 195 LLEIVSGRT 203
+ E+++GRT
Sbjct: 209 MAELLTGRT 217
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 2e-23
Identities = 44/211 (20%), Positives = 85/211 (40%), Gaps = 22/211 (10%)
Query: 18 IRLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI------DG 69
VA+K LS +++ K E+ M VN H+N++ L +
Sbjct: 37 YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKTLEEF 94
Query: 70 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 129
LV + M N + + + + ++ + G+ ++H ++HRD
Sbjct: 95 QDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRD 144
Query: 130 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 189
+K SNI++ + KI DFGL++ + T T Y APE + D++
Sbjct: 145 LKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIW 202
Query: 190 SFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 220
S G ++ E+V + + +++ V +
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.5 bits (223), Expect = 5e-22
Identities = 46/237 (19%), Positives = 91/237 (38%), Gaps = 29/237 (12%)
Query: 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 70
V LA + + T VA+K++ K + E+ + VN + K +
Sbjct: 28 TVWLA--KDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVN--DADNTKEDSMGANHI 82
Query: 71 CRIL-VYDYMPNNSLSQTLLGEE-----------KRRAKFGWKARREIIMGIGRGLAYIH 118
++L +++ N + ++ E ++I + GL Y+H
Sbjct: 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH 142
Query: 119 EEIQPHVVHRDIKTSNILLDQNFNP------KISDFGLSKLFPENTTHISTRVAGTLGYL 172
+ ++H DIK N+L++ +P KI+D G + + E+ T+ T Y
Sbjct: 143 --RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SIQTREYR 196
Query: 173 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMKLYS 229
+PE + +D++S L+ E+++G + D D + I L
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.0 bits (155), Expect = 3e-13
Identities = 27/144 (18%), Positives = 45/144 (31%), Gaps = 23/144 (15%)
Query: 19 RLQDGTIVAVKVLSVES----------KQGEKEFMSEVASMANVNVCHENLVKLHGGCID 68
+ VK V G+ F + + L KL G +
Sbjct: 20 YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA--IRSARNEFRALQKLQGLAV- 76
Query: 69 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 128
VY + N L + L + K + + E++ I +A + +VH
Sbjct: 77 ----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHG 127
Query: 129 DIKTSNILLDQNFNPKISDFGLSK 152
D+ N+L+ I DF S
Sbjct: 128 DLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 229 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.71 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.94 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=327.80 Aligned_cols=196 Identities=21% Similarity=0.370 Sum_probs=177.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| ++..+|+.||||.++.......+.+.+|+++++.++ ||||+++++++.+++..++||||+++
T Consensus 26 ~~iG~G~fg~Vy~a--~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 26 EKIGQGASGTVYTA--MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp EECCCSSSCEEEEE--EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEecCcCcEEEEE--EECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC--CCCEeeEeEEEEECCEEEEEEEecCC
Confidence 57999999999999 778899999999998766666678999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++ ....+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++..+..... .
T Consensus 102 g~L~~~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 102 GSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp CBHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CcHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 9999987 234699999999999999999999999 999999999999999999999999999987644322 2
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 3456799999999999999999999999999999999999999986553
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=324.07 Aligned_cols=197 Identities=30% Similarity=0.447 Sum_probs=176.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+| ++..+|+.||+|++... .....+.+.+|+++++.++ ||||+++++++.+++..++||||
T Consensus 12 ~~iG~G~fg~Vy~~--~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 12 RPLGKGKFGNVYLA--REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCCCcEEEEE--EECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC--CCCCCeEEEEEEECCEEEEEEee
Confidence 57999999999999 77789999999999743 2334567889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..+..++.|+++||+|||++ |++||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~g~L~~~l----~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 88 APLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp CTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred cCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999 5567899999999999999999999999 99999999999999999999999999997654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 211 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence 244679999999999999999999999999999999999999998765433
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=325.45 Aligned_cols=197 Identities=28% Similarity=0.447 Sum_probs=172.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||+| ++..+|+.||||.++... ....+.+.+|+++++.++ ||||+++++++.+++..++||||++
T Consensus 11 ~~lG~G~fg~V~~~--~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 11 QTLGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECC-------CHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEecCcCeEEEEE--EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC--CCCEeeEeeeeccCceeEEEEeccC
Confidence 57999999999999 778899999999997553 334467899999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC-c
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-T 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 159 (229)
+++|.+++ .....+++..+..++.|+++||+|||++ |++||||||+||++++++.+||+|||++....... .
T Consensus 87 gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 87 GGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999998 5667899999999999999999999999 99999999999999999999999999998764332 2
Q ss_pred cccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 23455679999999999988876 578999999999999999999997654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=322.01 Aligned_cols=204 Identities=25% Similarity=0.375 Sum_probs=165.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEc--CCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--~~~~~lv~e 77 (229)
+.||+|+||+||++ ++..+|+.||+|.++... ....+.+.+|++++++++ ||||+++++++.+ ++..|+|||
T Consensus 10 ~~iG~G~fg~Vy~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 10 YTIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC--CTTBCCEEEEEEC----CEEEEEE
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC--CCCEeeEEEEEEeCCCCEEEEEEe
Confidence 57999999999999 778899999999997553 334467889999999999 9999999999865 456799999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI--QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|+++++|.+++.........+++..++.++.|+++||+|||+.. ..+|+||||||+||+++.++.+||+|||++....
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 99999999999666566778999999999999999999999971 0139999999999999999999999999998764
Q ss_pred CCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence 4322 23456789999999999999999999999999999999999999987543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=322.84 Aligned_cols=198 Identities=24% Similarity=0.370 Sum_probs=174.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+| .+..+|+.||||+++.. .....+.+.+|++++++++ ||||+++++++.+++..|+||||
T Consensus 14 ~~lG~G~fg~Vy~a--~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 14 KILGEGSFSTVVLA--RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--HPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--STTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC--CCCeeEEEEEEEECCEEEEEEEc
Confidence 57999999999999 77788999999999754 2334467899999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ ...+.+++..+..++.|++.||+|||+. |++||||||+||++++++.++|+|||++..+....
T Consensus 90 ~~gg~L~~~~----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 90 AKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCCHHHhh----hccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999998 5667899999999999999999999999 99999999999999999999999999998764332
Q ss_pred -ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 -THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 2233456799999999999999999999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=322.66 Aligned_cols=200 Identities=22% Similarity=0.339 Sum_probs=176.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| ++..+|+.||+|+++.......+.+.+|+++++.++ ||||+++++++.+++..++||||+++
T Consensus 18 ~~iG~G~fg~Vy~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 18 GELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEeeCCCcEEEEE--EECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 57999999999999 778899999999998776677788999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|+++||.|||++ |++||||||+||+++.++.+||+|||++....... ..
T Consensus 94 g~L~~~~~---~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 94 GAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 99999873 3456799999999999999999999999 99999999999999999999999999987543221 12
Q ss_pred cccccCCccccCccccc-----cCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 162 STRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||......+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 23467999999999884 4568899999999999999999999998765433
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=328.37 Aligned_cols=194 Identities=24% Similarity=0.378 Sum_probs=173.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||++ ++..+|+.||+|+++... ......+.+|+.+++.++ ||||++++++|.+++..++||||++
T Consensus 12 ~~iG~G~fg~V~~~--~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 12 SELGAGNGGVVFKV--SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEECCSSCCEEEE--EETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC--CTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEecCCCeEEEEE--EECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEEcCC
Confidence 57999999999999 778899999999998653 333467899999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
+++|.+++ .....+++..+..++.|+++||.|||+ + ||+||||||+||+++.++.+||+|||++......
T Consensus 88 gg~L~~~l----~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 88 GGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp TEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 99999999 455679999999999999999999996 6 8999999999999999999999999999865332
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2244689999999999999999999999999999999999999998654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=323.69 Aligned_cols=199 Identities=28% Similarity=0.319 Sum_probs=178.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+| ++..+|+.||+|+++.. .....+.+.+|+.+++.++ ||||+++++++.+....|+||||
T Consensus 11 ~~lG~G~fg~V~~~--~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 11 KLLGKGTFGKVILV--REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCcCeEEEEE--EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC--CCCEEEEEeeeccccccccceec
Confidence 57999999999999 77889999999999754 2334577889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+++++|.+++ .....+++..++.++.|++.||+|||++ |++||||||+||+++++|.+||+|||++.......
T Consensus 87 ~~gg~L~~~~----~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 87 ANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cCCCchhhhh----hcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999998 5667899999999999999999999999 99999999999999999999999999998654332
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 23345679999999999999999999999999999999999999998876443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-51 Score=320.38 Aligned_cols=195 Identities=27% Similarity=0.438 Sum_probs=176.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+| ++..+|+.||||+++.. .....+.+.+|+.+++.++ ||||+++++++.+++..++||||
T Consensus 10 ~~lG~G~fg~Vy~a--~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 10 RTLGTGSFGRVHLI--RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--HPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--BTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEecCcCcEEEEE--EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc--CcChhheeeeEeeCCeeeeEeee
Confidence 57999999999999 77889999999999754 2334577889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++|++|..++ .....+++..+..++.|++.||+|||++ |++||||||+||+++.+|.+||+|||++......
T Consensus 86 ~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 86 IEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred cCCccccccc----cccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999988 6777889999999999999999999999 9999999999999999999999999999876443
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 207 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH
Confidence 23467999999999999999999999999999999999999999876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=309.94 Aligned_cols=191 Identities=26% Similarity=0.394 Sum_probs=167.1
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEc----CCceEEEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVY 76 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~----~~~~~lv~ 76 (229)
.||+|+||+||+| ++..+++.||+|.+... .....+.+.+|++++++++ ||||+++++++.+ +...++||
T Consensus 16 ~iG~G~fg~Vy~~--~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 16 EIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEECSSEEEEEE--EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEecCcCcEEEEE--EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEeeccccCCEEEEEE
Confidence 5999999999999 77788999999999754 3334567889999999999 9999999999875 34578999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEc-CCCceEEeccccccc
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLD-QNFNPKISDFGLSKL 153 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~ni~~~-~~~~~~l~dfg~~~~ 153 (229)
||+++++|.+++ .....+++..+..++.|+++||+|||++ + ++||||||+||+++ +++.+||+|||++..
T Consensus 92 E~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHH----hccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999 4567899999999999999999999998 7 99999999999996 578999999999976
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 165 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 43322 244679999999998865 5899999999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-51 Score=319.38 Aligned_cols=196 Identities=24% Similarity=0.384 Sum_probs=159.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||+| ++..+|+.||||++.... ......+.+|+++++.++ ||||+++++++.+++..++||||++
T Consensus 15 ~~lG~G~fg~Vy~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 15 DVLGTGAFSEVILA--EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK--HPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EESBSGGGGGEEEE--EETTTCCEEEEEEEEC----------CHHHHHHHTCC--CTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEeeccCeEEEEE--EECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEeccC
Confidence 46999999999999 777889999999997553 333456789999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc---CCCceEEeccccccccCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~---~~~~~~l~dfg~~~~~~~~ 157 (229)
|++|.+++ .....+++..+..++.|++.||+|||+. |++||||||+||++. +++.+||+|||++......
T Consensus 91 gg~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 91 GGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp SCBHHHHH----HTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCcHHHhh----hcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999999 5667899999999999999999999999 999999999999994 5788999999999765432
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 2 22346799999999999999999999999999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-50 Score=322.51 Aligned_cols=198 Identities=22% Similarity=0.322 Sum_probs=177.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| ++..+|+.||||+++.......+.+.+|+++++.++ ||||++++++|.+++..++||||+++
T Consensus 35 ~~lG~G~fg~V~~a--~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 35 EELGSGAFGVVHRC--VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--STTBCCEEEEEECSSEEEEEEECCCC
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 57999999999999 778899999999998766666678889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc--CCCceEEeccccccccCCCCc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~--~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++|.+.+. ....++++..++.++.|++.||+|||+. |++||||||+||+++ .++.++|+|||++.......
T Consensus 111 g~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 111 GELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred ChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 99998872 3455799999999999999999999999 999999999999997 67899999999998765432
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 234457899999999999999999999999999999999999999876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-50 Score=318.21 Aligned_cols=193 Identities=24% Similarity=0.384 Sum_probs=171.0
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+| ++..+|+.||||+++.... ...+.+.+|++++++++ ||||+++++++.+++..++||||
T Consensus 21 ~~lG~G~fg~Vy~a--~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 21 REIGHGSFGAVYFA--RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEECSSSEEEEE--EETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCCeEEEEE--EECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC--CCCEeeEEEEEEECCEEEEEEEe
Confidence 57999999999999 7788999999999975532 23366889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
|++++|..+. ....++++..+..++.|+++||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 97 CLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp CSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred cCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999997766 4567899999999999999999999999 999999999999999999999999999976533
Q ss_pred ccccccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 234579999999999864 4588999999999999999999999986543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-50 Score=320.87 Aligned_cols=198 Identities=23% Similarity=0.360 Sum_probs=176.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| ++..+|+.||||++........+.+.+|+.+++.++ ||||+++++++.+++..++||||+++
T Consensus 32 ~~lG~G~fg~Vy~~--~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 32 EELGTGAFGVVHRV--TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEETTEEEEEE--EETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC--CTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred EEEecCcCeEEEEE--EECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 56999999999999 778899999999998666666678999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEc--CCCceEEeccccccccCCCCc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~--~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++|.+++. .....+++..+..++.|++.||.|||++ |++||||||+||+++ .++.+||+|||++..+.....
T Consensus 108 g~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 108 GELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 99999882 3456799999999999999999999999 999999999999995 467899999999987654322
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 24467899999999999999999999999999999999999999876443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-50 Score=320.11 Aligned_cols=194 Identities=25% Similarity=0.353 Sum_probs=175.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+| ++..+|+.||||+++.. .....+.+.+|+.+++.++ ||||+++++++.+....++||||
T Consensus 47 ~~lG~G~fg~Vy~a--~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 47 KTLGTGSFGRVMLV--KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--FPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeecCcCcEEEEE--EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC--CCcEeeccccccccccccccccc
Confidence 57999999999999 77889999999999743 2333467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+.+++|.+++ .....+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++..+...
T Consensus 123 ~~~g~l~~~l----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 123 VAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccchhhhH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999998 4556899999999999999999999999 9999999999999999999999999999876433
Q ss_pred ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 2346799999999999999999999999999999999999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=313.49 Aligned_cols=202 Identities=27% Similarity=0.365 Sum_probs=171.3
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||+|.+....+++.||||.++.. .....+.+.+|++++++++ ||||+++++++.++ ..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC--CTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC--CCCCceEEEEeccC-CEEEEEEcC
Confidence 369999999999997666667789999999754 2333467999999999999 99999999998654 578999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++|+|.+++ .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 90 ~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 90 ELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TTEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999998 5667899999999999999999999999 999999999999999999999999999987644322
Q ss_pred c--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccc
Q 027015 160 H--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 213 (229)
Q Consensus 160 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~ 213 (229)
. ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~ 219 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH
Confidence 2 2234568899999999999999999999999999999997 8999987654433
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=310.77 Aligned_cols=201 Identities=27% Similarity=0.394 Sum_probs=171.4
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
.||+|+||+||+|.+....++..||||.++... ....+.+.+|++++++++ ||||+++++++.++ ..++||||+++
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~-~~~lvmE~~~~ 92 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQAE-ALMLVMEMAGG 92 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC--CCCEeeEeeeeccC-eEEEEEEeCCC
Confidence 389999999999966556667789999997553 344578999999999999 99999999998754 58899999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc-
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH- 160 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 160 (229)
|+|.+++. ..+..+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||++..+......
T Consensus 93 g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 93 GPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 99999872 4456799999999999999999999999 9999999999999999999999999999876543222
Q ss_pred -ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 161 -ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 161 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
......||+.|+|||++.+..++.++||||+|+++||+++ |+.||......+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~ 220 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence 2234568899999999998999999999999999999998 999998765443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-50 Score=311.57 Aligned_cols=195 Identities=28% Similarity=0.397 Sum_probs=172.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| +...+|+.||||.++.+ ....+.+.+|+++++.++ ||||+++++++.+++..++||||+++
T Consensus 23 ~~iG~G~fg~Vy~a--~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 23 HKLGGGQYGEVYEG--VWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp EETTTTTTSSEEEE--EEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeCCCeEEEEE--EECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCC--CCCEecCCccEeeCCeeEEEeecccC
Confidence 46999999999999 66778999999998744 334567999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|.+++.. .....+++..+..++.|+++||+|||++ |++||||||+||++++++.+||+|||++..........
T Consensus 98 g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 98 GNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp CBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999999832 2446789999999999999999999999 99999999999999999999999999998765554444
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCccc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
.....|++.|+|||.+.+..++.++||||+|+++|+|++|..||.
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 444568889999999999999999999999999999999766554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=308.32 Aligned_cols=196 Identities=29% Similarity=0.480 Sum_probs=160.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++. ..+++.||||.++.. ....+.+.+|+++++.++ ||||+++++++.+++..++||||+++
T Consensus 11 ~~iG~G~fg~Vy~~~---~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 11 QEIGSGQFGLVHLGY---WLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEECCSSCCEEEEE---ETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEEeeCCCeEEEEEE---ECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcC--CCCcccccceeccCCceEEEEEecCC
Confidence 579999999999993 346788999999754 334567999999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
++|.+++. .....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++..........
T Consensus 85 g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 85 GCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999883 4456789999999999999999999999 99999999999999999999999999998765443333
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~ 209 (229)
.....||+.|+|||++.+..++.++||||+|+++|||++ |++||....
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence 344668999999999999999999999999999999999 566666544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=309.33 Aligned_cols=198 Identities=23% Similarity=0.317 Sum_probs=174.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc------hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||+||+| ++..+|+.||||+++.... ...+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus 16 ~~lG~G~fg~Vy~~--~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 16 EELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEECSSEEEEEE--EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEE
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEE
Confidence 56999999999999 7778999999999975421 22467899999999999 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKISDFGLS 151 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~----~~~l~dfg~~ 151 (229)
|||+++++|.+++ .....+++..++.++.|+++||+|||+. +++||||||+||+++.++ .+||+|||++
T Consensus 92 ~E~~~gg~L~~~i----~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 92 LELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEcCCCccccchh----ccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999 4556899999999999999999999999 999999999999998776 4999999999
Q ss_pred cccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 152 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
....... ......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+
T Consensus 165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 223 (293)
T d1jksa_ 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223 (293)
T ss_dssp EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence 8764432 2244568999999999999999999999999999999999999998765433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-49 Score=316.49 Aligned_cols=202 Identities=25% Similarity=0.322 Sum_probs=171.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc---chhhHHHHHH---HHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES---KQGEKEFMSE---VASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e---~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||+||+| ++..+|+.||||++.... ......+.+| +..++.++ ||||+++++++.+++..|+|
T Consensus 10 ~~lG~G~fg~Vy~~--~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~--hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 10 RIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD--CPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEECSSCEEEEE--EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC--CTTBCCEEEEEECSSEEEEE
T ss_pred eEEecCCCeEEEEE--EECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC--CCcEEEEEEEEEECCEEEEE
Confidence 57999999999999 778899999999996432 2222334444 55666666 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||+++++|.+++ .....+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++..+.
T Consensus 86 mE~~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 86 LDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp ECCCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEecCCCcHHHHH----HhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999 5567889999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCccccccccch
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 217 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 217 (229)
... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||..........+.
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 218 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 432 24457999999999986 567899999999999999999999999876554444333
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=302.31 Aligned_cols=201 Identities=27% Similarity=0.432 Sum_probs=176.8
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccC
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
.+.||+|+||+||++++ .+++.||||.++... ...+.+.+|++.+++++ ||||+++++++.+++..++||||++
T Consensus 9 ~~~iG~G~fg~Vy~~~~---~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~--HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLS--HEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCEETTEEEEEEEE---TTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCC--CTTBCCEEEEECCSSSEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEE---CCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCceEEEEEccC
Confidence 36899999999999943 577899999998543 34568999999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+|+|.+++. .....+++..+..++.|+++||.|||+. |++||||||+||++++++.+||+|||++.........
T Consensus 83 ~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999872 5566789999999999999999999999 9999999999999999999999999999876554444
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 213 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~ 213 (229)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH
Confidence 4445678999999999999999999999999999999998 8999987654433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=310.96 Aligned_cols=199 Identities=26% Similarity=0.329 Sum_probs=173.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc---cchhhHHHHHHHHHHh-hhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMA-NVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~~~-~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||+| ++..+|+.||||+++.. .....+.+..|...+. .++ ||||+++++++.+++..|+|||
T Consensus 8 ~~iG~G~fg~Vy~~--~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~--hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 8 KMLGKGSFGKVFLA--EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEECSSSEEEEE--EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT--CTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEecCCCcEEEEE--EECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC--CCcEEEEEEEEccCCceeEEEe
Confidence 57999999999999 77889999999999754 2333455666776655 567 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++|+|.+++ .....+++..+..++.|++.||+|||++ |++||||||+||++++++.++|+|||++......
T Consensus 84 y~~~g~L~~~i----~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 84 YLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp CCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ecCCCcHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999 5667899999999999999999999999 9999999999999999999999999999765433
Q ss_pred CccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 158 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+...
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~ 210 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 2 23345679999999999999999999999999999999999999998765443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-49 Score=309.88 Aligned_cols=201 Identities=26% Similarity=0.441 Sum_probs=161.0
Q ss_pred CccCCcccccccccceEeccCC---cEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDG---TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||+|.+ ..+| ..||||.+... .....+.+.+|++++++++ ||||+++++++.+++..++|||
T Consensus 32 ~~lG~G~fg~Vy~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHL--KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEECSSSEEEEEEE--CC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEeeCCCeEEEEEEE--eCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC--CCCCccEEEEEeeCCEEEEEEE
Confidence 3699999999999943 3343 36899988754 3444567999999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|+++++|.+++. .....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++..+...
T Consensus 108 y~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 108 FMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999883 3456799999999999999999999999 9999999999999999999999999999876443
Q ss_pred Cccc----cccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccc
Q 027015 158 TTHI----STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 212 (229)
Q Consensus 158 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~ 212 (229)
.... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 2211 122457889999999999999999999999999999998 899998765443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=301.58 Aligned_cols=195 Identities=27% Similarity=0.441 Sum_probs=161.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||+++. +..||||+++.. .....+.+.+|++++++++ ||||+++++++. .+..++||||+
T Consensus 14 ~~lG~G~fg~Vy~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~-~~~~~lv~Ey~ 85 (276)
T d1uwha_ 14 QRIGSGSFGTVYKGKW-----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYST-APQLAIVTQWC 85 (276)
T ss_dssp SEEEECSSCEEEEEES-----SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEeeCCCcEEEEEEE-----CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeeeeEEEe-ccEEEEEEecC
Confidence 5799999999999932 246999999754 3445578899999999999 999999999864 45689999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT- 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 158 (229)
++++|.+++. .....+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 86 EGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999983 3446799999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccCCccccCcccccc---CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 223345678999999999864 3578999999999999999999999986543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=302.15 Aligned_cols=196 Identities=30% Similarity=0.418 Sum_probs=167.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+|. ..+++.||||.++... ...+.+.+|++++++++ ||||+++++++.+ +..++||||+++
T Consensus 19 ~~iG~G~fg~Vy~~~---~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 19 ERLGAGQFGEVWMGY---YNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQ--HQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp EEEEEETTEEEEEEE---ETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EEEecCCCcEEEEEE---ECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCC--CCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 469999999999993 3467899999997443 34567999999999999 9999999998754 567999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|.+++.. .....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++..........
T Consensus 92 g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 92 GSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp CBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999998732 2334699999999999999999999999 99999999999999999999999999998876554444
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCC-CcccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~-~pf~~~~ 209 (229)
.....+++.|+|||++.+..++.++||||||+++|+|++|. +||....
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~ 215 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence 45567889999999999889999999999999999999955 5555443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-48 Score=302.58 Aligned_cols=198 Identities=27% Similarity=0.391 Sum_probs=165.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc---hhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----ceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~l 74 (229)
+.||+|+||+||+| ++..+|+.||||+++.... ...+.+.+|+++++.++ ||||+++++++.... ..|+
T Consensus 13 ~~lG~G~fg~Vy~a--~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~--hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 13 EILGFGGMSEVHLA--RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC--CCCCCcccceeeeccCCCceEEE
Confidence 57999999999999 7788999999999975532 23467889999999999 999999999987643 3789
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
||||++|++|.+++ .....+++.++..++.|+++||+|||++ |++||||||+||+++.++..+++|||.+...
T Consensus 89 vmE~~~g~~L~~~~----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEECCCCCEehhhh----cccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999999988 5667899999999999999999999999 9999999999999999999999999988765
Q ss_pred CCCC--ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENT--THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 3322 2233446799999999999999999999999999999999999999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.9e-48 Score=298.08 Aligned_cols=199 Identities=27% Similarity=0.376 Sum_probs=173.7
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch---------hhHHHHHHHHHHhhhccCCCcccccceEEEcCCce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ---------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~ 72 (229)
+.||+|+||+||+| ++..+|+.||||+++..... ..+.+.+|+.+++.++ .||||+++++++.+++..
T Consensus 9 ~~iG~G~~g~V~~~--~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 9 EILGRGVSSVVRRC--IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-GHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEE
T ss_pred eEEecCcCeEEEEE--EECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc-CCCCeEEEEeecccCcce
Confidence 57999999999999 77889999999999754211 2246788999999996 399999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
|+||||+++++|.+++ .....+++..+..++.|+++||+|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 86 ~ivmE~~~~g~L~~~l----~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 86 FLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCchHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999 4567899999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCccccCcccccc------CCCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAIS------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
.+..... .....||+.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.......
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 7654332 344678999999998863 346889999999999999999999999765443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-49 Score=306.74 Aligned_cols=198 Identities=24% Similarity=0.315 Sum_probs=169.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccch-----hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
..||+|+||+||+| ++..+|+.||||+++..... ..+.+.+|+.+++.++ ||||+++++++.+++..++||
T Consensus 4 ~~lG~G~fg~Vy~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 4 DFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEEETTEEEEEE--ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC--CTTBCCEEEEECCTTCCEEEE
T ss_pred eEeccCcCeEEEEE--EECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC--CCCEeEEEeeeccCCceeehh
Confidence 57999999999999 67788999999998654221 1356889999999999 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
||++++++.... .....+++..+..++.|+++||+|||++ |++||||||+||+++.++.+||+|||.+.....
T Consensus 80 E~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 80 DFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp ECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred hhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC
Confidence 999888777665 5667899999999999999999999999 999999999999999999999999999977654
Q ss_pred CCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 157 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 153 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 207 (299)
T d1ua2a_ 153 PNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207 (299)
T ss_dssp CCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred Ccc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH
Confidence 332 2234578999999998874 56799999999999999999999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=305.40 Aligned_cols=197 Identities=15% Similarity=0.264 Sum_probs=173.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| ++..+|+.||+|+++... .+...+.+|+++++.++ ||||+++++++.+++.+|+|||||+|
T Consensus 11 ~~lG~G~fg~Vy~~--~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 11 EDLGRGEFGIVHRC--VETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIAR--HRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSC--CTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred EEEecCCCeEEEEE--EECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEEEecCCC
Confidence 57999999999999 778899999999997553 34456889999999999 99999999999999999999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCC--CceEEeccccccccCCCCc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN--FNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~--~~~~l~dfg~~~~~~~~~~ 159 (229)
++|.+++. .....+++.++..++.|+++||+|||+. |++||||||+||+++.+ ..++|+|||++.......
T Consensus 86 g~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 86 LDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 99999982 2344799999999999999999999999 99999999999999844 479999999998764332
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
......+++.|+|||...+..++.++|+|||||++|+|++|+.||...+..
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~ 209 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence 223456899999999999999999999999999999999999999876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=304.63 Aligned_cols=204 Identities=26% Similarity=0.376 Sum_probs=167.9
Q ss_pred CccCCcccccccccceEecc---CCcEEEEEEeecc-cchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ---DGTIVAVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||+|++.... ....||+|.+... .......+.+|+.++.++ + ||||+++++++.+.+..++||
T Consensus 43 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEE
T ss_pred eEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcC--CCcEeEEEEEEeeCCeEEEEE
Confidence 46999999999999553321 1246999998644 334456789999999998 6 999999999999999999999
Q ss_pred EccCCCCHHHHHhhhhc-------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 027015 77 DYMPNNSLSQTLLGEEK-------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~-------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~ 137 (229)
||+++|+|.+++..... ....+++..+..++.|+++||+|||++ +|+||||||+||++
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill 197 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV 197 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcccc
Confidence 99999999999954321 224689999999999999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccc
Q 027015 138 DQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 210 (229)
Q Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~ 210 (229)
+.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|+|++ |+.||.+...
T Consensus 198 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999765443222 2344567999999999999999999999999999999997 8999987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=304.71 Aligned_cols=193 Identities=22% Similarity=0.312 Sum_probs=165.8
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhh-ccCCCcccccceEEEc----CCceEEEEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHGGCID----GPCRILVYD 77 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~----~~~~~lv~e 77 (229)
.||+|+||+||+| ++..+|+.||||+++. .....+|++++.++ + ||||++++++|.+ +..+|+|||
T Consensus 19 ~lG~G~fg~Vy~a--~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~--hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 19 VLGLGINGKVLQI--FNKRTQEKFALKMLQD-----CPKARREVELHWRASQ--CPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp EEEECSSCEEEEE--EETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTT--STTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EeeeccCeEEEEE--EECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcC--CCCCCeEEEEEeecccCCCEEEEEEE
Confidence 4999999999999 7788999999999862 24567889886555 5 9999999999875 356799999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEecccccccc
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 154 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~~~~ 154 (229)
||+||+|.+++.. .....+++..+..++.|++.||.|||+. |++||||||+||+++. ++.+||+|||++...
T Consensus 90 y~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 90 CLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp CCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeec
Confidence 9999999999931 1235799999999999999999999999 9999999999999975 557999999999876
Q ss_pred CCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 211 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~ 211 (229)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 165 ~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 165 TSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp CCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred cCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 54322 34567999999999999999999999999999999999999999876543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=295.52 Aligned_cols=203 Identities=24% Similarity=0.325 Sum_probs=160.1
Q ss_pred CccCCcccccccccceEec-cCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||+|.+... ..+..||||.++... ....+.+.+|++++++++ ||||+++++++.+ +..++||||+
T Consensus 13 ~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~-~~~~iv~E~~ 89 (273)
T d1mp8a_ 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVITE-NPVWIIMELC 89 (273)
T ss_dssp EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEec-CeEEEEEEec
Confidence 4699999999999954332 234578999986543 333467899999999999 9999999999864 5789999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 90 ~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 90 TLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp TTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 9999999873 4556799999999999999999999999 999999999999999999999999999987654444
Q ss_pred cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 213 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~ 213 (229)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||......+.
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~ 218 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH
Confidence 44455668899999999999999999999999999999997 8999987665443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=294.13 Aligned_cols=197 Identities=25% Similarity=0.410 Sum_probs=159.4
Q ss_pred CccCCcccccccccceEeccC--CcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD--GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
+.||+|+||+||+|.+..... ...||||.++... ......+.+|++++++++ ||||+++++++.+....++||||
T Consensus 13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSEEEEEEC
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC--CCCEeeeeEEEecCCceEEEEEe
Confidence 469999999999995533211 2479999997553 334467889999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
++++++.+.+. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 91 MENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp CTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred cccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 99999998872 4556799999999999999999999999 99999999999999999999999999998764332
Q ss_pred c--cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCccc
Q 027015 159 T--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 159 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
. .......||+.|+|||.+.+..++.++||||||+++|||++|..||.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 2 12233467899999999999999999999999999999999655544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=296.33 Aligned_cols=197 Identities=24% Similarity=0.369 Sum_probs=167.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc--hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||+| ++..+|+.||||+++.... ...+.+.+|++++++++ ||||+++++++.+.+..|+||||+
T Consensus 8 ~~lG~G~fg~Vy~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEecCcCeEEEEE--EECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC--CCcEEEeccccccccceeEEEeec
Confidence 57999999999999 7788999999999975432 23578899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
.++ +.+++. ......+++..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~~-~~~~~~--~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 84 HQD-LKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp SEE-HHHHHH--HTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred CCc-hhhhhh--hhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 655 444441 23456799999999999999999999999 999999999999999999999999999987644332
Q ss_pred cccccccCCccccCccccccCC-CCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 160 HISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......|++.|+|||++.... ++.++|+||+|+++|+|++|+.||...+
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 334457899999999877655 5789999999999999999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=294.59 Aligned_cols=195 Identities=25% Similarity=0.330 Sum_probs=168.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc------hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||+||+| ++..+|+.||||.++.... .....+.+|+.+++.++..||||+++++++.+++..++|
T Consensus 10 ~~lG~G~fg~Vy~a--~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv 87 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87 (273)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence 57999999999999 7788999999999975421 122446789999999986699999999999999999999
Q ss_pred EEccCC-CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-CCceEEeccccccc
Q 027015 76 YDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL 153 (229)
Q Consensus 76 ~e~~~~-~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-~~~~~l~dfg~~~~ 153 (229)
||++.+ +++.+++ .....+++..++.++.|+++||+|||++ |++||||||+||+++. ++.++|+|||++..
T Consensus 88 ~e~~~~~~~l~~~~----~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 88 LERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCcchHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 999976 5777877 5567899999999999999999999999 9999999999999984 57899999999976
Q ss_pred cCCCCccccccccCCccccCccccccCCC-CCcccchhHHHHHHHHHhCCCcccCc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
..... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 161 ~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 161 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 54332 245679999999999987765 57789999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=294.30 Aligned_cols=196 Identities=30% Similarity=0.434 Sum_probs=159.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||++. . .+++.||||.++.. ....+.+.+|+.++++++ ||||+++++++.+ +..++||||+++
T Consensus 23 ~~iG~G~fg~Vy~~~--~-~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 23 VKLGQGCFGEVWMGT--W-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp EEEEECSSCEEEEEE--E-TTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred eEEeeCCCeEEEEEE--E-CCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcc--cCCEeEEEEEEec-CCeEEEEEecCC
Confidence 469999999999993 3 45578999999744 334567999999999999 9999999999854 567999999999
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCccc
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 161 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (229)
|+|..++.. .....+++..+..++.|++.||+|||++ |++||||||+||+++.++++||+|||++..........
T Consensus 96 g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999998842 2345699999999999999999999999 99999999999999999999999999998765444444
Q ss_pred cccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCc-ccCcc
Q 027015 162 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA-VDFDV 209 (229)
Q Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p-f~~~~ 209 (229)
.....+++.|+|||.+....++.++||||+|+++|+|++|..| |....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~ 219 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC
Confidence 4456789999999999999999999999999999999996555 45443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=297.68 Aligned_cols=205 Identities=25% Similarity=0.392 Sum_probs=167.2
Q ss_pred CccCCcccccccccceEeccCCc----EEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT----IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
+.||+|+||+||+| ....+|+ +||+|.++.. .....+.+.+|++++++++ ||||+++++++.++ ..++++
T Consensus 15 ~~lG~G~fG~Vy~~--~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 15 KVLGSGAFGTVYKG--LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEECSSEEEEEE--EECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC--CTTBCCEEEEEESS-SEEEEE
T ss_pred eEEecCCCeEEEEE--EEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecC-CeeEEE
Confidence 57999999999999 4555555 6888888643 3445678999999999999 99999999999875 567888
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
+++.+++|.+.+. .....+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 90 e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 9999999998873 4567899999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcc-ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccccch
Q 027015 157 NTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV 217 (229)
Q Consensus 157 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~~~~ 217 (229)
.... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||+.....+....+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 3322 2233468999999999999999999999999999999998 89999876554443333
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-46 Score=291.97 Aligned_cols=206 Identities=30% Similarity=0.381 Sum_probs=172.1
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeecccch-hhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||+|++.. ..+++.||||.++..... ..+.+.+|++++++++ ||||+++++++.+.+..+++||
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC--CCCcccceeeeccCCceEEEEE
Confidence 469999999999996643 346789999999765433 3567999999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh--------------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 027015 78 YMPNNSLSQTLLGEE--------------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 137 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~--------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~ 137 (229)
|+++++|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEE
Confidence 999999999985321 1223588999999999999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCCCC-ccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCC-CcccCccccc
Q 027015 138 DQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVDFDVQLG 212 (229)
Q Consensus 138 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~-~pf~~~~~~~ 212 (229)
+.++.+||+|||++..+.... ........+++.|+|||.+.+..++.++||||||+++|||++|. +||......+
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 999999999999997654332 22234456889999999999999999999999999999999985 6787765443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=290.93 Aligned_cols=199 Identities=26% Similarity=0.373 Sum_probs=164.9
Q ss_pred CccCCcccccccccceEeccC-CcEEEEEEeeccc--chhhHHHHHHHHHHhhhcc-CCCcccccceEEEc-----CCce
Q 027015 2 ASVGPIRLEKVDLAPFIRLQD-GTIVAVKVLSVES--KQGEKEFMSEVASMANVNV-CHENLVKLHGGCID-----GPCR 72 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~-~~~~i~~~~~~~~~-----~~~~ 72 (229)
+.||+|+||+||+| ++..+ ++.||||+++... ........+|+.+++.+.. .||||++++++|.. ....
T Consensus 13 ~~LG~G~fg~V~~a--~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~ 90 (305)
T d1blxa_ 13 AEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 90 (305)
T ss_dssp EEEEEETTEEEEEE--EETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred EEEecccCeEEEEE--EEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceE
Confidence 57999999999999 66555 6679999997543 2233456778888777632 29999999999853 2467
Q ss_pred EEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 027015 73 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 152 (229)
Q Consensus 73 ~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~ 152 (229)
++++|+++++++.... ......+++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+|||.+.
T Consensus 91 ~~~~e~~~~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 91 TLVFEHVDQDLTTYLD---KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEECCSCBHHHHHH---HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEEeccCCchhhhh---hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 8999999887765544 24567799999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 153 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
..... .......||+.|+|||++.+.+++.++|||||||++|+|++|+.||...+.
T Consensus 165 ~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 165 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 54322 233556799999999999999999999999999999999999999987653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=287.91 Aligned_cols=204 Identities=25% Similarity=0.330 Sum_probs=160.6
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-CceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-~~~~lv~ 76 (229)
+.||+|+||+||+|.+.. ..+++.||||.++.. .....+.+.+|...+.++. +|+||+.+++++... ...++||
T Consensus 19 ~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~-~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTSCCEEEE
T ss_pred eEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc-CCCeEEEeeeeeccCCCeEEEEE
Confidence 469999999999996543 335678999999754 3344567788888888875 388999999987654 4679999
Q ss_pred EccCCCCHHHHHhhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceE
Q 027015 77 DYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 144 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~ 144 (229)
||+++++|.+++..... ....+++..+..++.|+++||+|||++ +++||||||+||++++++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEE
Confidence 99999999999954322 234589999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhC-CCcccCcc
Q 027015 145 ISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDV 209 (229)
Q Consensus 145 l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g-~~pf~~~~ 209 (229)
|+|||++........ .......||+.|+|||.+.+..++.++||||+||++|+|++| +.||....
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 999999976543322 223456789999999999999999999999999999999986 56887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=285.78 Aligned_cols=201 Identities=25% Similarity=0.382 Sum_probs=160.1
Q ss_pred CccCCcccccccccceEecc-CCcEEEEEEeecc---cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||+|++.... .+..||||.++.. .....+.+.+|+++++.++ ||||+++++++.++ ..++|||
T Consensus 14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~~~g~~~~~-~~~lv~e 90 (273)
T d1u46a_ 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVLTP-PMKMVTE 90 (273)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSS-SCEEEEE
T ss_pred EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEeec-chheeee
Confidence 56999999999999653322 2347899998754 3334567899999999999 99999999999764 6789999
Q ss_pred ccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCC
Q 027015 78 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~ 157 (229)
|++++++.+++. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 91 LAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CCTTCBHHHHHH---HHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eecCcchhhhhh---cccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 999999999873 4456799999999999999999999999 9999999999999999999999999999876443
Q ss_pred Ccc--ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 158 TTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 158 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 222 2233457789999999999999999999999999999998 89999865433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-45 Score=286.91 Aligned_cols=197 Identities=23% Similarity=0.339 Sum_probs=167.2
Q ss_pred CCccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEc
Q 027015 1 MASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 78 (229)
Q Consensus 1 ~~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (229)
++.||+|+||+||+|+ + .+|+.||||+++... ....+.+.+|+.+++.++ ||||+++++++.+++..++++|+
T Consensus 7 ~~~iG~G~fg~Vy~~~--~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQ--N-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp EEEEEEETTEEEEEEE--E-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC--CTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccEEecCCCcEEEEEE--e-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC--CCcEEeeeeecccCCceeEEEEe
Confidence 3679999999999993 3 478999999997553 223578999999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCC
Q 027015 79 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 158 (229)
Q Consensus 79 ~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 158 (229)
+.++.+..+. .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9877777666 5678899999999999999999999999 99999999999999999999999999998764432
Q ss_pred ccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 159 THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 2 22344688999999998754 568999999999999999999999986543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=286.84 Aligned_cols=209 Identities=26% Similarity=0.391 Sum_probs=169.1
Q ss_pred CccCCcccccccccceEec-----cCCcEEEEEEeecccc-hhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL-----QDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||.||+|+.... .++..||||.++.+.. .....+.+|...+.++. +||||+++++++.+++..++|
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc-CCCeEEecccccccCCeEEEE
Confidence 5699999999999955332 2345799999976543 34477888999988883 299999999999999999999
Q ss_pred EEccCCCCHHHHHhhhh------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 76 YDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
|||+++|+|.+++.... .....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCe
Confidence 99999999999995432 1235689999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCccccccc
Q 027015 144 KISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEY 214 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~~~~ 214 (229)
||+|||.+........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........+
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999987644322 22344668899999999999999999999999999999998 79999876544433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=283.22 Aligned_cols=193 Identities=29% Similarity=0.446 Sum_probs=158.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEc-CCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 80 (229)
+.||+|+||.||++.+ .|+.||||.++.+ ...+.+.+|++++++++ ||||+++++++.+ ++..++||||++
T Consensus 13 ~~lG~G~fg~Vy~~~~----~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 13 QTIGKGEFGDVMLGDY----RGNKVAVKCIKND--ATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEEEECSSCEEEEEEE----TTEEEEEEECCCC--C--HHHHHTHHHHTTCC--CTTBCCEEEEECCC--CCEEEECCCT
T ss_pred EEEecCCCeEEEEEEE----CCeEEEEEEECcH--HHHHHHHHHHHHHHhCC--CCCEeeEEEEEEecCCcEEEEEeccC
Confidence 4699999999999943 5789999999643 33467899999999999 9999999998864 466899999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCcc
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 160 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (229)
+|+|.+++... ....+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 85 ~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 85 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999998422 334689999999999999999999999 9999999999999999999999999998764332
Q ss_pred ccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 161 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 233457889999999999999999999999999999998 78888876443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=291.07 Aligned_cols=203 Identities=28% Similarity=0.381 Sum_probs=174.3
Q ss_pred CccCCcccccccccceEe-ccCCcEEEEEEeecc----cchhhHHHHHHHHHHhhhccCC-CcccccceEEEcCCceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-LQDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-~~~~~~vavK~~~~~----~~~~~~~~~~e~~~~~~l~~~~-~~i~~~~~~~~~~~~~~lv 75 (229)
+.||+|+||+||+|.... ..+|+.||||.++.. .....+.+.+|++++++++ | |||+++++++.+....+++
T Consensus 30 ~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~--h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH--TCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhcc--CCCeEEEeeeeeccCCceeee
Confidence 579999999999995433 446899999998643 2234567889999999998 6 8999999999999999999
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccC
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 155 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~ 155 (229)
|||+.+++|.+++ .....+++..+..++.|++.||+|+|+. +++||||||+||+++.++.++|+|||++..+.
T Consensus 108 ~e~~~~~~L~~~i----~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 108 LDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp ECCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eecccccHHHHHH----HhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999998 5667788999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCccccccccCCccccCccccccC--CCCCcccchhHHHHHHHHHhCCCcccCcccccc
Q 027015 156 ENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213 (229)
Q Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~ 213 (229)
...........|++.|+|||.+.+. .++.++|||||||++|+|++|+.||......+.
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5544445567789999999998754 467899999999999999999999987654443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=289.19 Aligned_cols=197 Identities=25% Similarity=0.312 Sum_probs=163.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCC----ceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~lv~ 76 (229)
+.||+|+||+||+| ++..+|+.||||+++... ....+.+++|+++++.++ ||||+++++++.... ..++++
T Consensus 14 ~~LG~G~fg~Vy~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~--hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 14 SYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EECC---CCCEEEE--EETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC--CTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEeeccCeEEEEE--EECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC--CCCCCcEEEEEeeccccccceEEEE
Confidence 57999999999999 778899999999997543 334567899999999999 999999999987543 234455
Q ss_pred EccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCC
Q 027015 77 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 156 (229)
Q Consensus 77 e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~ 156 (229)
+++.+++|.+++. ...+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+|||++.....
T Consensus 90 ~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 90 THLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 5677999999982 34699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCc--cccccccCCccccCccccc-cCCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 157 NTT--HISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 157 ~~~--~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
... .......|++.|+|||++. +..++.++|+||+||++|+|++|+.||.....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 221 2234567899999999875 55678999999999999999999999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=287.40 Aligned_cols=200 Identities=24% Similarity=0.331 Sum_probs=166.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEc--------CCc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--------GPC 71 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~--------~~~ 71 (229)
+.||+|+||+||+| ++..+|+.||||++... .......+.+|+++++.++ ||||+++++++.. .+.
T Consensus 16 ~~LG~G~fg~Vy~a--~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 16 AKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC--CTTBCCEEEEEEC----------C
T ss_pred EEEecCcCeEEEEE--EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc--CCCccceEeeeecccccccccCce
Confidence 67999999999999 77789999999998654 2334577889999999999 9999999998854 346
Q ss_pred eEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 72 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 72 ~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
.+++||+++++.+.... .....+++..++.++.|+++||.|||+. |++||||||+||+++.++.++|+|||++
T Consensus 92 ~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp EEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 78999999877766555 5667899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc---cccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccccc
Q 027015 152 KLFPENTT---HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 212 (229)
Q Consensus 152 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~ 212 (229)
........ .......||+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~ 229 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence 76643221 122335689999999998754 68999999999999999999999998655433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=287.33 Aligned_cols=202 Identities=27% Similarity=0.375 Sum_probs=166.0
Q ss_pred CccCCcccccccccceEeccCCc--EEEEEEeecc-cchhhHHHHHHHHHHhhh-ccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGT--IVAVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~~~~l-~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||+|.+ ..+|. .||||.++.. .....+.+.+|++++.++ + ||||+++++++.+++..++|||
T Consensus 16 ~~iG~G~fg~Vy~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~--HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 16 DVIGEGNFGQVLKARI--KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp EEEECGGGCEEEEEEE--EETTEEEEEEEEEEECC------CHHHHHHHHHTTCCC--CTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEeeCCCcEEEEEEE--CCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccC--CCCEeeEEEEEecCCeeEEEEE
Confidence 4699999999999944 44555 4778887543 344557799999999998 6 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhh------------hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 027015 78 YMPNNSLSQTLLGE------------EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 145 (229)
Q Consensus 78 ~~~~~sL~~~~~~~------------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l 145 (229)
|+++|+|.+++... ......+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999998543 13446799999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCC-CcccCccccc
Q 027015 146 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVDFDVQLG 212 (229)
Q Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~-~pf~~~~~~~ 212 (229)
+|||++....... ......+|..|+|||.+.+..++.++||||||+++|+|++|. +||...+..+
T Consensus 169 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~ 234 (309)
T d1fvra_ 169 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234 (309)
T ss_dssp CCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999987543322 223456889999999999999999999999999999999965 6787655433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=289.05 Aligned_cols=192 Identities=27% Similarity=0.382 Sum_probs=161.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCC------ceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------CRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~------~~~ 73 (229)
+.||+|+||+||+| ++..+|+.||||+++.. .....+.+.+|+++++.++ ||||++++++|...+ .++
T Consensus 24 ~~lG~G~fg~V~~~--~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSA--VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEC------CEEEE--EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--BTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC--CCCeeEEEEEeccCccccccceEE
Confidence 57999999999999 77889999999999754 3334567889999999999 999999999997654 569
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||+ +.+|.... ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.++++|||.+..
T Consensus 100 lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence 999999 67777766 345799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... .....+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||...+.
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 6433 234578999999999876 4568999999999999999999999987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-44 Score=281.12 Aligned_cols=200 Identities=20% Similarity=0.222 Sum_probs=169.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 81 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (229)
+.||+|+||+||+| ++..+|+.||||+++... ....+.+|++.++.+. .+++++.+++++..+...++|||++ +
T Consensus 11 ~~iG~G~fG~Vy~a--~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 11 RRIGEGSFGVIFEG--TNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA-GCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEECSSCEEEEE--EETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTT-TCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhc-CCCCCCEEEEEeecCCccEEEEEec-C
Confidence 57999999999999 778899999999986442 2345778889998887 2589999999999999999999999 7
Q ss_pred CCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC-----CCceEEeccccccccCC
Q 027015 82 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-----NFNPKISDFGLSKLFPE 156 (229)
Q Consensus 82 ~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~-----~~~~~l~dfg~~~~~~~ 156 (229)
++|.+++. .....++...+..++.|++.+|++||++ |++||||||+||+++. ++.++|+|||++.....
T Consensus 85 ~~l~~~~~---~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 85 PSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred CCHHHHHH---hhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 89998883 3445799999999999999999999999 9999999999999964 57799999999987643
Q ss_pred CCc------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccccc
Q 027015 157 NTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 213 (229)
Q Consensus 157 ~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~ 213 (229)
... .......||+.|+|||++.+..++.++|+||||+++|+|++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~ 221 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence 221 123346799999999999999999999999999999999999999986554433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=281.45 Aligned_cols=198 Identities=25% Similarity=0.377 Sum_probs=165.9
Q ss_pred ccCCcccccccccceEecc-CCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEc-CCceEEEEEcc
Q 027015 3 SVGPIRLEKVDLAPFIRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVYDYM 79 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 79 (229)
.||+|+||+||+|.+.... ....||||.++.. .....+++.+|++++++++ ||||+++++++.+ ++..++||||+
T Consensus 34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC--CTTBCCCCEEEEETTTEEEEEEECC
T ss_pred EEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC--CCCEeEEeEEEEecCCceEEEEEEe
Confidence 5899999999999543322 2236899999743 4445578999999999999 9999999999865 56789999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
++++|.+++. .....+++..+..++.|++.||.|+|+. +++||||||+||++++++.+||+|||++........
T Consensus 112 ~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999883 4555678889999999999999999999 999999999999999999999999999987643322
Q ss_pred ---cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 160 ---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 160 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
.......||+.|+|||.+....++.++||||||+++|||++|..||...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 1223356889999999999999999999999999999999988887654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=283.76 Aligned_cols=209 Identities=24% Similarity=0.315 Sum_probs=174.9
Q ss_pred CccCCcccccccccceEec---cCCcEEEEEEeecc-cchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRL---QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||+||+|.+... .+++.||||.++.. .......+.+|++++++++ ||||+++++++......++|||
T Consensus 26 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC--CTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC--CCCEeeeeeEEecCCceeEEEe
Confidence 5699999999999976543 34678999999754 3334466889999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 027015 78 YMPNNSLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 151 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~ 151 (229)
|+++|+|.+++.... .....+++..+..++.|+++||.|||+. +++||||||+||++++++++||+|||++
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla 180 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccc
Confidence 999999999985432 1224578999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhC-CCcccCcccccccc
Q 027015 152 KLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQLGEYH 215 (229)
Q Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g-~~pf~~~~~~~~~~ 215 (229)
........ .......+++.|+|||.+.+..++.++|+||+|+++|+|++| +.||......+...
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 86644322 223445688999999999999999999999999999999998 57887765444443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=282.96 Aligned_cols=206 Identities=24% Similarity=0.360 Sum_probs=173.4
Q ss_pred CccCCcccccccccceEe---ccCCcEEEEEEeeccc-chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR---LQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 77 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e 77 (229)
+.||+|+||.||+|.+.. ..+++.||||.++... ......+.+|+..++.+. +||||+++++++.+.+..+++||
T Consensus 29 ~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc-CCCCEEEEEEEEeeCCEEEEEEE
Confidence 469999999999996543 4567899999997653 334467889999999993 39999999999999999999999
Q ss_pred ccCCCCHHHHHhhhh--------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 78 YMPNNSLSQTLLGEE--------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 78 ~~~~~sL~~~~~~~~--------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
|+++++|.+++.... .....+++..+..++.|+++|++|||++ +++||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcc
Confidence 999999999985432 1334699999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCc-cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHh-CCCcccCcccc
Q 027015 144 KISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 211 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~pf~~~~~~ 211 (229)
+++|||.+........ .......||+.|+|||.+.+..++.++||||||+++|+|++ |++||......
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999987654332 23344678999999999999999999999999999999998 66677665443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=286.21 Aligned_cols=195 Identities=26% Similarity=0.309 Sum_probs=162.2
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC------CceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~------~~~~lv 75 (229)
+.||+|+||+||+| ++..+|+.||||+++.+.. ...+|++++++++ ||||++++++|... ...++|
T Consensus 26 k~LG~G~fg~Vy~a--~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~--h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQA--KLCDSGELVAIKKVLQDKR----FKNRELQIMRKLD--HCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEETTEEEEEE--EETTTCCEEEEEEEECCSS----SCCHHHHHHHHCC--CTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred eEEeeCcCeEEEEE--EECCCCCEEEEEEECccch----HHHHHHHHHHhcC--CCCCCcEEEEEEecCccCCceEEEEE
Confidence 56999999999999 7788999999999975432 2347999999998 99999999998543 346899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEecccccccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLF 154 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~ 154 (229)
|||++++ +.+.+.........+++..++.++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||++...
T Consensus 98 ~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999765 4444433335667899999999999999999999999 999999999999998765 8999999999876
Q ss_pred CCCCccccccccCCccccCcccccc-CCCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.....
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 4432 2234578999999998775 5689999999999999999999999987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=279.93 Aligned_cols=193 Identities=28% Similarity=0.382 Sum_probs=154.6
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHH--HHHHHhhhccCCCcccccceEEEcCC----ceEEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMS--EVASMANVNVCHENLVKLHGGCIDGP----CRILV 75 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~~~~l~~~~~~i~~~~~~~~~~~----~~~lv 75 (229)
..||+|+||.||+++ .+|+.||||.++... .+...+ |+..+..++ ||||+++++++.+.+ ..++|
T Consensus 9 ~~iG~G~fg~Vy~~~----~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~--HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGK----WRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLR--HENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEEECCSSSEEEEEE----ETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEeeCCCeEEEEEE----ECCEEEEEEEECccc---hhHHHHHHHHHHHhhCC--CCcCcceEEEEEeCCCcceEEEEE
Confidence 368999999999994 268999999997442 233334 444555666 999999999997654 56899
Q ss_pred EEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEEcCCCCCCEEEcCCCceEEecccc
Q 027015 76 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGL 150 (229)
Q Consensus 76 ~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----~~~i~h~di~p~ni~~~~~~~~~l~dfg~ 150 (229)
|||+++++|.+++. ...+++..+..++.|++.+++++|+.. ..|++||||||+||+++.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~-----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999993 346899999999999999999999621 13899999999999999999999999999
Q ss_pred ccccCCCCcc---ccccccCCccccCccccccCC------CCCcccchhHHHHHHHHHhCCCcccCc
Q 027015 151 SKLFPENTTH---ISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSGRTAVDFD 208 (229)
Q Consensus 151 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~i~~~l~~g~~pf~~~ 208 (229)
+......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 9876433211 234467999999999987543 567899999999999999999888653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=274.84 Aligned_cols=193 Identities=20% Similarity=0.330 Sum_probs=169.9
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (229)
+.||+|+||+||+| ++..+|+.||||+++... ......+.+|+.+++.++ ||||+++++++.+....+++++++
T Consensus 8 ~~LG~G~fg~V~~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 8 EKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEECSSSEEEEE--EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEecCcCeEEEEE--EECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC--cCCEEeeccccccccceeEEeeec
Confidence 57999999999999 778899999999997553 334578899999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccccCCCCc
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 159 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 159 (229)
.+++|..+. .....+++..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 84 DQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ccccccccc----ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999988887 5667889999999999999999999999 999999999999999999999999999987654332
Q ss_pred cccccccCCccccCccccccCC-CCCcccchhHHHHHHHHHhCCCccc
Q 027015 160 HISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVD 206 (229)
Q Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~pf~ 206 (229)
......+++.|+|||.+.... ++.++|||||||++|+|++|+.||-
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 223345678899999887654 6899999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-43 Score=274.81 Aligned_cols=201 Identities=20% Similarity=0.270 Sum_probs=162.5
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCc-ccccceEEEcCCceEEEEEccC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILVYDYMP 80 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~-i~~~~~~~~~~~~~~lv~e~~~ 80 (229)
+.||+|+||+||+| ++..+|+.||||++..... ...+..|+++++.++ |++ |..+..++.++...++||||+
T Consensus 13 ~~iG~G~fG~Vy~a--~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~--~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 13 RKIGSGSFGDIYLG--TDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEECSSSEEEEE--EETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHST--TSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeeCCCcEEEEE--EECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHcc--CCCcccEEEEEEecCCEEEEEEEEc-
Confidence 57999999999999 6778899999999875432 345788999999998 665 455555667778888999999
Q ss_pred CCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcC---CCceEEeccccccccCCC
Q 027015 81 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLFPEN 157 (229)
Q Consensus 81 ~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~---~~~~~l~dfg~~~~~~~~ 157 (229)
+++|...+. .....+++..+..++.|++.||+|||++ |++||||||+||+++. +..++|+|||++..+...
T Consensus 86 ~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 566666552 4556899999999999999999999999 9999999999999863 456999999999876443
Q ss_pred Cc------cccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcccccccc
Q 027015 158 TT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 215 (229)
Q Consensus 158 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~~~~~~ 215 (229)
.. .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 21 12344679999999999999999999999999999999999999998765444433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.4e-43 Score=277.37 Aligned_cols=190 Identities=20% Similarity=0.303 Sum_probs=163.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcC--CceEEEEEcc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVYDYM 79 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 79 (229)
+.||+|+||+||+| ++..+|+.||||+++.. ..+.+.+|+++++.++ .||||+++++++... ...++||||+
T Consensus 41 ~~LG~G~fg~V~~a--~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~-~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 41 RKLGRGKYSEVFEA--INITNNEKVVVKILKPV---KKKKIKREIKILENLR-GGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHT-TSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEecCcCeEEEEE--EECCCCCEEEEEEECHH---HHHHHHHHHHHHHhcc-CCCCCcEEEEEEEecCCCceeEEEeec
Confidence 57999999999999 77889999999998743 3467889999999985 399999999999843 5689999999
Q ss_pred CCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccccCCCC
Q 027015 80 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFPENT 158 (229)
Q Consensus 80 ~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~-~~~l~dfg~~~~~~~~~ 158 (229)
++++|.... ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||.+.......
T Consensus 115 ~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 115 NNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred CCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999987653 4699999999999999999999999 999999999999998654 68999999998764432
Q ss_pred ccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 159 THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
......+|+.|+|||.+.+. .++.++|+||+||+++++++|+.||....
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 23445689999999998765 47999999999999999999999997543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=280.53 Aligned_cols=192 Identities=24% Similarity=0.259 Sum_probs=156.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeeccc--chhhHHHHHHHHHHhhhccCCCcccccceEEEc------CCceE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID------GPCRI 73 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~------~~~~~ 73 (229)
+.||+|+||+||+| ++..+|+.||||+++... ......+.+|+.+++.++ ||||++++++|.. ....|
T Consensus 23 ~~LG~G~fg~V~~~--~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 23 KPIGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EECSCC--CEEEEE--EETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EEeecCcCeEEEEE--EECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC--CCCeeEEEEEEecccccccCceeE
Confidence 58999999999999 778899999999997542 334467889999999998 9999999999963 35779
Q ss_pred EEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 74 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 74 lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+||||+.++++. .+ ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.++++|||.+..
T Consensus 99 iv~Ey~~~~l~~-~~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 99 LVMELMDANLCQ-VI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEECCSEEHHH-HH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeccchHHHH-hh------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 999999665444 33 24589999999999999999999999 999999999999999999999999998876
Q ss_pred cCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 154 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
..... ......+|+.|+|||++.+..++.++|+||+||++++|++|+.||.+.+
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 54322 2344568999999999999999999999999999999999999998654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=281.73 Aligned_cols=193 Identities=27% Similarity=0.357 Sum_probs=162.1
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecc--cchhhHHHHHHHHHHhhhccCCCcccccceEEEcC-----CceEE
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRIL 74 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~-----~~~~l 74 (229)
+.||+|+||+||+| ++..+|+.||||+++.. .....+.+.+|+++++.++ ||||+++++++... ...++
T Consensus 24 ~~LG~G~fg~Vy~a--~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 24 SPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EECGGGTTSSEEEE--EETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEecCCCeEEEEE--EECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC--CCCeeeEEEEEeeccccccCceEE
Confidence 57999999999999 77889999999999754 2334567889999999999 99999999998633 34466
Q ss_pred EEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccc
Q 027015 75 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 154 (229)
Q Consensus 75 v~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~~ 154 (229)
+++++.+++|.+++ ....+++..++.++.|++.||+|||++ |++||||||+||+++.++.++++|||.+...
T Consensus 100 i~~~~~gg~L~~~~-----~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 100 LVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEECCSEEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEeecCCchhhhc-----ccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence 67778899999988 335799999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCccccccccCCccccCccccccC-CCCCcccchhHHHHHHHHHhCCCcccCccc
Q 027015 155 PENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 210 (229)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~pf~~~~~ 210 (229)
.. ......|++.|+|||...+. .++.++|+|||||++|+|++|+.||.+.+.
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 32 23445688999999987765 468999999999999999999999987643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-37 Score=246.31 Aligned_cols=197 Identities=21% Similarity=0.244 Sum_probs=155.8
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhcc---------CCCcccccceEEEc--CC
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV---------CHENLVKLHGGCID--GP 70 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~---------~~~~i~~~~~~~~~--~~ 70 (229)
+.||+|+||+||+| ++..+|+.||||+++.+. ...+...+|+.+++.+.. .|+||+++++++.. ..
T Consensus 19 ~~LG~G~fg~Vy~~--~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 95 (362)
T d1q8ya_ 19 RKLGWGHFSTVWLA--KDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 95 (362)
T ss_dssp EEEEECSSEEEEEE--EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEeeCCCeEEEEE--EECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence 57999999999999 778899999999997442 233567788888887761 15789999998864 34
Q ss_pred ceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEEcCCCc------e
Q 027015 71 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFN------P 143 (229)
Q Consensus 71 ~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~~i~h~di~p~ni~~~~~~~------~ 143 (229)
..+++++++.......... .......+++..+..++.|+++||++||+ . ||+||||||+||+++.++. +
T Consensus 96 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccccee
Confidence 5566666664444333221 23566788999999999999999999998 6 9999999999999976543 8
Q ss_pred EEeccccccccCCCCccccccccCCccccCccccccCCCCCcccchhHHHHHHHHHhCCCcccCcc
Q 027015 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 209 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~pf~~~~ 209 (229)
+++|||.+...... .....|++.|+|||++.+..++.++|+||+||++++|++|+.||....
T Consensus 172 kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 172 KIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 99999998765332 244578999999999999999999999999999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=9.4e-26 Score=164.44 Aligned_cols=158 Identities=16% Similarity=0.090 Sum_probs=113.4
Q ss_pred CccCCcccccccccceEeccCCcEEEEEEeecccc------------------hhhHHHHHHHHHHhhhccCCCcccccc
Q 027015 2 ASVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVESK------------------QGEKEFMSEVASMANVNVCHENLVKLH 63 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~~~~l~~~~~~i~~~~ 63 (229)
+.||+|+||+||+| .+ .+|+.||||+++.... ........|...+..+. +++++..+
T Consensus 6 ~~IG~G~~g~Vy~a--~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~v~~~~ 80 (191)
T d1zara2 6 KLMGEGKESAVFNC--YS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--GLAVPKVY 80 (191)
T ss_dssp EEEEECSSEEEEEE--EE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--TSSSCCEE
T ss_pred CEeeeCcceEEEEE--EC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc--CCCcceEE
Confidence 47999999999999 33 5789999998753211 01133456778888888 89988877
Q ss_pred eEEEcCCceEEEEEccCCCCHHHHHhhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEcCCCce
Q 027015 64 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 143 (229)
Q Consensus 64 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni~~~~~~~~ 143 (229)
++. ..+++||++++..+. .++......++.|++.++++||+. |++|+||||+||+++++ .+
T Consensus 81 ~~~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEE----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EE
T ss_pred Eec----CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CE
Confidence 552 247999999875432 234455668899999999999999 99999999999999965 58
Q ss_pred EEeccccccccCCCCccccccccCCccccCcc-----ccccCCCCCcccchhHH
Q 027015 144 KISDFGLSKLFPENTTHISTRVAGTLGYLAPE-----YAISGRLTRKSDVYSFG 192 (229)
Q Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~aPE-----~~~~~~~~~~~Dv~slG 192 (229)
+|+|||.+.....+.... |.... .+..+.++.++|+||+.
T Consensus 142 ~liDFG~a~~~~~~~~~~---------~l~rd~~~~~~~f~r~y~~~~d~~s~~ 186 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWRE---------ILERDVRNIITYFSRTYRTEKDINSAI 186 (191)
T ss_dssp EECCCTTCEETTSTTHHH---------HHHHHHHHHHHHHHHHHCCCCCHHHHH
T ss_pred EEEECCCcccCCCCCcHH---------HHHHHHHHHHHHHcCCCCCcccHHHHH
Confidence 999999987653322111 11110 12246678899999964
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.84 E-value=1.3e-08 Score=75.93 Aligned_cols=74 Identities=12% Similarity=-0.059 Sum_probs=54.7
Q ss_pred ccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCCCHHHHH
Q 027015 10 EKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL 88 (229)
Q Consensus 10 ~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~ 88 (229)
+.||+. ..+++.+++|............+.+|...++.+.. +--+.+++.+..+++..++||++++|.++.+..
T Consensus 28 ~~v~rv----~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~-~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 28 AKVYKL----VGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp SEEEEE----ECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CcEEEE----EeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc-cCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 567765 23567788998876655556678889998888762 333567777778888889999999998876543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.49 E-value=1.7e-07 Score=69.44 Aligned_cols=76 Identities=13% Similarity=-0.008 Sum_probs=52.4
Q ss_pred cCCccc-ccccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEEEccCCC
Q 027015 4 VGPIRL-EKVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 82 (229)
Q Consensus 4 lg~G~~-~~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (229)
+..|.. +.||+. ...++..+++|...... ...+..|.+.++.+....--+.+++.+..+++..++||++++|.
T Consensus 18 ~~~G~s~~~v~r~---~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRL---SAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEE---ECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEE---EeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 444443 567765 45667788999875432 34577888888888733333566777777888889999999887
Q ss_pred CHH
Q 027015 83 SLS 85 (229)
Q Consensus 83 sL~ 85 (229)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.34 E-value=1.8e-06 Score=68.05 Aligned_cols=77 Identities=9% Similarity=-0.016 Sum_probs=47.9
Q ss_pred ccCCcccccccccceEeccCCcEEEEEEeecc-------cchhhHHHHHHHHHHhhhccCCCc-ccccceEEEcCCceEE
Q 027015 3 SVGPIRLEKVDLAPFIRLQDGTIVAVKVLSVE-------SKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRIL 74 (229)
Q Consensus 3 ~lg~G~~~~v~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~~~~l~~~~~~-i~~~~~~~~~~~~~~l 74 (229)
.||.|....||++ ....+++.++||...+. ......+...|.+.++.+...-|. +.+++. .+....++
T Consensus 33 eig~G~~N~vfrV--~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 33 EIGDGNLNYVFHI--YDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp ECCSSSSEEEEEE--EC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EeCCCceEeEEEE--EeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 5888999999987 33445788999976432 111234566788888877632333 444443 35556689
Q ss_pred EEEccCCCC
Q 027015 75 VYDYMPNNS 83 (229)
Q Consensus 75 v~e~~~~~s 83 (229)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.71 E-value=0.00011 Score=55.93 Aligned_cols=137 Identities=15% Similarity=0.076 Sum_probs=75.0
Q ss_pred cccccceEeccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccc-----eEEEcCCceEEEEEccCCCCHH
Q 027015 11 KVDLAPFIRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-----GGCIDGPCRILVYDYMPNNSLS 85 (229)
Q Consensus 11 ~v~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~-----~~~~~~~~~~lv~e~~~~~sL~ 85 (229)
.||++ ...+|+.+++|+.++. ......+..|...+..|...---++..+ ..+...+..+.++++++|..+.
T Consensus 37 ~vy~v---~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 37 RVYQF---QDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp EEEEE---CCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred eeEEE---EcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 46665 5578999999998754 2344567788888888773211111111 1234566778999998765321
Q ss_pred -----HH------H---hhhh-----ccccCCCH----------------------HHHHHHHHHHHHHHHHHh-hcCCC
Q 027015 86 -----QT------L---LGEE-----KRRAKFGW----------------------KARREIIMGIGRGLAYIH-EEIQP 123 (229)
Q Consensus 86 -----~~------~---~~~~-----~~~~~l~~----------------------~~~~~~~~~i~~~l~~lH-~~~~~ 123 (229)
.+ + +... ..+...+. ......+.++...+...- +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 00 0 0000 00011111 112222333333332221 12234
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 124 HVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 124 ~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
+++|+|++|.||+++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999743 46899998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.30 E-value=0.00031 Score=54.88 Aligned_cols=76 Identities=14% Similarity=0.111 Sum_probs=46.7
Q ss_pred CccCCcccccccccceEe-----ccCCcEEEEEEeecccchhhHHHHHHHHHHhhhccCCCcccccceEEEcCCceEEEE
Q 027015 2 ASVGPIRLEKVDLAPFIR-----LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 76 (229)
Q Consensus 2 ~~lg~G~~~~v~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~~~~l~~~~~~i~~~~~~~~~~~~~~lv~ 76 (229)
..|+.|-.-.+|+++... ....+.|++++.. . ........+|..+++.+.. +.-..+++.++.+ .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~-~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSE-RHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHH-TTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHh-CCCCCeEEEEcCC----ceEE
Confidence 346667777778763211 1234678888875 2 2233456788999988872 3334466665532 5899
Q ss_pred EccCCCCH
Q 027015 77 DYMPNNSL 84 (229)
Q Consensus 77 e~~~~~sL 84 (229)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.94 E-value=0.0032 Score=47.18 Aligned_cols=31 Identities=19% Similarity=0.238 Sum_probs=27.1
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 027015 123 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL 153 (229)
Q Consensus 123 ~~i~h~di~p~ni~~~~~~~~~l~dfg~~~~ 153 (229)
.|+||+|+.++|++++.+...-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999887778999998753
|